
(IN-PACKAGE :SP)
(DEFPARAMETER SPARSER::*NS-RD-PHASE3-15601-15900*
  '("A-Cdk2" "A-H" "A-dependent" "A-luc" "A-peak" "A1" "A1459P" "A146T" "A146V"
    "A1519T" "A15T" "A2A" "A4" "A45-B" "A555-EGF" "A6" "A9" "A986T" "AA-mTORC1"
    "AAVS1" "ABCG2-transportable" "ABL-negative" "ABLT315I" "AC-test"
    "AC093850.2" "AC141" "ACCAGATGAGTCAT" "ACTR2" "AD-AR" "ADIPOGen" "ADx"
    "AEBP1" "AECs" "AFAP" "AFAP1-AS1" "AG1522" "AGAP3‐BRAF" "AGC" "AGO" "AG→GC"
    "AH23848" "AIDS-like" "AJCC" "AKAR3EV" "AKT-dependent" "AKT-positive"
    "ALDHA1" "ALK-targeting" "ALLGGEN" "ALLGGEN-PROMO" "ALPHAscreen" "AMPKα"
    "ANLTs" "ANM" "ANRIL" "AOM+DSS" "AP" "AP26113" "APC-status" "APDS1" "APDS2"
    "APKD" "AR+OE" "AR-LBD" "AR-V" "AR-V-activated" "AR-V-driven"
    "AR-V-expressing" "AR-V-mediated" "AR-V-target" "AR-Vs" "AR-Vs." "AR-cDNA"
    "AR-dependent" "AR-null" "AR-positive" "AR-positivity" "AR-status" "ARBSs"
    "ARE-DNA" "ARE-dependent" "ARE-luciferase" "ARE4-luc" "ARE–hPAP" "ARGE"
    "ARLD" "ARN" "ARN-509" "ARP-2" "AR‐positive" "ASC-J9" "ASCO" "ASF1A-Red"
    "ASF2" "ASPM" "AT-RR1" "AT-RR2" "ATARiS" "ATCC" "ATE-i2-b4" "ATG13L"
    "ATG5-12" "ATM-dependence" "ATM-null" "ATM-proficient" "ATP‐binding" "ATS"
    "AUC1.28" "AUG" "AUS" "AV39518" "AVO" "AVOs" "AVi" "Ab1_EGFR" "Ab2_EGFR"
    "AbMed" "AbMed‐Alexa647" "Abankwa" "Abbott" "Abdel" "Abdel-Rahman"
    "Accelrys" "Achilles" "Ackerman" "Ad-Cre" "AdVp3000" "Adair" "Addgene"
    "Affymetrix" "AflIII" "Africa" "African" "African-American" "Africans"
    "Afro-Caribbeans" "Age-related" "Ahafo" "Ahn" "Akt-stimulated" "Akt2"
    "Akt3" "Alberta" "Alexa" "Alexa647" "Alexi" "Alibaba" "AlsoBe" "Alzheimer"
    "Alzheimer's" "Alzheimer’s" "America" "American" "Americans"
    "Amino-terminated" "Amoy" "AmpliSeq" "Amplicons" "Amresco" "Amsterdam"
    "Anderson" "Andreev" "Ann" "Annexin-V–FITC" "AntagomiR-1207" "Apaf"
    "Apicomplexa" "Apr" "Arachis" "Arbelet" "Arg194Trp" "Arg280His" "Arg399Gln"
    "Ariol" "Armstead" "Armstead’s" "Arp" "Arp5" "Arp8" "Arps" "Asian" "Asians"
    "Asta" "Atg8-II" "Auchincloss" "Auerbach" "AutoDockVina" "Autodock"
    "Ax7396" "AxxA" "Azeri" "Azidohomoalanine" "Aβ-oligomers" "B-bound"
    "B-cell-like" "B-cell-like-DLBCL" "B-like" "B-like-DLBCL" "B-luc"
    "B-symptoms" "B1" "B1R" "B2" "B3" "B30–2" "B4" "B6" "BA" "BAG-family"
    "BALB" "BALBk" "BARD1-directed" "BCA" "BCDX2" "BCLC" "BCR-ABL1" "BCR-only"
    "BCSCs" "BCSS" "BD-exposed" "BD-induced" "BD-related" "BFB" "BFB-cycles"
    "BGJ398" "BGL3" "BH3-like" "BH3-mimetic" "BH3-only" "BHK" "BHP10-3SC"
    "BIRC5A" "BIU" "BIU-87" "BJ" "BK‐induced" "BLX" "BLX-254"
    "BM-MSCs-enhanced" "BM-MSCs-increased" "BM-MSCs-induced" "BMICs" "BMIs"
    "BMI " "BMM" "BMMSCs" "BMS" "BMS-5" "BMets" "BNDF" "BP-1–102" "BPAP" "BPAQ"
    "BRA" "BRAC" "BRAC1-associating" "BRAC2" "BRAFmut" "BRATc1" "BRATc2"
    "BRCA1-defective" "BRCT-I" "BRCTa" "BT478" "BT530" "BT549-sh-Twist" "BUB"
    "BUCs" "BUD31-depleted" "BUD31-knockdown" "Ba" "Babinksi" "Background"
    "Balestra" "Ballabio" "Bao" "Barrett" "Barrett's" "Bartlett" "Bartonella"
    "Basel" "Baselga" "Baselga-Escudero" "Batalin" "Bax-PGAM5L-Drp1"
    "Bax-PGAM5S-Drp1" "Bay11-7085" "Bayes" "Bcl" "Bcl-xl" "Bcl2" "Bcl2-over"
    "BcnI" "BeadChip" "Beckwith" "Beckwith-Wiedemann" "Becton"
    "Becton–Dickinson" "Beeghly-Fadiel" "Begg" "Begg’s" "Benjamini"
    "Benjamini-Hochberg" "Benzo" "Berger" "Beuselinck" "Bevazicumab" "Beyotime"
    "Biacore" "BigDye" "Bio-Rad" "BioGRID" "BioID" "BioMark" "BioRad" "BioSune"
    "Biomax" "Biotech" "BirA*-Gag" "Bira" "Bittner" "Blackfan" "Blue-labeled"
    "Bmpr" "Bolivia" "Bonferroni" "Borneo" "Borrmann" "Bosch" "Boyden" "Braak"
    "Bradford" "Bragg" "Brannan" "Brazil" "British"
    "Bronchoconstrictor‐induced" "Brong" "Browser" "Bruch" "Bruch’s" "Bruton"
    "Bruton’s" "Bs‐Ab" "Burandt" "Burk" "Burkitt" "Burkitt's" "Burlingame"
    "C-C" "C-associated" "C-lobe" "C-p80" "C-p89" "C-shaped" "C-statistic"
    "C-ter" "C-terminally" "C-to-N" "C1" "C136S" "C139S" "C17Orf91" "C19MC"
    "C1orf186" "C1–GFP" "C2" "C3" "C3-i" "C3HC4-type" "C3T" "C5" "C6" "C8-i"
    "C9-i" "CA199" "CA19–9" "CA46" "CADD522" "CAP" "CARL" "CATTCC"
    "CATTCC-NNN-CATTCC" "CAU" "CBM" "CCAAT" "CCAAT-enhancer-binding" "CCAT2"
    "CCDC14" "CCDC22" "CCDC88A" "CCDC93" "CCDC97" "CCF" "CCF-NL"
    "CCF-NL-induced" "CCF-NL-treated" "CCF-NLs" "CCFs" "CCGG" "CCNE" "CCNI"
    "CCR" "CCWGG" "CCh" "CCh‐activated" "CCh‐induced" "CD110" "CD14+monocytes"
    "CD18-mediated" "CD235" "CD3+lymphocytes" "CD40L-only" "CD45-negative"
    "CDDO-Ethyl" "CDDO-Im" "CDK2-CyclinE" "CDR1as" "CENPJ" "CENPs" "CEP17"
    "CEP701" "CEP85L-ROS1" "CEP95" "CEU" "CFL2" "CGC" "CH5424802" "CHIL1"
    "CI1040" "CIMP" "CK-positive" "CK1ε" "CKNKRRSGKN" "CL" "CL097"
    "CL1-0-EGFR-L858R" "CL1-0-EGFR-WT" "CLI" "CLI-095" "CLIP-seq" "CMBs" "CNE"
    "COLM" "COLM-6" "COMM" "COMMD2" "COMPARZ" "COMPASS" "CON+AG" "CON+AG→GC"
    "CONCLUSION" "CON→AG" "CON→AG→GC" "CON→GC" "CORO1A" "CORUM" "COS-1"
    "COSM1732508AA" "COSMICv72" "COUP" "COUP-TFs" "COV362" "CP-690550"
    "CP-Tet-ON-miR-497" "CP-Tet-ON-miR-NS" "CPA2" "CPAT" "CPA‐induced" "CRAC1"
    "CREG2" "CRIP1" "CRISPR" "CRPC-relevant" "CRPCa" "CRs" "CSC-like" "CSCCs"
    "CSDE1" "CSL-p53interactions" "CSMD1" "CSWs" "CTCAE" "CTCs" "CTDel1" "CTFG"
    "CTG" "CTLA4‐Ig" "CTLA4‐Ig‐Alexa647" "CTLA‐Ig" "CTNNBIP" "CU" "CWG" "CWG1"
    "CWG10" "CWGs" "CWR22RV1" "CX3CR" "CXCL8-dependent" "CXCR" "CaMKIV"
    "Calalb" "Calbiochem" "Calcusyn" "Canada" "Capuani" "Caribbeans" "Carlsbad"
    "Carlsen" "Carmen" "Carnitine" "Carvalho" "Cary" "Casik" "Castleman"
    "Castro" "Castro-Nallar" "Caucasians" "Caucasions" "Caucasoids" "Cav1"
    "Cbl-dominant-negative" "Cd3δ" "Ce" "CellMask" "CellMiner" "Cep120" "CerS"
    "CerS1–6" "ChIP-on-chip" "ChIP-qPCR" "ChIP-quantitative" "ChIPpeakAnno"
    "ChIP–PCR" "Chang" "Changhai" "Chau" "Cheng" "Chi-square" "Chikumi" "Chile"
    "Choi" "Chopra" "Chou" "Chou-Talalay" "Cip" "Cip1" "Clara" "Clarke" "CldU"
    "Clendenen" "Clinical-pathological" "ClinicalTrials" "Clinico"
    "Clinico-pathological" "ClustalW" "Clínica" "Cnidaria" "Cns-A" "Cns-B"
    "Cntl" "CoIP-IVKA" "Cochran" "Cochrane" "Cofilin2" "Cohen" "Coiled-coil"
    "Coleus" "Coli" "Collet" "Colson" "Compendia" "Concentration‐dependent"
    "Consite" "Contal-O" "Control-FREEC" "Corchane" "Corp" "Cotinus" "Cowden"
    "Cox-model" "Cox-regression" "CpG10" "Cpz" "Cramer" "Cramer's"
    "Cre-recombination" "CreERT" "Cremer" "Cremer’s" "Creu" "Crizo" "Crohn"
    "Crohn’s" "Cross-contamination" "Cross-pathway" "Crot" "Cruciat" "Cruz"
    "Cu-Zn-SOD" "Cui" "Cupid" "Cut-off" "Cxcl14" "CyTOF" "Cyclohexamide"
    "Cyquant" "CytoScan" "Czech" "Cα" "CαH" "CδH" "C " "C‐terminal" "D-allele"
    "D-dimer" "D-loop" "D-loops" "D1-14" "D12D5" "D15-28" "D19S311" "D19S411"
    "D19S929" "D2" "D3" "D4" "D4D6" "D837N" "D9" "DAS28" "DBC" "DBC1-LXRα"
    "DBC1-positivity" "DDSs" "DE557,558AA" "DECMA-1" "DENND1C" "DENND4A" "DG"
    "DHS" "DHSs" "DICE" "DISCUSSION" "DKKI" "DLEU1" "DMARD-naïve" "DME25"
    "DMEM" "DNA-p53" "DNA-protein" "DNA9" "DNA–Topo" "DNA–protein" "DNp73"
    "DNp73s" "DNp73β" "DPQ" "DR-GFP" "DR-U2OS" "DRC-ICP-MS" "DRGFP" "DSAPGS"
    "DSBs" "DSGIS" "DU145-shSIRT3" "DZ" "DZ-Nep" "Daejeon" "Dal" "Dal-Pizzol’s"
    "Danish" "Danvers" "Datoga" "Daura" "David" "Deguchi" "Dendropanax"
    "Denmark" "Deoxynucleotide" "Der-p2" "Desbois-Mouthon" "Desferrioxamine"
    "Deuterostomes" "Dhamacon" "DiPaola" "Dick" "Dickinson" "Dickopf-1" "Diego"
    "Diekstra" "Digitizer" "Dil" "Doebele" "Domenech" "Dominant-negative"
    "Domingo-Domenech" "Doridot" "Doridot’s" "Dose-response" "Dose-responses"
    "Down-modulation" "Downers" "Dox" "Doyle" "DpSGxxpS" "DpT" "Drasin"
    "DsRed-SKL" "DsRed2-tagged" "Dsolv" "Dubrovska" "Dulbecco" "Dulbecco’s"
    "Dusun" "Dutch" "DyeMIX" "E-26-like" "E-3" "E-64d" "E-MTAB-1067" "E-box"
    "E-cadherin-immunonegative" "E-series" "E-twenty-six" "E0771ERB" "E14-E15"
    "E26-transformation" "E3-ligase" "E3-ubiqutin" "E4" "E4A4"
    "E6-ubiquitin-dependent" "E709X" "E746-A750" "E8" "E8-P9" "E9.5" "EACs"
    "EBA" "EBP-δ" "EBPβ" "EBVA" "EC109" "ECCO" "ECF" "ECFP" "ECFs" "ECIS"
    "ECOG" "ECP" "EDAA" "EF-1δ" "EFGR" "EGF-induced" "EGF-like" "EGF-treatment"
    "EGFP-SKL" "EGFP-USP18-transfected" "EGFR-13" "EGFR-14"
    "EGFR-Del-E745-A750" "EGFR-L858-dependent" "EGFR-L858R-specific"
    "EGFR-L858R–dependent" "EGFR-L858R–mutant" "EGFR-L858R–specific"
    "EGFR-L858–dependent" "EGFR-T790M-TKI-resistance" "EGFR-T790M-mutation"
    "EGFR-T790M-positive" "EGFR-copy" "EGFR-mutational" "EGFR-pathway" "EGFR29"
    "EGFR‐arm" "EID" "EKVX" "ELASA" "ELK1-positive" "ELK1-shRNA-expressing"
    "ELK1-short" "EMC" "EMC-D" "EMCA-19" "EMEA" "EMT-reversal" "EMTD" "ENOX1"
    "ENOX2" "ENOX3" "ENSG00000196634" "ENST00000327300" "ENST00000450554"
    "ENST00000504326" "ENST00000582730" "ENaC" "EOCs" "EORTC" "EP1–4" "EPC1-A"
    "EPC1-B" "EPC1-prom-luc" "EPIR" "EPefTS" "ER-Golgi" "ER-Golgi-vesicular"
    "ER-negative" "ER-positive" "ER-to-Golgi" "ERE2F1" "ERFFI1" "ERGO" "ERS"
    "ERα-positivity" "ER‐positive" "ESE" "ESEm" "ESMO" "ESP6500" "ESTRO" "ETGE"
    "ETGF" "ETVs" "EUFA30" "EULAR" "EVOS" "EVs" "EW8" "EZH2ΔSET" "EZHs"
    "Early-stage" "East-West" "Eckardstain" "Ectopic-expression" "Efimov"
    "Egger" "Egger’s" "Egypt" "Eighty-four" "Eighty-one" "Eighty-seven" "Elec"
    "Elmer" "Emilia" "End-stage" "Endocrinology" "Engauge" "Ensembl" "Epas1"
    "Epithelial-mesenchymal" "Epithelial-to-mesenchymal" "Eq" "ErbB"
    "ErbB-family" "ErbB2-EGFR" "ErbB2-dependent" "ErbB2-negative"
    "ErbB2-silenced" "ErbB2–4" "Erk2Q103A" "Erlotinib" "Erp" "Escudero"
    "Eskelinen" "Estonia" "Estonians" "Estradiol-which" "Eukarya" "Euroclone"
    "Europe" "European" "Europeans" "Evans" "Everett" "Ex19" "Ex19Del" "Ex20"
    "Ex20-KI" "Ex20Ins" "Ex9" "Ex9-KI" "Exosomes" "Exprotin5" "Eα" "Eμ"
    "Eμ-driven" "EμMyc" "Eμmyc" "F-FDG" "F1" "F10" "F2" "F3cells" "F5" "F7"
    "FA-J" "FA-patients" "FACScanto" "FAIRE" "FAK‐dependent" "FAK‐independent"
    "FAM171A1" "FARN" "FBJ" "FBW7-substrate" "FCNU" "FDA-US" "FDG-PET" "FDI"
    "FDI-6" "FEPD" "FER1L4" "FERpharma" "FHOSE" "FISSEQ" "FITC-PNA"
    "FITC-lectin" "FL3" "FL393" "FLAG" "FLAG-tag" "FLAIR" "FLI1-dependent"
    "FLI1-induced" "FLMP" "FLT3-ITD" "FLuci" "FMLP" "FMS-like"
    "FMS-like-tyrosine-kinase-3" "FNAs" "FOXA1-co-regulated" "FOXD4"
    "FOXM1-KD1" "FOXM1a" "FOXM1c" "FRB" "FREEC" "FSC" "FSK" "FUBP1"
    "Factor-KappaB" "Fadiel" "Fc" "Fe" "Fe-deprivation" "FeSV" "Fekrmandi"
    "Feng" "Fermentable" "Fifty-four" "Fifty-three" "FigS10.4" "Filus"
    "Fine-tuning" "Finland" "Finnish" "Finns" "Firat" "Firat-Karalar" "Flag"
    "Flag-BRAT" "Flag-Gag" "Flag-Gag-expressing" "Flag-WT-YBX1" "Flag-antibody"
    "Flk1-positive" "Flory" "Fluc" "Fluidigm" "Fluoroskan" "Follin"
    "Follin-Arbelet" "Follow-up" "Fondazione" "Fontes" "Forty-eight"
    "Forty-five" "Forty-four" "Forty-nine" "Forty-two" "Fos-B" "FoundationOne"
    "FpClass" "France" "Frantseva" "Frantseva’s" "Fraumeni" "French"
    "French–American–British" "Fu" "FuGENE" "Fucci" "Fuchs" "Full-Term"
    "Full-thickness" "Function" "Fura‐2" "Fuxia" "G-5G" "G-actin" "G-allele"
    "G-pS-P-X-X" "G-peak" "G-quadruplex" "G0" "G0–G1" "G1" "G1-S" "G12" "G17E"
    "G17Efs" "G17Efs*24" "G1–G5" "G2" "G2-M" "G2-NSCLC" "G3" "G3-NSCLC" "G309A"
    "G4" "G48R-mutant" "G719S+L861Q" "G719X" "GA" "GA+AA" "GAP-sensitivity"
    "GBR" "GCACTTT" "GCB" "GCGC" "GCV" "GD2-Src" "GD2-ligand" "GD2-ligands"
    "GDF15-konckdown" "GEC" "GEM+CDDP" "GFP-FKBP-CLCa" "GFP-cells" "GG" "GHD"
    "GHEA" "GI-50" "GIC" "GICs" "GIII" "GKS3" "GLEBS" "GM8429" "GO0032270"
    "GO0032990" "GO0051247" "GOBO" "GOFs" "GOG" "GOG-177" "GOG181B" "GOTERM"
    "GPCR-YAP" "GPCR‐induced" "GPCR‐mediated" "GSE10072" "GSE11729" "GSE14333"
    "GSE17536" "GSE20685" "GSE20842" "GSE21034" "GSE21122" "GSE22358"
    "GSE23604" "GSE29044" "GSE32269" "GSE35988" "GSE37138" "GSE3744" "GSE37751"
    "GSE38241" "GSE41656" "GSE50948" "GSE5325" "GSE58840" "GSE60335" "GSE6099"
    "GSE66654" "GSE6919" "GSE70446" "GSE70572" "GSK-3β-9ser" "GSK33β"
    "GSK650395" "GSKα" "GSKβ" "GSM699947" "GSM999373" "GST-dRad6" "GST-fusions"
    "GST-tag" "GT+GG" "GTPase-defective" "GTPγS-H-ras-D47A" "GWASs" "Gab1"
    "Gag-GFP" "Gain-of-function" "Gal4-AR" "Gallen" "Gamma-H2AX" "Gamma-T3"
    "Garcia" "Gastro" "Gastro-oesophageal" "Gaucher" "Gaucher’s"
    "Gehan-Breslow-Wilcoxon" "GelCode" "GenBank" "GenGen" "GenScript"
    "Gene-level" "GeneBank" "GeneMania" "GeneNote" "GenePharma" "Genechip"
    "Geno" "Genomatix" "Genome" "Genome-Wide" "Genome-wide" "Genomes"
    "Genome–wide" "Genotype" "German" "Germany" "Gerthoffer" "Ghana" "Gibbs"
    "Gibco" "Gilbert" "Gle2-binding-sequence" "Gleason" "Globocan" "Glutamine"
    "GolgiStop" "Gosens" "Gq" "Grabiner" "Graser" "Grasso" "Graziano" "Grb2"
    "Greece" "Greenland" "Gs" "Guangzhou" "Gui" "Guilluy" "Gunst" "Gy"
    "Göteborg" "Gαi" "G→A" "H&E" "H-R3-dendriplexes" "H-R3-p53-PAMAM-complexes"
    "H-bonds" "H-ras" "H-ras-GTP" "H-rasG12V" "H-rasG12V-D47A"
    "H-rasG12V-R128A" "H-score" "H-scores" "H-scores " "H-thymidine" "H1"
    "H1047R" "H1299-EGFR-L858R" "H1299-EGFR-L858R-siCXCR4"
    "H1299-EGFR-L858R-siScramble" "H1299-EGFR-WT" "H1299-EGFR-WT-siCXCR4"
    "H1299-EGFR-WT-siScramble" "H1650shTw" "H1975Over" "H216" "H2170-SR" "H2C9"
    "H3" "H3.1-H4" "H3.3-H4" "H3122" "H3K27" "H3K56Ac" "H3K9" "H3K9ac" "H4"
    "H4-K20" "H538A" "H5N1-infected" "H8" "H82L" "H85L" "H9c" "HA-HDAC6"
    "HA-Ub-K0" "HA-Ub-WT" "HA-tag" "HADDOCK" "HBGF" "HBGFs" "HCAECs"
    "HCCC-9810CCC" "HCTs" "HD-rPBEF" "HDFs" "HEK-293FLG" "HEK-293FLG-LIX1L"
    "HELF" "HEMA-LP" "HER2-IHC" "HER2-amplified" "HER2-mediated"
    "HER2-negative" "HER2-positive" "HER2E" "HER‐2‐positive" "HER‐3" "HESCs"
    "HFU251" "HGMD" "HGSC" "HGSOC" "HHV-5" "HIF1-α" "HK" "HL-7702"
    "HLTF156-1009" "HLTF156–1009" "HM11" "HMCLs" "HMGA1-CCNE2-YAP" "HMLE"
    "HNF4-α" "HNK-mediated-inhibition" "HNSCCs" "HOCs" "HOE-140" "HR-defective"
    "HRGm1" "HRGm1,2" "HRGm2" "HRPC" "HRT" "HRs" "HSA" "HSCORE" "HSCSP"
    "HSOCRE" "HSV-1" "HT-COLsi" "HT-DNA" "HT-GDF15" "HT-GDF15si" "HT-p53"
    "HUGO" "HVMEC" "HYI" "HZ4" "HZ4-FeSV" "Hadhb" "Hadza" "Han-Chinese"
    "Hanahan" "Hancock" "Hanil" "HapMap" "HapMap-CHB" "Haplotypes" "Haploview"
    "Hardy-Weinberg" "Hardy-Zuckerman" "Hardy–Weinberg" "Harris" "Harvey"
    "Hcy-thiolactone" "HeLa-miR-215" "Hef" "Heggelund" "Heidelberg" "Helsinki"
    "Heme" "Heni" "Hep40" "HepG2+ATMsiRNA" "Her2" "Herceptest" "Herpesvirinae"
    "Hetero" "HhaI" "HiSeq" "Hif2α" "High-LET" "High-RICTOR" "High-level"
    "High-risk" "HindIII" "Hindu" "Hippel" "Hippel-Lundau" "Hippo" "Hippo-YAP"
    "His-PLK1" "His-YB-1" "Hochberg" "Hodges" "Hodgkin" "Hodgkin's" "Hodgkin’s"
    "Hoechst" "Holliday" "Homo-FRET" "Hong" "Honokiol-treatment" "Hoogsteen"
    "Hop-62" "Hou" "Houston" "HpaII" "Hsa-miRNA-206" "Hscores" "Hsp7C" "Hsp90α"
    "Hspβ1" "Hsu" "HuRef" "HuRef-Hg19" "HuSNP" "HuURNA" "Huang" "Hubei"
    "Huggins" "Huh" "Huh7cells" "HumanMethylation450" "HumanNet" "Huntington"
    "Huntington’s" "HyClone" "Hypo-acetylation" "Hz" "I-II" "I-IIIA" "I-IV"
    "I-TASSER" "I-XI" "I-cut" "I-expressing" "I-positive" "I-square" "I2" "I2D"
    "I74N" "IASLC" "IBα" "IC50" "IC90" "ICGC" "ICHs" "ICSNPathway" "ID5"
    "IGF-FoxO" "IGF1R‐EGFR" "IGV" "IHC4" "II-11" "II-175.9" "II-199.9" "II-2"
    "II-3" "II-40.4" "II-5" "II-6" "II-7" "II-8" "II-9" "II-IV" "IIA" "IIC"
    "III-109.6" "III-1355" "III-43.5" "IIIA" "IIIB" "III–IV" "IIS" "IIα"
    "II–IV" "IKBα" "IKK-Ser176" "IKK3" "IKKs" "IL-17A-expressing" "IL-25R"
    "IL-2Rgc" "IL-2Rgc-signaling" "IL-8-regulated" "IL1-β" "ILMN" "INK"
    "INK4Cip1" "INO" "IOSE" "IOSE-118" "IOSE-121" "IOSE-364" "IOSE-SV" "IOSE-T"
    "IP3-dependent" "IPSPs" "IQ" "IQ-domain" "IQR" "IR-A" "IR-B" "IR-α" "IR-β"
    "IRB" "IRCCS" "IRCCS-Santa" "IRCCS–Istituto" "IRESs" "IRβ" "ISE" "ISG"
    "ISG-56" "ISGs" "ISI" "ITAF" "ITAFs" "ITC" "IVR" "Ichikawa" "Ichimura"
    "Ifnab" "IgA" "IgG-FITC" "IgG-fluorochrome" "IgPKD" "Igγ" "Igλ" "Il"
    "Il-2Rg-signaling" "Illumina" "ImageJ" "ImageMASTER" "Imager" "ImmPort"
    "Immune-Precipitation" "Importin-peptide" "Impα-NLS" "In-silico" "Inc"
    "Incheon" "Indo" "Indo-American" "Infinium" "Interferon-regulatory"
    "Intestine-specific" "Invitrogen" "Ir" "Ireland" "Ishigaki" "Isomäki"
    "Isoselenocyanates" "Istituto" "Italia" "IκBα-Ser32" "I–II" "J82"
    "JAK-STAT3" "JAK2V617F" "JAR" "JBC" "Jafari" "Jak3" "Jakobsen" "James"
    "Jantus-Lewintre" "Japanese" "Jeju" "Jiang" "Jiangsu" "Jin" "Jmj" "Jose"
    "Jung" "Justy" "K-30" "K-H" "K-M" "K-means" "K-rasG12V" "K-rasG12V-R164Q"
    "K-rasV152G" "K170A" "K285" "K3-EDTA" "K325" "K326" "K48-linked" "K540A"
    "K540M" "K6" "KD-1" "KD2" "KDEL" "KEGG-pathway" "KH16" "KH16p" "KHDRB1"
    "KIAA1549‐BRAF" "KKAA" "KKKK" "KKKK15" "KMN" "KOB-NDRG2" "KPSS" "KRKL"
    "KRPK" "KSEA" "KTSPRRPLILKRRRLPLPVQNAPSETSEEEPKRSPA" "KUCaP" "Kadazan"
    "Kadazan-Dusun" "Kakiuchi" "Kaplan" "Kaplan-Meier" "Kaplan–Meier" "Kaposi"
    "Kaposi’s" "Karmazyn" "Karnofsky" "Katsumoto" "Kawai" "Kazakh" "Kellgren"
    "Kellgren-Lawrence" "Kenya" "Ki-67" "Ki-67-positive" "Ki-67and" "Kiesten"
    "Killela" "Kim" "Kindin-2" "Kip" "Kirby" "Kiriyama" "Kirsten" "Kitagawa"
    "Knl-1" "Knock-down" "Knock-in" "Knudsen" "Knudson" "Kobashi" "Koch"
    "Koch’s" "Kodani" "Koma" "Komatsu" "Koolen" "Korea" "Korean" "Kovacs"
    "Kovacs’s" "Kruppel-like" "Kruskal-Wallis" "Krymskaya" "Kto" "Ku" "Kudat"
    "Kuroda" "Kyoto" "L-Azidohomoalanine" "L-Carnitine" "L1" "L11δ" "L858R"
    "LAN-5-Luc-transduced" "LAUDT1" "LC-2" "LC-II" "LC3-B" "LC3-I" "LC3II"
    "LCCA" "LCS6" "LGL-KRas" "LLAA" "LM609" "LMw" "LN95" "LNCaP" "LNCaP-wtAR"
    "LR" "LRs" "LS-MS" "LUADs" "LUBAC" "LVI" "LXRα" "LY30" "Labsystems" "Lac"
    "Lange" "Large-Cell" "Lauren" "Lauren’s" "Laurén" "Lechner" "Legrier"
    "Leng" "Leptin-antagonist" "Lestaurhas" "Lewintre" "Leydig" "Li"
    "Li-Fraumeni" "Liang" "Liang’s" "Lig3α" "Lig3β" "Ligand" "Liguori" "Lin12"
    "Lin28-let7" "Linc2GO" "Lindera" "Lineweaver" "Lineweaver-Burk" "Liposomes"
    "Liu" "Liu's" "Li’s" "Loewe" "Loffler" "Log" "Log-rank" "Logan" "Looper"
    "Lopez" "Losada" "Louis" "Lourmat" "Low-RICTOR" "Low-molecular-weight"
    "Low-power" "Low-risk" "LoxP" "LoxP-GFP" "Lu" "Lublin"
    "Luciferase-stably-transduced" "Luciferin" "Luminal-A" "Lundau" "Lv-HOXD10"
    "Lyn" "Lyn-Ip" "Lys-63-linked" "L–1" "M-checkpoint" "M1-like" "M1M2"
    "M2-like" "M2-phenotype" "M24RASSF8" "M2a" "M2c" "M6" "MA1A2-Luc" "MAB391"
    "MALDI-MS" "MALDI-TOF" "MALDI-TOF-MS" "MAPK-activity" "MAPK-regulated"
    "MAPK-signaling" "MAR" "MAR-Wiz" "MARCM" "MARK" "MC-701" "MC-702"
    "MCF10A-Twist" "MCF10A-Twist-sh-Ctrl" "MCF10A-Twist-sh-Twist" "MCF7-COLsi"
    "MCF7-EPIR" "MCM2–7" "MCULE" "MDA-MB-453s" "MDACC" "MDM2-mutp53" "MDR1"
    "ME1" "MELF" "MEME" "MEMα" "MEN" "MGC80-3" "MHBMA" "MHC-I" "MHCC"
    "MHCC-97L" "MI-2-2" "MIR34A" "MIR424" "MK2203" "MKRN1‐BRAF" "MM2206" "MMEJ"
    "MML2" "MMP6" "MMTV-ARE" "MMTV-Neu-induced" "MMTV-PyMT" "MMTV-TVA" "MNCs"
    "MNase-seq" "MOAP-1-Be" "MOAP-1-directed" "MOI" "MOONRAKER" "MPEs" "MPM-B"
    "MREs" "MS" "MS-PCR" "MSC-Th17" "MSC-cell-surface" "MSI-H" "MSI-L" "MSPCR"
    "MSRE" "MSRE-PCR" "MSigDB" "MTS" "MUT+AMP" "MUT-TP53" "MUT-p53" "MY09"
    "MY11" "MYC-dependency" "MYC-hyperactive" "MYC-normal" "MYC-shRNAs" "MYPT"
    "MYPT‐1" "Machacek" "Maddika" "Maki" "Malaysia" "Malhotra" "MammaPrint"
    "Manassas" "Manchón" "Manley" "Mapper" "Mapper2" "Marambio" "Maria" "Marne"
    "Marschall" "Martinc" "Martinc’s" "Martingale" "Martínez-Bosch" "MassARRAY"
    "Masson" "Masson’s" "Matei" "Material" "Matouk" "Matrigel-invasive"
    "Matrix-Attachment-Region" "Matveeva" "Mauban" "Max‐1" "Mazhab"
    "Mazhab-Jafari" "Mazzuferi" "McDermott" "McIntyre" "MedImmune" "Medeo"
    "Medicine-Endocrinology" "Medline" "Mehta" "Meier" "Meier's" "Melville"
    "Mesenchymal-Epithelial" "Metacore" "Metformin-vemurafenib" "Methods"
    "Meurs" "Mexican" "Mexico" "MiR-1207" "MiR-129" "MiR-137" "MiR-143"
    "MiR-145" "MiR-1908" "MiR-190a" "MiR-206" "MiR-224" "MiR-300" "MiR-329"
    "MiR-495" "MiR-497" "MiR-675" "MiRNA-1908" "MiRNA-206" "Micro-P"
    "MicroCosm" "MicroRNA-181a" "MicroRNA-215" "MicroRNA-34a" "MicroRNA-424"
    "Microglobulin" "Microtubular-targeted" "Mig6-YF" "Mig6-YY" "Mig6-YpY"
    "Mig6-pY394" "Mig6-pYpY" "Mihaylova" "Milan" "Milbrandt" "Millipore"
    "Mini-Protean" "Minimizer" "Mir30-shRNA-mediated" "Miskimins"
    "Mito-Tracker" "MitoTrap" "Mizukami" "Mmol" "Mms2-Ubc13-dependent"
    "Moffitt" "Mohammad" "Morel" "Morris" "Moruno" "Moruno-Manchón" "Moses"
    "Mother-to-daughter" "Mouthon" "Mukerji" "Multi-pathway" "Multisite"
    "Multi‐color" "Murata" "Mut0" "Mut1" "Mut2" "Mutp53" "MuvB" "Mws" "Mx"
    "MySi" "Myb-MuvB" "Myc" "Mycosporine-like" "Myr-Akt" "MβCD" "N+1"
    "N-NFE2L2" "N-acetyl" "N-benzyloxycarbonyl" "N-cad" "N-cadehrin"
    "N-cadherin" "N-cahderin" "N-formylmethionyl-leucyl-phenylalanine"
    "N-glycosylation" "N-rasG12V" "N-rasG12V-C51Y" "N-rasG12V-E49K" "N-rasT50I"
    "N-to-C" "N0" "NA" "NAMPT" "NANC" "NAT-A" "NAT-C" "NAT-D" "NAT-F"
    "NB-patients" "NBDs" "NBT" "NBUD" "NBUDs" "NC-MLN4924" "NC-shRNA-5"
    "NC-siRNA-transfected" "NCBI" "NCBInr" "NCE" "NCI" "NCI-60" "NCIC"
    "NCT01625234" "NCTs" "NDRG2-introduction" "NE-PER" "NE2" "NEDD4-like"
    "NF-κB-luc" "NF-κB1" "NF-κB·IκBα" "NFAIP3" "NFC" "NFCs" "NFkappaB1" "NFκB"
    "NH-bond" "NH-bonds" "NHCC" "NHEMs" "NIK-KK" "NIK-KK429" "NKI" "NL" "NL4-3"
    "NLS-E4" "NLS-Impα" "NLS2" "NLSs" "NMB-7" "NMIBCs" "NN90,91AA" "NNSplice"
    "NOD-SCID" "NOD-scid-gamma" "NODSCID" "NOESY" "NPB" "NPE" "NR2B-subunit"
    "NR4A" "NSPC" "NUCKS" "Nagao" "Nagashima" "Naik" "Nakagawa" "Nakamura"
    "Nakao" "Nakata" "Nasrin" "Navarra" "Nazionale" "Ncoa" "Ncoa1-knockout"
    "Ndrg2-deficient" "Nedd8-conjugating" "Needleman" "Needleman-Wunsch" "Neh"
    "Neh1–Neh7" "Neh3" "Neh4" "Neh5" "Neh6" "Nelson" "Nematostella" "Nep"
    "Netherlands" "Newcastle" "Newcastle-Ottawa" "Newcastle–Ottawa"
    "Next-generation" "Nidacon" "Niemann" "Niemann-Pick" "Niikawa" "Nikon"
    "Ninety-eight" "Ningbo" "Noh" "Nonsmall-cell" "Noonan" "Norway" "Notch"
    "Nottingham" "Nrf" "Nrf2" "Nrf2-ARE" "Nthy-ori" "Nucleic-acid" "Nultin"
    "Nuova" "Nurr77" "Nva123" "Nα-acetyltransferases" "Nα-terminal"
    "O-GlcNAcylation" "O6BG" "OB-fold" "OE-miR-145" "OHC" "OICR" "OICR-9429"
    "OMIM" "OR=0.1" "ORRs" "ORs" "OR–1.98" "OSHA" "OSI" "OSI-027" "OVC433"
    "OVCAS" "OVCAS-16" "Ob" "Off-label" "Off-target" "Oh" "Ohio" "OipA"
    "Olsson" "OncoFOCUS" "Oncologists" "Oncomine" "Oncotype" "One-way"
    "Operatiog" "Opin" "Opisthokonta" "Orai1" "Orthomyxoviridae" "Ortiz"
    "Osterrieth" "Ottawa" "Outerbridge" "Over-activation" "Overhauser" "Owen"
    "OxPAPC" "P+1" "P+2" "P-Tyr" "P1" "P1-P12" "P1-P5" "P13-K" "P13K" "P2"
    "P2-derived" "P53-null" "P6" "P77A" "P780ins" "P9" "P=0.001" "PACS"
    "PAI-1-675" "PAI-1-844" "PAK1P1" "PAM50" "PAMAM-DNA" "PAMPS" "PANTHER"
    "PARP1-ChIP-seq" "PARylation-mediated" "PARylation-methylation-mediated"
    "PB2B" "PBD2A" "PBEF-induced" "PBEF-mediated" "PBEF-specific" "PBEF–TLR4"
    "PBLs" "PBMs" "PC-1in" "PC9M" "PC9M2" "PCNA-polyubiquitin-ligase" "PCR-HRM"
    "PCR-RFLP" "PCSC" "PCSC-like" "PCSCs" "PCT" "PCs" "PD132" "PD170" "PD180"
    "PD19" "PD20" "PD21" "PD3" "PD34" "PD35" "PD85" "PDA" "PDBID" "PDGF"
    "PDGFa" "PDGFβ" "PD‐1" "PEAT" "PEG4000" "PET-CT" "PF-562271" "PF562271"
    "PFKB2" "PFT-α" "PF‐431396" "PF‐537228‐sensitive" "PF‐573228" "PF‐753228"
    "PG-C" "PG-S3–002" "PGAM5L-KD" "PGAM5S" "PGR-positivity" "PGR-status"
    "PHLBD1" "PHLBDI" "PI-incorporation" "PI-stained" "PI13K" "PI3K-like"
    "PI3KCA" "PI3KR2" "PI3 K" "PIC3CA" "PIK3CA-mutated" "PIK3CA-signalling"
    "PIK3CAis" "PIK3CAmutations" "PIKK" "PIKKs" "PKBβ" "PKCθ" "PKCθ-dependent"
    "PKD-1" "PKIG" "PKR-like" "PLACE-SSCP" "PLC-γ" "PLINK" "PLK1-C" "PLTs"
    "PMA" "PMR" "PMVEC" "PMVECs" "PNAS" "PNPT11" "POS" "POS-phagocytic" "POT"
    "PP2Acα" "PP5c" "PPI" "PPIs" "PPPIA" "PPPSP" "PR-C" "PR-negativity" "PRB"
    "PRJEB9805" "PRL8A2" "PROGINS" "PROMO" "PS-NA" "PSA-negative" "PSNSPPYVCY"
    "PTEN-Ser380" "PTENP1" "PTGF" "PTGF-β" "PTH-containing" "PTHN11" "PTNT11"
    "PTSG2" "PVP-K30" "PXD" "PXD002319-PXD002328" "PXXP" "PY136" "PY36" "PY95"
    "PYK2-mediated" "Padova" "Pakistan" "Pakistani" "Pam3CSK4" "Panax" "Pankau"
    "Papanicolaou" "Papeleu" "Parker" "Parkinson" "Parkinson's" "Patchdock"
    "Pau" "Pcont" "Pearson" "Pearson’s" "PeproTech" "Perkin" "Pertel"
    "Philadelphia" "Phospho" "PhosphoMotif" "PhosphoSite" "Phyllodes"
    "PhyloCSF" "Pi3KN" "Pico" "Pihr2" "Pillinger" "Pim-1L" "Pinedo" "Pinelli"
    "Plaines" "Plk1" "Plk1T210D" "Plk1TD–RFP" "Poisson" "Poland" "Polo-box"
    "Polyphen-2" "Polyphen2" "Polβ" "Porkka" "Porphyra-334" "Post-operative"
    "Post-transcriptional" "Post-translational" "Poznan" "PreMix"
    "Pro-angiogenic" "Pro-tumorigenic" "Proband" "PrognoScan" "Proof-of"
    "Protein" "Protein-DNA" "ProteomeXchange" "Proteosome-mediated"
    "ProtoArray" "Protostomes" "Prp19" "Ptprt" "Puerto" "Pull-down" "Pvu"
    "P = 0.001" "Q-pS-P-X-K" "Q-statistic" "Q126X" "QEDS" "QQESNQAEASKEVA"
    "QSAR" "QSTAR" "Qiagen" "Quantikine" "QuickChange" "Quigley" "R&D" "R-to-T"
    "R1" "R172H" "R2" "R23X" "R273C-DNA" "R273C_T284R" "R273H-DNA"
    "R273H_S240R" "R273H_T284R" "R3" "R3047X" "R4" "R454" "R5" "R544C" "R5Q"
    "R93Q" "R=0.37" "R=0.40" "RAD3-related" "RAD51-ssDNA" "RAD6-MDM2"
    "RAD6-MDM2-regulated" "RAD6-RAD18-catalyzed" "RAS-MARK" "RAS-regulatory"
    "RAS-wildtype" "RASEF" "RASSF1-10" "RASSF1A-dependent" "RASSF2A"
    "RASSF7-10" "RASwt" "RCAS-PyMT" "RDOCK" "RECK4" "REMBRANDT" "REV-T" "RFLP"
    "RFPL" "RFs" "RGDI-2" "RING" "RING-finger" "RK-33" "RK-33-related" "RLPs"
    "RLuci" "RMSD" "RMSD " "RMSF" "RNA-RNA" "RNA-protein" "RNA2-1-5p"
    "RNAi-rescue" "RNF168-dependent" "RNU1" "ROC-AUC" "ROC-AUCs"
    "ROCK-controlled" "ROI" "RORβ" "RORγ" "RORγ1" "RORγgene" "RP11–403A3"
    "RPA-32" "RPE-ErbB2" "RPE-J" "RPISeq" "RPS6K" "RQ-ATM" "RRGYIAMLAVDSKYRRN"
    "RRPM2" "RRRCWWGYYY" "RSApSEP" "RSF1-C1" "RSF1-C2" "RSF1-FL" "RSF1-V5"
    "RSMADs" "RSX" "RSXpS" "RT-qPCR" "RTOG" "RXF" "RXRβ" "RY-2f" "Rab-small"
    "Rac1-GTP" "Rad3" "Rad3-related" "Radiation-induced" "Radioresistance"
    "Radkay" "RafRBD" "Rahman" "Rajagopalan" "Ramirez" "Ramirez-Pinedo" "Randi"
    "Rapamycin-vemurafenib" "Rapold" "Ras-Raf-isoform" "Ras-association"
    "Ras-isoform-specific" "Raso" "Rb-E2F" "Re-ChIP" "Re-expression" "Rebbeck"
    "RecA-like" "RecG" "RecQ-like" "Refseq" "Reggio" "Reiss" "Reiter" "Rejeeth"
    "Retroviral" "Rey" "Rey-Osterrieth" "Rg3" "Rh123" "Rho-YAP" "Rho-family"
    "RhoA-ROCK" "RhoA-ROCK-LIM" "RhoA-ROCK-LIMK-cofilin-controlled"
    "Rho‐kinase" "Rho‐kinase‐dependent" "Rho‐kinase‐mediated" "Ribeiro"
    "Richardson" "Rico" "Ring-domain" "Ritchie" "Roa" "Roche" "Rochefordiere"
    "Rosa26R" "Rounding-up" "Rouquette" "Rozengurt" "Rs10893872" "Rungus" "Rv1"
    "S*" "S-H" "S-L" "S-arrest" "S-pS" "S-pT" "S-related" "S-transferases" "S1"
    "S1387" "S141" "S17N" "S1981" "S1B–D" "S1C" "S1D" "S1E" "S1F" "S1–S40"
    "S2-S5" "S231-S232" "S240R" "S259E" "S266E" "S268E" "S2A" "S2B" "S2C" "S2D"
    "S2E" "S2F" "S2G" "S2H" "S2I" "S2a" "S2b" "S3" "S310F" "S33" "S330A" "S37"
    "S386A" "S3B-C" "S3C" "S3D" "S3D-F" "S3E" "S3F" "S3G" "S3H" "S4"
    "S402-N412" "S424" "S486A" "S4A" "S4B" "S4C" "S4C-F" "S4D" "S4E" "S4G"
    "S5–S7" "S6" "S6-Ser240" "S6-protein-phosphorylation" "S636" "S6A" "S6C"
    "S7" "S752-I759" "S75P" "S7A" "S7B" "S7b" "S7c" "S8" "S8A" "S8A-B" "S8B"
    "S8C" "S9" "SBE13" "SC514" "SCC9shRNA004" "SCC9shRNA159"
    "SCF-complex-mediated" "SCOV3" "SD6" "SDC-11" "SDC-5" "SDC-like" "SDF-1α"
    "SDS-soluble" "SD±1.62" "SD±34.6" "SELEX" "SENPs" "SF3B" "SF3b" "SFCs"
    "SFRPs" "SH2-domain" "SH2-domains" "SIFT" "SILAC" "SIRT" "SIRT1made"
    "SIRTs" "SISH" "SK-Mel-147" "SKMG-4" "SKP-Cullin1-F-Box" "SLM"
    "SMAD4-SMAD2" "SMARTpool" "SMMC" "SMS-KAN" "SN3" "SN50" "SNBs" "SNCB"
    "SNF-dependent" "SNF2-related" "SNP-level" "SNP285" "SNP309G" "SNP344"
    "SNP55" "SNP55C" "SNP55T" "SNPinfo" "SNPs" "SNU" "SNU-119" "SNV" "SNV's"
    "SNVs" "SOCE‐dependent" "SOCE‐induced" "SOCE‐mediated" "SOS" "SP600124"
    "SPAG" "SPARKI" "SPC-A-1sci" "SPSS" "SPSS17.0" "SPapS" "SPasT" "SPvkT" "SR"
    "SR-IκBα" "SRC-3delta4" "SS57" "SS58" "SSBR" "SSCP" "STAR-FISH"
    "STAR-FISH-derived" "STAT-mediated" "STATA" "STE" "STIL" "STRING"
    "SU-DHL-1" "SUM-185PE" "SUMO-specific" "SUMOplot" "SUPPLEMENTAY"
    "SUPPLEMENTRY" "SUVpeak" "SVP" "SVZ" "SW-1783" "SW-839-sh-AR"
    "SW1088-anti-miR1908" "SW1116csc" "SW116" "SW40" "SW480-anti-miR-106b"
    "SWOG" "SWR" "SYNV1" "SYVN1-IRE1α-dependent" "Sabah" "Saharan" "Sakai"
    "Salah" "Salmena" "Sam68" "Same-cell" "Samsung" "Sandhoff" "Sanger" "Sant"
    "Santacana" "Saoa" "Saoa2-R175H" "Saracatinib" "Sawalha" "Scaffold"
    "Scaltriti" "Sce" "Schaafsma" "Scheffzeck" "Schelten" "Scheltens"
    "Schizosaccharomyces" "Schmitz" "Schnackenberg" "Schoenfeld" "Schultz"
    "Schulze" "Schwarz" "ScienCell" "Sd" "SdBP" "Self-assembled" "Selinanova"
    "Sema-related" "Sema3-NRP-PlxnA" "Sema3-Plexin" "Sema3s"
    "Semi-quantitative" "Sendai" "Sequenom" "Ser-218" "Ser-222" "Ser235"
    "Ser32" "Ser424" "Ser473" "Ser54" "Sertoli" "Seventy-five" "Shannon"
    "Sheffield" "Sheng" "Shiyan" "Short-term" "Shukla" "Siah" "Sianos"
    "Side-by-side" "Sigma-Aldrich" "Silva" "Simbolo" "Simpson" "Singh"
    "Single-cell" "Single‐stained" "Siomycin" "Sirtuin-deacetylases"
    "Skp1–Cul1–Rbx1" "Smad2" "Smads" "Small-Cell" "Small-molecule" "Smart-R17"
    "Socrates" "Solman" "Solon" "Solway" "Somlyo" "Soslow" "Spanish"
    "Spearman’s" "Specific-To-Allele" "Speleman" "Sperinde" "Src" "Src-Tyr527"
    "Src-family" "Src-protrusion" "SrcFK" "SrcFKs" "SrcFK‐dependent"
    "SrcFK‐mediated" "Src‐dependent" "Src‐family" "Stangeland" "Stat3"
    "Staufen1" "Stillingia" "Stockley" "Stop-LoxP" "Stransky" "Stress-induced"
    "Stroke" "Strongylocentrotus" "Struct" "Structure–function"
    "Study-population" "Suadi" "Sub-G1" "Sub-Saharan" "Sub-cellular" "Sugasawa"
    "Sunaga" "Sunyani" "Super-enhancer" "Super-enhancers" "Sutherland" "Suzuki"
    "Sweden" "Swedish" "Swith" "Switzerland" "S→D" "T*Q" "T-309G" "T-NFE2L2"
    "T-allele" "T-category" "T-lymphoma" "T-lymphotropic" "T-to-G" "T0N0" "T1"
    "T1-T2N0" "T1-T2N1" "T1D" "T1N0" "T2" "T24-DNA" "T257E" "T284R" "T2D"
    "T2DM" "T3" "T4" "T41" "T421" "T790M" "TAA" "TAAACA" "TAIL-PCR" "TAK1-TAB1"
    "TAK1–TAB1" "TALEN" "TAM-administration" "TAM-fed" "TAP-MS" "TARID"
    "TASSER" "TATA" "TAX327" "TAp73" "TAp73s" "TAp73β" "TB3" "TBARS" "TBS"
    "TBS-T" "TBST" "TC+CC" "TCF-dependent" "TCF4-promoter" "TCF4-reporter"
    "TCGG" "TCGG-TCGA" "TCGG-TCGG" "TCRα" "TCT" "TD" "TDU" "TEAD-driven"
    "TEAD2-VP16" "TEADs" "TEL-2" "TF–lncRNA–protein-coding" "TGACTCA" "TGCA"
    "TGFB1R" "TGFβ1R" "TGX" "THP-1and" "TIA" "TINCR" "TISCs" "TKI-therapy" "TL"
    "TLDA" "TLR2-dependant" "TMPRSS" "TNBCs" "TNF-κ" "TNFRSF11" "TNNBIP1"
    "TOCSY" "TOPflash" "TOPsimple" "TOR-autophagy" "TOX" "TPA" "TPBPA" "TPS"
    "TPxxS" "TRAR-low" "TRD2" "TRIM33-SMAD2" "TRPP" "TRP‐dependent" "TSI"
    "TTAGGG" "TTT" "TTTT" "TVriS" "TWIST" "TWSIT1" "TXCOOH" "TZL" "TZL's"
    "TZMbl-2" "Taiwan" "Taiwanese" "Talalay" "Talins" "Tan3" "Tangen"
    "Tanzania" "Tap73" "Taqman" "TargetScan" "TargetScan6.2" "Targetscan6.2"
    "Tax-independent" "Tayside" "Temecula" "Teng" "Tenovin-1" "Tet-ON-induced"
    "Tet-On" "Tet-On-based" "Texas" "Tfn" "Tg" "Tgi" "Th1135" "TheR273"
    "Thermo" "Thibault" "Thirty-five" "Thirty-six" "Thr-202" "Thr308" "Thr37"
    "Thr382" "Thr383" "Thr421" "Thr559" "Three-dimensional" "Time-course"
    "TissueScan" "Tm" "Toll-like" "Toll–like" "Total‐IGF1R"
    "Trans-diaphragmatic" "Trans-well" "TransAM" "Transcription" "Translation"
    "Transwell" "Trcp" "Triple-negative" "Triple-staining" "Triple‐negative"
    "Tris-HCl" "Trithorax" "Trotman" "Trzmiel" "Trzmiel-Bira" "Tsai" "Tsui"
    "Tumor-adjacent" "Tumori" "Tumour-initiating" "Turcot" "Tween" "Tween-20"
    "Twenty-five" "Twenty-four" "Twenty-nine" "Twenty-six" "Twenty-two"
    "Twist-driven" "Twist-high" "Twist-induced" "Twist-low"
    "Twist-overexpressing" "Twist-positive" "Twist1" "Two-tailed" "Two-way"
    "Tx50" "Tx600" "Type-2" "Tyr-204" "Tyr-P" "Tyr-protein" "Tyr279" "T→C"
    "U-Mann" "U-rich" "U1" "U1026" "U138MG" "U2" "U2-related" "U2AF65-mediated"
    "U2OS-shp53" "U373" "U87-miR-1908" "UAS" "UAS-bantam" "UBAN" "UCSC" "UEA"
    "UEA-I" "UM-SCC-74B" "UMUC" "UMUC3-AR-shRNA" "UMUC3-ELK1-shRNA"
    "UMUC3-control-shRNA" "UPR-eIF2α-CHOP-Akt" "URT" "USA"
    "USP18-ubiquitinated-TAK1" "UTR-wild" "UTRs" "UV-Vis" "UV-Visible" "UVA"
    "UVA-irradiated" "UWB1.289" "UYAUC" "Uighur" "Ukraine" "UltraView"
    "Uncoupling" "Universidad" "Urata" "Uterine-serous-carcinoma" "UvsW"
    "V-Ki-ras2" "V-catenin" "V1.0" "V2.3" "V394L" "V5" "V5-tagged" "VA-Luc"
    "VCM" "VEGF-receptor" "VEGFc" "VEGFd" "VEGFs" "VEGFα" "VGLL4-TEAD1" "VIIB"
    "VIIa" "VLCFAs" "VOCE" "VOCE‐mediated" "VPARP" "VPKRPKLP" "VP→AA" "VRNA2-1"
    "VTRNA1-1" "VTRNA1-2" "VTRNA2" "VTRNA2-1" "VTRNA2-1-5p"
    "VTRNA2-1-5p-inhibitor" "VTRNA2-1-5p-mimic" "VTRNAs" "Vaiman" "Valencia"
    "Vallee" "Varela" "Varella" "Varella-Garcia" "Vb" "Vec-AR+NC" "Vec-AR+OE"
    "Vectashield" "Vector-pLKO" "Vegf-A" "Vegf-a" "Veldt" "Veneto" "Venn"
    "Ventilator-induced" "Versteeg" "Vi7392" "Vi74523" "Vi7453" "Vilber" "Vina"
    "Visser" "Vivek" "Vysis" "W1" "W184R" "W2" "W231R" "W741L" "WB11" "WB7"
    "WLX" "WLX-8" "WM" "WMLs" "WST1" "WT+AMP" "WT-ATM" "WT-FGF1" "WT-P65"
    "WT-PEX5" "WT-YBX1" "WT-p53" "WXL-8" "Waals" "Waf" "Wagle" "Wald" "Wallis"
    "Walsh" "Waltham" "Warburg" "Watson" "Watson–Crick" "Weinberg" "Weinberg’s"
    "Welch" "Well-designed" "Wenzhou" "Werner" "Werzowa" "Western-blot"
    "Western-blots" "Whitney" "Wiedemann" "Wiener" "Wirthmueller" "Witney"
    "Wnt-off" "Wnt-on" "Wnt-treated" "Wolff" "Wolff's" "Wp" "Wp-0614" "Wroclaw"
    "Wts" "Wu" "Wunsch" "X-396" "X-ray" "X-rays" "X03363" "XF" "XI" "XIAP"
    "XTT" "XX" "Xcovery" "Xia" "Xiamen" "Xiang" "Xiao" "XiaoJi" "Xie" "Xpress"
    "Xray" "Xu" "Y-box" "Y1068" "Y1234" "Y204" "Y216" "Y216E" "Y279"
    "Y394–Y395" "Y576" "YAP-miR-130a-VGLL4" "YAP1-coactivator" "YAP1-relevant"
    "YAP1-transcriptional" "YB-1-RNA" "YB-1–RNA" "YE" "YX" "YZXJ" "Yale"
    "Yamachika" "Yamamoto" "Yang" "YangZheng" "Yes-associated" "Yoon" "Yorki"
    "Yoshii" "Youden" "Youden-Index" "Yu" "Yue" "Z-score" "Z-sections" "Z-test"
    "ZBTB7A" "ZDOCK" "ZKSCAN1‐BRAF" "ZR" "ZR-75" "ZRANK" "ZST474"
    "Zawacka-Pankau" "Zellweger" "Zeng" "Zhang" "Zhao" "Zhejiang" "Zhu" "Zhuo"
    "Zn" "Zn-Finger" "ZnCl" "Zuckerman" "aCGH" "aOR" "abnormities"
    "above-stated" "absorbance" "acLDL" "acLDL-Dil" "acetate-induced"
    "acetohydrazide" "acetyl-lysine" "acetylation-mimicking" "acid-A"
    "acid-cleaving" "acid-induced" "acrosome-intact" "acrosomes"
    "actin-remodeling" "activation-induced-celldeath" "activation-loop"
    "activators" "active-site" "acute-type" "acyl" "adduct" "adducts" "adeno"
    "adenoma-adenocarcinoma" "adenoma-carcinoma" "adenoma-carcinoma-sequence"
    "adenomatoid" "adenoma–carcinoma-sequence" "adenopathy" "adenyl" "adenylyl"
    "adheren" "adherens" "adhesion‐induced" "adipo" "adjudin" "advanced-stage"
    "advancements" "aenobufagin" "aetio" "aetio-pathogenesis"
    "affinity-purification" "againstcancer" "agar" "age-associated"
    "age-related" "age-specific" "agents" "agents-did" "agomir" "algorithm"
    "algorithms" "alkyl" "all-or-nothing" "all-time" "alloThr121" "allodynia"
    "amines" "amino-acid" "amino-terminal" "amino-terminally" "aminoacid"
    "ammonium" "amplicon" "amplifications" "amygdala" "analogical-to-digital"
    "analyte" "anchorage-independence" "andA" "andC" "andand" "andmiRNA"
    "andmiRNA-200a" "androgen-depravation" "androgen-deprivation"
    "androgen-like" "androgen-sensitive" "androgenic-like" "and–positive"
    "aneuploid" "aneuploidy" "angiogenesis-inducing" "angiography" "angiome"
    "angiopoietins" "anhydrase-like" "animal‐dependent" "anisotropy" "anoxia"
    "antagomiR-1207" "antegrade" "antenna-like" "anterograde" "antibody-drug"
    "antibody‐mediated" "antibrain" "antigen" "antigens" "antimiRs"
    "antiparallel" "antiphosphotyrosine" "antitumour" "anti‐CD80"
    "anti‐CD80‐PE" "anti‐CD86" "anti‐CD86‐APC" "anti‐EGFR" "anti‐HER‐2"
    "anti‐IGF1R" "anti‐drug" "anti‐receptor" "antrum" "aphidocholin" "aplasia"
    "apocrine" "apoptosis-sensitivity" "apoptotic-inducing" "approx"
    "approximately13.0" "arNOX" "arenobufagin" "arginine-glycine-glycine)"
    "arisen" "aromatase-which" "arrayscan" "arrhizus" "arrhythmia" "arterioles"
    "as-yet" "asHER‐2" "asparaginase-II" "at-risk" "atcodon" "atelocollagen"
    "athanogene" "atypia" "aurora-kinase" "authophagy" "auto-PARylation"
    "auto-adjuvant" "auto-degradation" "auto-parylation" "auto-regulatory"
    "autofeedback" "autoinhibits" "autophagosomesj" "autophagy-manipulation"
    "auto‐phosphorylation" "axon" "azadC" "a–d" "back-forward" "bafilomycin"
    "bafliomycin" "bandeiraea" "barcode-tag" "basal-like" "basal-like-type"
    "basal-type" "base-pair" "basic-region" "begun" "belatacept"
    "benzyloxycarbonyl" "beta1-integrin-dependent" "better-known"
    "between-group" "between-studies" "between-study" "bi" "bi-allelic"
    "bi-plot" "biallele" "bidentate" "bilayer" "biliverdin"
    "binding-incompetent" "bio" "bio-informatics" "bio-marker"
    "bio-therapeutic" "bioanalyzer" "bioenergy" "biofate" "biomaterials"
    "biomolecules" "biopharmaceuticals" "bioprocess" "biosensor-expressing"
    "biospecimens" "biospies" "biotin" "bisflavones" "bisphospate"
    "bisphosphate" "bi‐specific" "blastocyst" "blastocysts" "bleaching-through"
    "bleedings" "block1" "block2" "blocker" "blockers" "blood-brain"
    "blood-derived" "border-line" "botulinum" "box-binding" "bp"
    "brain-metastatic" "brainstem" "break-apart" "breakage-fusion-bridge"
    "breakpoint" "breakpoints" "breast-invasive" "bright-field" "brighter"
    "broad-complex" "broad-range" "broad-spectrum" "broader"
    "bronchoconstrictor‐induced" "bronchoconstrictor‐mediated" "bryostatin"
    "butadiene-polymer" "bw" "b–d" "c-Fos-mediated" "c-Jun-null" "c1c1" "c1c2"
    "c2c2" "cBIO" "cDNA-PCR" "cHGF" "cIAP" "cKITT670I" "cT" "cT3-4N0-2M0"
    "cT3-4N1-2" "cadehrin" "cahderin" "cal" "caliper" "calorimetry"
    "canakinumab" "canaliculi" "cancer-invasion-related" "cancer-relevant"
    "cancer‐specific" "caner" "cannabinoid" "cap-dependent" "cap-independent"
    "capsid" "capspase-3" "carbonyl" "carboplatin-paclitaxel" "carboxyl"
    "carboxyl-termini" "carboxy‐terminal" "cardia" "cardiomyocyte-like"
    "cardioplegia" "carinatum" "carotid" "case-control" "casepase-3"
    "case–control" "castrate-like" "castration-sensitive" "castration-tolerant"
    "catRAPID" "catalyse" "ccRCC" "cdc42racPathway" "ceRNA" "ceRNAs" "cecum"
    "celiac" "cell-adaptive" "cell-autonomous" "cell-cycle"
    "cell-cycle-associated" "cell-like" "cell-line-based" "cell-specifically"
    "cell-viability" "cells" "cells-of-origin" "cells-or-origin" "cell‐free"
    "centrally-located" "centriole" "centriole-like" "centromere"
    "centromere-associated" "centrum" "cerebellum" "cerebrum" "cerevisiae"
    "cetumximab" "cfDNA" "cfDNAas" "cfDNAcould" "cfDNAhad" "ch17"
    "chamberslides" "characteristics-area" "characteristics-areas"
    "charcoal-stripped" "cheaper" "checkpoint-induced" "chelate" "chemo"
    "chemo-naive" "chemo-preventive" "chemo-radiotherapy" "chemo-sensitivity"
    "chemo-therapeutic" "chemoattractant" "chemonaïve" "chemoradiotherapy"
    "chemoradiotheray" "chemoresistance" "chemoresistant" "chemoresponse"
    "chemotactic-like" "chemotherapy+trastuzumab" "chemotherapy-naive"
    "chemotherapy-resistance" "chemotherapy-resistant" "chi-square"
    "chi-squared" "childcare" "chloroethyl" "chloroform-methanol-ultrapure"
    "chlorophenyl" "cholamidopropyl" "cholesterol-depleting" "cholesterol-rich"
    "choline" "choriocapillaris" "chosen" "chromatid" "chromatids"
    "chromatin-regulatory" "chromo-ATPase" "chromobox" "chromosome-alignment"
    "chromosome-level" "chromosome-negative" "chromosome12p12.3" "cidofovir"
    "circRNA" "circRNAs" "cis-dichlorodiamineplatinum" "cis-elements"
    "cis-regulatory" "cistromes" "clade" "clades" "classifier" "classifiers"
    "clear-cell" "clearer" "clinic-pathological" "clinical-pathological"
    "clinical-radiological" "clinically-relevant" "clinicians"
    "clinico-pathological" "clonus" "closed-loop" "cnidarians" "co-cultured"
    "co-localized" "coIP" "coactivate" "coactivator-1α" "coauthors"
    "cobblestone-like" "cocarcinogen" "codon" "codons" "coggygria"
    "coiled-coil" "coiled-coil-containing" "coiled–coil" "cold-stable"
    "colforsin" "colitis-associated" "colitis-induced" "collagens" "colloid"
    "colon-cancer" "colony-enhancing" "colony-formation" "colony-forming"
    "combination-treated" "commonest" "comorbidities" "compactin-treatment"
    "complement-activation-related" "complex-1" "complex-2" "compound-induced"
    "concatemer" "concatemers" "concentration‐dependence"
    "concentration‐dependent" "concentration‐response" "concomitance"
    "condicio" "conflictions" "conformer" "conformers" "constitutively-bound"
    "constraint-release-induced" "contact-independent" "contour-based"
    "control-shRNA-expressing" "control–both" "coredomain" "coregulate"
    "corticosteroids" "cost-effectiveness" "cost-intensive" "counter-intuitive"
    "counter-regulate" "covariables" "covariance" "covariate" "covariates"
    "coworkers" "coxsackie" "co‐expressed" "co‐expressing" "co‐expression"
    "crizotinib+3-methyladenine" "crizotinib+chloroquine" "cross-phosphorylate"
    "cross-phosphorylation" "cross-reactivity" "cross-regulation"
    "cross-sectional" "cross-species" "cross-validation" "cross‐reactivity"
    "cryosections" "ctbs" "currently-available" "cut-off" "cut-offs" "cut‐off"
    "cyan" "cyanobacteria" "cyclocytidine" "cyclohexamine" "cyclophiline"
    "cylin" "cystatin-like" "cystectomy" "cysteine-X-cysteine" "cyto"
    "cyto-protective" "cytochromes" "cytokine-like" "cytology" "cytome"
    "cytometer" "cytometry‐based" "cytoskeketon" "cytospins" "c‐Src" "dE2f1"
    "dPRP" "damage-induced" "damage-signaling" "damage-specific" "daropate"
    "dataset" "datasets" "daughter-associated" "day‐to" "day‐to‐day" "dbSNP"
    "dbSNP138" "ddPCR" "de-activated" "de-activation" "de-intensify"
    "de-localization" "de-novo" "de-parylation" "de-polymerization"
    "de-regulated" "de-repressed" "de-repression" "deacetylase-dependent"
    "decidua" "deciduas" "deciles" "decondenses" "deeper" "deferens"
    "deficient-like" "deformations" "degron" "degrons" "dehydrocholesterol"
    "deletions" "dendropanoxide" "dense-core" "density-gradient"
    "deoxynucleotidyl" "depolarization‐induced" "depressant" "derepresses"
    "destabiliser" "destabilises" "destabilizer" "determinants"
    "deubiquitylases" "df" "di-2-pyridylketone" "di-methylate"
    "di-phosphorylated" "diabetes-susceptible" "dichlorodiamineplatinum"
    "dichlorofluorescein" "dichroism" "dictyostelium" "diet-induced"
    "diet-treated" "differentiated-MPN" "differentiation-marker"
    "differently-sized" "diffuse-type" "diffusion-associated" "difluoride"
    "dihydroethidium" "diindolymethane" "diluent-treated"
    "dimerization-competent" "dimethylammonio" "dimethyloxaloylglycine"
    "dimethylsulphoxide" "dimmers" "dimorphism" "dipeptidyl" "diphosphate"
    "diphosphate-ribose" "diploid" "diplotype" "diplotypes" "dipyridyl"
    "disassemble" "discoideum" "discrepant" "discriminant" "disease-relevant"
    "disease‐free" "dislipidemia" "disphenyl" "disulfide-thiol"
    "ditehylnitrosamine" "dnUbc12" "docataxel" "doi" "domain-1"
    "dominant-interfering" "dominant-negative" "donor-2" "dormancy"
    "dosage-dependent" "dosage–response" "dose-dependency" "dose-dependently"
    "dose-independent" "dose-range" "dose-response" "dose-responses"
    "dose-titration-proliferation-assays" "dose‐dependent" "dose‐range"
    "dose–response" "double-blind" "double-membrane" "double-mutant"
    "double-strand" "double-transgenic" "double‐stained" "doubly-bound"
    "doubly-phosphorylated" "down-modulated" "down-modulating"
    "down-modulation" "down-stream" "downfield" "doxo" "dpYAP" "drawn"
    "droplet" "drug-efflux" "drug-kinase" "drug-like" "drug-recognition"
    "drugs" "dsDNA" "dsDNA-translocase" "dsRBD" "dsRBM" "dsRBM1" "dsRBM2"
    "dsRBMs" "dual-acting" "dual-color" "dual-reporter" "dual-staining"
    "ductular-like" "ductules" "duplexes" "dwarfism" "dyad" "dye-efflux"
    "dynes" "dyslipidaemia" "dyslipidemia" "dysmorphisms" "dysphagia"
    "dysplasia" "eCCA" "eIF4E2-directed" "eLife" "earler" "early-cancer"
    "early-detection" "early-phase" "early-secretory" "early-stage"
    "early‐stage" "ectodomain" "ectopic-overexpression" "ectopically-expressed"
    "edema" "el" "element-binding" "elrotinib" "eluate" "embryo-like"
    "empty-plasmid" "encephalomyocarditis" "end-to-end"
    "endogenously-expressing" "endometria" "endometrioid" "endometrium"
    "endothelia" "endothelial-enriched" "endothelial-specific" "endpoint"
    "endpoints" "energy-producing" "englerin" "enhancer" "enhancer-binding"
    "enthalpy" "eosin" "eosin-Y" "eosinophils" "epicatechin" "epididymis"
    "epigenome" "epilepticus" "epileptiform" "epithelia" "epithelial-derived"
    "epithelial-like" "epithelial-mesenchymal"
    "epithelial-mesenchymal-transition" "epithelial-to-mesenchymal"
    "epithelial-tomesenchymal" "epithelial–mesenchymal" "epithelioid"
    "epithelium" "eppendorf" "er" "ercc1#2" "ercc2#1" "eritoran" "erotinib"
    "error-proof" "esophagectomy" "estradiol-like" "estrogen-has"
    "estrogen-was" "et" "etheno" "etheno-DNA" "ethnicities" "euglobulin" "ex"
    "ex-vivo" "exome" "exomes" "exon-intron" "exon20" "exon4" "exons"
    "exon–intron" "exosome" "expression-array" "extensiveness" "extra-pelvic"
    "extrauterine" "extrinsic-independent" "e–h" "facies" "facilitators"
    "facio" "facio-cutaneous" "factor-15" "factor-2" "factor-like" "fail-safe"
    "failsafe" "false-discovery" "family-wise" "farther" "feed-forward"
    "feedback-controlled" "feedforward" "fer-1-like" "fetal-derived"
    "fetal-maternal" "fibrates" "fibroblast-like" "fide" "figshare"
    "filling-in" "filopodium-like" "fine-tuned" "fine-tuning" "first-degree"
    "first-generation" "first-line" "five-miRNA-based" "five-stranded"
    "five-year" "flavonoid" "flavonoids" "flu-like" "fluid-filled" "fluoresce"
    "fluorescence‐CTLA4‐Ig" "fluorescence‐labeled" "fluorescently-labelled"
    "fluorodeoxyglucose" "fluorophore" "fluorophores" "fluouracil"
    "flurorouracil" "fold-ratio" "follicle" "follicles" "follow-up"
    "followed-up" "footpads" "forager" "foragers" "fork-like" "forkhead-like"
    "forskohlii" "foscarnet" "four-stranded" "frameshift" "free-enzyme"
    "free‐CD80" "free‐CD86" "free‐IGF1R" "frequently-mutated" "frominto"
    "front-line" "frozen" "fructose-6-phosphate" "full-term" "full‐length"
    "fulminant" "fumigatus" "function-2" "fusiform" "fusion‐positive" "futher"
    "gB" "gDNA" "gH" "gL" "gain-in" "gain-of-function" "galactomannan"
    "gallbladder" "gamma-T3" "gamma-phosphate" "gamma-phosphorylation"
    "gamma-radiation" "gapdh" "gastro-oesophageal" "gatekeeper" "gefitinb"
    "gefitinib-treatment" "gemcitabine+cisplatin" "gene-1" "gene-3"
    "gene-environment" "gene-gene" "gene-promoter-specific" "gene-proximal"
    "gene-signature" "gene-to-chromosome" "gene-to-environment" "gene-to-gene"
    "genes" "genetically-engineered" "genetically-induced" "genome"
    "genome-wide" "genomic–intensive" "genotype-toxicity" "genotypes"
    "germ-line" "germline" "gfp" "gifitinib" "gingiva" "gingival-derived"
    "gland-derived" "glia" "glomas" "glucan" "glucans" "glucocorticoid-induced"
    "glucose-metabolism" "glucosylceramide" "glucosylsphngosine"
    "glutamate-induced" "glycoaminglycan" "glycogen-3" "glycosphinogolipid"
    "glycosphinogolipids" "go-or-grow" "goes" "gonad" "gossypol"
    "gram-negative" "grandiflora" "granulose" "greater" "greatest"
    "green-fluorescent-labelled" "growth-suppressive" "gt" "guanosine-5"
    "gut-associated" "h-R3-DNA-PAMAM" "h-R3-PAMAM" "h-R3-PAMAM-DNA"
    "h-R3-dendriplex" "h-R3-dendriplexes" "h-R3-p53-PAMAM" "h-ov" "h1" "h2"
    "hASMC" "hIes6-knockdown" "hMSC" "hMSC-Th17" "hMSCs" "hRFPL1" "hRluc"
    "hTERT-IMEC" "hTERT-immortalized" "hXRCC1" "hadPIK3CAmutations"
    "hairpin-like" "half-ARE" "half-life" "half-lives" "half-maximal"
    "half-saturation" "half-site" "hand-foot" "haplotype" "haplotype-level"
    "harzad" "has-miRNA-520a-5p" "head-and-neck" "head-neck-body-foot"
    "heat-shock" "heat-shock-independent" "heavy-smoking"
    "helicase-SANT-associated" "helicase-defective" "helicase-like" "helices"
    "helix" "helix-breaker" "helix-loop-helix" "hemi" "hemi-CWG1" "hemi-CWG10"
    "hemi-CpG10" "hemocytometer" "hemorrhoids" "henotype" "henselae"
    "hepatectomy" "hepatitis-associated" "hepato" "hepato-oncogenesis"
    "heretofore-unappreciated" "herpesvirus-4" "hetero-FRET" "hetero-dimeric"
    "hetero-dimers" "heterodimmers" "heteroduplex" "heterozygote" "hexamer"
    "hexamers" "hg19" "hidden" "hif-lα" "high-LET" "high-Mw"
    "high-RKIP-expressing" "high-affinity" "high-confidence" "high-content"
    "high-depth" "high-dose" "high-expression" "high-fidelity" "high-field"
    "high-grade" "high-intensity" "high-level" "high-mobility"
    "high-molecular-weight" "high-occurrence" "high-oscillatory" "high-pass"
    "high-performance" "high-power" "high-prevalence" "high-priority"
    "high-resolution" "high-risk" "higher-affinity" "higher-order"
    "higher-risk" "highest-incidence" "highest-ranked" "highest-risk"
    "highly-conserved" "highly-glycosylated" "highly-specialized" "high‐dose"
    "hilar" "hippocampi" "hirsutism" "histochemistry" "histogel" "histologies"
    "histology" "histone-DNA" "histone-trimethylation" "histopathology"
    "histotype" "histotypes" "hoc" "holdout" "homeodomain" "homo-CWG1"
    "homo-CWG10" "homo-CpG10" "homo-tetramer" "homogenates" "homografts"
    "homolog" "homologs" "homozygote" "homozygotes" "hormone-ablation"
    "hormone-and" "hormone-dependent" "hormone-naïve" "horticulturalists"
    "host-cell" "hot-spot" "hot-spot-mutated" "hotspot" "hotspots" "hottest"
    "hoxa" "hr" "hsa-375" "hsa-let-7g" "hsa-miR-125b" "hsa-miR-145"
    "hsa-miR-149" "hsa-miR-181b" "hsa-miR-182" "hsa-miR-183" "hsa-miR-184"
    "hsa-miR-205" "hsa-miR-222" "hsa-miR-31" "hsa-miR-518d-5p"
    "hsa-miR-519b-5p" "hsa-miR-519c-5p" "hsa-miR-520c" "hsa-miR-526a"
    "hsa-miR-526b" "hsa-miR-886-5p" "hsa-miR-96" "hsa-mir-21" "hsa00603"
    "hsa04930" "hsa05030" "htSNP" "htSNPs" "huHer2" "human-like" "human-only"
    "human1osteosarcoma" "hunter-gatherer" "hunter-gatherers" "huntingdon"
    "hydrocele" "hydrogen-bond" "hydroxycholesterol" "hydroxydoxorubicin"
    "hydroxyl" "hydroxyphenyl" "hydroxystilbene" "hyper" "hyper-aggressive"
    "hyper-dependency" "hyper-proliferative" "hyper-recombination"
    "hyperandrogenism" "hypercholes" "hypercholes-terolemia"
    "hyperglobulinemia" "hyperleptinemia" "hyperplasia-like" "hyperreflexia"
    "hyperresponsiveness" "hyper‐responsiveness" "hypo-methylated"
    "hypo-phosphorylated" "hypodiploid" "hypogaea" "hypopharynx"
    "hypothalamic-pituitary-gonadal" "hypothalamic-pituitary-ovarian"
    "hypothalamic-pituitary-testicular" "hypothermia" "i+1" "iCLIP" "iCLIP-seq"
    "iMAC2" "iMycCα" "iTRAQ" "identifiers" "ie" "ii" "iii" "imidazole"
    "immune-associated" "immune-deficient" "immune-modulating" "immune-related"
    "immune-tolerant" "immunhistochemistry" "immuno" "immuno-competent"
    "immuno-precipitation" "immunoFISH" "immunoassay" "immunobiology"
    "immunocytochemistry" "immunocytohistochemistry" "immunoglobulin"
    "immunoglobulin-like" "immunogold" "immunohistochmeistry" "immunohistology"
    "immunophillin" "immunoprecipitations" "immunosurveillance"
    "immunotherapies" "immunotherapy" "impedance" "importin-α" "in-depth"
    "in-focus" "in-frame" "in-gel-angiogenesis" "in-group" "in-vitro"
    "in-vitro-expanded" "in-vivo" "in-ward" "inCEBPA" "inFig" "incompleteness"
    "independant" "individually-treated" "induced-down" "infection-induced"
    "infection-mediated" "inflammation-associated" "inflammation-induced"
    "inflammatory-induced" "inflata" "infoldings" "infra-tentorial"
    "infra-tentorium" "inframe" "initiators" "insNPG" "inside-out" "insightful"
    "insulin-induced" "insulin-like" "insulin-mediated" "insulin-signaling"
    "insulin-stimulated" "integrin‐induced" "intein" "intensity-based"
    "inter-centriolar" "inter-individual" "inter-relationship"
    "inter-relationships" "inter-strand" "interactome" "interactomes"
    "interdomain" "interferon-a" "intermediate-risk" "intermembrane"
    "interobserver" "interologs" "interquartile" "interstrand" "interstudy"
    "intestinal-type" "intestine-specific" "intima" "intra" "intra-S"
    "intra-centrosomal" "intra-chromosomal" "intra-mitochondrial"
    "intra-patient" "intra-tracheally-instilled" "intra-tumor" "intra-tumoral"
    "intra-tumoural" "intracanalicular-type" "intracardiac" "intratumour"
    "invaginations" "invariant" "invasion-positive" "invasion-suppressor"
    "in‐frame" "ionic" "iron-ions" "irradiation-induced"
    "irradiation-modulated" "irradiation-treated" "ischemia-reperfusion"
    "isofagomine" "isolectin" "isomers" "isonicotinoyl" "isotype"
    "isotype‐Alexa647" "isotype‐PE" "ites" "iv" "junction-specific"
    "juxtamemberane" "k-means" "kainate" "kainite" "kallikrein-like" "kaposin"
    "kappa-B" "karyorrhexis" "karyotype" "keV" "key-role" "kg" "kinase-3"
    "kinome" "kit-8" "knock-down" "knock-in" "knocked-down" "knockin"
    "knocking-down" "knocksideways" "konckdown" "laevi" "laevis" "lamellipod"
    "lamellopodia" "large-cell" "large-scale" "large-scaled" "late-secretory"
    "late-stage" "latency-associated" "lavage" "leakiness" "leave-one-out"
    "lenti-virus-mediated" "lentiviral-mediated" "leptin-antagonist"
    "leptin-antagonists" "leptin-function" "lesion-adjacent" "let-7a"
    "let-7a-2" "let-7b" "let-7e" "let-7g" "let-7i" "let7c" "letters"
    "leucopenia" "leukoencephalopathy" "level-set-based" "licochalcone"
    "licofelone" "lifespan" "ligand-less" "ligand-ligand" "ligand-receptor"
    "ligand‐independent" "light‐chain" "light‐chain‐20" "lincRNA-RoR"
    "lindenenyl" "line-width" "lineages" "lipid-lipid" "lipofuscin"
    "lipopolysaccharide" "lipopolysaccharides" "liposome" "literature-derived"
    "littermate" "littermates" "live-cell" "lncRNA-ATB" "lncRNA-BGL3" "lo"
    "lobectomy" "localizations" "locally-advanced" "loco-regional"
    "log-likelihood" "log2" "log‐lank" "lonaprisan" "long-lasting" "long-lived"
    "long-range" "long-standing" "longer-period" "longer-term" "loss-function"
    "loss-of-function" "lost-of-function" "low-LET" "low-Mw"
    "low-RKIP-expressing" "low-affinity" "low-concentration" "low-dose"
    "low-expression" "low-fidelity" "low-grade" "low-level"
    "low-molecular-weight" "low-penetrance" "low-prevalence" "low-resolution"
    "low-risk" "lowM" "lower-grade" "lowfat" "low‐dose" "loxoribine" "lumens"
    "luminal-A" "luminal-A-profile" "luminal-B" "luminescence-reporter"
    "luminol" "luminometer" "lung-to-brain" "lutea" "lymphoadenopathy"
    "lymphoblastoid" "lymphoblasts" "lymphoma-2" "lymphoma-extra" "lysis"
    "lysosomo" "lysosomo-tropic" "lysozyme-immunopositive" "m-ov" "m-shaped"
    "mDia" "mGFP" "mLANA" "mR-190a" "mRFP" "mRFPSKL" "mT" "mTOCR1" "mTOR-4EBP1"
    "mTOR-mediated" "mTORC1-independent" "mTmG" "mV" "mac239" "make-up"
    "male-male" "male-to-female" "malignance" "malignances" "mammoplasties"
    "mammosphere" "mammospheres" "mappings" "marker-negative" "mastectomy"
    "maternal-embryo" "maternal-fetal" "matoxylin" "matoxylin-eosin"
    "matrix-remodeling" "maytansinoid" "mdivi-1" "mdsRBM1" "mdsRBM2" "mean±s"
    "mean ± S" "mechanobiology" "mediated-defense" "megabases" "melanogaster"
    "melanolysosomes" "melatonin" "mellitus" "membrane-permeable" "men–a"
    "mesenchymal-epithelial" "mesenchymal-like" "meshwork" "mesoderm"
    "meta-dataset" "meta-regression" "metagene" "metagenes" "metal-induced"
    "metallothionein-III" "metaphase-anaphase" "metastases"
    "metastasis-suppressor" "metastasise" "metastatic-associated"
    "metastatic-related" "meta‐analyses" "metformin+GC-4"
    "metformin-vemurafenib" "methoxy" "methyl-β-cyclodextrin" "methyladenine"
    "methylene" "methylnitronitrosoguanidine" "mevalonate" "mfe" "miR-101"
    "miR-106a-5p" "miR-106a∼363" "miR-106b" "miR-106b-25" "miR-106b~25"
    "miR-106b∼25" "miR-10a" "miR-10a's" "miR-1207" "miR-1207-deregulated"
    "miR-1207-mediated" "miR-1207-overexpressing" "miR-1207-silenced"
    "miR-1207-transduced" "miR-1207–induced" "miR-1207–transduced" "miR-122"
    "miR-124" "miR-124-3p" "miR-1248" "miR-126-mimic" "miR-128" "miR-128-3p"
    "miR-129" "miR-1296" "miR-130b-3p" "miR-132" "miR-134" "miR-137"
    "miR-138-5p" "miR-141" "miR-143" "miR-145" "miR-146" "miR-148a" "miR-155"
    "miR-160b" "miR-17" "miR-17-92" "miR-17∼92" "miR-185" "miR-186" "miR-18a"
    "miR-1908" "miR-1908-induced" "miR-1908-mediated" "miR-1908-overexpresison"
    "miR-1908–mediated" "miR-190a" "miR-192" "miR-193a-3p" "miR-193a-5p"
    "miR-195" "miR-195-Inhi" "miR-195-induced" "miR-195-over-expressed"
    "miR-195-transfected" "miR-197" "miR-19a" "miR-19a-3p" "miR-200"
    "miR-200-ZEB1" "miR-200b-Kindlin-2" "miR-200b-ZEB1" "miR-200c-141"
    "miR-203" "miR-205" "miR-206" "miR-206-agomir-treated" "miR-206-expressing"
    "miR-206-expression" "miR-20a" "miR-210" "miR-214" "miR-214-induced"
    "miR-215" "miR-22" "miR-222" "miR-223" "miR-223-3p" "miR-224" "miR-22HG"
    "miR-23a-agomir" "miR-23a-agomir-injected" "miR-23b" "miR-24-1" "miR-244"
    "miR-24–1" "miR-26a" "miR-26a-2" "miR-29a" "miR-29b-1" "miR-300" "miR-301"
    "miR-30b" "miR-31" "miR-324-3p" "miR-326" "miR-329" "miR-33" "miR-338-3p"
    "miR-33a" "miR-33b" "miR-34" "miR-34a-5p" "miR-34a-inhibitor" "miR-362-3p"
    "miR-365" "miR-372" "miR-374c" "miR-375" "miR-381" "miR-3941" "miR-423-5p"
    "miR-424" "miR-424+Akt3" "miR-424+Akt3+E2F3" "miR-424+E2F3"
    "miR-424+shAkt3" "miR-424-induced" "miR-424-mediatd" "miR-4477a" "miR-452"
    "miR-4714" "miR-495" "miR-497" "miR-497-inhibited" "miR-512-5P"
    "miR-512-5P-scramble" "miR-512-5p" "miR-512-5p-scramble" "miR-513a-5p"
    "miR-548b-5p" "miR-590-5p" "miR-603" "miR-625" "miR-655" "miR-655-mediated"
    "miR-655-treated" "miR-675" "miR-675-3p" "miR-675-5p" "miR-675-induced"
    "miR-675-overexpressing" "miR-675microRNA" "miR-886" "miR-886-3p" "miR-9"
    "miR-93" "miR-95" "miR-99a" "miR-99b" "miR-NS" "miR-SC" "miR-US25-1"
    "miR-agonists" "miR-quantitative" "miR130" "miR130a" "miR190" "miR22"
    "miR224" "miR31" "miRCont" "miRDip" "miRNA-10a" "miRNA-126" "miRNA-133b"
    "miRNA-135b" "miRNA-138" "miRNA-141" "miRNA-145" "miRNA-145-expressing"
    "miRNA-150" "miRNA-1908" "miRNA-1908-overexpressing" "miRNA-21"
    "miRNA-216b" "miRNA-22-3p" "miRNA-222" "miRNA-300" "miRNA-31"
    "miRNA-338-3p" "miRNA-338-p" "miRNA-375" "miRNA-520a-5p" "miRNA-7-5p"
    "miRNA-93" "miRNA-like" "miRNP" "miRStart" "miRWalk" "miRZip" "miRZip-1207"
    "miRZip-224" "miRanda" "miRcode" "miRnome" "mice" "micelles"
    "micro-environment" "micro-environmental" "micro-fabrication" "micro-molar"
    "micro-oncogene" "micro-pattern" "micro-patterned" "microRNA"
    "microRNA-10a" "microRNA-21" "microRNA-223" "microRNA-33" "microRNA-429"
    "microRNA-675" "microbeam" "microbial-specific" "microcarrier"
    "microdeletions" "microdomains" "micrographs" "microphotographs"
    "microsatellite" "microsatellite-instability" "microsatellite-stability"
    "microsatellites" "microtubular-targeted" "microtubule-depolymerization"
    "microvasculature" "microvessel" "microvessels" "mid-piece" "mid-secretory"
    "midbrain" "midpiece" "midpoints" "mimickers" "mimosine" "minigene"
    "minimally-upregulated" "mir" "mir-21" "mir-300" "mir-329" "mir-381"
    "mir-655" "mis-segregation" "mis-sense" "misalign" "mismatch-repair"
    "misrecruit" "missense" "mito-tracker" "mitochondrial-dependent"
    "mitochondrial-mediated" "mitochondrial-related" "mitochrondria"
    "mitogen‐activated" "mitoses" "mitotic-like" "mixed-type" "mlU" "mln"
    "mock-infected" "mock-knockdown" "mock-treated" "moderate-linkage"
    "modifications" "modus" "molecularly-detailed" "molecule-1" "molecule-2"
    "moncytes" "mono-allelic" "mono-and" "mono-infected" "mono-methyl"
    "mono-methylation" "monocyte-derived" "monocytogenes" "monolayer"
    "monopartite" "monosome" "monotherapy" "monoubituitinates" "mono‐specific"
    "moots" "morbidities" "morbiferus" "morderate" "morphine-intractable"
    "morpholino" "morphologically-changed" "morphotypes"
    "mortality-to-incidence" "mortem" "most-well-known" "mother–daughter"
    "motif-1" "motif-2" "motile" "motogens" "mp53" "mtor" "mucin-phenotype"
    "mucosa" "multi-centric" "multi-component" "multi-drug" "multi-factorial"
    "multi-fold" "multi-functional" "multi-gene" "multi-lineage" "multi-modal"
    "multi-nodular" "multi-pathway" "multi-polar" "multi-potency"
    "multi-protein" "multi-species" "multi-specificity" "multi-step"
    "multicenter" "multicentre" "multidomain" "multigene" "multilevel"
    "multilineage" "multimerizes" "multipartite" "multiple-step" "multiprotein"
    "multistage" "multivariate" "murid" "muscle-invasive" "muscularis"
    "musculus" "mutants" "mutant‐negative" "mutant‐positive"
    "mutation-detection" "mutation-null" "mutations" "mutation‐negative"
    "mutation‐positive" "mutyh#5" "myc-tag" "myc-tag-IκBα" "mycBioID"
    "myocardium" "myocytes" "myofilaments" "myometrium" "myristate" "myristoyl"
    "n=12" "n=20" "n=22" "nM–10" "nM–5" "naevus" "nano" "nano-complexes"
    "nanocluster-activity" "nanoclustering-FRET" "nanoclustering-FRET-analysis"
    "nanoclustering-response" "nanocrystals" "nanodiscs" "nanoliposomes"
    "nanomaterials" "nanoscale" "nares" "nasopharynx" "native-DNA" "naïve"
    "nc886" "ncomms8847" "ncomms8904" "ncomms8999" "ncomms9077"
    "near-consensus" "near-isogenic" "near-normal" "near-total" "near-whole"
    "near-whole-genome" "nearest" "necropsy" "negative-feedback" "neo-adjuvant"
    "neoadjuvan" "neoadjuvant" "neocortex" "neoformans" "neovasculature"
    "neu-amplification" "neu-amplified" "neurite" "neuro" "neuro-degeneration"
    "neuro-developmental" "neuro-inflammation" "neuro-pathological"
    "neuro-radiological" "neuroendocrine" "neuropathology" "neuropil"
    "neuropsychiatry" "neutropenia" "never-overweight" "never-smokers"
    "never-smoking" "new-onset" "next-generation" "next‐generation" "nick-end"
    "nidus" "nifedipine" "nitro" "nitroblue" "no-response" "node-negative"
    "node-positive" "node‐positive" "nominal-weight" "nonSpitzoid"
    "nonapeptide" "noncarriers" "nondrinkers" "nonhistone" "nonhybrid"
    "nonmalignant" "nonmuscle" "nonmuscle-invasive" "nonobese" "nonredundant"
    "nonsense-mediated" "nonsmall" "nonsmall‐cell" "non‐specific"
    "normal-adenoma–carcinoma" "normal-weight" "normovolemia" "nose-only" "nt"
    "nuc-ChIP-seq" "nuc-PARP1-ChIP-seq" "nucleases" "nucleosome-ChIP"
    "nucleotide-resolution" "nude-BALB" "numbers" "nusieve" "n = 12"
    "o-Phenanthroline" "obese-hyperleptinemic" "occupational-exposed"
    "occurrences" "octoploid" "ofHER‐2" "ofPIK3CAmajor" "ofPIK3CAmutations"
    "ofRFSandBCSSin" "off-rate" "off-target" "off-tumor" "offs"
    "oil-stimulated" "older–an" "oligo" "oligoFISH" "oligodendroglioblastomas"
    "oligopyrimidine" "oligos" "oligosaccharide-binding" "omega-3" "on-going"
    "on-line" "on-target" "on-tumor" "onHER‐2" "onco"
    "oncogenic-PIK3CA-mutations" "oncolipid" "oncology" "oncomiR" "oncomiR-21"
    "oncomiRs" "oncotarget" "oncovin" "one-dimensional" "one-fifth"
    "one-fourth" "one-half" "one-order" "one-third" "one-way" "onplants"
    "ontogeny" "oocytes" "oophorectomy" "operandi" "opioids" "or-independent"
    "organelle" "organelle-specificity" "organelles" "ori" "orientation-switch"
    "oropharynx" "ortholog" "osteo" "osteoblast-like" "osteoblasts"
    "osteopenia" "osteophyte" "osteoprogenitors" "ought" "out-of-focus"
    "outgroup" "outs" "outside-in" "outweighd" "oval-like" "ovarian-adjacent"
    "over-activated" "over-activation" "over-dominant" "over-duplication"
    "over-induction" "over-packing" "over-proliferation" "over-stabilization"
    "overall-survival" "overridden" "overview" "oxidases" "oxido-reductase"
    "oxodG" "oxoguanine" "oxygenase-1" "oxygens" "p185HER2" "p21C98A" "p21Waf1"
    "p38β" "p50α" "p53-DNA" "p53-RE" "p53-S20p" "p53-defective" "p53-depedent"
    "p53-mediated" "p53-miR-200c" "p53-null" "p53-status" "p53AIP1etc." "p53C"
    "p53KO" "p53RE" "p53WT" "p53mt" "p53si-D3" "p53si-E1" "p53si-E2" "p53β"
    "p53γ" "p55α" "p65-pS536" "p65siRNA" "p70S6K" "p85-b" "p85α" "p85γ"
    "p90ATF6" "p95HER2" "p95HER2-negative" "p95HER2-positive" "p95HER‐2"
    "p=0.0000001" "p=0.000001" "p=0.00003" "p=0.0001" "p=0.0004" "p=0.001"
    "p=0.003" "pAMPK" "pBS-Vector" "pBS-shINO80" "pBS-shRNA" "pBTK" "pBUBR1"
    "pBax" "pC" "pC53-SN3" "pCDNA-SIRT1" "pCDNA3-luciferase" "pCDNA3.1" "pCMV"
    "pCR" "pCRs" "pCa6.5" "pDEST40" "pDEST40-CHFR-PBZ" "pDEST40-wt-CHFR"
    "pDNMT1" "pEFGR" "pEGFP" "pEGFP-C1" "pEGFP-C2-HDAC4" "pEGFR" "pFUGW"
    "pFra-1" "pGL3-Myc-5" "pGL3-basic" "pGL3-rs4705343C" "pGL3-rs4705343T"
    "pGPU6" "pGab1" "pH" "pH-sensors" "pH3-immunopositive" "pHER2" "pHER3"
    "pHistone" "pHs" "pLKO" "pLuc" "pLuc-p21-3" "pM" "pMET" "pMIR-CDS1"
    "pMIR-REPORT" "pMIRGLO" "pMig6" "pMito-mCherry-FRB" "pNL4-3" "pNUCKS1"
    "pR5UTRF" "pRPAS4" "pRb-E2F" "pRb-mediated" "pS" "pS-P" "pS-P-X-R"
    "pS-X-X-F" "pS102" "pS233" "pS259" "pS473" "pS621" "pS636" "pS7" "pSORT"
    "pSPXR" "pSTAT3" "pT1a" "pT1aN0" "pT1b" "pT1c" "pT202" "pTNM" "pUL44"
    "pUL54" "pUL69" "pUL97-cylin" "pValue" "pY1045" "pY1068" "pY1086" "pY216"
    "pY307" "pY394pY395" "pY394–pY395" "pY395" "pY567" "pY627" "pYs"
    "padlock-probe" "pahway" "pair-wise" "paired-end" "paired-samples"
    "paired-tumor" "pairings" "pairwise" "palliative-cytoreductive" "pan-SUMO"
    "pan-inhibitors" "pancytokeratin" "pancytopenia" "pan‐kinase" "para-aortic"
    "para-cancerous" "para-carcinoma" "para-follicular" "paracrine" "parafilm"
    "parallel-redundant" "paralog" "parenchyma" "parotid"
    "parsylation-mediated" "partial-response" "particulate" "partly-identical"
    "parylation-dependent" "patho" "patho-physiology" "pathobiology"
    "pathogen-associated" "pathogen-derived" "pathogen-induced"
    "pathogen-recognition" "pathophysiology" "pathway-Nrf2" "pathways"
    "pathway‐dependent" "patients-even" "pcDNA3" "pcDNA3.1" "pcDNA3HA-CCNE2"
    "peak-finder" "peak-to-gene" "peakzilla" "pectoris" "pectus" "penetrance"
    "penetrant" "penicillin-streptomycin" "peptide-library" "peptide-substrate"
    "per-molecule" "perhaps" "pericanalicular-type" "perineurium" "peritoneum"
    "permeant" "peroxins" "person-years" "pharmacotherapies" "phenethyl"
    "phenotypes" "phenyl" "phonotype" "phoshoproteome" "phosphacan"
    "phosphatidylcholine‐specific" "phosphatidylinositide"
    "phosphatidylinositol-3-OH" "phosphatidylinositol-4"
    "phosphatidylinositol-4,5-biphosphate" "phospho-Akt" "phospho-c-Jun"
    "phosphodegron" "phosphodegrons" "phosphoesterases" "phosphoform"
    "phosphoinositide-binding" "phosphoinositides" "phosphoinositol-3"
    "phosphomutant" "phosphomutants" "phosphopeptide" "phosphopeptides"
    "phosphoproteome" "phosphor-tyrosine" "phosphoribosyl"
    "phosphorylation-defective" "phosphorylaton" "phosphosites"
    "phosphotransfer" "phosphotyrosines" "photo-induced" "photo-oxidative"
    "photo-protective" "photochemotherapy" "photodamage" "photomicrographs"
    "phyla" "physiologically-relevant" "physiopathology" "pifithrin-α"
    "piggyBac" "pir-miR-34a" "pitstop2" "pixel" "pixels" "placenta-derived"
    "pladienolide" "pladienolides" "plasmacytoid" "plasmon" "platelet‐derived"
    "platinum-taxane" "platinum-taxol" "pleura" "ploidy" "pluri"
    "pluripotency-associated" "pmiR-RB-REPORT" "pmirGLO" "pmoL" "pneumophila"
    "pnkp#1" "pocket-blocked" "point-mutant" "point-mutated" "polII" "polo-box"
    "poly-A" "poly-L-lysine" "poly-arthritis" "poly-l-lysine-treated"
    "polyamidoamine" "polycations" "polyethyleneglycol" "polyethylenimine"
    "polygyny" "polymerase-1" "polymorphonucleocytes" "polynucleosomes"
    "polyphenol" "polyphenols" "polyploid" "polyprotein" "polysomies"
    "polysomy" "polytherapy" "polyvinylidene" "pombe" "pons" "poor-prognosis"
    "poorer" "poorest" "poorly-differentiated" "poorly-structured" "pore-size"
    "porphyra" "porphyra-334" "porphyra-334-treated" "porphyra-344"
    "porphyra-344-treated" "porphyrin" "positron" "post-ECP" "post-Golgi"
    "post-HSA" "post-bicalutamide" "post-exposure" "post-germinal"
    "post-implantation" "post-injection" "post-irradiation" "post-menopausal"
    "post-mitotic" "post-mortem" "post-neoadjuvant" "post-operation"
    "post-operative" "post-operatively" "post-radiation" "post-stasis"
    "post-surgeries" "post-surgery" "post-surgical" "post-therapy"
    "post-transciptional" "post-transcriptional" "post-transcriptionally"
    "post-transduction" "post-transfection" "post-translation"
    "post-translational" "post-translationally" "post-treatment" "post-wound"
    "potentialnew" "poxivirus" "ppRB" "preS2" "preceding-residue"
    "preclinical‐to" "predose" "preussin" "pri-miR-130a" "pri-miR-22"
    "pri-miR-221" "pri-miR-24-1" "pri-miR-24–1" "pri-miR-29b-2" "pri-miR-300"
    "pri-miR-34a" "pri-miR-381" "pri-miR-497" "pri-miR-655" "pri-miRNA-34a"
    "primer-based" "primers" "priori" "pro-angiogenesis" "pro-angiogenic"
    "pro-apoptosis" "pro-caspase-1" "pro-caspase-9" "pro-death"
    "pro-inflammatory" "pro-invasive" "pro-leukaemic" "pro-lymphangiogenesis"
    "pro-lymphangiogenic" "pro-malignant" "pro-metastatic" "pro-migratory"
    "pro-proliferative" "pro-survival" "pro-survive" "pro-tumor" "pro-tumoral"
    "pro-tumorigenic" "proCASP3" "proCASP7" "proNGF" "procentriole"
    "procentrioles" "proform" "progenies" "progenitors" "progeny" "progestin"
    "progression-relevant" "proheparin‐binding" "prokaryotic-expressed"
    "proliferation-quiescent" "proliferative-dependent"
    "proliferator-activated" "proline-rich" "prolyl-4-hydroxylase"
    "promoter-context" "promoterless" "promyeolocityc" "proof-of-concept"
    "proof-of-principle" "propanesulphonate" "propanodeoxyguanosine"
    "prostaglandins" "prostatectomy" "proteasome-like" "protein-5"
    "protein-DNA" "protein-RNA" "protein-coding" "protein-interaction"
    "protein-lipid" "protein-peptide" "protein-to-protein" "proteins" "proteo"
    "proteo-lipid" "proteome" "proteome-wide" "proto-oncoproteins"
    "protoncogene" "protonophore" "protooncogene" "proven"
    "proximity-dependent" "pseudo-hypoxic" "pseudogene" "pseudogenes"
    "pseudopodes" "psittaci" "pull-down" "pulldown" "pulse-chase" "punctae"
    "purpuratus" "putamen" "pyramidine" "pyrazolo" "pyrroloquinoline" "p "
    "q-value" "qdPCR" "qua" "quadruplex" "quality-of-life" "quick-turnover"
    "quinovose" "quinquefolius" "rCCL5" "rHDGF" "rLuciferase" "rSNP" "rSNPs"
    "rTLR4" "radiation-activated" "radiation-induced" "radiation-therapy"
    "radio-sensitivity" "radioesistance" "radioiodine" "radioresistant"
    "radioresponse" "radiosurgery" "radiotherapy-treated" "rafts-inserted-Lyn"
    "random-effect" "rapalog" "rapalogs" "rarer" "re-analysed" "re-analyzed"
    "re-appears" "re-biopsy" "re-bound" "re-circularisation" "re-classified"
    "re-defined" "re-designated" "re-direction" "re-distribution" "re-enforce"
    "re-establish" "re-established" "re-establishment" "re-evaluate"
    "re-examination" "re-examine" "re-exposed" "re-express" "re-expressed"
    "re-expression" "re-grow" "re-grown" "re-immunoprecipitation"
    "re-introduction" "re-iteratively" "re-mined" "re-organisation"
    "re-organization" "re-oxygenation-mediated" "re-sensitized"
    "re-sensitizing" "re-surgeries" "re-treated" "reaction–restriction"
    "read-out" "read-outs" "readout" "readouts" "real-time-PCR" "rearrangments"
    "recent-onset" "receptor-like" "receptor-proximal" "receptor-α"
    "receptors-α" "receptor‐bound" "receptor‐operated" "receptor‐positive"
    "reconfirm" "recurrences" "red-colored" "red-labeled" "redirect"
    "region-of-interest" "regression-tree" "regulators" "reinitiate"
    "relapse‐free" "relapsing-remitting-type" "relaxant" "remodeler"
    "remodelers" "remodeling" "remodeller" "renilla" "repeat-region"
    "replication-associated" "replication-dependent" "replication-forks"
    "replication-independent" "replicons" "reponses" "reporter-based"
    "reporter-binding" "repressors" "reproductive-aged" "reprogramme"
    "repurpose" "residuals" "resp" "responder" "responders" "retrovirus"
    "retrovirus-like" "reuse" "reverse-transcribed" "reverse-transcription"
    "reviewer#3's" "re‐applied" "rhGDF15" "rhHMGB1" "rhIL" "rhIL-25" "rhLIF"
    "rhSCF" "rhWNT" "rhWNT3A" "rhWNT3A-induced" "rhabdoid" "ribonucleopreotein"
    "ribose" "rilonacept" "ringfinger" "risk-associated" "risk-taking"
    "roadmap" "rolling-circle" "rosette-like" "rpm" "rs10406453" "rs10406543"
    "rs1042522" "rs10431923" "rs10462021" "rs10483813" "rs1053004" "rs1059234"
    "rs1064122" "rs1064261" "rs1064261and" "rs1071518" "rs1071598" "rs10893872"
    "rs11121704" "rs11221332" "rs1130214" "rs1130233" "rs1136201" "rs114207045"
    "rs11547455" "rs116307792" "rs117039649" "rs1196333" "rs12185157"
    "rs12919719" "rs13029602" "rs13072632" "rs1364455" "rs13689" "rs16260"
    "rs1690916" "rs17000728" "rs17300539" "rs17690554" "rs17715799" "rs1799768"
    "rs1799889" "rs1801270" "rs1801320" "rs1801321" "rs1801552" "rs185246578"
    "rs1883965" "rs200220" "rs2059254" "rs2227310" "rs2227631" "rs2279744"
    "rs2293303" "rs2295080" "rs2304256" "rs2304258" "rs2494732" "rs2498804"
    "rs2536" "rs2736100" "rs2853669" "rs2870820" "rs3176352" "rs3218536"
    "rs35719940" "rs3784099" "rs3803300" "rs4135385" "rs4352251" "rs4533622"
    "rs4705343" "rs4705343-rs712" "rs4705343TC" "rs4705343TT" "rs4705343 TC"
    "rs4755779" "rs4783689" "rs4796793" "rs4937333" "rs519982" "rs6092"
    "rs61997065" "rs62075772" "rs6713972" "rs712" "rs712GG" "rs712GT"
    "rs7186053" "rs7198799" "rs7200690" "rs73013527" "rs7389" "rs74561951"
    "rs822387" "rs861539" "rs937282" "rs937283" "rs9909659" "rubella"
    "s11060-015-1891-1" "s12858-015-0050-9" "s12871-015-0101-1"
    "s12885-015-1614-1" "s12918-015-0201-z" "s12920-015-0127-8"
    "s12943-015-0423-0" "s12943-015-0432-z" "s12967-015-0592-z"
    "s12967-015-0622-x" "s12967-015-0633-7" "s12967-015-0639-1"
    "s12967-015-0650-6" "s12985-015-0365-6" "s13041-015-0138-6"
    "s13058-015-0624-x" "sE-Cad" "sEGFRon" "sEGFRs" "sSNPs" "sTLR2"
    "salt-bridge" "salt-insoluble" "sample‐specific" "samplings"
    "sanguinolenta" "sapiens" "sarcomatoid" "satellite-mediated" "scRNA"
    "scaled-up" "scr" "screenings" "sec-13" "second-generation"
    "second-leading" "second-line" "second-most" "second-site" "secretome"
    "sediments" "seed-binding" "segmentectomy" "seizure-induced" "seizure-like"
    "seizure-mediated" "self-FRET" "self-amplifying" "self-antigen"
    "self-antigens" "self-assembled" "self-assembly" "self-cleavage"
    "self-defense" "self-destruction" "self-digestion" "self-interaction"
    "self-limited" "self-limiting" "self-oligomerization" "self-primed"
    "self-priming" "self-recruitment" "self-regulation" "self-renew"
    "self-renewal" "self-reports" "self-stabilizing" "self-sufficiency"
    "self-sufficient" "self-tolerance" "self-ubiquitination" "self‐induced"
    "semi" "semi-logarithmic" "semi-nomadic" "semi-quantitative" "semiovale"
    "senescence-determinants" "senescence-effector" "senescence-like" "seq"
    "sequence-specific" "ser235" "serine-X-X-phenylalanine" "serine-rich"
    "serine-to-alanine" "serine-to-arginine" "serosa" "serum-replete" "sessile"
    "set-point" "sex-determining" "sh#1" "sh#3" "sh-AR+NC" "sh-AR+miR-145"
    "sh-AR-induced" "shAMPK" "shAkt3" "shBUD31" "shBUD31-barcodes" "shCon"
    "shControl" "shINO" "shINO80-transfected" "shJMJD1A" "shLUADT1" "shLuc"
    "shN" "shN-cad" "shNC" "shPAK2" "shRNA-#1" "shRNA1" "shSTAT3" "shSTAT3–1"
    "shSTMN1" "shTCP80" "shTw" "sheet-like" "short-patch" "short-term"
    "short-time" "shorter-lived" "showen" "shp53-753" "shp53-814" "shrunken"
    "si-Akt" "siALK" "siAR" "siATG" "siATG7-mediated" "siATG7-transfected"
    "siArp8" "siControl" "siCtrl" "siDDX3" "siEXO4" "siEXOC2" "siEXOC4"
    "siFANCJ-2" "siFra-1" "siHDAC1" "siHDAC2" "siIL" "siIL-25" "siIL-25R"
    "siINO80" "siIRE1α" "siIes2" "siIes6" "siN-cadherin" "siNon" "siP27"
    "siP27-DMSO" "siP27-MLN4924" "siPD-L1" "siR-3" "siRELA" "siRNA" "siRNA#1"
    "siRNA#2" "siRNA-1" "siRNA-2" "siRNA-LUADT1" "siRNA1" "siRNA3" "siRict"
    "siSCR" "siTWIST1" "side-chain" "side-effects" "sidechain" "sidechains"
    "silico" "simplest" "simplicifolia" "simulation-based" "single-cell"
    "single-centre" "single-factor" "single-institution" "single-knockdown"
    "single-membrane" "single-motif" "single-nucleotide" "single-site"
    "single-strand" "single-target" "singly-bound" "sinusoids" "sip65" "sites"
    "six-hour" "six-month" "six-stranded" "size-controlling" "size-exclusion"
    "skeleto" "skeleto-muscular" "skewness" "skin-derived" "sland" "small-cell"
    "small-molecule" "small-scale" "smaller-scale" "smokers" "sodwanone"
    "soft-lithography-based" "soft-tissue" "solenoid" "solute" "solutes"
    "sought" "spacer" "spearman" "spearman's" "species-diverse" "specifice"
    "sphere-formation" "sphere-forming" "sphere-size" "sphingolipidoses"
    "spindle-like" "spitzoid" "spliceosome-dependency"
    "spliceosome-hypomorphic" "spline" "splitomycin" "spot-activating"
    "squamous-cell" "srep12738" "srep12807" "srep12841" "srep12870" "srep12917"
    "srep12949" "srep12963" "srep13001" "srep13002" "srep13076" "srep13135"
    "srep13144" "srep13189" "srep13300" "srep13347" "srep13405" "srep13422"
    "srep13426" "srep13445" "srep13461" "srep13474" "srep13528" "srep13547"
    "srep13574" "srep13676" "srep13718" "srep13735" "srep13815" "srep13846"
    "srep13959" "srep14035" "ssRNA40" "stably-associated" "stably-expressed"
    "stage-I" "stageI" "stageI-II" "stageIII" "stageIII-IV" "standalone"
    "standard-of-care" "state-SILAC" "status-independent" "steady-state"
    "steady–state" "steeper" "stem-PCR" "stem-cell" "stem-like" "stem-loop"
    "stemloop" "stemness" "step-size" "step-wise" "stepwise" "steroid-depleted"
    "stimulators" "stiochiometries" "stop-transfer" "store‐operated"
    "straight-line" "straurosporine" "stress-ATF4-CHOP-TRIB3-Akt-mTOR"
    "stress-activated" "stress-induced" "stress-mediated" "stress-response"
    "stressful" "stressors" "stress–induced" "stretch-activated"
    "stretch-induced" "stretch‐activated" "stroma-like" "stromal-decidual"
    "stromal-endothelial" "stromal-trophoblast" "stromelysins"
    "structure-activity" "structure-based" "structure-specific"
    "structure–function" "strychnifolia" "sub-G1" "sub-Saharan" "sub-acrosome"
    "sub-categories" "sub-cellular" "sub-centimeter" "sub-centrosomal"
    "sub-distal" "sub-family" "sub-group" "sub-groups" "sub-lethal"
    "sub-networks" "sub-nuclear" "sub-optimal" "sub-pathway" "sub-pathways"
    "sub-phenotypes" "sub-population" "sub-scale" "sub-set"
    "sub-stoichiometric" "sub-types" "sub-units" "subG0" "subclasses"
    "subcohort" "subcohorts" "subcomplex" "subcomplexes" "subdomain"
    "subfamilies" "subfertile" "subject‐to" "sublines" "submucosa" "subroutine"
    "subset" "subsets" "substage" "substrate-competitive" "subtribe" "subtype"
    "subunit‐1" "sub‐maximal" "sugar-phosphate" "super-TDU" "super-enhancer"
    "super-enhancer-associated" "super-family" "super-repressor" "supercomplex"
    "supergroup" "supernatant" "supernatants" "supress" "surgery-based"
    "susceptibility-associated" "synapse" "synapses" "synchronicities"
    "syndrome-associated" "synergises" "synergism" "synoviolin-1" "synthases"
    "synuclein-gamma" "system-wide" "tEGFR" "tachypnea" "tacrolimus" "tagSNPs"
    "tagged-p85α" "tau-pathological" "tau-pathology" "tazarotene"
    "telomerase-immortalized" "telomerase-negative" "telomerase-positive"
    "telomere-dysfunction" "temozolamide" "temporo" "temporo-parietal"
    "tenovins" "tentorium" "terminal-deoxynucleotidyl-transferase-mediated"
    "terolemia" "tetrakis" "tetraplegia" "tetraploid" "tetratransmembrane"
    "tetrazolium" "thalami" "thalamus" "thatHER‐2" "the14-3-3ζ" "theHER‐2"
    "thePIK3CAmajor" "theTP53" "therapeutically-exploited"
    "therapeutically-relevant" "therapy-resistance" "therapy-specific" "thes"
    "theses" "thiazole" "thiazolyl" "thiolactone" "thiosemicarbazones"
    "third-generation" "third-line" "third-most" "thirty-six" "thr202" "thr204"
    "thr37" "three-dimensional" "three-field" "three-stranded" "three-way"
    "threonine-187-phosphorylated" "threonine-containing" "threonine-specific"
    "threonine-to-methionine" "threshold-like" "thrombi" "thrombocytes"
    "thrombocythaemia" "thrombocythemia" "thromboelastography"
    "thromboelastometry" "thrombus" "thymidine-nocodazole" "thyroidectomy"
    "time-course" "time-dependently" "time-lapse" "time-of-flight" "time-point"
    "time-points" "timeframe" "timepoints" "time‐matched" "tissues" "titer"
    "titers" "tm1b" "to-2.2" "to15%" "tocyto" "toll-like" "toluidine"
    "topology" "toroid" "total‐IGF1R" "trachealis" "trachomatis" "tramtrack"
    "trans-factor" "trans-factors" "trans-membrane" "trans-well"
    "transcription-PCR" "transcriptome" "transcriptomes" "transducer"
    "transfactors" "transfected-CNE2-IR" "transfections" "transferase-mediated"
    "transferase1" "transgenes" "transgenic-mouse" "translocases" "transposon"
    "trastuzamab" "trastuzumab-drug" "trastuzumab-emtansine"
    "trastuzumab-naïve" "trastuzumab±s" "treatment-dose" "treatment-naive"
    "treatment-naïve" "treatments" "tribe–Rungus" "trichrome" "triggererd"
    "trihydroxyisoflavone" "trihydroxystilbene" "trilineage" "trimester"
    "trinucleotide" "triphosphate" "triple-labeling" "triple-negative"
    "triple-stained" "triple-staining" "triple-stranded" "triplexes"
    "trisphosphate" "triton-insoluble" "triton-soluble" "trophoblast-mediated"
    "tropicalis" "troubleshoot" "tubastatin" "tubules" "tumor-adjacent"
    "tumor-like" "tumor-node-metastasis" "tumor-nodes-metastasis"
    "tumor-relevant" "tumor-suppresive" "tumor-suppressive" "tumor-to-normal"
    "tumorsphere" "tumorspheres" "tumor‐type" "tumour-associated"
    "tumour-initiating" "tumour-necrosis" "tumour-suppressive" "turn-over"
    "two-chamber" "two-cycle" "two-hit" "two-hybrid" "two-sample" "two-sided"
    "two-stage" "two-step" "two-tailed" "two-thirds" "two-way" "two-year" "txr"
    "type-1" "type-c" "typical-enhancer" "tyrosin" "tyrosin-kinase" "ubH2A"
    "ubiquitin-proteosome" "ubiquitine" "ubiqutin" "ug"
    "ultra-micropositioning" "ultra-structural" "ultrapure" "ultrastructure"
    "un" "under-explored" "under-expressed" "under-expressing" "undergoes"
    "undergone" "underpinnings" "undertaken" "univariate" "unmet"
    "unresponsiveness" "untreated-parental" "up-concentration" "up-stream"
    "up-tuned" "upregulatd" "urea" "urothelium" "usefull" "uteri"
    "uterine-serous-carcinoma" "uveal" "v-IRF3" "vCYC" "vHMEC-hTERT" "vRNA"
    "vacuole" "vacuoles" "valganciclovir" "values" "variants" "varicocele"
    "vas" "vault-independent" "vdw" "vegf-A" "vehicle-treated"
    "ventilation-induced" "ventilator–induced" "venules" "vera" "viabilty"
    "villi" "villus" "viral-induced" "viral-infection" "virus-like" "viscera"
    "vital-suppressive" "vitro" "vivo" "voltage‐operated" "vs.1.01" "vs.1.72"
    "vs.1.74" "wall-to-wall" "water-soluble" "weakest" "weas" "website"
    "week-old" "well-accepted" "well-circumscribed" "well-conserved"
    "well-controlled" "well-coordinated" "well-defined" "well-developed"
    "well-differentiated" "well-documented" "well-matched" "well-moderate"
    "well-orchestrated" "well-oriented" "well-positioned" "well-preserved"
    "well-recognized" "well-studied" "well-suited" "well-timed"
    "well-tolerated" "well-written" "wheelchair-bound" "whole-brain"
    "whole-cell" "whole-exome" "whole-exome-sequenced" "whole-genome"
    "whole-transcriptome" "wide-range" "wide-ranging" "wide-type" "wide‐type"
    "wild-type-PIK3CA" "wild‐type" "window-of-opportunity" "winged-helix"
    "withdrawn" "within-tribal" "wok" "workers" "workshift" "world-wide"
    "wound-like" "written" "wt-CHFR" "wtBRCA1" "wtBrca1" "wtp53" "x10-5" "xl"
    "y-axis" "ycle" "year-old" "yes-associated" "yet-to-be-identified"
    "ypT0-2N0" "ypT0-2N0M0" "yr" "z-DEVD-FMK" "z-score" "zeta-potential"
    "zinc-associated" "zinc-dependent" "zinc-induced" "zymography" "z " "×10"
    "× 10" "× 10 " "× 10" "ɣ-irradiation" "ɣ-tubulin" "Δ1" "Δ12-39" "Δ133p53α"
    "Δ133p53β" "Δ133p53γ" "Δ16HER‐2" "Δ24" "Δ401-702" "Δ40p53" "Δ40p53α" "Δ45"
    "Δ640-702" "Δ65" "Δ9-tetrahydrocannabinol" "ΔM1" "ΔM2" "ΔNp53" "ΔNp63"
    "ΔR-CHFR" "ΔRING" "ΔSET" "ΔSUV" "ΔSUVpeak" "ΔSUVs" "Δp53-transduced"
    "ΔrodA" "ΔΨ" "ΔΨm" "Ιn" "Μurine" "Ψm" "α-adrenergic" "α-form" "α-helical"
    "α-helices" "α-helicity" "α-helix" "α-satellite" "α-solenoid" "α-subunit"
    "α-α-helical" "α-β" "α1c" "α22" "α23" "α28" "α2δ" "α3" "α4" "α5" "α5-α6"
    "α6" "α6β4" "α7" "α7-α8" "α8" "αC" "αC‐helix" "αC‐β4" "αN" "α‐toxin" "β-1"
    "β-Herpesvirinae" "β-NEMO" "β-Trap" "β-barrel" "β-barrels"
    "β-catenin-driven" "β-dimer" "β-glucans" "β-glucosidase" "β-induced"
    "β-oxidation" "β-sheet" "β-strand" "β-strands" "β-subunit-like"
    "β-transducin" "β1" "β1-AKT" "β1-dependent" "β2-3" "β2-β3-loop" "β2MG" "β3"
    "β3-tubulin" "β4" "βGEO" "γ-H2Ax" "γ-T3" "γ-herpesvirus" "γ-irradiation"
    "ε-amino" "κB" "μCT" "μL" "μg" "μg " "μl" "μmol" "π-stacking" "π-π" "χ2"
    "кB" "‘gatekeeper’" "‘hotspot'" "‘hotspots’" "‘monosome’" "„TKI-resistance"
    "„pan-HER-inhibitors" "„second" "‹0.05" "∆DBD" "∆LBD" "∗G" "∗T" "│R"))

(DEFPARAMETER SPARSER::*BIO-ENTITY-HEADS-PHASE3-15601-15900*
  '("potentialnew" "themolecular subsets" "2q33" "Stransky" "bisphospate"
    "the most aggressive subtype" "8/8" "Nasrin" "tenovins" "GSE17536"
    "nonobese" "the antiinflammatory drug licofelone" "licofelone" "p53 − / −"
    "P21  Waf1/Cip1" "available primary amines" "amines" "Ritchie" "*during"
    "GeneMANIA" "PANTHER" "Biotin" "pNL4-3" "BirA*-Gag" "Addgene" "mycBioID"
    "*-Gag" "capsid (CA)" "capsid" "multimerizes" "polyprotein" "vRNA" "BioID"
    "Co-immunoprecipitations" "p53mt" "reinitiate" "p53 −/−" "p65 siRNA" "B1R"
    "HOE-140" "cells /field" "0.014/pixel" "dichlorofluorescein" "cells/field"
    "Dil" "acLDL" "MNCs" "anti-senescence" "KKS" "mellitus (DM)" "0.001/"
    "0 ng/mL" "mutant/null" "Morel" "Twist1/p-4E-BP1" "co-overexpression"
    "shTw" "p-4E-BP1" "H1975Over" "H1650shTw" "gene/protein" "1 H" "mutant/"
    "Ptprt" "CytoScan" "phosphacan" "glycoaminglycan" "non-differentiated"
    "commercially available primary osteoblasts" "toluidine" "Xray"
    "primary calvarial osteoblasts" "osteopenia" "non-mineralized"
    "murine primary calvarial osteoblasts" "the mesenchymal osteoprogenitors"
    "osteoprogenitors" "1:100.000" "osteogenic differentiation ex vivo" "1  +"
    "co-purifying" "≥ 5" "co-purified" "diagnostic and therapeutic algorithms"
    "promyeolocityc" "TGCA" "Speleman" "the parental UM-SCC-74B cells"
    "UM-SCC-74B cells" "74BSerpE1up" "74B-SerpE1up" "SCC9shRNA159"
    "SCC9shRNA004" "UM-SCC-74B cell" "_SERPINE1" "-Meier" "Pau (HSCSP)" "HSCSP"
    "Pau" "Sant" "Creu" "shorter LRFS" "LRFS" "squamous mucosa" "= 0.015"
    "= 0.029" "LNCaP/met" "Bay 11–7085" "LNCaP/shAMPK" "TWIST/N-cadherin" "shN"
    "cadehrin" "PC3/p65" "siTWIST1" "Bay 11-7085" "metformin+GC-4" "Bay11-7085"
    "PC3/N-cadherin" "PC3/N-cad" "PC3/control" "PC3/met" "shcontrol" "pAMPK"
    "shAMPK" "N-cahderin" "cahderin" "the anti-tumor's" "prostatectomy" "7/23"
    "anti-LR" "multipartite" "STE" "SIRT1/3" "miR34a" "anti-thrombocytic" "LRs"
    "TISCs" "BCSCs" "hyperleptinemia" "grandiflora" "HNK" "shRNA1"
    "fibroblast-like" "COX-2/PGE 2" "E-series" "4T1/COX-2" "weight/volume"
    "PBMs" "caner" "IL-12/23" "= 0.024" "synergistic anti-tumor" "ATE-i2-b4"
    "Mouthon" "│= 0.42" "Cns" "9ser" "maintained/induced"
    "Sub-cellular co-localizations" "Globocan" "GSK-3β-9ser" "│R" "ProtoArray"
    "Anti-V5" "= 0.42" "co-localizations" "strong synergism" "PD:AZ" "Loewe"
    "0.25:1" "PD0325901 / Saracatinib" "AZ" "Legrier" "Sos" "co-treatments"
    "10.1038/srep14035" "Xiang" "Rochefordiere" "McIntyre" "Alexi" "RFS"
    "98/666" "8/105" "previously identified hotspots" "histological subtype"
    "= 0.54" "non-squamous" "Rebbeck" "generally 5 times greater" "canakinumab"
    "rilonacept" "Clendenen" "iNOS" "biallele" "Valencia" "Qiagen" "wtBRCA1"
    "wtBrca1" "BRATc1" "the ovarian epithelium" "FHOSE"
    "cortical invaginations" "prophylactic oophorectomy" "oophorectomy"
    "a premature stop codon" "the fallopian tube epithelium"
    "the ovarian surface epithelium (OSE)" "epithelium (OSE)" "OCs" "OC"
    "1  μ g" "Hou" "IIIA" "dysphagia" "using Pearson's"
    "underwent esophagectomy" "adherens" "EBA" "molecule-1" "isolectin"
    "simplicifolia" "bandeiraea" "fusiform" "larger solutes" "solutes" "PMVEC"
    "Evans" "PMVECs" "Lipopolysaccharide" "cobblestone-like"
    "larger scale co-clinical trials" "co-clinical trials" "auto-parylation"
    "Vina" "Autodock" "AutoDockVina" "MCULE" "EKVX" "aphidocholin" "docataxel"
    "∼130kDA" "pDEST40-CHFR-PBZ" "pDEST40-wt-CHFR" "ubiqutin" "ringfinger"
    "PBZ" "= 0.24" "oncotarget" "tocyto" "co-lolalization" "OMM" "triggererd"
    "aenobufagin" "iMAC2" "Mdivi-1" "mdivi-1" "WCE" "punctae" "The lowered ΔΨm"
    "-Val-Ala-Asp-fluoromethylketone" "benzyloxycarbonyl" "karyorrhexis"
    "pseudopodes" "subroutine" "Arenobufagin" "arenobufagin" "PGAM5L" "PGAM5S"
    "Δ Ψ m" "non-soluble" "futher" "BCR-ABL1" "shSTMN1" "viabilty"
    "destabilizer" "thrombocythemia (ET)" "Philadelphia" "T-lymphoma"
    "JAK2 V617F" "ETVs" "concomitance" "submucosa" "pathologic mitoses"
    "exogenous rhSCF" "rhSCF" "non-CRMAC" "AOM+DSS" "Yamachika" "COLM"
    "gefitinb" "CRMAC" "n = 20" "5-years" "Werzowa" "laevi" "HM11" "OSI-027"
    "OSI" "NHEMs" "phosphatidylinositol-4,5-biphosphate" "ser235/236"
    "Ser235/236" "Histological re-examination" "=8.4" "phyllodes" "Phyllodes"
    "re-examination" "Non-tumor" "misalign" "LMW" "andC" "Δ65" "andA"
    "Rajagopalan" "10.1038/srep13959" "20.7+" "E709X" "G719X" "37.5+" "14.8+"
    "gifitinib" "The predominant pathological subtype" "onco" "4/5" "≤3"
    "p  = 0.003" "~60%" "transfactors" "GST/GSH" "almost undetectable 24 h"
    "Polβ" "MMEJ" "the subsequent 24 h" "p-p70S6K" "p-4EBP1" "T/C"
    "re-distribution" "erlotinib/gefitinib" "non-toxic" "arrhythmia" "Matouk"
    "proNGF" "ALPHAscreen" "7h" "-miR-675-Cbl" "theses" "miR-675-3p"
    "Wiedemann" "Beckwith" "Brannan" "2 P" "pathway‐dependent" "AR‐positive"
    "log‐lank" "early‐stage" "‐10" "‐rank" "cut‐off" "‐off" "qdPCR" "Fluidigm"
    "BioMark" "cell‐free" "gDNA" "receptor‐positive"
    "a discriminatory predictor ofRFSandBCSSin early‐stageTNBCpatients"
    "‐stageTNBCpatients" "ofRFSandBCSSin" "cfDNAcould" "‐lank" "BCSS"
    "cfDNAhad" "hadPIK3CAmutations" "‐stage" "ddPCR" "cfDNAas"
    "ofPIK3CAmutations" "‐freeDNA" "3‐kinase" "= 0.006" "= 0.018"
    "next‐generation" "‐amplified" "‐negative" "Ortiz" "Isomäki"
    "non-responder" "EULAR" "CD3 +" "= 17" "CD14 + monocytes" "CD8 +" "Hadhb"
    "Crot" "gastric cancer-associated antigens" "miR-33b"
    "gastric cancer biomarker CA199" "CA199" "miR-33a" "43/57" "repurpose"
    "Erotinib" "hoc" "vs" "erotinib" "+cisplatin" "Monolayer" "pEFGR" "Matei"
    "mg/m" "clades" "spreading/actin" "morphotypes" "anterograde" "siEXOC4"
    "siEXOC2" "stromal cell-derived factor 1α" "H82L/H85L" "shPAK2" "shCon"
    "8161k9" "Cpz" "EDAA" "LLAA" "KKAA" "myristoyl" "PACS/AP-1" "AxxA"
    "Mukerji" "NL4-3" "chemoattractants" "assembly/function" "EXOC" "200 ng/ml"
    "SDF-1α" "patho" "Rejeeth" "terolemia" "hypercholes" "Tenovin-1" "OHC"
    "hydroxycholesterol" "~50 %" "~25 %" "ppRB" "leukemia/lymphoma (ATLL)"
    "10p11" "ZRANK" "RDOCK" "ZDOCK" "Accelrys" "Looper" "Minimizer" "TASSER"
    "coauthors" "EPIR" "polynucleosomes" "coregulate" "ERGO" "Anti-cancer"
    "catalyse" "Hef" "RecA-like" "UvsW" "bacterial RecG" "RecG"
    "helicases/translocases" "replication fork-like" "heteroduplex"
    "HLTF156-1009" "AflIII" "fork-like" "HLTF156–1009" "replicons"
    "DE557,558AA" "NN90,91AA" "90/91" "PDBID" "BcnI" "nucleases"
    "phosphoesterases" "standalone" "supress" "HIRAN" "2B" "10.1038/srep13718"
    "juxtamemberane" "0.09–1.30" "1.05–2.95" "≤5/50 HPFs" "≥5/50 " "1.05–2.17"
    "≤5 " "≥5 " "0.51–1.95" "z " "NOQAS" "Auerbach" "The viral genome" "HZ4"
    "FeSV" "HZ" "Zuckerman" "v-" "v" "protooncogene" "10.1038/srep13676"
    "D40/Knl-1" "Urata" "CIMD" "Kitagawa" "intracardiac" "siRNA/atelocollagen"
    "microphotographs" "LOF" "KMN" "atelocollagen" "mean ± S" "Caspase 3/7"
    "caspase 3/7" "CSWs" "HESN" "infection/integration" "PAMPS" "Heggelund"
    "ssRNA40" "urea" "TLR2/6" "TZMbl-2" "sTLR2" "Thibault" "gB" "plasmacytoid"
    "co-infected" "premature co-morbidities" "NHP" "TLR2/1" "P  = 0.0004"
    "= 0.0002" "–4 " "Pam 3 CSK 4" "non-pathogenic" "malignance" "HNSCCs"
    "=0.13" "mg/kg/d" "Ras/" "P13K/AKT" "χ  2" "50 ng/mL" "=0.06" "HGF/Met"
    "nonhistone" "arrest/death" "molecular/metabolic" "nanomaterials"
    "splitomycin" "multidomain" "NLs" "NL" "CCF-NL-induced" "Shiyan" "Hubei"
    "Multilamellar phosphatidylcholine liposomes" "epicatechin" "liposomes"
    "nanocrystals" "micelles" "DDSs" "Liposomes" "particulate" "thrombi"
    "pectoris" "Coggygria (CC)" "Coggygria" "SIRT" "SIRTs" "lymphoma/leukemia"
    "antibrain" "liposome" "polyethyleneglycol" "CCFs" "coggygria (CC)"
    "coggygria" "Cotinus" "polyphenol" "senescence-like" "peroxisomal ROS/RNS"
    "sites/modifications" "phosphorylation/ubiquitination"
    "hypolipidemic fibrates" "fibrates" "authophagy" "lymphoblasts" "mRFPSKL"
    "autophagic flux/pexophagy" "SKL" "peroxins" "PhosphoSite" "HA-Ub-K0"
    "mono-and" "S/T" "pan-phospho-" "*/T" "*Q" "dihydroethidium (DHE)"
    "dihydroethidium" "Zellweger" "VLCFAs" "mean ±s" "1μg/ml" "phospho-4E-BP1"
    "BioGRID" "PXD" "identifiers" "ProteomeXchange" "PPIs" "roadmap"
    "pladienolide" "CCDC97" "protostomes" "deuterostomes" "GLEBS" "cnidarians"
    "Given CCDC22’s" "COMMD2/3" "CCDC22" "morpholino" "COMM" "stiochiometries"
    "AP/MS" "supergroup" "Opisthokonta" "Eukarya" "~1/3" "~500 million"
    "GeneMania" "CORUM" "Apicomplexa" "clade" "Cnidaria" "Protostomes"
    "Deuterostomes" "phyla"
    "interactors showed highly correlated co-fractionation" "holdout"
    "interologs" "co-complex" "external datasets" "HumanNet"
    "high pair-wise protein co-fractionation" "discoideum" "Nematostella"
    "purpuratus" "Strongylocentrotus" "musculus" "Dictyostelium"
    "co-fractionation" "PPI" "interactomes" "soluble multiprotein" "SF3b"
    "smooth muscle-22α" "dictyostelium" "lamellipod" "phosphoinositides"
    "14/48" "37/68" "13/48" "41/68" "ImageMASTER" "NEEC" "Kazakh"
    "Material/Methods" "10.1038/srep13846" "Maki" "Ichimura" "Komatsu" "ME1"
    "non-smoker" "tetratransmembrane" "LUADs" "n  = 12" "migration/invasion"
    "deoxynucleotidyl" "ELK1-shRNA-expressing" "disphenyl" "thiazolyl"
    "respective scrambled control-shRNA-expressing" "control-shRNA-expressing"
    "/65.9%" "UMUC3-" "UMUC" "urothelium" "6 /10" "-shRNA-expressing" "= 0.042"
    "pahway" "E-box" "BT549/p53" "MCF10A-Twist-sh-Ctrl" "MCF10A-Twist-sh-Twist"
    "EMR" "re-grow" "and 2-oxoglutarate-dependent" "rCCL5" "CWR22RV1"
    "factor 2α" "PCDNA3" "Sema3s" "Sema3" "Sema3-NRP-PlxnA" "leave-one-out"
    "GSE32269" "GSE38241" "GSE35988" "GSE6919" "angiome" "GSE21034"
    "discriminant" "Subsets" "multigene"
    "previously published prostate cancer microarray datasets" "p  = 0.001"
    "± 3 " "K -means" "thromboelastography/thromboelastometry" "euglobulin"
    "normovolemia" "anti-fibrinolytic" "re-bound" "hypothermia"
    "larger blood loss 24 h" "D-allele" "G-5G" "The latter genotype"
    "significantly higher blood loss 4 h" "cardioplegia" "RAAS"
    "4Guanine/5Guanine" "increases a 15-fold only 2 h" "type-1" "bleedings"
    "D-dimer" "I/D" "= 0.02" "P  = 0.0001" "Insertion/Deletion" "D/D" "I/I"
    "siINO80" "forkhead box A1/2" "Arp8-" "Arp" "Arps" "pBS-shINO80" "p53-/-"
    "BRAC2/CDKN1A" "INO80-" "INO" "shINO" "pBS" "EMTD" "co-occupy" "Re-ChIP"
    "Arp8" "co-occupancy" "non-treatment" "p53+/+" "p21 Waf1/Cip1" "melatonin"
    "opioids" "PCT" "myocardium" "omega-3" "Americans" "DHA" "Wnt/ β -catenin"
    "/Akt/mammalian" "Leng" "etheno" "VCM" "a risky haplotype" "μ g/L" "MHBMA"
    "short-time airborne environmental exposure samplings" "samplings" "OSHA"
    "Poisson" "NPBs" "DHBMA" "workshift" "TWA" "ex-" "apurinic/apyrimidinic"
    "Ningbo" "c1c1" "/high" "NPB" "Czech" "HPRT" "common genotoxic endpoints"
    "endpoints" "NBUD" "TCGG" "diphosphate" "cytome" "CBMN" "NBUDs"
    "1,3-butadiene-" "BD-" "= 1.3 " "1 p" "± 0.02 " "Arg399Gln"
    "polymorphic variants rs3218536" "Ribeiro" "a polymorphic variant c"
    "Fuchs" "unnecessary biopsies" "BigDye" "rs861539" "rs3218536" "rs3784099"
    "rs10483813" "rs1801321" "BCDX2" "15q15.1" "Poland" "rs1801320" "19q" "μ L"
    "=0.006" "=0.012" "K/L" "n=20" "nM/mL" "ENOX3" "to 2H" "ENOX2" "ENOX1"
    "oxidases" "ENOX" "osteophyte" "Kellgren" "Outerbridge" "arNOX" "=22" "=20"
    "DiPaola" "oncovin" "hydroxydoxorubicin" "co-inhibition" "Crizo"
    "necrosis/apoptosis" "anti-tumoral" "siATG" "siALK" "Eskelinen" "AVi"
    "FEPD" "SU-DHL-1" "fluoresce" "lysosomo" "visualization/quantification"
    "10.1038/srep13815" "phospho-eIF2α" "PBA" "p-p70S6" "phospho-p70S6" "CQ-"
    "keV/μm" "approximately 2.3 Gy" "LQ" "CQ" "OER" "Bragg" "6 Gy"
    "10.1038/srep13574" "CX3CR" "CCR" "CXCR" "JAK-STAT3" "GSE11729" "μl"
    "cell lines—H1299-EGFR-WT" "MPEs" "pleura" "MPE" "100 ng/ml" "NOD/SCID"
    "The inconsistent conclusions drawn" "H-scores " "≥15" "10.1038/srep13547"
    "ΔΨm" "·IκBα" "anoxia" "SN50" "p65siRNA" "further increased 24 h" "IKK-α/β"
    "TransAM" "timepoints" "parafilm" "activation/injury" "MODS"
    "Co-localization" "1 h" "0.5 μg/ml" "miR-195-Inhi" "siFra-1" "Wt"
    "online algorithms" "Porkka" "1 × 10" "2–3 " "miR -23b" "miR-181b"
    "killing/apoptosis" "decreased late stage autopagic vacuoles"
    "early stage autophagic vacuoles" "autophagosomesj" "Selinanova" "2DG"
    "Nultin" "energy/nutrient" "bafliomycin" "Manchón" "Moruno" "Pinedo"
    "Ramirez" "cultured cardiac myocytes" "Marambio" "ULK1/2" "recycling/reuse"
    "Pankau" "DG" "co-treated" "Non-canonical"
    "promoting ovarian cancer stemness" "/CD133 +" "heterogeneous lineages"
    "flash/" "publicly available algorithms" "diabetic/severe"
    "ovarian cancer cell stemness" "antagomiR-1207" "CSC-like" "SP +" "SFRPs"
    "ovarian cancer stemness" "Chau" "β-catenin /" "24-hours" "0.5 μg/ml"
    "Wnt/ β-catenin" "stem cell -like" "casein kinase 1α"
    "analytical algorithms" "CCLE" "ATARiS" "the SMARCA4 typical enhancer"
    "Mir30-shRNA-mediated" "Mir" "MSigDB" "microsatellites" "CAV1/2"
    "Enhancers" "Enhancer" "near-whole genome" "= 13" "IC 50 s" "CRISPR/Cas"
    "Trcp" "HDAC1/2" "siHDAC2" "siHDAC1" "ΔSET" "Mapper2" "Consite"
    "co-repressor" "spindle-like" "sapiens" "dRad6" "immunohistology" "SMMC"
    "eluate" "GenScript" "HL-7702" "H3K56Ac" "CAF-1 further deposits H3/H4"
    "H3/H4" "Anti-silencing" "RAD6" "Sugasawa" "EUFA30" "G-quadruplex"
    "siControl" "quadruplex" "triplexes" "D-loops" "non-pCR" "Jung" "Koolen"
    "ΔSUVs" "neoadjuvan" "ought" "non-pCRs" "pCRs" "ΔSUVpeak" "SUVpeak"
    "tomography/computed" "ΔSUV" "= 0.031" "destabiliser" "Lu" "Hu"
    "both AR-activated and—repressed transcriptomes" "ASF2" "LN95" "Jin"
    "ARBSs" "Cyclin E2" "non-duplicated" "2b" "DRE" "androgenic cistromes"
    "cistromes" "FAIRE" "CWR22Rv1" "non-androgenic" "co-regulated"
    "N-glycosylation" "BALBk" "HRGm1,2" "HRGm2" "HRGm1" "28/31" "QSTAR" "XL"
    "WB11" "WB7" "bipotential HOCs" "HOCs" "iTRAQ" "LC–MS/MS" "maytansinoid"
    "pHistone" "outweighd" "trastuzamab" "pM" "initiation/progression" "Sheng"
    "mean ± s" "nu / nu" "anti–phosphotyrosine" "polyethylenimine" "CCF"
    "oxodG" "Parker" "adduct" "Adair" "CCNU" "GHD" "cyclophiline" "O6BG" "CTG"
    "NCIC" "Canada" "siRNA #3" "U373" "chorionic villi" "MIR34A" "MIR"
    "stemloop" "Doridot’s" "trimester" "-URT" "URT" "the chorionic villi"
    "villi" "Doridot" "deciduas" "MicroRNA-34a" "24 h" "Cohen" "Cheng"
    "Richardson" "+0.92" "lowM" "chelate" "ΔNp63"
    "4,4-dimethyl-3-thiosemicarbazone" "DpT" "thiosemicarbazones" "dipyridyl"
    "PIH" "2-hydroxy-1-napthylaldehyde" "Desferrioxamine" "Fe" "isonicotinoyl"
    "immunohistochmeistry" "TALEN" "TTTT" "6–10B" "5–8F" "screenings"
    "15–50/100,000" "χ2" "wok" "Spanish" "interstudy" "Colson" "h  " "IIC"
    "Pvu" "6q25.1" "95% CI " "re-biopsy" "co-presence" "Graziano" "cfDNA"
    "Non-small" "cyt c’s" "non-polar" "Burk" "Lineweaver" "Randi" "mV"
    "14 fungal cyt c" "cytochromes" "410/280 " "ammonium" "410/280"
    "this fungal cyt c" "Silva" "Medeo" "protein/factor" "capspase-3"
    "arrhizus" "non-apoptotic" "w / v" "v / v" "non-linear" "epithelial-like"
    "β3" "mesoderm" "α3" "α6" "adoptive immunotherapy"
    "specifically target tumor antigens" "homozygotes/heterozygotes" "E9.5"
    "Milbrandt" "dysmorphic facies" "facies"
    "subsequent phenotypic deformations" "deformations" "Losada" "pombe"
    "Schizosaccharomyces" "concatemers" "re-circularisation" "tg"
    "a long unidirectional concatemer" "their heterozygous littermates"
    "facial dysmorphisms" "dysmorphisms" "subsequent penetrance" "PRJEB9805"
    "The latter two breakpoints" "concatemer" "FREEC" "Socrates" "mappings"
    "Refseq" "Genbank" "Yamamoto" "oocytes" "E0771ERB" "24JKERB" "Carmen" "WGS"
    "cerebrum" "antigens (TSA)" "Tumor-associated antigens"
    "tumor-associated antigens (TAA)" "TAA" "M24 RASSF8" "PEAT" "1/II"
    "adheren" "R2/DR5" "Cntl" "Wp" "Microglobulin" "ID:11228" "siRNA 1"
    "shRNA 1" "Talins" "Cofilin2" "miR-200-ZEB1/2" "miR-200-ZEB1"
    "both Barrett's" "active integrin β1" "β1"
    "an immortalized esophageal epithelial cell line NE2" "NE2" "EC109"
    "ZEB1/ 2" "footpads" "cytoskeketon" "12p13" "β1-AKT" "ZEB1/2"
    "invasion/metastasis" "miR-200b" "SUPPLEMENTAY" "metagene" "metagenes"
    "GSE50948" "GSE22358" "GHEA" "pCR" "non-HER2E" "the Metabric dataset"
    "HER2E" "clinico" "available whole-transcriptome datasets" "TRAR" "CD8+"
    "CD20+" "= 0.73" "= 8.0" "10.1038/srep13735" "Endometrium" "+9325 " "+9325"
    "TAAACA" "thiostrepton-treated HESCs" "pH3-immunopositive HESCs"
    "proliferating HESCs" "approximate every 24 h" "vehicle-treated HESCs"
    "HSOCRE" "HSCORE" "glandular epithelium" "human endometrial biopsies"
    "human menstrual endometrium"
    "insulin-like growth factor binding protein-1" "an active gatekeeper"
    "HESCs" "5 × 10" "1 μg/ml" "= 14" "= 15" "n = 12" "MiR-128-3p" "MiR-19a-3p"
    "MiR-223-3p" "1p35.3" "16q22.1" "normal gastric adjacent mucosa" "3p26.3"
    "antrum" "Bartlett" "miR-124-3p" "miR-130b-3p" "miR-128-3p" "miR-19a-3p"
    "miR-223-3p" "aetio" "MiR-19a" "miR-19a" "sample‐specific" "‐distribution"
    "receptor‐bound" "‐bound" "co‐expression" "‐drug" "bi‐specific"
    "mono‐specific" "‐fold" "low‐dose" "Free‐CD80" "bound CTLA4‐Ig"
    "bound biopharmaceuticals" "anti‐CD80/anti‐CD86" "CD14+ monocytes"
    "CD3+ lymphocytes" "anti‐CD80‐PE/anti‐CD86‐APC" "CTLA4‐Ig‐Alexa647"
    "CD14+monocytes" "CD3+lymphocytes" "CD3+CD80+" "to15%" "‐expression"
    "CD86+" "CD80+" "CD3+CD80+CD86+" "CD14+" "anti‐CD80‐PE/anti‐CD86"
    "co‐expressed" "cross‐reactivity" "free‐CD86" "free‐CD80" "anti‐CD86‐APC"
    "‐APC" "anti‐CD80‐PE" "anti‐CD86" "anti‐CD80" "‐expressed" "anti‐receptor"
    "‐CTLA4‐Ig" "fluorescence‐labeled" "‐CD86" "‐CD80" "‐labeled" "Medimmune"
    "Biacore" "belatacept" "‐day" "day‐to" "dose‐range"
    "antidrug anti‐bodies (ADA)" "‐bodies (ADA)" "high‐dose" "predose"
    "dose‐dependent" "‐dose" "‐range" "1H7‐PE" "AbMed‐Alexa647"
    "double‐stained" "Alexa647" "‐stained"
    "the respective isotype‐PE/isotype‐Alexa647" "‐Alexa647" "‐647" "‐PE"
    "total‐IGF1R" "Total‐IGF1R" "Anti‐IGF1R" "free‐IGF1R" "‐arm"
    "cytometry‐based" "anti‐IGF1R" "MedImmune" "‐EGFR" "‐color"
    "a quantitative immunoassay" "analyte" "immunoassay" "‐human"
    "Biopharmaceuticals" "biopharmaceuticals" "CTLA4‐Ig" "Bs‐Ab" "‐reactivity"
    "‐Ig" "‐IGF1R" "‐Ab" "± 3" "concentration‐dependent"
    "Concentration‐dependent" "‐expressing" "‐based" "24–48 h" "‐to"
    "‐receptor" "SD6" "an aggressive molecular subtype" "SF3B" "pladienolides"
    "shBUD31" "each major spliceosomal subcomplex" "Sm" "subcomplex"
    "subcomplexes" "=6" "week-old" "inframe" "OICR-9429" "non-peptide" "OICR"
    "MI-2-2" "hoxa" "mono-methylation" "H3K9ac" "FL393" "COMPASS" "ites (TSS)"
    "ites" "mevalonate" "insertion/deletion" "Re-expression" "p53 WT"
    "MDA-MB-453s" "G12/13" "Gq/11" "Gs" "subunit 12/13" "ECF" "ECFs" "pHs"
    "non-PCSCs" "non-CSCs" "OCSC" "miR-99b" "growth/metastasis" "let-7b"
    "α2β1 +" "CD133/AC141" "Domenech" "nidus" "Pim-1L" "miscellaneous subsets"
    "lo" "Dick" "MCF7/AdVp3000" "canaliculi" "at least two NBDs" "NBDs"
    "androgen-like" "ERPC" "HRPC" "Hodges" "Huggins" "TAX327" "SWOG" "2-3"
    "PCSC" "PCSCs" "CD133 +" "negative/low" "non-sense" "= 0.02" "murid"
    "mLANA" "only splenic PBs" "polyvalent antigen" "responder" "operandi"
    "exogenous antigens" "antigens" "severe EMH" "EMH" "loxoribine"
    "hyperresponsiveness" "a polyvalent antigen" "≤0.0004" "hyperglobulinemia"
    "IgA" "migratory PBs" "long-lived PCs" "some long-lived PCs"
    "cell proliferation/activation" "PBs" "iMycCα" "MZ" "TD" "v-IRF3/LANA-2"
    "the latency-associated nuclear antigen (LANA)" "antigen (LANA)" "kaposin"
    "vCYC" "penetrant" "Cα" "non-Hodgkin’s" "Kaposi’s"
    "multicentric Castleman’s" "multicentric Castleman" "Castleman"
    "Myc/latency" "3B" "CD138 +" "C57BL/6" "non-Hodgkin" "L858R/T790M" "pEGFR"
    "in vitro / in vivo" "2 +" "I/II" "bisflavones" "hypodiploid"
    "trihydroxyisoflavone" "-6-methoxy-4H-chromen-4-ylidene" "7-hydroxy-3-"
    "acetohydrazide" "hydroxyphenyl" "anti-oxidation"
    "in vitro and in vivo pleiotropic anti-tumor" "A2780/CDDP" "RY-2f"
    "mean ± S" "cells / mL" "1H" "Cip/Kip" "BALB/C" "Anti-tumor" "Liu's" "Liu"
    "7q21–31" "pmiR" "hRluc" "HELF" "SCLS" "IARC" "NSCLS" "miR-29a" "∼50%"
    "metastasise" "Yale" "‘hotspot'" "=0.08" "FISH+" "wild-type/FISH+" "pHER2"
    "their IC 50 's" "±s" "nearly 20-times" "=0.02" "mean±s" "GOG" "Oncology"
    "extrauterine" "dose-titration-proliferation-assays" "USC" "=0.03" "μ g "
    "P =0.0001" "P =0.001" "=0.01" "Nakagawa" "Cochrane" "exon 4" "to 2p"
    "p63 +" "upregulatd" "RASEF" "subcohort" "CCNI" "AEBP1" "TNFRSF11" "/2/5/6"
    "subcohorts" "LR" "polysomies" "GCB-" "cIAP" "nonredundant"
    "germinal center B-like (GCB)" "B-like (GCB)" "GCB" "B-cell-like-DLBCL"
    "= 0.37" "= 0.26" "Tap73" "co-amplification" "and 3E" "ubH2A" "laevis"
    "PBD2A" "andand" "yet-to-be-identified" "H538A/K540A" "deubiquitylases"
    "anti–rabbit" "anti–mouse" "WT/" "WT/S" "3 B" "replication-dependent DSBs"
    "D-loop" "dsDNA" "replication-associated DSBs" "S2D" "terminated/stalled"
    "CldU" "pRPAS4/S8" "immunocytohistochemistry" "S4/S8" "NUCKS1-" "NUCKS"
    "the recombinational reporter cell line U2OS-DRGFP" "DRGFP" "ctbs"
    "pNUCKS1" "QEDS" "CKNKRRSGKN" "mimosine" "interstrand" "tropicalis"
    "ClustalW" "ssDNA" "DSBR" "paralogs" "S6A" "S4D" "as 1 h" "∼2-fold" "S2A"
    "1 h" "8 Gy" "S1981" "1 h" "Rad3" "Rs519982" "rs7389" "rs519982" "PHLBDI"
    "HBGFs" "HBGF" "rs4755779" "extrapancreatic CPA2" "CPA2" "LRC" "SNPinfo"
    "non-uniform" "SNPS" "rs10462021" "rs116307792"
    "marginally significant SNPs" "carboxypeptidase A2" "rs61997065"
    "rs10406453" "rs1071598" "BMIs" "skewness" "racial/ethnic" "Ghana"
    "Sunyani" "Ahafo" "Brong" "non-parametric" "= 0.1" "~48%" "immunobiology"
    "eosinophils" "autoimmune/inflammatory" "IL-25R" "rhIL" "/ionomycin"
    "siCtrl" "siIL" "placenta-derived hMSCs and human BMMSCs"
    "in-vitro-expanded IL-17A-expressing PBLs" "Approximately 1%–3" "myristate"
    "PBLs" "placenta-derived hMSCs" "BMMSCs" "trilineage" "-17A-secreting"
    "the paraxial mesodermal lineages" "hMSC" "hMSCs" "1 × 10" "5 × 10" "S2B"
    "S1F" "Th17" "the external validation dataset" "MiR-20a" "non-responders"
    "= 113" "≤ 1" "external stimuli all cause miRNA expression abnormities"
    "pcDNA3.1/p53" "Dox-" "promoterless" "doxo" "Genomatix" "pmirGLO-"
    "pmirGLO" "miR-362-3p" "c" "14q32.31" "mfe" "Miranda" "RRRCWWGYYY"
    "6-week-old" "Co-transfection" "300 +" "A/T" "S→" "re-direction" "Sce"
    "begun" "S/G2/M" "Fucci" "UWB1.289" "Holliday"
    "phospho-serine-X-X-phenylalanine" "1P" "2P" "smaller tumorspheres"
    "cell:cell adhesion" "the shed soluble ectodomain" "Isotype" "DECMA-1"
    "re-treated" "siRNA #1" "siRNA#3" "siRNA#2" "siRNA#1" "Tumorsphere"
    "RUNX2:DNA binding" "CADD" "CADD522" "trastuzumab/chemotherapy"
    "tumorsphere" "epidermal growth factor receptor-2" "ectodomain"
    "non-amplified" "recurrence/metastasis" "Hscores" "expression/activation"
    "P  = 0.001" "= 0.004" "χ 2" "× 10 " "5 × 10 " "2 + " "1 + "
    "Recurrent/metastatic" "recurrent/metastatic" "GeneNote" "Sutherland"
    "Biomax" "PFKB2" "1h" "GelCode" "Hanahan" "Vaiman"
    "a multifunctional DNA/RNA-binding protein"
    "the important nuclear factor κB" "1μg/mL" "II α" "McDermott"
    "telomere-compromised p16 INK4a -deficent vHMECs" "S-arrest" "procentriole"
    "p16 INK4a -deficent vHMECs" "finite vHMECs" "proliferating vHMECs" "2CT"
    "PD85" "PD35" "4 NEDD1" "octoploid" "S/G2" "at least 2 CT" "2 CT"
    "oligoFISH" "PD34" "PD21" "chamberslides" "around PD35" "immunoFISH"
    "Tetraploid" "BFB" "vHMEC" "vHMECs" "methoxy" "Escudero" "Baselga"
    "miRnome" "miR -20a" "caliper" "bw" "EV" "pMIRGLO" "GGAGTAT" "GCACTTT"
    "miRanda/MicroCosm" "-106a" "106a" "oncomiRs" "-hydroxystilbene"
    "hydroxystilbene" "-trihydroxystilbene" "trihydroxystilbene"
    "deletions/mutations" "miR-20a" "log2" "Ki-67 and" "miR-106b∼25" "or/and"
    "22q12.3" "RFPL" "Lac" "co-accumulation" "the Pearson's"
    "a cardinal transcriptional co-activator" "TTAGGG" "co-anchoring" "siRNA1"
    "co-regulate" "the first available dataset" "immunophillin" "SKOV3/Tx600"
    "SKOV3/Tx50" "RFs" "-hexamer" "SPARKI" "OVCAS" "solute" "MetaCore" "txr"
    "anti-AGO2" "VTRNA2-1-5p directly targets p53 UTRs" "p53γ" "5q31"
    "VTRNA1-2" "VTRNA1-1" "Mature miR-886-3p" "VRNA2-1" "-UTR-MUT" "-UTR-WT"
    "Wunsch" "Needleman" "Δ40p53α" "p53β" "nc886" "9±0.075%" "7±0.056%"
    "5±0.064%" "miranda" "mature VTRNA2-1-5p" "anti-AGO" "miRNP"
    "mature let-7e" "miR-886-3p" "VTRNA2-1" "VPARP" "VTRNAs" "browser" "HUGO"
    "VTRNA2" "CSCCs" "VTRNA2-1-5p" "RNA2-1-5p" "VTRNA" "±0.02" "Δ40p53"
    "non-transfected" "p = 0.0001" "= 6" "CerS1–6" "acyl" "co-aggregation"
    "Alexa" "MβCD" "quinovose" "STC" "anti-leukemic" "SM" "CerS" "synthases"
    "siRNA-2" "siRNA-1" "chr2:173417684–173417697" "ACCAGATGAGTCAT" "NCTs" "XX"
    "Niikawa" "non-mucinous" "6F11" "ID5" "Rouquette" "Kawai" "Raso" "pT1aN0"
    "minimally invasive subtype" "colloid" "micropapillary subtype"
    "histologic subtype" "ATS" "IASLC" "FoxP3+" "CD3+" "ERS" "P- values" "= 74"
    "specifice" "cell migration/invasion" "P-exposed" "independant" "biospies"
    "matoxylin" "Wenzhou" "P-induced" "P/B" "ditehylnitrosamine" "кB" "Benzo"
    "Isoselenocyanates" "Thr421/Ser424" "TissueScan"
    "the online clinical datasets" "phenethyl" "DNA9" "4/4" "T421/S424"
    "Adjudin" "adjudin" "diagnosis/prognosis" "mitochrondria" "Meier's"
    "Sirtuin" "N-acetyl" "Oncologists" "CTNNBIP" "27/30" "Kto" "DICE" "CU"
    "SUMOplot" "anti-pan-SUMO" "RGDI-2" "Mws" "Hsp7C" "Hsp90α" "MALDI-TOF/MS"
    "bortezomib-treated CA46" "bortezomib-treated Burkitt's"
    "bortezomib-treated Burkitt" "antigen (EBVA)" "EBVA" "human Burkitt's"
    "SENPs" "dipeptidyl" "Parkinson's" "Alzheimer's" "Parkinson"
    "Most Burkitt's" "non-Hodgkin's" "Burkitt's" "LMw" "both human Burkitt's"
    "CA46" "Burkitt" "-κB" "pcDNA 3" "bioprocess" "LSCM" "CaMKII/IV" "pEGFP"
    "/nuclear" "CaMKIV/II" "CO-IP" "Co-IP" "a smaller subset"
    "co-amplifications" "9p" "advanced or refractory Hodgkin's"
    "a clinically significant subset" "2/68" "12/41" "≥1" "Amplicons" "PDA"
    "aCGH" "diploid" "tetraploid" "aneuploid" "HER2+" "9p24" "amplicon"
    "genomes" "= 15" "non-receptor protein-tyrosine" "log 2" "a 3-day"
    "treated EACs" "chemonaïve" "esophagectomy" "dysplastic Barrett's"
    "dysplastic Barrett" "additive/synergistic" "IC90" "3-day" "siNon" "Doyle"
    "growth factor-1" "Barrett's" "Barrett" "EACs" "Non-target" "/95%"
    "factor/lymphoid" "HK" "ECAR" "positron" "-fluorodeoxyglucose"
    "fluorodeoxyglucose" "biomaterials" "bioenergy" "Carnitine" "Papeleu" "Noh"
    "slightly stronger" "induction/reduction" "SBE13-" "SBE13" "= 0.06"
    "p = 0.003" "= 0.0002" "non-functional" "Zeng" "microRNA-10a" "CHIL1"
    "miR-10a's" "miRWalk" "MiR-10a" "miR-10a" "5×10" "Gain-of-" "Set7/9 KD"
    "non-homologous" "methylnitronitrosoguanidine" "Set7/9KD"
    "an important transcriptional co-regulator" "CCNE" "Suv39 h1" "h1/h2"
    "recognises" "megabases" "and 2 μg" "5 × 10" "non-treated" "GSK33β" "OipA"
    "14q32.32" "the v- AKT murine thymoma viral oncogene homolog" "TC+CC"
    "covariables" "nondrinkers" "CON→AG→GC" "CON→AG" "CON→GC" "AG→GC"
    "rs1064261and" "Lauren’s" "Lauren" "Borrmann" "rs1064261 and" "rs2498804"
    "rs3803300" "rs1130214" "rs2494732" "G→A" "T→C" "rs2536" "rs1883965"
    "rs2295080" "GA+AA" "rs1130233" "rs1064261" "=0.0081" "LCS6"
    "also known as V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog"
    "hsa-let-7g" "=6.83" "let-7 is" "=3" "≥80" "14%±2%" "G 1 /S" "Sunaga"
    "the histological subtype" "histologies" "= 6.839" "histotypes" "Clinico"
    "histotype" "stereotactic radiosurgery" "radiosurgery" "WBRT"
    "corticosteroids" "7q31" "Auto-" "prognostic/predictive" "= 0.043" "xl"
    "Bcl" "polyphenols" "Flavonoids" "flavonoid" "Caspase-3/7"
    "intervetion/prevention" "cell cycle/ E2F" "Computational algorithms"
    "mesenchymal-like" "Drasin" "cell cycle/E2F" "PicTar algorithms" "BCLC"
    "NHCC" "ANLTs" "SLHCC" "P = 0.003" "andmiRNA" "miRNA-135b" "homografts"
    "miR-338-3p" "miRanda" "miRNA-338-3p" "preS2" "non-infected" "PNPT11/SHP2"
    "genes/pathways" "SFCs" "Mammosphere" "approx" "pluri" "mammospheres"
    "miR-23a/" "miR-23a increased NPC radioresistance" "8Gy" "&plusmn" "6Gy"
    "miR-23a increased NPC radioesistance" "radioesistance" "miR-23b"
    "miR-324-3p" "reduced miR-23a promoted NPC cell radioresistance" "agomir"
    "radioresponse" "∼60%" "≤12" "= 0.55" "= 0.58" "Bosch" "thrombocytes"
    "abnormities" "24 h" "C57BL/6J" "BRCA 1/2" "shSTAT3" "miRDip" "BT530"
    "PG-S3–002" "NODSCID" "BT478" "shSTAT3–1" "the active phosphoform"
    "phosphoform" "shControl" "V1.0" "V2.3" "FpClass" "TSM" "tumorspheres"
    "Loffler" "TIC" "Transducers" "oncomir" "BMIC" "BMICs" "neuro-" "osteo-"
    "osteo" "adipo-" "adipo" "non-orthodox" "radiation-induced DSBs"
    "secondary DNA DSBs" "MRN" "radiation-induced DNA DSBs" "multistage"
    "H2AX around radiation-induced DSBs" "Gingival biopsy" "gingiva" "ug/mL"
    "p = 0.0004" "Suzuki" "an aggressive subset" "RTOG"
    "-3-cyclohexyl-L-nitrosourea" "chloroethyl" "mut/" "wt/" "1p/19q" "FCNU"
    "parenchyma" "= 79" "‐generation" "ZKSCAN1‐BRAF" "‐driven" "KIAA1549‐BRAF"
    "nonhybrid" "certain histologic subsets"
    "subsequently underwent robotic‐assisted lobectomy" "46‐year‐old" "54/55"
    "‐18" "1–3" "‐ BRAF" "‐BRAF" "270/4,013" "Nonsmall‐cell"
    "high grade anaplastic astrocytoma histology" "191/531" "epithelioid"
    "4/2,154" "8/4,013" "nonsmall‐cell" "3/1,062" "3/294" "15/701" "14/531"
    "BRA" "nonSpitzoid" "Spitzoid" "FoundationOne" "‐old" "‐year" "‐cell"
    "10.1038/srep13528" "co-regulatory" "antigen (PSA)" "ARE4" "∆LBD" "∆DBD"
    "EGFP-AR-" "Y-box" "dormancy" "NBL" "co-regulator" "miR-18a"
    "auto-regulatory" "miR-190a" "MiR-190a" "preussin" "Annexin V/propidium"
    "intermembrane" "siP27" "siP27-MLN4924" "24 h" "MGC80-3" "24h"
    "0.5  μ g/ml" "intratumour" "synchronous BMets" "metachronous BMets"
    "cardia" "Microsatellite" "Western Africa" "BMets" "interquartile" "gastro"
    "multicentre" "Gastro" "=11" "and 3D" "prostaglandins" "isofagomine"
    "Neuronopathic Gaucher’s" "Neuronopathic Gaucher" "both two Gaucher’s"
    "human Gaucher’s" "other Gaucher’s" "transgenes" "viscera" "Crohn’s"
    "Crohn" "Niemann" "Sandhoff" "sphingolipidoses" "neuronpathic Gaucher’s"
    "neuronpathic Gaucher" "Mizukami" "glucosylsphngosine" "mouse Gaucher’s"
    "neuronopathic Gaucher’s" "neuronopathic Gaucher" "Three Gaucher’s"
    "all Gaucher’s" "glucosylceramide" "Gaucher’s" "Gaucher" "pg/ml" "Cruciat"
    "BIRC5A" "Δ45" "siDDX3" "arrayscan" "multilevel" "p = 0.001" "= 0.04"
    "= 0.01" "malignances" "re-sensitized" "E-64d/pepstatin" "E-64d" "d"
    "more acridine orange-stained acidic vesicular organelles" "Akt/mTOR" "Huh"
    "1 μg/ml" "mol/L" "dendropanoxide (DP)" "morbiferus" "Dendropanax"
    "dendropanoxide" "autophagic vacuoles" "proform" "flavonoids"
    "cervical cytology" "acidic autophagic vacuoles" "LC3II" "BA" "bafilomycin"
    "AVO" "acidic vesicular organelles" "AVOs" "Batalin" "inflata"
    "Licochalcone" "methyladenine" "licochalcone" "10.1038/srep13474" "CSDE1"
    "HEK-293FLG-LIX1L/PY136" "NCBInr" "5p" "has-miRNA-520a-5p" "and 3p" "scRNA"
    "pseudogenes" "HEK-293FLG" "MALDI-TOF/TOF" "pY136" "HEK-293FLG-LIX1L"
    "PY95" "PSNSPPYVCY" "PY36" "Pcont" "YGRKKRRQRRR" "dsRBD" "-#2"
    "Representative photomicrographs" "photomicrographs" "Homeodomain" "1q21.1"
    "lowfat" "PY136" "homeodomain" "1-like" "#5" "and 2 μg"
    "anti-phosphotyrosine" "non–small" "−7–" "anti-tumour" "pMET" "DME25"
    "ECIS" "activation/phosphorylation" "motogens" "cHGF" "XiaoJi (YZXJ)"
    "EVOS" "namely YangZheng XiaoJi ( YZXJ )" "XiaoJi ( YZXJ )" "YZXJ" "XiaoJi"
    "YangZheng" "50 ng/ml" "12 h" "10.1038/srep13426" "Stockley" "thes"
    "an intronic splicing enhancer (ISE)" "enhancer (ISE)" "ISE" "Ensembl"
    "ENST00000504326" "Grasso" "~2.5-fold" "TMPRSS"
    "any discrete subnuclear organelle" "SNBs" "co-localise"
    "co-immunoreprecipitated" "~1.5-fold" "ESEm"
    "exonic splicing enhancer (ESE)" "enhancer (ESE)" "ESE"
    "a premature termination codon (PTC)" "codon (PTC)" "LBD" "minigene" "3b"
    "CRPCa" "1 × 10" "non- silencing" "Non-Target" "pcDNA3" "anti-Rabbit"
    "anti-Mouse" "= 0.00003" "= 0.03" "= 0.01" "p  = 0.0001" "= 0.04"
    "= 0.0003" "co-activates" "-Rg3-induced" "quinquefolius" "Panax" "-Rg3"
    "Rg3" "Gallbladder" "G 0 /G 1 phase" "nu/nu" "Anderson" "biofate" "Hoechst"
    "minimal co-localization" "endosome/lysosome" "h-R3/DNA" "polycations"
    "N/P" "H-R3" "dendriplex" "CLSM" "nano" "polyamidoamine" "Dendriplexes" "h"
    "dendriplexes" "tumor-associated neovasculature" "neovasculature" "gapdh"
    "gfp" "TPA" "Erk2Q103A"
    "publicly available DNA microarray expression datasets" "zymography"
    "168FARN" "FARN" "Balb/c" "re- expression" "severe WMLs" "hypertensive ICH"
    "ICHs" "Choi" "year-old" "Jeju" "the modified Schelten’s"
    "the average Schelten’s" "Schelten" "moderate or severe WMLs" "2-R544C-3"
    "D19S411" "D19S929" "CMBs" "putamen" "pons" "temporo"
    "Moderate or severe WMLs" "WMLs" "brainstem" "tentorium" "semiovale"
    "centrum" "thalami" "Stroke/TIA" "TIA" "ICH" "Veneto" "Taiwanese"
    "southern Korea" "the most frequently mutated exons" "Dutch" "HGMD" "OMIM"
    "rarer" "Taiwan" "hepato" "pneumophila" "Guangzhou" "tacrolimus"
    "non-cancerous" "Cary" "Pearson’s" "Downers" "Imager" "propanesulphonate"
    "dimethylammonio" "cholamidopropyl" "FITC-PNA/mL" "w/v" "hypogaea"
    "Arachis" "Waltham" "Elmer" "Perkin" "UltraView" "μm/s" "FLMP" "FMLP"
    "Labsystems" "Fluoroskan" "μL" "cells/mL" "40/80" "Calbiochem" "FERpharma"
    "Göteborg" "Nidacon" "PSW" "Temecula" "Heidelberg" "Italia" "Padova"
    "Endocrinology" "condicio" "qua" "caveolae/microdomains" "co-addition"
    "withdrawn" "non-viable" "RLU" "luminol" "luminometer" "CASA"
    "4-Amino-5-(4-chlorophenyl)-7-( t -butyl)pyrazolo" "-7-" "4-Amino-5-"
    "pyrazolo" "chlorophenyl" "infertile/subfertile" "polymorphonucleocytes"
    "midpiece" "NVC" "Asta" "rs2227310" "Zhu" "siRELA" "p65-pS536" "granulose"
    "anti-correlation" "H3122/miRCont" "H3122/miR224" "OSU" "Ohio" "proCASP7"
    "proCASP3" "QuickChange" "miRZip" "1×10" "non-genetic" "P = 0.0001"
    "10.1038/srep13445" "Xia" "STTM" "Cupid" "Ce" "silico mathematical ceRNA"
    "CDR1as" "approximately 70 MREs" "circRNA" "circRNAs" "BGL3" "miRcode"
    "CARL" "MREs" "Salmena" "fer-1-like" "ceRNAs" "miR-106a-5p" "FER1L4"
    "ceRNA" "pseudogene" "G 0 /G 1" "follicle" "ovarian hyperandrogenism"
    "the ovarian hyperandrogenism" "their causing ovarian hyperandrogenism"
    "the most severe hyperandrogenism" "nonmalignant" "hirsutism"
    "hyperandrogenism" "10.1038/srep13001" "Arbelet" "Follin" "BMM" "Talalay"
    "Chou" "A2A" "HMCLs" "mg/day" "daropate" "colforsin" "Hindu" "forskohlii"
    "Coleus" "Non-Targeting" "Anti-rabbit" "full‐length" "disease‐free"
    "‐T798M" "‘gatekeeper’" "‐L726I" "ATP‐binding" "Mmol/l" "‐agents"
    "anti‐HER‐2" "heterodimmers" "‐analysis" "Africans" "meta‐analyses"
    "‐analyses" "Xie" "atcodon" "commonest" "dimmers" "HER‐3" "subdomain"
    "HER‐2‐positive" "‐length" "611‐CTF" "‐CTF" "‐HER‐2" "p95HER‐2" "Δ16HER‐2"
    "S310F/Y" "‐terminal" "‐3" "in‐frame" "phospholipase Cγ" "αC‐helix"
    "transducers" "ligand‐independent" "αC" "‐binding" "wild‐type"
    "epidermal growth factor receptor‐2" "P780ins" "modus" "‐frame" "‐helix"
    "‐loop" "‐4" "previously classified asHER‐2" "asHER‐2" "theHER‐2" "ofHER‐2"
    "‐positive" "HER‐2" "erbB" "‐derived" "95% CI " "V/V" "‐free" "‐β" "ENaC"
    "FSK-" "phosphomutant" "~74%" "FSK" "cyan" "PolII" "Mihaylova" "IIa"
    "subfamilies" "PP1/2" "~70%" "non-genomic" "Visser" "J82/B cells" "pCDNA"
    "co-implanted" "J82" "co-culturing" "hrs" "tissues/cells" "Antigen" "TME"
    "1 × 10" "angiopoietins" "Bmpr" "the uterine decidua" "Nagashima"
    "maternal decidua" "blastocyst" "leakiness" "lamellopodia" "HESC" "TPBPA"
    "timeframe" "the lateral sinusoids" "sinusoids" "pregnant uteri"
    "pregnant Rac1  d/d uteri" "follicles" "lutea (CL)" "CL" "lutea"
    "six-month" "d/d" "f/f" "the mesometrial and antimesometrial decidua"
    "histochemistry" "blastocysts" "uteri" "the maternal decidua" "decidua"
    "the maternal endometrium" "insulin-like" "DHS" "DPQ" "MSPCR" "BRAC" "BPAP"
    "GCGC" "HhaI" "CCGG" "HpaII" "HindIII" "MSRE" "iv" "BeadChip" "Infinium"
    "hemi" "CWG10" "CWG1" "CWGs" "CCWGG" "CWG" "Browser" "UCSC" "DHSs"
    "figshare" "midpoints" "deciles" "Matveeva" "HuRef" "nusieve" "remodelers"
    "auto-PARylation" "remodeler"
    "Poly (ADP-ribose) Ribose Polymerase-1 (PARP1) also known as ADP-ribosyl transferase1"
    "transferase1" "Ribose" "Polymerase-1" "polymerase-1" "CpG10" "~20%"
    "co-localizes" "= 0 . 4" "Hg19" "Murata" "Vec" "PROMO" "ALLGGEN" "AR+NC"
    "AR+miR-145" "scr" "0 ng/ml" "10.1038/srep13405" "Kirby" "Wirthmueller"
    "Lange" "non-linked" "S268E" "S266E" "S259E" "M1M2" "sidechains" "TPS"
    "W184R/W231R" "KRPK" "ΔM2" "ΔM1" "N/C " "N/C" "CellMask"
    "the two most probable monopartite" "Mapper" "peptide/Impα" "RMSD " "-X-"
    "K/R" "SVP" "oxygens" "nonapeptide" "and 2–4" "VPKRPKLP" "KRKL"
    "only two helices" "Fontes" "hXRCC1" "Lig3β" "Lig3α"
    "constitutively bound DNA ligase 3α" "co-transport" "Kiriyama"
    "monopartite" "NLSs" "BRCTa" "SSBR" "Impα" "H-bonds" "1 and 2"
    "co-evolution" "Head/Neck" "PTSG2" "composition/remodeling" "pValue"
    "ChIPpeakAnno" "Metacore" "plus/minus" "head/neck" "injection/tumor" "HDF"
    "HDFs" "CSL-p53interactions" "againstcancer" "Secretome" "failsafe" "hg19"
    "50 ng/ml" "100 ng/ml" "200 ng/ml" "500 ng/ml" "Dickopf-1" "mtor"
    "Calcusyn" "Synergism" "synergism" "gatekeeper" "Thr37/46"
    "vascular endothelia" "endothelia" "immunotherapies" "R172H/+" "G12D/+"
    "caspase-3/7" "≥50" "CyTOF" "FISSEQ" "priori" "WT+AMP" "MUT+AMP"
    "chemotherapy+trastuzumab" "Simpson" "Shannon" "Neoadjuvant" "droplet"
    "CEP17" "11q13" "histogel" "clinically relevant mutational hotspots"
    "topology" "Co-occurrence" "ASCO/CAP" "K-means" "= 0.0003" "≥ 2" "vitro"
    "Paracrine" "Schulze" "monotherapy" "Bevazicumab" "ESMO"
    "a considerable subset" "CIMP" "henotype" "sland" "epigenome" "villus"
    "progeny" "co-occurrence" "initiators" "cecum" "18/50" "sessile"
    "the normal intestinal epithelium" "-wildtype" "co-occur" "co-depend"
    "the intestinal epithelium" "co-occurrences" "9/9" "non-redundant" "Leydig"
    "Eckardstain" "Ukraine" "Wroclaw" "Greenland" "Bira" "Trzmiel" "Filus"
    "Caucasoids" "Caribbeans" "Ackerman" "Carlsen" "Western Europe" "Estonians"
    "Finns" "Estonia" "Finland" "mln/ml" "Finnish" "spermatozoa/ml" "p=0.003"
    "=0.0004" "p=0.001" "=0.003" "the Spearman’s" "hydrocele" "varicocele"
    "deferens" "vas" "epididymis" "=−0.38" "=0.000001" "p=0.0000001" "=0.0003"
    "=−0.34" "p=0.0001" "R=0.37" "=0.00003" "R=0.40" "=0.0001" "=0.37"
    "=0.0000001" "Greater" "trinucleotide" "SHGB" "Sertoli" "gonad"
    "Spearman’s" "=0.40" "Lublin" "Poznan" "±3" "ROI" "COMBO" "QD" "stressful"
    "nanoliposomes" "Xcovery" "unresponsiveness" "2p" "rearrangments"
    "paediatric oncology" "oncology" "TL" "anti-GD 2" "IC 50" "Non-Small"
    "QQESNQAEASKEVA" "KTSPRRPLILKRRRLPLPVQNAPSETSEEEPKRSPA" "non-HGSC"
    "genes/proteins" "-Rho-YAP" "ELASA" "ARGE" "Danvers" "cyclohexamine"
    "-Rho-ROCK-protein phosphatase 1A" "MK2203"
    "cell proliferation/mutagenesis" "dpYAP" "LPA 1–3" "HGSC" "oncolipid"
    "0.5 μg/mL" "C/T" "FOXM1C" "FOXM1A" "100 ng/mL" "anti-proliferation"
    "12/13" "10.1038/srep13422" "ANRIL" "Kobashi" "Schwarz" "hsa04930"
    "rs822387" "case/control" "GWASs" "GO0032990" "ABSI" "GO0051247"
    "GO0032270" "significant empirical P -values" "hsa05030" "T2DM" "DLEU1"
    "CREG2" "ADIPOGen" "ICSNPathway" "cdc42racPathway" "hsa00603"
    "Algorithm (GSEA)" "GenGen" "BMI " "Algorithm" "±3 " "CDKN2A/B" "P = 0.001"
    "= 0.019" "hypoxia-inducible factors 1and 2" "1and 2" "TZL's"
    "PKCθ-dependent" "CellMiner" "bryostatin" "QSAR" "sodwanone" "NCI"
    "addressed TZL's" "addressed TZL" "sanguinolenta" "Stillingia" "Mexican"
    "englerin" "PKCθ" "CCRCC" "TZL" "a possible co-regulation" "Fuxia" "LSCc"
    "Killela" "Salah" "10/226" "Swedish population healthy controls 22/806"
    "22/806" "Hsu" "the intronic SNV rs2736100"
    "three additional intragenic SNVs" "co-activate" "heterozygotes"
    "the other analyzed TERT SNV's" "rs35719940" "inCEBPA" "POT" "SNV's"
    "several TERT SNV's" "SNV" "karyotype" "rs2853669" "rs2736100" "SNVs"
    "co-regulation" "non-mutated" "non-centriolar" "Flory" "Schnackenberg"
    "letters/numbers" "letter/number" "only CEP63 co-localized"
    "exposure/brightness" "Wiener" "fluorophore" "fluorophores" "#6"
    "co-depletion" "SMARTpool" "Dhamacon" "misrecruit" "#282" "#283" "Graser"
    "co-depleted" "troubleshoot" "de-localization"
    "there indeed more protein co-localizing" "co-localizing" "brighter"
    "localization/pattern" "IRB" "insightful" "Reiter" "Malhotra" "Vivek"
    "ASPM" "melanogaster" "the proximal centriole" "co-depleting"
    "Centriolar satellite component CCDC14" "rs185246578" "_001254729:exon5:c"
    "SIFT" "exomes" "MC-702" "carinatum" "pectus" "nares" "Babinksi" "clonus"
    "hyperreflexia" "Achilles" "later developed tetraplegia" "tetraplegia"
    "MC-701" "Pakistani" "the centriolar satellite protein CEP90"
    "Centriolar satellite protein CEP90" "co-precipitating"
    "Centriolar satellite protein MOONRAKER" "gt/gt" "SPAG5-" "SPAG" "Firat"
    "procentrioles" "only two or three centrioles" "co-fractionated" "Balestra"
    "Jakobsen" "CENPJ" "STIL" "primordial dwarfism" "dwarfism" "Kodani" "goes"
    "CCDC14" "CEP90" "MOONRAKER" "re-establishment" "MTs"
    "activation/inactivation" "ADR/ZnCl" "wtp53/DNA binding" "WAF1/Cip1"
    "ubiquitine" "DSB" "0.5 μg/ml" "1 μg/ml" "stability/activity"
    "reactivators" "`mutant-like" "ZnCl" "** P  " "* P  " "mg/Kg" "2  + "
    "midbrain" "IR β" "Reiss" "phosphorylaton" "Ir" "Heni" "Clarke" "Braak"
    "S7c" "activation/reactivity" "S7b" "fluorimetric Cyquant" "S7a"
    "cell growth/viability" "Cyquant" "growth/viability" "ug/ml" "MAB391"
    "degradation/internalisation" "Threonine 202/Tyrosine 204" "p44/42"
    "mature IRβ" "I/F" "IRβ" "Chang" "synapses" "pS636/639" "NFTs" "GVD"
    "vacuoles" "neuropil" "NFTS" "Sheffield" "S636/639" "sought" "S2b"
    "F10:MEMα" "S2a" "Sciencell" "temporal neocortex" "neocortex"
    "insulin/IGF1" "the tripartite synapse" "synapse" "mortem"
    "Immunocytochemistry" "neuropathology" "IIS" "= 3" "μ g/ml" "Everett"
    "200ng/ml" "50ng/ml" "100ng/ml" "1000ng/ml" "500ng/ml" "300ng/ml" "rHDGF"
    "non-tumor colorectal mucosa (ANM)" "ANM" "intestinal epithelium"
    "Co-Immunoprecipitation" "hilar" "ductules" "tumoral epithelia"
    "extensiveness" "ductular-like" "pBax" "caspases 3/7" "GEM+CDDP"
    "active caspases 3/7" "rhLIF" "17/19" "eCCA" "12 h" "Stem cell-like" "= 12"
    "pg/mL" "pSTAT3" "Simbolo" "huntingdon" "glutamine:fructose-6-phosphate"
    "HiSeq" "breakpoints" "adenomatous polyposis coli" "Lundau" "Hippel"
    "breakpoint" "Kiesten rat sarcoma viral oncogene homolog"
    "Harvey rat sarcoma viral oncogene homolog" "Kiesten" "Harvey" "AmpliSeq"
    "co-existing" "exon 20" "= 3" "= 14" "Trithorax" "Yorki"
    "a genome-wide co-occupancy" "co-occupied" "Bayes" "nearest"
    "two independent biological replicates"
    "highly reproducible biological replicates" "a 3bp" "TGACTCA" "CATTCC"
    "MEME" "peakzilla" "two independent biological ChIP-seq replicates"
    "YAP1 transcriptional co-activation" "spacer" "Smads" "non-transformed"
    "YAP1/Hippo" "anti-YAP" "non-cancer" "FOXO1/3" "Akt/" "PI3 kinase/"
    "Ku-0063794-" "Ku" "electrical impedance" "impedance" "monolayers" "~75%"
    "siRict" "anti-angiogenesis" "onplants" "microcarrier" "~2.4"
    "phosphatidylinositide" "complex-2" "complex-1" "microvasculature"
    "Rapalog" "re-organization" "± 3" "+ 1" "non-silencing" "mTORC1/2"
    "antiparallel" "imidazole" "phenyl" "pS/T" "RSApSEP" "pS233" "pS/TXCOOH"
    "carboxyl" "RXF" "RSX" "isomers" "pS7" "Patchdock" "the 14-3-3ζ"
    "methylene" "CαH" "inFig" "TOCSY" "to 14-3-3ζ"
    "the protein-bound ligand/peptide" "NOESY" "Overhauser" "downfield" "KH16"
    "Gibbs" "enthalpy" "cal" "Isothermal titration calorimetry (ITC)"
    "Circular dichroism" "pS259" "KH16p" "RSXpS" "pS621"
    "dimeric protein 14-3-3ζ" "circular dichroism (CD)" "CD" "dichroism"
    "isothermal titration calorimetry (ITC)" "calorimetry (ITC)" "ITC"
    "calorimetry" "14-3-3ζ" "anti-parallel" "Melville" "Nikon" "Burlingame"
    "Vectashield" "Ab1_EGFR" "Tumori" "Nazionale" "Istituto" "Fondazione"
    "_EGFR" "BioRad" "TGX" "PeproTech" "Na" "Bio" "Aldrich" "hemocytometer"
    "Euroclone" "Plaines" "Abbott" "Vysis" "Garcia" "Varella" "intra-" "R&D"
    "&D" "Milan" "Quantikine" "Schoenfeld" "Wald" "Youden" "Helsinki" "Emilia"
    "Reggio" "Nuova" "Maria" "IRCCS" "non-statistical" "Jantus-Lewintre"
    "Lewintre" "non-advanced" "bio" "…-" "1 μg/mL" "sEGFRon" "Quigley"
    "residuals" "Martingale" "NA" "IQR" "polysomy" "anatomic segmentectomy"
    "segmentectomy" "lobectomy" "protoncogene" "receptors/cell" "sEGFRs" "NLST"
    "LDCT" "five-year" "≥2" "non-invasive" "straurosporine"
    "Parental Ba/F3cells" "Knudson" "co-localize" "hyper‐responsiveness"
    "‐populations" "adhesion‐induced" "‐muscle cells" "SrcFK‐mediated"
    "‐inhibition" "‐sensitive" "‐537228" "Gerthoffer" "similarly treated hASMC"
    "the relatively weak FAK auto‐phosphorylation" "adherent hASMC" "Deguchi"
    "non‐specific" "sub‐maximal" "‐maximal" "Gui" "Wu" "Rozengurt" "‐type"
    "FAK‐dependent" "Mauban" "‐activated" "CPA‐induced" "‐γ" "Schmitz" "Lopez"
    "subsequent depolarization‐induced" "Singh" "Andreev" "Guilluy" "Chikumi"
    "SrcFK‐dependent" "Krymskaya" "Gosens" "‐responsiveness" "Schaafsma"
    "Yoshii" "Rho‐kinase‐mediated" "CCh‐induced" "Pertel" "‐specific"
    "‐examined" "Src‐family" "c‐Src" "‐family" "bronchoconstrictor‐induced"
    "‐Src" "‐53228" "Y576/577" "BK‐induced" "‐release" "nifedipine" "blocker"
    "SOCE‐mediated" "PF‐431396" "‐application" "‐applied" "KPSS" "‐753228"
    "Bronchoconstrictor‐induced" "trachealis" "the phospho‐antibodies" "Calalb"
    "‐fitting" "concentration‐dependence" "‐permeabilization"
    "concentration‐response" "α‐toxin" "Rho‐kinase‐dependent" "‐matched" "‐2"
    "‐dependence" "‐test" "PF‐573228" "‐431396" "‐573228" "‐incubation"
    "‐response" "‐mediated" "FAK‐independent" "SOCE/ROCE" "GPCR‐induced"
    "Sakai" "Nakao" "SrcFKs" "Katsumoto" "‐induced" "Chopra" "relaxant"
    "Ishigaki" "Owen" "‐receptor tyrosine kinases" "Feng" "Rho‐kinase"
    "subunit‐1" "‐endoplasmic reticulum (SR)" "VOCE" "voltage‐operated"
    "store‐operated" "light‐chain‐20" "Somlyo" "Gunst" "myofilaments" "MLCP"
    "Meurs" "Solway" "Pinelli" "Auchincloss" "Gilbert" "NANC" "‐operated"
    "light‐chain" "‐chain" "‐sensitization" "‐independent"
    "partially FAK‐dependent" "‐dependent" "auto‐phosphorylation" "SR" "MYPT‐1"
    "‐phosphorylation" "MYPT" "‐kinase" "CCh" "‐20" "hASMC" "‐1" "‐toxin"
    "SrcFK" "~80%" "~50%" "=10" "72 h" "= 11" "Roa" "blockers" "serosa" "10q23"
    "Pakistan" "Mexico" "Bolivia" "Indo" "Chile" "GBC" "gallbladder" "1 + "
    "microdeletions" "‹0.05" "Alibaba" "SNP55T" "Weinberg’s" "rs2870820"
    "endometrial cancer samples using marker SNP rs937283"
    "20 showed heterozygous SNP rs1690916 and SNP rs937283"
    "heterozygous SNP rs937283" "precisely quantitate" "quantitate" "rs937283"
    "SSCP" "SNP55C" "SNP309G" "SNP285" "SNP344" "C/G" "GenBank" "3T3DM"
    "BALB/c" "CRAC1" "oligo" "HuSNP" "rSNP" "rSNPs" "SNP55" "rs1690916"
    "endometria" "ASE" "P -values" "10.1038/ncomms9077" "Shukla"
    "ultrastructure" "immature daughter centrioles"
    "their only partial co-localization" "Cep120" "1hBIRO" "in 1hBIRO"
    "the mother centriole's" "SIM" "toroid" "decondenses" "=12" "HU" "=14"
    "484±49" "408±43" "micrographs" "Centrioles" "Z-sections" "farther" "CLEM"
    "dox" "Plk1TD" "Centriole" "microbeam" "Plk1T210D" "centrioles" "centriole"
    "** P" "* P" "≤9" "100-nm" "12 h" "=9" "orthologs" "GeneBank" "JAR"
    "targetscan" "stromelysins" "C19MC" "miR-526b" "10.1038/srep12949"
    "Pillinger" "daunorubicin/cytarabine" "pathway/s" "CEP701" "Lestaurhas"
    "siRNA3" "pBTK" "non-FLT3" "synergises" "Transducer" "ITD" "Bruton’s"
    "Bruton" "FMS-like-tyrosine-kinase-3" "CD34+" "co-cultures"
    "non-receptor tyrosine kinases" "CD133+" "6/6" "pSORT" "RRGYIAMLAVDSKYRRN"
    "Stangeland" "chemo-" "S8A" "S8B" "the neuronal marker β3-tubulin"
    "β3-tubulin" "S8C" "hypoxia induced factor 1α" "protonophore" "ΔΨ"
    "steeper" "S4G" "Representative cryosections" "cryosections" "Eosin"
    "Welch" "XTT" "KD2" "KD1" "Non-silencing" "_at" "REMBRANDT" "WM" "HPC"
    "SVZ" "NFC" "GIC" "NFCs" "Nα-acetyltransferases" "co-translationally" "Nt-"
    "Nt" "person-years" "GICs" "72 h" "non-translated"
    "Penicillin/streptomycin" "mTOR/" "S4C" "the relatively egalitarian Hadza"
    "30s" "20s" "horticulturalists" "Kenya" "African" "outgroup relations"
    "outgroup" "60+" "Chi-square = 9" "df" "BPAQ" "polygyny" "moots"
    "childcare" "redirect" "the polygynous Datoga" "the monogamous Hadza"
    "forager" "northern Tanzania" "Datoga" "foragers" "Hadza" "Tanzania" "DKKI"
    "non-smokers" "significantly stronger" "H3K27" "catRAPID"
    "an online algorithm" "RPISeq" "RNU1" "shLUADT1" "H1975"
    "human bronchial epithelium (HBE)" "CPAT" "PhyloCSF" "6q23-6q25" "453nt"
    "TARID" "TINCR" "AFAP" "6q24.3" "CCAT2" "LSCC" "LUADT1" "non-smokes" "LUAD"
    "=0.019" "P- value" "Sendai" "− / −MEFs" "infectious progenies" "progenies"
    "Apaf-1-" "Apaf" "Ap" "permeant" "Bcl-2-associated athanogene" "CPAF"
    "trachomatis" "psittaci" "immunosurveillance" "vacuole" "g/mL" "TNBCs"
    "NNSplice" "Xiamen" "Amoy" "ADx" "Written" "Zhejiang" "naevus" "Denmark"
    "Fraumeni" "Turcot" "Bonferroni" "Sweden" "× 10" "10.1038/srep13347" "Fu"
    "cyclocytidine" "adenomatoid" "I-expressing" "granular elastase I-positive"
    "I-positive" "Ki-67-positive" "SDC-like" "necropsy" "dyad"
    "invasive carcinoma ( xref , panel f ) co-existed" "co-existed"
    "ductal epithelium" "eosin" "Masson’s" "trichrome" "Masson" "lumens"
    "sporadic dysplasia" "dysplasia" "H&E" "28-days" "rhabdoid" "&E" "Rosa26R"
    "TAM-fed" "mT" "mTmG" "Nagao" "OncoFOCUS" "mimickers" "parotid"
    "59.1-years" "biospecimens" "tubules" "LGL" "LoxP" "Justy"
    "promoter/enhancer" "apocrine" "CreERT" "A146T" "sarcomatoid" "5-days"
    "= 9" "3-years" "10.1038/srep13300" "Carvalho" "heterozygote" "Azeri"
    "the heterozygous genotype" "The heterozygous GC genotype"
    "the heterozygous GC genotype" "the combined homozygous genotypes"
    "Histopathology" "ICRB" "rs2279744" "a naturally occurring SNP"
    "germinal/heritable" "rs1042522" "P  = 0.001" "≤1" "P  = 0.001"
    "non-synonymous" "Koch’s" "Koch" "non-obese" "anti-GAD" "GAD"
    "anti-glutamic acid" "Japanese" "15597G/T" "flu-like" "19p13.2" "19p13"
    "SWR" "encephalomyocarditis (EMC)" "fulminant" "EMC" "encephalomyocarditis"
    "antigen ( MDA )" "rubella" "coxsackie" "T2D" "T1D" "= 0.002" "= 0.005"
    "GSE29044" "GSE37751" "BUB" "11 publically available microarray datasets"
    "GOBO" "Clara" "GeneChip" "website" "Yoon"
    "pituitary tumor-transforming gene-1" "MAD2 mitotic arrest deficient-like"
    "deficient-like" "Hochberg" "Benjamini" "DAVID" "gene-1" "−4" "= 10"
    "Non-targeting" "gossypol" "coactivate" "venules" "arterioles" "Bittner"
    "MA1A2-Luc" "PDGFa" "RCAS" "VEGFs" "VEGFd" "VEGFc" "PyMT" "Tg" "Ncoa"
    "Co-expression" "Kuroda" "0.85–2.89" "0.91–3.24" "Non-BIM" "Nonsmall"
    "non-BIM" "ORR" "ORRs" "nonsmall" "≥6" "P  = 0.001" "10.1038/srep13461"
    "Varela" "Carotid" "microvessels" "APKD" "anti-IgPKD" "disassemble"
    "dislipidemia" "unstable/complicated" "Vb" "RCCA" "LCCA" "dynes/cm 2"
    "autofeedback" "cardiac myocytes" "myocytes" "TRPP" "dyslipidemia"
    "carotid" "PCs" "0.5 μg" "× 10" "APDS2" "lymphoadenopathy" "p50α" "p55α"
    "exome" "naïve" "APDS" "p85α" "-triphosphate" "triphosphate" "Sperinde"
    "Scaltriti" "Herceptest" "Cytospins" "SCOV3" "an internal AUG codon" "AUG"
    "Ariol" "pancytokeratin" "cytospins" "CTCs" "p95HER2" "Suadi" "rs4135385"
    "a synonymous SNP" "sSNPs" "tagSNPs" "Polymorphisms" "htSNP" "British"
    "C/A" "rs12919719" "rs2059254" "Fadiel" "XF" "Zhang" "Cui" "rs16260"
    "rs4533622" "homozygote" "rs4783689" "aOR" "the relatively important SNPs"
    "included all the five at-risk SNPs" "two-sided x" "rs2293303" "diplotypes"
    "block2" "block1" "rs7186053" "rs12185157" "BMI" "polymorphism (SNP)"
    "rs7198799" "rs7200690" "homozygotes" "FFTP" "GMDR" "rs13689" "rs17715799"
    "CGC/TGC" "diplotype" "TaqMan" "htSNPs" "10/10" "non-infectious"
    "mammoplasties" "Gallen" "azadC" "aminoacid" "the triple-negative subtype"
    "B-like" "ontogeny" "non-luminal" "≥ 50" "72 h"
    "synergistic anti-proliferative" "-hydroxyl" "hydroxyl" "Nthy-ori"
    "Deoxynucleotide" "ori" "more profound anti-proliferative" "BHP10-3SC"
    "drastic anti-proliferative" "approximately one-half" "radioiodine" "8505c"
    "TUNEL" "/mL" "Anti-proliferative" "Co-treatment" "one-half" "RLPs"
    "copy/EV" "mir" "re-surgeries" "with/without" "U251" "KPS" "Karnofsky" "VI"
    "CGGA" "Operatiog" "glomas" "non-glioma" "bioanalyzer" "choline" "EVs"
    "SOP" "RECK4" "exosomes" "Exosomes" "the subsequent biopsy"
    "timely/comprehensive" "exosome" "~2.5" "biliverdin" "hemorrhoids" "IFO"
    "dichlorodiamineplatinum" "erythroid 2-like" "Oxygenase-1" "antigen"
    "H5N1-infected" "anti-IAV" "53KO" "Ifnab" "antiviral ISGs" "Mx" "ISGs"
    "ImmPort" "/ml" "EID" "homogenates" "titer" "tachypnea" "Orthomyxoviridae"
    "p53WT" "p53KO" "IAV" "= 10" "readouts" "non-senescent" "co-cultured" "5PT"
    "destabilises" "Zn" "biotin" "KSEA" "‘monosome’" "non-polysome" "monosome"
    "Azidohomoalanine" "Cyclohexamide" "lifespan" "secretome" "BJ" "paracrine"
    "oligopyrimidine" "TASCC" "non-cell-autonomous" "tEGFR" "1p31" "1p" "1p36"
    "1 + 2" "pY394" "hairpin-like" "sidechain" "pY395" "carbonyl" "L858R/D837N"
    "co-eluted" "intein" "1+2" "non-receptor tyrosine kinase" "pYpY" "P+1"
    "YpY" "pY394pY395" "exon20" "insNPG" "Ex19Del" "phosphotransfer"
    "the classic subtype" "1 +" "+1" "COUP" "level/absence" "NR4A"
    "mammosphere" "= 5.5E-07" "PCC" "Pairwise" "important classifiers"
    "classifiers" "GSE20685" "300+" "co-clustering" "Wallis" "RORβ" "TLDA"
    "Tayside" "RORγ" "HRT" "progestins" "lonaprisan" "PAM50" "= 0.041"
    "proliferation/cell cycle progression" "v/v" "Penicillin/Streptomycin"
    "Jmj" "Gleason" "IVIS" "ARLD" "shJMJD1A" "chromogenic readout"
    "stem cell-like" "immuno" "Rv1" "NED" "neuroendocrine" "enhancers" "H3K9"
    "re-expressed" "10.1038/srep13189" "rs1801270" "non-significance"
    "0.78–1.27" "The Begg’s" "T-allele" "1.17–1.94" "Both Cochran’s" "Cochran"
    "ISI" "Medline" "_CDK2" "introns" "6p21.2" "rs1059234" "95% CI "
    "Nottingham" "FFPE" "NKI" "Maddika" "Trotman" "axon" "proto" "Swedish"
    "HRs" "Li’s" "0.90–4.02" "0.72–1.47" "0.31–1.66" "0.88–1.65" "0.72–1.15"
    "0.96–1.21" "Greece" "Ireland" "Brazil" "95 % CIs" "95 % CI "
    "temozolamide" "AJCC" "oxoguanine" "pyramidine"
    "Hypoxia Inducible Factor-1α" "DSBs" "PIKKs" "10-year" "multicenter"
    "JAK1/2" "eIF" "CRIP1" "Overview" "4γ1" "chromobox" "S100A8/9" "PPPIA"
    "VIIB" "phosphoribosyl" "CORO1A" "botulinum" "HYI" "Venn" "FOXD4" "SNCB"
    "HuURNA" "JAK2V617F" "essential thrombocythaemia (ET)" "thrombocythaemia"
    "ET/PMF" "vera (PV)" "essential thrombocythemia (ET)" "vera"
    "thrombocythemia" "TSC1/2" "CD34 +" "36 RRRR" "drawn" "monoubituitinates"
    "S33/37" "YE" "JBC" "KKKK" "pY216" "PPPSP"
    "dual FAK/PYK2 kinase inhibitor PF-562271" "PF562271" "GSKβ" "R454/R454"
    "knockin" "PF-562271" "Y279/Y216" "S37" "36RRRR" "KKKK15" "KO/GSK3α"
    "GSK3α/β" "DpSGxxpS" "supercomplex" "5/6"
    "tumor suppressor adenomatous polyposis coli ( APC )" "coli ( APC )"
    "min/+" "overview" "Struct" "Opin" "Tsai" "hetero" "conformer" "Mohammad"
    "PNAS" "Hancock" "RafRBD" "Abankwa" "HVR" "2–3" "nanodiscs" "Jafari"
    "Mazhab" "neurite" "outs" "spitzoid" "ICGC" "β2-β3-loop" "SOS" "anisotropy"
    "mGFP-" "immunogold" "BHK" "mRFP" "mGFP" "K170A" "conformers" "hvr"
    "proteo" "Noonan" "facio" "Scheffzeck" "Solman" "‘hotspots’" "nanoscale"
    "Hotspot" "auto-" "co-localization" "co-transfections" "× 10" "α4" "Harris"
    "monolayer" "×10" "PI3KR2" "μmol/L" "Xiao" "er" "IC50" "Werner" "1q25"
    "PCE" "MCF-7/shTCP80" "SN3" "pC" "Miskimins" "Jiang" "dsRBM" "dsRBMs"
    "Renilla" "renilla" "Fluc"
    "The bicistronic dual-luciferase reporter vector pR5UTRF" "pR5UTRF"
    "Xpress" "ITAF" "ITAFs" "IRESs" "cyto-" "cyto" "IRES" "μ g" "Mehta"
    "Liguori" "Rapold" "Collet" "French" "Knudsen" "Danish" "kg/m 2" "Efimov"
    "resp" "angiography" "antegrade" "Sianos" "1.009–2.718" "5G/5G"
    "dyslipidaemia" "yrs" "rs1799889" "rs6092" "A15T" "G/G" "A/G" "A/A"
    "rs2227631" "thrombus" "mellitus" "homozygous genotypes" "4G/4G" "stent"
    "4G/5G" "= 0.038" "10.1038/srep13135" "Der-p2" "eritoran"
    "NAMPT/PBEF-mediated" "NAMPT/PBEF" "NAMPT/" "chemoattractant" "Der" "~30%"
    "rTLR4" "plasmon" "OxPAPC" "CLI" "alveolar epithelium" "ARDS/VILI"
    "phosphorylation/activation" "hr" "rPBEF" "lavage" "pharmacotherapies"
    "VILI" "Toll-Like" "Toll–like" "antimiRs" "TDU" "feedforward" "MARCM"
    "UAS-bantam" "UAS" "SdBP/tgi"
    "the PicTar microRNA target prediction algorithm" "co-injection" "piggyBac"
    "transposon" "pre-miR130a" "miR130" "a well-defined readout" "miRStart"
    "TEADs" "bantam directly targets SdBP/Tgi" "q/11" "uveal" "fide" "Sd"
    "paralog" "Lats1/2" "Mst1/2" "Wts" "homologs" "SdBP/Tgi"
    "the Drosophila Hippo pathway target bantam functionally mimics miR-130a"
    "VGLL4" "miR-130a" "the Trp(194)-Arg(399) haplotype"
    "the Arg(194)-Gln(399) haplotype" "399 Arg/Arg" "194 Arg/Arg" "194Arg/Arg"
    "194Arg/Trp" "194Trp" "un" "the cellular BER/SSB" "Arg280His" "280His"
    "19q13.2–13.3" "399Arg/Trp" "Hong" "Egypt" "Rahman" "Abdel" "280 Arg/Arg"
    "1.52–4.89" "194Trp/Trp" "194 Arg" "1.06–3.67" "1.05–3.54" "1.06–2.01"
    "399Gln/Gln" "399Arg/Arg" "genotypic polymorphisms" "1.76–4.99"
    "propanodeoxyguanosine" "cocarcinogen" "bulky adducts" "adducts"
    "genotypic polymorphism" "DRC" "399Gln" "194Arg" "399Arg/Gln" "1.27–2.84"
    "RFLP" "Jiangsu" "95 % CI" "IP/LC-MS/MS" "reviewer#3's" "#3" "#2" "written"
    "#1" "Manley" "James" "several tumor-associated mutational hotspots"
    "co-chaperone" "Taqman" "PrognoScan" "flurorouracil"
    "the most important mutp53 GOFs" "Chemoresistance" "Saoa" "LC-MS/MS"
    "R172H/R172H" "non-stressed" "wtp53" "GOFs" "several mutational hotspots"
    "Zhao" "Yue" "eLife" "DOI" "athanogene" "mutp53" "Mutp53" "Anti-mouse"
    "= 0.035" "co-localized" "co-transfecting" "co-IP" "LTR" "SP600124"
    "suppressive HAART" "C/EBP" "p38β" "SC514" "ImageJ" "GolgiStop"
    "immunocytochemistry" "donor-2" "12h" "FACScanto" "cytometer" "72h" "BBB"
    "HAART" "Anti-Retroviral" "Anti-Mouse" "Anti-Rabbit" "0.5 μg" "cylin"
    "multiprotein" "these catalytically inactive C-terminally" "C-terminally"
    "IVKA" "Vi7392" "GCV" "Ax7396"
    "the viral DNA polymerase processivity factor pUL44" "pUL44" "Fc" "CoIP"
    "Marschall" "codons" "invariant" "XI" "EF-1δ" "A/C"
    "the viral mRNA transporter pUL69" "pUL69" "cerevisiae"
    "downregulated/suppressed" "upregulated/activated"
    "the viral DNA polymerase pUL54" "pUL54" "foscarnet" "cidofovir"
    "valganciclovir" "Herpesvirinae" "pUL97" "ortholog" "pcDNA3.1" "FLAIR"
    "Germany" "II-3" "rs114207045" "pairings" "the proband's" "proband"
    "Polyphen-2" "EGF-like" "Exons" "thalamus" "NPI" "Osterrieth" "Rey"
    "Neuropsychiatry" "Proband" "neuropsychiatry" "Borneo"
    "aggregation/accumulation" "Notch/Lin12" "epidermal growth factor-like"
    "subtribe" "Scheltens" "Sabah" "Kudat" "Dusun" "Kadazan" "Rungus"
    "leukoencephalopathy" "= 9" "interactome" "hypoxia inducible factor 1α"
    "Yu" "Warburg" "aneuploidy" "chromatids" "TNFα/CHX" "AlsoBe"
    "reduced/absent" "frameshift" "ZR" "more aggressive breast cancer subtypes"
    "Alberta" "NHBE" "Amsterdam" "Versteeg" "gastric datasets" "Ann"
    "Compendia" "Oncomine" "APC/C" "-ribose" "ribose" "family 1A" "PR+" "ER+"
    "10.1038/srep13002" "Fekrmandi" "hotspots" "TVriS" "SPasT" "SPvkT" "SPapS"
    "EPefTS" "degron" "phosphodegron" "CHX" "coIP" "phosphodegrons" "Hodgkin’s"
    "Hodgkin" "NF-κB1" "non-classical" "hormonal 1,25-dihydroxyvitamin D3"
    "dehydrocholesterol" "**P " "*P " "10.1038/srep12841" "Ichikawa" "430AA"
    "KK429" "PP5c" "NIK-" "NIK" "miR31" "OA" "NDRG2+" "KOB" "Hetero" "Ser32/36"
    "HTLV-1+" "NDRG2/SAS" "protein phosphatase 2A" "IKKs" "retrovirus"
    "leukemia/lymphoma" "leukemia/lymphoma (ATL)" "co-treatment"
    "10.1038/srep13076" "Nakata" "stroma-like" "immunoglobulin" "MM2206"
    "cytoplasmic/membrane" "PC9M" "Wnt/β-catenin" "elrotinib"
    "cytoplasm/nucleus" "PC9M2" "stem-like" "Wnt/"
    "Δ9-tetrahydrocannabinol (THC)" "cannabinoid" "Karmazyn" "galactomannan"
    "glucans" "C3T" "ΔrodA" "henselae" "Bartonella" "β-1" "monocytogenes"
    "neoformans" "The opportunistic pathogen Aspergillus fumigatus" "glucan"
    "BMS" "AECs" "fumigatus" "anti-inflammation" "non-phosphorylated" "U/mL"
    "„pan-HER-inhibitors" "Northern Europe" "„TKI-resistance" "„second"
    "european" "Europe" "Houston" "MDACC" "Texas" "Teng" "traditional Sanger"
    "Norway" "immunhistochemistry" "asian" "usefull" "BRCA1/2" "phoshoproteome"
    "Ex20" "Ex9" "Kinome" "pulldown" "antiphosphotyrosine" "SILAC" "Ex"
    "Phosphoproteome" "phosphosites" "kinome" "824 unique phosphopeptides"
    "the global phosphotyrosine proteome" "proteome" "phosphopeptides" "mg/mL"
    "0.5 μ g" "μ g/mL" "KEGG" "Kyoto" "Genomes" "Transcriptome" "μg/ml" "S-L"
    "weakest" "ITH" "distinct invasive and migratory capacities co-exist"
    "co-exist" "S-H" "A-H" "invasive/migratory" "P = 0.001" "P -value"
    "co-regulators" "function-2" "subtle allosteric re-organisation"
    "re-organisation" "Nelson" "siScr" "enzalutamide/ARN-509" "GSK650395"
    "wtAR" "15/21" "52/79" "the bicalutamide-driven transcriptome"
    "the resultant transcriptome" "offs" "siSCR" "siAR" "hyper" "W741L/C"
    "ARN-509" "ARN" "KUCaP" "CRPC" "de-regulated" "probable non-redundant"
    "PXXP" "volume/size" "DNp73s" "TAp73β" "Siah1-" "Siah" "dnUbc12" "DNp73β"
    "Nedd" "dimethyloxaloylglycine" "AP" "TAp73" "DNp73" "TAp73s"
    "a pro-apoptotic TAp73" "** p" "* p" "1 μg" "0.5 μg" "pCDNA3.1"
    "non-overlapping" "S/MAR" "CTFG" "YAP-5SA" "pcDNA" "Boyden"
    "the more aggressive breast cancer subtypes"
    "corresponding Cox proportional hazards models using public datasets"
    "highly invasive basal-like cancer subtype" "YAP/TAZ" "LATS1/2" "Group A1"
    "anti-FLAG" "MST1/2" "anaplastic oligodendroglioblastomas"
    "oligodendroglioblastomas" "SW1088-anti-miR1908" "P13K" "RLuci" "FLuci"
    "stageI" "stageIII" "-4" "S3C" "48 h" "10.1038/ncomms8999" "Capuani"
    "hidden" "multisite" "1045+" "j" "x" "Eq" "pY1068/pY1086" "pY1045"
    "Y1068/86" "EGFR-Y1045+" "phosphomutants" "1pY-EGFR" "2pY-EGFR" "pYs"
    "kinase:Tyr" "EGFR-3Y+" "Multisite" "∼80%" "NCE" "phosphotyrosines" "1 μg"
    "0.5 μg " "μg " "1/3" "diindolymethane" "EOCs" "rs9909659" "chemoresponse"
    "dbSNP" "GBR" "TSI" "CEU" "miR-423-5p" "rs1053004" "GA" "rs74561951"
    "noncarriers" "ORs" "rs62075772" "rs1364455" "CRs" "Germline" "Illumina"
    "Moffitt" "SPSS" "Biotech" "Koma" "Thermo" "Pico" "anti-mouse"
    "anti-rabbit" "Cruz" "TBS" "Corp" "Millipore" "difluoride" "polyvinylidene"
    "BCA" "Supernatants" "Incheon" "Hanil" "rpm" "Geno" "pH" "Daejeon" "DyeMIX"
    "PreMix" "Intron" "Vallee" "Marne" "Lourmat" "Vilber" "BLX" "J/cm 2"
    "Dulbecco’s" "Logan" "HyClone" "Gibco" "DMEM" "Dulbecco" "Manassas" "ATCC"
    "Inc" "ultrapure" "lipopolysaccharide (LPS)" "supernatant" "supernatants"
    "UV-induced photodamage" "photodamage" "absorbance" "cyanobacteria" "Nrf2-"
    "Nrf" "Porphyra" "UVA-irradiated" "UVA" "porphyra" "Switzerland" "Basel"
    "Roche" "FuGENE" "GenePharma" "TBST" "Tween" "OH" "Solon" "Amresco"
    "Bradford" "Beyotime" "lysis" "RIPA" "BioSune" "Carlsbad" "Invitrogen"
    "eppendorf" "Jose" "BD" "Louis" "penicillin/streptomycin" "Diego"
    "ScienCell" "Changhai" "Perhaps" "-Hcy-protein" "thiolactone" "H2C9"
    "almost all the HCAECs" "MiR-30b" "mmol/L" "microvessel" "miR-30b" "HCAECs"
    "Let-7g" "Digitizer" "Engauge" "deeper" "1/2" "11q22" "the Egger’s"
    "Begg’s" "Begg" "1.537–2.297" "1.163–1.886" "1.549–2.937" "Caucasions"
    "1.548–3.232" "morderate" "Q-statistic" "1.406–3.179" "1.465–2.275"
    "Ottawa" "Newcastle" "Xu" "France" "Korea" "pTNM" "poorest" "Egger’s"
    "Egger" "STATA" "harzad" "CBM" "Corchane" "95% CIs" "neuro" "kainite"
    "strychnifolia" "Lindera" "lindenenyl" "Li" "SRS" "TLE" "Mazzuferi" "TFEA"
    "hippocampi" "Morris" "control mice underwent chronic amygdala" "coworkers"
    "epilepticus" "Kovacs’s" "Kovacs" "porphyrin" "tetrakis" "kainate"
    "Liang’s" "Liang" "Martinc’s" "Martinc" "epileptiform" "Frantseva’s"
    "amygdala" "Frantseva" "TBARS" "Dal" "pmoL/mm 2" "NBT" "tetrazolium"
    "nitroblue" "kg" "Armstead’s" "Armstead" "IPSPs" "ionic" "glia"
    "cerebral edema" "edema" "polytherapy" "ILAE" "synchronicities"
    "Alzheimer’s" "Alzheimer" "ETGF" "Neh6" "Neh5" "Neh4" "Neh3" "DSAPGS"
    "DSGIS" "region/linker region" "IVR" "ETGE" "degrons" "tramtrack" "Neh"
    "NAD(P)H:quinone oxidoreductase-1" "oxygenase-1"
    "nuclear factor (erythroid-derived 2)-like" "CNS" "physiopathology"
    "10.1038/srep12963" "Zhuo" "de-polymerization" "de-activation"
    "the temporal CC" "The Src-translocation temporal CC" "CC" "RhoA/mDia"
    "non-polarized" "non-protrusive" "the geometric conflictions"
    "geometric conflictions" "conflictions" "spline"
    "a level-set based algorithm" "algorithm" "perinuclear organelles"
    "ECFP/FRET" "Machacek" "Semi" "ECFP" "meshwork" "antitumour"
    "co-administration" "Ob" "undertaken" "–4" "ER +" "p53 +" "perineurium"
    "G1/S" "FACS" "frozen" "g/ml" "MOI" "25/28" "anti-tumorigenic"
    "Non-transfected" "10.1038/ncomms8847" "Nakamura" "CD68 +" "Oh" "CD163 +"
    "CD163+" "CD68+" "pathophysiology" "FBJ" "reprogramme" "dimethylsulphoxide"
    "co-culture" "hepatectomy" "HVMEC" "littermate" "F/F" "M2-like" "HMVEC"
    "isotype" "lipopolysaccharides" "M2c" "M2a" "subsets" "CNV"
    "anti-inflammatory" "10.1038/ncomms8904" "kinetochore/centromere"
    "CENP-S/X" "3S/TA" "PhosphoMotif" "∼30%" "H538A/K540M" "phosphopeptide"
    "co-precipitate" "phosphoproteome" "IIα" "co-stained" "CENPs" "centromeres"
    "mimicks" "centromere" "remodeller" "48 h" "1 μg " "non-phosphorylatable"
    "p53 +/+" "ClinicalTrials" "IIA" "SMAD2/3" "arisen" "TGFβ1R"
    "transcriptome" "Genechip" "RSMADs" "lymphoblastoid" "homolog (BAMBI)"
    "collagens" "David" "PCA" "transcriptomes" "Affymetrix" "non-canonical"
    "pancytopenia" "pathobiology" "multilineage" "aplasia" "Blackfan"
    "stem/progenitor" "pMIR" "MiR-512-5p" "weas" "miR-512-5p" "CNE"
    "MiR-512-5P" "hypopharynx" "oropharynx" "nasopharynx" "miR-512-5P" "HNSCC"
    "48 h" "SPSS 17.0" "48h" "Non-coding" "sensitivity/resistance"
    "a different mutational hotspot" "α8" "α7" "A1459P" "α5" "α5-α6" "alkyl"
    "PI3KCA" "Cowden" "autoinhibits" "simplest" "rapalogs" "A1519T"
    "rapamycin/nutrient" "Thr 37/46" "Thr37/47" "Grabiner" "TRD2" "solenoid"
    "α23" "HRD" "Helices" "helices" "cBIO" "rapalog" "AGC"
    "publicly available tumor genome" "ccRCC" "Anti-FLAG" "U2OS-shp53"
    "p53  +/+" "siIRE1α" "KDEL" "SEAP" "SYNV1" "endpoint" "derepresses" "Tm"
    "BFA" "shLuc" "synoviolin-1" "at least one-half" "organelle" "p53  +"
    "ubiquitination/degradation" "C136S/C139S" "VP→AA" "Co-immunoprecipitation"
    "G0 /G1 phase" "non-operative" "indeterminate cytology" "thyroidectomy"
    "consistently benign cytology" "cytologically indeterminate FNAs" "FNAs"
    "indeterminate or malignant cytology" "Radkay" "Moses" "Castro"
    "benign cytology" "benign histology" "subsequent GEC" "secondary biopsy"
    "adenopathy" "undergone" "GEC" "AUS" "clinicians"
    "post-operative histopathology" "FNA" "Post-operative histopathology"
    "histopathology" "cytology" "adenomatous polyposis coli (APC)" "coli (APC)"
    "the online software STRING" "coli" "STRING" "si" "non-target" "transwell"
    "0.5μg" "1 μg" "μg" "1μg" "pCMV" "only 4 cases (12.12%) PLTs"
    "non-expression" "autologous PLTs" "PLTs" "HCTs" "MHCC" "IQ-domain" "IQ"
    "GTC" "CTC" "CGC" "The Nutlin-3-treated NPC sublines" "sublines" "p53si-D3"
    "pLKO" "soft agar" "NPE" "Kaposi" "Malaysia" "the nasopharyngeal mucosa"
    "agar" "wt" "p53 C" "method/primers" "PROGINS" "PRB" "progestin"
    "endometrium" "recurrences/metastases" "Soslow" "comorbidities" "Tangen"
    "Santacana" "cytological atypia" "atypia"
    "endometrial metastases/recurrences" "PMR" "H-score" "mitoses/10"
    "peritoneum" "myometrium" "MELF" "H-scores" "endometrioid" "5-year"
    "glycosphinogolipids" "allodynia" "adenylyl" "BNDF" "~100%"
    "density/complexity" "cellular density/complexity" "size/volume" "SSC"
    "FSC" "SS57" "non-binding"
    "GPCR agonists indirectly causes TrkB phosphorylation o" "o" "adenyl"
    "Ca ++" "++" "SS58" "immunotherapy" "anti-GD2" "re-expression" "cerebellum"
    "glycosphinogolipid" "*P" "transducer" "TC/CC" "rs4705343 TC/CC"
    "Polymorphism" "1.01–2.15" "rs712GT/TT" "rs4705343 TC/CC" "1.01–1.72"
    "1.05–1.80" "rs4705343TC" "rs4705343C" "rs4705343T" "145-" "rs4705343 TC"
    "rs4705343" "rs712" "rs4705343C/T" "TATA" "= 0.001" "cetumximab"
    "ypT0-2N0M0" "responders" "3-year" "codon" "reponses"
    "preoperative chemoradiotherapy (CRT)"
    "received preoperative chemoradiotherapy" "chemoradiotherapy"
    "preoperative chemoradiotheray" "chemoradiotheray" "homolog" "Kirsten"
    "biopsy" "cT" "P -values " "skeleto" "transforming growth factor-β1"
    "osteoblast-like" "p-" "bone-forming osteoblasts" "osteoblasts" "Wolff's"
    "Wolff" "osteoblastic mechanobiology" "mechanobiology" "Hz"
    "microsatellite" "G17Efs*24" "G17E" "R5Q" "Kakiuchi" "fluouracil" "ie"
    "phenotypic/genotypic" "T-category" "G3/G4" "G17Efs" "advancements"
    "Laurén" "*24" "European" "Lechner" "bp" "PKIG" "pcDNA 3.1"
    "10.1038/srep12870" "Tsui" "Further whole genome" "konckdown" "explants"
    "sediments" "5-day" "COLsi" "reconfirm" "MTS" "5-aza-2" "ELISA" "PTGF-β"
    "PTGF" "American" "rhGDF15" "10.1038/srep13144" "Wagle" "ycle" "LXRα" "DBC"
    "proteosome" "RhoA" "17/35" "p  " "co-transfected" "= 0.001" "= 0.002"
    "= 0.035" "= 0.004" "= 0.005" "el" "Doebele" "non-statistically" "EFGR"
    "Witney" "ECOG" "PS" "poorer" "tyrosin" "p " "Navarra" "Universidad"
    "Clínica" "= 0.03" "= 0.4" "= 0.038" "17/30" "doi:10.1186" "= 0.001"
    "Casik" "non-small" "Transwell" "·NRF2" "USA" "Dickinson" "Becton"
    "normal cervical epithelia" "MassARRAY" "Sequenom" "GIII" "GI" "FIGO"
    "Whitney" "normal cervical epithelium"
    "oxidative and electrophilic stressors" "stressors" "the viral genome"
    "Papanicolaou" "CSCC" "Uighur" "1+" "basal-like" "facilitators"
    "invaginations" "S4B" "S4A" "S7A" "epithelia" "HMLE" "at least 20 pixels"
    "pixels" "pGab1" "TIRFM" "pS473" "pY627" "pY1068" "CLC/CHC" "GFP-FKBP-CLCa"
    "anti–phospho-Akt" "pS" "MitoTrap" "FRB" "Knocksideways" "Pitstop2" "°C"
    "pitstop2" "Tfn" "CHC" "ErbBs" "ErbB" "-bisphosphate" "bisphosphate"
    "-trisphosphate" "trisphosphate"
    "unique plasma membrane signaling microdomains" "microdomains"
    "knocksideways" "undergoes" "S1E" "S1D" "SUPPLEMENTRY" "broader" "clearer"
    "Our isogenic genome" "mitoses" "RING" "mutant/VUS" "polyploid" "ploidy"
    "Sanger" "our previously characterized BRCA1  185delAG" "mutation/VUS"
    "VUS/mutations" "ɣ-irradiation" "heterozygous BRCA1 mutations/VUS"
    "mutations/VUS" "AAV" "adeno" "targeting/genome" "non-tumorigenic" "ɣ"
    "185delAG" "bi" "germline" "VUS" "desirable anti-tumor" "Schultz"
    "overridden" "Bao" "anti-proliferative" "subclasses" "mg/kg" "Pre"
    "rhWNT3A" "WLX" "Huh7 cells" "Hep40" "biopsies" "non-tumor" "anti-tumor"
    "TNKS1/2" "α/β" "Adenomatous Polyposis Coli (APC)" "Coli (APC)" "Coli"
    "unmet" "Africa" "Saharan" "intra" "TOPflash" "rhWNT" "semi" "nitro"
    "Non-specific" "μg/mL" "10.1038/srep12917" "9KQ" "9KR" "H216/611A"
    "Tubastatin" "tubastatin" "HA" "A-dependent" "motile" "organelles" "subset"
    "extracorporeal photochemotherapy (ECP)" "Berger" "ECP" "photochemotherapy"
    "tazarotene" "Walsh" "EZHs" "co-activator"
    "transcriptional co-activators/regulators" "Nep" "DZ" "co- repressors"
    "co-precipitated" "miR-22HG" "oncomiR" "co-repressors" "miR22" "earler"
    "Il" "PSOR" "MySi" "non-malignant" "Ballabio" "a minimal miRNA classifier"
    "classifier" "co-activators" "IL-2Rgc" "the associated Janus kinase-3"
    "TOX" "a transcriptional co-activator" "iii" "ii" "kinase-3"
    "non-targeting" "anti-cancer" "discrepant" "high/PAR-2" "high/PAR-1"
    "*PAR-1" "*PAR-2" "intima" "using Pearson’s" "Pearson" "Meier" "Kaplan"
    "DDFS" "95% CI" "= 0.019" "P-values" "= 5.5" "Hoogsteen" "Watson"
    "bidentate" "readout" "R273C-DNA" "Dsolv" "vdw" "Waals" "Elec" "HADDOCK"
    "et" "Daura" "covariance" "shrunken" "biomolecules" "ps" "ED" "NH-bonds"
    "NH" "RMSF" "RMSD" "R273H_S240R" "R273C_T284R" "R273H_T284R" "T284R/S240R"
    "coredomain" "hotspot" "proven" "missense" "*CP" "*GP" "_S240R" "_T284R"
    "/S" "Veldt" "der" "Kim" "CTCAE" "TT/TA" "Beuselinck"
    "demographic covariates" "Diekstra" "covariates" "2455A/G" "NCBI" "Erp"
    "covariate" "non-significant" "PFS" "= 0.03" "Univariate" "2677G/TA"
    "PLINK" "pairwise" "3435C/T" "Asians" "Naik" "polymorphism" "German"
    "Netherlands" "2677G/T" "1236C/T" "America" "GG" "neutropenia" "COMPARZ"
    "=0.1" "TTT" "=0.3" "leucopenia" "= 0.005" "= 0.004" "=0.005" "=0.001"
    "=0.004" "pyrroloquinoline" "Choriocapillaris" "UEA" "the Bruch’s"
    "6-month-old" "infoldings" "melanolysosomes" "littermates" "Huntington’s"
    "Huntington" "binding/recognition" "RGD" "vivo" "lipofuscin" "bilayer"
    "the retinal pigment epithelium (RPE)" "Bruch’s" "choriocapillaris" "Bruch"
    "ex" "retinal pigment epithelium (RPE)" "epithelium (RPE)"
    "peroxisome proliferator-activated receptor γ coactivator-1α"
    "coactivator-1α" "epithelium" "POS" "FDI" "Siomycin" "thiazole" "COV362"
    "SNU-119" "SNU" "histology" "FOXM1 as" "~12%" "datasets" "12p13.33"
    "FOXM1a" "VIIa" "exons" "MuvB" "helix" "FOX" "virtually all HGSOC"
    "the pathological and genetic underpinnings" "underpinnings" "Rb" "IOSE"
    "FOXM1c" "EOC" "HGSOC" "non-specific" "non-asthmatic" "PIKK" "interdomain"
    "chromatid" "titers" "lineages" "ethnicities" "dimorphism" "Sawalha"
    "enhancer" "hottest" "haplotypes" "Haplotypes" "Haplotype" "genotype"
    "95%CI" "Genotype" "rs 10893872" "Haploview" "HWE" "Weinberg" "mm/h"
    "DAS28" "showen" "Europeans" "GWAS" "Caucasians" "celiac" "rs10893872"
    "Asian" "Rs10893872" "genotypes" "rs11221332" "rs4937333" "TCT" "haplotype"
    "rs73013527" "SNP" "SPSS17.0" "HapMap" "SNPs" "polymorphisms" "= 0.002"
    "= 0.001" "incompleteness" "Ahn" "KBCRS" "Korean" "re-classified"
    "Oncotype" "MammaPrint" "neoadjuvant" "pre-" "chosen" "Cremer’s" "Cremer"
    "Cramer's" "Cramer" "stepwise" "LVI" "mastectomy" "Ki-67+" "Ki-67 +" "p53+"
    "Ki-67-" "triple negative breast cancer (TNBC) subtype" "TNBC" "P-value"
    "greatest" "DFS" "subtypes" "p53-" "p" "Apr" "Samsung"
    "overexpression/amplification" "Burandt" "Olsson" "cheaper"
    "aggressive subtype" "subtype" "fluorescent ISH (FISH)" "ISH" "3+" "ASCO"
    "mucosa" "interobserver" "muscularis" "substage" "Multivariate"
    "univariate" "=0.002" "and 3+" "NMIBCs" "2+" "pT1c" "pT1b" "pT1a" "MARK"
    "EORTC" "cystectomy" "yr" "nonmuscle" "multivariate" "6/141" "4/141"
    "-SISH" "SISH" "NMIBC" "ZKD" "miR-221/222" "oligos" "pri-miR-24-1"
    "pri-miR-24–1" "pre-miR-29b-2" "miR-29b-1" "both the mature miR-221/222"
    "miR-29b-2" "which packs mRNA non-specifically" "wildtype" "CAU" "SELEX"
    "hexamers" "hexamer" "intron" "replicates" "IGV" "frominto" "UV"
    "non-specifically" "ribonucleopreotein" "A/P" "penetrance" "duplexes"
    "polII" "typically ∼22 nt" "nt" "pri-" "pri" "UYAUC" "seq" "iCLIP" "let-7g"
    "non-coding" "10.1038/srep12738" "doi" "Yang" "TLR7/8" "LUBAC" "Pam3CSK4"
    "CL097" "THP-1 and" "KO" "K325/326R" "K285/309R" "anti-Flag" "IKKα/β"
    "moncytes" "ISG" "lipopolysaccharide" "luc" "genome" "-1β" "stimulators"
    "UBAN" "κB" "Toll-like" "10.1038/srep12807" "Huang" "G0/G1" "multi"
    "G0/G1 phase" "shNC" "CON" "BIU-87" "BIU" "IHC" "WB" "non-tumour"
    "non-histone" "BUCs" "BUC" "SW480- anti-miR-106b" "hypothesise" "Dubrovska"
    "anti-apoptotic" "Spearman" "S3D" "pcDNA3.1/PTEN" "pLuc-" "pLuc"
    "co-transfection" "-UTRs" "Targetscan" "UTRs" "greater"
    "immunohistochemistry" "**p" "**P" "radioresistant" "miR-160b" "Gy" "*p"
    "NSPC" "MiR-106b" "NFkappaB1" "perhaps" "pre" "z" "stemness" "miR-106b"
    "radioresistance" "miR-106b-25" "b" "Radioresistance" "let-7e"
    "chemoresistance" "let-7i" "spearman's" "spearman" "TCGA" "Genome" "silico"
    "A2780/CP-Tet-ON-miR-NS" "-UTR" "UTR"
    "several well-developed miRNA algorithms" "TargetScan" "algorithms"
    "stronger" "Dox" "SKOV3/CP-Tet-ON-miR-497" "A2780/CP-Tet-ON-miR-497"
    "cisplatin-resistant ovarian cancer phonotype" "pri-miR-497" "SKOV3/CP"
    "A2780/CP" "chemoresistant" "dataset" "phonotype" "chemo"))

(DEFPARAMETER SPARSER::*BIO-CHEMICAL-HEADS-PHASE3-15601-15900*
  '(("reverse transcriptase-polymerase" . SPARSER::COLLECTION)
    ("ALK and ROS1" . SPARSER::COLLECTION) ("EZR" . SPARSER::PROTEIN)
    ("FISH and IHC" . SPARSER::COLLECTION)
    ("ROS1 and ALK" . SPARSER::COLLECTION) ("FIG-ROS1" . SPARSER::COLLECTION)
    ("FIG" . SPARSER::PROTEIN)
    ("plus temozolomide and 12.1 months" . SPARSER::COLLECTION)
    ("IHC and FISH" . SPARSER::COLLECTION) ("Isocitrate" . SPARSER::DRUG)
    ("the most aggressive type" . TYPE) ("SDC4" . SPARSER::PROTEIN)
    ("SLC34A2" . SPARSER::PROTEIN) ("LRIG3" . SPARSER::PROTEIN)
    ("KDELR2" . SPARSER::PROTEIN) ("CCDC6" . SPARSER::PROTEIN)
    ("CC1" . SPARSER::PROTEIN) ("Fused in Glioblastoma" . SPARSER::PROTEIN)
    ("CPZ and other conventional anti-CRC drugs" . SPARSER::COLLECTION)
    ("Inauhzin" . SPARSER::DRUG) ("inauhzin" . SPARSER::DRUG)
    ("Ku70, E2F1, and FOXO" . SPARSER::COLLECTION) ("Waf" . SPARSER::PROTEIN)
    ("SIRT1 and PCNA" . SPARSER::COLLECTION)
    ("p53, p21 Waf1/Cip1 , and PARP" . SPARSER::COLLECTION)
    ("PD98059 or SB203580" . SPARSER::COLLECTION)
    ("SB203580 or PD98059" . SPARSER::COLLECTION)
    ("PD98059 and SB203580" . SPARSER::COLLECTION)
    ("ERK and p38" . SPARSER::COLLECTION)
    ("p21waf1/Cip1" . SPARSER::COLLECTION)
    ("p53 and its downstream targets p21 Waf1/Cip1 , BAX, and PARP"
     . SPARSER::COLLECTION)
    ("BAX and NOXA" . SPARSER::COLLECTION)
    ("TP53 , p21 , BAX , and NOXA" . SPARSER::COLLECTION)
    ("FMK" . SPARSER::PROTEIN) ("Mcl-1 and Bcl-x" . SPARSER::COLLECTION)
    ("phenylindole" . SPARSER::MOLECULE) ("dopamine" . SPARSER::PROTEIN)
    ("phenothiazine" . SPARSER::DRUG) ("Chlorpromazine" . SPARSER::DRUG)
    ("molecules and diseases" . SPARSER::COLLECTION)
    ("MDM2, MDMX, SIRT1, and HDACs" . SPARSER::COLLECTION)
    ("histone deacetylase (HDAC) and sirtuin 1 (SIRT1)" . SPARSER::COLLECTION)
    ("p300/CREB binding protein" . SPARSER::COLLECTION)
    ("MDM2 and MDMX" . SPARSER::COLLECTION)
    ("ubiquitin–protein" . SPARSER::COLLECTION) ("MDMX" . SPARSER::PROTEIN)
    ("BAX , PUMA , NOXA , and P21  Waf1/Cip1" . SPARSER::COLLECTION)
    ("JNK, and JNK" . SPARSER::COLLECTION)
    ("chlorpromazine (CPZ)" . SPARSER::DRUG) ("CPZ" . SPARSER::PROTEIN)
    ("chlorpromazine" . SPARSER::DRUG) ("antipsychotic" . SPARSER::DRUG)
    ("Ku70" . SPARSER::HUMAN-PROTEIN-FAMILY) ("− 3" . SPARSER::PROTEIN)
    ("waf1" . SPARSER::PROTEIN) ("Bcl-x" . SPARSER::PROTEIN)
    ("sirtuin 1" . SPARSER::PROTEIN)
    ("a MA-deleted Gag mutant" . SPARSER::MUTANT)
    ("Different antiretroviral drugs" . SPARSER::DRUG)
    ("the translational activator S6K1" . SPARSER::PROTEIN)
    ("Staufen" . SPARSER::PROTEIN) ("GFP and Flag" . SPARSER::COLLECTION)
    ("GFP or Gag-GFP" . SPARSER::COLLECTION)
    ("Flag or Flag-Gag" . SPARSER::COLLECTION) ("antisera" . SPARSER::PROTEIN)
    ("the viral protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("also known as Metadherin or astrocyte-elevated gene 1 (AEG-1)"
     . SPARSER::COLLECTION)
    ("Metadherin" . SPARSER::PROTEIN) ("lentiviral DNA" . SPARSER::DNA)
    ("RNA and DNA" . SPARSER::COLLECTION)
    ("cytokines and type I" . SPARSER::COLLECTION)
    ("protein and extracellular matrix protein" . SPARSER::COLLECTION)
    ("biotinylated proteins revealed 64 unique peptide" . SPARSER::PEPTIDE)
    ("proximal interactors" . SPARSER::PROTEIN) ("pNL" . SPARSER::PROTEIN)
    ("MYC and p24" . SPARSER::COLLECTION)
    ("a promiscuous biotin ligase" . SPARSER::LIGASE)
    ("VLPs" . SPARSER::PROTEIN) ("BirA" . SPARSER::PROTEIN)
    ("mature Gag proteins p17 matrix (MA)" . SPARSER::PROTEIN-FAMILY)
    ("matrix (MA)" . SPARSER::PROTEIN-FAMILY)
    ("The integrated proviral DNA" . SPARSER::DNA)
    ("DDX17 and RPS6" . SPARSER::COLLECTION)
    ("proteins and complexes" . SPARSER::COLLECTION)
    ("ribonucleoprotein complexes" . SPARSER::BIO-COMPLEX)
    ("AEG-1" . SPARSER::PROTEIN) ("HO3" . SPARSER::PROTEIN)
    ("histidyl-tRNA synthetase" . SPARSER::PROTEIN) ("L35" . SPARSER::PROTEIN)
    ("L28" . SPARSER::PROTEIN) ("L27" . SPARSER::PROTEIN)
    ("extracellular matrix protein" . SPARSER::PROTEIN)
    ("Gag proteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Gag-Pol polyprotein" . SPARSER::PROTEIN)
    ("Gag polyprotein" . SPARSER::PROTEIN)
    ("NF-κB and Fascin" . SPARSER::COLLECTION)
    ("mesenchymal markers N-cadherin, Vimentin and Fascin"
     . SPARSER::COLLECTION)
    ("N-cadherin, Vimentin and Fascin" . SPARSER::COLLECTION)
    ("E-cadherin and Fascin" . SPARSER::COLLECTION)
    ("p53 and cancer-invasion-related" . SPARSER::COLLECTION)
    ("Fascin and E-cadherin" . SPARSER::COLLECTION)
    ("protein and Fascin" . SPARSER::COLLECTION)
    ("Zeb, and Sip1" . SPARSER::COLLECTION)
    ("Sip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Sip" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Slug" . SPARSER::PROTEIN)
    ("p53 and Fascin" . SPARSER::COLLECTION) ("Fascin" . SPARSER::PROTEIN)
    ("IKK-2" . SPARSER::PROTEIN) ("IMD-0354" . SPARSER::DRUG)
    ("collagenase-2 and -3" . SPARSER::COLLECTION)
    ("inversely control RB" . SPARSER::PROTEIN)
    ("B2R/AKT" . SPARSER::COLLECTION)
    ("cell cycle-associated proteins" . SPARSER::PROTEIN)
    ("GPCR/PI3K/AKT" . SPARSER::COLLECTION)
    ("Cyclin D1 and RB" . SPARSER::COLLECTION)
    ("cyclin D1 and RB" . SPARSER::COLLECTION)
    ("P16/cyclin/RB" . SPARSER::COLLECTION)
    ("P53/P21/cyclin/RB" . SPARSER::COLLECTION)
    ("associated molecules" . SPARSER::MOLECULE)
    ("skeletal myoblasts" . SPARSER::PROTEIN) ("myoblasts" . SPARSER::PROTEIN)
    ("receptors (GPCR)" . SPARSER::RECEPTOR) ("AKT/eNOS" . SPARSER::COLLECTION)
    ("B2R/PI3K/AKT" . SPARSER::COLLECTION) ("MPO and BK" . SPARSER::COLLECTION)
    ("/Cyclin D1/RB" . SPARSER::COLLECTION)
    ("AKT/Cyclin D1/RB" . SPARSER::COLLECTION)
    ("B2R/CD34" . SPARSER::COLLECTION)
    ("antagonist or siRNA" . SPARSER::COLLECTION)
    ("BK and H 2 O 2" . SPARSER::COLLECTION)
    ("RB, and cyclin D1" . SPARSER::COLLECTION)
    ("B2R/EGFR/cyclin D1/RB" . SPARSER::COLLECTION)
    ("B2R/AKT/cyclin D1/RB" . SPARSER::COLLECTION)
    ("H 2 O 2 and BK" . SPARSER::COLLECTION)
    ("RB and B2R" . SPARSER::COLLECTION) ("Efficient B2R" . SPARSER::PROTEIN)
    ("33 senescence-associated genes" . SPARSER::GENE)
    ("diacetate" . SPARSER::MOLECULE)
    ("CD34, KDR, CD105, and B2R" . SPARSER::COLLECTION)
    ("receptor (KDR)" . SPARSER::RECEPTOR) ("MPO" . SPARSER::PROTEIN)
    ("bradykinin (BK)" . SPARSER::BRADYKININ)
    ("vasodilator" . SPARSER::PROTEIN)
    ("tissue kallikrein-kinin" . SPARSER::COLLECTION)
    ("kinin" . SPARSER::PROTEIN-FAMILY) ("SIP" . SPARSER::PROTEIN)
    ("PI3K and EGFR" . SPARSER::COLLECTION)
    ("B2R, PI3K, and EGFR" . SPARSER::COLLECTION)
    ("RB, AKT, and cyclin D1" . SPARSER::COLLECTION)
    ("H 2 O 2 -induced senescent hEPCs" . SPARSER::PROTEIN)
    ("hEPCs" . SPARSER::PROTEIN) ("hEPC" . SPARSER::PROTEIN)
    ("myeloperoxidase" . SPARSER::PROTEIN) ("K 3" . SPARSER::PROTEIN)
    ("K 4" . SPARSER::PROTEIN) ("low-density lipoprotein" . SPARSER::PROTEIN)
    ("triton X-100" . SPARSER::MOLECULE) ("collagenase-2" . SPARSER::PROTEIN)
    ("ADAM-17" . SPARSER::PROTEIN) ("LY-294002" . SPARSER::PROTEIN)
    ("tissue kallikrein" . SPARSER::PROTEIN) ("B2R" . SPARSER::PROTEIN)
    ("Twist1 and wild type p53" . SPARSER::COLLECTION)
    ("mTOR and 4E-BP1" . SPARSER::COLLECTION) ("/p-mTOR" . SPARSER::COLLECTION)
    ("/p-AKT" . SPARSER::COLLECTION) ("mTOR and mTOR" . SPARSER::COLLECTION)
    ("many reported 4E-BP1-associated kinases" . SPARSER::PROTEIN)
    ("4E-BP1 and p-4E-BP1" . SPARSER::COLLECTION)
    ("4E-BP1 and Twist1" . SPARSER::COLLECTION)
    ("Twist1 and 4E-BP1" . SPARSER::COLLECTION)
    ("associated scaffolding proteins" . SPARSER::PROTEIN)
    ("a well-recognized eIF4E-binding protein" . SPARSER::PROTEIN)
    ("4E-BP1 as well as p-4E-BP1" . SPARSER::COLLECTION)
    ("H1975 and H1975Over" . SPARSER::COLLECTION) ("ZEB" . SPARSER::PROTEIN)
    ("EGF/RAS" . SPARSER::COLLECTION)
    ("Twist1 and EGFR, K-ras, or p53" . SPARSER::COLLECTION)
    ("EGFR, K-ras, or p53" . SPARSER::COLLECTION)
    ("different histologic subtypes" . SPARSER::PROTEIN)
    ("FOS and PTGS2" . SPARSER::COLLECTION)
    ("BRCA1 and p53" . SPARSER::COLLECTION)
    ("BRCA1, CD44, CTNNB1, MDM2, and p53" . SPARSER::COLLECTION)
    ("ACTB, BRCA1, CAV1, CCND1, CDK1, GSK3B, MYC, NR3C1, and TCF7L2"
     . SPARSER::COLLECTION)
    ("CD14, FOS, IGFBP3, and PTGS2" . SPARSER::COLLECTION)
    ("ACTB" . SPARSER::PROTEIN) ("Twist1 or p-4E-BP1" . SPARSER::COLLECTION)
    ("eIF2α, and p-eIF2α" . SPARSER::COLLECTION)
    ("multi-blot" . SPARSER::COLLECTION) ("p-eIF4E" . SPARSER::COLLECTION)
    ("4E-BP1 and mTOR" . SPARSER::COLLECTION) ("histopathologic type" . TYPE)
    ("Twist1 and phosphoinositide 3-kinase (PI3K)/protein kinase B (PKB/Akt)/mammalian target of rapamycin"
     . SPARSER::COLLECTION)
    ("Twist1 and phosphoinositide 3-kinase" . SPARSER::COLLECTION)
    ("factor 1, and NF-κB" . SPARSER::COLLECTION)
    ("PKB/Akt" . SPARSER::COLLECTION) ("bHLH" . SPARSER::PROTEIN)
    ("Twist1 and p-4E-BP1" . SPARSER::COLLECTION)
    ("4E-BP1 and p53" . SPARSER::COLLECTION)
    ("TATA-box binding protein" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 1" . SPARSER::PROTEIN)
    ("NR3C1" . SPARSER::PROTEIN)
    ("histone acetyltransferase 1" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription-3" . SPARSER::PROTEIN)
    ("basic helix-loop-helix" . SPARSER::PROTEIN)
    ("a role Rptpζ or its putative substrates" . SPARSER::COLLECTION)
    ("the tested candidates included Fyn" . SPARSER::PROTEIN)
    ("p42/44-Mapk" . SPARSER::COLLECTION) ("Git-1" . SPARSER::PROTEIN)
    ("Mapk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Fak" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Git" . SPARSER::PROTEIN)
    ("the most relevant phosphatase" . SPARSER::PHOSPHATASE)
    ("PTPRT" . SPARSER::PROTEIN) ("cFos" . SPARSER::PROTEIN)
    ("up smaller foci" . SPARSER::PROTEIN) ("Mdk/Rptpζ" . SPARSER::COLLECTION)
    ("growth factors, Pleiotrophin and Mdk" . SPARSER::COLLECTION)
    ("glycosaminoglycan" . SPARSER::MOLECULE)
    ("Pleiotrophin" . SPARSER::PROTEIN) ("a soluble form" . SPARSER::FORM)
    ("anhydrase" . SPARSER::PROTEIN) ("MDK" . SPARSER::PROTEIN)
    ("Mdk" . SPARSER::PROTEIN)
    ("ABL2, CRK, NCK2, Pi3KN and SRC" . SPARSER::COLLECTION)
    ("KN" . SPARSER::PROTEIN) ("CRK" . SPARSER::PROTEIN)
    ("/Ptprz1" . SPARSER::COLLECTION) ("SLR" . SPARSER::PROTEIN)
    ("a postmitotic state" . SPARSER::BIO-STATE) ("Midkine" . SPARSER::PROTEIN)
    ("ribs" . SPARSER::DRUG) ("Ptprz1" . SPARSER::PROTEIN)
    ("neo-" . SPARSER::PROTEIN) ("Rptpρ" . SPARSER::PROTEIN)
    ("fibronectin type III" . SPARSER::PROTEIN) ("PTPRZ1" . SPARSER::PROTEIN)
    ("NCK2" . SPARSER::PROTEIN) ("CT 40" . SPARSER::PROTEIN)
    ("AT-3" . SPARSER::PROTEIN) ("RECQL4" . SPARSER::PROTEIN)
    ("Rptpζ" . SPARSER::PROTEIN) ("SPARC" . SPARSER::PROTEIN)
    ("SERPINE1 and uPAR" . SPARSER::COLLECTION)
    ("under-expressed SERPINE1" . SPARSER::PROTEIN)
    ("under-expressing SERPINE1" . SPARSER::PROTEIN) ("TRC" . SPARSER::PROTEIN)
    ("PNI" . SPARSER::PROTEIN) ("Alcohol" . SPARSER::DRUG)
    ("SERPINE1-mRNA" . SPARSER::COLLECTION) ("CART" . SPARSER::PROTEIN)
    ("a prospective ( n = 190) cohorts" . SPARSER::MOLECULE)
    ("activators (PA)" . SPARSER::ACTIVATOR) ("Plasminogen" . SPARSER::PROTEIN)
    ("tPA and uPA" . SPARSER::COLLECTION) ("tPA" . SPARSER::PROTEIN)
    ("new predictive biomarkers" . SPARSER::MOLECULE)
    ("loco" . SPARSER::PROTEIN) ("PI3-Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Gag-Pol" . SPARSER::PROTEIN) ("p8" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Serpine1" . SPARSER::PROTEIN) ("PAI-039" . SPARSER::DRUG)
    ("MK-2206" . SPARSER::MOLECULE) ("HR1" . SPARSER::PROTEIN-FAMILY)
    ("TWIST1/N-Cadherin/NF-kappaB" . SPARSER::COLLECTION)
    ("AMPK or NF-kappaB" . SPARSER::COLLECTION)
    ("compound C or AMPK" . SPARSER::COLLECTION)
    ("TWIST1 and SNAIL" . SPARSER::COLLECTION)
    ("c-Fos, c-FLIP and FBXL10" . SPARSER::COLLECTION)
    ("c-FLIP [ xref ] and FBXL10 [ xref ]" . SPARSER::COLLECTION)
    ("c-Fos [ xref ], c-FLIP [ xref ] and FBXL10 [ xref ]"
     . SPARSER::COLLECTION)
    ("GC-4 (N-cadherin neutralizing antibody) or Bay 11–7085 (a specific NF-kappaB inhibitor)"
     . SPARSER::COLLECTION)
    ("mediating metformin's" . SPARSER::DRUG)
    ("antibody, or siRNA" . SPARSER::COLLECTION)
    ("DICER and c-MYC" . SPARSER::COLLECTION) ("DICER" . SPARSER::PROTEIN)
    ("p-p65" . SPARSER::COLLECTION)
    ("N-cadherin, NF-kB and AMPK" . SPARSER::COLLECTION)
    ("TWIST1 and N-cadherin" . SPARSER::COLLECTION)
    ("TWIST1/N-cadherin" . SPARSER::COLLECTION)
    ("metformin and lack of metformin-induced cell death"
     . SPARSER::COLLECTION)
    ("p65 and c-Fos" . SPARSER::COLLECTION)
    ("LNCaP/N-cad" . SPARSER::COLLECTION)
    ("TWIST1 and N-Cadherin" . SPARSER::COLLECTION)
    ("subline" . SPARSER::PROTEIN)
    ("TWIST1, N-cadehrin, p65 and c-FLIP" . SPARSER::COLLECTION)
    ("TWIST1/N-cadherin/p65" . SPARSER::COLLECTION)
    ("TWIST1, N-cadherin or p65" . SPARSER::COLLECTION)
    ("N-cadherin and TWIST1" . SPARSER::COLLECTION)
    ("TWIST1 or N-cadherin" . SPARSER::COLLECTION)
    ("sip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TWIST1, N-cadherin and p65" . SPARSER::COLLECTION)
    ("N-cadherin and p65" . SPARSER::COLLECTION)
    ("p65 and its downstream molecules (c-FLIP, FBXL10)" . SPARSER::COLLECTION)
    ("p65 and its downstream molecules (c-FLIP and FBXL10 [ xref ])"
     . SPARSER::COLLECTION)
    ("N-cadherin, p65 and its downstream molecules (c-FLIP and FBXL10 [ xref ])"
     . SPARSER::COLLECTION)
    ("c-FLIP and FBXL10" . SPARSER::COLLECTION)
    ("p-AMPK" . SPARSER::COLLECTION)
    ("metformin and N-cadherin" . SPARSER::COLLECTION)
    ("TWIST1/N-cadherin/NF-kappaB" . SPARSER::COLLECTION)
    ("p27 and p21" . SPARSER::COLLECTION) ("p53/REDD1" . SPARSER::COLLECTION)
    ("LKB1/AMPK" . SPARSER::COLLECTION)
    ("N-cadherin, p65 and AMPK" . SPARSER::COLLECTION)
    ("N-cadherin/NF-kappaB" . SPARSER::COLLECTION)
    ("N-cadherin and metformin" . SPARSER::COLLECTION)
    ("N- cad" . SPARSER::PROTEIN) ("AMPK α1" . SPARSER::PROTEIN)
    ("AMPKα1" . SPARSER::PROTEIN) ("anti-neoplastic" . SPARSER::DRUG)
    ("ADH-1" . SPARSER::PROTEIN) ("anti-diabetic" . SPARSER::DRUG)
    ("O-P" . SPARSER::PROTEIN) ("compound C" . SPARSER::MOLECULE)
    ("E-G" . SPARSER::PROTEIN) ("FBXL10" . SPARSER::PROTEIN)
    ("c-FLIP" . SPARSER::PROTEIN) ("N-cad" . SPARSER::PROTEIN)
    ("GC-4" . SPARSER::PROTEIN) ("REDD1" . SPARSER::PROTEIN)
    ("TWIST1" . SPARSER::PROTEIN) ("NF-kappaB" . SPARSER::PROTEIN)
    ("Allo-aca" . SPARSER::COLLECTION) ("aca" . SPARSER::PROTEIN)
    ("Aca" . SPARSER::PROTEIN)
    ("directly targeting leptin or deactivating leptin receptor"
     . SPARSER::COLLECTION)
    ("soluble leptin receptors" . SPARSER::RECEPTOR)
    ("EMT, and stemness" . SPARSER::COLLECTION)
    ("STRAD and MO25" . SPARSER::COLLECTION)
    ("STRAD (STE-related adapter) and MO25 (mouse protein 25)"
     . SPARSER::COLLECTION)
    ("STRAD" . SPARSER::PROTEIN)
    ("many mesenchymal marker proteins" . SPARSER::PROTEIN)
    ("EMT, stemness and leptin-function" . SPARSER::COLLECTION)
    ("Sirtuin" . SPARSER::PROTEIN)
    ("Oct4, nanog and Sox2" . SPARSER::COLLECTION) ("nanog" . SPARSER::PROTEIN)
    ("mesenchymal and epithelial genes" . SPARSER::GENE)
    ("hyperleptinemic state" . SPARSER::BIO-STATE)
    ("other pro-metastatic traits" . SPARSER::PROTEIN)
    ("mesenchymal traits" . SPARSER::PROTEIN)
    ("EMT, stemness and mammosphere" . SPARSER::COLLECTION)
    ("Oct4, Nanog and Sox2" . SPARSER::COLLECTION)
    ("HNK and miR-34a" . SPARSER::COLLECTION)
    ("slug and Zeb1" . SPARSER::COLLECTION)
    ("mesenchymal markers Fibronectin and Vimentin" . SPARSER::COLLECTION)
    ("Fibronectin and Vimentin" . SPARSER::COLLECTION)
    ("E-cadherin, Occludin and CK-18" . SPARSER::COLLECTION)
    ("Fibronectin" . SPARSER::PROTEIN)
    ("EMT, stemness and leptin" . SPARSER::COLLECTION)
    ("mer" . SPARSER::PROTEIN) ("sirtuin-deacetylases" . SPARSER::COLLECTION)
    ("sirtuin" . SPARSER::PROTEIN) ("SIRT1 and SIRT3" . SPARSER::COLLECTION)
    ("Sirtuin-deacetylases, SIRT1 and SIRT3" . SPARSER::COLLECTION)
    ("Sirtuin-deacetylases" . SPARSER::COLLECTION)
    ("JNK and p53" . SPARSER::COLLECTION) ("AMPK-mTOR" . SPARSER::COLLECTION)
    ("leptin and honokiol" . SPARSER::COLLECTION)
    ("Oct4, and Nanog" . SPARSER::COLLECTION)
    ("HNK and leptin" . SPARSER::COLLECTION)
    ("vimentin, fibronectin, Zeb1/2 and slug" . SPARSER::COLLECTION)
    ("snail, Zeb1 and Zeb2" . SPARSER::COLLECTION) ("Zeb2" . SPARSER::PROTEIN)
    ("proteins, Zeb1/2 and snail" . SPARSER::COLLECTION)
    ("fibronectin and vimentin" . SPARSER::COLLECTION)
    ("CK-18 and occludin" . SPARSER::COLLECTION)
    ("occludin, and cytokeratin-18" . SPARSER::COLLECTION)
    ("fibronectin, and vimentin" . SPARSER::COLLECTION)
    ("leptin and HNK" . SPARSER::COLLECTION) ("Honokiol (HNK)" . SPARSER::DRUG)
    ("Honokiol" . SPARSER::DRUG)
    ("synthetic leptin-antagonists, and anti-LR monoclonal antibodies"
     . SPARSER::ANTIBODY)
    ("soluble Leptin receptors" . SPARSER::RECEPTOR)
    ("Leptin and leptin-signaling pathway" . SPARSER::COLLECTION)
    ("leptin-leptin receptor" . SPARSER::COLLECTION)
    ("leptin and leptin receptor" . SPARSER::COLLECTION)
    ("adipocytokines" . SPARSER::PROTEIN-FAMILY)
    ("polypeptides" . SPARSER::PROTEIN) ("Adipocytes" . SPARSER::PROTEIN)
    ("LKB1 and miR-34a" . SPARSER::COLLECTION)
    ("inhibiting HNK's" . SPARSER::DRUG) ("Zeb1" . SPARSER::PROTEIN)
    ("Oct4 and Nanog" . SPARSER::COLLECTION) ("HNK" . SPARSER::DRUG)
    ("honokiol" . SPARSER::DRUG) ("adipocytokine" . SPARSER::PROTEIN-FAMILY)
    ("D6D" . SPARSER::PROTEIN) ("Leptin receptor" . SPARSER::PROTEIN)
    ("LPA-2" . SPARSER::PROTEIN) ("MO25" . SPARSER::PROTEIN)
    ("miR-34 a" . SPARSER::MOLECULE) ("Liver kinase B1" . SPARSER::PROTEIN)
    ("Liver Kinase B1" . SPARSER::PROTEIN) ("Zeb1/2" . SPARSER::PROTEIN)
    ("CK-18" . SPARSER::PROTEIN) ("cytokeratin-18" . SPARSER::PROTEIN)
    ("chemokines or cytokines" . SPARSER::COLLECTION)
    ("Bcl-2, Bax and p-gp" . SPARSER::COLLECTION)
    ("Bcl-2 and p-gp" . SPARSER::COLLECTION)
    ("TGF-β and IL-1β" . SPARSER::COLLECTION)
    ("PKC, PKA or TGF-β" . SPARSER::COLLECTION) ("COX" . SPARSER::PROTEIN)
    ("Bcl-2, P-gp and COX-2" . SPARSER::COLLECTION)
    ("protein (LRP)" . SPARSER::PROTEIN)
    ("multi-drug resistance-associated protein 1"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BCRP/ABCG2" . SPARSER::COLLECTION) ("MRP1/ABCC1" . SPARSER::COLLECTION)
    ("P-gp/ABCB1" . SPARSER::COLLECTION) ("BCRP" . SPARSER::PROTEIN)
    ("ADM and Rho" . SPARSER::COLLECTION)
    ("the common anti-apoptotic proteins (Bcl-2 and Bcl-xl) and pro-apoptotic proteins (Bax, Bad and Bid)"
     . SPARSER::COLLECTION)
    ("Bax, Bad and Bid" . SPARSER::COLLECTION)
    ("Bcl-2 and P-glycoprotein" . SPARSER::COLLECTION)
    ("exogenous PGE 2" . SPARSER::DRUG)
    ("arginase activity and cytokines" . SPARSER::COLLECTION)
    ("EP2 (AH6809) and EP4 (AH23848)" . SPARSER::COLLECTION)
    ("AH" . SPARSER::MOLECULE) ("EP2 and EP4" . SPARSER::COLLECTION)
    ("EP" . SPARSER::PROTEIN) ("EP1, EP2, EP3 and EP4" . SPARSER::COLLECTION)
    ("prostaglandin" . SPARSER::PROTEIN) ("EP1" . SPARSER::PROTEIN)
    ("CCK-8 or PI" . SPARSER::COLLECTION)
    ("adenoviral COX-2 or siRNA COX-2" . SPARSER::PROTEIN)
    ("COX-2 or siRNA" . SPARSER::COLLECTION)
    ("an independent prognostic biomarker" . SPARSER::MOLECULE)
    ("COX-2 and CD163" . SPARSER::COLLECTION)
    ("normal MDMs" . SPARSER::PROTEIN)
    ("normal macrophages" . SPARSER::PROTEIN) ("MDMs" . SPARSER::PROTEIN)
    ("IL-10 and arginase-1" . SPARSER::COLLECTION)
    ("/CD206" . SPARSER::COLLECTION) ("PGs" . SPARSER::PROTEIN)
    ("immunosuppressive cytokines" . SPARSER::PROTEIN)
    ("pro-inflammatory mediators" . SPARSER::PROTEIN)
    ("IL-1β and IL-12/23" . SPARSER::COLLECTION)
    ("IL-10 and TGF-β" . SPARSER::COLLECTION)
    ("CD163 and CD206" . SPARSER::COLLECTION)
    ("IL-4 and IL-13" . SPARSER::COLLECTION)
    ("Bcl-2 and P-gp" . SPARSER::COLLECTION)
    ("severe combined immunodeficiency" . SPARSER::PROTEIN)
    ("SO4" . SPARSER::PROTEIN) ("L-arginine" . SPARSER::MOLECULE)
    ("Arginase activity" . SPARSER::PROTEIN) ("Dnase I" . SPARSER::PROTEIN)
    ("M-CSF" . SPARSER::PROTEIN) ("CCL18" . SPARSER::PROTEIN)
    ("p-gp" . SPARSER::PROTEIN) ("COX-1" . SPARSER::PROTEIN)
    ("cancer resistance protein" . SPARSER::PROTEIN)
    ("ABCC1" . SPARSER::PROTEIN) ("MRP1" . SPARSER::PROTEIN)
    ("arginase activity" . SPARSER::PROTEIN) ("AH6809" . SPARSER::DRUG)
    ("EP4" . SPARSER::PROTEIN) ("EP3" . SPARSER::PROTEIN)
    ("EP2" . SPARSER::PROTEIN) ("prostaglandin E 2" . SPARSER::MOLECULE)
    ("Cyclooxygenase-2" . SPARSER::PROTEIN)
    ("mannose receptor" . SPARSER::PROTEIN) ("CD206" . SPARSER::PROTEIN)
    ("arginase-1" . SPARSER::PROTEIN)
    ("GSK-3β and/or Nur77" . SPARSER::COLLECTION)
    ("HIF-1α and NDRG1" . SPARSER::COLLECTION)
    ("Nur77 and NDRG1" . SPARSER::COLLECTION)
    ("Nur77 and β-catenin" . SPARSER::COLLECTION) ("ATE" . SPARSER::PROTEIN)
    ("TR3 or NR4A1" . SPARSER::COLLECTION) ("LiCl" . SPARSER::DRUG)
    ("FRAT1 and PAK4" . SPARSER::COLLECTION)
    ("p53/Siah-1/APC" . SPARSER::COLLECTION)
    ("GSK-3β/APC/Axin1" . SPARSER::COLLECTION)
    ("NDRG1, GSK-3β, Nur77, and β-catenin" . SPARSER::COLLECTION)
    ("β-catenin and its downstream target gene Cyclin D1"
     . SPARSER::COLLECTION)
    ("their respective NDRG1 shRNA" . SPARSER::PROTEIN)
    ("NDRG1-Nur77" . SPARSER::COLLECTION)
    ("NDRG1-GSK-3β" . SPARSER::COLLECTION)
    ("LY294002, or Nur77" . SPARSER::COLLECTION)
    ("Nur77-β-catenin" . SPARSER::COLLECTION)
    ("GSK-3β-β-catenin" . SPARSER::COLLECTION)
    ("GSK-3β or Nur77" . SPARSER::COLLECTION)
    ("GSK-3β–p53/p16" . SPARSER::COLLECTION)
    ("reliable HCC biomarkers" . SPARSER::MOLECULE)
    ("GSK-3β and Nur77" . SPARSER::COLLECTION) ("Histone 3" . SPARSER::PROTEIN)
    ("p-Rb" . SPARSER::PROTEIN) ("H-9" . SPARSER::PROTEIN)
    ("TR3" . SPARSER::PROTEIN) ("FRAT1" . SPARSER::PROTEIN)
    ("Siah-1" . SPARSER::PROTEIN)
    ("N-Myc downstream regulated gene 1" . SPARSER::PROTEIN)
    ("N-myc downstream regulated gene 1" . SPARSER::PROTEIN)
    ("SRC and MAPK" . SPARSER::COLLECTION)
    ("SRC and MEK" . SPARSER::COLLECTION)
    ("Saracatinib and PD0325901" . SPARSER::COLLECTION)
    ("PD0325901, Saracatinib and drug" . SPARSER::COLLECTION)
    ("Iodide" . SPARSER::PROTEIN) ("FAK and PXN" . SPARSER::COLLECTION)
    ("FAK-SRC-PXN" . SPARSER::COLLECTION)
    ("E-cadherin (Fig. xref ) and Plakoglobin (Fig. xref )"
     . SPARSER::COLLECTION)
    ("individual drug" . SPARSER::DRUG)
    ("its immediate downstream targets FAK" . SPARSER::PROTEIN)
    ("its immediate downstream target ERK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AZ" . SPARSER::DRUG)
    ("PD0325901 (PD) and Saracatinib (AZ) co-treatment" . SPARSER::COLLECTION)
    ("PD0325901 or Saracatinib" . SPARSER::COLLECTION)
    ("MEK and SRC" . SPARSER::COLLECTION)
    ("EGF, HGF, and IGF-1" . SPARSER::COLLECTION)
    ("MAPK and mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("Gefitinib and Erlotinib" . SPARSER::COLLECTION)
    ("MAPK and SRC pathway inhibitors in advanced stage NSCLC"
     . SPARSER::INHIBITOR)
    ("E-cadherin and Plakoglobin" . SPARSER::COLLECTION)
    ("Snail1, FAK and PXN" . SPARSER::COLLECTION) ("PXN" . SPARSER::PROTEIN)
    ("Plakoglobin" . SPARSER::PROTEIN) ("MAPK and SRC" . SPARSER::COLLECTION)
    ("PD0325901 and Saracatinib" . SPARSER::COLLECTION)
    ("mm 3" . SPARSER::PROTEIN) ("2 – 4" . SPARSER::PROTEIN)
    ("SRC kinase" . SPARSER::PROTEIN) ("IGF-IR" . SPARSER::PROTEIN)
    ("PD0325901" . SPARSER::DRUG) ("a longer RFS" . SPARSER::PROTEIN)
    ("ASCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HD and KD" . SPARSER::COLLECTION)
    ("buparlisib, everolimus and temsirolimus" . SPARSER::COLLECTION)
    ("buparlisib" . SPARSER::DRUG)
    ("an attractive cancer therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("KD-R" . SPARSER::PROTEIN) ("IB1" . SPARSER::PROTEIN)
    ("other proinflammatory cytokines" . SPARSER::PROTEIN)
    ("monoclonal anti-IL-1 β antibody" . SPARSER::ANTIBODY)
    ("currently three IL-1 inhibitors" . SPARSER::INHIBITOR)
    ("anakinra" . SPARSER::PROTEIN)
    ("circulatory inflammatory cytokines, IL-2, IL-4, IL-6, IL-12, and IL-13"
     . SPARSER::COLLECTION)
    ("cytokines, IL-2, IL-4, IL-6, IL-12, and IL-13" . SPARSER::COLLECTION)
    ("InsC" . SPARSER::PROTEIN)
    ("proinflammatory mediators, IL-6 and IL-8" . SPARSER::COLLECTION)
    ("mediators, IL-6 and IL-8" . SPARSER::COLLECTION)
    ("CREB and AP1" . SPARSER::COLLECTION)
    ("IL-1 β , IL-6, and IL-8" . SPARSER::COLLECTION)
    ("NALP3-ASC" . SPARSER::COLLECTION)
    ("CREB and western blot" . SPARSER::COLLECTION)
    ("phospho-CREB and CREB" . SPARSER::COLLECTION)
    ("PCDNA or Flag-BRAT" . SPARSER::COLLECTION) ("PCDNA" . SPARSER::PROTEIN)
    ("a proinflammatory cytokine" . SPARSER::PROTEIN)
    ("a strong FH" . SPARSER::PROTEIN)
    ("overtly normal OSE" . SPARSER::PROTEIN) ("NFH" . SPARSER::PROTEIN)
    ("X-linked inhibitor of apoptosis protein (XIAP)" . SPARSER::PROTEIN)
    ("Hereditary OCs" . SPARSER::PROTEIN) ("FH" . SPARSER::PROTEIN)
    ("OCs" . SPARSER::PROTEIN)
    ("the proinflammatory cytokine" . SPARSER::PROTEIN)
    ("IL-1B" . SPARSER::PROTEIN) ("beta1" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-1" . SPARSER::PROTEIN)
    ("IL-16" . SPARSER::PROTEIN) ("IL-13" . SPARSER::PROTEIN)
    ("nitric oxide synthase" . SPARSER::PROTEIN)
    ("cyclooxygenase-2" . SPARSER::PROTEIN)
    ("CREB binding" . SPARSER::PROTEIN-FAMILY) ("NALP3" . SPARSER::PROTEIN)
    ("Caspase-1" . SPARSER::PROTEIN) ("IL-1Ra" . SPARSER::PROTEIN)
    ("Large T-Antigen" . SPARSER::PROTEIN)
    ("Interleukin-1 beta" . SPARSER::PROTEIN) ("CA125" . SPARSER::DRUG)
    ("X-linked inhibitor of apoptosis protein" . SPARSER::PROTEIN)
    ("cIAP1" . SPARSER::PROTEIN) ("Interleukin-1 β" . SPARSER::PROTEIN)
    ("new therapeutic targets and diagnostic biomarkers" . SPARSER::COLLECTION)
    ("diagnostic biomarkers" . SPARSER::MOLECULE)
    ("mTOR or PTEN" . SPARSER::COLLECTION)
    ("other biological molecules" . SPARSER::MOLECULE)
    ("AKT and PI3K" . SPARSER::COLLECTION)
    ("the western blot" . SPARSER::PROTEIN)
    ("the western blot and IHC" . SPARSER::COLLECTION)
    ("western blot and IHC" . SPARSER::COLLECTION)
    ("protein, lipid and nucleotide" . SPARSER::COLLECTION)
    ("mTOR complex 1 (mTORC1) and mTORC2 [ xref ]" . SPARSER::COLLECTION)
    ("two functionally and structurally multiprotein distinct complexes"
     . SPARSER::BIO-COMPLEX)
    ("an atypical serine/threonine kinase" . SPARSER::KINASE)
    ("the most predominant form" . SPARSER::FORM)
    ("two main pathological types" . TYPE)
    ("phosphoinositide kinase" . SPARSER::PROTEIN)
    ("Mammalian Target of Rapamycin" . SPARSER::PROTEIN)
    ("PP2 or the caveolae" . SPARSER::COLLECTION) ("zonula" . SPARSER::PROTEIN)
    ("FYN" . SPARSER::PROTEIN) ("Alexa 488-labeled albumin" . SPARSER::PROTEIN)
    ("ZO-1 and Occludin" . SPARSER::COLLECTION) ("Occludin" . SPARSER::PROTEIN)
    ("interleukin-8 and VEGF" . SPARSER::COLLECTION)
    ("cytokines, interleukin-8 and vascular endothelial" . SPARSER::COLLECTION)
    ("PP1, Saracatinib and Quercetin" . SPARSER::COLLECTION)
    ("PP1, Saracatinib, and Quercetin" . SPARSER::COLLECTION)
    ("the intercellular cell adhesion molecule-2 protein" . SPARSER::PROTEIN)
    ("the intercellular cell adhesion molecule-1 protein" . SPARSER::PROTEIN)
    ("p-clathrin" . SPARSER::COLLECTION)
    ("the endothelial barrier" . SPARSER::PROTEIN)
    ("a dynamic barrier" . SPARSER::PROTEIN)
    ("PP2 and MβCD blocked LPS-induced increase in Evans Blue-labeled BSA level"
     . SPARSER::COLLECTION)
    ("albumin" . SPARSER::PROTEIN)
    ("interleukin-8 and vascular endothelial" . SPARSER::COLLECTION)
    ("ZO-1 and occludin" . SPARSER::COLLECTION) ("occludin" . SPARSER::PROTEIN)
    ("both PP2 and caveolae disruptor MβCD inhibited LPS-induced increase of triton-insoluble Cav-1"
     . SPARSER::COLLECTION)
    ("PP2, PP1, Saracatinib, and Quercetin" . SPARSER::COLLECTION)
    ("Quercetin" . SPARSER::MOLECULE)
    ("triton-soluble Cav-1 protein" . SPARSER::PROTEIN)
    ("triton-insoluble Cav-1" . SPARSER::PROTEIN)
    ("pCav-1" . SPARSER::COLLECTION) ("triton" . SPARSER::MOLECULE)
    ("CD34 antigen" . SPARSER::PROTEIN) ("interleukin-8" . SPARSER::PROTEIN)
    ("caveolin-1" . SPARSER::PROTEIN)
    ("Previously parylated PARP-1" . SPARSER::PROTEIN)
    ("CHFR and PARP" . SPARSER::COLLECTION)
    ("previously un-parylated PARP-1" . SPARSER::PROTEIN)
    ("CHFR/PARP" . SPARSER::COLLECTION)
    ("docetaxel and the combination" . SPARSER::COLLECTION)
    ("CD1" . SPARSER::PROTEIN) ("mm3" . SPARSER::PROTEIN)
    ("A3 and docetaxel" . SPARSER::COLLECTION) ("Chemical" . SPARSER::MOLECULE)
    ("PARP1-CHFR" . SPARSER::COLLECTION) ("PARP1/CHFR" . SPARSER::COLLECTION)
    ("CHFR/PARP1" . SPARSER::COLLECTION)
    ("CHFR and PARP-1" . SPARSER::COLLECTION)
    ("docetaxel and the PARP-inhibitor ABT-888" . SPARSER::COLLECTION)
    ("CHFR or PARP1" . SPARSER::COLLECTION) ("CHFR-PARP" . SPARSER::COLLECTION)
    ("PARP1 which is mediated by CHFR's" . SPARSER::PROTEIN)
    ("wt-PARP1" . SPARSER::COLLECTION)
    ("PARP-1 and CHFR" . SPARSER::COLLECTION)
    ("wt-PARP-1" . SPARSER::COLLECTION)
    ("approximately 130 kDA" . SPARSER::PROTEIN) ("kDA" . SPARSER::PROTEIN)
    ("CHFR and other proteins" . SPARSER::COLLECTION)
    ("V5-tagged CHFR" . SPARSER::PROTEIN)
    ("full-length CHFR (pDEST40-wt-CHFR) or PBZ mutant CHFR (pDEST40-CHFR-PBZ*)"
     . SPARSER::COLLECTION)
    ("wt" . SPARSER::PROTEIN) ("wt-CHFR" . SPARSER::COLLECTION)
    ("the CHFR's" . SPARSER::PROTEIN) ("PARP1 and CHFR" . SPARSER::COLLECTION)
    ("The mitotic checkpoint gene" . SPARSER::GENE)
    ("A3 and taxane" . SPARSER::COLLECTION)
    ("CHFR and PARP1" . SPARSER::COLLECTION)
    ("CHFR-PARP1" . SPARSER::COLLECTION) ("poly-ADP" . SPARSER::PROTEIN)
    ("CHFR" . SPARSER::PROTEIN) ("ABT888" . SPARSER::DRUG)
    ("group C" . SPARSER::PROTEIN) ("group B" . SPARSER::PROTEIN)
    ("group A" . SPARSER::PROTEIN) ("Beta Tubulin" . SPARSER::PROTEIN)
    ("B – A" . SPARSER::PROTEIN) ("del 1" . SPARSER::PROTEIN)
    ("ABT-888" . SPARSER::DRUG) ("RNF3" . SPARSER::PROTEIN)
    ("MOMP and mitochondria" . SPARSER::COLLECTION)
    ("the mitochondrial PGAM5L" . SPARSER::PROTEIN)
    ("Dominant-negative Drp1" . SPARSER::PROTEIN)
    ("further dephosphorylated Drp1" . SPARSER::PROTEIN)
    ("Drp1 around mitochondria" . SPARSER::PROTEIN)
    ("an indispensable component" . SPARSER::COMPONENT)
    ("PGAM5/Drp1" . SPARSER::COLLECTION)
    ("PGAM5 and Bax" . SPARSER::COLLECTION) ("PGAM" . SPARSER::PROTEIN)
    ("Smac and cyto" . SPARSER::COLLECTION) ("Smac" . SPARSER::PROTEIN)
    ("shRNA and Drp1" . SPARSER::COLLECTION)
    ("Bax, PGAM5L and Drp1" . SPARSER::COLLECTION)
    ("Bax-PGAM5L-Drp1" . SPARSER::COLLECTION)
    ("Bax and PGAM5" . SPARSER::COLLECTION)
    ("PGAM5, Drp1 and Bax" . SPARSER::COLLECTION)
    ("Drp1 and Bax" . SPARSER::COLLECTION) ("Drp1-PGAM5" . SPARSER::COLLECTION)
    ("Bax, Drp1 and PGAM5" . SPARSER::COLLECTION)
    ("Drp1 and PGAM5" . SPARSER::COLLECTION)
    ("PGAM5-Drp1" . SPARSER::COLLECTION)
    ("PGAM5L and Drp1" . SPARSER::COLLECTION)
    ("siRNA and Mdivi-1" . SPARSER::COLLECTION)
    ("normal mitochondria" . SPARSER::PROTEIN)
    ("PGAM5 and Drp1" . SPARSER::COLLECTION)
    ("siRNA or mdivi-1" . SPARSER::COLLECTION)
    ("siRNA or PGAM5S" . SPARSER::COLLECTION)
    ("siRNA or Drp1" . SPARSER::COLLECTION) ("PGAM5L" . SPARSER::PROTEIN)
    ("-KD" . SPARSER::COLLECTION) ("PGAM5L-KD" . SPARSER::PROTEIN-PAIR)
    ("mito" . SPARSER::DRUG) ("fraction, and PGAM5L" . SPARSER::COLLECTION)
    ("The mitochondrial PGAM5" . SPARSER::PROTEIN)
    ("mature AIF" . SPARSER::PROTEIN)
    ("PARP and caspase-3" . SPARSER::COLLECTION) ("IMM" . SPARSER::PROTEIN)
    ("MOMP" . SPARSER::PROTEIN) ("Dimers" . SPARSER::DIMER)
    ("Bax and Drp1" . SPARSER::COLLECTION)
    ("caspase 9 and caspase 3" . SPARSER::COLLECTION)
    ("PGAM5, Bax and Drp1" . SPARSER::COLLECTION)
    ("possibly other unidentified proteins" . SPARSER::PROTEIN)
    ("Staurosporine" . SPARSER::DRUG) ("PGAM5 and Drp-1" . SPARSER::COLLECTION)
    ("ROS- and calcium" . SPARSER::COLLECTION)
    ("the shorter form (PGAM5S) and the longer isoform (PGAM5L)"
     . SPARSER::COLLECTION)
    ("the longer isoform" . SPARSER::ISOFORM)
    ("the shorter form" . SPARSER::FORM)
    ("orthotropic and heterotropic CRC" . SPARSER::PROTEIN)
    ("SOCS6" . SPARSER::PROTEIN)
    ("suppressor of cytokine signaling 6" . SPARSER::PROTEIN)
    ("type 5" . SPARSER::PROTEIN) ("A–G" . SPARSER::PROTEIN)
    ("Z-VAD-fmk" . SPARSER::DRUG) ("Val-Ala" . SPARSER::MOLECULE)
    ("Drp-1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Drp1" . SPARSER::PROTEIN)
    ("long form" . SPARSER::PROTEIN) ("PGAM5" . SPARSER::PROTEIN)
    ("Stathmin 1/STAT3" . SPARSER::COLLECTION)
    ("a microtubule-targeted chemotherapeutic drug" . SPARSER::DRUG)
    ("STAT3/Stathmin 1" . SPARSER::COLLECTION) ("CALR" . SPARSER::PROTEIN)
    ("PML-RARα" . SPARSER::COLLECTION)
    ("paclitaxel or ruxolitinib" . SPARSER::COLLECTION)
    ("JAK2 and STAT3" . SPARSER::COLLECTION)
    ("caspase 3/PARP1" . SPARSER::COLLECTION)
    ("JAK2/STAT3" . SPARSER::COLLECTION)
    ("the efficient Stathmin 1" . SPARSER::PROTEIN)
    ("Stathmin 1 (shSTMN1) or a shRNA" . SPARSER::COLLECTION)
    ("Ruxolitinib" . SPARSER::DRUG)
    ("PI3K, ERK1/2 and JNK1/2" . SPARSER::COLLECTION)
    ("Oncoprotein 18 (OP18) or Leukemia-associated phosphoprotein p18 (LAP18)"
     . SPARSER::COLLECTION)
    ("erythroid, and megakaryocytic/granulocytic" . SPARSER::COLLECTION)
    ("STAT3 and Stathmin 1" . SPARSER::COLLECTION) ("L40" . SPARSER::PROTEIN)
    ("Jak2" . SPARSER::PROTEIN) ("1 K" . SPARSER::PROTEIN)
    ("LAP18" . SPARSER::PROTEIN)
    ("Leukemia-associated phosphoprotein p18" . SPARSER::PROTEIN)
    ("OP18" . SPARSER::PROTEIN) ("Oncoprotein 18" . SPARSER::PROTEIN)
    ("Stathmin 1" . SPARSER::PROTEIN) ("ERK and/or ETVs" . SPARSER::COLLECTION)
    ("ERK-ETV1" . SPARSER::COLLECTION) ("c-kit-ERK-ETV4" . SPARSER::COLLECTION)
    ("MMP-7, N-cadherin and vimentin" . SPARSER::COLLECTION)
    ("MMPs and EMT" . SPARSER::COLLECTION)
    ("less frequent p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-kit and SCF" . SPARSER::COLLECTION)
    ("c-kit or scf" . SPARSER::COLLECTION)
    ("scf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-kit and AKT" . SPARSER::COLLECTION)
    ("c-kit, SCF and AKT" . SPARSER::COLLECTION) ("apc" . SPARSER::PROTEIN)
    ("c-kit, SCF and ETV4" . SPARSER::COLLECTION)
    ("N-cadherin and vimentin" . SPARSER::COLLECTION)
    ("AKT and cyclin D1" . SPARSER::COLLECTION) ("Lv-" . SPARSER::MOLECULE)
    ("the AKT and its downstream p53 and cyclin D1" . SPARSER::COLLECTION)
    ("p53 and cyclin D1" . SPARSER::COLLECTION)
    ("c-kit, SCF and MUC2" . SPARSER::COLLECTION)
    ("c-kit and its ligand SCF" . SPARSER::COLLECTION)
    ("ETV1, ETV4 and ETV5" . SPARSER::COLLECTION)
    ("c-kit/SCF" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor (EGFR) and HER2" . SPARSER::COLLECTION)
    ("exogenous EGF" . SPARSER::PROTEIN) ("heregulin" . SPARSER::PROTEIN)
    ("extracellular mucin" . SPARSER::PROTEIN) ("DSS" . SPARSER::PROTEIN)
    ("AOM" . SPARSER::PROTEIN) ("Beta-actin" . SPARSER::PROTEIN)
    ("Hath1" . SPARSER::PROTEIN) ("Math1" . SPARSER::PROTEIN)
    ("MMP-7" . SPARSER::PROTEIN) ("stem cell factor" . SPARSER::PROTEIN)
    ("C-kit" . SPARSER::PROTEIN) ("TGF-α" . SPARSER::PROTEIN)
    ("insulin-like growth factor-1 receptor" . SPARSER::PROTEIN)
    ("ETV4" . SPARSER::PROTEIN) ("c-kit" . SPARSER::PROTEIN)
    ("RICTOR and cyclin D1" . SPARSER::COLLECTION)
    ("BRAF or NRAS" . SPARSER::COLLECTION)
    ("the p70 ribosomal S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("mTORC2 and more precisely RICTOR" . SPARSER::COLLECTION)
    ("more precisely RICTOR" . SPARSER::PROTEIN)
    ("a dual PI3K/mTOR inhibitor" . SPARSER::INHIBITOR)
    ("RICTOR/AKT" . SPARSER::COLLECTION)
    ("BRAF and NRAS" . SPARSER::COLLECTION)
    ("the dual PI3K/mTOR inhibitor" . SPARSER::INHIBITOR)
    ("LY294002 and GDC-0980" . SPARSER::COLLECTION)
    ("PI3K and mTOR" . SPARSER::COLLECTION)
    ("mTORC1/mTORC2 inhibitor (OSI-027) or dual PI3K/mTOR inhibitor (GDC-0980)"
     . SPARSER::COLLECTION)
    ("dual PI3K/mTOR inhibitor" . SPARSER::INHIBITOR)
    ("mTORC1/mTORC2" . SPARSER::COLLECTION)
    ("PI3K or mTORC1" . SPARSER::COLLECTION) ("PI3K–AKT" . SPARSER::COLLECTION)
    ("PI3K, AKT and mTOR" . SPARSER::COLLECTION)
    ("PI3K, AKT or mTOR" . SPARSER::COLLECTION)
    ("PI3K or downstream kinases" . SPARSER::COLLECTION)
    ("AKT and mTOR" . SPARSER::COLLECTION)
    ("PI3K [ xref , xref ] and AKT3 [ xref ]" . SPARSER::COLLECTION)
    ("the predominant AKT isoform" . SPARSER::ISOFORM)
    ("phosphatidylinositols" . SPARSER::PROTEIN)
    ("synthase" . SPARSER::PROTEIN) ("AKT1/2/3" . SPARSER::COLLECTION)
    ("the serine-threonine kinase AKT and phosphoinositide-dependent kinase-1 (PDK1)"
     . SPARSER::COLLECTION)
    ("Receptor Tyrosine Kinases (RTKs) and RAS proteins" . SPARSER::COLLECTION)
    ("RAS–RAF–MEK–ERK" . SPARSER::COLLECTION)
    ("AKT and mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("dual PI3K/mTOR inhibitors" . SPARSER::INHIBITOR)
    ("Chr 5" . SPARSER::PROTEIN) ("IRS-1" . SPARSER::PROTEIN)
    ("ZSTK 474" . SPARSER::DRUG) ("ZSTK474" . SPARSER::DRUG)
    ("GDC-0980" . SPARSER::DRUG) ("kinase-1" . SPARSER::PROTEIN)
    ("Receptor Tyrosine Kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the principal neoplastic component" . SPARSER::COMPONENT)
    ("p16, p53 and Rb" . SPARSER::COLLECTION)
    ("ATRX or DAXX" . SPARSER::COLLECTION)
    ("repetitive nucleotide" . SPARSER::NUCLEOTIDE)
    ("several classic oncogenes" . SPARSER::ONCOGENE)
    ("TP53 , RB1 , CDKN2A and EGFR" . SPARSER::COLLECTION)
    ("the major histological types" . TYPE)
    ("ATRX and DAXX" . SPARSER::COLLECTION) ("DAXX" . SPARSER::PROTEIN)
    ("ATRX" . SPARSER::PROTEIN) ("MED12" . SPARSER::PROTEIN)
    ("a highly mutated tumor suppressor" . SPARSER::SUPPRESSOR)
    ("multifunctional tumor suppressors" . SPARSER::SUPPRESSOR)
    ("both truncated cyclin E and the prosurvival factor MCL1"
     . SPARSER::COLLECTION)
    ("the prosurvival factor MCL1" . SPARSER::PROTEIN)
    ("cyclin B1 and Securin" . SPARSER::COLLECTION)
    ("antimitotic" . SPARSER::MOLECULE) ("FBW7 and p53" . SPARSER::COLLECTION)
    ("a currently undruggable tumor suppressor gene" . SPARSER::PROTEIN)
    ("full-length nondegradable cyclin E" . SPARSER::PROTEIN)
    ("nondegradable MCL1" . SPARSER::PROTEIN)
    ("a full-length nondegradable cyclin E" . SPARSER::PROTEIN)
    ("BUBR1 and the SAC" . SPARSER::COLLECTION)
    ("this FBW7-associated substrate" . SPARSER::SUBSTRATE)
    ("cyclin E and MCL1" . SPARSER::COLLECTION)
    ("nocodazole or paclitaxel" . SPARSER::COLLECTION)
    ("poisons" . SPARSER::MOLECULE)
    ("these components caused a significant decrease in cell growth in FBW7 −/− cells"
     . SPARSER::COMPONENT)
    ("SAC, BUB1, and MPS1" . SPARSER::COLLECTION)
    ("an intact SAC" . SPARSER::PROTEIN) ("Securin" . SPARSER::PROTEIN)
    ("the mitotic SAC" . SPARSER::PROTEIN) ("GARP" . SPARSER::PROTEIN)
    ("HCT116 FBW7 +/+ and HCT116 FBW7 −/−" . SPARSER::COLLECTION)
    ("FBW7 and BUBR1" . SPARSER::COLLECTION)
    ("conditional FBW7 alleles" . SPARSER::ALLELE)
    ("NF1, and MCL1" . SPARSER::COLLECTION)
    ("miRNAs, and promoter" . SPARSER::COLLECTION)
    ("only one allele" . SPARSER::ALLELE)
    ("substrates and phenotypes" . SPARSER::COLLECTION)
    ("just BUBR1" . SPARSER::PROTEIN)
    ("mitotic APC/C substrates" . SPARSER::SUBSTRATE)
    ("BUB1 and MPS1" . SPARSER::COLLECTION)
    ("FBXW7 or hCDC4" . SPARSER::COLLECTION)
    ("anti-mitotic" . SPARSER::MOLECULE) ("c-JUN" . SPARSER::PROTEIN)
    ("SKP1" . SPARSER::PROTEIN) ("MPS1" . SPARSER::PROTEIN)
    ("hCDC4" . SPARSER::PROTEIN)
    ("F-box and WD repeat domain containing 7" . SPARSER::PROTEIN)
    ("classic EGFR" . SPARSER::PROTEIN)
    ("variant, and E709X" . SPARSER::COLLECTION)
    ("EGFR and BRAF" . SPARSER::COLLECTION)
    ("a favorable RFS" . SPARSER::PROTEIN) ("MIA" . SPARSER::PROTEIN)
    ("cisplatin and PARP" . SPARSER::COLLECTION)
    ("CREB and KRAS" . SPARSER::COLLECTION) ("ATF/CREB" . SPARSER::COLLECTION)
    ("ATF" . SPARSER::PROTEIN) ("KRAS(G12C) and Polβ" . SPARSER::COLLECTION)
    ("UV light" . SPARSER::PROTEIN) ("SSA and MMEJ" . SPARSER::COLLECTION)
    ("γH2AX and 53BP1" . SPARSER::COLLECTION)
    ("53BP1-foci" . SPARSER::COLLECTION) ("exogenous KRAS" . SPARSER::PROTEIN)
    ("cisplatin and PA" . SPARSER::COLLECTION)
    ("KRAS(wt), KRAS(G12C), KRAS(G12D) and KRAS(G12V)" . SPARSER::COLLECTION)
    ("cisplatin and PA or MA" . SPARSER::COLLECTION)
    ("the KRAS(wt), KRAS(G12D) and KRAS(G12V)" . SPARSER::COLLECTION)
    ("KRAS(G12C) and KRAS(wt) or KRAS(G12D)" . SPARSER::COLLECTION)
    ("KRAS(wt) or KRAS(G12D)" . SPARSER::COLLECTION)
    ("FANCA, FANCC, FANCD2 and FANCF" . SPARSER::COLLECTION)
    ("FANCF" . SPARSER::PROTEIN) ("FANCC" . SPARSER::PROTEIN)
    ("KRAS(G12C) and KRAS(G12D)" . SPARSER::COLLECTION)
    ("53BP1, BRCA1, KU70, MLH1 or RAD52" . SPARSER::COLLECTION)
    ("KU70, MLH1 and RAD52" . SPARSER::COLLECTION)
    ("MLH1 and RAD52" . SPARSER::COLLECTION) ("SSA" . SPARSER::PROTEIN)
    ("XPA and XPF" . SPARSER::COLLECTION)
    ("ERCC1 , XPA , XPF and XPG" . SPARSER::COLLECTION)
    ("XPG" . SPARSER::PROTEIN)
    ("two antagonistic components" . SPARSER::COMPONENT)
    ("53BP1 and BRCA1" . SPARSER::COLLECTION)
    ("high equitoxic cisplatin" . SPARSER::DRUG)
    ("the best known apical activator" . SPARSER::ACTIVATOR)
    ("ICP" . SPARSER::PROTEIN) ("CTR-1" . SPARSER::COLLECTION)
    ("CTR" . SPARSER::PROTEIN) ("p-PRAS40" . SPARSER::COLLECTION)
    ("p-S6(ser235/236) and p-4EBP1(thr37/46)" . SPARSER::COLLECTION)
    ("p-Erk" . SPARSER::COLLECTION) ("p-MEK" . SPARSER::COLLECTION)
    ("MAPK and PI3K" . SPARSER::COLLECTION)
    ("the KRAS(G12C) and the KRAS(wt)" . SPARSER::COLLECTION)
    ("guanosine" . SPARSER::MOLECULE)
    ("KRAS(wt), KRAS(G12D) and KRAS(G12V)" . SPARSER::COLLECTION)
    ("KRAS(G12D) and KRAS(G12V)" . SPARSER::COLLECTION)
    ("KRAS(G12C) and KRAS(G12V)" . SPARSER::COLLECTION)
    ("KRAS(G12D) or KRAS(G12V)" . SPARSER::COLLECTION)
    ("KRAS(wt), KRAS(G12D) or KRAS(G12V)" . SPARSER::COLLECTION)
    ("conventional chemotherapeutic and targeted drugs" . SPARSER::DRUG)
    ("ALK-EML4" . SPARSER::COLLECTION)
    ("expressing mutated forms" . SPARSER::FORM)
    ("Caspases 3" . SPARSER::PROTEIN)
    ("mismatch repair protein" . SPARSER::PROTEIN)
    ("DNA polymerase beta" . SPARSER::PROTEIN) ("RAD52" . SPARSER::PROTEIN)
    ("KU70" . SPARSER::PROTEIN) ("ERCC1" . SPARSER::PROTEIN)
    ("p-S6" . SPARSER::PROTEIN) ("G-proteins" . SPARSER::PROTEIN)
    ("mRNA and microRNA" . SPARSER::COLLECTION) ("icotinib" . SPARSER::DRUG)
    ("alkaloids" . SPARSER::MOLECULE) ("isoquinoline" . SPARSER::DRUG)
    ("Berberine" . SPARSER::MOLECULE)
    ("miR-675 indirectly targets slug" . SPARSER::PROTEIN)
    ("slug" . SPARSER::PROTEIN)
    ("the tripartite complex" . SPARSER::BIO-COMPLEX)
    ("the tripartite complex Cdc42" . SPARSER::PROTEIN)
    ("p85Cool-1/βPix" . SPARSER::COLLECTION)
    ("c-Cbl, Cbl-b and Cbl-c" . SPARSER::COLLECTION)
    ("Twist1, CALN1, TGFβ1, and Cadherin11" . SPARSER::COLLECTION)
    ("CALN" . SPARSER::PROTEIN) ("ERK/MAPK" . SPARSER::COLLECTION)
    ("HGF, EGF and FGF-2" . SPARSER::COLLECTION)
    ("AKT and Erk" . SPARSER::COLLECTION) ("EGF or HGF" . SPARSER::COLLECTION)
    ("NGF" . SPARSER::PROTEIN) ("c-Met, Akt and Erk" . SPARSER::COLLECTION)
    ("EGFR, Akt and Erk" . SPARSER::COLLECTION)
    ("pMIR-mut" . SPARSER::COLLECTION) ("pMIR-3" . SPARSER::COLLECTION)
    ("pMIR-CDS2" . SPARSER::COLLECTION) ("pMIR" . SPARSER::PROTEIN)
    ("pMIR-CDS1" . SPARSER::COLLECTION) ("CDS1 and CDS2" . SPARSER::COLLECTION)
    ("c-Cbl/Cbl-b" . SPARSER::COLLECTION)
    ("c-Cbl or Cbl-b" . SPARSER::COLLECTION)
    ("Cbl and tyrosine kinase" . SPARSER::COLLECTION)
    ("thioredoxin" . SPARSER::PROTEIN)
    ("enzymes, Drosha and Dicer" . SPARSER::COLLECTION)
    ("two mature miRNAs" . SPARSER::PROTEIN)
    ("a tumor suppressor in Wilm's" . SPARSER::SUPPRESSOR)
    ("the maternal allele" . SPARSER::ALLELE)
    ("directly binding c-Cbl and Cbl-b mRNA" . SPARSER::PROTEIN)
    ("Akt and Erk" . SPARSER::COLLECTION)
    ("c-Cbl and Cbl-b" . SPARSER::COLLECTION)
    ("PolyVinylidene Fluoride" . SPARSER::DRUG)
    ("Reducing Agent" . SPARSER::MOLECULE) ("βPix" . SPARSER::PROTEIN)
    ("p85Cool-1" . SPARSER::PROTEIN) ("Cbl-c" . SPARSER::PROTEIN)
    ("Cadherin11" . SPARSER::PROTEIN) ("cl2" . SPARSER::PROTEIN)
    ("CDS2" . SPARSER::PROTEIN) ("CDS1" . SPARSER::PROTEIN)
    ("Cbl-b" . SPARSER::PROTEIN) ("grasp" . SPARSER::PROTEIN)
    ("PI3K or the mammalian target of rapamycin (mTOR)" . SPARSER::COLLECTION)
    ("LAR" . SPARSER::PROTEIN) ("Anti" . SPARSER::PROTEIN)
    ("RFS ( P = 0.062) and BCSS ( P = 0.022)" . SPARSER::COLLECTION)
    ("AR and RFS" . SPARSER::COLLECTION)
    ("RFS ( P = 0.014) and BCSS ( P = 0.030)" . SPARSER::COLLECTION)
    ("RFS ( P = 0.0099) and BCSS ( P = 0.018)" . SPARSER::COLLECTION)
    ("TN" . SPARSER::PROTEIN) ("‐negative" . SPARSER::PROTEIN)
    ("‐positive" . SPARSER::PROTEIN)
    ("significantly better RFS ( P = 0.014 and P = 0.030) and BCSS ( P = 0.0099 and P = 0.018)"
     . SPARSER::COLLECTION)
    ("significantly better RFS" . SPARSER::PROTEIN)
    ("RFS (hazards ratio [HR], 3.88e‐10; 95% CI, 0.28–0.28; P = 0.006) and BCSS (HR, 3.93e‐10; 95% CI, 0.36–0.36; P = 0.022)"
     . SPARSER::COLLECTION)
    ("both RFS ( P = 0.067 and P = 0.052) and BCSS ( P = 0.10 and 0.077)"
     . SPARSER::COLLECTION)
    ("both RFS ( P = 0.0072) and BCSS ( P = 0.016; Fig. xref )"
     . SPARSER::COLLECTION)
    ("a noninvasive prognostic biomarker" . SPARSER::MOLECULE)
    ("ERα, PgR and HER2" . SPARSER::COLLECTION)
    ("estrogen receptor (ER) and progesterone receptor (PgR)"
     . SPARSER::COLLECTION)
    ("PgR" . SPARSER::PROTEIN) ("RFS and BCSS" . SPARSER::COLLECTION)
    ("a potential noninvasive biomarker" . SPARSER::MOLECULE)
    ("CAis" . SPARSER::DRUG)
    ("a novel predictive biomarker" . SPARSER::MOLECULE)
    ("systemic inflammation biomarkers" . SPARSER::MOLECULE)
    ("IL-6, IL-17 and IL-22" . SPARSER::COLLECTION)
    ("erosive RA" . SPARSER::PROTEIN)
    ("monocytes and CD3 +" . SPARSER::COLLECTION)
    ("kinases or negative regulators" . SPARSER::COLLECTION)
    ("IL-6/STAT3" . SPARSER::COLLECTION)
    ("IL-6 and IL-17" . SPARSER::COLLECTION)
    ("ESR, CRP, IL-6, IL-17 and IL-21" . SPARSER::COLLECTION)
    ("CRP and proinflammatory cytokines" . SPARSER::COLLECTION)
    ("early erosive RA" . SPARSER::PROTEIN)
    ("a biological DMARD (tocilizumab) and methotrexate" . SPARSER::COLLECTION)
    ("a biological DMARD" . SPARSER::DRUG) ("tocilizumab" . SPARSER::DRUG)
    ("sulfasalazine" . SPARSER::DRUG)
    ("IL-6, IL-17 and IL-21" . SPARSER::COLLECTION) ("DMARD" . SPARSER::DRUG)
    ("cytokines and growth factors" . SPARSER::COLLECTION)
    ("receptors and trigger" . SPARSER::COLLECTION)
    ("transducers and activators" . SPARSER::COLLECTION)
    ("phosphospecific whole blood flow cytometry" . SPARSER::PROTEIN)
    ("helpful biomarkers" . SPARSER::MOLECULE)
    ("the inflammatory cytokines tumour necrosis factor (TNF) or interleukin (IL)"
     . SPARSER::COLLECTION)
    ("tumour necrosis factor (TNF)" . SPARSER::PROTEIN)
    ("biological DMARDs" . SPARSER::DRUG) ("DMARDs" . SPARSER::DRUG)
    ("disease-modifying antirheumatic drugs" . SPARSER::DRUG)
    ("interleukin (IL)" . SPARSER::PROTEIN)
    ("IL-17 and IL-21" . SPARSER::COLLECTION) ("CD18" . SPARSER::PROTEIN)
    ("CD11b" . SPARSER::PROTEIN) ("granzyme B" . SPARSER::PROTEIN)
    ("suppressor of cytokine signaling 3" . SPARSER::PROTEIN)
    ("IgG 2b" . SPARSER::BIO-COMPLEX) ("SK1" . SPARSER::PROTEIN)
    ("SK3" . SPARSER::PROTEIN) ("tumour necrosis factor" . SPARSER::PROTEIN)
    ("PIM1, which may be" . SPARSER::PROTEIN)
    ("p53 or CDK6" . SPARSER::COLLECTION)
    ("Abca1, Abcg1 and Npc1" . SPARSER::COLLECTION)
    ("Ampk, Cpt1a, Crot, Hadhb and Sirt6" . SPARSER::COLLECTION)
    ("Cpt1a" . SPARSER::PROTEIN) ("Npc1" . SPARSER::PROTEIN)
    ("Abcg1" . SPARSER::PROTEIN) ("Abca1" . SPARSER::PROTEIN)
    ("Ampk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Npc" . SPARSER::MOLECULE)
    ("a useful predictive biomarker" . SPARSER::MOLECULE)
    ("CCND1 and CDK6" . SPARSER::COLLECTION)
    ("CDK6, CCND1, PIM1 and p53" . SPARSER::COLLECTION)
    ("CDK6 and CCND1" . SPARSER::COLLECTION) ("CCN" . SPARSER::PROTEIN-FAMILY)
    ("miR-33a directly targets CDK6, CCND1 and PIM1" . SPARSER::COLLECTION)
    ("CDK6, CCND1 and PIM1" . SPARSER::COLLECTION)
    ("the normal gastric cell line GES-1" . SPARSER::PROTEIN)
    ("Srebp-1" . SPARSER::PROTEIN) ("Srebp-2" . SPARSER::PROTEIN)
    ("Srebp" . SPARSER::PROTEIN-FAMILY) ("miRNAs/miRs" . SPARSER::COLLECTION)
    ("CDK-6, CCND1 and PIM1" . SPARSER::COLLECTION)
    ("cyclin D1 (CCND1) and serine/threonine kinase PIM-1"
     . SPARSER::COLLECTION)
    ("cyclin-dependent kinase 6 (CDK6), cyclin D1 (CCND1) and serine/threonine kinase PIM-1"
     . SPARSER::COLLECTION)
    ("Sirt6" . SPARSER::PROTEIN) ("single-stranded RNAs" . SPARSER::RNA)
    ("PIM1" . SPARSER::PROTEIN) ("CDK-6" . SPARSER::PROTEIN)
    ("kinase PIM-1" . SPARSER::PROTEIN)
    ("AG1478 and Erlotinib" . SPARSER::COLLECTION)
    ("DNMT3L [ xref ] or DNMT1 [ xref ]" . SPARSER::COLLECTION)
    ("methyltransferase activity and DNA" . SPARSER::COLLECTION)
    ("decitabine and carboplatin" . SPARSER::COLLECTION)
    ("CPR and Erlotinib" . SPARSER::COLLECTION)
    ("DNMT3A, DNMT3B and DNMT3L" . SPARSER::COLLECTION)
    ("DNMT1 and a phosphorylated form" . SPARSER::COLLECTION)
    ("DNMTs" . SPARSER::PROTEIN)
    ("cisplatin, cell type and interaction" . SPARSER::COLLECTION)
    ("MCA" . SPARSER::PROTEIN) ("CPR" . SPARSER::PROTEIN)
    ("ERK1/2 or STAT3" . SPARSER::COLLECTION)
    ("JAK2 and AKT" . SPARSER::COLLECTION)
    ("cisplatin and AG1478" . SPARSER::COLLECTION)
    ("Platinum or cisplatin" . SPARSER::COLLECTION)
    ("Jak/Stat" . SPARSER::COLLECTION)
    ("methyltransferases (DNMT)" . SPARSER::PROTEIN)
    ("–taxane" . SPARSER::DRUG)
    ("Epidermal Growth Factor Receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DNMT" . SPARSER::PROTEIN) ("ZIC1" . SPARSER::PROTEIN)
    ("DNMT3L" . SPARSER::PROTEIN) ("DNMT3A" . SPARSER::PROTEIN)
    ("PAKs" . SPARSER::PROTEIN-FAMILY) ("antivirals" . SPARSER::DRUG)
    ("peripheral membrane (Lck) proteins" . SPARSER::PROTEIN)
    ("a soluble chemokine" . SPARSER::PROTEIN)
    ("cofilin and possibly additional substrates" . SPARSER::COLLECTION)
    ("possibly additional substrates" . SPARSER::SUBSTRATE)
    ("paxillin" . SPARSER::PROTEIN) ("Vav" . SPARSER::PROTEIN)
    ("little peripheral F-actin" . SPARSER::BIO-COMPLEX)
    ("host cell receptors and peripheral membrane proteins"
     . SPARSER::COLLECTION)
    ("peripheral membrane proteins" . SPARSER::PROTEIN)
    ("the peripheral membrane protein Lck" . SPARSER::PROTEIN)
    ("cell surface CXCR4 ( xref and xref ) and major histocompatibility complex"
     . SPARSER::COLLECTION)
    ("PAK2 or EXOC" . SPARSER::COLLECTION) ("GFP or SF2" . SPARSER::COLLECTION)
    ("EXOC2 or EXOC4" . SPARSER::COLLECTION)
    ("Actin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PAK2, EXOC2, or EXOC4" . SPARSER::COLLECTION)
    ("EXOC4 and EXOC2" . SPARSER::COLLECTION)
    ("dimerized conformation" . SPARSER::BIO-CONFORMATION)
    ("lentiviral Nef-yellow fluorescent protein (YFP)" . SPARSER::PROTEIN)
    ("YFP" . SPARSER::PROTEIN)
    ("the Nef-associated kinase complex" . SPARSER::BIO-COMPLEX)
    ("GFP-Trap" . SPARSER::COLLECTION) ("the viral protein" . SPARSER::PROTEIN)
    ("nanotube" . SPARSER::MOLECULE)
    ("cytoskeletal players (such as the small GTPases Cdc42 and Ral or the actin nucleator Arp2/3) position EXOC"
     . SPARSER::BIO-COMPLEX)
    ("Cdc42 and Ral" . SPARSER::COLLECTION)
    ("Ral" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an evolutionarily conserved octameric complex" . SPARSER::BIO-COMPLEX)
    ("relevant complex components" . SPARSER::COMPONENT)
    ("Cdc42/Rac1" . SPARSER::COLLECTION)
    ("Nef-associated PAK2 protein" . SPARSER::PROTEIN)
    ("a larger macromolecular complex" . SPARSER::BIO-COMPLEX)
    ("SF2 or NL4.3" . SPARSER::COLLECTION)
    ("chemoattractants" . SPARSER::PROTEIN) ("TGN" . SPARSER::PROTEIN)
    ("receptor (TCR)" . SPARSER::RECEPTOR)
    ("vpr" . SPARSER::HUMAN-PROTEIN-FAMILY) ("vpu" . SPARSER::PROTEIN)
    ("vif" . SPARSER::PROTEIN) ("PAK2 and EXOC" . SPARSER::COLLECTION)
    ("Rac1/Cdc42" . SPARSER::COLLECTION)
    ("Nef-associated PAK2" . SPARSER::PROTEIN)
    ("lentiviral Nef proteins" . SPARSER::PROTEIN)
    ("EXOC" . SPARSER::BIO-COMPLEX)
    ("an octameric protein complex" . SPARSER::BIO-COMPLEX)
    ("complex (EXOC)" . SPARSER::BIO-COMPLEX)
    ("exocyst" . SPARSER::BIO-COMPLEX) ("CD3ε" . SPARSER::PROTEIN)
    ("CCR7" . SPARSER::PROTEIN)
    ("stromal cell-derived factor 1" . SPARSER::PROTEIN)
    ("IPA3" . SPARSER::MOLECULE) ("EXOC4" . SPARSER::PROTEIN)
    ("EXOC1" . SPARSER::PROTEIN)
    ("yellow fluorescent protein" . SPARSER::PROTEIN)
    ("G2A" . SPARSER::PROTEIN) ("EXOC2" . SPARSER::PROTEIN)
    ("Vav1" . SPARSER::PROTEIN) ("exchange factor" . SPARSER::EXCHANGE-FACTOR)
    ("NL4" . SPARSER::PROTEIN) ("T-cell receptor" . SPARSER::PROTEIN)
    ("PAK2" . SPARSER::PROTEIN) ("Fulvestrant" . SPARSER::DRUG)
    ("nanoparticle" . SPARSER::MOLECULE)
    ("p53 and ribosomal protein" . SPARSER::COLLECTION)
    ("simvastatin" . SPARSER::DRUG) ("788 unique genes" . SPARSER::GENE)
    ("receptor (ER)" . SPARSER::RECEPTOR)
    ("a standard and endogenous ligand" . SPARSER::LIGAND)
    ("p53-MDM2" . SPARSER::COLLECTION) ("MDM2 and p53" . SPARSER::COLLECTION)
    ("oxysterol" . SPARSER::MOLECULE)
    ("Nutlin-3 and Mdm2" . SPARSER::COLLECTION)
    ("selective estrogen receptor modulator (SERM)" . SPARSER::DRUG)
    ("SERM" . SPARSER::DRUG) ("Estrogen" . SPARSER::MOLECULE)
    ("RPL26" . SPARSER::PROTEIN) ("HMG-CoA" . SPARSER::DRUG)
    ("CYP7B1" . SPARSER::PROTEIN) ("β-estradiol" . SPARSER::MOLECULE)
    ("Double Minute 2 protein" . SPARSER::PROTEIN)
    ("CYP27A1" . SPARSER::PROTEIN) ("Estrogen Receptor" . SPARSER::PROTEIN)
    ("selective estrogen receptor modulator" . SPARSER::DRUG)
    ("tumor progression-relevant genes" . SPARSER::GENE)
    ("NuA4 or PRC2" . SPARSER::COLLECTION)
    ("E2F1 and EZH2 or Tip60" . SPARSER::COLLECTION)
    ("EZH2 or Tip60" . SPARSER::COLLECTION)
    ("prohibitin ( xref ) and ppRB ( xref )" . SPARSER::COLLECTION)
    ("KAP1 ( xref ), Jab1 ( xref ), DP1 ( xref ), prohibitin ( xref ) and ppRB ( xref )"
     . SPARSER::COLLECTION)
    ("Complexes" . SPARSER::BIO-COMPLEX) ("AcH" . SPARSER::PROTEIN)
    ("EZH2 or other PcG proteins" . SPARSER::COLLECTION)
    ("HOXA9 and HOXA10" . SPARSER::COLLECTION)
    ("EZH2, EED and SUZ12" . SPARSER::COLLECTION)
    ("the EPC1-E2F6 repressive complex" . SPARSER::BIO-COMPLEX)
    ("EPC1-E2F6" . SPARSER::COLLECTION) ("EPC1-E2F1" . SPARSER::COLLECTION)
    ("stimulating cancer progression-relevant genes" . SPARSER::GENE)
    ("E2F1 pro-apoptotic target genes" . SPARSER::GENE)
    ("EPC1 and EPC2" . SPARSER::COLLECTION)
    ("protein (RFP)" . SPARSER::PROTEIN) ("relevant genes" . SPARSER::GENE)
    ("SRF" . SPARSER::PROTEIN) ("Hop" . SPARSER::PROTEIN)
    ("Tip60-EP400" . SPARSER::COLLECTION) ("E2F1-EPC1" . SPARSER::COLLECTION)
    ("E2F1 or EPC1" . SPARSER::COLLECTION)
    ("Flag-tagged full-length E2F1 (1–437) or mutants" . SPARSER::COLLECTION)
    ("transcriptional activator and repressor" . SPARSER::COLLECTION)
    ("activator or repressor" . SPARSER::COLLECTION)
    ("anti- and pro-apoptotic genes" . SPARSER::COLLECTION)
    ("a component of the NuA4 acetyltransferase complex and interaction partner"
     . SPARSER::COLLECTION)
    ("p27 and Bcl-2" . SPARSER::COLLECTION)
    ("pro-apoptotic targets Bim and p27" . SPARSER::COLLECTION)
    ("Bcl-2 and BIRC5" . SPARSER::COLLECTION)
    ("p27, FAS, Casp3, Apaf-1 and Bim" . SPARSER::COLLECTION)
    ("Casp" . SPARSER::PROTEIN) ("FAS" . SPARSER::PROTEIN)
    ("BIRC5, BRCA1, BRCA2 and Bcl-2" . SPARSER::COLLECTION)
    ("GST-E2F1" . SPARSER::COLLECTION) ("EPC1 and E2F5" . SPARSER::COLLECTION)
    ("E2F5 and EPC1" . SPARSER::COLLECTION)
    ("E2F1 and EPC1" . SPARSER::COLLECTION) ("DS" . SPARSER::PROTEIN)
    ("protein–protein" . SPARSER::COLLECTION)
    ("EPC1 and this complex" . SPARSER::COLLECTION)
    ("normally pro-apoptotic E2F1" . SPARSER::PROTEIN)
    ("EPC1 or sh" . SPARSER::COLLECTION) ("cDDP" . SPARSER::DRUG)
    ("epirubicin" . SPARSER::DRUG) ("E2F2 and E2F3" . SPARSER::COLLECTION)
    ("pGL3-luciferase" . SPARSER::COLLECTION) ("ER-E2F1" . SPARSER::COLLECTION)
    ("EPC1 and EZH2" . SPARSER::COLLECTION)
    ("EED and SUZ12" . SPARSER::COLLECTION)
    ("EZH2, and EPC1" . SPARSER::COLLECTION)
    ("EZH2 and EED" . SPARSER::COLLECTION) ("EED" . SPARSER::PROTEIN)
    ("Mel" . SPARSER::PROTEIN) ("pRB/E2F" . SPARSER::COLLECTION)
    ("INK4A-ARF" . SPARSER::COLLECTION)
    ("termed Polycomb repressive complexes" . SPARSER::BIO-COMPLEX)
    ("multimeric complexes" . SPARSER::BIO-COMPLEX)
    ("PRC1 and PRC2" . SPARSER::COLLECTION) ("PcG" . SPARSER::PROTEIN-FAMILY)
    ("silencing homeotic genes" . SPARSER::GENE)
    ("PcGs" . SPARSER::PROTEIN-FAMILY) ("Polycomb" . SPARSER::PROTEIN)
    ("fibronectin ( xref ) or other E2F1-dependent genes"
     . SPARSER::COLLECTION)
    ("RHAMM and EGFR" . SPARSER::COLLECTION) ("RHAMM" . SPARSER::PROTEIN)
    ("hyaluronan" . SPARSER::PROTEIN) ("VEGF-C/VEGFR-3" . SPARSER::COLLECTION)
    ("VEGF-C and its cognate receptor VEGFR-3" . SPARSER::COLLECTION)
    ("matrix metalloproteinase (MMP) genes and collagen degradation ( xref – xref )"
     . SPARSER::COLLECTION)
    ("pro-apoptotic genes" . SPARSER::GENE)
    ("proteins, Apaf-1 and caspases" . SPARSER::COLLECTION)
    ("EPC1 and E2F1" . SPARSER::COLLECTION)
    ("BCL-2 or Survivin/BIRC5" . SPARSER::COLLECTION)
    ("Survivin/BIRC5" . SPARSER::COLLECTION)
    ("bifunctional E2F1" . SPARSER::PROTEIN)
    ("DP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("KAP1" . SPARSER::PROTEIN)
    ("HOXA9" . SPARSER::PROTEIN) ("EPC2" . SPARSER::PROTEIN)
    ("serum response factor" . SPARSER::PROTEIN) ("EP400" . SPARSER::PROTEIN)
    ("ERE2" . SPARSER::PROTEIN) ("EPC-1" . SPARSER::PROTEIN)
    ("Glutathione S-transferase" . SPARSER::PROTEIN)
    ("E2F6" . SPARSER::PROTEIN) ("E2F5" . SPARSER::PROTEIN)
    ("TM 5" . SPARSER::PROTEIN) ("E2F2" . SPARSER::PROTEIN)
    ("pAX2" . SPARSER::PROTEIN) ("MAS5" . SPARSER::PROTEIN)
    ("NuA4" . SPARSER::PROTEIN-FAMILY)
    ("Enhancer of zeste homolog 2" . SPARSER::PROTEIN)
    ("PDGF-B" . SPARSER::PROTEIN) ("VEGFR-3" . SPARSER::PROTEIN)
    ("enhancer of polycomb homolog 1" . SPARSER::PROTEIN)
    ("EPC1" . SPARSER::PROTEIN)
    ("Transcription factor E2F1" . SPARSER::PROTEIN)
    ("novel fork reversal enzymes" . SPARSER::ENZYME)
    ("HIRAN, OB, HARP, or winged-helix" . SPARSER::COLLECTION)
    ("various fork reversal enzymes" . SPARSER::ENZYME)
    ("fork reversal enzymes" . SPARSER::ENZYME)
    ("BLM and WRN" . SPARSER::COLLECTION)
    ("the archaeal Hef helicase" . SPARSER::PROTEIN)
    ("HIRAN and OB" . SPARSER::COLLECTION)
    ("a partial triple-stranded DNA" . SPARSER::DNA)
    ("ATPase, and dsDNA" . SPARSER::COLLECTION)
    ("other fork reversal enzymes" . SPARSER::ENZYME)
    ("a fork reversal enzyme" . SPARSER::ENZYME)
    ("clamp" . SPARSER::PROTEIN-FAMILY) ("fluorescein" . SPARSER::MOLECULE)
    ("asparagines" . SPARSER::AMINO-ACID) ("HIRAN" . SPARSER::PROTEIN)
    ("the circular lagging arm" . SPARSER::PROTEIN)
    ("ubiquitin ligase and ATPase" . SPARSER::COLLECTION)
    ("whose dsDNA region HLTF" . SPARSER::PROTEIN)
    ("a partial three-stranded DNA substrate" . SPARSER::SUBSTRATE)
    ("circular plasmid DNA" . SPARSER::DNA)
    ("Mms2-Ubc13" . SPARSER::COLLECTION) ("Rad6-Rad18" . SPARSER::COLLECTION)
    ("RFC" . SPARSER::PROTEIN)
    ("ATPase, ubiquitin ligase, and dsDNA" . SPARSER::COLLECTION)
    ("the HLTF156–1009 protein completely lacking the N-terminal HIRAN domain and the point mutant HLTF NN90,91AA protein (Figure xref )"
     . SPARSER::COLLECTION)
    ("ubiquitin ligase, ATPase, and dsDNA" . SPARSER::COLLECTION)
    ("alkaline" . SPARSER::PROTEIN)
    ("the HIRAN deletion mutant and the NN90,91AA mutant HLTF"
     . SPARSER::COLLECTION)
    ("mutant, or RING" . SPARSER::COLLECTION)
    ("our previously described RING mutant" . SPARSER::MUTANT)
    ("only one dinucleotide" . SPARSER::MOLECULE)
    ("the SWI/SNF enzymes and the canonical helicases" . SPARSER::COLLECTION)
    ("the canonical helicases" . SPARSER::PROTEIN)
    ("WRN and BLM" . SPARSER::COLLECTION) ("RecQ" . SPARSER::PROTEIN-FAMILY)
    ("FANCM" . SPARSER::PROTEIN)
    ("SMARCAL1, ZRANB3, and Rad54" . SPARSER::COLLECTION)
    ("Rad5/HLTF" . SPARSER::COLLECTION) ("complete PRR" . SPARSER::PROTEIN)
    ("protein or fused" . SPARSER::COLLECTION) ("ssDNA" . SPARSER::PROTEIN)
    ("Rad6–Rad18" . SPARSER::COLLECTION)
    ("HLTF and SHPRH" . SPARSER::COLLECTION)
    ("homologues, HLTF and SHPRH" . SPARSER::COLLECTION)
    ("SHPRH" . SPARSER::PROTEIN) ("RAD6-RAD18" . SPARSER::COLLECTION)
    ("a canonical DNA polymerase" . SPARSER::PROTEIN)
    ("a more universal solution" . SPARSER::MOLECULE)
    ("the stalled high-fidelity replicative polymerase" . SPARSER::PROTEIN)
    ("the HARP2" . SPARSER::PROTEIN) ("HARP" . SPARSER::PROTEIN)
    ("ubiquitin ligase, ATPase and dsDNA" . SPARSER::COLLECTION)
    ("DNA and tumour" . SPARSER::COLLECTION) ("HLTF" . SPARSER::PROTEIN)
    ("two domains" . SPARSER::PROTEIN) ("SF2" . SPARSER::PROTEIN)
    ("32P" . SPARSER::|32P|) ("HR3" . SPARSER::PROTEIN)
    ("2-l" . SPARSER::PROTEIN) ("UBA1" . SPARSER::PROTEIN)
    ("UBC13" . SPARSER::PROTEIN) ("MMS2" . SPARSER::PROTEIN)
    ("Rad54" . SPARSER::PROTEIN) ("ZRANB3" . SPARSER::PROTEIN)
    ("SMARCAL1" . SPARSER::PROTEIN) ("ATPase activity" . SPARSER::PROTEIN)
    ("Rad18" . SPARSER::PROTEIN) ("Ubc13" . SPARSER::PROTEIN)
    ("Mms2" . SPARSER::PROTEIN) ("RAD5" . SPARSER::PROTEIN)
    ("rad5" . SPARSER::PROTEIN) ("Rad5" . SPARSER::PROTEIN)
    ("MAP and PI3 kinase" . SPARSER::COLLECTION) ("KIP" . SPARSER::PROTEIN)
    ("RAF, MEK, and ERK" . SPARSER::COLLECTION)
    ("PDGFRA and PDGFRB" . SPARSER::COLLECTION) ("PDGFRB" . SPARSER::PROTEIN)
    ("more precisely assessed RFS" . SPARSER::PROTEIN)
    ("KIT or platelet-derived growth factor receptor alpha (PDGFRA)"
     . SPARSER::COLLECTION)
    ("KIT or platelet-derived growth factor receptor alpha"
     . SPARSER::COLLECTION)
    ("adenosine triphosphate (ATP)" . SPARSER::MOLECULE)
    ("Cajal" . SPARSER::PROTEIN)
    ("a transmembrane tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("the cellular homologue" . SPARSER::PROTEIN) ("HPFs" . SPARSER::PROTEIN)
    ("c-KIT" . SPARSER::PROTEIN) ("CSF1R" . SPARSER::PROTEIN)
    ("colony stimulating- factor" . SPARSER::PROTEIN)
    ("platelet-derived growth factor receptor alpha" . SPARSER::PROTEIN)
    ("C- KIT" . SPARSER::PROTEIN) ("c- KIT" . SPARSER::PROTEIN)
    ("a monoclonal anti-EGFR" . SPARSER::PROTEIN)
    ("Functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pro-metastatic molecules" . SPARSER::MOLECULE)
    ("a mitochondrial protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("iPS" . SPARSER::PROTEIN) ("AIF and Endo" . SPARSER::COLLECTION)
    ("caspase and p53" . SPARSER::COLLECTION)
    ("mitochondria, cytochrome c and caspase 3/7" . SPARSER::COLLECTION)
    ("Endo" . SPARSER::PROTEIN)
    ("Apaf1, caspase 9, and caspase 3/7" . SPARSER::COLLECTION)
    ("adriamycin" . SPARSER::DRUG) ("trio" . SPARSER::PROTEIN)
    ("Trio" . SPARSER::PROTEIN) ("Knl-1" . SPARSER::COLLECTION)
    ("Mis12 and Ndc80" . SPARSER::COLLECTION)
    ("Bub1 and BubR1, and Protein Phosphatase 1" . SPARSER::COLLECTION)
    ("BubR1, and Protein Phosphatase 1" . SPARSER::COLLECTION)
    ("SAC" . SPARSER::PROTEIN) ("Knl-1/Blinkin" . SPARSER::COLLECTION)
    ("Blinkin" . SPARSER::PROTEIN)
    ("D40 siRNA and the atelocollagen complex" . SPARSER::COLLECTION)
    ("B17" . SPARSER::PROTEIN) ("Cytochrome c" . SPARSER::PROTEIN)
    ("mitotic checkpoint protein" . SPARSER::PROTEIN)
    ("Endonuclease G" . SPARSER::PROTEIN)
    ("Apoptosis-Inducing" . SPARSER::PROTEIN) ("Apaf1" . SPARSER::PROTEIN)
    ("KIAA1570" . SPARSER::PROTEIN) ("CASC5" . SPARSER::PROTEIN)
    ("mental retardation" . SPARSER::PROTEIN)
    ("Protein Phosphatase 1" . SPARSER::PROTEIN) ("Ndc80" . SPARSER::PROTEIN)
    ("Mis12" . SPARSER::HUMAN-PROTEIN-FAMILY) ("AF15q14" . SPARSER::PROTEIN)
    ("innate PAMPs" . SPARSER::PROTEIN)
    ("the m-shaped heterodimer" . SPARSER::HETERODIMER)
    ("p17-" . SPARSER::PROTEIN) ("COX-2 and TNF-α" . SPARSER::COLLECTION)
    ("p17, p24, or gp41 and TLR2" . SPARSER::COLLECTION)
    ("gp41 and TLR2" . SPARSER::COLLECTION)
    ("a TLR2/1 heterdimeric complex" . SPARSER::BIO-COMPLEX)
    ("multiple viral proteins" . SPARSER::PROTEIN)
    ("here revealed TLR2" . SPARSER::PROTEIN)
    ("antibodies or TLR2/1" . SPARSER::COLLECTION) ("pDC" . SPARSER::PROTEIN)
    ("GALT" . SPARSER::PROTEIN) ("the mucosal barrier" . SPARSER::PROTEIN)
    ("p24 and Pam 3 CSK 4 , p17, or gp41" . SPARSER::COLLECTION)
    ("p24 and TLR2" . SPARSER::COLLECTION)
    ("viral proteins (p17, p24, gp41, and gp120) or Pam 3 CSK 4"
     . SPARSER::COLLECTION)
    ("p17 and p24" . SPARSER::COLLECTION)
    ("p24 and gp41" . SPARSER::COLLECTION)
    ("p17 and Pam 3 CSK 4" . SPARSER::COLLECTION)
    ("the chemotactic cytokine" . SPARSER::PROTEIN)
    ("p17 and gp41, and Pam 3 CSK 4" . SPARSER::COLLECTION)
    ("gp41, and Pam 3 CSK 4" . SPARSER::COLLECTION)
    ("p17, p24, gp1, and gp120" . SPARSER::COLLECTION)
    ("gp1" . SPARSER::PROTEIN)
    ("TLRs and HIV-1 structural proteins" . SPARSER::COLLECTION)
    ("p17, p24, gp41, and CD14" . SPARSER::COLLECTION)
    ("TLR1 and viral proteins p17 and gp41" . SPARSER::COLLECTION)
    ("p24 or other viral components (Figure xref C)" . SPARSER::COLLECTION)
    ("other viral components" . SPARSER::COMPONENT)
    ("viral proteins p17 and gp41" . SPARSER::COLLECTION)
    ("proteins, or CD14" . SPARSER::COLLECTION)
    ("pure CD14" . SPARSER::PROTEIN) ("TLR2 and gp120" . SPARSER::COLLECTION)
    ("using TLR2 or TLR1-specific antibodies" . SPARSER::COLLECTION)
    ("protein–TLR" . SPARSER::COLLECTION)
    ("p17, p24, gp41, gp120, and nef" . SPARSER::COLLECTION)
    ("TLR2 and specific HIV-1 proteins" . SPARSER::COLLECTION)
    ("TLR1/TLR2" . SPARSER::COLLECTION) ("viral p17" . SPARSER::PROTEIN)
    ("TLR1 and TLR2" . SPARSER::COLLECTION)
    ("TLR1 or TLR2" . SPARSER::COLLECTION)
    ("TLR2 and/or TLR1" . SPARSER::COLLECTION)
    ("pro-inflammatory cytokine" . SPARSER::PROTEIN)
    ("proteins, p17 and gp41" . SPARSER::COLLECTION)
    ("recombinant viral proteins" . SPARSER::PROTEIN)
    ("p17, gp41, and p24" . SPARSER::COLLECTION)
    ("TLR2 and both heterodimers TLR1 and TLR6 (Figure xref D, insert)"
     . SPARSER::COLLECTION)
    ("TLR1 and TLR6" . SPARSER::COLLECTION)
    ("p24 and gp120" . SPARSER::COLLECTION)
    ("proteins or Pam 3 CSK 4" . SPARSER::COLLECTION)
    ("p24 or gp120" . SPARSER::COLLECTION)
    ("p17, gp41, and Pam 3 CSK 4" . SPARSER::COLLECTION)
    ("p17, p24, gp41, and gp120" . SPARSER::COLLECTION)
    ("inducing pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("glycoproteins and matrix" . SPARSER::COLLECTION)
    ("TLR2, and TLR2" . SPARSER::COLLECTION) ("viral DNA" . SPARSER::DNA)
    ("revealed significantly increased HIV-1 proviral DNA" . SPARSER::DNA)
    ("increased HIV-1 proviral DNA" . SPARSER::DNA)
    ("synthetic bacterial TLR2/1 ligand" . SPARSER::MOLECULE)
    ("functional TLR2 and TLR1" . SPARSER::COLLECTION)
    ("TLR2 and TLR1" . SPARSER::COLLECTION)
    ("siRNA or anti-TLR2" . SPARSER::COLLECTION)
    ("soluble TLR2" . SPARSER::PROTEIN)
    ("p17, p24, and gp41" . SPARSER::COLLECTION)
    ("TLR1, TLR6, and TLR10" . SPARSER::COLLECTION)
    ("innate PRRs" . SPARSER::PROTEIN) ("ssRNA" . SPARSER::RNA)
    ("uridine" . SPARSER::PROTEIN) ("PAMP" . SPARSER::PROTEIN)
    ("PRRs" . SPARSER::PROTEIN) ("CXCR2 and syndecan2" . SPARSER::COLLECTION)
    ("p24 and p17" . SPARSER::COLLECTION)
    ("ENV, gp120/160 or matrix" . SPARSER::COLLECTION)
    ("ENV" . SPARSER::PROTEIN)
    ("proteins and glycoproteins" . SPARSER::COLLECTION)
    ("cART" . SPARSER::HUMAN-PROTEIN-FAMILY) ("proviral DNA" . SPARSER::DNA)
    ("these viral PAMPs and TLR2" . SPARSER::COLLECTION)
    ("PAMPs and TLR2" . SPARSER::COLLECTION)
    ("p17 and gp41" . SPARSER::COLLECTION)
    ("TLR2 and its heterodimers" . SPARSER::COLLECTION)
    ("proteins, p17, p24, and gp41" . SPARSER::COLLECTION)
    ("significantly increased proviral DNA" . SPARSER::DNA)
    ("CXCR1" . SPARSER::PROTEIN) ("TLR3" . SPARSER::PROTEIN)
    ("anti-Histone" . SPARSER::PROTEIN) ("–2 " . SPARSER::PROTEIN)
    ("p3 " . SPARSER::HUMAN-PROTEIN-FAMILY) ("RPL13A" . SPARSER::PROTEIN)
    ("reverse-transcriptase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL2 " . SPARSER::PROTEIN) ("poly I:C" . SPARSER::MOLECULE)
    ("TLR10" . SPARSER::PROTEIN) ("anti-viral" . SPARSER::DRUG)
    ("syndecan2" . SPARSER::PROTEIN) ("CXCR2" . SPARSER::PROTEIN)
    ("TLR6" . SPARSER::PROTEIN) ("TLR1" . SPARSER::PROTEIN)
    ("gp41" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p17" . SPARSER::PROTEIN)
    ("CCR5" . SPARSER::PROTEIN)
    ("PF-2341066 or yield additional insights in the differential response to Met inhibition"
     . SPARSER::COLLECTION)
    ("vimentin and Snail" . SPARSER::COLLECTION)
    ("Met and downstream signals such as AKT and ERK" . SPARSER::COLLECTION)
    ("orally bioavailable inhibitor" . SPARSER::INHIBITOR)
    ("c-Met and HGF" . SPARSER::COLLECTION)
    ("GAB1, GRB2, phospholipase C, and SRC" . SPARSER::COLLECTION)
    ("ERK, and STAT3" . SPARSER::COLLECTION)
    ("AKT, and ERK" . SPARSER::COLLECTION)
    ("Snail and vimentin" . SPARSER::COLLECTION)
    ("PF-2341066 and cisplatin" . SPARSER::COLLECTION)
    ("HGF, and PF-2341066" . SPARSER::COLLECTION)
    ("Western blot and immunohistochemistry" . SPARSER::COLLECTION)
    ("/Met" . SPARSER::COLLECTION) ("GRB2" . SPARSER::PROTEIN)
    ("GAB1" . SPARSER::PROTEIN)
    ("receptor-like tyrosine kinase" . SPARSER::PROTEIN)
    ("protein expressed in" . SPARSER::PROTEIN) ("N 5" . SPARSER::PROTEIN)
    ("N 3" . SPARSER::PROTEIN) ("N5" . SPARSER::PROTEIN)
    ("Type III" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PF-2341066" . SPARSER::DRUG)
    ("ERK and p-ERK" . SPARSER::COLLECTION)
    ("histone and tubulin" . SPARSER::COLLECTION)
    ("SIRT1 and SIRT2" . SPARSER::COLLECTION) ("salermide" . SPARSER::DRUG)
    ("SIRT1 and p53" . SPARSER::COLLECTION)
    ("mitochondria, and SIRT1" . SPARSER::COLLECTION)
    ("rutin, fisetin, quercetin, and myricetin" . SPARSER::COLLECTION)
    ("fisetin" . SPARSER::DRUG) ("Phospholipid" . SPARSER::PHOSPHOLIPID)
    ("PVP" . SPARSER::MOLECULE) ("drug or agent" . SPARSER::COLLECTION)
    ("cambinol" . SPARSER::DRUG) ("sirtinol" . SPARSER::DRUG)
    ("ERK and phosphor-ERK" . SPARSER::COLLECTION)
    ("SIRT1 and Akt" . SPARSER::COLLECTION)
    ("particularly multidomain-type proapoptotic Bcl-2 family proteins"
     . SPARSER::PROTEIN)
    ("caspase-3 and cytochrome c" . SPARSER::COLLECTION)
    ("pCDNA-SIRT1" . SPARSER::PROTEIN-PAIR) ("rutin" . SPARSER::MOLECULE)
    ("PEG" . SPARSER::PROTEIN) ("Vis" . SPARSER::DRUG)
    ("extracellular signal-regulated kinase (ERK) and mitochondrial proteins"
     . SPARSER::COLLECTION)
    ("the antiapoptotic Bcl-2, proapoptotic Bax, Akt, extracellular signal-regulated kinase (ERK) and mitochondrial proteins"
     . SPARSER::COLLECTION)
    ("the antiapoptotic Bcl-2" . SPARSER::PROTEIN)
    ("Bcl-2-associated X protein" . SPARSER::PROTEIN)
    ("other prosurvival proteins" . SPARSER::PROTEIN)
    ("mitochondria, PI3K, and mitogen-activated protein kinases"
     . SPARSER::COLLECTION)
    ("Akt or mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("epigallocatechin-3-gallate (EGCG)" . SPARSER::DRUG)
    ("liposomes and lipid" . SPARSER::COLLECTION) ("EGCG" . SPARSER::DRUG)
    ("catechin" . SPARSER::MOLECULE) ("surfactant" . SPARSER::PROTEIN)
    ("xref inorganic nanoparticles" . SPARSER::MOLECULE)
    ("nanotubes" . SPARSER::MOLECULE) ("anticoagulant" . SPARSER::DRUG)
    ("herbal medicine" . SPARSER::DRUG)
    ("enzyme and gallbladder" . SPARSER::COLLECTION)
    ("sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("proapoptotic Bcl-2-associated X protein" . SPARSER::PROTEIN)
    ("polyvinylpyrrolidone" . SPARSER::DRUG) ("SIRT2" . SPARSER::PROTEIN)
    ("SIRT 1" . SPARSER::PROTEIN) ("per 1" . SPARSER::PROTEIN)
    ("O5" . SPARSER::PROTEIN) ("C–4" . SPARSER::PROTEIN)
    ("epigallocatechin-3-gallate" . SPARSER::DRUG)
    ("ROS and oxygen" . SPARSER::COLLECTION)
    ("the last 10 amino acids" . SPARSER::AMINO-ACID)
    ("a monomer or a dimer" . SPARSER::COLLECTION)
    ("catalase and superoxide" . SPARSER::COLLECTION)
    ("superoxide and H 2 O 2" . SPARSER::COLLECTION)
    ("this peroxisomal protein" . SPARSER::PROTEIN)
    ("AMPK and TSC2" . SPARSER::COLLECTION) ("proteosome" . SPARSER::PROTEIN)
    ("these peroxisomal proteins" . SPARSER::PROTEIN)
    ("peroxisomal membrane protein PMP34" . SPARSER::PROTEIN)
    ("parkin" . SPARSER::PROTEIN)
    ("puncta, PEX1 and PEX14" . SPARSER::COLLECTION)
    ("EGFP and mRFP" . SPARSER::COLLECTION)
    ("the S141E phosphomimetic PEX5 mutant" . SPARSER::MUTANT)
    ("EGFP-SKL and mRFPSKL" . SPARSER::COLLECTION)
    ("EGFP-SKL" . SPARSER::PROTEIN-PAIR) ("p-PEX5" . SPARSER::COLLECTION)
    ("GFP-LC3 (an autophagosome marker) and DsRed-SKL (a peroxisome marker)"
     . SPARSER::COLLECTION)
    ("peroxisomal proteins PEX1 and PEX14" . SPARSER::COLLECTION)
    ("PEX1 and PEX14" . SPARSER::COLLECTION)
    ("FIP200 (ULK1 complex component) or ATG16L1 (ATG5 complex component)"
     . SPARSER::COLLECTION)
    ("p62 and ubiquitin" . SPARSER::COLLECTION)
    ("this peroxisomal E3 ligase" . SPARSER::LIGASE)
    ("PEX2, PEX10 and PEX12" . SPARSER::COLLECTION)
    ("Myc-PEX5" . SPARSER::COLLECTION) ("Ubiquitin" . SPARSER::PROTEIN)
    ("N-1 and N-3" . SPARSER::COLLECTION)
    ("ATM ( xref ) or TSC2 (TSC2 −/− MEFs)" . SPARSER::COLLECTION)
    ("Clofibrate" . SPARSER::DRUG) ("peroxisomal ROS" . SPARSER::PROTEIN)
    ("DCFDA" . SPARSER::DRUG) ("DHE" . SPARSER::DRUG)
    ("PPAR" . SPARSER::PROTEIN) ("clofibrate" . SPARSER::DRUG)
    ("exogenous ROS" . SPARSER::PROTEIN) ("Peroxisomal ROS" . SPARSER::PROTEIN)
    ("an active dimer" . SPARSER::DIMER) ("RQ" . SPARSER::MOLECULE)
    ("SRL" . SPARSER::PROTEIN) ("Peroxisomal proteins" . SPARSER::PROTEIN)
    ("the peroxisomal protein catalase" . SPARSER::PROTEIN)
    ("peroxisomal ATM" . SPARSER::PROTEIN)
    ("proteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("complex (TSC)" . SPARSER::BIO-COMPLEX) ("LIR" . SPARSER::PROTEIN)
    ("Tert-butyl hydroperoxide" . SPARSER::MOLECULE)
    ("potassium chloride" . SPARSER::MOLECULE)
    ("Hydrogen peroxide" . SPARSER::MOLECULE) ("ATG16L" . SPARSER::PROTEIN)
    ("ACAA1" . SPARSER::PROTEIN) ("lamin A/C" . SPARSER::PROTEIN)
    ("p70-S6K" . SPARSER::PROTEIN) ("PPARα" . SPARSER::PROTEIN)
    ("NBR1" . SPARSER::PROTEIN) ("PMP34" . SPARSER::PROTEIN)
    ("PTS1" . SPARSER::PROTEIN) ("mitofusin 2" . SPARSER::PROTEIN)
    ("PEX14" . SPARSER::PROTEIN) ("PEX1" . SPARSER::PROTEIN)
    ("ATG16L1" . SPARSER::PROTEIN) ("FIP200" . SPARSER::PROTEIN)
    ("PEX12" . SPARSER::PROTEIN) ("PEX10" . SPARSER::PROTEIN)
    ("PEX2" . SPARSER::PROTEIN) ("KU55933" . SPARSER::DRUG)
    ("N-3" . SPARSER::PROTEIN) ("N-1" . SPARSER::PROTEIN)
    ("PEX6" . SPARSER::PROTEIN) ("PMP70" . SPARSER::PROTEIN)
    ("ubiquitin-binding protein p62" . SPARSER::PROTEIN)
    ("long chain" . SPARSER::PROTEIN) ("PEX5" . SPARSER::PROTEIN)
    ("GART" . SPARSER::PROTEIN) ("PAICS" . SPARSER::PROTEIN)
    ("G protein and MAP kinase" . SPARSER::COLLECTION)
    ("macrolide" . SPARSER::MOLECULE)
    ("a sub-stoichiometric component" . SPARSER::COMPONENT)
    ("brain markers PAX6, EN2 and KROX20/EGR1 ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("KROX20/EGR1" . SPARSER::COLLECTION) ("whose subunits" . SPARSER::PROTEIN)
    ("literature-derived complexes" . SPARSER::BIO-COMPLEX)
    ("These primordial complexes" . SPARSER::BIO-COMPLEX)
    ("ancient subunits" . SPARSER::PROTEIN) ("Fungi" . SPARSER::PROTEIN)
    ("orthologous protein" . SPARSER::PROTEIN)
    ("stably-associated proteins" . SPARSER::PROTEIN)
    ("1,127 biochemical fractions" . SPARSER::COMPONENT)
    ("putatively interacting orthologs" . SPARSER::PROTEIN)
    ("conserved reference annotated protein" . SPARSER::PROTEIN)
    ("human proteins and their orthologs" . SPARSER::COLLECTION)
    ("Mus" . SPARSER::PROTEIN)
    ("a more comprehensive and accurate map" . SPARSER::PROTEIN)
    ("global molecular interaction maps" . SPARSER::PROTEIN)
    ("contemporary components" . SPARSER::COMPONENT)
    ("ancestral complexes" . SPARSER::BIO-COMPLEX)
    ("Macromolecular complexes" . SPARSER::BIO-COMPLEX)
    ("spliceosomal complex" . SPARSER::BIO-COMPLEX) ("Gle2" . SPARSER::PROTEIN)
    ("Bub3" . SPARSER::PROTEIN) ("zinc finger protein" . SPARSER::PROTEIN)
    ("ZNF207" . SPARSER::PROTEIN) ("KROX20" . SPARSER::PROTEIN)
    ("EN2" . SPARSER::PROTEIN) ("PAX6" . SPARSER::PROTEIN)
    ("MURR1" . SPARSER::PROTEIN) ("yeast)" . SPARSER::PROTEIN)
    ("Transgelin" . SPARSER::PROTEIN)
    ("Cofilin-1 and transgelin" . SPARSER::COLLECTION)
    ("streptavidin-peroxidase" . SPARSER::COLLECTION)
    ("transgelin" . SPARSER::PROTEIN) ("Bmi-1" . SPARSER::PROTEIN)
    ("LAPTM4B/NRF2" . SPARSER::COLLECTION)
    ("LAPTM4B-NRF2" . SPARSER::COLLECTION) ("cisplatinum" . SPARSER::DRUG)
    ("macrophages and neutrophils" . SPARSER::COLLECTION)
    ("NRF2/HMOX1" . SPARSER::COLLECTION)
    ("NRF2 and its anti-oxidant target gene HMOX1" . SPARSER::COLLECTION)
    ("malic enzyme 1 ( ME1 ) and solute carrier family 7 member 11 ( SLC7A11 )"
     . SPARSER::COLLECTION)
    ("siRNA or LAPTM4B" . SPARSER::COLLECTION)
    ("NRF2 and HMOX1" . SPARSER::COLLECTION)
    ("NRF2 and downstream NRF2-target genes" . SPARSER::COLLECTION)
    ("PI3K and MEK" . SPARSER::COLLECTION)
    ("LY294002 and U0126" . SPARSER::COLLECTION)
    ("siRNA and LAPTM4B" . SPARSER::COLLECTION)
    ("p62/SQSTM1" . SPARSER::COLLECTION)
    ("LAPTM4 B-siRNA" . SPARSER::COLLECTION) ("LC3A" . SPARSER::PROTEIN)
    ("as 2 " . SPARSER::PROTEIN)
    ("Histone H2B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SLC7A11" . SPARSER::PROTEIN)
    ("solute carrier family 7 member 11" . SPARSER::PROTEIN)
    ("SQSTM1" . SPARSER::PROTEIN) ("LAPTM4 B" . SPARSER::PROTEIN)
    ("putative oncogene" . SPARSER::PROTEIN)
    ("heme oxygenase 1" . SPARSER::PROTEIN) ("LAPTM4B" . SPARSER::PROTEIN)
    ("lysosomal protein transmembrane 4 beta" . SPARSER::PROTEIN)
    ("AR or ELK1" . SPARSER::COLLECTION) ("TMAs" . SPARSER::MOLECULE)
    ("AR [ xref ] or estrogen receptor [ xref ]" . SPARSER::COLLECTION)
    ("ELK1 and AR" . SPARSER::COLLECTION) ("AR and ELK1" . SPARSER::COLLECTION)
    ("MMP-2/MMP-9" . SPARSER::COLLECTION)
    ("an AR as well as estrogen receptors" . SPARSER::COLLECTION)
    ("a functional AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ELK1 and its downstream target c-fos" . SPARSER::COLLECTION)
    ("classical androgen-regulated genes" . SPARSER::GENE)
    ("prostate-specific antigen and NKX3-1" . SPARSER::COLLECTION)
    ("charcoal-stripped FBS and 1 nM DHT" . SPARSER::COLLECTION)
    ("charcoal-stripped FBS and no additional androgens" . SPARSER::COLLECTION)
    ("LNCaP-ELK1-shRNA" . SPARSER::COLLECTION) ("nick" . SPARSER::PROTEIN)
    ("ELK1 mRNA (Figure xref ) and protein (Figure xref )"
     . SPARSER::COLLECTION)
    ("DHT and/or HF" . SPARSER::COLLECTION)
    ("DHT and/or an AR antagonist hydroxyflutamide (HF)" . SPARSER::COLLECTION)
    ("hydroxyflutamide (HF)" . SPARSER::DRUG)
    ("-polymerase" . SPARSER::COLLECTION) ("HF" . SPARSER::PROTEIN)
    ("ELK1/p-ELK1" . SPARSER::COLLECTION)
    ("ELK1 and phospho-ELK1" . SPARSER::COLLECTION)
    ("control-shRNA and UMUC3-AR-shRNA" . SPARSER::COLLECTION)
    ("further study ELK1" . SPARSER::PROTEIN)
    ("ELK1 (3.7-fold) and ROR (2.9-fold)" . SPARSER::COLLECTION)
    ("MyoD" . SPARSER::PROTEIN) ("RAR" . SPARSER::PROTEIN)
    ("NFAT" . SPARSER::PROTEIN) ("methyltrienolone" . SPARSER::MOLECULE)
    ("-2 and MMP-9" . SPARSER::COLLECTION)
    ("androgens or AR" . SPARSER::COLLECTION)
    ("β-catenin, CD24, epidermal growth factor receptor, and extracellular signal-regulated kinases"
     . SPARSER::COLLECTION)
    ("ELK1-shRNA" . SPARSER::COLLECTION) ("p-ELK1" . SPARSER::COLLECTION)
    ("R-250" . SPARSER::PROTEIN) ("B-4" . SPARSER::PROTEIN)
    ("NKX3-1" . SPARSER::PROTEIN) ("1–8" . SPARSER::PROTEIN)
    ("NKX2–5" . SPARSER::PROTEIN) ("proto-oncogene c-fos" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ARF/MDM2/p53" . SPARSER::COLLECTION)
    ("β1-integrin-FAK-PI3K-AKT-mTOR" . SPARSER::COLLECTION)
    ("PKM2 and other glycolytic enzymes" . SPARSER::COLLECTION)
    ("a chemical inhibitor or RNAi interference" . SPARSER::COLLECTION)
    ("β1-integrin/FAK/PI3K/AKT" . SPARSER::COLLECTION)
    ("the active dimer" . SPARSER::DIMER) ("active dimers" . SPARSER::DIMER)
    ("PKM2, GLUT1 and LDHA" . SPARSER::COLLECTION)
    ("kinase (PK)" . SPARSER::KINASE)
    ("β1-integrin/FAK-PI3K/AKT" . SPARSER::COLLECTION)
    ("LY294002 (Fig. xref , left down) or restoration" . SPARSER::COLLECTION)
    ("mut-p53-Luc" . SPARSER::COLLECTION) ("p53-Luc" . SPARSER::COLLECTION)
    ("the EMR-associated PKM2 and LDHA" . SPARSER::COLLECTION)
    ("β1-integrin/FAK" . SPARSER::COLLECTION)
    ("EMR biomarker" . SPARSER::MOLECULE)
    ("MCF10A-Twist/mTOR siRNA ( xref ) and BT549/mTOR siRNA ( xref )"
     . SPARSER::COLLECTION)
    ("p53 and G6PD" . SPARSER::COLLECTION)
    ("PKM2 and LDHA" . SPARSER::COLLECTION)
    ("PKM2, LDHA and G6PD" . SPARSER::COLLECTION)
    ("G6PD, PKM2, LDHA, PGK1, ENO1 and TPI1" . SPARSER::COLLECTION)
    ("energy metabolism-associated genes" . SPARSER::GENE)
    ("swollen mitochondria" . SPARSER::PROTEIN) ("Mito" . SPARSER::DRUG)
    ("Lactate" . SPARSER::LACTATE)
    ("pyruvate and lactate" . SPARSER::COLLECTION)
    ("siRNA or specific chemical inhibitors" . SPARSER::COLLECTION)
    ("β1-integrin/FAK/PI3K/AKT/mTOR" . SPARSER::COLLECTION)
    ("PKM2, LDHA, and G6PD" . SPARSER::COLLECTION)
    ("Epidermal Growth Factor" . SPARSER::PROTEIN) ("TPI1" . SPARSER::PROTEIN)
    ("ENO1" . SPARSER::PROTEIN) ("PGK1" . SPARSER::PROTEIN)
    ("basic Helix-Loop-Helix" . SPARSER::PROTEIN)
    ("glucose-6-phosphate" . SPARSER::MOLECULE)
    ("Hexokinase 2" . SPARSER::PROTEIN) ("β1-integrin" . SPARSER::PROTEIN)
    ("anti-CCL5/HIF2α/AR" . SPARSER::COLLECTION) ("PDHs" . SPARSER::PROTEIN)
    ("HIF1α and HIF2α" . SPARSER::COLLECTION)
    ("AR and HSP90" . SPARSER::COLLECTION)
    ("C4-2 and CWR22RV1" . SPARSER::COLLECTION)
    ("HIF2α-siRNA" . SPARSER::COLLECTION) ("CCL5-HIF2α" . SPARSER::COLLECTION)
    ("BM-MSCs and CCL5" . SPARSER::COLLECTION)
    ("VHL and HIF2α" . SPARSER::COLLECTION) ("GFP-VHL" . SPARSER::COLLECTION)
    ("HIF2α and VHL" . SPARSER::COLLECTION) ("VHL-siRNA" . SPARSER::COLLECTION)
    ("PHD1 and PHD4" . SPARSER::COLLECTION)
    ("ubiquitin (Ub) and HIF2α" . SPARSER::COLLECTION)
    ("VHL-HIF2α" . SPARSER::COLLECTION)
    ("CD133 and ZEB-1" . SPARSER::COLLECTION)
    ("the key cytokine" . SPARSER::PROTEIN) ("MScs" . SPARSER::PROTEIN)
    ("ZEB-1 and CXCR4" . SPARSER::COLLECTION)
    ("LNCaP and C4-2" . SPARSER::COLLECTION)
    ("HSP90 and AR" . SPARSER::COLLECTION)
    ("ligase—von Hippel-Lindau tumor suppressor (VHL)" . SPARSER::COLLECTION)
    ("ligase—von Hippel-Lindau tumor suppressor" . SPARSER::COLLECTION)
    ("HIFs" . SPARSER::PROTEIN-FAMILY) ("iron-" . SPARSER::MOLECULE)
    ("HIF" . SPARSER::PROTEIN-FAMILY)
    ("those distinct AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("systematically suppresses/reduces androgen" . SPARSER::MOLECULE)
    ("CD133, ZEB-1 and CXCR4" . SPARSER::COLLECTION)
    ("CCL5 and AR" . SPARSER::COLLECTION)
    ("CCL2/CCR2-STAT3" . SPARSER::COLLECTION)
    ("CCL5/HIF2α/AR" . SPARSER::COLLECTION) ("PHDs" . SPARSER::PROTEIN)
    ("AR-HSP90" . SPARSER::COLLECTION)
    ("heat shock protein 90" . SPARSER::PROTEIN) ("HIF2a" . SPARSER::PROTEIN)
    ("PHD4" . SPARSER::PROTEIN) ("PHD1" . SPARSER::PROTEIN)
    ("HIF2 α" . SPARSER::PROTEIN)
    ("von Hippel-Lindau tumor suppressor" . SPARSER::PROTEIN)
    ("Hypoxia-inducible factor" . SPARSER::PROTEIN)
    ("ZEB-1" . SPARSER::PROTEIN) ("CCR2" . SPARSER::PROTEIN)
    ("VEGFRs" . SPARSER::PROTEIN) ("Plexins" . SPARSER::PROTEIN-FAMILY)
    ("Neuropilins" . SPARSER::PROTEIN-FAMILY)
    ("VEGF and Semaphorins" . SPARSER::COLLECTION)
    ("VEGF and class" . SPARSER::COLLECTION)
    ("bevacizumab as well as drugs" . SPARSER::COLLECTION)
    ("Sema3" . SPARSER::PROTEIN) ("Sema3-Plexin" . SPARSER::PROTEIN-PAIR)
    ("VEGF or VEGFR2" . SPARSER::COLLECTION)
    ("NRP2 , VEGFC , and KDR" . SPARSER::COLLECTION)
    ("additional relevant RTK families" . SPARSER::PROTEIN-FAMILY)
    ("simulation-based biomarkers" . SPARSER::MOLECULE)
    ("the characteristic signaling state" . SPARSER::BIO-STATE)
    ("Sema-Plexin" . SPARSER::COLLECTION) ("Plexin" . SPARSER::PROTEIN)
    ("VEGFA-VEGFR2" . SPARSER::COLLECTION)
    ("VEGFR2 (accelerator ‘ON’) and PlxnA1 (brake ‘OFF’)"
     . SPARSER::COLLECTION)
    ("‘ON’" . SPARSER::PROTEIN) ("VEGF-Sema" . SPARSER::COLLECTION)
    ("endothelial NRP1 and/or NRP2" . SPARSER::COLLECTION)
    ("endothelial NRP1" . SPARSER::PROTEIN)
    ("VEGFA-VEGFR-2" . SPARSER::COLLECTION)
    ("neuropilins and plexins" . SPARSER::COLLECTION)
    ("VEGFR-2 and VEGFR-1" . SPARSER::COLLECTION)
    ("VEGF and Semaphorin" . SPARSER::COLLECTION)
    ("ligand and receptor" . SPARSER::COLLECTION)
    ("receptor tyrosine kinases and their associated ligands"
     . SPARSER::COLLECTION)
    ("their associated ligands" . SPARSER::LIGAND)
    ("IGF/IGFR" . SPARSER::COLLECTION) ("Ang/Tie" . SPARSER::COLLECTION)
    ("Tie" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Ang" . SPARSER::PROTEIN)
    ("VEGFC and SEMA6A" . SPARSER::COLLECTION)
    ("semaphorins, KDR , and NRP2" . SPARSER::COLLECTION)
    ("KDR and NRP2" . SPARSER::COLLECTION)
    ("NRP1 , PLXNA1 , and PLXNA3" . SPARSER::COLLECTION)
    ("the major pro-angiogenic ligand" . SPARSER::LIGAND)
    ("VEGFC , KDR, and NRP1" . SPARSER::COLLECTION)
    ("VEGFA and SEMA4B" . SPARSER::COLLECTION)
    ("FIGF (VEGFD) and NRP2" . SPARSER::COLLECTION)
    ("FIGF (VEGFD)" . SPARSER::PROTEIN)
    ("NRP2 , PLXNA1 , PLXNB1 , PLXNB3 , and SEMA5B" . SPARSER::COLLECTION)
    ("PLXNB2 and SEMA4D" . SPARSER::COLLECTION) ("FIGF" . SPARSER::PROTEIN)
    ("DA" . SPARSER::MOLECULE) ("both pro-angiogenic VEGF" . SPARSER::PROTEIN)
    ("VEGFA , VEGFB , and VEGFC" . SPARSER::COLLECTION)
    ("SEMA3A , SEMA3B , SEMA3C , SEMA3D , and SEMA3E" . SPARSER::COLLECTION)
    ("SEMA" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the semaphorins and their plexin receptors" . SPARSER::COLLECTION)
    ("the receptors VEGFR2 ( KDR ) and NRP1" . SPARSER::COLLECTION)
    ("VEGFR2 ( KDR )" . SPARSER::PROTEIN)
    ("two key pro-angiogenic ligands" . SPARSER::LIGAND)
    ("VEGF and semaphorin" . SPARSER::COLLECTION)
    ("Predictive biomarkers" . SPARSER::MOLECULE)
    ("These multicomponent biomarkers" . SPARSER::MOLECULE)
    ("the aggressive triple-negative form" . SPARSER::FORM)
    ("semaphorin/plexin family" . SPARSER::COLLECTION)
    ("plexins" . SPARSER::PROTEIN) ("semaphorin" . SPARSER::PROTEIN-FAMILY)
    ("neuropilins" . SPARSER::PROTEIN-FAMILY)
    ("semaphorins" . SPARSER::PROTEIN-FAMILY)
    ("three receptor tyrosine kinases (VEGFR1, VEGFR2, and VEGFR3) and two neuropilin co-receptors (NRP1 and NRP2)"
     . SPARSER::COLLECTION)
    ("VEGFA, VEGFB, VEGFC, VEGFD, and PlGF" . SPARSER::COLLECTION)
    ("VEGFR1, VEGFR2, and VEGFR3" . SPARSER::COLLECTION)
    ("NRP1 and NRP2" . SPARSER::COLLECTION) ("neuropilin" . SPARSER::PROTEIN)
    ("PlGF" . SPARSER::PROTEIN) ("VEGFB" . SPARSER::PROTEIN)
    ("developing predictive biomarkers" . SPARSER::MOLECULE)
    ("Bevacizumab and aflibercept" . SPARSER::COLLECTION)
    ("pazopanib" . SPARSER::DRUG) ("aflibercept" . SPARSER::DRUG)
    ("Semaphorins" . SPARSER::PROTEIN-FAMILY) ("plexin" . SPARSER::PROTEIN)
    ("VEGF and Sema" . SPARSER::COLLECTION)
    ("VEGFC and VEGFD" . SPARSER::COLLECTION) ("VEGFD" . SPARSER::PROTEIN)
    ("VEGFC" . SPARSER::PROTEIN) ("VEGF/Sema" . SPARSER::COLLECTION)
    ("Neuropilin" . SPARSER::PROTEIN) ("Sema" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Semaphorin" . SPARSER::PROTEIN-FAMILY) ("PlxnA1" . SPARSER::PROTEIN)
    ("VEGFR-1" . SPARSER::PROTEIN) ("VEGFR-2" . SPARSER::PROTEIN)
    ("VEGF 121" . SPARSER::PROTEIN) ("SEMA6A" . SPARSER::PROTEIN)
    ("PLXNA3" . SPARSER::PROTEIN) ("SEMA4D" . SPARSER::PROTEIN)
    ("PLXNB2" . SPARSER::PROTEIN) ("SEMA5B" . SPARSER::PROTEIN)
    ("PLXNB3" . SPARSER::PROTEIN) ("PLXNB1" . SPARSER::PROTEIN)
    ("PLXNA1" . SPARSER::PROTEIN) ("SEMA3E" . SPARSER::PROTEIN)
    ("SEMA3D" . SPARSER::PROTEIN) ("SEMA3B" . SPARSER::PROTEIN)
    ("SEMA3A" . SPARSER::PROTEIN) ("S14" . SPARSER::PROTEIN)
    ("S13" . SPARSER::PROTEIN) ("S12" . SPARSER::PROTEIN)
    ("plexin family" . SPARSER::PROTEIN-FAMILY) ("NRP2" . SPARSER::PROTEIN)
    ("NRP1" . SPARSER::PROTEIN) ("co-receptors" . SPARSER::PROTEIN)
    ("antiplasmin-plasmin" . SPARSER::COLLECTION) ("TEG" . SPARSER::MOLECULE)
    ("ACE, PAI-1 and t-PA/PAI-1 complex" . SPARSER::COLLECTION)
    ("PAI-1 and t-PA/PAI-1 complex" . SPARSER::COLLECTION)
    ("PAI-1-" . SPARSER::PROTEIN)
    ("PAI-1 and the highest D-dimer levels 24 h" . SPARSER::COLLECTION)
    ("preoperative PAI-1" . SPARSER::PROTEIN)
    ("complex and D-dimer" . SPARSER::COLLECTION)
    ("ACE and PAI-1" . SPARSER::COLLECTION)
    ("PAI-1 and t-PA" . SPARSER::COLLECTION)
    ("converting enzyme (ACE)" . SPARSER::PROTEIN)
    ("renin-angiotensin-aldosterone" . SPARSER::COLLECTION)
    ("Adenosine/Guanine" . SPARSER::COLLECTION)
    ("Adenosine" . SPARSER::PROTEIN) ("Guanine" . SPARSER::PROTEIN)
    ("thrombin" . SPARSER::PROTEIN) ("t-PA/PAI-1" . SPARSER::COLLECTION)
    ("ACE" . SPARSER::PROTEIN) ("angiotensin-II" . SPARSER::PROTEIN)
    ("G-5" . SPARSER::PROTEIN) ("Plasminogen activator" . SPARSER::PROTEIN)
    ("t-PA" . SPARSER::PROTEIN) ("converting enzyme" . SPARSER::PROTEIN)
    ("plasminogen activator inhibitor -1" . SPARSER::PROTEIN)
    ("Cdk1/Cyclin" . SPARSER::COLLECTION) ("Hur" . SPARSER::PROTEIN)
    ("the INO80 complex and p53 co-occupy" . SPARSER::COLLECTION)
    ("available INO80 and YY1 antibodies" . SPARSER::ANTIBODY)
    ("INO80 or Arp8" . SPARSER::COLLECTION)
    ("INO80-, Arp8-, hIes2- or hIes6-knockdown" . SPARSER::COLLECTION)
    ("highly evolutionarily orthodox core subunits" . SPARSER::FRAGMENT)
    ("subunits and YY1" . SPARSER::COLLECTION)
    ("metazoan" . SPARSER::PROTEIN-FAMILY) ("SWI/SNF2" . SPARSER::COLLECTION)
    ("INO80-p53" . SPARSER::COLLECTION) ("INO80-INO80" . SPARSER::COLLECTION)
    ("p53 or pcDNA3.1" . SPARSER::COLLECTION)
    ("p21, pBS-shINO80 or pBS-Vector" . SPARSER::COLLECTION)
    ("pBS-INO80" . SPARSER::COLLECTION) ("INO80 and p53" . SPARSER::COLLECTION)
    ("p53-S46p" . SPARSER::COLLECTION) ("p53-S33p" . SPARSER::COLLECTION)
    ("p53-S15p" . SPARSER::COLLECTION) ("INO80 and YY1" . SPARSER::COLLECTION)
    ("INO80, and YY1" . SPARSER::COLLECTION)
    ("YY1 (a subunit of INO80 complex) and p53 antibodies"
     . SPARSER::COLLECTION)
    ("using INO80, YY1 (a subunit of INO80 complex) and p53 antibodies"
     . SPARSER::COLLECTION)
    ("Obvious p21" . SPARSER::PROTEIN) ("INO80-" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 6 ( CDK6 ) and p21" . SPARSER::COLLECTION)
    ("BCCIP" . SPARSER::PROTEIN) ("CCNC" . SPARSER::PROTEIN)
    ("pBS" . SPARSER::PROTEIN) ("pBS-shRNA" . SPARSER::PROTEIN-PAIR)
    ("INO80, hIes2, hIes6, and hArp8" . SPARSER::COLLECTION)
    ("INO80 complex and p53 co-occupy" . SPARSER::COLLECTION)
    ("p400 and SRCAP" . SPARSER::COLLECTION) ("SRCAP" . SPARSER::PROTEIN)
    ("response elements (PRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("PRE" . SPARSER::PROTEIN)
    ("both a classical tumor suppressor" . SPARSER::SUPPRESSOR)
    ("a universal inhibitor" . SPARSER::INHIBITOR)
    ("checkpoint kinases and the Ino80 complex" . SPARSER::COLLECTION)
    ("Arp4 and Arp8" . SPARSER::COLLECTION)
    ("ATPase, and nucleosome" . SPARSER::COLLECTION)
    ("HSA/PTH" . SPARSER::COLLECTION) ("PTH" . SPARSER::PROTEIN)
    ("HSA" . SPARSER::PROTEIN) ("ATPase and DNA" . SPARSER::COLLECTION)
    ("which shares eight core subunits" . SPARSER::FRAGMENT)
    ("Arp4, Arp5 and Arp8, Tip49a and Tip49b" . SPARSER::COLLECTION)
    ("ATPases, and hIes2 and hIes6" . SPARSER::COLLECTION)
    ("hIes2 and hIes6" . SPARSER::COLLECTION) ("hIes6" . SPARSER::PROTEIN)
    ("hIes2" . SPARSER::PROTEIN) ("Tip49b" . SPARSER::PROTEIN)
    ("Tip49a" . SPARSER::PROTEIN) ("ATPase-INO80" . SPARSER::COLLECTION)
    ("ATPases" . SPARSER::PROTEIN) ("SWI/SNF" . SPARSER::COLLECTION)
    ("forkhead box A1" . SPARSER::PROTEIN) ("S46" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 2" . SPARSER::PROTEIN)
    ("cyclinG1" . SPARSER::PROTEIN) ("cyclin C" . SPARSER::PROTEIN)
    ("CDC34" . SPARSER::PROTEIN) ("CCNG1" . SPARSER::PROTEIN)
    ("Doxorubicin hydrochloride" . SPARSER::DRUG) ("M/L" . SPARSER::PROTEIN)
    ("hArp8" . SPARSER::PROTEIN) ("anti-Flag" . SPARSER::PROTEIN)
    ("Anti-Flag" . SPARSER::PROTEIN) ("YY1" . SPARSER::PROTEIN)
    ("H2AZ" . SPARSER::PROTEIN) ("p400" . SPARSER::PROTEIN)
    ("SWI2" . SPARSER::PROTEIN) ("Tip49" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Arp4" . SPARSER::PROTEIN) ("SNF2" . SPARSER::PROTEIN)
    ("and -1" . SPARSER::PROTEIN) ("INO80" . SPARSER::PROTEIN)
    ("Ino80" . SPARSER::PROTEIN) ("ATP-dependent" . SPARSER::PROTEIN)
    ("STATs (PIAS)" . SPARSER::PROTEIN) ("PIAS" . SPARSER::PROTEIN-FAMILY)
    ("kinase (RISK)" . SPARSER::KINASE)
    ("Akt and glycogen synthase" . SPARSER::COLLECTION)
    ("leptin, resveratrol, melatonin, and erythropoietin"
     . SPARSER::COLLECTION)
    ("urocortin" . SPARSER::PROTEIN) ("Calcium" . SPARSER::CALCIUM)
    ("ROS and calcium" . SPARSER::COLLECTION) ("MPTP" . SPARSER::PROTEIN)
    ("tyr" . SPARSER::AMINO-ACID) ("WSX-1 and gp130" . SPARSER::COLLECTION)
    ("residual gp130" . SPARSER::PROTEIN)
    ("growth factors and cytokines" . SPARSER::COLLECTION)
    ("growth factors or cytokines" . SPARSER::COLLECTION)
    ("High glucose, high sodium, and/or fatty acid levels"
     . SPARSER::COLLECTION)
    ("IL-1 β , IL-6, and TNF- α" . SPARSER::COLLECTION)
    ("IL-27/STAT3" . SPARSER::COLLECTION)
    ("stattic or stattic" . SPARSER::COLLECTION)
    ("high glucose (G), high NaCl (S), and/or cholesterol (C) treatment"
     . SPARSER::COLLECTION)
    ("severe hypoxia" . SPARSER::PROTEIN) ("DCs" . SPARSER::MOLECULE)
    ("gp130 and WSX-1" . SPARSER::COLLECTION)
    ("a heterodimeric cytokine" . SPARSER::PROTEIN)
    ("several cardioprotective genes" . SPARSER::GENE)
    ("tumor necrosis factor-" . SPARSER::PROTEIN) ("IL-" . SPARSER::PROTEIN)
    ("interleukin-" . SPARSER::PROTEIN) ("ROS-" . SPARSER::PROTEIN)
    ("stattic" . SPARSER::DRUG)
    ("The mRNA of glycoprotein (gp) 130 and WSX-1" . SPARSER::COLLECTION)
    ("cardiotrophin-1" . SPARSER::PROTEIN)
    ("Activating Factor" . SPARSER::PROTEIN) ("TNF- α" . SPARSER::PROTEIN)
    ("factor- κ B" . SPARSER::PROTEIN)
    ("murine leukemia virus" . SPARSER::PROTEIN)
    ("Its receptor" . SPARSER::PROTEIN) ("IL-27p28" . SPARSER::PROTEIN)
    ("IL-27" . SPARSER::PROTEIN) ("WSX-1" . SPARSER::PROTEIN)
    ("Atg5 and Atg12" . SPARSER::COLLECTION) ("-CaMKK" . SPARSER::COLLECTION)
    ("CaMKK" . SPARSER::PROTEIN) ("DHA-treatment" . SPARSER::MOLECULE)
    ("phospho-mTOR and LC3-II" . SPARSER::COLLECTION)
    ("PI3K, Akt, and phospho-PTEN" . SPARSER::COLLECTION)
    ("phospho-S6K1 and phospho-4E-BP1" . SPARSER::COLLECTION)
    ("selectively eliminating vital components" . SPARSER::COMPONENT)
    ("that Clioquinol and Rhabdastrellic acid-A" . SPARSER::COLLECTION)
    ("Clioquinol" . SPARSER::DRUG)
    ("hypoxia and the anticancer drug" . SPARSER::COLLECTION)
    ("Nelfinavir" . SPARSER::DRUG) ("Atg5 and Atg7" . SPARSER::COLLECTION)
    ("DHA-autophagy" . SPARSER::MOLECULE)
    ("CQ and Bafilomycin A1" . SPARSER::COLLECTION)
    ("Lysotracker" . SPARSER::DRUG) ("nuclear DNA-strand" . SPARSER::DNA)
    ("DNA-strand" . SPARSER::DNA) ("AKT-mTOR" . SPARSER::COLLECTION)
    ("DHA" . SPARSER::MOLECULE)
    ("Docosahexaenoic acid (DHA)" . SPARSER::MOLECULE)
    ("p70 ribosomal S6 kinases" . SPARSER::PROTEIN-FAMILY)
    ("AMP/ATP" . SPARSER::PROTEIN-PAIR)
    ("lapidated microtubule-associated light chain 3" . SPARSER::PROTEIN)
    ("Atg12 and Atg5" . SPARSER::COLLECTION) ("AMPK-" . SPARSER::PROTEIN)
    ("docosahexaenoic acid (DHA)" . SPARSER::MOLECULE)
    ("PUFA" . SPARSER::MOLECULE) ("PUFAs" . SPARSER::MOLECULE)
    ("2–4 " . SPARSER::PROTEIN) ("LC3B" . SPARSER::PROTEIN)
    ("tensin homolog" . SPARSER::PROTEIN)
    ("activator protein 1" . SPARSER::PROTEIN)
    ("polyunsaturated fatty acid" . SPARSER::MOLECULE)
    ("Docosahexaenoic acid" . SPARSER::MOLECULE)
    ("Atg8" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Fat-1" . SPARSER::PROTEIN)
    ("docosahexaenoic acid" . SPARSER::MOLECULE)
    ("the metabolic genes and DNA repair genes" . SPARSER::COLLECTION)
    ("the newly developed biomarkers" . SPARSER::MOLECULE)
    ("promiscuous DNA" . SPARSER::DNA) ("EM-C11" . SPARSER::COLLECTION)
    ("EM9" . SPARSER::PROTEIN) ("susceptible XRCC1" . SPARSER::PROTEIN)
    ("several polymorphic genes" . SPARSER::GENE)
    ("creatinine" . SPARSER::PROTEIN)
    ("the main urinary metabolites" . SPARSER::PROTEIN)
    ("DHBMA and MHBMA" . SPARSER::COLLECTION) ("DHBMA" . SPARSER::PROTEIN)
    ("FRs" . SPARSER::DRUG)
    ("XRCC1 , MGMT , ADPRT, or APE1" . SPARSER::COLLECTION)
    ("XRCC1 , MGMT , APE1 , and ADPRT" . SPARSER::COLLECTION)
    ("O 6 -methylguanine-DNA methyltransferase (MGMT)" . SPARSER::PROTEIN)
    ("PAHs" . SPARSER::PROTEIN)
    ("poly (adenosine diphosphate-ribose) polymerases ( ADPRT ) and apurinic/apyrimidinic endonucleases (APE1)"
     . SPARSER::COLLECTION)
    ("epoxide" . SPARSER::MOLECULE)
    ("metabolic enzyme genes and DNA repair genes" . SPARSER::COLLECTION)
    ("environmental interactive genes" . SPARSER::GENE)
    ("mEH" . SPARSER::PROTEIN) ("HPRT" . SPARSER::PROTEIN)
    ("the major metabolites" . SPARSER::PROTEIN)
    ("an industrial chemical" . SPARSER::MOLECULE)
    ("Butadiene" . SPARSER::MOLECULE) ("MNi and NPBs" . SPARSER::COLLECTION)
    ("polymerases ( ADPRT )" . SPARSER::PROTEIN)
    ("polymorphism (RFLP)" . SPARSER::PROTEIN)
    ("cross-complementing" . SPARSER::PROTEIN)
    ("endonucleases" . SPARSER::PROTEIN) ("ADPRT" . SPARSER::PROTEIN)
    ("polymerases" . SPARSER::PROTEIN)
    ("Newly developed biomarkers" . SPARSER::MOLECULE)
    ("NPBs" . SPARSER::PROTEIN) ("MNi" . SPARSER::PROTEIN)
    ("butadiene" . SPARSER::MOLECULE)
    ("cytochrome P450" . SPARSER::PROTEIN-FAMILY) ("CYP2E1" . SPARSER::PROTEIN)
    ("GSTT1" . SPARSER::PROTEIN)
    ("hypoxanthine-guanine phosphoribosyltransferase" . SPARSER::PROTEIN)
    ("O 6 -methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("X-ray repair" . SPARSER::PROTEIN)
    ("the polymorphic variants" . SPARSER::VARIANT)
    ("hereditary colon cancer" . SPARSER::PROTEIN)
    ("XRCC2 and XRCC3" . SPARSER::COLLECTION)
    ("the RAD51B gene rs10483813 polymorphic variants" . SPARSER::VARIANT)
    ("P300/CBP" . SPARSER::COLLECTION)
    ("Human RAD51 and its paralogs RAD51B , XRCC2 , and XRCC3"
     . SPARSER::COLLECTION)
    ("RAD51B , XRCC2 , and XRCC3" . SPARSER::COLLECTION)
    ("polymorphic variants" . SPARSER::VARIANT)
    ("RAD51B, XRCC2, and XRCC3" . SPARSER::COLLECTION)
    ("genotoxic chemicals" . SPARSER::MOLECULE)
    ("kallikrein" . SPARSER::PROTEIN) ("PSAT" . SPARSER::PROTEIN)
    ("homozygous (OR = 2.98) C genotype variants" . SPARSER::VARIANT)
    ("both the prostate cancer group and the control group"
     . SPARSER::COLLECTION)
    ("RAD51 , rs10483813 and rs3784099" . SPARSER::COLLECTION)
    ("XRCC2 , and rs861539" . SPARSER::COLLECTION)
    ("RAD51 , RAD51B , XRCC2 , and XRCC3" . SPARSER::COLLECTION)
    ("RAD51 and its paralogs" . SPARSER::COLLECTION)
    ("The RAD51 paralogs form two major complexes, RAD51B-RAD51C-RAD51D-XRCC2 (BCDX2) and RAD51C-XRCC3 (CX3), as well as two subcomplexes"
     . SPARSER::COLLECTION)
    ("RAD51D-XRCC2" . SPARSER::COLLECTION)
    ("RAD51B-RAD51C" . SPARSER::COLLECTION)
    ("RAD51C-XRCC3" . SPARSER::COLLECTION)
    ("RAD51B-RAD51C-RAD51D-XRCC2" . SPARSER::COLLECTION)
    ("RAD51B, RAD51C, RAD51D, XRCC2, and XRCC3" . SPARSER::COLLECTION)
    ("P300" . SPARSER::PROTEIN) ("RAD51D" . SPARSER::PROTEIN)
    ("RAD51C" . SPARSER::PROTEIN) ("XRCC2" . SPARSER::PROTEIN)
    ("RAD51B" . SPARSER::PROTEIN) ("NADH" . SPARSER::MOLECULE)
    ("transmembranous glucose transporter" . SPARSER::PROTEIN)
    ("hypoxia, and GLUT-1 and -3" . SPARSER::COLLECTION)
    ("GLUT-1 and -3" . SPARSER::COLLECTION)
    ("survive ischemia and hypoxia" . SPARSER::COLLECTION)
    ("ischemia and hypoxia" . SPARSER::COLLECTION)
    ("a profound hypoxia/ischemia" . SPARSER::COLLECTION)
    ("hypoxia/ischemia" . SPARSER::COLLECTION)
    ("HIF-1α and GLUT-1" . SPARSER::COLLECTION)
    ("oxygen and glucose" . SPARSER::COLLECTION)
    ("β-galactosidase, GLUT-1, and HIF-1α" . SPARSER::COLLECTION)
    ("HIF-1α and GLUT1" . SPARSER::COLLECTION)
    ("GLUT-1 and HIF-1α" . SPARSER::COLLECTION) ("ACR" . SPARSER::PROTEIN)
    ("bilateral knee ROA" . SPARSER::PROTEIN)
    ("ESR, and C-reactive protein" . SPARSER::COLLECTION)
    ("oxido" . SPARSER::MOLECULE) ("NOX" . SPARSER::PROTEIN)
    ("electrons" . SPARSER::MOLECULE) ("ENOX" . SPARSER::PROTEIN)
    ("thiol" . SPARSER::MOLECULE) ("Oxygen and glucose" . SPARSER::COLLECTION)
    ("Oxygen" . SPARSER::MOLECULE) ("unilateral ROA" . SPARSER::PROTEIN)
    ("bilateral ROA" . SPARSER::PROTEIN) ("ROA" . SPARSER::PROTEIN)
    ("β-galactosidase, HIF-1α, and GLUT-1" . SPARSER::COLLECTION)
    ("ferricytochrome" . SPARSER::MOLECULE) ("GLUT-1" . SPARSER::PROTEIN)
    ("NADPH oxidase" . SPARSER::PROTEIN) ("hydroxychloroquine" . SPARSER::DRUG)
    ("crizotinib and chloroquine or 3-methyladenine" . SPARSER::COLLECTION)
    ("chloroquine or 3-methyladenine" . SPARSER::COLLECTION)
    ("Ctrl" . SPARSER::PROTEIN) ("AAD" . SPARSER::MOLECULE)
    ("annexinV" . SPARSER::PROTEIN)
    ("crizotinib or chloroquine" . SPARSER::COLLECTION)
    ("autophagosomal membrane-bound form" . SPARSER::FORM)
    ("16kDa" . SPARSER::PROTEIN) ("18kDa" . SPARSER::PROTEIN)
    ("crizotinib or siALK transfection" . SPARSER::COLLECTION)
    ("Vps34 and Beclin1" . SPARSER::COLLECTION)
    ("PI3-kinase/Beclin1" . SPARSER::COLLECTION) ("Vps34" . SPARSER::PROTEIN)
    ("Vps" . SPARSER::PROTEIN)
    ("crizotinib (500 nM, 24 h) or rapamycin (100 nM, 24 h)"
     . SPARSER::COLLECTION)
    ("hydrolases" . SPARSER::PROTEIN) ("toxic protein" . SPARSER::PROTEIN)
    ("ASP" . SPARSER::PROTEIN) ("ALK and c-Met" . SPARSER::COLLECTION)
    ("The resultant NPM-ALK fusion protein" . SPARSER::PROTEIN)
    ("NPM-ALK" . SPARSER::COLLECTION) ("Two systemic forms" . SPARSER::FORM)
    ("crizotinib and chloroquine" . SPARSER::COLLECTION)
    ("P250" . SPARSER::PROTEIN) ("PI3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("WIPI1" . SPARSER::PROTEIN) ("MAP1LC3B" . SPARSER::PROTEIN)
    ("PIK3C3" . SPARSER::PROTEIN) ("MAP1LC3" . SPARSER::PROTEIN-FAMILY)
    ("LDK 378" . SPARSER::DRUG) ("heavy ions" . SPARSER::MOLECULE)
    ("eIF2α and CHOP" . SPARSER::COLLECTION)
    ("the Western blot" . SPARSER::PROTEIN) ("salinomycin" . SPARSER::DRUG)
    ("Akt-TSC-mTOR" . SPARSER::COLLECTION)
    ("TNFR-associated factor 2" . SPARSER::PROTEIN)
    ("IRE1-TRAF2-ASK1" . SPARSER::COLLECTION) ("TNFR" . SPARSER::PROTEIN)
    ("ATF4-DDIT3/CHOP-TRIB3-Akt-mTOR" . SPARSER::COLLECTION)
    ("Bip and GRP94" . SPARSER::COLLECTION)
    ("Akt-mTOR-p70S6K" . SPARSER::COLLECTION) ("Luteolin" . SPARSER::DRUG)
    ("a natural naphthoquinone" . SPARSER::MOLECULE)
    ("naphthoquinone" . SPARSER::MOLECULE) ("plumbagin" . SPARSER::DRUG)
    ("the membrane-associated form" . SPARSER::FORM)
    ("Beclin 1, p-eIF2α and LC3-II" . SPARSER::COLLECTION)
    ("Bip and CHOP" . SPARSER::COLLECTION)
    ("phospho-JNK (p-JNK) or Beclin 1" . SPARSER::COLLECTION)
    ("CHOP and LC3-II" . SPARSER::COLLECTION)
    ("eIF2α and JNK" . SPARSER::COLLECTION) ("Bip" . SPARSER::PROTEIN)
    ("phosphor-mTOR (p-mTOR) and phospho-p70S6 (p-p70S6)"
     . SPARSER::COLLECTION)
    ("phospho-Akt (p-Akt), phosphor-mTOR (p-mTOR) and phospho-p70S6 (p-p70S6)"
     . SPARSER::COLLECTION)
    ("autophagic catabolism, and rapamycin" . SPARSER::COLLECTION)
    ("catabolism, and rapamycin" . SPARSER::COLLECTION)
    ("CQ" . SPARSER::PROTEIN) ("chloroquine (CQ)" . SPARSER::PROTEIN)
    ("the soluble form" . SPARSER::FORM)
    ("phosphatidylethanolamine" . SPARSER::MOLECULE)
    ("long-lived proteins" . SPARSER::PROTEIN)
    ("This feature makes heavy ion" . SPARSER::MOLECULE)
    ("other heavy ions" . SPARSER::MOLECULE) ("CHOP" . SPARSER::PROTEIN)
    ("Heavy ion" . SPARSER::MOLECULE) ("GRP78" . SPARSER::PROTEIN)
    ("TRIB3" . SPARSER::PROTEIN) ("DDIT3" . SPARSER::PROTEIN)
    ("ATF4" . SPARSER::PROTEIN) ("GRP94" . SPARSER::PROTEIN)
    ("ATG13" . SPARSER::PROTEIN)
    ("antibody, and antagonist" . SPARSER::COLLECTION)
    ("CXCL12 and CXCR4" . SPARSER::COLLECTION)
    ("ERK1/2 and STAT3—using pharmacological inhibitors" . SPARSER::COLLECTION)
    ("EGF signaling pathways—EGFR, AKT, ERK1/2 and STAT3—using pharmacological inhibitors"
     . SPARSER::COLLECTION)
    ("at least 20 human chemokine receptors" . SPARSER::RECEPTOR)
    ("Chemokine receptors and their corresponding ligands"
     . SPARSER::COLLECTION)
    ("Chemokine" . SPARSER::PROTEIN)
    ("chemokines and chemokine" . SPARSER::COLLECTION)
    ("Chemokines" . SPARSER::PROTEIN)
    ("antibody or antagonist" . SPARSER::COLLECTION)
    ("antibody (12G5) or CXCR4 antagonist (AMD3100)" . SPARSER::COLLECTION)
    ("EGFR and ERK" . SPARSER::COLLECTION)
    ("AG1478 and ERK" . SPARSER::COLLECTION)
    ("EGFR, ERK, AKT, and STAT3" . SPARSER::COLLECTION)
    ("phosphorylated-AKT and phosphorylated-STAT3" . SPARSER::COLLECTION)
    ("10 μM EGFR inhibitor AG1478 and 10 μM ERK inhibitor U0126"
     . SPARSER::COLLECTION)
    ("AG1478 and U0126" . SPARSER::COLLECTION)
    ("LY294002 and AG490" . SPARSER::COLLECTION)
    ("EGF, CXCR4 and CX3CR1" . SPARSER::COLLECTION)
    ("CXCR5 and CXCR6—were" . SPARSER::COLLECTION)
    ("receptors—CXCR4" . SPARSER::COLLECTION)
    ("EGFR-L858R-specific siRNA" . SPARSER::PROTEIN)
    ("the EGFR-L858R–specific siRNAs" . SPARSER::PROTEIN)
    ("-CACAGATTTTGGGCGGGCCAA-3" . SPARSER::COLLECTION)
    ("EGFR, and H1299-EGFR-L858R" . SPARSER::COLLECTION)
    ("IL21 and IL17" . SPARSER::COLLECTION)
    ("CCL2 and CXCL12" . SPARSER::COLLECTION)
    ("interleukins" . SPARSER::PROTEIN)
    ("the predominant histological type" . TYPE)
    ("CXCL12-CXCR4" . SPARSER::COLLECTION)
    ("antibody, or receptor" . SPARSER::COLLECTION)
    ("IgG2B" . SPARSER::BIO-COMPLEX) ("CX3" . SPARSER::PROTEIN)
    ("G protein-coupled receptor" . SPARSER::PROTEIN)
    ("AMD3100" . SPARSER::DRUG) ("AG1478" . SPARSER::DRUG)
    ("CX3CR1" . SPARSER::PROTEIN) ("CXCR6" . SPARSER::PROTEIN)
    ("CXCR5" . SPARSER::PROTEIN) ("CL1-0" . SPARSER::PROTEIN)
    ("SDF-1" . SPARSER::PROTEIN) ("IL17" . SPARSER::PROTEIN)
    ("IL21" . SPARSER::PROTEIN) ("PI3K or RAS" . SPARSER::COLLECTION)
    ("PTEN, and AKT1" . SPARSER::COLLECTION)
    ("AKT1, AKT2, ERK1/2, and STAT3" . SPARSER::COLLECTION)
    ("AKT1, AKT2, ERK1, ERK2, and STAT3" . SPARSER::COLLECTION)
    ("AKT, ERK and STAT3" . SPARSER::COLLECTION)
    ("EGFR and its downstream effectors AKT, ERK, and STAT3"
     . SPARSER::COLLECTION)
    ("AKT, ERK, and STAT3" . SPARSER::COLLECTION)
    ("the most common histological type" . TYPE)
    ("p-STAT3" . SPARSER::COLLECTION) ("p-AKT2" . SPARSER::COLLECTION)
    ("p-AKT1" . SPARSER::COLLECTION)
    ("EGFR and several components" . SPARSER::COLLECTION)
    ("H10" . SPARSER::PROTEIN) ("ERK2" . SPARSER::PROTEIN)
    ("ERK1" . SPARSER::PROTEIN) ("NF-κB/ROS/MAPK" . SPARSER::COLLECTION)
    ("JNK (SP600125) and p38 (SB203580)" . SPARSER::COLLECTION)
    ("antioxidant, APO, or NAC" . SPARSER::COLLECTION)
    ("stress-activated ERK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("JNK-p38" . SPARSER::COLLECTION)
    ("JNKs and p38 MAPKs" . SPARSER::COLLECTION) ("JNKs" . SPARSER::PROTEIN)
    ("ERKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERK1/2, JNK, and p38" . SPARSER::COLLECTION)
    ("MAPK and caspase" . SPARSER::COLLECTION)
    ("NF-κB/HSP27" . SPARSER::COLLECTION)
    ("p65-associated NF-κB" . SPARSER::PROTEIN)
    ("BAY11-7082 or p65" . SPARSER::COLLECTION)
    ("a very powerful inducer" . SPARSER::PROTEIN)
    ("JNK, ERK, or p38" . SPARSER::COLLECTION)
    ("JNK and p38, SP600125 and SB203580" . SPARSER::COLLECTION)
    ("p38, SP600125 and SB203580" . SPARSER::COLLECTION)
    ("APO or N-acetyl-L-cysteine" . SPARSER::COLLECTION)
    ("ROS or MAPK" . SPARSER::COLLECTION)
    ("ROS or MAPKs" . SPARSER::COLLECTION)
    ("ROS and MAPKs" . SPARSER::COLLECTION) ("BAY11-7082–" . SPARSER::DRUG)
    ("the fluorescent dye DCFH-DA" . SPARSER::DRUG)
    ("apocynin (APO)" . SPARSER::MOLECULE) ("APO" . SPARSER::PROTEIN)
    ("NF-κB and HSP27" . SPARSER::COLLECTION)
    ("HSP27 and NF-κB" . SPARSER::COLLECTION)
    ("IκBα and p65" . SPARSER::COLLECTION)
    ("HSP27 and HSP70" . SPARSER::COLLECTION)
    ("proteins that mediate a cell’s" . SPARSER::PROTEIN)
    ("NF-κB/IκBα" . SPARSER::COLLECTION)
    ("subunits, IKKα and IKKβ" . SPARSER::COLLECTION)
    ("HSP27, ROS, and MAPKs" . SPARSER::COLLECTION)
    ("SP600125 and SB203580" . SPARSER::COLLECTION)
    ("antioxidant, apocynin," . SPARSER::PROTEIN)
    ("antioxidant, apocynin, or N-acetyl cysteine" . SPARSER::COLLECTION)
    ("apocynin" . SPARSER::MOLECULE) ("HSP27 and p65" . SPARSER::COLLECTION)
    ("p65 and IκBα" . SPARSER::COLLECTION) ("p38 MAPKs" . SPARSER::PROTEIN)
    ("Ang II" . SPARSER::PROTEIN) ("N-acetyl-L-cysteine" . SPARSER::MOLECULE)
    ("Extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IKK-α" . SPARSER::PROTEIN) ("ERK 1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BAY11-7082" . SPARSER::DRUG)
    ("a potential biological molecule" . SPARSER::MOLECULE)
    ("MMP1, MMP9 and c-Met" . SPARSER::COLLECTION)
    ("MMP1 and MMP9" . SPARSER::COLLECTION)
    ("MMP-1 and MMP-9" . SPARSER::COLLECTION)
    ("MMP-2 and MMP-9" . SPARSER::COLLECTION)
    ("Jun (c-Jun, Jun-B and Jun-D) and Fos (c-Fos, Fos-B, Fra-1 and Fra-2) proto-oncogenes"
     . SPARSER::COLLECTION)
    ("c-Jun, Jun-B and Jun-D" . SPARSER::COLLECTION)
    ("c-Fos, Fos-B, Fra-1 and Fra-2" . SPARSER::COLLECTION)
    ("metastatic PCa" . SPARSER::PROTEIN)
    ("c-Met, vimentin and HMGA1" . SPARSER::COLLECTION)
    ("vimentin and HMGA1" . SPARSER::COLLECTION)
    ("c-Met, MMP1, MMP9, Vimentin and HMGA1" . SPARSER::COLLECTION)
    ("wildtype (Wt) or mutant (Mut)" . SPARSER::COLLECTION)
    ("PC-3 and DU145" . SPARSER::COLLECTION)
    ("E2F3 and CCND3" . SPARSER::COLLECTION)
    ("cyclin D1, CDK6, and E2F3" . SPARSER::COLLECTION)
    ("Src kinase, miR-125a and miR-125b" . SPARSER::COLLECTION)
    ("ERBB2 and ERBB3" . SPARSER::COLLECTION)
    ("miR-125a and miR-125b" . SPARSER::COLLECTION)
    ("hsa-miR-221" . SPARSER::COLLECTION)
    ("hsa-miR-181b" . SPARSER::PROTEIN-PAIR)
    ("hsa-miR-16" . SPARSER::COLLECTION)
    ("approximately 22 nucleotides" . SPARSER::NUCLEOTIDE)
    ("peroxidase and DAB" . SPARSER::COLLECTION) ("DAB" . SPARSER::MOLECULE)
    ("Fra-2" . SPARSER::PROTEIN) ("Jun-D" . SPARSER::PROTEIN)
    ("Jun-B" . SPARSER::PROTEIN) ("CCND3" . SPARSER::PROTEIN)
    ("MED1" . SPARSER::PROTEIN) ("miR-16" . SPARSER::PROTEIN)
    ("autophagic degradation p62" . SPARSER::PROTEIN)
    ("TIRON" . SPARSER::MOLECULE) ("Monodansylcadaverine" . SPARSER::DRUG)
    ("bafilomycin A1 and chloroquine" . SPARSER::COLLECTION)
    ("NADPH" . SPARSER::PROTEIN) ("TSC1 and DRAM" . SPARSER::COLLECTION)
    ("DRAM" . SPARSER::PROTEIN)
    ("a stress responsive transcription factor and potent tumor suppressor"
     . SPARSER::COLLECTION)
    ("ATG3 and ATG12" . SPARSER::COLLECTION) ("Tiron" . SPARSER::MOLECULE)
    ("Glucose" . SPARSER::PROTEIN) ("Superoxide" . SPARSER::MOLECULE)
    ("GFP-p62" . SPARSER::COLLECTION)
    ("the insoluble fraction" . SPARSER::COMPONENT)
    ("the soluble and insoluble fractions" . SPARSER::COMPONENT)
    ("the insoluble fraction (IF)" . SPARSER::COMPONENT)
    ("the soluble fraction (SF)" . SPARSER::COMPONENT)
    ("soluble and insoluble fractions" . SPARSER::COMPONENT)
    ("Triton" . SPARSER::MOLECULE) ("LC3 and p62" . SPARSER::COLLECTION)
    ("three different human fibroblasts AG1522" . SPARSER::PROTEIN)
    ("ATG7 and ATG10" . SPARSER::COLLECTION)
    ("ATG5 and ATG12" . SPARSER::COLLECTION)
    ("ATG5, ATG7, and ATG10" . SPARSER::COLLECTION)
    ("Bafilomycin A1 or Chloroquine" . SPARSER::COLLECTION)
    ("Chloroquine" . SPARSER::PROTEIN) ("AVs" . SPARSER::MOLECULE)
    ("even smaller fraction" . SPARSER::COMPONENT)
    ("LAMP2-GFP-LC3" . SPARSER::COLLECTION)
    ("Nutlin and bafilomycin A1" . SPARSER::COLLECTION)
    ("S4 and SJSA1 cells co-treated" . SPARSER::COLLECTION)
    ("LC3-II and p62" . SPARSER::COLLECTION)
    ("ULK1 and ULK2" . SPARSER::COLLECTION)
    ("G6PD, PFK1, and PFKP" . SPARSER::COLLECTION)
    ("PFK2, TIGAR, and PARKIN" . SPARSER::COLLECTION)
    ("PARKIN" . SPARSER::PROTEIN) ("TIGAR" . SPARSER::PROTEIN)
    ("PGA" . SPARSER::PROTEIN) ("phosphoglycerate" . SPARSER::MOLECULE)
    ("PFK1 and PFKP" . SPARSER::COLLECTION) ("pentose" . SPARSER::MOLECULE)
    ("HK2, G6PD, PFK1, PFKP , and PGAM2" . SPARSER::COLLECTION)
    ("PFKP" . SPARSER::PROTEIN) ("Seahorse" . SPARSER::PROTEIN)
    ("p21, MDM2, and Puma" . SPARSER::COLLECTION) ("nutlin" . SPARSER::DRUG)
    ("deoxyglucose" . SPARSER::MOLECULE)
    ("Nutlin and its derivatives" . SPARSER::COLLECTION)
    ("p53 and MDM2 and stabilizing/activating" . SPARSER::COLLECTION)
    ("MDM2 and stabilizing/activating" . SPARSER::COLLECTION)
    ("AMPK-mTORC1" . SPARSER::COLLECTION)
    ("apoptotic caspases" . SPARSER::PROTEIN)
    ("a stress-responsive transcription factor and potent tumor suppressor"
     . SPARSER::COLLECTION)
    ("chloroquine or bafilomycin A1" . SPARSER::COLLECTION)
    ("Canonical p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LY2603618" . SPARSER::DRUG) ("SESN1" . SPARSER::PROTEIN)
    ("P62" . SPARSER::PROTEIN) ("ATG12" . SPARSER::PROTEIN)
    ("ATG10" . SPARSER::PROTEIN) ("ATG7" . SPARSER::PROTEIN)
    ("ATG5" . SPARSER::PROTEIN) ("LAMP2" . SPARSER::PROTEIN)
    ("ULK2" . SPARSER::PROTEIN) ("PFK2" . SPARSER::PROTEIN)
    ("Hexokinase-2" . SPARSER::PROTEIN) ("PGAM2" . SPARSER::PROTEIN)
    ("PFK1" . SPARSER::PROTEIN) ("G6PD" . SPARSER::PROTEIN)
    ("ATG3" . SPARSER::PROTEIN) ("AMPKα" . SPARSER::PROTEIN-FAMILY)
    ("anti-oxidant" . SPARSER::DRUG) ("Sestrin-1" . SPARSER::PROTEIN)
    ("ULK1" . SPARSER::PROTEIN) ("SCO2" . SPARSER::PROTEIN)
    ("Nutlin-3a" . SPARSER::DRUG) ("sensitive to apoptosis" . SPARSER::PROTEIN)
    ("a new prognostic biomarker" . SPARSER::MOLECULE)
    ("β-catenin and TCF" . SPARSER::COLLECTION)
    ("The tumor suppressive gene retinoic acid receptor responder 3"
     . SPARSER::PROTEIN)
    ("AXIN2 ( r = −0.72, P < 0.05) and ICAT ( r = −0.88, P < 0.05)"
     . SPARSER::COLLECTION)
    ("SFRP1 ( r = −0.74, P < 0.05), AXIN2 ( r = −0.72, P < 0.05) and ICAT ( r = −0.88, P < 0.05)"
     . SPARSER::COLLECTION)
    ("functionally relevant effectors" . SPARSER::EFFECTOR)
    ("SFRP1, AXIN2, and ICAT" . SPARSER::COLLECTION)
    ("C-myc, Cyclin D1 and LEF1" . SPARSER::COLLECTION)
    ("FOP" . SPARSER::PROTEIN)
    ("BMI1, ABCG2, OCT4, SOX2 and NANOG" . SPARSER::COLLECTION)
    ("Nanog homeobox (NANOG)" . SPARSER::PROTEIN)
    ("traits and CD133" . SPARSER::COLLECTION)
    ("SFRP1, AXIN2 and ICAT" . SPARSER::COLLECTION)
    ("GSK-3β, CK1α and APC" . SPARSER::COLLECTION)
    ("the Frizzled receptor (Fz) and the low-density lipoprotein receptor-related protein-5/6 (LRP-5/6)"
     . SPARSER::COLLECTION)
    ("consequently releases β-catenin" . SPARSER::PROTEIN)
    ("protein-5/6" . SPARSER::PROTEIN-PAIR)
    ("Dvl" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AXIN2 and inhibitor" . SPARSER::COLLECTION)
    ("β-catenin and TCF-4" . SPARSER::COLLECTION) ("ICAT" . SPARSER::PROTEIN)
    ("s 2" . SPARSER::MOLECULE) ("p84" . SPARSER::PROTEIN)
    ("C-myc" . SPARSER::PROTEIN) ("Nanog homeobox" . SPARSER::PROTEIN)
    ("homeobox 1" . SPARSER::PROTEIN) ("LRP-5" . SPARSER::PROTEIN)
    ("SFRP1" . SPARSER::PROTEIN)
    ("secreted Frizzled-related protein 1" . SPARSER::PROTEIN)
    ("CDK4/6 inhibitors and PI3K inhibitors" . SPARSER::COLLECTION)
    ("doxorubicin, vincristine, ifosfamide, cyclophosphamide and etoposide"
     . SPARSER::COLLECTION)
    ("LEE011 and other orally available CDK4/6 inhibitors"
     . SPARSER::COLLECTION)
    ("other orally available CDK4/6 inhibitors" . SPARSER::INHIBITOR)
    ("CDK4/6-cyclin D1" . SPARSER::COLLECTION)
    ("cyclin D1/CDK4/6/Rb" . SPARSER::COLLECTION)
    ("CDK4 and CDK6" . SPARSER::COLLECTION) ("mitogens" . SPARSER::MITOGEN)
    ("Many potential targets currently lack effective chemical inhibitors"
     . SPARSER::INHIBITOR)
    ("CDK4 and shRNA" . SPARSER::COLLECTION)
    ("cyclinD1/CDK4" . SPARSER::COLLECTION)
    ("hairpins" . SPARSER::PROTEIN-FAMILY)
    ("cyclin D1 or CDK4" . SPARSER::COLLECTION)
    ("CDK4, cyclin D1 and Rb" . SPARSER::COLLECTION)
    ("cyclin D1/CDK4/6" . SPARSER::COLLECTION)
    ("an indirect inhibitor" . SPARSER::INHIBITOR)
    ("SB216763 and CHIR-99021" . SPARSER::COLLECTION)
    ("GSK-3α and the highly homologous GSK-3β" . SPARSER::COLLECTION)
    ("the highly homologous GSK-3β" . SPARSER::PROTEIN)
    ("glycogen synthase kinase 3 alpha ( GSK-3α ) and microtubule-associated protein tau ( MAPT )"
     . SPARSER::COLLECTION)
    ("CADO-ES-1" . SPARSER::COLLECTION) ("EWS/ERG" . SPARSER::COLLECTION)
    ("cyclin D1/CDK4" . SPARSER::COLLECTION)
    ("CAV1 and CCND1" . SPARSER::COLLECTION)
    ("super-enhancers and typical enhancers" . SPARSER::COLLECTION)
    ("typical-enhancers" . SPARSER::PROTEIN)
    ("the typical enhancer-associated gene SMARCA4" . SPARSER::PROTEIN)
    ("a typical enhancer-associated gene SMARCA4" . SPARSER::PROTEIN)
    ("the largest super-enhancers" . SPARSER::PROTEIN)
    ("super-enhancer associated genes" . SPARSER::GENE)
    ("NKX2.2 , ID2 and CCND1" . SPARSER::COLLECTION)
    ("the 250 super-enhancers in TC32 and the 138 super-enhancers in TC71"
     . SPARSER::COLLECTION)
    ("all transcriptionally active genes" . SPARSER::GENE)
    ("nominated super-enhancer-associated genes" . SPARSER::GENE)
    ("Enhancers" . SPARSER::PROTEIN) ("typical enhancers" . SPARSER::PROTEIN)
    ("promoter and enhancer" . SPARSER::COLLECTION)
    ("EWS/ETS" . SPARSER::COLLECTION) ("CCND1 and CDK4" . SPARSER::COLLECTION)
    ("a publically available chemical" . SPARSER::MOLECULE)
    ("divergent chromatin" . SPARSER::PROTEIN)
    ("a possible component" . SPARSER::COMPONENT)
    ("the EWS gene and the 3" . SPARSER::COLLECTION)
    ("CDK4 and cyclin D1" . SPARSER::COLLECTION)
    ("super-enhancers" . SPARSER::PROTEIN)
    ("cyclin D1 and CDK4" . SPARSER::COLLECTION)
    ("EWS/FLI1" . SPARSER::COLLECTION)
    ("the EWS gene and a gene" . SPARSER::COLLECTION)
    ("EWS" . SPARSER::PROTEIN)
    ("insulin-like growth factor receptor" . SPARSER::PROTEIN)
    ("cyclin D1B" . SPARSER::PROTEIN)
    ("cyclin dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LEE011" . SPARSER::DRUG) ("PD0332991" . SPARSER::DRUG)
    ("CHIR-99021" . SPARSER::MOLECULE) ("SB216763" . SPARSER::DRUG)
    ("microtubule-associated protein tau" . SPARSER::PROTEIN)
    ("glycogen synthase kinase 3 alpha" . SPARSER::PROTEIN)
    ("ES-1" . SPARSER::PROTEIN) ("ID2" . SPARSER::PROTEIN)
    ("NKX2.2" . SPARSER::PROTEIN) ("H3K27Ac" . SPARSER::MOLECULE)
    ("FLI1" . SPARSER::PROTEIN)
    ("DAB2IP and Ezh2, DAB2IP and Snail" . SPARSER::COLLECTION)
    ("Ezh2, DAB2IP and Snail" . SPARSER::COLLECTION)
    ("snail and EZH2" . SPARSER::COLLECTION)
    ("GSK-3β/β-catenin" . SPARSER::COLLECTION)
    ("GSK3β/β-catenin" . SPARSER::COLLECTION)
    ("EZH2, HDAC1/2 and snail" . SPARSER::COLLECTION)
    ("snail/HDAC1/HDAC2" . SPARSER::COLLECTION)
    ("polycomb repressive complexes" . SPARSER::BIO-COMPLEX)
    ("DAB2IP and Skp2" . SPARSER::COLLECTION)
    ("Ezh2 and Snail" . SPARSER::COLLECTION)
    ("DAB2IP and Ezh2" . SPARSER::COLLECTION)
    ("Ezh2 or Snail" . SPARSER::COLLECTION) ("Ezh2" . SPARSER::PROTEIN)
    ("DAB2IP, EZH2 and Snail" . SPARSER::COLLECTION)
    ("DAB2IP, Snail and EZH2" . SPARSER::COLLECTION)
    ("Snail/DAB2IP" . SPARSER::COLLECTION) ("Trap" . SPARSER::PROTEIN)
    ("DAB2IP and Snail" . SPARSER::COLLECTION) ("LiCL" . SPARSER::DRUG)
    ("GSK3β-β-catenin" . SPARSER::COLLECTION)
    ("snail and DAB2IP" . SPARSER::COLLECTION)
    ("EZH2, HDAC1/2 and Snail" . SPARSER::COLLECTION)
    ("EZH2 or HDAC1/2 and Snail" . SPARSER::COLLECTION)
    ("EZH2 and Snail" . SPARSER::COLLECTION)
    ("EZH2/HDAC/snail" . SPARSER::COLLECTION)
    ("EZH2 and snail" . SPARSER::COLLECTION)
    ("HDAC1 or HDAC2" . SPARSER::COLLECTION)
    ("EZH2, HDAC1 and HDAC2" . SPARSER::COLLECTION)
    ("snail, HDAC1 or HDAC2" . SPARSER::COLLECTION)
    ("EZH2, HDACs and snail" . SPARSER::COLLECTION) ("SET" . SPARSER::PROTEIN)
    ("HDAC1/HDAC2" . SPARSER::COLLECTION)
    ("EZH2 and histone deacetylase" . SPARSER::COLLECTION)
    ("polycomb" . SPARSER::PROTEIN) ("EZH2/HDAC/Snail" . SPARSER::COLLECTION)
    ("snail" . SPARSER::PROTEIN) ("TRED" . SPARSER::PROTEIN)
    ("the mesenchymal marker Vimentin and concomitantly reduced epithelial markers E-cadherin and α-catenin (Figure xref )"
     . SPARSER::COLLECTION)
    ("the mesenchymal marker Vimentin" . SPARSER::PROTEIN)
    ("E-cadherin and α-catenin" . SPARSER::COLLECTION)
    ("a unique protein complex" . SPARSER::BIO-COMPLEX)
    ("RasGAP" . SPARSER::PROTEIN) ("Snail and EZH2" . SPARSER::COLLECTION)
    ("Snail and DAB2IP" . SPARSER::COLLECTION)
    ("EZH2/HDAC1/Snail" . SPARSER::COLLECTION) ("DP2" . SPARSER::PROTEIN)
    ("SET domain" . SPARSER::PROTEIN)
    ("enhancer of zeste homolog 2" . SPARSER::PROTEIN)
    ("AIP1" . SPARSER::PROTEIN) ("ASK1" . SPARSER::PROTEIN)
    ("dRad6/RAD6-MDM2" . SPARSER::COLLECTION)
    ("dASF1/ASF1A" . SPARSER::COLLECTION)
    ("Drosophila and Homo sapiens" . SPARSER::COLLECTION)
    ("ASF1 and H3K56Ac" . SPARSER::COLLECTION)
    ("RAD6/MDM2" . SPARSER::COLLECTION)
    ("dRad6 and dASF1 and dASF1" . SPARSER::COLLECTION)
    ("dASF1 and dASF1" . SPARSER::COLLECTION)
    ("Drosophila dRad6 and Homo RAD6" . SPARSER::COLLECTION)
    ("a functional ternary complex" . SPARSER::BIO-COMPLEX)
    ("transcriptional elongation" . SPARSER::PROTEIN)
    ("a new ASF1" . SPARSER::PROTEIN) ("dRad6-HA" . SPARSER::COLLECTION)
    ("“dRAD6-HA" . SPARSER::COLLECTION) ("dRAD6" . SPARSER::PROTEIN)
    ("dASF1 and H3K56Ac" . SPARSER::COLLECTION)
    ("dRad6 or dASF1" . SPARSER::COLLECTION)
    ("dASF1 or dRad6" . SPARSER::COLLECTION)
    ("anti-dRad6 or anti-GFP" . SPARSER::COLLECTION)
    ("GFP-dASF1" . SPARSER::COLLECTION)
    ("dRad6 and dASF1" . SPARSER::COLLECTION)
    ("anti-dASF1 or dRad6" . SPARSER::COLLECTION)
    ("HA or GFP" . SPARSER::COLLECTION)
    ("HA-tagged dRad6 or GFP-tagged dASF1" . SPARSER::COLLECTION)
    ("dRad6" . SPARSER::PROTEIN) ("GST-dRad6" . SPARSER::PROTEIN-PAIR)
    ("drosophila" . SPARSER::PROTEIN) ("RAD6A and ASF1A" . SPARSER::COLLECTION)
    ("ASF1A, H3K56Ac and MDM2" . SPARSER::COLLECTION)
    ("RAD6 and MDM2 protein" . SPARSER::COLLECTION)
    ("ASF1A and H3K56Ac" . SPARSER::COLLECTION)
    ("Myc-MDM2" . SPARSER::COLLECTION)
    ("an anti-MDM2 antibody or a control IgG" . SPARSER::COLLECTION)
    ("Myc-RAD6" . SPARSER::COLLECTION)
    ("RAD6, MDM2, and ASF1A" . SPARSER::COLLECTION)
    ("RAD6 and MDM2" . SPARSER::COLLECTION)
    ("RAD6, MDM2 and ASF1A" . SPARSER::COLLECTION)
    ("MDM2 and ASF1A" . SPARSER::COLLECTION)
    ("a control siRNA or MDM2-specific siRNA" . SPARSER::COLLECTION)
    ("antibody and DAPI" . SPARSER::COLLECTION)
    ("MDM2-Myc" . SPARSER::COLLECTION) ("ASF1A and RAD6" . SPARSER::COLLECTION)
    ("anti-ASF1A or anti-RAD6" . SPARSER::COLLECTION)
    ("MDM2 or other E3 ligases" . SPARSER::COLLECTION)
    ("Cont" . SPARSER::PROTEIN) ("NASP" . SPARSER::PROTEIN)
    ("RAD6B-GFP" . SPARSER::COLLECTION) ("RAD6A-GFP" . SPARSER::COLLECTION)
    ("RAD6 and ASF1A" . SPARSER::COLLECTION)
    ("RAD6A and RAD6B" . SPARSER::COLLECTION)
    ("anti-ASF1A or anti-Myc" . SPARSER::COLLECTION)
    ("RAD6A or Myc-tagged" . SPARSER::COLLECTION)
    ("RAD6 and ASF1" . SPARSER::COLLECTION)
    ("ASF1 and Rad6" . SPARSER::COLLECTION)
    ("the RAD6-MDM2 complex synergistically targets p53"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAD6" . SPARSER::PROTEIN) ("ASF1 and histone" . SPARSER::COLLECTION)
    ("histones or H3.3-H4" . SPARSER::COLLECTION)
    ("transcription factor or RNA polymerase II" . SPARSER::COLLECTION)
    ("ASF1A and ASF1B" . SPARSER::COLLECTION)
    ("chromatin assembly factor 1 (CAF-1) and histone regulatory homolog"
     . SPARSER::COLLECTION)
    ("HIRA" . SPARSER::PROTEIN) ("approximately 147 bp DNA" . SPARSER::DNA)
    ("H2A and H2B" . SPARSER::COLLECTION) ("RAD6-MDM2" . SPARSER::COLLECTION)
    ("an evolutionary conserved interacting protein" . SPARSER::PROTEIN)
    ("Texas red" . SPARSER::DRUG) ("RAD6B" . SPARSER::PROTEIN)
    ("RAD6A" . SPARSER::PROTEIN) ("dASF1" . SPARSER::PROTEIN)
    ("Rad6" . SPARSER::PROTEIN) ("K56" . SPARSER::PROTEIN)
    ("CAF-1" . SPARSER::PROTEIN) ("assembly factor 1" . SPARSER::PROTEIN)
    ("ASF1A" . SPARSER::PROTEIN) ("ASF1" . SPARSER::PROTEIN)
    ("FANCD2 and the other FA proteins" . SPARSER::COLLECTION)
    ("MLH1 and the FA core complex [ xref , xref ]" . SPARSER::COLLECTION)
    ("ICLs" . SPARSER::PROTEIN) ("MRE11 and BRCA1" . SPARSER::COLLECTION)
    ("MLH1 [ xref ] and TopBP1 [ xref ]" . SPARSER::COLLECTION)
    ("the BLM helicase [ xref ], Replication protein A (RPA) [ xref ], the nuclease MRE11 [ xref ], MLH1 [ xref ] and TopBP1 [ xref ]"
     . SPARSER::COLLECTION)
    ("protein A (RPA)" . SPARSER::PROTEIN)
    ("the latter protein" . SPARSER::PROTEIN)
    ("Chk1, Chk2 and RPA" . SPARSER::COLLECTION)
    ("Both the ubiquitin proteasome inhibitor MG-132 and the pan-caspase inhibitor Z-VAD-FMK"
     . SPARSER::COLLECTION)
    ("intact FANCJ" . SPARSER::PROTEIN) ("still forms foci" . SPARSER::PROTEIN)
    ("functional FANCJ" . SPARSER::PROTEIN)
    ("Chk2 and single strand DNA binding protein RPA [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("checkpoint kinases Chk1, Chk2 and single strand DNA binding protein RPA [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("replication stress-mediated DDR" . SPARSER::PROTEIN)
    ("Chk1 and Chk2" . SPARSER::COLLECTION)
    ("RAD51 and RAD18" . SPARSER::COLLECTION)
    ("hydroxyurea (HU)" . SPARSER::DRUG)
    ("resolving atypical DNA" . SPARSER::DNA)
    ("basal FANCD2" . SPARSER::PROTEIN)
    ("were fractioned" . SPARSER::BIO-FRACTION) ("caspase-" . SPARSER::PROTEIN)
    ("DMSO and Z-VAD-FMK" . SPARSER::COLLECTION)
    ("appropriate siRNAs" . SPARSER::PROTEIN)
    ("MG-132 and Z-VAD-FMK" . SPARSER::COLLECTION)
    ("Caspases" . SPARSER::PROTEIN) ("leupeptin" . SPARSER::DRUG)
    ("FANCJ or FANCD2" . SPARSER::COLLECTION)
    ("FANCD2 and FANCJ" . SPARSER::COLLECTION)
    ("this study effectively decrease FANCJ" . SPARSER::PROTEIN)
    ("FANCD2 (Figure xref ) and FANCI (data not shown) proteins"
     . SPARSER::COLLECTION)
    ("a previously validated second siRNA" . SPARSER::PROTEIN)
    ("FANCD2 and its regulatory partner FANCI" . SPARSER::COLLECTION)
    ("either wild-type FANCJ or a helicase dead (FANCJ-K52R) mutant both efficiently rescued FANCD2/FANCI proteins"
     . SPARSER::COLLECTION)
    ("FANCD2/FANCI" . SPARSER::COLLECTION)
    ("FANCJ and FANCD2" . SPARSER::COLLECTION)
    ("forked duplex DNA" . SPARSER::DNA) ("DEAH" . SPARSER::PROTEIN-FAMILY)
    ("the BRCA1-associated C-terminal helicase (BACH1) and the BRCA1-interacting protein (BRIP1)"
     . SPARSER::COLLECTION)
    ("the BRCA1-associated C-terminal helicase" . SPARSER::PROTEIN)
    ("proteins or FANCD2 and FANCI" . SPARSER::COLLECTION)
    ("other repair-associated proteins" . SPARSER::PROTEIN)
    ("FANCD2 and FANCI" . SPARSER::COLLECTION)
    ("FANCD2-FANCI" . SPARSER::COLLECTION) ("FANCE" . SPARSER::PROTEIN)
    ("mitomycin C, cisplatin, diepoxybutane and melphalan"
     . SPARSER::COLLECTION)
    ("diepoxybutane" . SPARSER::MOLECULE) ("FANCA" . SPARSER::PROTEIN)
    ("FANCD2 and its co-regulator FANCI" . SPARSER::COLLECTION)
    ("FANCI" . SPARSER::PROTEIN) ("FA-BRCA" . SPARSER::COLLECTION)
    ("FANCJ" . SPARSER::PROTEIN) ("FA" . SPARSER::PROTEIN)
    ("Beta-Actin" . SPARSER::PROTEIN) ("calpain inhibitor" . SPARSER::PROTEIN)
    ("TopBP1" . SPARSER::PROTEIN) ("MRE11" . SPARSER::PROTEIN)
    ("RAD18" . SPARSER::PROTEIN) ("h-TERT" . SPARSER::PROTEIN)
    ("BRIP1" . SPARSER::PROTEIN) ("FANCD1" . SPARSER::PROTEIN)
    ("Fanconi anemia" . SPARSER::PROTEIN) ("underwent NAC" . SPARSER::PROTEIN)
    ("SUVs" . SPARSER::PROTEIN) ("GLUT1 and hexokinase" . SPARSER::COLLECTION)
    ("hexokinase" . SPARSER::PROTEIN) ("notable SUV" . SPARSER::PROTEIN)
    ("NAC and trastuzumab" . SPARSER::COLLECTION) ("SUV" . SPARSER::PROTEIN)
    ("ALN" . SPARSER::MOLECULE) ("Estrogen receptor" . SPARSER::PROTEIN)
    ("AR-V-expressing CRPC" . SPARSER::PROTEIN)
    ("CCNA2 , CCNB1 , CCNE2 and CDK1" . SPARSER::COLLECTION)
    ("FL-AR- and AR-V-mediated" . SPARSER::COLLECTION)
    ("FL-AR-" . SPARSER::PROTEIN) ("Niclosamide" . SPARSER::DRUG)
    ("AR-V-driven genes" . SPARSER::GENE)
    ("steroid-depleted media" . SPARSER::PROTEIN)
    ("UBE2C and CCNA2" . SPARSER::COLLECTION)
    ("UBE2C , NKX3.1, ATAD2 and CCNA2" . SPARSER::COLLECTION)
    ("AR, AR-Vs or FOXA1" . SPARSER::COLLECTION)
    ("co-regulated" . SPARSER::PROTEIN)
    ("Intriguingly ASF2 and U2AF65 mRNA" . SPARSER::PROTEIN)
    ("ASF" . SPARSER::PROTEIN) ("quantitative mRNA" . SPARSER::PROTEIN)
    ("G 2/ M-" . SPARSER::PROTEIN)
    ("DHT and anti-androgen" . SPARSER::COLLECTION)
    ("DHT and Enzalutamide" . SPARSER::COLLECTION)
    ("FOXA1, AR or AR-Vs" . SPARSER::COLLECTION)
    ("Cyclin A2 ( CCNA2 ), Cyclin B1 ( CCNB1 ), Cyclin E2 ( CCNE2 ) and Cyclin-dependent Kinase 1 (CDK1)"
     . SPARSER::COLLECTION)
    ("pro-proliferative genes" . SPARSER::GENE)
    ("FOXA1-co-regulated" . SPARSER::PROTEIN-PAIR)
    ("UBE2C and ATAD2" . SPARSER::COLLECTION)
    ("FOXA1, AR and AR-V" . SPARSER::COLLECTION)
    ("UBE2C , NKx3.1 and ATAD2" . SPARSER::COLLECTION)
    ("FOXA1 and AR" . SPARSER::COLLECTION)
    ("ectopically-expressed AR-V7" . SPARSER::PROTEIN)
    ("FOXA1 and AR-Vs" . SPARSER::COLLECTION)
    ("FOXA1 and AR-V" . SPARSER::COLLECTION)
    ("AR-V7 and AR-1/2/3/2b" . SPARSER::COLLECTION)
    ("anti-AR-V7 and AR" . SPARSER::COLLECTION)
    ("only AR variants" . SPARSER::VARIANT)
    ("FOXA1 and receptor" . SPARSER::COLLECTION)
    ("PSA, KLK2 and AR-V" . SPARSER::COLLECTION)
    ("response elements (FAIRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("formaldehyde" . SPARSER::MOLECULE)
    ("Bicalutamide or Enzalutamide" . SPARSER::COLLECTION)
    ("the clinically-relevant AR-V7 protein" . SPARSER::PROTEIN)
    ("both proximal promoter" . SPARSER::PROMOTER)
    ("AR and FOXA1" . SPARSER::COLLECTION)
    ("AR-chromatin" . SPARSER::COLLECTION)
    ("Enzalutamide [ xref , xref ] and abiraterone [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("a more aggressive form" . SPARSER::FORM)
    ("Enzalutamide and Abiraterone" . SPARSER::COLLECTION)
    ("Abiraterone" . SPARSER::DRUG) ("GATA2" . SPARSER::PROTEIN)
    ("EPI-001" . SPARSER::DRUG) ("G 2/ M" . SPARSER::PROTEIN)
    ("Cyclin-dependent Kinase 1" . SPARSER::PROTEIN)
    ("Cyclin A2" . SPARSER::PROTEIN) ("ATAD2" . SPARSER::PROTEIN)
    ("NKx3.1" . SPARSER::PROTEIN) ("AR-1" . SPARSER::PROTEIN)
    ("FL-AR" . SPARSER::PROTEIN) ("Erk1/2, and HRG" . SPARSER::COLLECTION)
    ("coregulatory molecules" . SPARSER::MOLECULE)
    ("receptors and ligands" . SPARSER::COLLECTION)
    ("proteoglycans" . SPARSER::PROTEIN)
    ("prokaryotic-expressed recombinant HRG" . SPARSER::PROTEIN)
    ("HRG, and FGFR" . SPARSER::COLLECTION)
    ("P38 and JNK" . SPARSER::COLLECTION) ("RPLC" . SPARSER::PROTEIN)
    ("HRG and HCC" . SPARSER::COLLECTION) ("sulfate (HS)" . SPARSER::MOLECULE)
    ("AFP" . SPARSER::PROTEIN)
    ("heparin, and heparan sulfate (HS)" . SPARSER::COLLECTION)
    ("divalent cations" . SPARSER::MOLECULE)
    ("heparin, and heparan sulfate" . SPARSER::COLLECTION)
    ("fibrinogen" . SPARSER::PROTEIN) ("cations" . SPARSER::MOLECULE)
    ("cystatin" . SPARSER::PROTEIN) ("HRG and heparin" . SPARSER::COLLECTION)
    ("bFGF" . SPARSER::PROTEIN) ("glycoprotein (HRG)" . SPARSER::PROTEIN)
    ("DLC" . SPARSER::PROTEIN) ("HRG" . SPARSER::PROTEIN)
    ("heparan sulfate" . SPARSER::MOLECULE) ("FcγR" . SPARSER::PROTEIN-FAMILY)
    ("Zn 2+" . SPARSER::MOLECULE)
    ("other clinically available drugs" . SPARSER::DRUG)
    ("neuregulins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HER2 and its phosphorylated form" . SPARSER::COLLECTION)
    ("maytansine" . SPARSER::DRUG)
    ("docetaxel and vinorelbine" . SPARSER::COLLECTION)
    ("cisplatin, carboplatin, docetaxel or vinorelbine" . SPARSER::COLLECTION)
    ("vinorelbine" . SPARSER::DRUG)
    ("chemotherapeutical drugs" . SPARSER::DRUG)
    ("trastuzumab and T-DM1" . SPARSER::COLLECTION)
    ("lapatinib or the antibody-drug" . SPARSER::COLLECTION)
    ("the only HER family receptor" . SPARSER::RECEPTOR)
    ("EGFR, HER2 and HER4" . SPARSER::COLLECTION)
    ("EGFR, HER2 and HER3" . SPARSER::COLLECTION)
    ("FAK (37%) and HER4 (25%)" . SPARSER::COLLECTION)
    ("HER2 (95% of patients), HER3 (80%), EGFR (37%), FAK (37%) and HER4 (25%)"
     . SPARSER::COLLECTION)
    ("kinases, Dtk and EphA2" . SPARSER::COLLECTION)
    ("receptor tyrosine kinases, HER4, Dtk and EphA2" . SPARSER::COLLECTION)
    ("Dtk" . SPARSER::PROTEIN)
    ("receptor and cytosolic tyrosine kinases" . SPARSER::COLLECTION)
    ("trastuzumab or pertuzumab" . SPARSER::COLLECTION)
    ("trastuzumab and pertuzumab" . SPARSER::COLLECTION)
    ("pertuzumab" . SPARSER::DRUG) ("Pertuzumab" . SPARSER::DRUG)
    ("the related ErbB2/HER2 transmembrane tyrosine kinase" . SPARSER::PROTEIN)
    ("ErbB2/HER2" . SPARSER::COLLECTION)
    ("which targets both PDGFR and c-Kit" . SPARSER::COLLECTION)
    ("PDGFR and c-Kit" . SPARSER::COLLECTION)
    ("The platelet-derived growth factor receptors (PDGFR) and their ligands [ xref ]"
     . SPARSER::COLLECTION)
    ("receptors (PDGFR)" . SPARSER::RECEPTOR)
    ("phospho-Histone" . SPARSER::PROTEIN) ("emtansine" . SPARSER::DRUG)
    ("cyclin D3" . SPARSER::PROTEIN) ("Wee1" . SPARSER::PROTEIN)
    ("Ret2" . SPARSER::PROTEIN) ("PDGFRβ" . SPARSER::PROTEIN)
    ("Flt3" . SPARSER::PROTEIN) ("FGFR4" . SPARSER::PROTEIN)
    ("FGFR3" . SPARSER::PROTEIN) ("CSF-1R" . SPARSER::PROTEIN)
    ("wee1" . SPARSER::PROTEIN) ("c-Kit" . SPARSER::PROTEIN)
    ("Ercc1, Ercc2, Mutyh and Pnkp" . SPARSER::COLLECTION)
    ("Ercc2, Mutyh and Pnkp" . SPARSER::COLLECTION)
    ("Ercc1-XPF" . SPARSER::COLLECTION) ("XPF" . SPARSER::PROTEIN)
    ("PEI" . SPARSER::MOLECULE) ("Pnkp" . SPARSER::PROTEIN)
    ("Mutyh" . SPARSER::PROTEIN) ("Ercc2" . SPARSER::PROTEIN)
    ("universal component" . SPARSER::COMPONENT)
    ("ercc1 and ercc2" . SPARSER::COLLECTION) ("NER" . SPARSER::PROTEIN)
    ("efficient siRNA" . SPARSER::PROTEIN)
    ("Mgmt and TMZ" . SPARSER::COLLECTION) ("mgmt" . SPARSER::PROTEIN)
    ("DNA-repair and chemoresistance" . SPARSER::COLLECTION)
    ("fotemustine or the presently used TMZ" . SPARSER::COLLECTION)
    ("Vincristine" . SPARSER::DRUG) ("Lomustine" . SPARSER::DRUG)
    ("Procarbazine" . SPARSER::DRUG) ("GFP-siRNA" . SPARSER::COLLECTION)
    ("Ercc1-siRNA #3" . SPARSER::PROTEIN-PAIR)
    ("Ercc1-siRNA" . SPARSER::COLLECTION)
    ("CDDP and TMZ" . SPARSER::COLLECTION) ("gold" . SPARSER::MOLECULE)
    ("mutyh and pnkp" . SPARSER::COLLECTION)
    ("siRNAs, ercc1#2, ercc2#1, mutyh#5 and pnkp#1" . SPARSER::COLLECTION)
    ("the most efficient siRNA" . SPARSER::PROTEIN)
    ("ercc1, ercc2, mutyh, pnkp, ruvbl2 and pold1" . SPARSER::COLLECTION)
    ("pold1" . SPARSER::PROTEIN) ("ruvbl2" . SPARSER::PROTEIN)
    ("the GFP siRNA's" . SPARSER::PROTEIN) ("ercc-1" . SPARSER::PROTEIN)
    ("ercc1 , ercc2 , mutyh and pnkp" . SPARSER::COLLECTION)
    ("BG" . SPARSER::PROTEIN)
    ("loss of heterozygosity (LOH)" . SPARSER::PROTEIN)
    ("Ercc1" . SPARSER::PROTEIN)
    ("ercc1 , ercc2 , mutyh , and pnkp" . SPARSER::COLLECTION)
    ("ercc2" . SPARSER::PROTEIN) ("ercc1" . SPARSER::PROTEIN)
    ("pnkp" . SPARSER::PROTEIN) ("mutyh" . SPARSER::PROTEIN)
    ("SiRNAs" . SPARSER::PROTEIN)
    ("cisplatin (CDDP) and TMZ" . SPARSER::COLLECTION)
    ("TMZ and Mgmt" . SPARSER::COLLECTION) ("Mgmt" . SPARSER::PROTEIN)
    ("the first chemotherapeutic drug" . SPARSER::DRUG)
    ("3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("Green Fluorescent Protein" . SPARSER::PROTEIN)
    ("nuclease activity" . SPARSER::PROTEIN)
    ("xeroderma pigmentosum" . SPARSER::PROTEIN) ("p32" . SPARSER::PROTEIN)
    ("O6" . SPARSER::PROTEIN)
    ("O-6-methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("placental growth factor and endoglin" . SPARSER::COLLECTION)
    ("the soluble proteins" . SPARSER::PROTEIN)
    ("growth factor and endoglin" . SPARSER::COLLECTION)
    ("endoglin" . SPARSER::PROTEIN)
    ("directly target MYC mRNA" . SPARSER::PROTEIN)
    ("miR-34a or MYC" . SPARSER::COLLECTION)
    ("miR-34a and MYC" . SPARSER::COLLECTION) ("pir" . SPARSER::PROTEIN)
    ("the mature miR-34a" . SPARSER::MOLECULE)
    ("MYC and miR-34a" . SPARSER::COLLECTION) ("p-EGFP" . SPARSER::COLLECTION)
    ("miR-34a or non-targeting control (NC) expression vectors"
     . SPARSER::COLLECTION)
    ("mature miR-34a" . SPARSER::MOLECULE)
    ("yet mature miR-34a" . SPARSER::MOLECULE)
    ("miRNA and antisense" . SPARSER::COLLECTION)
    ("ribonuclease" . SPARSER::PROTEIN)
    ("approximately 70-nucleotide stem-loop precursor miRNAs"
     . SPARSER::PROTEIN)
    ("metalloproteinases and FOS" . SPARSER::COLLECTION)
    ("the placental vasculature" . SPARSER::PROTEIN)
    ("reliable early biomarkers" . SPARSER::MOLECULE)
    ("finding reliable biomarkers" . SPARSER::MOLECULE)
    ("proteinuria" . SPARSER::PROTEIN)
    ("placental vasculature" . SPARSER::PROTEIN)
    ("mitomycin-C" . SPARSER::DRUG)
    ("vascular endothelial growth factor receptor-1" . SPARSER::PROTEIN)
    ("MiR-34a" . SPARSER::MOLECULE)
    ("Drosha ribonuclease III" . SPARSER::PROTEIN)
    ("cyclins and cdks" . SPARSER::COLLECTION) ("cdks" . SPARSER::PROTEIN)
    ("p21 and MDM2" . SPARSER::COLLECTION) ("ribosomal RNA" . SPARSER::RNA)
    ("p21 and p53" . SPARSER::COLLECTION)
    ("Dp44mT or DFO" . SPARSER::COLLECTION)
    ("approximately 63 kDa and 74 kDa" . SPARSER::COLLECTION)
    ("approximately 63 kDa" . SPARSER::PROTEIN)
    ("p53 and p63" . SPARSER::COLLECTION)
    ("chelators and DNA-damage" . SPARSER::COLLECTION)
    ("p21 and the p75 MDM2 isoform" . SPARSER::COLLECTION)
    ("chelators and CP" . SPARSER::COLLECTION)
    ("MDM2 or p75" . SPARSER::COLLECTION) ("MDM2 or p90" . SPARSER::COLLECTION)
    ("namely p50 MDM2" . SPARSER::PROTEIN)
    ("approximately 37 kDa" . SPARSER::PROTEIN)
    ("any previously reported MDM2 isoforms" . SPARSER::ISOFORM)
    ("p21 (Fig. xref ) and p75 MDM2 (Fig. xref )" . SPARSER::COLLECTION)
    ("its shorter isoforms" . SPARSER::ISOFORM)
    ("any previously reported MDM2 isoform" . SPARSER::ISOFORM)
    ("approximately 23 kDa" . SPARSER::PROTEIN)
    ("MDM2 and p90" . SPARSER::COLLECTION)
    ("these two latter isoforms" . SPARSER::ISOFORM)
    ("namely p90 MDM2 and p75 MDM2" . SPARSER::PROTEIN)
    ("MDM2 and p75" . SPARSER::COLLECTION)
    ("an oncoprotein and a negative regulator" . SPARSER::COLLECTION)
    ("DNA-damage [ xref , xref , xref ]" . SPARSER::DNA)
    ("Dp44mT, or DFO" . SPARSER::COLLECTION)
    ("cisplatin (CP) and mitomycin C (MC) [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("mitomycin C (MC)" . SPARSER::DRUG)
    ("cdk4/6 and cyclin D1" . SPARSER::COLLECTION)
    ("cdk4/6" . SPARSER::PROTEIN) ("cyclin E/cdk2" . SPARSER::COLLECTION)
    ("both p53 [ xref ] and NDRG1 [ xref ]" . SPARSER::COLLECTION)
    ("NDRG1 and p53" . SPARSER::COLLECTION)
    ("ligands form redox-active complexes" . SPARSER::BIO-COMPLEX)
    ("the pyridoxal isonicotinoyl hydrazone (PIH) class" . CLASS)
    ("alternative chelators" . SPARSER::MOLECULE) ("DFO" . SPARSER::MOLECULE)
    ("tumor suppressor and metastasis suppressor genes [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("cdk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Iron" . SPARSER::MOLECULE)
    ("NDRG1, MDM2 and ΔNp63" . SPARSER::COLLECTION)
    ("chelators" . SPARSER::MOLECULE)
    ("2-hydroxy-1-napthylaldehyde isonicotinoyl hydrazone (311) and di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT) target tumor cell iron"
     . SPARSER::COLLECTION)
    ("hydrazone" . SPARSER::MOLECULE) ("Chelators" . SPARSER::MOLECULE)
    ("TAp63" . SPARSER::PROTEIN) ("Histone deacetylase 1" . SPARSER::PROTEIN)
    ("p60" . SPARSER::PROTEIN) ("cdk4" . SPARSER::PROTEIN)
    ("p75" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Dp44mT" . SPARSER::DRUG)
    ("di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone" . SPARSER::DRUG)
    ("consequently increase SERPINE1" . SPARSER::PROTEIN)
    ("PTX3, ITGBL1, DIO2, RP11–403A3 and NPEPPS" . SPARSER::COLLECTION)
    ("NPEPPS" . SPARSER::PROTEIN)
    ("ELK1, Ets-1 and ELK3" . SPARSER::COLLECTION)
    ("SIRT1 and HDAC11" . SPARSER::COLLECTION)
    ("uPA-uPAR" . SPARSER::COLLECTION)
    ("TEL2 or SERPINE1" . SPARSER::COLLECTION)
    ("TEL2 and/or SERPINE1" . SPARSER::COLLECTION)
    ("SERPINE1 and TEL2" . SPARSER::COLLECTION)
    ("S26-SERPINE1" . SPARSER::COLLECTION)
    ("S26 and 6–10B" . SPARSER::COLLECTION) ("HA-TEL2" . SPARSER::COLLECTION)
    ("S26 and 6–10B cell" . SPARSER::COLLECTION)
    ("S18 and 5–8F" . SPARSER::COLLECTION)
    ("S26 and S18" . SPARSER::COLLECTION) ("S18 and S26" . SPARSER::COLLECTION)
    ("TEL" . SPARSER::PROTEIN) ("TEL2 and SERPINE1" . SPARSER::COLLECTION)
    ("DIO2" . SPARSER::PROTEIN) ("ITGBL1" . SPARSER::PROTEIN)
    ("PTX3" . SPARSER::PROTEIN) ("ELK3" . SPARSER::PROTEIN)
    ("SIRT-1" . SPARSER::PROTEIN) ("HDAC11" . SPARSER::PROTEIN)
    ("LRP1" . SPARSER::PROTEIN) ("S26" . SPARSER::PROTEIN)
    ("S18" . SPARSER::PROTEIN) ("TEL2" . SPARSER::PROTEIN)
    ("polymorphisms and migraine" . SPARSER::COLLECTION)
    ("polymorphism and migraine" . SPARSER::COLLECTION)
    ("AA and AG" . SPARSER::COLLECTION) ("CG " . SPARSER::PROTEIN)
    ("Polymorphism and Migraine" . SPARSER::COLLECTION)
    ("ESR1 , and migraine" . SPARSER::COLLECTION)
    ("migraine and genetic polymorphisms" . SPARSER::COLLECTION)
    ("The polymorphic estrogen receptor 1 ( ESR1 ) gene" . SPARSER::GENE)
    ("17beta-estradiol or E2" . SPARSER::COLLECTION)
    ("metazoans" . SPARSER::PROTEIN-FAMILY) ("introns" . SPARSER::PROTEIN)
    ("aura (MA) and migraine" . SPARSER::COLLECTION)
    ("AA " . SPARSER::MOLECULE) ("CG and CC" . SPARSER::COLLECTION)
    ("incident migraine" . SPARSER::PROTEIN)
    ("17beta-estradiol" . SPARSER::MOLECULE) ("alpha)" . SPARSER::PROTEIN)
    ("SCN1A" . SPARSER::PROTEIN) ("estrogen receptor 1" . SPARSER::PROTEIN)
    ("cetuximab and afatinib" . SPARSER::COLLECTION)
    ("the mesenchymal-epithelial transition ( MET ) proto-oncogene and human epidermal growth factor receptor"
     . SPARSER::COLLECTION)
    ("the mesenchymal-epithelial transition ( MET ) proto-oncogene"
     . SPARSER::PROTEIN)
    ("MET and HER2" . SPARSER::COLLECTION) ("RPP30" . SPARSER::PROTEIN)
    ("new antifungal drugs" . SPARSER::DRUG) ("Cyt" . SPARSER::MOLECULE)
    ("asparaginase" . SPARSER::PROTEIN)
    ("some special cue" . SPARSER::PROTEIN-FAMILY)
    ("cue" . SPARSER::PROTEIN-FAMILY)
    ("a more accessible heme" . SPARSER::PROTEIN)
    ("cardiolipin" . SPARSER::MOLECULE) ("cytochrome" . SPARSER::PROTEIN)
    ("vis" . SPARSER::DRUG) ("syn" . SPARSER::PROTEIN)
    ("anion" . SPARSER::MOLECULE) ("lipase" . SPARSER::PROTEIN)
    ("filamentous fungi" . SPARSER::PROTEIN)
    ("many homologous mammalian apoptotic proteins" . SPARSER::PROTEIN)
    ("fungi" . SPARSER::PROTEIN)
    ("protease-activating factor-1" . SPARSER::COLLECTION)
    ("cyt" . SPARSER::MOLECULE) ("spp" . SPARSER::PROTEIN)
    ("Both native and recombinant cytochrome c" . SPARSER::PROTEIN)
    ("fungal cytochrome c" . SPARSER::PROTEIN)
    ("mitochondrial cytochrome c" . SPARSER::PROTEIN)
    ("mM −1  " . SPARSER::PROTEIN) ("mgL −1" . SPARSER::PROTEIN)
    ("K88" . SPARSER::PROTEIN) ("L −1" . SPARSER::PROTEIN)
    ("1 L" . SPARSER::PROTEIN) ("activating factor" . SPARSER::PROTEIN)
    ("HB-EGF, and insulin-like growth factor" . SPARSER::COLLECTION)
    ("PI3K, p38, JNK or AP-1" . SPARSER::COLLECTION)
    ("TGF-β1 and FGF1" . SPARSER::COLLECTION)
    ("FGFR and integrin" . SPARSER::COLLECTION)
    ("exogenous FGF1" . SPARSER::PROTEIN)
    ("αvβ3-FGF1-FGF1" . SPARSER::COLLECTION) ("FGFRs" . SPARSER::PROTEIN)
    ("FGF1-" . SPARSER::PROTEIN)
    ("the FGFR1-FGF1-integrin αvβ3 ternary complex" . SPARSER::BIO-COMPLEX)
    ("FGFR1-FGF1-integrin" . SPARSER::COLLECTION)
    ("proteins, and growth factor" . SPARSER::COLLECTION)
    ("FGF1 and TGF-β1" . SPARSER::COLLECTION)
    ("form morphologically normal mammary acini" . SPARSER::PROTEIN)
    ("acinus" . SPARSER::PROTEIN) ("FGF1 and integrin" . SPARSER::COLLECTION)
    ("FGF1 and Integrin" . SPARSER::COLLECTION)
    ("TGF-β1 and 50 ng/ml" . SPARSER::COLLECTION)
    ("TGF receptor and other tyrosine kinase receptors" . SPARSER::COLLECTION)
    ("extracellular signal-regulated kinase (ERK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("N-cadherin, PAI-1 and vimentin" . SPARSER::COLLECTION)
    ("growth factor-integrin" . SPARSER::COLLECTION)
    ("αvβ3 and FGF1" . SPARSER::COLLECTION) ("TGF-β-EMT" . SPARSER::COLLECTION)
    ("-integrin" . SPARSER::COLLECTION)
    ("molecules, and growth factors" . SPARSER::COLLECTION)
    ("the genes involved in the EMT" . SPARSER::GENE)
    ("Snail" . SPARSER::PROTEIN) ("FGFs" . SPARSER::PROTEIN)
    ("Antagonists" . SPARSER::MOLECULE)
    ("αvβ3 and FGFR1" . SPARSER::COLLECTION) ("Integrins" . SPARSER::PROTEIN)
    ("FGF-1" . SPARSER::PROTEIN) ("TGF- β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Snail2" . SPARSER::PROTEIN) ("Snail1" . SPARSER::PROTEIN)
    ("D11" . SPARSER::PROTEIN) ("C-15" . SPARSER::PROTEIN)
    ("PD173074" . SPARSER::DRUG) ("TβR-II" . SPARSER::PROTEIN)
    ("Fibroblast growth factors" . SPARSER::PROTEIN-FAMILY)
    ("αvβ3" . SPARSER::PROTEIN)
    ("fibroblast growth factors" . SPARSER::PROTEIN-FAMILY)
    ("perinatal" . SPARSER::PROTEIN)
    ("only clinical trial involving genetically modified chimeric antigen receptor (CAR)"
     . SPARSER::RECEPTOR)
    ("receptor (CAR)" . SPARSER::RECEPTOR) ("enteric" . SPARSER::PROTEIN)
    ("Pds5a and Pds5b" . SPARSER::COLLECTION) ("Pds5a" . SPARSER::PROTEIN)
    ("Pds5 null S . cerevisiae" . SPARSER::PROTEIN)
    ("an intact genomic Pds5b" . SPARSER::PROTEIN)
    ("using Southern Blot" . SPARSER::PROTEIN)
    ("phenotypic malformations" . SPARSER::PROTEIN)
    ("fetal hepatocytes" . SPARSER::PROTEIN)
    ("Pds5A or wildtype" . SPARSER::COLLECTION) ("Pds5A" . SPARSER::PROTEIN)
    ("Pds5" . SPARSER::PROTEIN) ("APRIN" . SPARSER::PROTEIN)
    ("Nucleotide" . SPARSER::NUCLEOTIDE) ("new transgene" . SPARSER::PROTEIN)
    ("a highly active promoter" . SPARSER::PROMOTER) ("ERB" . SPARSER::PROTEIN)
    ("a homozygous state" . SPARSER::BIO-STATE)
    ("MMTV and WAP" . SPARSER::COLLECTION) ("WAP" . SPARSER::PROTEIN)
    ("TSAs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Pds5b" . SPARSER::PROTEIN)
    ("CD25" . SPARSER::PROTEIN) ("S . cerevisiae" . SPARSER::PROTEIN)
    ("c-ErbB2" . SPARSER::PROTEIN) ("E19" . SPARSER::PROTEIN)
    ("whey acidic protein" . SPARSER::PROTEIN)
    ("RASSF6 and RASSF10" . SPARSER::COLLECTION)
    ("5-aza-2-deoxycytidine" . SPARSER::PROTEIN-PAIR)
    ("-CDK4/6" . SPARSER::COLLECTION) ("-CDK1" . SPARSER::COLLECTION)
    ("inhibitor (CKI)" . SPARSER::INHIBITOR)
    ("Wnt and NF-κB" . SPARSER::COLLECTION)
    ("RASSF1-RASSF6" . SPARSER::COLLECTION) ("p-IκBα" . SPARSER::COLLECTION)
    ("SR-IκBα" . SPARSER::PROTEIN-PAIR) ("P50 and IκBα" . SPARSER::COLLECTION)
    ("p-P65" . SPARSER::COLLECTION) ("β-catenin and P65" . SPARSER::COLLECTION)
    ("P21 and TRAIL" . SPARSER::COLLECTION)
    ("P53, P21 and Cyclin D1" . SPARSER::COLLECTION)
    ("Wp-0614 Cntl and Wp-0614 RASSF8, M101 Cntl and M101 shRNA ( xref and xref )"
     . SPARSER::COLLECTION)
    ("P53 and P21" . SPARSER::COLLECTION) ("p12" . SPARSER::PROTEIN)
    ("the classical C-terminal RASSF proteins" . SPARSER::PROTEIN)
    ("family (RASSF)" . SPARSER::PROTEIN-FAMILY)
    ("P53-P21" . SPARSER::COLLECTION)
    ("P65 and its downstream target IL-6" . SPARSER::COLLECTION)
    ("p-65" . SPARSER::PROTEIN) ("sodium hydroxide" . SPARSER::MOLECULE)
    ("Beta-2-microglobulin" . SPARSER::PROTEIN) ("BAY 11-7082" . SPARSER::DRUG)
    ("(Beta" . SPARSER::PROTEIN) ("RASSF10" . SPARSER::PROTEIN)
    ("RASSF7" . SPARSER::PROTEIN) ("HOJ1" . SPARSER::PROTEIN)
    ("RASSF8" . SPARSER::PROTEIN) ("miR-200b-ZEB1/2" . SPARSER::COLLECTION)
    ("ZEB1/2" . SPARSER::PROTEIN) ("miR-200b" . SPARSER::PROTEIN)
    ("miR-200b-Kindlin-2" . SPARSER::PROTEIN-PAIR)
    ("FAK and Rho" . SPARSER::COLLECTION)
    ("Kindlins" . SPARSER::PROTEIN-FAMILY) ("fibronectins" . SPARSER::PROTEIN)
    ("EGFR-AKT" . SPARSER::COLLECTION)
    ("Kindlin-2-EGFR-AKT" . SPARSER::COLLECTION)
    ("Src and Kindlin-2" . SPARSER::COLLECTION)
    ("Kindlin-2 and oncogenic tyrosine kinases" . SPARSER::COLLECTION)
    ("ZEB1/2-EMT" . SPARSER::PROTEIN-PAIR)
    ("WASF3, Moesin, FHOD1, PPM1F, WIPF1 and Cofilin2" . SPARSER::COLLECTION)
    ("EMT or E-cadherin" . SPARSER::COLLECTION)
    ("E-cadherin or EMT" . SPARSER::COLLECTION)
    ("Kinlin-2-integrin" . SPARSER::COLLECTION)
    ("pAKT, and re-expression" . SPARSER::COLLECTION)
    ("E-cadherin and miR-200b or ZEB1/2" . SPARSER::COLLECTION)
    ("neither E-cadherin nor vimentin" . SPARSER::COLLECTION)
    ("RhoA and CDC42" . SPARSER::COLLECTION)
    ("WASF3, Moesin, WIPF1 and Cofilin2" . SPARSER::COLLECTION)
    ("Moesin" . SPARSER::PROTEIN) ("ZEB1, ZEB2 and SLUG" . SPARSER::COLLECTION)
    ("Kindlin-2-integrin" . SPARSER::COLLECTION) ("PPM1F" . SPARSER::PROTEIN)
    ("FHOD1" . SPARSER::PROTEIN) ("WIPF1" . SPARSER::PROTEIN)
    ("WASF3" . SPARSER::PROTEIN) ("Kindlin-2" . SPARSER::PROTEIN)
    ("simultaneous high ERBB2" . SPARSER::PROTEIN)
    ("kinase (LCK)" . SPARSER::KINASE)
    ("STAT1 and interferon" . SPARSER::COLLECTION) ("TRUP" . SPARSER::PROTEIN)
    ("all other collective subtypes" . SPARSER::PROTEIN)
    ("HER2 ( ERBB2 , GRB7 , ORMDL3) or ER ( C1orf186 , ESR1 , RERG )"
     . SPARSER::COLLECTION)
    ("RERG" . SPARSER::PROTEIN) ("orf" . SPARSER::PROTEIN)
    ("TRAstuzumab" . SPARSER::DRUG) ("neo" . SPARSER::PROTEIN)
    ("CD56" . SPARSER::PROTEIN) ("ORMDL3" . SPARSER::PROTEIN)
    ("GRB7" . SPARSER::PROTEIN) ("JAKs-STAT3" . SPARSER::COLLECTION)
    ("their respective nuclear receptors" . SPARSER::RECEPTOR)
    ("intercellular cAMP" . SPARSER::PROTEIN)
    ("FoxM1-cyclin B1" . SPARSER::COLLECTION)
    ("FoxM1 and STAT3" . SPARSER::COLLECTION) ("pyridone" . SPARSER::MOLECULE)
    ("STAT3 and C/EBPβ" . SPARSER::COLLECTION)
    ("C/EBPβ-STAT3" . SPARSER::COLLECTION)
    ("PRL and IGFBP-1" . SPARSER::COLLECTION)
    ("Caspase 3, Caspase 3 and Caspase 9" . SPARSER::COLLECTION)
    ("-PR" . SPARSER::COLLECTION) ("decidual marker genes" . SPARSER::GENE)
    ("can transcriptionally active" . SPARSER::ACTIVE)
    ("Trident" . SPARSER::PROTEIN) ("−2 " . SPARSER::PROTEIN)
    ("Caspase 9" . SPARSER::PROTEIN) ("PGL3" . SPARSER::PROTEIN)
    ("caspase 9" . SPARSER::PROTEIN) ("pH3" . SPARSER::MOLECULE)
    ("insulin-like growth factor binding protein" . SPARSER::PROTEIN)
    ("Klf12" . SPARSER::PROTEIN) ("HOXA10" . SPARSER::PROTEIN)
    ("MPP2" . SPARSER::PROTEIN) ("HFH-11" . SPARSER::PROTEIN)
    ("HNF-3" . SPARSER::PROTEIN) ("Forkhead Box M1" . SPARSER::PROTEIN)
    ("miRNAs, miR-223-3p, miR-19a-3p, miR-128-3p, miR-130b-3p, miR-34a-5p and miR-124-3p"
     . SPARSER::COLLECTION)
    ("Sucrose" . SPARSER::MOLECULE)
    ("intestinal gastric subtypes" . SPARSER::PROTEIN)
    ("sporadic GC" . SPARSER::PROTEIN)
    ("hereditary diffuse GC" . SPARSER::PROTEIN)
    ("ARID1A, CDH1, cMET and PIK3CA" . SPARSER::COLLECTION)
    ("the lipid kinase PIK3CA and the P53 tumor-suppressor gene"
     . SPARSER::COLLECTION)
    ("ARID1A , MLL3 and MLL" . SPARSER::COLLECTION)
    ("CDH1 , cMET and PIK3CA" . SPARSER::COLLECTION)
    ("a unique component" . SPARSER::COMPONENT) ("KMO" . SPARSER::PROTEIN)
    ("c-MET and PIK3CA" . SPARSER::COLLECTION)
    ("ARID1A, CDH1, c-MET and PIK3CA" . SPARSER::COLLECTION)
    ("MET , FGFR1 , MYC and CDH1" . SPARSER::COLLECTION)
    ("TP53 , PIK3CA , ERBB2 , ERBB3 , ARID1A and KRAS" . SPARSER::COLLECTION)
    ("cMET and PIK3CA" . SPARSER::COLLECTION)
    ("ARID1A, cMET and PIK3CA" . SPARSER::COLLECTION)
    ("ARID1A , CDH1 , cMET and PIK3CA" . SPARSER::COLLECTION)
    ("v19" . SPARSER::PROTEIN) ("TBS 1" . SPARSER::PROTEIN)
    ("growth hormone" . SPARSER::PROTEIN) ("p26" . SPARSER::PROTEIN)
    ("FAT4" . SPARSER::PROTEIN) ("MLL3" . SPARSER::PROTEIN)
    ("miR-221-3p" . SPARSER::MOLECULE) ("c-MET" . SPARSER::PROTEIN)
    ("ARID1A" . SPARSER::PROTEIN)
    ("phosphatidylinositol-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("bispecific antibodies" . SPARSER::ANTIBODY) ("azide" . SPARSER::MOLECULE)
    ("CD80 and CD86 receptors as well as IGF1R" . SPARSER::COLLECTION)
    ("a fluorescence‐labeled secondary antibody" . SPARSER::PROTEIN)
    ("a multiplex mixture" . SPARSER::MOLECULE)
    ("an immunoinhibitory molecule" . SPARSER::MOLECULE)
    ("a competitive anti‐IGF1R antibody" . SPARSER::ANTIBODY)
    ("using fluorescence‐labeled anti‐receptor detection reagents or a fluorescence‐labeled drug"
     . SPARSER::COLLECTION)
    ("antibodies or multi" . SPARSER::COLLECTION)
    ("anti‐receptor competitive antibodies" . SPARSER::ANTIBODY)
    ("CD80/CD86" . SPARSER::COLLECTION) ("‐PB/anti" . SPARSER::COLLECTION)
    ("IgG or anti‐CD86" . SPARSER::COLLECTION)
    ("IgG, anti‐CD80, anti‐CD86, or CTLA4‐Ig" . SPARSER::COLLECTION)
    ("CTLA4 and the Fc fragment" . SPARSER::COLLECTION)
    ("abatacept" . SPARSER::DRUG)
    ("Receptors, CD80 and CD86" . SPARSER::COLLECTION)
    ("ADA" . SPARSER::PROTEIN) ("max" . SPARSER::PROTEIN)
    ("spiked" . SPARSER::PROTEIN)
    ("the respective blocking reagents" . SPARSER::MOLECULE)
    ("soluble EGFR" . SPARSER::PROTEIN) ("scFv" . SPARSER::PROTEIN)
    ("EGFR and IGF1R" . SPARSER::COLLECTION)
    ("IGF1R and EGFR" . SPARSER::COLLECTION) ("Receptors" . SPARSER::PROTEIN)
    ("reliable and accurate RO" . SPARSER::PROTEIN)
    ("CTLA4 or PD‐1" . SPARSER::COLLECTION)
    ("antibodies and multi" . SPARSER::COLLECTION)
    ("assay reagents and determination" . SPARSER::COLLECTION)
    ("receptors and CD" . SPARSER::COLLECTION) ("Part" . SPARSER::COMPONENT)
    ("Cytometry" . SPARSER::PROTEIN) ("CD80 and CD86" . SPARSER::COLLECTION)
    ("Bs" . SPARSER::PROTEIN)
    ("pharmacodynamic (PD) biomarkers" . SPARSER::MOLECULE)
    ("target cell" . SPARSER::PROTEIN) ("CD86" . SPARSER::PROTEIN)
    ("CD80" . SPARSER::PROTEIN) ("bispecific antibody" . SPARSER::DRUG)
    ("SF3B1 and U2AF1" . SPARSER::COLLECTION)
    ("Components" . SPARSER::COMPONENT) ("oncogene (MYC)" . SPARSER::ONCOGENE)
    ("100,000 randomly drawn gene" . SPARSER::GENE) ("prep" . SPARSER::PROTEIN)
    ("core spliceosomal genes" . SPARSER::GENE)
    ("MYC and spliceosome" . SPARSER::COLLECTION)
    ("steady-state cellular mRNA" . SPARSER::PROTEIN)
    ("spliceosome-hypomorphic state" . SPARSER::BIO-STATE)
    ("MYC and BUD31" . SPARSER::COLLECTION) ("Intron" . SPARSER::PROTEIN)
    ("intron" . SPARSER::PROTEIN) ("significantly more IR" . SPARSER::PROTEIN)
    ("the normal and oncogenic MYC" . SPARSER::PROTEIN)
    ("exon-exon" . SPARSER::COLLECTION) ("exon-intron" . SPARSER::COLLECTION)
    ("cellular mRNA" . SPARSER::PROTEIN) ("called SD6" . SPARSER::PROTEIN)
    ("FR" . SPARSER::PROTEIN)
    ("each spliceosomal component" . SPARSER::COMPONENT)
    ("HER2 and EGFR" . SPARSER::COLLECTION)
    ("spliceosomal proteins" . SPARSER::PROTEIN)
    ("binding core spliceosomal proteins" . SPARSER::PROTEIN)
    ("a core spliceosomal protein" . SPARSER::PROTEIN)
    ("U4/U6" . SPARSER::COLLECTION) ("snRNPs" . SPARSER::BIO-COMPLEX)
    ("BUD31 and proteins" . SPARSER::COLLECTION)
    ("proteins (SNRPF)" . SPARSER::PROTEIN) ("SF3A1" . SPARSER::PROTEIN)
    ("SNRPF" . SPARSER::PROTEIN) ("snRNP" . SPARSER::BIO-COMPLEX)
    ("BUD31 and the spliceosome" . SPARSER::COLLECTION)
    ("134 core spliceosomal components" . SPARSER::COMPONENT)
    ("Flag-BUD31" . SPARSER::COLLECTION) ("-shRNA" . SPARSER::COLLECTION)
    ("-shRNAs" . SPARSER::RNA) ("MYC-ER" . SPARSER::COLLECTION)
    ("U2AF1" . SPARSER::PROTEIN) ("SF3B1" . SPARSER::PROTEIN)
    ("macromolecules" . SPARSER::MOLECULE) ("NCOR2" . SPARSER::PROTEIN)
    ("eIF3" . SPARSER::BIO-COMPLEX) ("EIF2S1" . SPARSER::PROTEIN)
    ("RPS8" . SPARSER::PROTEIN) ("B Protein" . SPARSER::PROTEIN)
    ("CL4" . SPARSER::PROTEIN) ("4-OHT" . SPARSER::DRUG)
    ("HME1" . SPARSER::PROTEIN) ("MYC protein" . SPARSER::PROTEIN)
    ("splicing factor" . SPARSER::PROTEIN) ("U4" . SPARSER::PROTEIN)
    ("EFTUD2" . SPARSER::PROTEIN) ("U5" . SPARSER::PROTEIN)
    ("PRPF19" . SPARSER::PROTEIN) ("CDC5L" . SPARSER::PROTEIN)
    ("SF3" . SPARSER::PROTEIN) ("BUD31" . SPARSER::PROTEIN)
    ("menin or WDR5" . SPARSER::COLLECTION)
    ("mll1, mll2 , and moz" . SPARSER::COLLECTION)
    ("actin and gapdh" . SPARSER::COLLECTION)
    ("p21, mdm2 and puma" . SPARSER::COLLECTION)
    ("WDR5/MLL1/RbBP5" . SPARSER::COLLECTION)
    ("the previously reported menin antagonist" . SPARSER::MOLECULE)
    ("p53 and p53" . SPARSER::COLLECTION) ("menin" . SPARSER::PROTEIN)
    ("Menin" . SPARSER::PROTEIN) ("NSG" . SPARSER::PROTEIN-FAMILY)
    ("mll1 or mll2" . SPARSER::COLLECTION)
    ("MLL1 or MLL2" . SPARSER::COLLECTION)
    ("GOF p53 MEFs significantly higher H3K4" . SPARSER::PROTEIN)
    ("hox" . SPARSER::PROTEIN) ("TSS-associated H3K4" . SPARSER::PROTEIN)
    ("p53 or GOF" . SPARSER::COLLECTION) ("MLL1 and MOZ" . SPARSER::COLLECTION)
    ("H3K27ac and H" . SPARSER::COLLECTION)
    ("WT p53 or p53 null MEFs" . SPARSER::PROTEIN)
    ("p53 or p53" . SPARSER::COLLECTION) ("p53 null MEFs" . SPARSER::PROTEIN)
    ("mll1, mll2, and moz" . SPARSER::COLLECTION)
    ("MLL1 and MLL2" . SPARSER::COLLECTION) ("tri" . SPARSER::PROTEIN)
    ("mll1, mll2, or moz" . SPARSER::COLLECTION)
    ("p53 or PolII" . SPARSER::COLLECTION) ("Nutlin" . SPARSER::DRUG)
    ("mll1 , mll2 and moz" . SPARSER::COLLECTION)
    ("MLL, MOZ, and histone" . SPARSER::COLLECTION) ("MLL" . SPARSER::PROTEIN)
    ("GOF p53 or WT p53" . SPARSER::COLLECTION)
    ("mll1 and moz" . SPARSER::COLLECTION)
    ("p21 and mdm2" . SPARSER::COLLECTION)
    ("rbbp5, ogt and ppp1cc" . SPARSER::COLLECTION)
    ("smarcd2 and dcaf10" . SPARSER::COLLECTION) ("smarcd2" . SPARSER::PROTEIN)
    ("ppp1cc" . SPARSER::PROTEIN) ("ogt" . SPARSER::PROTEIN)
    ("mll1 , mll2 , and moz" . SPARSER::COLLECTION)
    ("kat6a" . SPARSER::PROTEIN) ("moz" . SPARSER::PROTEIN)
    ("mdm2 and bbc3" . SPARSER::COLLECTION) ("bbc3" . SPARSER::PROTEIN)
    ("cdkn1a" . SPARSER::PROTEIN) ("puma" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("rbbp5" . SPARSER::PROTEIN) ("mll1 and mll2" . SPARSER::COLLECTION)
    ("kmt2a (mll1) and kmt2d (mll2)" . SPARSER::COLLECTION)
    ("kmt2d" . SPARSER::PROTEIN) ("kmt2a" . SPARSER::PROTEIN)
    ("LFS" . SPARSER::PROTEIN) ("MLL1 , MLL2 , and MOZ" . SPARSER::COLLECTION)
    ("wildtype or p53" . SPARSER::COLLECTION)
    ("the methyltransferases KMT2A ( MLL1 ) and KMT2D ( MLL2 )"
     . SPARSER::COLLECTION)
    ("MOZ or MYST3" . SPARSER::COLLECTION) ("MOZ" . SPARSER::PROTEIN)
    ("methyl-transferases" . SPARSER::PROTEIN)
    ("ETS2 protein" . SPARSER::PROTEIN) ("K14" . SPARSER::PROTEIN)
    ("RbBP5" . SPARSER::PROTEIN) ("ets1" . SPARSER::PROTEIN)
    ("ets2" . SPARSER::PROTEIN) ("dcaf10" . SPARSER::PROTEIN)
    ("ppp1" . SPARSER::PROTEIN-FAMILY) ("mdm2" . SPARSER::PROTEIN)
    ("Set1" . SPARSER::PROTEIN) ("mll2" . SPARSER::PROTEIN)
    ("mll1" . SPARSER::PROTEIN) ("MYST3" . SPARSER::PROTEIN)
    ("KAT6A" . SPARSER::PROTEIN) ("MLL1" . SPARSER::PROTEIN)
    ("KMT2A" . SPARSER::PROTEIN)
    ("mediators and effectors" . SPARSER::COLLECTION)
    ("statin" . SPARSER::MOLECULE) ("viral shRNA" . SPARSER::PROTEIN)
    ("ROCK and LATS" . SPARSER::COLLECTION)
    ("CTGF , Cyr61 and ANKRD1" . SPARSER::COLLECTION)
    ("GPCR-Rho" . SPARSER::COLLECTION)
    ("GTPases and ROCK" . SPARSER::COLLECTION) ("ACs" . SPARSER::PROTEIN)
    ("a common apoptotic inducer" . SPARSER::PROTEIN)
    ("GPR4 and G12/13" . SPARSER::COLLECTION)
    ("GPR4, GPR65 and GPR132" . SPARSER::COLLECTION) ("p-S" . SPARSER::PROTEIN)
    ("GPR132" . SPARSER::PROTEIN) ("GPR68" . SPARSER::PROTEIN)
    ("GPR65" . SPARSER::PROTEIN) ("GPR4" . SPARSER::PROTEIN)
    ("subunit 12" . SPARSER::PROTEIN) ("phenotypic traits" . SPARSER::PROTEIN)
    ("p53-NanogP8" . SPARSER::COLLECTION) ("p53/NanogP8" . SPARSER::COLLECTION)
    ("BMI-1, NanogP8 and TGF-β" . SPARSER::COLLECTION)
    ("castration-tolerant PCa" . SPARSER::PROTEIN)
    ("chemotherapeutic drug Taxotere" . SPARSER::DRUG)
    ("PCa or CRPC" . SPARSER::COLLECTION) ("Taxotere" . SPARSER::DRUG)
    ("the dual PI3K/mTOR inhibitor NVP-BEZ235" . SPARSER::DRUG)
    ("/CD44" . SPARSER::COLLECTION) ("AKT and Bcl-2" . SPARSER::COLLECTION)
    ("newly identified tumor-suppressive microRNAs" . SPARSER::RNA)
    ("Target" . SPARSER::TARGET-PROTEIN) ("AKT/PI3K" . SPARSER::COLLECTION)
    ("dominant-negative h-RAS" . SPARSER::PROTEIN)
    ("RAS/MAPK" . SPARSER::COLLECTION)
    ("Notch1 and its ligand Jagged1" . SPARSER::COLLECTION)
    ("highly metastatic PCa and CRPC" . SPARSER::COLLECTION)
    ("AKT, mTOR and NF-κB" . SPARSER::COLLECTION)
    ("further suggesting ABCG2" . SPARSER::PROTEIN)
    ("ABCG2 and stem cell markers Wnt-1" . SPARSER::COLLECTION)
    ("miscellaneous types" . TYPE)
    ("cytokeratin (CK)" . SPARSER::PROTEIN-FAMILY)
    ("/CK19" . SPARSER::COLLECTION) ("ALDH" . SPARSER::PROTEIN)
    ("APLN" . SPARSER::PROTEIN) ("PSA-negative/low" . SPARSER::PROTEIN-PAIR)
    ("rhodamine" . SPARSER::PROTEIN) ("Anthracycline" . SPARSER::MOLECULE)
    ("mitoxantrone and doxorubicin" . SPARSER::COLLECTION)
    ("NBD" . SPARSER::PROTEIN) ("evidence suggesting CRPC" . SPARSER::PROTEIN)
    ("estrogen and hydroxyflutamide" . SPARSER::COLLECTION)
    ("hydroxyflutamide" . SPARSER::DRUG)
    ("hormone refractory/resistant PCa (HRPC) or endocrine resistant PCa (ERPC)"
     . SPARSER::COLLECTION)
    ("PCa (ERPC)" . SPARSER::PROTEIN) ("PCa (HRPC)" . SPARSER::PROTEIN)
    ("P-glycoprotein and multidrug" . SPARSER::COLLECTION)
    ("Docetaxel" . SPARSER::DRUG) ("mitoxantrone" . SPARSER::DRUG)
    ("estramustine" . SPARSER::DRUG) ("Taxanes" . SPARSER::DRUG)
    ("Taxane" . SPARSER::DRUG) ("microRNAs and PCSCs" . SPARSER::COLLECTION)
    ("miscellaneous microRNAs" . SPARSER::RNA)
    ("aberrant AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("prostate-specific antigen (PSA) and AR" . SPARSER::COLLECTION)
    ("PSA and AR" . SPARSER::COLLECTION) ("EMA" . SPARSER::PROTEIN)
    ("Medicines" . SPARSER::DRUG) ("prednisone" . SPARSER::DRUG)
    ("Mitoxantrone" . SPARSER::DRUG)
    ("genomic non-coding microRNAs and key signaling pathways"
     . SPARSER::COLLECTION)
    ("PCa and CRPC" . SPARSER::COLLECTION) ("BMI-1" . SPARSER::PROTEIN)
    ("NanogP8" . SPARSER::PROTEIN) ("abiraterone acetate" . SPARSER::DRUG)
    ("Du145" . SPARSER::PROTEIN) ("S17" . SPARSER::PROTEIN)
    ("h-RAS" . SPARSER::PROTEIN) ("Wnt-1" . SPARSER::PROTEIN)
    ("Pim-1" . SPARSER::PROTEIN) ("CK5" . SPARSER::PROTEIN)
    ("CK18" . SPARSER::PROTEIN) ("CK19" . SPARSER::PROTEIN)
    ("REV1" . SPARSER::PROTEIN) ("PSME3" . SPARSER::PROTEIN)
    ("ZBTB7" . SPARSER::PROTEIN) ("GSTT2" . SPARSER::PROTEIN)
    ("Anti-androgen" . SPARSER::DRUG) ("the viral miRNAs" . SPARSER::PROTEIN)
    ("LANA and EBNA-1" . SPARSER::COLLECTION)
    ("EBNA-1 and Myc" . SPARSER::COLLECTION)
    ("the EBV EBNA1 protein and the EBV miRNAs" . SPARSER::COLLECTION)
    ("LMP-1 and LMP-2" . SPARSER::COLLECTION) ("WEHI-231" . SPARSER::PROTEIN)
    ("vIRF-3/LANA2" . SPARSER::COLLECTION)
    ("rather various KSHV latent proteins" . SPARSER::PROTEIN)
    ("viral miRNAs" . SPARSER::PROTEIN) ("Myc and Bcl-X" . SPARSER::COLLECTION)
    ("BCR/TLR" . SPARSER::COLLECTION) ("FHIT and WWOX" . SPARSER::COLLECTION)
    ("TLR/MyD88/IRAK" . SPARSER::COLLECTION) ("BCR/PI3K" . SPARSER::COLLECTION)
    ("IRAK" . SPARSER::PROTEIN) ("WWOX" . SPARSER::PROTEIN)
    ("FHIT" . SPARSER::PROTEIN) ("the weak Cα Myc allele" . SPARSER::ALLELE)
    ("lacked discernible GCs" . SPARSER::PROTEIN)
    ("myeloid and erythroid" . SPARSER::COLLECTION)
    ("Lymphoid" . SPARSER::PROTEIN)
    ("Myc and KSHV latent genes" . SPARSER::COLLECTION)
    ("methylcellulose" . SPARSER::DRUG)
    ("Myc and Myc/latency" . SPARSER::COLLECTION)
    ("anti-IgM or anti-CD40" . SPARSER::COLLECTION)
    ("TLR and BCR" . SPARSER::COLLECTION)
    ("anti-IgM, and anti-CD40" . SPARSER::COLLECTION)
    ("the viral latent genes" . SPARSER::GENE)
    ("BCR and Toll-like" . SPARSER::COLLECTION) ("IgM" . SPARSER::PROTEIN)
    ("the KSHV transgene and the Myc transgene" . SPARSER::COLLECTION)
    ("Myc, and Myc/latency" . SPARSER::COLLECTION)
    ("PC and PB" . SPARSER::COLLECTION) ("PB" . SPARSER::PROTEIN)
    ("miRNAs and mRNAs" . SPARSER::COLLECTION)
    ("host Myc and KSHV latent genes" . SPARSER::COLLECTION)
    ("pristane" . SPARSER::DRUG)
    ("its own promoter and Eα enhancer" . SPARSER::COLLECTION)
    ("Histidine" . SPARSER::AMINO-ACID)
    ("the very weak IgH Cα Myc allele" . SPARSER::ALLELE)
    ("LANA and vIRF3" . SPARSER::COLLECTION)
    ("GC and MZ" . SPARSER::COLLECTION) ("all viral miRNAs" . SPARSER::PROTEIN)
    ("all viral micro RNAs" . SPARSER::RNA)
    ("a viral FLICE inhibitory protein" . SPARSER::PROTEIN)
    ("a viral homolog of cellular cyclin D2" . SPARSER::PROTEIN)
    ("vFLIP" . SPARSER::PROTEIN) ("FLICE" . SPARSER::PROTEIN)
    ("LANA" . SPARSER::PROTEIN) ("80 viral genes" . SPARSER::GENE)
    ("overtly symptomatic MCD" . SPARSER::PROTEIN) ("IgH" . SPARSER::PROTEIN)
    ("all micro RNAs" . SPARSER::RNA) ("all viral microRNAs" . SPARSER::RNA)
    ("Class B" . SPARSER::PROTEIN) ("CD23" . SPARSER::PROTEIN)
    ("SP6" . SPARSER::PROTEIN) ("CD21" . SPARSER::PROTEIN)
    ("Fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("EBNA-1" . SPARSER::PROTEIN) ("EBNA1" . SPARSER::PROTEIN)
    ("LMP-2" . SPARSER::PROTEIN) ("LMP-1" . SPARSER::PROTEIN)
    ("LANA2" . SPARSER::PROTEIN) ("vIRF-3" . SPARSER::PROTEIN)
    ("TLR9" . SPARSER::PROTEIN) ("anti-IgM" . SPARSER::PROTEIN)
    ("IgG 3" . SPARSER::BIO-COMPLEX) ("IgG 1" . SPARSER::BIO-COMPLEX)
    ("vIRF3" . SPARSER::PROTEIN) ("LANA-2" . SPARSER::PROTEIN)
    ("v-IRF" . SPARSER::PROTEIN) ("heavy chain" . SPARSER::PROTEIN)
    ("afatinib and cetuximab" . SPARSER::COLLECTION) ("Ib" . SPARSER::DRUG)
    ("the receptor and a TKI" . SPARSER::COLLECTION)
    ("erlotinib or cetuximab" . SPARSER::COLLECTION)
    ("Bosutinib" . SPARSER::DRUG)
    ("erlotinib, bosutinib, or dasatinib" . SPARSER::COLLECTION)
    ("EGFR, Src, Akt and MAPK" . SPARSER::COLLECTION)
    ("cetuximab and saracatinib" . SPARSER::COLLECTION)
    ("cetuximab or cetuximab" . SPARSER::COLLECTION)
    ("cetuximab and the combination" . SPARSER::COLLECTION)
    ("Src and Akt" . SPARSER::COLLECTION) ("dasatanib" . SPARSER::DRUG)
    ("the anti-EGFR drugs erlotinib (Figure xref , xref and xref ) or cetuximab (Figure xref , xref and xref )"
     . SPARSER::COLLECTION)
    ("Src and EGFR" . SPARSER::COLLECTION)
    ("Saracatinib, dasatinib and erlotinib" . SPARSER::COLLECTION)
    ("Saracatinib and dasatinib" . SPARSER::COLLECTION)
    ("Saracatinib" . SPARSER::DRUG)
    ("erlotinib and saracatinib" . SPARSER::COLLECTION)
    ("erlotinib-" . SPARSER::DRUG)
    ("saracatinib or bosutinib" . SPARSER::COLLECTION)
    ("EGFR/Src" . SPARSER::COLLECTION)
    ("saracatinib and/or bosutinib (Figure xref and xref )"
     . SPARSER::COLLECTION)
    ("EGFR and Src" . SPARSER::COLLECTION)
    ("Src, Akt and MAPK" . SPARSER::COLLECTION) ("PC-9" . SPARSER::PROTEIN)
    ("typical EGFR TKIs" . SPARSER::PROTEIN)
    ("saracatinib [ xref , xref ] or dasatinib [ xref ]" . SPARSER::COLLECTION)
    ("saracatinib and dasatinib" . SPARSER::COLLECTION)
    ("MET or HER2" . SPARSER::COLLECTION)
    ("AXL, PI3K or IGF-1R" . SPARSER::COLLECTION)
    ("EGFR or MEK" . SPARSER::COLLECTION) ("EGFR/Ras" . SPARSER::COLLECTION)
    ("saracatinib, dasatinib and bosutinib" . SPARSER::COLLECTION)
    ("bosutinib" . SPARSER::DRUG) ("saracatinib" . SPARSER::DRUG)
    ("P41" . SPARSER::PROTEIN) ("PDB 2" . SPARSER::PROTEIN)
    ("M–1" . SPARSER::PROTEIN) ("H1975" . SPARSER::PROTEIN)
    ("phosphoinositide-3-Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("B-RAF" . SPARSER::PROTEIN) ("PI3K/ATK" . SPARSER::COLLECTION)
    ("AKT, and RY-2f" . SPARSER::COLLECTION)
    ("suppressor and negative regulator" . SPARSER::COLLECTION)
    ("PI3K and AKT" . SPARSER::COLLECTION) ("/mTOR" . SPARSER::COLLECTION)
    ("blot and immunohistochemistry" . SPARSER::COLLECTION)
    ("the pro-apoptotic factor Bad" . SPARSER::PROTEIN)
    ("insulin-stimulated PI3K" . SPARSER::PROTEIN-FAMILY)
    ("external growth factors" . SPARSER::GROWTH-FACTOR)
    ("mTOR and NF-κB" . SPARSER::COLLECTION) ("proto" . SPARSER::PROTEIN)
    ("the pro-apoptotic proteins Bax and Bad" . SPARSER::COLLECTION)
    ("anti- and pro-apoptotic Bcl-2 family proteins" . SPARSER::COLLECTION)
    ("pro-apoptotic Bcl-2 family proteins" . SPARSER::PROTEIN)
    ("anti- and pro-apoptotic proteins" . SPARSER::COLLECTION)
    ("the pro-apoptotic factor Bax" . SPARSER::PROTEIN)
    ("AKT and cyclin" . SPARSER::COLLECTION) ("myr" . SPARSER::MOLECULE)
    ("PI3K p110 α and total AKT" . SPARSER::COLLECTION)
    ("apoptosis-associated proteins" . SPARSER::PROTEIN)
    ("Annexin-V/PI" . SPARSER::COLLECTION)
    ("p21 Cip1 and cyclin B1" . SPARSER::COLLECTION)
    ("cyclin B1 and CDK2" . SPARSER::COLLECTION)
    ("glycitein and genistein" . SPARSER::COLLECTION)
    ("HEY" . SPARSER::PROTEIN-FAMILY)
    ("genistein, glycitein, and daidzein" . SPARSER::COLLECTION)
    ("daidzein" . SPARSER::DRUG) ("glycitein" . SPARSER::DRUG)
    ("genistein" . SPARSER::PROTEIN) ("isoflavones" . SPARSER::MOLECULE)
    ("Isoflavones" . SPARSER::MOLECULE) ("PI3K/ATK/mTOR" . SPARSER::COLLECTION)
    ("platinum-" . SPARSER::MOLECULE)
    ("p21, cyclin B1, Bax, Bad and cleaved-PARP" . SPARSER::COLLECTION)
    ("CDK2 and Bcl-2" . SPARSER::COLLECTION) ("isoflavone" . SPARSER::MOLECULE)
    ("P110α" . SPARSER::PROTEIN)
    ("encoded pro-survive protein Bcl2" . SPARSER::PROTEIN)
    ("hepatocyte growth factor and a tyrosine kinase (receptor-type tyrosine kinase)"
     . SPARSER::COLLECTION)
    ("cyclin D1 and cyclin D2" . SPARSER::COLLECTION)
    ("CCND1 and CCND2" . SPARSER::COLLECTION)
    ("CCND1, CCND2 and MMP-9" . SPARSER::COLLECTION)
    ("oncogenes or tumor suppressors" . SPARSER::COLLECTION)
    ("cyclin D1 and gene" . SPARSER::COLLECTION)
    ("cyclin D1, cyclin D2 and matrix metalloproteinase" . SPARSER::COLLECTION)
    ("MET and Bcl2" . SPARSER::COLLECTION) ("western-blot" . SPARSER::PROTEIN)
    ("annexin/PI" . SPARSER::COLLECTION) ("annexin" . SPARSER::PROTEIN)
    ("bank" . SPARSER::PROTEIN)
    ("DNA damaging and nuclear fragmentation (Fig. xref )"
     . SPARSER::COLLECTION)
    ("miR-206 inhibitor or miR-206 inhibitor NC" . SPARSER::COLLECTION)
    ("cyclin D1 protein (Fig. xref ) and mRNA" . SPARSER::COLLECTION)
    ("CCND2 (Fig. xref ) and MMP-9 (Fig. xref )" . SPARSER::COLLECTION)
    ("c-Met (Fig. xref ) and Bcl2 (Fig. xref ) protein" . SPARSER::COLLECTION)
    ("MET (Fig. xref ) and BCL2 (Fig. xref )" . SPARSER::COLLECTION)
    ("Our western blot" . SPARSER::PROTEIN)
    ("-mut-BCL2–3" . SPARSER::COLLECTION) ("-mut-MET-3" . SPARSER::COLLECTION)
    ("-MET-3" . SPARSER::COLLECTION)
    ("c-Met (Fig. xref ) or Bcl2 (Fig. xref )" . SPARSER::COLLECTION)
    ("MET or BCL2" . SPARSER::COLLECTION)
    ("our western blot" . SPARSER::PROTEIN)
    ("c-Met, Bcl2 and cyclin D1" . SPARSER::COLLECTION)
    ("ang" . SPARSER::PROTEIN) ("MET and BCL2" . SPARSER::COLLECTION)
    ("MMP-9, CCND1 and CCND2" . SPARSER::COLLECTION)
    ("subsequent Western blot" . SPARSER::PROTEIN)
    ("c-Met and Bcl2" . SPARSER::COLLECTION) ("Hsa" . SPARSER::PROTEIN)
    ("Ac-DEVD-pNA" . SPARSER::DRUG) ("Kip2" . SPARSER::PROTEIN)
    ("a cell surface-associated fragment" . SPARSER::FRAGMENT)
    ("a relevant molecular target" . SPARSER::TARGET-PROTEIN)
    ("serous component" . SPARSER::COMPONENT)
    ("HER2/Neu" . SPARSER::COLLECTION) ("USPC-ARK-1" . SPARSER::COLLECTION)
    ("USPC-ARK-2" . SPARSER::COLLECTION) ("USPC" . SPARSER::PROTEIN)
    ("HER2/PI3K/mTOR" . SPARSER::COLLECTION)
    ("PIK3CA and ARK-2" . SPARSER::COLLECTION)
    ("c-erbB2 and a wild-type PIK3CA gene" . SPARSER::COLLECTION)
    ("c-erbB2 and a mutated PIK3CA gene" . SPARSER::COLLECTION)
    ("PIK3CA/AKT/mTOR" . SPARSER::COLLECTION)
    ("the Gynecologic Oncology Group" . SPARSER::MOLECULE)
    ("HER1, HER3 and HER4" . SPARSER::COLLECTION)
    ("four transmembrane glycoproteins" . SPARSER::PROTEIN)
    ("erbB1, erbB2, erbB3 and erbB4" . SPARSER::COLLECTION)
    ("erbB4" . SPARSER::PROTEIN) ("erbB2" . SPARSER::PROTEIN)
    ("glycoproteins" . SPARSER::PROTEIN)
    ("States and accounts" . SPARSER::COLLECTION)
    ("HER2 and S6-protein-phosphorylation" . SPARSER::COLLECTION)
    ("-genes" . SPARSER::GENE) ("T-DM1" . SPARSER::PROTEIN)
    ("PI3kinase" . SPARSER::PROTEIN) ("pS6" . SPARSER::PROTEIN)
    ("Ribosomal Protein" . SPARSER::PROTEIN) ("a 20 " . SPARSER::PROTEIN)
    ("ARK-1" . SPARSER::PROTEIN) ("ARK-2" . SPARSER::PROTEIN)
    ("HER4" . SPARSER::PROTEIN) ("HER1" . SPARSER::PROTEIN)
    ("erbB3" . SPARSER::PROTEIN) ("erbB1" . SPARSER::PROTEIN)
    ("a BH3-mimetic drug or vorinostat" . SPARSER::COLLECTION)
    ("drug or vorinostat" . SPARSER::COLLECTION) ("vorinostat" . SPARSER::DRUG)
    ("BH3-mimetic drugs" . SPARSER::DRUG)
    ("group and BIM" . SPARSER::COLLECTION) ("Cis" . SPARSER::PROTEIN)
    ("JK" . SPARSER::PROTEIN)
    ("a common intronic deletion polymorphism" . SPARSER::PROTEIN)
    ("the prognostic biomarkers" . SPARSER::MOLECULE)
    ("potentially c-Rel/c-Rel dimers" . SPARSER::DIMER)
    ("c-Rel/c-Rel" . SPARSER::COLLECTION) ("/p63" . SPARSER::COLLECTION)
    ("/Bcl-2" . SPARSER::COLLECTION) ("p53 and Myc" . SPARSER::COLLECTION)
    ("Myc and p53" . SPARSER::COLLECTION)
    ("Myc, AKT and p53" . SPARSER::COLLECTION)
    ("proapoptotic PUS10 (mapped to 2p) and the tumor suppressor genes CSMD1, KISS1R, NDNL2, TUSC1 and DENND4A (repressing MYC transcription)"
     . SPARSER::COLLECTION)
    ("proapoptotic PUS10" . SPARSER::PROTEIN)
    ("REL, TP53 and TP63" . SPARSER::COLLECTION)
    ("TP63 and p63" . SPARSER::COLLECTION)
    ("KDM5A and MYSM1" . SPARSER::COLLECTION) ("CREBZF" . SPARSER::PROTEIN)
    ("LPIN1 and CKMT1A/B" . SPARSER::COLLECTION) ("CTTN" . SPARSER::PROTEIN)
    ("BCL6, EGR1, AEBP1, C7orf68, CCNG2, CCNI, ILKAP , and PSMG4"
     . SPARSER::COLLECTION)
    ("ILKAP" . SPARSER::PROTEIN) ("CCNK and CCNI" . SPARSER::COLLECTION)
    ("tyrosine kinase, and PSMF1" . SPARSER::COLLECTION)
    ("CCNK" . SPARSER::PROTEIN) ("JUN" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("/p50" . SPARSER::COLLECTION) ("/p65" . SPARSER::COLLECTION)
    ("SIGIRR" . SPARSER::PROTEIN) ("p65 or p50" . SPARSER::COLLECTION)
    ("p50/RelB" . SPARSER::COLLECTION) ("p50/p52" . SPARSER::COLLECTION)
    ("p65/p65" . SPARSER::COLLECTION) ("p50/p50" . SPARSER::COLLECTION)
    ("c-Rel/p65" . SPARSER::COLLECTION) ("c-Rel/p50" . SPARSER::COLLECTION)
    ("BET" . SPARSER::PROTEIN) ("IκBα and NF-κB" . SPARSER::COLLECTION)
    ("antiapoptotic BCL2L1" . SPARSER::PROTEIN)
    ("antiapoptotic CFLAR" . SPARSER::PROTEIN) ("CFLAR" . SPARSER::PROTEIN)
    ("IL1B, IL3, IL6, IL10RA, IL12B, IL12RB1, IL17A, STAT3, JAK1/3, RUNX1/3, CXCR4, PRDM1, TP63 , and CDKN1A"
     . SPARSER::COLLECTION)
    ("IKK2 and IκB" . SPARSER::COLLECTION)
    ("A20 and TNIP1" . SPARSER::COLLECTION)
    ("MALT1, IKK3 and TRAF6" . SPARSER::COLLECTION)
    ("IκB-zeta" . SPARSER::COLLECTION) ("IKK and IκB" . SPARSER::COLLECTION)
    ("IKK2/IKBKB" . SPARSER::COLLECTION) ("IKBKB" . SPARSER::PROTEIN)
    ("A20/TNFAIP3" . SPARSER::COLLECTION)
    ("TLR4 (GCB, P = 0.53; ABC, P = 0.06 for downregulation) and etc ."
     . SPARSER::COLLECTION)
    ("TNFRSF13C (encoding BAFFR) and TLR2" . SPARSER::COLLECTION)
    ("BAFFR" . SPARSER::PROTEIN) ("TNF, MAPK and TLR" . SPARSER::COLLECTION)
    ("TNFRSF" . SPARSER::PROTEIN) ("BAFF" . SPARSER::PROTEIN)
    ("CD79A, CD19, LYN, SYK, CARD11, MALT1, BLNK, BTK , and ZAP70"
     . SPARSER::COLLECTION)
    ("BLNK" . SPARSER::PROTEIN) ("c-Rel and pAKT" . SPARSER::COLLECTION)
    ("c-Rel and Myc" . SPARSER::COLLECTION)
    ("c-Rel and p53" . SPARSER::COLLECTION)
    ("AKT, Myc, and p53" . SPARSER::COLLECTION) ("GEP" . SPARSER::PROTEIN)
    ("IPI" . SPARSER::PROTEIN)
    ("the functionally relevant c-Rel dimers" . SPARSER::DIMER)
    ("Myc or pAKT" . SPARSER::COLLECTION)
    ("c-Rel predominately forms dimers" . SPARSER::DIMER)
    ("NFKB1 and RELA" . SPARSER::COLLECTION)
    ("NFKB2 or RELB" . SPARSER::COLLECTION)
    ("p65 and p52" . SPARSER::COLLECTION)
    ("p50, p52 and RelB" . SPARSER::COLLECTION)
    ("p52 and RelB" . SPARSER::COLLECTION)
    ("NF-κB and TP53" . SPARSER::COLLECTION)
    ("CDKN1A/p21" . SPARSER::COLLECTION) ("ΔNp63α–c-Rel" . SPARSER::COLLECTION)
    ("NF-κB and p63" . SPARSER::COLLECTION)
    ("p53 and NF-κB" . SPARSER::COLLECTION)
    ("BCL2L1, BCL2A1, XIAP, cIAP , and cyclins" . SPARSER::COLLECTION)
    ("BCLXL" . SPARSER::PROTEIN)
    ("c-Rel and other NF-κB subunits" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinases (MAPK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptors (TCR)" . SPARSER::RECEPTOR)
    ("receptors (BCR)" . SPARSER::RECEPTOR) ("p65/c-Rel" . SPARSER::COLLECTION)
    ("p65/p50" . SPARSER::COLLECTION)
    ("the unique regulators" . SPARSER::REGULATOR)
    ("p50/c-Rel" . SPARSER::COLLECTION) ("p50/p65" . SPARSER::COLLECTION)
    ("kappaB" . SPARSER::PROTEIN)
    ("MEG3 and other tumor suppressors" . SPARSER::COLLECTION)
    ("the overall- or germinal center B-like-DLBCL cohort" . SPARSER::MOLECULE)
    ("pAKT and Myc" . SPARSER::COLLECTION)
    ("c-Rel/NF-κB" . SPARSER::COLLECTION) ("CEP2" . SPARSER::PROTEIN)
    ("TUSC1" . SPARSER::PROTEIN) ("NDNL2" . SPARSER::PROTEIN)
    ("KISS1R" . SPARSER::PROTEIN) ("PUS10" . SPARSER::PROTEIN)
    ("TRIM28" . SPARSER::PROTEIN) ("MAGEA3" . SPARSER::PROTEIN)
    ("CRM1" . SPARSER::PROTEIN) ("XPO1" . SPARSER::PROTEIN)
    ("ubiquitin-protein ligase" . SPARSER::PROTEIN)
    ("RNF180" . SPARSER::PROTEIN) ("COMMD1" . SPARSER::PROTEIN)
    ("USP34" . SPARSER::PROTEIN) ("CCT4" . SPARSER::PROTEIN)
    ("BCL2L11" . SPARSER::PROTEIN) ("MYSM1" . SPARSER::PROTEIN)
    ("KDM5A" . SPARSER::PROTEIN) ("NSD1" . SPARSER::PROTEIN)
    ("YME1L1" . SPARSER::PROTEIN) ("CKMT1A" . SPARSER::PROTEIN)
    ("SH3GL1" . SPARSER::PROTEIN) ("FBXO22" . SPARSER::PROTEIN)
    ("PSMG4" . SPARSER::PROTEIN) ("CCNG2" . SPARSER::PROTEIN)
    ("C7orf68" . SPARSER::PROTEIN) ("EGR1" . SPARSER::PROTEIN)
    ("PSMF1" . SPARSER::PROTEIN) ("DDR2" . SPARSER::PROTEIN)
    ("LPIN1" . SPARSER::PROTEIN) ("MYC binding protein" . SPARSER::PROTEIN)
    ("MYCBP2" . SPARSER::PROTEIN) ("PSMG1" . SPARSER::PROTEIN)
    ("SETD6" . SPARSER::PROTEIN) ("Hsp27" . SPARSER::PROTEIN)
    ("HSPB1" . SPARSER::PROTEIN) ("CD40L" . SPARSER::PROTEIN)
    ("TFE3" . SPARSER::PROTEIN) ("RBM5" . SPARSER::PROTEIN)
    ("BRD2" . SPARSER::PROTEIN) ("SDCCAG1" . SPARSER::PROTEIN)
    ("UBA7" . SPARSER::PROTEIN) ("PRDM1" . SPARSER::PROTEIN)
    ("IL17A" . SPARSER::PROTEIN) ("IL12RB1" . SPARSER::PROTEIN)
    ("IL12B" . SPARSER::PROTEIN) ("IL10RA" . SPARSER::PROTEIN)
    ("IL3" . SPARSER::PROTEIN) ("IL1B" . SPARSER::PROTEIN)
    ("PPP2R2A" . SPARSER::PROTEIN) ("PIN1" . SPARSER::PROTEIN)
    ("IKK1" . SPARSER::PROTEIN) ("TNIP1" . SPARSER::PROTEIN)
    ("TLR 1" . SPARSER::PROTEIN) ("TNFRSF13C" . SPARSER::PROTEIN)
    ("MAP3K3" . SPARSER::PROTEIN) ("MAP3K8" . SPARSER::PROTEIN)
    ("TNFSF8" . SPARSER::PROTEIN) ("TNFRSF8" . SPARSER::PROTEIN)
    ("TNFSF11" . SPARSER::PROTEIN) ("MAP3K14" . SPARSER::PROTEIN)
    ("MAP3K7" . SPARSER::PROTEIN) ("ZAP70" . SPARSER::PROTEIN)
    ("CARD11" . SPARSER::PROTEIN) ("CD19" . SPARSER::PROTEIN)
    ("CD79A" . SPARSER::PROTEIN) ("E-5" . SPARSER::PROTEIN)
    ("NFKB1" . SPARSER::PROTEIN) ("ΔNp63α" . SPARSER::PROTEIN)
    ("NFKB2" . SPARSER::PROTEIN) ("BCL2A1" . SPARSER::PROTEIN)
    ("BCL2L1" . SPARSER::PROTEIN) ("tumor-necrosis factor" . SPARSER::PROTEIN)
    ("MALT1" . SPARSER::PROTEIN) ("IκBβ" . SPARSER::PROTEIN)
    ("IκBε" . SPARSER::PROTEIN) ("MEG3" . SPARSER::PROTEIN)
    ("ectopically expressing RNAi-resistant WT Usp16 and its mutants"
     . SPARSER::COLLECTION)
    ("Usp16 and Usp16" . SPARSER::COLLECTION)
    ("both Usp16 and Xenopus Plk1" . SPARSER::COLLECTION)
    ("Plk1 and PBD2A" . SPARSER::COLLECTION)
    ("GFP-fused" . SPARSER::COLLECTION) ("GFP-Usp16" . SPARSER::COLLECTION)
    ("Plk1–Usp16" . SPARSER::COLLECTION)
    ("Usp16 and BubR1" . SPARSER::COLLECTION)
    ("Plk1–BubR1" . SPARSER::COLLECTION)
    ("Plk1 and BubR1" . SPARSER::COLLECTION)
    ("Plk1 and the kinetochore-localized protein BubR1" . SPARSER::COLLECTION)
    ("Usp16 and KLHL22" . SPARSER::COLLECTION)
    ("KLHL22 or CUL3" . SPARSER::COLLECTION)
    ("CUL3 or KLHL22" . SPARSER::COLLECTION)
    ("CUL3 and its adaptor KLHL22" . SPARSER::COLLECTION)
    ("Plk1 and Usp16" . SPARSER::COLLECTION)
    ("endogenous Plk1 and GFP-tagged Usp16" . SPARSER::COLLECTION)
    ("Plk1 and its interacting proteins" . SPARSER::COLLECTION)
    ("an important mitotic regulator" . SPARSER::REGULATOR)
    ("peptidase" . SPARSER::PROTEIN)
    ("mitotic regulator Plk1" . SPARSER::PROTEIN)
    ("CDK1 and Plk1" . SPARSER::COLLECTION) ("B/Cdk1" . SPARSER::PROTEIN)
    ("Hec1" . SPARSER::PROTEIN) ("T-1" . SPARSER::PROTEIN)
    ("C–E" . SPARSER::PROTEIN) ("KLHL22" . SPARSER::PROTEIN)
    ("PBD2" . SPARSER::PROTEIN) ("cullin 3" . SPARSER::PROTEIN)
    ("Usp16" . SPARSER::PROTEIN) ("BRCA1 and PALB2" . SPARSER::COLLECTION)
    ("MSH2 or MLH1" . SPARSER::COLLECTION) ("poisoning" . SPARSER::MOLECULE)
    ("poison" . SPARSER::MOLECULE) ("dNTPs" . SPARSER::MOLECULE)
    ("RAD51-ssDNA" . SPARSER::PROTEIN-PAIR)
    ("NUCKS1 and RAD51" . SPARSER::COLLECTION)
    ("the purified human histone octamer and a 588 bp biotin-labeled dsDNA fragment"
     . SPARSER::COLLECTION)
    ("octamer" . SPARSER::PROTEIN) ("GST-NUCKS1" . SPARSER::COLLECTION)
    ("TPT" . SPARSER::PROTEIN) ("topotecan" . SPARSER::DRUG)
    ("RAD51AP1 or PALB2" . SPARSER::COLLECTION)
    ("fresh medium containing 2 mM HU" . SPARSER::DRUG)
    ("RAD51AP1, BRCA2 and PALB2" . SPARSER::COLLECTION) ("IdU" . SPARSER::DRUG)
    ("pRPA" . SPARSER::PROTEIN) ("RAD51AP1 or XRCC3" . SPARSER::COLLECTION)
    ("chromatin-associated RAD51" . SPARSER::PROTEIN)
    ("RAD51 or RAD51AP1" . SPARSER::COLLECTION)
    ("RAD51AP1 and RAD51" . SPARSER::COLLECTION) ("NUCKS1-" . SPARSER::PROTEIN)
    ("ATM, FANCD2, RAD51AP1, RAD51 or XRCC3" . SPARSER::COLLECTION)
    ("RAD51AP1-" . SPARSER::PROTEIN)
    ("soluble nuclear RAD51" . SPARSER::PROTEIN)
    ("chromatin-associated ATM, FANCD2, MSH2, RAD51AP1, RAD51, XRCC3 and NUCKS1"
     . SPARSER::COLLECTION)
    ("NUCKS1, RAD51AP1 or XRCC3" . SPARSER::COLLECTION)
    ("ATM, FANCD2, MSH2, RAD51AP1, RAD51, XRCC3 and NUCKS1"
     . SPARSER::COLLECTION)
    ("NUCKS1 or RAD51AP1" . SPARSER::COLLECTION)
    ("FANCD2-Ub" . SPARSER::COLLECTION) ("HCA2-hTERT" . SPARSER::COLLECTION)
    ("HCA2" . SPARSER::PROTEIN) ("dNTP" . SPARSER::MOLECULE)
    ("CPT" . SPARSER::PROTEIN) ("RAD51AP1 and NUCKS1" . SPARSER::COLLECTION)
    ("RAD51AP1 and XRCC3" . SPARSER::COLLECTION)
    ("NUCKS1 and RAD51AP1" . SPARSER::COLLECTION)
    ("a substrate of either the ataxia telangiectasia mutated serine/threonine-protein kinase (ATM) or the ataxia telangiectasia and Rad3-related serine/threonine-protein kinase (ATR)"
     . SPARSER::COLLECTION)
    ("the radiomimetic drug neocarzinostatin" . SPARSER::PROTEIN)
    ("serine/threonine-protein kinase (ATR)" . SPARSER::PROTEIN)
    ("serine/threonine-protein kinase (ATM)" . SPARSER::PROTEIN)
    ("neocarzinostatin" . SPARSER::PROTEIN)
    ("kinase and cyclin-dependent kinases" . SPARSER::COLLECTION)
    ("both RAD51 ( xref ) and DMC1 ( xref , xref )" . SPARSER::COLLECTION)
    ("the homologous DNA" . SPARSER::DNA)
    ("RAD51-associated protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a chromatin-associated protein" . SPARSER::PROTEIN)
    ("MMC" . SPARSER::PROTEIN) ("paralogs" . SPARSER::PROTEIN)
    ("kinase and cyclin-dependent kinase" . SPARSER::COLLECTION)
    ("RNF20" . SPARSER::PROTEIN) ("RPA2" . SPARSER::PROTEIN)
    ("chromosomal region 1" . SPARSER::PROTEIN)
    ("RAD51 recombinase" . SPARSER::PROTEIN)
    ("Fanconi Anemia" . SPARSER::PROTEIN) ("30K" . SPARSER::PROTEIN)
    ("NU7026" . SPARSER::DRUG) ("KU60019" . SPARSER::DRUG)
    ("HMGB2" . SPARSER::PROTEIN) ("α-MSH" . SPARSER::PROTEIN)
    ("α-HA" . SPARSER::MOLECULE) ("KU80" . SPARSER::PROTEIN)
    ("FANCD2" . SPARSER::PROTEIN) ("XRCC3" . SPARSER::PROTEIN)
    ("serine/threonine-protein kinase" . SPARSER::PROTEIN)
    ("DMC1" . SPARSER::PROTEIN)
    ("RAD51 associated protein 1" . SPARSER::PROTEIN)
    ("NUCKS1" . SPARSER::PROTEIN)
    ("multiple circadian clock genes" . SPARSER::GENE)
    ("allele and genotype" . SPARSER::COLLECTION)
    ("the PAI-1 promoter and increases PAI-1 expression [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("ARTNL/CLOCK" . SPARSER::COLLECTION) ("PER3/CRY" . SPARSER::COLLECTION)
    ("ARNTL/CLOCK" . SPARSER::COLLECTION) ("CRY" . SPARSER::PROTEIN)
    ("CLOCK" . SPARSER::PROTEIN) ("PER3 and ARNTL" . SPARSER::COLLECTION)
    ("growth factors (HBGF)" . SPARSER::GROWTH-FACTOR)
    ("EXT2 and PAI-1" . SPARSER::COLLECTION) ("sulfate" . SPARSER::MOLECULE)
    ("EXT2 and rs10462021" . SPARSER::COLLECTION)
    ("Angiotensin" . SPARSER::PROTEIN) ("LRC" . SPARSER::BIO-COMPLEX)
    ("complex ( LRC )" . SPARSER::BIO-COMPLEX)
    ("ARSB and PAI-1" . SPARSER::COLLECTION)
    ("a larger amino acid" . SPARSER::AMINO-ACID)
    ("Methionine" . SPARSER::AMINO-ACID)
    ("member 1 (PHLDB1 ) and trehalase (TREH) genes ( PHLDB1/TREH gene region)"
     . SPARSER::COLLECTION)
    ("chromosome 11 containing both the pleckstrin homology-like domain , family B , member 1 (PHLDB1 ) and trehalase (TREH) genes ( PHLDB1/TREH gene region)"
     . SPARSER::COLLECTION)
    ("chromosome 11 containing both the pleckstrin homology-like domain"
     . SPARSER::PROTEIN)
    ("PHLDB1/TREH" . SPARSER::COLLECTION) ("TREH" . SPARSER::PROTEIN)
    ("trehalase" . SPARSER::PROTEIN) ("triglyceride" . SPARSER::MOLECULE)
    ("other biological traits" . SPARSER::PROTEIN)
    ("the PAI-1’s" . SPARSER::PROTEIN)
    ("another circadian clock gene ( ARNTL )" . SPARSER::GENE)
    ("gene ( ARNTL )" . SPARSER::GENE) ("ARNTL" . SPARSER::PROTEIN)
    ("clock" . SPARSER::PROTEIN)
    ("the most clinically relevant part" . SPARSER::COMPONENT)
    ("arylsulfatase B ( ARSB )" . SPARSER::PROTEIN) ("ARSB" . SPARSER::PROTEIN)
    ("peroxiredoxin-1" . SPARSER::PROTEIN) ("PHLDA1" . SPARSER::PROTEIN)
    ("family A" . SPARSER::PROTEIN) ("pleckstrin homology" . SPARSER::PROTEIN)
    ("PLEKHB2" . SPARSER::PROTEIN) ("member 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("aryl hydrocarbon receptor nuclear translocator" . SPARSER::PROTEIN)
    ("HBGF-1" . SPARSER::PROTEIN) ("EXT2" . SPARSER::PROTEIN)
    ("immunoglobulin superfamily" . SPARSER::PROTEIN)
    ("PHLDB1" . SPARSER::PROTEIN) ("member 1" . SPARSER::PROTEIN)
    ("family B" . SPARSER::PROTEIN)
    ("pleckstrin homology-like domain" . SPARSER::PROTEIN)
    ("PAI1" . SPARSER::PROTEIN) ("carboxypeptidase A" . SPARSER::PROTEIN)
    ("LENG9" . SPARSER::PROTEIN)
    ("leukocyte receptor cluster member 9" . SPARSER::PROTEIN)
    ("PER3" . SPARSER::PROTEIN) ("period circadian clock 3" . SPARSER::PROTEIN)
    ("arylsulfatase B" . SPARSER::PROTEIN)
    ("Plasminogen activator inhibitor 1" . SPARSER::PROTEIN)
    ("IL-25 or PD-L1" . SPARSER::COLLECTION)
    ("PD-L1/PD-1" . SPARSER::COLLECTION) ("IL-17A/Th17" . SPARSER::COLLECTION)
    ("nucleotide " . SPARSER::NUCLEOTIDE) ("siPD" . SPARSER::PROTEIN)
    ("a strong inhibitor" . SPARSER::INHIBITOR)
    ("Exogenous IL-25" . SPARSER::PROTEIN)
    ("also known as IL17E and a potent suppressor" . SPARSER::COLLECTION)
    ("IL-25, also known as IL17E and a potent suppressor"
     . SPARSER::COLLECTION)
    ("IL-17A/IFN-γ" . SPARSER::COLLECTION)
    ("anti-CD3/CD28" . SPARSER::COLLECTION) ("Th17" . SPARSER::PROTEIN)
    ("MSC-Th17" . SPARSER::PROTEIN-PAIR) ("MSC" . SPARSER::PROTEIN)
    ("IDO" . SPARSER::PROTEIN) ("chondrocytes" . SPARSER::PROTEIN)
    ("IL-25/STAT3/PD-L1" . SPARSER::COLLECTION)
    ("JNK and STAT3" . SPARSER::COLLECTION) ("IgG2b" . SPARSER::BIO-COMPLEX)
    ("IL-17" . SPARSER::PROTEIN) ("WP1066" . SPARSER::DRUG)
    ("IL-22" . SPARSER::PROTEIN) ("IL17E" . SPARSER::PROTEIN)
    ("Th2" . SPARSER::PROTEIN) ("CD4 " . SPARSER::PROTEIN)
    ("PGE 2" . SPARSER::DRUG) ("prostaglandin E2" . SPARSER::MOLECULE)
    ("indoleamine 2,3-dioxygenase" . SPARSER::PROTEIN)
    ("programmed death ligand-1" . SPARSER::PROTEIN)
    ("IL-17E" . SPARSER::PROTEIN) ("IL-25" . SPARSER::PROTEIN)
    ("interleukin-17A" . SPARSER::PROTEIN)
    ("adducin" . SPARSER::PROTEIN-FAMILY)
    ("possible therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("a methylated MGMT promoter" . SPARSER::PROMOTER)
    ("Only two individual miRNAs" . SPARSER::PROTEIN)
    ("temozolomide (TMZ)" . SPARSER::DRUG)
    ("protective miRNAs" . SPARSER::PROTEIN)
    ("risky and protective miRNAs" . SPARSER::PROTEIN)
    ("risky miRNAs" . SPARSER::PROTEIN) ("Micro (mi)RNAs" . SPARSER::RNA)
    ("-methylguanine DNA methyltransferase" . SPARSER::COLLECTION)
    ("methylguanine DNA methyltransferase" . SPARSER::PROTEIN)
    ("LN18" . SPARSER::PROTEIN) ("Pttg1" . SPARSER::PROTEIN)
    ("the adenomatous polyposis coli (APC) tumor suppressor gene"
     . SPARSER::PROTEIN)
    ("miRNAs/PTTG1/p53" . SPARSER::COLLECTION)
    ("p53 and PTTG1-targeting miRNAs" . SPARSER::COLLECTION)
    ("PTTG1, p53 and PTTG1-targeting miRNAs" . SPARSER::COLLECTION)
    ("intergenic miRNAs" . SPARSER::PROTEIN)
    ("the miRNAs and the PTTG1 mRNA ( xref )" . SPARSER::COLLECTION)
    ("Previously described and predicted PTTG1-targeting miRNAs"
     . SPARSER::PROTEIN)
    ("p53/miRNAs/PTTG1" . SPARSER::COLLECTION) ("PTTG" . SPARSER::PROTEIN)
    ("purine" . SPARSER::DRUG)
    ("miRNAs and other transcriptional activators [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("p53, Sp1, and upstream stimulatory factor 1" . SPARSER::COLLECTION)
    ("-2 and vascular endothelial" . SPARSER::COLLECTION)
    ("hPTTG" . SPARSER::PROTEIN) ("securin" . SPARSER::PROTEIN)
    ("valuable therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("miRNAs, PTTG1 and p53" . SPARSER::COLLECTION)
    ("upstream stimulatory factor 1" . SPARSER::PROTEIN)
    ("fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("cells perceive un-phosphorylated BRCA1" . SPARSER::PROTEIN)
    ("RAP80 or Abraxas" . SPARSER::COLLECTION)
    ("BACH1 and CtIP" . SPARSER::COLLECTION)
    ("a triple SQ-cluster BRCA1 mutant" . SPARSER::MUTANT)
    ("hypo-phosphorylated BRCA1" . SPARSER::PROTEIN)
    ("BRCA1 SQ-sites" . SPARSER::MOLECULE)
    ("RAD51 and RPA" . SPARSER::COLLECTION) ("SQ-sites" . SPARSER::MOLECULE)
    ("BRCA1-complemented" . SPARSER::COLLECTION)
    ("the entire SQ-cluster" . SPARSER::MOLECULE) ("ICL" . SPARSER::PROTEIN)
    ("the SQ-cluster ( xref )" . SPARSER::MOLECULE)
    ("PALB2-BRCA1" . SPARSER::COLLECTION)
    ("a S1387/1423A double mutant (BRCA1 2P ) as well as a S1387/1423/1457/1524A quadruple mutant (BRCA1 4P )"
     . SPARSER::COLLECTION)
    ("DR" . SPARSER::MOLECULE) ("the BRCA1 SQ-cluster" . SPARSER::MOLECULE)
    ("BRCA1 SQ-cluster" . SPARSER::MOLECULE) ("ATM-" . SPARSER::PROTEIN)
    ("a serine- and threonine-rich region which is phosphorylated by the ataxia telangiectasia mutated (ATM)"
     . SPARSER::COLLECTION)
    ("RAD3-related (ATR) kinases" . SPARSER::KINASE)
    ("ataxia telangiectasia mutated (ATM)" . SPARSER::PROTEIN)
    ("BRCA1, BRCA2, and RAD51" . SPARSER::COLLECTION)
    ("CtIP" . SPARSER::PROTEIN) ("BRCA1 and RAP80" . SPARSER::COLLECTION)
    ("Abraxas" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("At least three distinct BRCA1 protein" . SPARSER::PROTEIN)
    ("the SQ-cluster known to be phosphorylated by ATM and ATR result"
     . SPARSER::MOLECULE)
    ("the SQ-cluster" . SPARSER::MOLECULE)
    ("ATM and ATR" . SPARSER::COLLECTION) ("SQ-cluster" . SPARSER::MOLECULE)
    ("serine-glutamine (SQ)" . SPARSER::COLLECTION)
    ("serine-glutamine" . SPARSER::COLLECTION) ("SQ" . SPARSER::MOLECULE)
    ("Dna2" . SPARSER::PROTEIN) ("Exo1" . SPARSER::PROTEIN)
    ("CHK1" . SPARSER::PROTEIN) ("Mitomycin C" . SPARSER::DRUG)
    ("mitomycin C" . SPARSER::DRUG) ("CHK2" . SPARSER::PROTEIN)
    ("RAP80" . SPARSER::PROTEIN) ("BARD1" . SPARSER::PROTEIN)
    ("BRCA1-associated protein" . SPARSER::PROTEIN)
    ("PALB2" . SPARSER::PROTEIN) ("RUNX2 and sE-Cad" . SPARSER::COLLECTION)
    ("TAZ and HER2" . SPARSER::COLLECTION)
    ("both full-length E-Cadherin and the sE-Cad ectodomain"
     . SPARSER::COLLECTION)
    ("MMP and matrix" . SPARSER::COLLECTION)
    ("MMP11, MMP12, and MMP16" . SPARSER::COLLECTION)
    ("a classic EMT" . SPARSER::PROTEIN)
    ("E-Cadherin and ER" . SPARSER::COLLECTION)
    ("TEAD or p73" . SPARSER::COLLECTION)
    ("an active oncogene" . SPARSER::ONCOGENE)
    ("the transcriptional cofactor" . SPARSER::MOLECULE)
    ("soluble E-Cadherin" . SPARSER::PROTEIN)
    ("HER2 and sE-Cad" . SPARSER::COLLECTION)
    ("functional HER2" . SPARSER::PROTEIN)
    ("TGFβ and IgG" . SPARSER::COLLECTION)
    ("E-Cadherin and sE-Cad" . SPARSER::COLLECTION)
    ("Phenanthroline" . SPARSER::MOLECULE)
    ("laminin and collagen" . SPARSER::COLLECTION)
    ("thrombospondin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("laminin" . SPARSER::PROTEIN)
    ("MMP11, MMP12, MMP16, and ADAMTS8" . SPARSER::COLLECTION)
    ("numerous MMP genes and extracellular matrix molecules [ xref ]"
     . SPARSER::COLLECTION)
    ("-chelator" . SPARSER::MOLECULE) ("sE-Cadherin" . SPARSER::COLLECTION)
    ("Cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("N-Cadherin and Vimentin" . SPARSER::COLLECTION)
    ("Vimentin" . SPARSER::PROTEIN)
    ("scrambled siRNA or three specific siRNAs" . SPARSER::COLLECTION)
    ("RUNX2 and TAZ" . SPARSER::COLLECTION)
    ("important RUNX2 transcriptional cofactors" . SPARSER::PROTEIN)
    ("RUNX2:TAZ" . SPARSER::BIO-COMPLEX)
    ("a functional metastatic biomarker" . SPARSER::MOLECULE)
    ("MMPs and ADAM" . SPARSER::COLLECTION) ("ADAM" . SPARSER::PROTEIN)
    ("Disintegrin and Metalloproteinase" . SPARSER::COLLECTION)
    ("MMP2, MMP9, and ADAM15" . SPARSER::COLLECTION)
    ("ADAMs" . SPARSER::PROTEIN) ("Metalloproteinase" . SPARSER::PROTEIN)
    ("Disintegrin" . SPARSER::PROTEIN)
    ("an ectodomain soluble oncogenic fragment" . SPARSER::FRAGMENT)
    ("TAZ and RUNX2" . SPARSER::COLLECTION) ("TGFβ/Smad" . SPARSER::COLLECTION)
    ("osteopontin, MMPs, and VEGF" . SPARSER::COLLECTION)
    ("osteopontin" . SPARSER::PROTEIN)
    ("TAZ, sE-Cad, and HER2" . SPARSER::COLLECTION)
    ("Herceptin and lapatinib" . SPARSER::COLLECTION)
    ("antibodies or TAZ" . SPARSER::COLLECTION)
    ("an oncogenic soluble E-Cadherin fragment" . SPARSER::FRAGMENT)
    ("RUNX2/TAZ" . SPARSER::COLLECTION) ("sE" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NO 3" . SPARSER::PROTEIN) ("Cl 2" . SPARSER::PROTEIN)
    ("L27A" . SPARSER::PROTEIN) ("ER-α" . SPARSER::PROTEIN)
    ("ADAMTS8" . SPARSER::PROTEIN) ("MMP16" . SPARSER::PROTEIN)
    ("MMP12" . SPARSER::PROTEIN) ("MMP11" . SPARSER::PROTEIN)
    ("N-Cadherin" . SPARSER::PROTEIN) ("ADAM15" . SPARSER::PROTEIN)
    ("E-Cadherin" . SPARSER::PROTEIN)
    ("EGFR and HGF/MET tyrosine-kinase inhibitors" . SPARSER::COLLECTION)
    ("MET or its ligand" . SPARSER::COLLECTION)
    ("MET, or antibody" . SPARSER::COLLECTION)
    ("MET and EGFR" . SPARSER::COLLECTION)
    ("the ligand HGF [ xref ] or the MET receptor kinase"
     . SPARSER::COLLECTION)
    ("another transmembrane tyrosine-kinase receptor" . SPARSER::PROTEIN)
    ("STAT3, and PLCγ" . SPARSER::COLLECTION) ("Biomarker" . SPARSER::MOLECULE)
    ("group and 15 (62 %)" . SPARSER::COLLECTION)
    ("-EGFR" . SPARSER::COLLECTION) ("anti-HGF/MET" . SPARSER::COLLECTION)
    ("foretinib" . SPARSER::DRUG) ("ficlatuzumab" . SPARSER::DRUG)
    ("rilotumumab" . SPARSER::DRUG) ("MET and HGF" . SPARSER::COLLECTION)
    ("hepatocyte growth factor (HGF)" . SPARSER::PROTEIN)
    ("specific biological drugs" . SPARSER::DRUG)
    ("target growth factors and their receptors" . SPARSER::COLLECTION)
    ("p-MET" . SPARSER::COLLECTION) ("HGF and MET" . SPARSER::COLLECTION)
    ("tyrosine-kinase receptor" . SPARSER::PROTEIN)
    ("alpha-" . SPARSER::PROTEIN) ("ATP5E" . SPARSER::PROTEIN)
    ("HC2" . SPARSER::PROTEIN) ("phospho-tyrosines" . SPARSER::MOLECULE)
    ("IgG2" . SPARSER::BIO-COMPLEX)
    ("directly target NF-κB" . SPARSER::PROTEIN) ("oxidase" . SPARSER::PROTEIN)
    ("a very classical NF-κB" . SPARSER::PROTEIN)
    ("NF-κB and YBX1" . SPARSER::COLLECTION) ("P65/P50" . SPARSER::COLLECTION)
    ("CKII" . SPARSER::PROTEIN) ("YBX1 and P65" . SPARSER::COLLECTION)
    ("both Flag-tagged YBX1 and endogenous P65" . SPARSER::COLLECTION)
    ("a pleiotropic cytokine" . SPARSER::PROTEIN)
    ("fructose and mannose" . SPARSER::COLLECTION)
    ("TRIM" . SPARSER::HUMAN-PROTEIN-FAMILY) ("OSM" . SPARSER::PROTEIN)
    ("mannose" . SPARSER::MOLECULE) ("ctrl" . SPARSER::PROTEIN)
    ("anti-Flag-antibody" . SPARSER::PROTEIN-PAIR)
    ("YBX1 and NF-κB" . SPARSER::COLLECTION) ("v-REL" . SPARSER::COLLECTION)
    ("REV" . SPARSER::PROTEIN-FAMILY)
    ("inactive IκB-bound complex" . SPARSER::BIO-COMPLEX)
    ("The prototypic NF-κB" . SPARSER::PROTEIN)
    ("p65 and p50" . SPARSER::COLLECTION) ("NF-κB/Rel" . SPARSER::COLLECTION)
    ("RHD" . SPARSER::PROTEIN) ("p50/p105" . SPARSER::COLLECTION)
    ("vinblastine" . SPARSER::DRUG)
    ("many DNA- and mRNA-dependent processes" . SPARSER::COLLECTION)
    ("also known as nuclease-sensitive element-binding protein [NSEP1] or DNA-binding protein B [DBPB]"
     . SPARSER::COLLECTION)
    ("Y-box binding protein [YBX1], also known as nuclease-sensitive element-binding protein [NSEP1] or DNA-binding protein B [DBPB]"
     . SPARSER::COLLECTION)
    ("DBPB" . SPARSER::PROTEIN) ("nuclease" . SPARSER::PROTEIN)
    ("YBX1 and the important nuclear factor κB [NF-κB]" . SPARSER::COLLECTION)
    ("a multifunctional protein" . SPARSER::PROTEIN)
    ("Colon cancer" . SPARSER::PROTEIN) ("type VII" . SPARSER::PROTEIN)
    ("p5" . SPARSER::HUMAN-PROTEIN-FAMILY) ("P50" . SPARSER::PROTEIN)
    ("TRIM4" . SPARSER::PROTEIN) ("TRIM14" . SPARSER::PROTEIN)
    ("tripartite motif-containing 14" . SPARSER::PROTEIN)
    ("oncostatin M" . SPARSER::PROTEIN)
    ("6-phosphofructo-2-kinase" . SPARSER::PROTEIN)
    ("phosphatidylinositide 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DNA-binding protein B" . SPARSER::PROTEIN) ("NSEP1" . SPARSER::PROTEIN)
    ("YBX1" . SPARSER::PROTEIN) ("cyclin D1-Cdk4" . SPARSER::COLLECTION)
    ("CDKI" . SPARSER::DRUG) ("cyclin E-Cdk2" . SPARSER::COLLECTION)
    ("TRF1 or POT1" . SPARSER::COLLECTION) ("shelterin" . SPARSER::PROTEIN)
    ("pRb/p16 INK4a" . SPARSER::COLLECTION) ("NOK-hTERT" . SPARSER::COLLECTION)
    ("NOK" . SPARSER::PROTEIN)
    ("centrosomes as well as centrosomes" . SPARSER::COLLECTION)
    ("pRB/p16 INK4a" . SPARSER::COLLECTION)
    ("BrdU and propidium" . SPARSER::COLLECTION) ("HU" . SPARSER::DRUG)
    ("Chk2-p53-p21" . SPARSER::COLLECTION) ("finite vHMEC" . SPARSER::PROTEIN)
    ("RPA" . SPARSER::PROTEIN) ("a functional p16 INK4a" . SPARSER::PROTEIN)
    ("cyclin D1/Cdk4/p21" . SPARSER::COLLECTION)
    ("WAF1/CIP1" . SPARSER::COLLECTION) ("cesium" . SPARSER::MOLECULE)
    ("DNA-damage" . SPARSER::DNA) ("telomeric FISH" . SPARSER::PROTEIN)
    ("vHMEC and pre-stasis" . SPARSER::COLLECTION)
    ("mainly MN vHMECs" . SPARSER::PROTEIN)
    ("CEP170/centrin" . SPARSER::COLLECTION)
    ("both MN and BN vHMECs (Table xref )" . SPARSER::COLLECTION)
    ("both MN and BN vHMECs (X 2 , p < 0.05, for both cell lines; Table xref )"
     . SPARSER::COLLECTION)
    ("late passage MEFs" . SPARSER::PROTEIN)
    ("Usually all NEDD1/centrin" . SPARSER::COLLECTION)
    ("MN and BN vHMECs (Table xref and xref )" . SPARSER::COLLECTION)
    ("NEDD1/centrin" . SPARSER::COLLECTION) ("the predominant type" . TYPE)
    ("pericentrin and centrin" . SPARSER::COLLECTION)
    ("the pericentriolar protein rich matrix (PCM)" . SPARSER::PROTEIN-FAMILY)
    ("matrix (PCM)" . SPARSER::PROTEIN-FAMILY)
    ("β-tubulin and pericentrin" . SPARSER::COLLECTION)
    ("pericentrin" . SPARSER::PROTEIN)
    ("supernumerary centrosomes" . SPARSER::PROTEIN) ("MN" . SPARSER::PROTEIN)
    ("vHMEC" . SPARSER::PROTEIN) ("vHMECs" . SPARSER::PROTEIN)
    ("vHMEC-hTERT" . SPARSER::COLLECTION) ("CEP 4" . SPARSER::PROTEIN)
    ("RPA32" . SPARSER::PROTEIN) ("TRF1" . SPARSER::PROTEIN)
    ("Loss of heterozygosity" . SPARSER::PROTEIN) ("n c" . SPARSER::PROTEIN)
    ("NEDD1" . SPARSER::PROTEIN)
    ("chemopreventive biomarkers" . SPARSER::MOLECULE)
    ("dietary pterostilbene" . SPARSER::DRUG)
    ("miRs-17 and -106a" . SPARSER::COLLECTION)
    ("Drosha or other miRNA machinery-related genes" . SPARSER::COLLECTION)
    ("Dicer, Drosha or other miRNA machinery-related genes"
     . SPARSER::COLLECTION)
    ("certain tumor suppressive miRNAs and Argonaute-2" . SPARSER::COLLECTION)
    ("miRNAs and Argonaute-2" . SPARSER::COLLECTION)
    ("the mature miRNAs" . SPARSER::PROTEIN)
    ("commercially available synthetic miRNAs" . SPARSER::PROTEIN)
    ("pre-miRs" . SPARSER::COLLECTION)
    ("miRs-17 and -20a" . SPARSER::COLLECTION)
    ("miRs -17, -20a and -106a" . SPARSER::COLLECTION)
    ("resveratrol and its potent analog pterostilbene" . SPARSER::COLLECTION)
    ("dietary resveratrol" . SPARSER::PROTEIN)
    ("miRs-17 and 106a" . SPARSER::COLLECTION) ("sera" . SPARSER::PROTEIN)
    ("normal cohort" . SPARSER::MOLECULE) ("Pterostilbene" . SPARSER::DRUG)
    ("PTEN mRNA (Figure xref ) and protein (Figure xref )"
     . SPARSER::COLLECTION)
    ("DU145-Luc" . SPARSER::COLLECTION)
    ("resveratrol or pterostilbene" . SPARSER::COLLECTION)
    ("all three miRs (GCACTTT) or its mutant (mut) form (GGAGTAT)"
     . SPARSER::COLLECTION)
    ("form (GGAGTAT)" . SPARSER::FORM) ("miRs (GCACTTT)" . SPARSER::PROTEIN)
    ("miRs-17, -20a and -106b" . SPARSER::COLLECTION)
    ("Resveratrol and pterostilbene" . SPARSER::COLLECTION)
    ("miRs -17 or -20a or -106b" . SPARSER::COLLECTION)
    ("both resveratrol and its natural analog pterostilbene"
     . SPARSER::COLLECTION)
    ("miRs-17, -20a, -106a and -106b" . SPARSER::COLLECTION)
    ("Diana-microT-CDS" . SPARSER::COLLECTION) ("CDS" . SPARSER::PROTEIN)
    ("b, miR-106a and b" . SPARSER::COLLECTION)
    ("LNCaP and DU145" . SPARSER::COLLECTION)
    ("Dietary stilbenes" . SPARSER::MOLECULE) ("Pter" . SPARSER::PROTEIN)
    ("make miRNAs incomparable potential biomarkers" . SPARSER::MOLECULE)
    ("posttranscriptional regulators" . SPARSER::REGULATOR)
    ("potential chemopreventive and predictive biomarkers" . SPARSER::MOLECULE)
    ("miR-20a and miR-106b directly target PTEN" . SPARSER::PROTEIN)
    ("dietary stilbenes" . SPARSER::MOLECULE)
    ("resveratrol and pterostilbene" . SPARSER::COLLECTION)
    ("pterostilbene" . SPARSER::DRUG) ("stilbenes" . SPARSER::MOLECULE)
    ("dual- luciferase" . SPARSER::PROTEIN) ("Ago-2" . SPARSER::PROTEIN)
    ("Argonaute-2" . SPARSER::PROTEIN) ("miRs -17" . SPARSER::PROTEIN)
    ("miRs-17" . SPARSER::PROTEIN)
    ("Phosphatase and Tensin homolog" . SPARSER::PROTEIN)
    ("CBP and their co-anchoring" . SPARSER::COLLECTION)
    ("p53, p73, and E2F" . SPARSER::COLLECTION)
    ("histones and other transcription proteins [ xref ]"
     . SPARSER::COLLECTION)
    ("SP-1 and AP-2" . SPARSER::COLLECTION)
    ("proteins and co-factors" . SPARSER::COLLECTION)
    ("PIC" . SPARSER::BIO-COMPLEX) ("siRNA, or RFPL3" . SPARSER::COLLECTION)
    ("siRNA and hTERT" . SPARSER::COLLECTION)
    ("hTERT promoter-driven luciferase" . SPARSER::PROTEIN)
    ("CBP, RFPL3 and hTERT" . SPARSER::COLLECTION)
    ("using anti-RFPL3 antibody or the non-specific IgG control protein"
     . SPARSER::COLLECTION)
    ("CBP and RFPL3" . SPARSER::COLLECTION) ("HLF" . SPARSER::PROTEIN)
    ("RFPL3 or CBP" . SPARSER::COLLECTION)
    ("RFPL3, CBP and hTERT" . SPARSER::COLLECTION)
    ("histones and other regulatory proteins [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("whose CBP and p300 proteins" . SPARSER::PROTEIN)
    ("CBP and p300" . SPARSER::COLLECTION) ("CtBP" . SPARSER::PROTEIN)
    ("RFPL3/CBP/hTERT" . SPARSER::COLLECTION)
    ("RFPL3 protein and their co-anchoring" . SPARSER::COLLECTION)
    ("RFPL3 and CBP" . SPARSER::COLLECTION)
    ("streptavidin-agarose" . SPARSER::DRUG)
    ("Streptavidin-agarose" . SPARSER::DRUG) ("c646" . SPARSER::MOLECULE)
    ("acetyltransferase activity" . SPARSER::PROTEIN)
    ("RFPL1" . SPARSER::PROTEIN) ("RFPL 1" . SPARSER::PROTEIN)
    ("C646" . SPARSER::MOLECULE) ("activator protein-1" . SPARSER::PROTEIN)
    ("ribonucleoprotein complex" . SPARSER::BIO-COMPLEX)
    ("RFPL3" . SPARSER::PROTEIN)
    ("lipid and androgen biosynthesis" . SPARSER::COLLECTION)
    ("c-Myc and AR" . SPARSER::COLLECTION)
    ("c-Myc, AP-1, and STAT3" . SPARSER::COLLECTION)
    ("AR and other transcription factor genes" . SPARSER::COLLECTION)
    ("the AR-driven genes" . SPARSER::GENE)
    ("c-Myc, STATs, NFκB, ETV1, and ERG" . SPARSER::COLLECTION)
    ("ERG" . SPARSER::PROTEIN) ("Proteins" . SPARSER::PROTEIN)
    ("membrane proteins (ABCB1, ABCB6, ABCG2, FGFR2, TMPRSS15) and chromatin protein (H1F0)"
     . SPARSER::COLLECTION)
    ("further driver genes" . SPARSER::GENE)
    ("the typical marker gene" . SPARSER::GENE)
    ("taxol or Wortmannin" . SPARSER::COLLECTION)
    ("pAKT and AR" . SPARSER::COLLECTION)
    ("Wortmannin and SP600125" . SPARSER::COLLECTION)
    ("AKT and p38" . SPARSER::COLLECTION)
    ("TMPRSS15 and SRCRB4D" . SPARSER::COLLECTION)
    ("AR, C/EBP, ERα, HNF4-α, c-Myc, and SP1" . SPARSER::COLLECTION)
    ("AP1/c-Jun" . SPARSER::COLLECTION) ("FKBP5/AR" . SPARSER::COLLECTION)
    ("gadd45a and cds1" . SPARSER::COLLECTION)
    ("ABCG2 and ABCB6" . SPARSER::COLLECTION)
    ("194 upregulated genes and 1" . SPARSER::COLLECTION)
    ("c-PARP" . SPARSER::COLLECTION)
    ("taxol and vincristine" . SPARSER::COLLECTION)
    ("both taxol (Fig. xref ) and vincristine (Fig. xref )"
     . SPARSER::COLLECTION)
    ("various chemotherapeutic drugs" . SPARSER::DRUG)
    ("the identified driver genes and downstream target genes"
     . SPARSER::COLLECTION)
    ("a palindromic response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("androgen/glucocorticoid" . SPARSER::COLLECTION)
    ("-AGAACA-3" . SPARSER::COLLECTION)
    ("TGF-β1 and TGF-β2" . SPARSER::COLLECTION)
    ("microtubule-associated proteins" . SPARSER::PROTEIN)
    ("tau, stathmin, and MAP4" . SPARSER::COLLECTION)
    ("stathmin" . SPARSER::PROTEIN) ("MAPs" . SPARSER::PROTEIN)
    ("no valid biomarkers" . SPARSER::MOLECULE)
    ("MDR-1/P-gp" . SPARSER::COLLECTION)
    ("BRCA1 and the spindle assembly checkpoint proteins MAD2"
     . SPARSER::COLLECTION)
    ("This chemotherapeutic drug" . SPARSER::DRUG)
    ("At least 10 additional ABC proteins" . SPARSER::PROTEIN)
    ("around 20 different cytostatic drugs" . SPARSER::DRUG)
    ("multidrug resistance protein 1, or MDR1" . SPARSER::COLLECTION)
    ("ATP-binding cassette (ABC)" . SPARSER::PROTEIN)
    ("The taxanes paclitaxel (taxol) and docetaxel" . SPARSER::COLLECTION)
    ("AKT and JNK" . SPARSER::COLLECTION)
    ("abcb1, abcb6, abcg2, bmp5, fat3, fgfr2, h1f0, srcrb4d, and tmprss15"
     . SPARSER::COLLECTION)
    ("h1f0" . SPARSER::PROTEIN) ("fgfr2" . SPARSER::PROTEIN)
    ("abcb6" . SPARSER::PROTEIN) ("bmp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("The androgen receptor (AR) and its target genes" . SPARSER::COLLECTION)
    ("c-Myc, and SP-1" . SPARSER::COLLECTION)
    ("c-Jun/AP-1" . SPARSER::COLLECTION) ("FOXA1" . SPARSER::PROTEIN)
    ("PPAR-gamma" . SPARSER::PROTEIN) ("cds1" . SPARSER::PROTEIN)
    ("gadd45a" . SPARSER::PROTEIN) ("TMPRSS15" . SPARSER::PROTEIN)
    ("SRCRB4D" . SPARSER::PROTEIN) ("H1F0" . SPARSER::PROTEIN)
    ("FAT3" . SPARSER::PROTEIN) ("ABCB6" . SPARSER::PROTEIN)
    ("BMP5" . SPARSER::PROTEIN) ("glucocorticoid receptor" . SPARSER::PROTEIN)
    ("TGF-β2" . SPARSER::PROTEIN)
    ("transforming growth factor-beta" . SPARSER::PROTEIN)
    ("prostate-specific antigen" . SPARSER::PROTEIN)
    ("MAP4" . SPARSER::PROTEIN) ("MDR-1" . SPARSER::PROTEIN)
    ("BUBR1" . SPARSER::PROTEIN)
    ("multidrug resistance protein 1" . SPARSER::PROTEIN)
    ("P-gp" . SPARSER::PROTEIN) ("ATP-binding cassette" . SPARSER::PROTEIN)
    ("tmprss15" . SPARSER::PROTEIN) ("srcrb4d" . SPARSER::PROTEIN)
    ("fat3" . SPARSER::PROTEIN) ("abcg2" . SPARSER::PROTEIN)
    ("abcb1" . SPARSER::PROTEIN) ("HNF4" . SPARSER::PROTEIN)
    ("SP-1" . SPARSER::PROTEIN) ("C/EBPβ" . SPARSER::PROTEIN)
    ("proteins and VTRNA2-1-5p" . SPARSER::COLLECTION)
    ("p21, p14, MDM2, Bax and BcL-2" . SPARSER::COLLECTION)
    ("Bax [ xref ] and p14 ARF" . SPARSER::COLLECTION)
    ("FLp53, p53β, p53γ, and Δ40p53" . SPARSER::COLLECTION)
    ("FLp" . SPARSER::PROTEIN)
    ("p53, p53β, p53γ, Δ133p53α, Δ133p53β, and Δ133p53γ" . SPARSER::COLLECTION)
    ("Isoforms" . SPARSER::ISOFORM)
    ("strong p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a classic pro-apoptotic molecule" . SPARSER::MOLECULE)
    ("the mature form" . SPARSER::FORM) ("dsRNAs" . SPARSER::RNA)
    ("Fas and proapoptotic Bax [ xref ]" . SPARSER::COLLECTION)
    ("proapoptotic Bax" . SPARSER::PROTEIN) ("dsRNA" . SPARSER::RNA)
    ("ncRNA" . SPARSER::RNA) ("hvg-2" . SPARSER::COLLECTION)
    ("hvg-1" . SPARSER::COLLECTION) ("regular miRNA" . SPARSER::PROTEIN)
    ("mature forms" . SPARSER::FORM) ("the AGO2-associated RNA" . SPARSER::RNA)
    ("the AGO2-associated RNAs" . SPARSER::RNA)
    ("VTRNA2-1-5p directly targets p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53, p21 , MDM2, Bax and BcL-2" . SPARSER::COLLECTION)
    ("p53, p21 , p14, Bax and BcL-2" . SPARSER::COLLECTION)
    ("MDM2, Bax and BcL-2" . SPARSER::COLLECTION) ("asp" . SPARSER::AMINO-ACID)
    ("p53 and the p53β isoform" . SPARSER::COLLECTION)
    ("p53 and related proteins" . SPARSER::COLLECTION)
    ("a chemotherapeutic drug" . SPARSER::DRUG)
    ("a functional mature miRNA" . SPARSER::PROTEIN)
    ("ZNF785, SLC25A45, LAT2, EGR3 and DMPK" . SPARSER::COLLECTION)
    ("DMPK" . SPARSER::PROTEIN) ("a mature miRNA" . SPARSER::PROTEIN)
    ("18S and 28S ribosomal RNA" . SPARSER::RNA)
    ("their associated mRNAs" . SPARSER::PROTEIN)
    ("Also known as protein 53 or tumor protein 53" . SPARSER::COLLECTION)
    ("proteins, TEP1 and VPARP" . SPARSER::COLLECTION) ("MDa" . SPARSER::DRUG)
    ("RNP" . SPARSER::PROTEIN) ("VTRNA" . SPARSER::RNA)
    ("RNA (VTRNA)" . SPARSER::RNA) ("a canonical miRNA" . SPARSER::PROTEIN)
    ("ligand and repressor" . SPARSER::COLLECTION)
    ("a noncoding RNA instead of a vault RNA" . SPARSER::COLLECTION)
    ("CYP3A4" . SPARSER::PROTEIN) ("AGO2" . SPARSER::PROTEIN)
    ("BcL-2" . SPARSER::PROTEIN) ("p14" . SPARSER::PROTEIN)
    ("p14 ARF" . SPARSER::PROTEIN) ("EGR3" . SPARSER::PROTEIN)
    ("LAT2" . SPARSER::PROTEIN) ("SLC25A45" . SPARSER::PROTEIN)
    ("ZNF785" . SPARSER::PROTEIN) ("AGO 2" . SPARSER::PROTEIN)
    ("S100" . SPARSER::PROTEIN) ("TEP1" . SPARSER::PROTEIN)
    ("protein kinase RNA-activated" . SPARSER::PROTEIN)
    ("CerS6 and ceramide" . SPARSER::COLLECTION)
    ("Fas and downstream signaling molecules" . SPARSER::COLLECTION)
    ("kinase, and caspase-8" . SPARSER::COLLECTION) ("SM" . SPARSER::MOLECULE)
    ("glycosphingolipids" . SPARSER::MOLECULE)
    ("sphingolipids" . SPARSER::MOLECULE)
    ("CerS5 and CerS6" . SPARSER::COLLECTION)
    ("CerS4 and CerS6" . SPARSER::COLLECTION) ("CerS2" . SPARSER::PROTEIN)
    ("Ceramides" . SPARSER::MOLECULE) ("CerS6-shRNA-1" . SPARSER::COLLECTION)
    ("NC-shRNA-3" . SPARSER::COLLECTION) ("NC-shRNA-1" . SPARSER::COLLECTION)
    ("CerS6 and p-p38" . SPARSER::COLLECTION)
    ("CerS6, ceramide, and p-p38" . SPARSER::COLLECTION)
    ("molecules and rafts" . SPARSER::COLLECTION)
    ("annexin-V/PI" . SPARSER::COLLECTION) ("Fas/CD95" . SPARSER::COLLECTION)
    ("CTx" . SPARSER::PROTEIN)
    ("Fas, CerS6, ceramide, and p38" . SPARSER::COLLECTION)
    ("Fas, caspase-8, caspase-9, caspase-3, and CerS6" . SPARSER::COLLECTION)
    ("Fas and its downstream signaling molecules" . SPARSER::COLLECTION)
    ("Fas, CerS6, or ceramide" . SPARSER::COLLECTION)
    ("ERK and JNK" . SPARSER::COLLECTION)
    ("ERK, JNK, and p38" . SPARSER::COLLECTION)
    ("kinase and JNK" . SPARSER::COLLECTION) ("kinase (ERK)" . SPARSER::KINASE)
    ("kinase, and c-Jun" . SPARSER::COLLECTION)
    ("cytochrome c, Smac/DIABLO, and AIF" . SPARSER::COLLECTION)
    ("caspase-9 or caspase-3" . SPARSER::COLLECTION)
    ("nonspecific control siRNA" . SPARSER::PROTEIN)
    ("CerS4 or CerS5" . SPARSER::COLLECTION)
    ("CerS4, CerS5, and CerS6" . SPARSER::COLLECTION)
    ("CerS5" . SPARSER::PROTEIN) ("CerS4" . SPARSER::PROTEIN)
    ("propidium iodide (PI) and FITC-conjugated annexin V"
     . SPARSER::COLLECTION)
    ("Fas and CerS6" . SPARSER::COLLECTION) ("fumonisin" . SPARSER::MOLECULE)
    ("neutral SMase" . SPARSER::PROTEIN) ("SMase" . SPARSER::PROTEIN)
    ("stichoposide" . SPARSER::DRUG) ("stichoposides" . SPARSER::DRUG)
    ("glycosides" . SPARSER::MOLECULE) ("SMases" . SPARSER::PROTEIN)
    ("sphingomyelinases" . SPARSER::PROTEIN)
    ("sphingomyelin" . SPARSER::MOLECULE) ("Ceramide" . SPARSER::MOLECULE)
    ("etoposide or Ara-C" . SPARSER::COLLECTION)
    ("Fas/CerS6/p38" . SPARSER::COLLECTION)
    ("Fas, CerS6, and p38" . SPARSER::COLLECTION) ("nystatin" . SPARSER::DRUG)
    ("CerS6 and p38" . SPARSER::COLLECTION)
    ("ceramide synthase 6 (CerS6) and p38 kinase" . SPARSER::COLLECTION)
    ("Fas (CD95), ceramide synthase 6 (CerS6) and p38 kinase"
     . SPARSER::COLLECTION)
    ("CerS6" . SPARSER::PROTEIN) ("glycoside" . SPARSER::MOLECULE)
    ("triterpene" . SPARSER::MOLECULE) ("Stichoposide" . SPARSER::DRUG)
    ("DiOC 6" . SPARSER::DRUG) ("COX IV" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Smac/DIABLO" . SPARSER::PROTEIN) ("FB1" . SPARSER::PROTEIN)
    ("C2-ceramide" . SPARSER::MOLECULE) ("Ara-C" . SPARSER::DRUG)
    ("β-cyclodextrin" . SPARSER::MOLECULE)
    ("ceramide synthase 6" . SPARSER::PROTEIN)
    ("TGF-β-Smad" . SPARSER::COLLECTION)
    ("Smad" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("N-cadherin and E-cadherin" . SPARSER::COLLECTION)
    ("PDK1-Akt/PKB-TSC2-MTORC1" . SPARSER::COLLECTION)
    ("PDK1 and several AGC kinases" . SPARSER::COLLECTION)
    ("PDK1 and JunB" . SPARSER::COLLECTION)
    ("anti-PDK1, N-cadherin, JunB, and E-cadherin" . SPARSER::COLLECTION)
    ("E-cadherin and FN1" . SPARSER::COLLECTION)
    ("E-cadherin and fibronectin 1" . SPARSER::COLLECTION)
    ("N-cadherin and V-catenin" . SPARSER::COLLECTION)
    ("si-PDK1" . SPARSER::COLLECTION)
    ("B, and PDK1 in mice" . SPARSER::PROTEIN) ("GDC-SD" . SPARSER::COLLECTION)
    ("siRNA-PDK1" . SPARSER::COLLECTION) ("bot" . SPARSER::PROTEIN)
    ("c-Jun and JunB" . SPARSER::COLLECTION)
    ("a strong transcriptional activator" . SPARSER::PROTEIN-FAMILY)
    ("JunB and c-Jun share extensive homology" . SPARSER::PROTEIN)
    ("JunB and c-Jun" . SPARSER::COLLECTION)
    ("Akt2 and PKC-α" . SPARSER::COLLECTION)
    ("Akt1, Akt2, and Akt3" . SPARSER::COLLECTION)
    ("Akt or PKC" . SPARSER::COLLECTION)
    ("transporter (GLUT)" . SPARSER::PROTEIN) ("GLUT" . SPARSER::PROTEIN)
    ("phosphoinositide" . SPARSER::PROTEIN)
    ("Akt and PDK1" . SPARSER::COLLECTION)
    ("protein 3-phosphoinositide-dependent protein kinase 1"
     . SPARSER::COLLECTION)
    ("ARL5A" . SPARSER::PROTEIN) ("MTORC1" . SPARSER::PROTEIN)
    ("chr2" . SPARSER::PROTEIN) ("fibronectin 1" . SPARSER::PROTEIN)
    ("immediate early" . SPARSER::PROTEIN)
    ("phosphoinositide-dependent protein kinase 1" . SPARSER::PROTEIN)
    ("other immunogenic proteins" . SPARSER::PROTEIN)
    ("modulators and aromatase" . SPARSER::COLLECTION)
    ("receptors and aromatase-which" . SPARSER::COLLECTION)
    ("Tamoxifen" . SPARSER::MOLECULE) ("Estradiol" . SPARSER::PROTEIN)
    ("CD74-NRG1" . SPARSER::COLLECTION)
    ("non-mucinous invasive subtypes" . SPARSER::PROTEIN)
    ("EGFR/KRAS" . SPARSER::COLLECTION)
    ("transcription factor-1" . SPARSER::COLLECTION)
    ("different monoclonal antibodies" . SPARSER::ANTIBODY)
    ("tumoral ERα" . SPARSER::PROTEIN)
    ("The two anti-ERα mouse monoclonal antibodies" . SPARSER::ANTIBODY)
    ("EGFR or KRAS" . SPARSER::COLLECTION)
    ("mucinous subtypes" . SPARSER::PROTEIN)
    ("histologic subtypes and sex steroid hormone receptors"
     . SPARSER::COLLECTION)
    ("histologic subtypes" . SPARSER::PROTEIN)
    ("tumoral IL-12Rβ2" . SPARSER::PROTEIN)
    ("tumoral interleukin-7 receptor" . SPARSER::PROTEIN)
    ("ERα, ERβ, and PR" . SPARSER::COLLECTION)
    ("favorable prognostic biomarker" . SPARSER::MOLECULE)
    ("ERα and ERβ" . SPARSER::COLLECTION) ("ERs" . SPARSER::PROTEIN)
    ("the estrogen receptor (ER) and the progesterone receptor (PR)"
     . SPARSER::COLLECTION)
    ("progesterone receptor (PR)" . SPARSER::PROTEIN)
    ("estrogen receptor (ER)" . SPARSER::PROTEIN)
    ("FoxP3/CD3" . SPARSER::COLLECTION) ("CIR" . SPARSER::PROTEIN)
    ("ERα and PR" . SPARSER::COLLECTION) ("NRG1" . SPARSER::PROTEIN)
    ("CD74" . SPARSER::PROTEIN) ("IL-12Rβ2" . SPARSER::PROTEIN)
    ("IL-7R" . SPARSER::PROTEIN) ("interleukin-7 receptor" . SPARSER::PROTEIN)
    ("FoxP3" . SPARSER::PROTEIN) ("forkhead box P3" . SPARSER::PROTEIN)
    ("CD3" . SPARSER::PROTEIN) ("a major cytokine" . SPARSER::PROTEIN)
    ("AP1, NF-кB and Sp1" . SPARSER::COLLECTION)
    ("directly interacting and deacetylating cortactin" . SPARSER::PROTEIN)
    ("histone and non-histone" . SPARSER::COLLECTION)
    ("Cigarette smoke and vehicle exhaust" . SPARSER::COLLECTION)
    ("CFL" . SPARSER::PROTEIN)
    ("TNF-α and Wnt/β-catenin" . SPARSER::COLLECTION)
    ("NF-κB and COX-2" . SPARSER::COLLECTION)
    ("SIRT1-shRNA" . SPARSER::COLLECTION)
    ("SIRT1-luciferase" . SPARSER::COLLECTION)
    ("TNF-α, NF-кB and COX-2" . SPARSER::COLLECTION)
    ("COX-2 and NF-кB" . SPARSER::COLLECTION)
    ("β-catenin-E-cadherin" . SPARSER::COLLECTION)
    ("homologues" . SPARSER::PROTEIN) ("HC" . SPARSER::PROTEIN)
    ("Resveratrol" . SPARSER::PROTEIN) ("PAH" . SPARSER::PROTEIN)
    ("Cigarette" . SPARSER::DRUG) ("TNF-α/β-catenin" . SPARSER::COLLECTION)
    ("TNF-α and β-catenin" . SPARSER::COLLECTION) ("pyrene" . SPARSER::PROTEIN)
    ("Brefeldin A" . SPARSER::MOLECULE)
    ("phenylmethanesulfonyl fluoride" . SPARSER::MOLECULE)
    ("DLL4" . SPARSER::PROTEIN) ("NAD +" . SPARSER::MOLECULE)
    ("NAD-dependent deacetylase sirtuin-1" . SPARSER::PROTEIN)
    ("PI3K/PTEN/TSC2" . SPARSER::COLLECTION)
    ("TSC1-TSC2" . SPARSER::COLLECTION)
    ("PI3K or active" . SPARSER::COLLECTION)
    ("TSC2, TSC1, and TBC1D7" . SPARSER::COLLECTION)
    ("Tuberin" . SPARSER::PROTEIN)
    ("mTOR kinase, its associated protein rector, and SIN1/MIP1 [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("SIN1/MIP1" . SPARSER::COLLECTION)
    ("cyclin D1, cyclin E, and Skp2" . SPARSER::COLLECTION)
    ("p21 Cip1 , p27 Kip1 , p57, p130, Tob1, and FoxO1" . SPARSER::COLLECTION)
    ("Cyclin E/CDK2" . SPARSER::COLLECTION)
    ("Cyclin D and Cdk4 or Cdk6" . SPARSER::COLLECTION)
    ("Cdk4 or Cdk6" . SPARSER::COLLECTION) ("Cyclin-D1" . SPARSER::PROTEIN)
    ("AKT1 or AKT2" . SPARSER::COLLECTION)
    ("TSC1 (Figure xref ) or TSC2 (Figure xref )" . SPARSER::COLLECTION)
    ("BRAF and AKT3" . SPARSER::COLLECTION)
    ("AKT3 and BRAF" . SPARSER::COLLECTION)
    ("PC-3 and LNCaP" . SPARSER::COLLECTION)
    ("B-Raf, TSC1, and TSC2" . SPARSER::COLLECTION)
    ("AKT3 and siRNA" . SPARSER::COLLECTION)
    ("B-Raf, TSC1 and TSC2" . SPARSER::COLLECTION)
    ("TSC1, TSC2, p21 Cip1 and mTOR" . SPARSER::COLLECTION)
    ("B-Raf, and phospho-mTOR" . SPARSER::COLLECTION)
    ("S-phase kinase-associated protein" . SPARSER::PROTEIN)
    ("caffeic acid phenethyl ester (CAPE)" . SPARSER::MOLECULE)
    ("ester (CAPE)" . SPARSER::MOLECULE) ("CAPE" . SPARSER::PROTEIN)
    ("AKT1 and AKT2" . SPARSER::COLLECTION)
    ("AKT1, AKT2, or AKT3" . SPARSER::COLLECTION)
    ("AKT1, AKT2, and AKT3" . SPARSER::COLLECTION)
    ("TSC1 and TSC2" . SPARSER::COLLECTION)
    ("decreased TSC1 (tuberous sclerosis 1) and TSC2 (tuberous Sclerosis Complex 2) proteins"
     . SPARSER::COLLECTION)
    ("Complex" . SPARSER::BIO-COMPLEX) ("S21" . SPARSER::PROTEIN)
    ("GSK-3α" . SPARSER::PROTEIN) ("TBC1D7" . SPARSER::PROTEIN)
    ("MIP1" . SPARSER::PROTEIN) ("SIN1" . SPARSER::PROTEIN)
    ("Tob1" . SPARSER::PROTEIN) ("p130" . SPARSER::PROTEIN)
    ("Cullin 1" . SPARSER::PROTEIN) ("cyclin family" . SPARSER::PROTEIN)
    ("Cdk6" . SPARSER::PROTEIN) ("Cdk4" . SPARSER::PROTEIN)
    ("Cyclin-D" . SPARSER::PROTEIN) ("Akt and c-MYC" . SPARSER::COLLECTION)
    ("Oncoproteins" . SPARSER::PROTEIN)
    ("This mitochrondrial tumor suppressor" . SPARSER::SUPPRESSOR)
    ("SIRT3-Akt-c-Myc" . SPARSER::COLLECTION)
    ("a mitochrondria-located antioxidants trigger [ xref , xref ] and ROS"
     . SPARSER::COLLECTION)
    ("Myr" . SPARSER::MOLECULE) ("myristoylated" . SPARSER::PROTEIN)
    ("SIRT3 and c-MYC" . SPARSER::COLLECTION)
    ("C42B-SIRT3 and PC3-SIRT3" . SPARSER::COLLECTION)
    ("PIN" . SPARSER::PROTEIN) ("second most deadly cancer type" . TYPE)
    ("c-MYC" . SPARSER::PROTEIN) ("SIRT3" . SPARSER::PROTEIN)
    ("TYMS and MDM2" . SPARSER::COLLECTION) ("TYMS" . SPARSER::PROTEIN)
    ("Bcl-2, Zeb2, and VEGFA" . SPARSER::COLLECTION) ("Zeb" . SPARSER::PROTEIN)
    ("a-SMA and fibronectin" . SPARSER::COLLECTION)
    ("CTNNBIP1, α-SMA, and fibronectin" . SPARSER::COLLECTION)
    ("α-SMA and fibronectin" . SPARSER::COLLECTION)
    ("mIR10b" . SPARSER::PROTEIN) ("mIR" . SPARSER::PROTEIN)
    ("both healthy and diseased states" . SPARSER::BIO-STATE)
    ("around 22 nucleotides" . SPARSER::NUCLEOTIDE)
    ("the most serious form" . SPARSER::FORM)
    ("beta-catenin, alpha-SMA, and fibronectin" . SPARSER::COLLECTION)
    ("Anti-β" . SPARSER::PROTEIN) ("beta-actin" . SPARSER::PROTEIN)
    ("DKC1" . SPARSER::PROTEIN) ("BMP-6" . SPARSER::PROTEIN)
    ("mIR-10b" . SPARSER::MOLECULE) ("a-SMA" . SPARSER::PROTEIN)
    ("HR 2" . SPARSER::PROTEIN) ("HR 1" . SPARSER::PROTEIN-FAMILY)
    ("G1–3" . SPARSER::PROTEIN) ("CTNNBIP1" . SPARSER::PROTEIN)
    ("alpha-SMA" . SPARSER::PROTEIN) ("TGF-beta1" . SPARSER::PROTEIN)
    ("bortezomib and other drugs" . SPARSER::COLLECTION)
    ("monoclonal antibody [ xref ] and the DNA methyltransferase inhibitor decitabine [ xref ]"
     . SPARSER::COLLECTION)
    ("LOX" . SPARSER::PROTEIN) ("lipoxygenase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FLIP" . SPARSER::PROTEIN)
    ("c-Src , eIF4E , and c-Myc" . SPARSER::COLLECTION)
    ("barely expressed LMw hnRNP K" . SPARSER::PROTEIN)
    ("SUMO and ubiquitin" . SPARSER::COLLECTION)
    ("hnRNP A2/B1 and ~50-kDa" . SPARSER::COLLECTION)
    ("hnRNP A1, hnRNP F, and hnRNP K" . SPARSER::COLLECTION)
    ("hnRNP" . SPARSER::PROTEIN)
    ("approximately 64 kDa and 51 kDa" . SPARSER::COLLECTION)
    ("approximately 64 kDa" . SPARSER::PROTEIN)
    ("SENP1 and SENP2" . SPARSER::COLLECTION)
    ("hnRNP K and luciferase" . SPARSER::COLLECTION)
    ("hnRNP K and SUMO-1" . SPARSER::COLLECTION)
    ("Sra-HA-SUMO-1" . SPARSER::COLLECTION) ("Sra" . SPARSER::PROTEIN)
    ("hnRNP K and pan-SUMO" . SPARSER::COLLECTION)
    ("anti-SUMO-1 or anti-pan-SUMO" . SPARSER::COLLECTION)
    ("approximately 12 kDa" . SPARSER::PROTEIN)
    ("a high-Mw (HMw) group (of around 64 kDa) and a low-Mw (LMw) group (of around 51 kDa)"
     . SPARSER::COLLECTION)
    ("hnRNP K and RGDI-2" . SPARSER::COLLECTION)
    ("RGDI-2" . SPARSER::COLLECTION) ("c-Myc and BCL-2" . SPARSER::COLLECTION)
    ("reptin" . SPARSER::PROTEIN) ("SUMO" . SPARSER::PROTEIN)
    ("sentrin" . SPARSER::PROTEIN)
    ("p53, IκB, PML, and c-Jun" . SPARSER::COLLECTION)
    ("PML" . SPARSER::PROTEIN) ("at least four isoforms" . SPARSER::ISOFORM)
    ("SUMO-1, SUMO-2, SUMO-3, and SUMO-4" . SPARSER::COLLECTION)
    ("SUMOs" . SPARSER::PROTEIN)
    ("pre-messenger (m)RNA and mRNA stability [ xref ]" . SPARSER::COLLECTION)
    ("caspase-3 and caspase-8" . SPARSER::COLLECTION)
    ("a dipeptidyl boronic acid proteasome inhibitor" . SPARSER::INHIBITOR)
    ("Proteasomes" . SPARSER::PROTEIN)
    ("methotrexate, cytosine arabinoside, and cyclophosphamide"
     . SPARSER::COLLECTION)
    ("rituximab" . SPARSER::DRUG) ("methotrexate" . SPARSER::DRUG)
    ("an aggressive B-cell type" . TYPE) ("HMw and LMw" . SPARSER::COLLECTION)
    ("hnRNP K and c-Myc" . SPARSER::COLLECTION) ("HMw" . SPARSER::PROTEIN)
    ("hnRNP K, hnRNP H, Hsp90α, Grp78, and Hsp7C" . SPARSER::COLLECTION)
    ("Grp" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Bortezomib" . SPARSER::DRUG)
    ("Myc protein" . SPARSER::PROTEIN)
    ("thymidine phosphorylase" . SPARSER::PROTEIN)
    ("hnRNP M" . SPARSER::PROTEIN) ("hnRNP A2/B1" . SPARSER::PROTEIN)
    ("hnRNP F" . SPARSER::PROTEIN) ("hnRNP A1" . SPARSER::PROTEIN)
    ("SENP1" . SPARSER::PROTEIN) ("SENP2" . SPARSER::PROTEIN)
    ("Hsp60" . SPARSER::PROTEIN) ("IRF-1" . SPARSER::PROTEIN)
    ("KAI1" . SPARSER::PROTEIN) ("Ubc9" . SPARSER::PROTEIN)
    ("SUMO-4" . SPARSER::PROTEIN) ("SUMO-3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SUMO-2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SUMO-1" . SPARSER::PROTEIN)
    ("Heterogeneous nuclear ribonucleoprotein K" . SPARSER::PROTEIN)
    ("cytochrome C" . SPARSER::PROTEIN) ("PI 3 K" . SPARSER::PROTEIN-FAMILY)
    ("cytosine arabinoside" . SPARSER::DRUG) ("hnRNP H" . SPARSER::PROTEIN)
    ("hnRNP K" . SPARSER::PROTEIN) ("STMN1 and CaMKII" . SPARSER::COLLECTION)
    ("PKA, MAPK, CaMKII/IV and CDKs" . SPARSER::COLLECTION)
    ("α/β" . SPARSER::PROTEIN)
    ("STMN1 and vice versa (Figure xref and xref )" . SPARSER::COLLECTION)
    ("STMN1 and vice versa (Figure xref )" . SPARSER::COLLECTION)
    ("tubulin and form" . SPARSER::COLLECTION)
    ("PIWIL1, α-tubulin and STMN1" . SPARSER::COLLECTION)
    ("PIWIL1, STMN1 and tubulin" . SPARSER::COLLECTION)
    ("STMN1 and α-tubulin" . SPARSER::COLLECTION)
    ("PIWIL1-STMN1-tubulin" . SPARSER::COLLECTION)
    ("polymerized microtubules" . SPARSER::PROTEIN)
    ("polymerized α-tubulin" . SPARSER::PROTEIN)
    ("CaMKII and STMN1" . SPARSER::COLLECTION)
    ("CaMKII and active-CaMKII" . SPARSER::COLLECTION)
    ("CaMKII and CaMKIV" . SPARSER::COLLECTION)
    ("PKA (cAMP-dependent protein kinase) and CaMKII/IV (calmodulin-dependent protein kinase)"
     . SPARSER::COLLECTION)
    ("RLIM and STMN1" . SPARSER::COLLECTION)
    ("STMN1 and RLIM" . SPARSER::COLLECTION)
    ("PIWIL1 and STMN1" . SPARSER::COLLECTION)
    ("STMN1 and form" . SPARSER::COLLECTION)
    ("PIWIL1/STMN1/tubulin" . SPARSER::COLLECTION)
    ("/calmodulin-dependent protein kinase" . SPARSER::COLLECTION)
    ("CaMKIV" . SPARSER::PROTEIN)
    ("a ternary T2S complex" . SPARSER::BIO-COMPLEX)
    ("α/β-tubulin" . SPARSER::COLLECTION)
    ("PIWI" . SPARSER::HUMAN-PROTEIN-FAMILY) ("piRNAs" . SPARSER::RNA)
    ("CaMKII and Stathmin1" . SPARSER::COLLECTION)
    ("CaMKII" . SPARSER::PROTEIN) ("RLIM" . SPARSER::PROTEIN)
    ("Piwi" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HIWI" . SPARSER::PROTEIN)
    ("1–1" . SPARSER::PROTEIN) ("pS16" . SPARSER::PROTEIN)
    ("cAMP-dependent" . SPARSER::PROTEIN)
    ("calmodulin-dependent protein kinase" . SPARSER::PROTEIN)
    ("T2S" . SPARSER::PROTEIN) ("STMN1" . SPARSER::PROTEIN)
    ("PIWI subfamily" . SPARSER::PROTEIN)
    ("Piwi-interacting RNAs" . SPARSER::RNA) ("Stathmin1" . SPARSER::PROTEIN)
    ("PIWIL1" . SPARSER::PROTEIN) ("JAK2 and PD-1" . SPARSER::COLLECTION)
    ("pembrolizumab or MPDL3280A" . SPARSER::COLLECTION)
    ("PD-1/PD-L1" . SPARSER::COLLECTION)
    ("arm and polysomy" . SPARSER::COLLECTION)
    ("JAK2 and PD-L1" . SPARSER::COLLECTION)
    ("JAK2, PD-L1 and PD-L2" . SPARSER::COLLECTION)
    ("JAK2, PD-L1, and PD-L2" . SPARSER::COLLECTION)
    ("HER2 and MYC" . SPARSER::COLLECTION) ("SRO" . SPARSER::PROTEIN)
    ("JAK2 and the PD-1 ligands" . SPARSER::COLLECTION)
    ("PD-L1, PD-L2, and JAK2" . SPARSER::COLLECTION)
    ("both PD-1 ligands and increase sensitivity to JAK2 inhibitors"
     . SPARSER::COLLECTION)
    ("IL-6-" . SPARSER::PROTEIN)
    ("cytokine and growth factor" . SPARSER::COLLECTION)
    ("JAKs" . SPARSER::PROTEIN)
    ("JAK1, JAK2, JAK3 and non-receptor protein-tyrosine"
     . SPARSER::COLLECTION)
    ("predictive biomarkers" . SPARSER::MOLECULE)
    ("a larger cohort" . SPARSER::MOLECULE) ("ipilimumab" . SPARSER::DRUG)
    ("nivolumab and pembrolizumab" . SPARSER::COLLECTION)
    ("pembrolizumab" . SPARSER::DRUG) ("nivolumab" . SPARSER::DRUG)
    ("PD-1 and its ligands" . SPARSER::COLLECTION)
    ("CD28 and CTLA-4" . SPARSER::COLLECTION)
    ("PD-L1 and PD-L2" . SPARSER::COLLECTION)
    ("PD-L1 , PD-L2 , and JAK2" . SPARSER::COLLECTION)
    ("PDJ" . SPARSER::PROTEIN) ("MRPL19" . SPARSER::PROTEIN)
    ("PDCD1LG2" . SPARSER::PROTEIN) ("CD274" . SPARSER::PROTEIN)
    ("ADM2" . SPARSER::PROTEIN) ("P40" . SPARSER::PROTEIN)
    ("type 3" . SPARSER::PROTEIN) ("De-" . SPARSER::MOLECULE)
    ("MPDL3280A" . SPARSER::DRUG) ("CTLA-4" . SPARSER::PROTEIN)
    ("CD28" . SPARSER::PROTEIN) ("PD-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PD-L2" . SPARSER::PROTEIN) ("PD-L1" . SPARSER::PROTEIN)
    ("p24" . SPARSER::PROTEIN)
    ("cixutumumab and selumetinib" . SPARSER::COLLECTION)
    ("cixutumumab" . SPARSER::DRUG)
    ("VIII, selumetinib and trametinib" . SPARSER::COLLECTION)
    ("RAS/RAF/ERK" . SPARSER::COLLECTION) ("PC-3" . SPARSER::PROTEIN)
    ("insulin receptor-AKT" . SPARSER::COLLECTION) ("NHE" . SPARSER::PROTEIN)
    ("EGFR-MAPK" . SPARSER::COLLECTION) ("mask" . SPARSER::PROTEIN)
    ("childhood acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("Our clinical group and others" . SPARSER::COLLECTION)
    ("taxanes and antimetabolites" . SPARSER::COLLECTION)
    ("antimetabolites" . SPARSER::DRUG) ("VIII and si" . SPARSER::COLLECTION)
    ("AKT and IGFBP2" . SPARSER::COLLECTION)
    ("selumetinib and trametinib" . SPARSER::COLLECTION)
    ("Effector" . SPARSER::EFFECTOR) ("IGF1 and CDDP" . SPARSER::COLLECTION)
    ("ERK or AKT" . SPARSER::COLLECTION) ("IGF1-" . SPARSER::PROTEIN)
    ("CDDP and 5-FU" . SPARSER::COLLECTION)
    ("IGFBP2 and its effectors" . SPARSER::COLLECTION)
    ("Si" . SPARSER::PROTEIN) ("IGF1 or IGFBP2" . SPARSER::COLLECTION)
    ("PI3K and MAPK" . SPARSER::COLLECTION)
    ("ERK and AKT" . SPARSER::COLLECTION)
    ("IGFBP2 ( xref ) nor exogenous IGFBP2 ( xref )" . SPARSER::COLLECTION)
    ("exogenous IGFBP2" . SPARSER::PROTEIN)
    ("either exogenous IGF1 or IGF2" . SPARSER::COLLECTION)
    ("IGF1 or IGF2" . SPARSER::COLLECTION)
    ("CDDP or 5-FU" . SPARSER::COLLECTION)
    ("pEGFP-IGFBP2" . SPARSER::COLLECTION)
    ("IGFBP2 and these genes" . SPARSER::COLLECTION)
    ("MMP1 , MMP9 and SNAI1" . SPARSER::COLLECTION)
    ("SNAI1 , SNAI2 and FN1" . SPARSER::COLLECTION)
    ("CDH1 and VIM" . SPARSER::COLLECTION)
    ("several epithelial-mesenchymal transition-related genes" . SPARSER::GENE)
    ("SNAI1 , ZEB1 , VIM , MMP9 , and MMP1" . SPARSER::COLLECTION)
    ("VIM" . SPARSER::PROTEIN) ("SiRNA" . SPARSER::PROTEIN)
    ("exogenous human recombinant IGFBP2" . SPARSER::PROTEIN)
    ("exogenous IGF1" . SPARSER::PROTEIN)
    ("exogenous human recombinant IGFs" . SPARSER::PROTEIN)
    ("IGF1 and IGFBP2" . SPARSER::COLLECTION)
    ("cisplatin (CDDP)" . SPARSER::MOLECULE)
    ("targeted pharmacologic inhibitors" . SPARSER::INHIBITOR)
    ("arginine-glycine-aspartic acid" . SPARSER::COLLECTION)
    ("heparin" . SPARSER::PROTEIN)
    ("IGF1R [ xref ] as well as IGF1 microsatellite" . SPARSER::COLLECTION)
    ("MEK1/2 (selumetinib or trametinib) or AKT (AKT Inhibitor VIII) inhibitors"
     . SPARSER::COLLECTION)
    ("selumetinib or trametinib" . SPARSER::COLLECTION)
    ("selumetinib" . SPARSER::DRUG) ("IGF and integrin" . SPARSER::COLLECTION)
    ("EAC" . SPARSER::PROTEIN) ("p200" . SPARSER::PROTEIN)
    ("GSK1120212" . SPARSER::DRUG) ("NVP-AEW541" . SPARSER::DRUG)
    ("tissue type" . SPARSER::PROTEIN) ("PD98059" . SPARSER::MOLECULE)
    ("Na+/H+" . SPARSER::PROTEIN) ("CDH2" . SPARSER::PROTEIN)
    ("SNAI2" . SPARSER::PROTEIN) ("SNAI1" . SPARSER::PROTEIN)
    ("Insulin-like growth factor" . SPARSER::PROTEIN)
    ("GLUT1 and NDRG1" . SPARSER::COLLECTION)
    ("glutamine and glutamate" . SPARSER::COLLECTION)
    ("GLUT1, HK2, PKM2, LDHA, ASCT2 and GLS1" . SPARSER::COLLECTION)
    ("glutamine transporter (ASCT2) and glutaminase" . SPARSER::COLLECTION)
    ("lactate dehydrogenase A (LDHA), glutamine transporter (ASCT2) and glutaminase"
     . SPARSER::COLLECTION)
    ("glucose transporter GLUT1 and glycolytic key enzymes HK2, PKM2 and LDHA"
     . SPARSER::COLLECTION)
    ("glutamine transporter ASCT2 and glutaminolytic enzyme GLS1"
     . SPARSER::COLLECTION)
    ("glutaminolytic enzyme GLS1" . SPARSER::PROTEIN)
    ("c-Myc, β-catenin, GLUT1, HK2, PKM2, LDHA, ASCT2, and GLS1"
     . SPARSER::COLLECTION)
    ("NDRG2 and target molecules" . SPARSER::COLLECTION)
    ("GLUT1, HK2, PKM2, LDHA, ASCT2, GLS1, β-catenin and c-Myc"
     . SPARSER::COLLECTION)
    ("NDRG2 and the target molecules" . SPARSER::COLLECTION)
    ("NDRG2 and c-Myc" . SPARSER::COLLECTION)
    ("GSK-3β and casein kinase 1α" . SPARSER::COLLECTION)
    ("GLUT1, HK2, PKM2 and LDHA" . SPARSER::COLLECTION)
    ("siRNA-2" . SPARSER::COLLECTION)
    ("The glucose transporter 1 and key regulatory enzymes"
     . SPARSER::COLLECTION)
    ("glutamine transporters and glutaminolytic pathway-related enzymes"
     . SPARSER::COLLECTION)
    ("glutaminolytic pathway-related enzymes" . SPARSER::ENZYME)
    ("NDRG2-" . SPARSER::PROTEIN) ("ASCT2 and GLS1" . SPARSER::COLLECTION)
    ("LDH" . SPARSER::PROTEIN) ("NBDG" . SPARSER::DRUG)
    ("HK2, PKM2 and LDHA" . SPARSER::COLLECTION)
    ("glucose transporters and glycolytic pathway-related enzymes"
     . SPARSER::COLLECTION)
    ("GLUT1, HK2, PKM2, and LDHA" . SPARSER::COLLECTION)
    ("glutaminolytic metabolites" . SPARSER::PROTEIN)
    ("Metabolites" . SPARSER::PROTEIN)
    ("ASCT2 and glutaminase" . SPARSER::COLLECTION)
    ("GTP and leucine [ xref – xref ]" . SPARSER::COLLECTION)
    ("Glutaminase" . SPARSER::PROTEIN)
    ("ASC amino-acid transporter" . SPARSER::PROTEIN)
    ("glutaminase (GLS) and glutamate dehydrogenase (GDH)"
     . SPARSER::COLLECTION)
    ("dehydrogenase (GDH)" . SPARSER::PROTEIN) ("GDH" . SPARSER::PROTEIN)
    ("GLS" . SPARSER::PROTEIN) ("Myc and HIF-1" . SPARSER::COLLECTION)
    ("protein (SP)" . SPARSER::PROTEIN)
    ("the last rate-limiting enzyme" . SPARSER::ENZYME)
    ("oncogenes and tumor suppressor genes" . SPARSER::COLLECTION)
    ("several oncogenes and tumor suppressor genes" . SPARSER::COLLECTION)
    ("-FDG" . SPARSER::COLLECTION) ("FDG" . SPARSER::PROTEIN)
    ("glutamine transporter ASC amino-acid transporter 2 (ASCT2) and glutaminase"
     . SPARSER::COLLECTION)
    ("glutamine transporter and the catalytic enzymes" . SPARSER::COLLECTION)
    ("glutamine transporter ASC amino-acid transporter" . SPARSER::PROTEIN)
    ("glutaminase" . SPARSER::PROTEIN)
    ("glucose transporters and the catalytic enzymes" . SPARSER::COLLECTION)
    ("Oncogene" . SPARSER::ONCOGENE) ("α-ketoglutarate" . SPARSER::MOLECULE)
    ("PMD2" . SPARSER::MOLECULE) ("PAX2" . SPARSER::PROTEIN)
    ("LKB1-AMPK" . SPARSER::PROTEIN) ("CK1α" . SPARSER::PROTEIN)
    ("N-Myc downstream-regulated gene 2" . SPARSER::PROTEIN)
    ("SP2" . SPARSER::PROTEIN)
    ("hypoxia inducible factor-1" . SPARSER::PROTEIN)
    ("C-MYC" . SPARSER::PROTEIN) ("Transcription factor" . SPARSER::PROTEIN)
    ("GLS1" . SPARSER::PROTEIN) ("ASCT2" . SPARSER::PROTEIN)
    ("hexokinase 2" . SPARSER::PROTEIN) ("gene 2" . SPARSER::PROTEIN)
    ("N-Myc" . SPARSER::PROTEIN) ("suppressor and G1/S" . SPARSER::COLLECTION)
    ("hypo-phosphorylated Rb protein" . SPARSER::PROTEIN)
    ("Cyclin A/Cdk" . SPARSER::COLLECTION)
    ("SAHA or SAHA" . SPARSER::COLLECTION)
    ("transcriptional cofactor" . SPARSER::MOLECULE)
    ("Our Western blot" . SPARSER::PROTEIN) ("SNF" . SPARSER::PROTEIN-FAMILY)
    ("SWI" . SPARSER::PROTEIN) ("Trichostatin" . SPARSER::MOLECULE)
    ("Plk1 or p21 protein" . SPARSER::COLLECTION)
    ("the expected strong decreased phospho-Rb protein" . SPARSER::PROTEIN)
    ("p21 and pRb" . SPARSER::COLLECTION) ("pRb and p21" . SPARSER::COLLECTION)
    ("Vorinostat" . SPARSER::DRUG) ("WAF/CIP1" . SPARSER::COLLECTION)
    ("WAF" . SPARSER::PROTEIN) ("Plk1 and HDAC" . SPARSER::COLLECTION)
    ("dominant-negative mutants" . SPARSER::MUTANT)
    ("One attractive target gene" . SPARSER::GENE)
    ("more cancer-relevant genes" . SPARSER::GENE)
    ("Parp and Caspase 3" . SPARSER::COLLECTION) ("Parp" . SPARSER::PROTEIN)
    ("almost completely vanished pRb" . SPARSER::PROTEIN)
    ("CIP1" . SPARSER::PROTEIN)
    ("blot and dual-luciferase" . SPARSER::COLLECTION)
    ("EphA8" . SPARSER::PROTEIN) ("EphA" . SPARSER::PROTEIN-FAMILY)
    ("Hudson" . SPARSER::PROTEIN)
    ("metastasis-associated miRNAs" . SPARSER::PROTEIN)
    ("both tumor oncogenes and tumor suppressors" . SPARSER::COLLECTION)
    ("AKT (ser473) and ERK (thr202/thr204)" . SPARSER::COLLECTION)
    ("thr" . SPARSER::AMINO-ACID)
    ("PTEN (si-PTEN) and miR-10a inhibitors" . SPARSER::COLLECTION)
    ("si-PTEN" . SPARSER::COLLECTION) ("anti-miR-NC" . SPARSER::COLLECTION)
    ("Trans" . SPARSER::PROTEIN-FAMILY) ("a predominant type" . TYPE)
    ("PTEN/AKT/ERK" . SPARSER::COLLECTION) ("SPC-A-1" . SPARSER::COLLECTION)
    ("SPC" . SPARSER::PROTEIN) ("Smad2" . SPARSER::PROTEIN)
    ("MDM4" . SPARSER::PROTEIN) ("HOXA1" . SPARSER::PROTEIN)
    ("MiR-10" . SPARSER::PROTEIN) ("miR-200c" . SPARSER::MOLECULE)
    ("miR-10" . SPARSER::PROTEIN) ("A-1" . SPARSER::PROTEIN)
    ("the principal regulators" . SPARSER::REGULATOR)
    ("genotoxic drugs" . SPARSER::DRUG)
    ("Set7/9 and HDAC2 or XRCC5" . SPARSER::COLLECTION)
    ("HDAC2 or XRCC5" . SPARSER::COLLECTION)
    ("HDAC2 and XRCC5" . SPARSER::COLLECTION)
    ("p53 and mutant" . SPARSER::COLLECTION)
    ("the Set7/9 protein and the 61-491 fragment" . SPARSER::COLLECTION)
    ("E2F1, PCAF, Tip60 and NBS1" . SPARSER::COLLECTION)
    ("p53 and the regulator" . SPARSER::COLLECTION)
    ("p53, E2F1, and AR" . SPARSER::COLLECTION)
    ("Doxorubicin" . SPARSER::PROTEIN) ("ATM/ATR" . SPARSER::COLLECTION)
    ("FACs" . SPARSER::PROTEIN) ("p53 and cyclin E" . SPARSER::COLLECTION)
    ("Noxa and several other pro-apoptotic genes" . SPARSER::COLLECTION)
    ("pro-apoptotic TP73 gene" . SPARSER::GENE)
    ("several other pro-apoptotic genes" . SPARSER::GENE)
    ("p53 and E2F1" . SPARSER::COLLECTION) ("p300/CBP" . SPARSER::COLLECTION)
    ("cdk2/cyclinE" . SPARSER::COLLECTION) ("p21/Cip" . SPARSER::COLLECTION)
    ("cyclinE" . SPARSER::PROTEIN-FAMILY)
    ("E2F1 and p53" . SPARSER::COLLECTION)
    ("p53 [ xref ] and E2F1 [ xref ]" . SPARSER::COLLECTION)
    ("PCAF" . SPARSER::PROTEIN)
    ("SET8 (PR-SET7) and Suv4-20 h1/h2" . SPARSER::COLLECTION)
    ("methylated lysines" . SPARSER::AMINO-ACID) ("MMSET" . SPARSER::PROTEIN)
    ("γH2AX and H2B" . SPARSER::COLLECTION) ("KMT Suv39 h1" . SPARSER::PROTEIN)
    ("acetyltransferase (HAT)" . SPARSER::PROTEIN) ("HAT" . SPARSER::PROTEIN)
    ("MDC1 and the Mre11/Rad50/Nbs1 (MRN) complex" . SPARSER::COLLECTION)
    ("Mre11/Rad50/Nbs1" . SPARSER::COLLECTION)
    ("ATM/DNA-PK" . SPARSER::COLLECTION)
    ("Chek1 and Chek2" . SPARSER::COLLECTION) ("Chek2" . SPARSER::PROTEIN)
    ("Chek1" . SPARSER::PROTEIN) ("ATM and DNA-PK" . SPARSER::COLLECTION)
    ("the most dangerous forms" . SPARSER::FORM)
    ("Set7/9 and Mdm2" . SPARSER::COLLECTION) ("Set7/9" . SPARSER::PROTEIN)
    ("KMT" . SPARSER::PROTEIN) ("H2Ax" . SPARSER::PROTEIN)
    ("Topoisomerase" . SPARSER::PROTEIN) ("I-SceI" . SPARSER::PROTEIN)
    ("micro-RNAs" . SPARSER::MICRO-RNA) ("XRCC5" . SPARSER::PROTEIN)
    ("HDAC2" . SPARSER::PROTEIN) ("SetD7" . SPARSER::PROTEIN)
    ("si-RNA" . SPARSER::RNA) ("transporter activity" . SPARSER::PROTEIN)
    ("Rad51" . SPARSER::PROTEIN) ("PP4" . SPARSER::PROTEIN)
    ("TP73" . SPARSER::PROTEIN) ("cdk2" . SPARSER::PROTEIN)
    ("TAF10" . SPARSER::PROTEIN) ("SET7/9" . SPARSER::PROTEIN)
    ("H3-K4" . SPARSER::PROTEIN) ("Suv4-20" . SPARSER::PROTEIN)
    ("PR-SET7" . SPARSER::PROTEIN) ("SET8" . SPARSER::PROTEIN)
    ("RNF168" . SPARSER::PROTEIN) ("RNF8" . SPARSER::PROTEIN)
    ("Suv39 h" . SPARSER::PROTEIN) ("H3-K9" . SPARSER::PROTEIN)
    ("Tip60" . SPARSER::PROTEIN) ("K5" . SPARSER::PROTEIN)
    ("Nbs1" . SPARSER::PROTEIN) ("Rad50" . SPARSER::PROTEIN)
    ("Mre11" . SPARSER::PROTEIN) ("Set7" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3K/MTOR/AKT" . SPARSER::COLLECTION) ("VacA" . SPARSER::PROTEIN-FAMILY)
    ("PI3K/PDK1" . SPARSER::COLLECTION) ("PAI and OipA" . SPARSER::COLLECTION)
    ("PAI" . SPARSER::PROTEIN) ("kda" . SPARSER::PROTEIN)
    ("PI3K , AKT , and PTEN" . SPARSER::COLLECTION)
    ("the downstream targets eukaryotic initiation factor 4E (eIF-4E) binding protein 1 (4E-BP1) and ribosome 40S small subunit S6 protein kinase (p70S6K)"
     . SPARSER::COLLECTION)
    ("kinase (PIK)" . SPARSER::KINASE) ("MTOR/AKT" . SPARSER::COLLECTION)
    ("the MTOR rs1064261 or AKT rs1130233 polymorphism and total or phosphorylated MTOR and AKT proteins"
     . SPARSER::COLLECTION)
    ("total or phosphorylated MTOR and AKT proteins" . SPARSER::PROTEIN)
    ("GC and AG" . SPARSER::COLLECTION)
    ("allele and rs1130214" . SPARSER::COLLECTION)
    ("PI3K/AKT/MTOR" . SPARSER::COLLECTION) ("HP" . SPARSER::PROTEIN)
    ("total and phosphorylated MTOR and AKT proteins" . SPARSER::PROTEIN)
    ("MTOR and AKT" . SPARSER::COLLECTION)
    ("/mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("/protein kinase B" . SPARSER::COLLECTION)
    ("virulence factor" . SPARSER::PROTEIN-FAMILY)
    ("virulence factors" . SPARSER::PROTEIN-FAMILY)
    ("v- AKT" . SPARSER::PROTEIN) ("AKT 1" . SPARSER::PROTEIN)
    ("Emphysema" . SPARSER::PROTEIN) ("ATK" . SPARSER::PROTEIN)
    ("Tobacco" . SPARSER::DRUG) ("TG" . SPARSER::PROTEIN)
    ("miRNA/mRNA" . SPARSER::COLLECTION)
    ("KRAS and let-7g" . SPARSER::COLLECTION) ("COPD" . SPARSER::PROTEIN)
    ("Ki-ras" . SPARSER::PROTEIN) ("Let-7" . SPARSER::RNA)
    ("hsa-let-7" . SPARSER::RNA) ("CDK1, and Cdc25C" . SPARSER::COLLECTION)
    ("the two major CKIs" . SPARSER::PROTEIN)
    ("cyclin–CDK" . SPARSER::COLLECTION)
    ("COLsi and MCF7" . SPARSER::COLLECTION) ("CGH" . SPARSER::PROTEIN)
    ("the most famous PTEN downstream proteins" . SPARSER::PROTEIN)
    ("MCF7-PTENsi- 2" . SPARSER::COLLECTION)
    ("p21 (slightly decreased) and p27" . SPARSER::COLLECTION)
    ("Cdc25C, and CDK1" . SPARSER::COLLECTION)
    ("CDK2, CDK4, and CDK6" . SPARSER::COLLECTION)
    ("p21 and p27" . SPARSER::COLLECTION) ("COLsi" . SPARSER::PROTEIN)
    ("The Western blot" . SPARSER::PROTEIN)
    ("MCF7-PTENsi-2" . SPARSER::COLLECTION)
    ("MCF7-PTENsi-1" . SPARSER::COLLECTION)
    ("MCF7-COLsi" . SPARSER::COLLECTION)
    ("Further Western blot" . SPARSER::PROTEIN)
    ("p-p70s6k" . SPARSER::COLLECTION) ("p-ERK1/2" . SPARSER::PROTEIN)
    ("CDK 2" . SPARSER::PROTEIN) ("E2F-1" . SPARSER::PROTEIN)
    ("- 2" . SPARSER::PROTEIN) ("Cdc25" . SPARSER::PROTEIN)
    ("Cdc25C" . SPARSER::PROTEIN) ("type and stage" . SPARSER::COLLECTION)
    ("a multifunctional scaffolding protein" . SPARSER::PROTEIN)
    ("Cav-1" . SPARSER::PROTEIN) ("CAV1" . SPARSER::PROTEIN)
    ("Cav1" . SPARSER::PROTEIN) ("caveolin 1" . SPARSER::PROTEIN)
    ("CDK-interacting protein 1 or cyclin-dependent kinase inhibitor 1"
     . SPARSER::COLLECTION)
    ("the repressive effect myricetin" . SPARSER::DRUG)
    ("Bax, Puma, and Noxa" . SPARSER::COLLECTION)
    ("family and DR5" . SPARSER::COLLECTION)
    ("Bcl-2/Bax" . SPARSER::COLLECTION)
    ("DR5, FADD, and caspase-8" . SPARSER::COLLECTION)
    ("Bax/Bcl-2" . SPARSER::COLLECTION)
    ("complex (DISC)" . SPARSER::BIO-COMPLEX) ("DISC" . SPARSER::BIO-COMPLEX)
    ("Bax, Bad, and p21 proteins and myricetin" . SPARSER::COLLECTION)
    ("p21 proteins and myricetin" . SPARSER::COLLECTION)
    ("cmyc and Bcl" . SPARSER::COLLECTION) ("pifithrin" . SPARSER::DRUG)
    ("p53 and p21 proteins" . SPARSER::COLLECTION) ("cmyc" . SPARSER::PROTEIN)
    ("DR5 and caspase-8" . SPARSER::COLLECTION) ("FADD" . SPARSER::PROTEIN)
    ("Caspase-Glo" . SPARSER::COLLECTION) ("Glo" . SPARSER::PROTEIN)
    ("procaspase-9 and Puma" . SPARSER::COLLECTION)
    ("Bax and Bad" . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-xl" . SPARSER::COLLECTION)
    ("Puma, Bcl-2, Bcl-xl, Bax, Bad and caspase-9" . SPARSER::COLLECTION)
    ("Caspase-Glo 3" . SPARSER::PROTEIN-PAIR) ("Caspase" . SPARSER::PROTEIN)
    ("wine" . SPARSER::MOLECULE) ("ligand (TRAIL)" . SPARSER::MOLECULE)
    ("P-glycoprotein and p53" . SPARSER::COLLECTION)
    ("investigational anticancer drugs" . SPARSER::DRUG)
    ("a multifunctional tumor suppressor" . SPARSER::SUPPRESSOR)
    ("myricetin" . SPARSER::DRUG) ("Myricetin" . SPARSER::DRUG)
    ("DR-5" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor 1" . SPARSER::PROTEIN)
    ("CDK-interacting protein 1" . SPARSER::PROTEIN)
    ("FAS-associated death domain protein" . SPARSER::PROTEIN)
    ("procaspase-8" . SPARSER::PROTEIN) ("procaspase-9" . SPARSER::PROTEIN)
    ("p21 proteins" . SPARSER::PROTEIN)
    ("Tumor necrosis factor" . SPARSER::PROTEIN)
    ("mitochondrial)" . SPARSER::PROTEIN) ("P-glycoprotein" . SPARSER::PROTEIN)
    ("DR5" . SPARSER::PROTEIN)
    ("cyclin D, cyclin E, GSK3, c-Myc and cdc2" . SPARSER::COLLECTION)
    ("EMT-MET" . SPARSER::COLLECTION)
    ("Cyclin D and GSK3" . SPARSER::COLLECTION)
    ("Cyclin E, C-Myc and Cdc-2" . SPARSER::COLLECTION)
    ("F3, or miR-424+Akt3+E2F3" . SPARSER::COLLECTION)
    ("E2F3 and Akt3" . SPARSER::COLLECTION)
    ("siRNA and E2F3" . SPARSER::COLLECTION)
    ("blot and IF" . SPARSER::COLLECTION)
    ("E-cadherin and vimentin" . SPARSER::COLLECTION)
    ("blot and IHC" . SPARSER::COLLECTION)
    ("cohort, SHCC and SLHCC" . SPARSER::COLLECTION)
    ("SHCC and SLHCC" . SPARSER::COLLECTION) ("cirrhosis" . SPARSER::PROTEIN)
    ("ANLT/HCC" . SPARSER::COLLECTION) ("SHCC" . SPARSER::PROTEIN)
    ("well-conserved noncoding RNA molecules" . SPARSER::MOLECULE)
    ("this special HCC" . SPARSER::PROTEIN) ("pheno" . SPARSER::DRUG)
    ("Akt3 and E2F3" . SPARSER::COLLECTION) ("pRb-E2F" . SPARSER::PROTEIN-PAIR)
    ("HIF-1 alpha" . SPARSER::PROTEIN) ("c-Myb" . SPARSER::PROTEIN)
    ("Cdc25A" . SPARSER::PROTEIN) ("Cdc-2" . SPARSER::PROTEIN)
    ("Cdc2" . SPARSER::PROTEIN) ("E2F3" . SPARSER::PROTEIN)
    ("Mst1" . SPARSER::PROTEIN) ("HBV-associated HCC" . SPARSER::PROTEIN)
    ("HBsAg" . SPARSER::DRUG) ("siRNA and preS2" . SPARSER::COLLECTION)
    ("hTERT and FOXP3" . SPARSER::COLLECTION)
    ("siR-2 and siR-3" . SPARSER::COLLECTION)
    ("oncogenes or pathways" . SPARSER::COLLECTION)
    ("c-raf-1/Erk2" . SPARSER::COLLECTION)
    ("HCC and HBx" . SPARSER::COLLECTION)
    ("CREB" . SPARSER::HUMAN-PROTEIN-FAMILY) ("etc" . SPARSER::PROTEIN)
    ("Transcription co-activators Yes-associated protein (YAP) and transcriptional co-activator"
     . SPARSER::COLLECTION)
    ("Transcription co-activators Yes-associated protein (YAP)"
     . SPARSER::PROTEIN)
    ("hTERT and Foxp3" . SPARSER::COLLECTION)
    ("the minimal functional fragment" . SPARSER::FRAGMENT)
    ("viral proteins" . SPARSER::PROTEIN)
    ("almost all the HBV related HCC" . SPARSER::PROTEIN)
    ("HBx and preS2" . SPARSER::COLLECTION) ("preS" . SPARSER::PROTEIN)
    ("HBx" . SPARSER::PROTEIN) ("Lats2" . SPARSER::PROTEIN)
    ("FOXP3" . SPARSER::PROTEIN) ("siR-2" . SPARSER::PROTEIN)
    ("c-raf-1" . SPARSER::PROTEIN) ("Foxp3" . SPARSER::PROTEIN)
    ("surface protein" . SPARSER::PROTEIN)
    ("conventional chemotherapeutic drugs" . SPARSER::DRUG)
    ("ERBB2/HER2" . SPARSER::COLLECTION)
    ("the SHP2 protein and dominant-negative SHP2" . SPARSER::COLLECTION)
    ("dominant-negative SHP2" . SPARSER::PROTEIN)
    ("HSCs/progenitors" . SPARSER::PROTEIN)
    ("ERK and Akt" . SPARSER::COLLECTION) ("Ptpn11" . SPARSER::PROTEIN)
    ("HSCs" . SPARSER::PROTEIN)
    ("v-myc myelocytomatosis viral oncogene homolog (c-Myc) and zinc finger E-box binding homeobox 1 (ZEB1)"
     . SPARSER::COLLECTION)
    ("SHP1/SHP2" . SPARSER::COLLECTION)
    ("ERBB2, ESR1, and TGF-β" . SPARSER::COLLECTION)
    ("JAK/STAT/RAS/ERK" . SPARSER::COLLECTION) ("SCC4" . SPARSER::PROTEIN)
    ("C-Myc and CyD" . SPARSER::COLLECTION)
    ("Bcl-XL and Spred" . SPARSER::COLLECTION)
    ("SHP1/SHP2/RAS/ERK" . SPARSER::COLLECTION)
    ("Spred" . SPARSER::PROTEIN-FAMILY) ("CyD" . SPARSER::MOLECULE)
    ("self-renewal gene TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E6/E7" . SPARSER::COLLECTION)
    ("two important self-renewal genes" . SPARSER::GENE)
    ("TGF-β and LIF" . SPARSER::COLLECTION)
    ("H-Ras and K-Ras" . SPARSER::COLLECTION)
    ("Ras/mitogen activated protein kinase" . SPARSER::COLLECTION)
    ("a trans-membrane receptor protein and an up-stream activator"
     . SPARSER::COLLECTION)
    ("RAS-ERK" . SPARSER::COLLECTION) ("ERBB2 and ESR1" . SPARSER::COLLECTION)
    ("p-SHP2" . SPARSER::COLLECTION) ("SHP1 and/or SHP2" . SPARSER::COLLECTION)
    ("CD24/CD44" . SPARSER::COLLECTION) ("CD44 and CD24" . SPARSER::COLLECTION)
    ("c-Myc and ZEB1" . SPARSER::COLLECTION)
    ("onco-protein" . SPARSER::COLLECTION)
    ("the downstream target RAS and other components" . SPARSER::COLLECTION)
    ("Grb2 and Gab2 and form" . SPARSER::COLLECTION)
    ("Gab2 and form" . SPARSER::COLLECTION)
    ("SHP2/Grb2/Gab2" . SPARSER::COLLECTION) ("JAK/Stat" . SPARSER::COLLECTION)
    ("SHP1 and SHP2" . SPARSER::COLLECTION)
    ("gamma-T3 specifically targets SHP2" . SPARSER::PROTEIN)
    ("RAS/ERK" . SPARSER::COLLECTION)
    ("self-renewal genes TGF-beta and LIF" . SPARSER::COLLECTION)
    ("TGF-beta and LIF" . SPARSER::COLLECTION) ("ESR" . SPARSER::PROTEIN)
    ("tocotrienol" . SPARSER::MOLECULE) ("Shp2" . SPARSER::PROTEIN)
    ("zinc finger E-box binding homeobox 1" . SPARSER::PROTEIN)
    ("v-myc myelocytomatosis viral oncogene homolog" . SPARSER::PROTEIN)
    ("phosphoinositide-3 kinase" . SPARSER::PROTEIN)
    ("mitogen activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptor protein" . SPARSER::RECEPTOR-PROTEIN)
    ("TGF-β-2" . SPARSER::PROTEIN) ("TGF-β-1" . SPARSER::PROTEIN)
    ("SPH2" . SPARSER::PROTEIN) ("ZEB1" . SPARSER::PROTEIN)
    ("PTPN11" . SPARSER::PROTEIN) ("Gab2" . SPARSER::PROTEIN)
    ("MDR1" . SPARSER::PROTEIN) ("phosphatase 1" . SPARSER::PROTEIN)
    ("molecules or signaling pathways" . SPARSER::COLLECTION)
    ("miR-23a, and IL-8" . SPARSER::COLLECTION)
    ("Nucleic-acid drugs" . SPARSER::DRUG) ("IL-8/Sat3" . SPARSER::COLLECTION)
    ("IL-8 or antibody" . SPARSER::COLLECTION)
    ("the radiosensitive NPCs" . SPARSER::MOLECULE) ("Stattic" . SPARSER::DRUG)
    ("the miR-23a mimic-transfected or IL-8 knockdown CNE2-IR cells (Figure xref )"
     . SPARSER::COLLECTION)
    ("secretory IL-8" . SPARSER::PROTEIN) ("RPF" . SPARSER::PROTEIN)
    ("radiosensitive NPCs" . SPARSER::MOLECULE) ("NPCs" . SPARSER::MOLECULE)
    ("11 differential miRNAs" . SPARSER::PROTEIN)
    ("topoisomerase" . SPARSER::PROTEIN)
    ("IL-8 and phospho-Stat3" . SPARSER::COLLECTION)
    ("IL-8/Stat3" . SPARSER::COLLECTION) ("1-8" . SPARSER::PROTEIN)
    ("Sat3" . SPARSER::PROTEIN) ("MiR-23a" . SPARSER::MOLECULE)
    ("genes, and microRNAs" . SPARSER::COLLECTION)
    ("Akt, ERK1/2, JNK, and p38" . SPARSER::COLLECTION)
    ("the classical ligand" . SPARSER::LIGAND)
    ("AML1-ETO" . SPARSER::COLLECTION)
    ("TPO/MPL/PI3K/Akt" . SPARSER::COLLECTION)
    ("TPO/MPL/Bcl-xL" . SPARSER::COLLECTION) ("ETO" . SPARSER::PROTEIN)
    ("TPO/MPL" . SPARSER::COLLECTION)
    ("MPL, GADD45g, TOB1, SLA, and ETS1" . SPARSER::COLLECTION)
    ("SLA" . SPARSER::PROTEIN)
    ("MDM2, VEGFR1, and MMP28" . SPARSER::COLLECTION)
    ("BRCA1-" . SPARSER::PROTEIN) ("CKI" . SPARSER::PROTEIN)
    ("CKIs" . SPARSER::PROTEIN) ("FAB" . SPARSER::PROTEIN)
    ("PARP-1 and its potential downstream molecule MPL" . SPARSER::COLLECTION)
    ("MPL and PARP-1" . SPARSER::COLLECTION)
    ("differentially expressed genes" . SPARSER::GENE)
    ("cyclin B1 and CDK1" . SPARSER::COLLECTION)
    ("thrombopoietin (TPO)" . SPARSER::PROTEIN) ("TPO" . SPARSER::PROTEIN)
    ("The myeloproliferative leukemia virus oncogene (MPL)"
     . SPARSER::ONCOGENE)
    ("symporter" . SPARSER::PROTEIN)
    ("other chromatin-associated proteins" . SPARSER::PROTEIN)
    ("HSPCs" . SPARSER::PROTEIN) ("Akt and ERK1/2" . SPARSER::COLLECTION)
    ("PARP-1 and MPL" . SPARSER::COLLECTION)
    ("the myeloproliferative leukemia virus oncogene (MPL)"
     . SPARSER::ONCOGENE)
    ("oncogene (MPL)" . SPARSER::ONCOGENE) ("MPL" . SPARSER::PROTEIN)
    ("P38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("extracellular signal-regulated kinase 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AML1" . SPARSER::PROTEIN) ("GADD45g" . SPARSER::PROTEIN)
    ("MMP28" . SPARSER::PROTEIN) ("p-P38" . SPARSER::PROTEIN)
    ("sodium iodide" . SPARSER::MOLECULE) ("PARP-1" . SPARSER::PROTEIN)
    ("miR-21 and STAT3" . SPARSER::COLLECTION)
    ("HNRPK , SPRY1 , RHOB , RECK and BTG2" . SPARSER::COLLECTION)
    ("RHOB" . SPARSER::PROTEIN) ("HNRPK" . SPARSER::PROTEIN)
    ("SPRY2 , TIMP3 , CDKN1A , SERPINB5 and PTEN" . SPARSER::COLLECTION)
    ("STAT3 and phosphorylated-STAT3" . SPARSER::COLLECTION)
    ("SPRY2 and TIMP3" . SPARSER::COLLECTION)
    ("SPRY2 , TIMP3 , PTEN and CDKN1A" . SPARSER::COLLECTION)
    ("STAT3-miR-21" . SPARSER::COLLECTION)
    ("STAT3 and hsa-mir-21" . SPARSER::COLLECTION) ("miR21" . SPARSER::PROTEIN)
    ("both STAT3 and the active phosphoform" . SPARSER::COLLECTION)
    ("the most efficient KD" . SPARSER::PROTEIN)
    ("CD133 and EpCAM" . SPARSER::COLLECTION) ("EpCAM" . SPARSER::PROTEIN)
    ("miR-21 and miR-181b" . SPARSER::COLLECTION)
    ("a vital regulator" . SPARSER::REGULATOR) ("TICs" . SPARSER::PROTEIN)
    ("cooperative regulators" . SPARSER::REGULATOR)
    ("STAT3 and miR-21" . SPARSER::COLLECTION)
    ("our previously described BMIC regulatory genes" . SPARSER::GENE)
    ("Transcription Factor" . SPARSER::PROTEIN) ("stat3" . SPARSER::PROTEIN)
    ("3–2" . SPARSER::PROTEIN) ("VMP1" . SPARSER::PROTEIN)
    ("TFAP2C" . SPARSER::PROTEIN) ("BTG2" . SPARSER::PROTEIN)
    ("SPRY1" . SPARSER::PROTEIN) ("SERPINB5" . SPARSER::DRUG)
    ("BP-1" . SPARSER::PROTEIN) ("TIMP3" . SPARSER::PROTEIN)
    ("SPRY2" . SPARSER::PROTEIN) ("miR -21" . SPARSER::PROTEIN)
    ("3–1" . SPARSER::PROTEIN) ("DNA-PKcs and ATR" . SPARSER::COLLECTION)
    ("foci or DNA" . SPARSER::COLLECTION)
    ("inactive ATM dimers" . SPARSER::DIMER)
    ("foci and ii" . SPARSER::COLLECTION) ("temporary foci" . SPARSER::PROTEIN)
    ("ions" . SPARSER::MOLECULE)
    ("a low dose group (20, 40 and 80 mGy) and an intermediate dose group (160 and 250 mGy)"
     . SPARSER::COLLECTION)
    ("only lone γH2AX foci" . SPARSER::PROTEIN)
    ("only few radiation-induced pATM foci" . SPARSER::PROTEIN)
    ("Foci" . SPARSER::PROTEIN) ("fits" . SPARSER::PROTEIN-FAMILY)
    ("γH2AX and pATM foci and their co-localization" . SPARSER::COLLECTION)
    ("ATM and H2AX" . SPARSER::COLLECTION)
    ("pATM and γH2AX foci and their co-localization" . SPARSER::COLLECTION)
    ("pATM and γH2AX" . SPARSER::COLLECTION) ("BLM" . SPARSER::PROTEIN)
    ("Rad3-related (ATR) kinases and DNA-dependent protein kinase catalytic subunit"
     . SPARSER::COLLECTION)
    ("kinases and DNA-dependent protein kinase catalytic subunit"
     . SPARSER::COLLECTION)
    ("ATR" . SPARSER::PROTEIN) ("ataxia" . SPARSER::PROTEIN)
    ("conformational chromatin" . SPARSER::PROTEIN)
    ("sugar" . SPARSER::MOLECULE)
    ("Oct4, Sox2 and Nanog" . SPARSER::COLLECTION)
    ("gingival MSCs" . SPARSER::PROTEIN) ("Gingival MSCs" . SPARSER::PROTEIN)
    ("gingival-derived MSCs" . SPARSER::PROTEIN)
    ("γH2AX and pATM" . SPARSER::COLLECTION) ("pATM" . SPARSER::PROTEIN)
    ("MSCs" . SPARSER::PROTEIN) ("Y-2" . SPARSER::PROTEIN)
    ("adhesion molecule" . SPARSER::PROTEIN) ("CD13" . SPARSER::PROTEIN)
    ("CD54" . SPARSER::PROTEIN) ("5–2" . SPARSER::PROTEIN)
    ("alpha-particle" . SPARSER::MOLECULE) ("SMC1" . SPARSER::PROTEIN)
    ("Rad17" . SPARSER::PROTEIN) ("Chk2" . SPARSER::PROTEIN)
    ("DNA-dependent protein kinase catalytic subunit" . SPARSER::PROTEIN)
    ("a predictive biomarker" . SPARSER::MOLECULE) ("PCV" . SPARSER::MOLECULE)
    ("vincristine" . SPARSER::DRUG) ("procarbazine" . SPARSER::DRUG)
    ("post-operative CHT" . SPARSER::PROTEIN)
    ("mut and IDH" . SPARSER::COLLECTION)
    ("combined TERT promoter and IDH mutations" . SPARSER::COLLECTION)
    ("IDH wt/ TERT mut ( n = 20) and IDH wt/ TERT wt ( n = 58)"
     . SPARSER::COLLECTION)
    ("Group A and Group B" . SPARSER::COLLECTION)
    ("fotemustine (FCNU, 12.1%) and nimustine (ACNU, 5.7%)"
     . SPARSER::COLLECTION)
    ("ACNU" . SPARSER::DRUG) ("nimustine" . SPARSER::DRUG)
    ("fotemustine" . SPARSER::DRUG) ("MeCCNU" . SPARSER::DRUG)
    ("semustine" . SPARSER::DRUG) ("TMZ" . SPARSER::DRUG)
    ("postoperative CHT" . SPARSER::PROTEIN) ("-TTCC-3" . SPARSER::COLLECTION)
    ("ETS" . SPARSER::PROTEIN) ("dehydrogenase" . SPARSER::PROTEIN)
    ("isocitrate" . SPARSER::PROTEIN) ("Adjuvant" . SPARSER::DRUG)
    ("IDH and TERT" . SPARSER::COLLECTION)
    ("telomerase reverse transcriptase ( TERT )" . SPARSER::PROTEIN)
    ("CHT" . SPARSER::PROTEIN) ("chr5" . SPARSER::PROTEIN)
    ("Group B" . SPARSER::PROTEIN) ("IDH2" . SPARSER::PROTEIN)
    ("kinase and MEK" . SPARSER::COLLECTION)
    ("IDH1 (2 cases; 4%) and EGFR (4 cases; 7%)" . SPARSER::COLLECTION)
    ("GNAS (3 cases; 5%), IDH1 (2 cases; 4%) and EGFR (4 cases; 7%)"
     . SPARSER::COLLECTION)
    ("GNAS" . SPARSER::PROTEIN) ("Only one (2%) BRAF V600E" . SPARSER::PROTEIN)
    ("BRAF and RAF1" . SPARSER::COLLECTION)
    ("bevacizumab and temsirolimus" . SPARSER::COLLECTION)
    ("MET , PDGFRA , RET and TSC2" . SPARSER::COLLECTION)
    ("PDGFRA" . SPARSER::PROTEIN)
    ("PBRM1 , APC and EGFR" . SPARSER::COLLECTION) ("AGK" . SPARSER::PROTEIN)
    ("KIAA1549 and BRAF" . SPARSER::COLLECTION)
    ("dabrafenib and vemurafenib" . SPARSER::COLLECTION)
    ("certain histologic subtypes" . SPARSER::PROTEIN)
    ("trametinib and sorafenib" . SPARSER::COLLECTION)
    ("trametinib" . SPARSER::DRUG) ("IDH1" . SPARSER::PROTEIN)
    ("ZKSCAN1" . SPARSER::PROTEIN) ("PBRM1" . SPARSER::PROTEIN)
    ("MKRN1" . SPARSER::PROTEIN) ("SND1" . SPARSER::PROTEIN)
    ("TRIM24" . SPARSER::PROTEIN) ("KIAA1549" . SPARSER::PROTEIN)
    ("CSPC and CRPC" . SPARSER::COLLECTION)
    ("promoter, and miR-190a" . SPARSER::COLLECTION) ("DNA-" . SPARSER::DNA)
    ("Androgen receptor (AR)" . SPARSER::PROTEIN) ("CSPC" . SPARSER::PROTEIN)
    ("a clinically relevant biomarker" . SPARSER::MOLECULE)
    ("digoxigenin-labeled locked nucleic acid (LNA)-miRNA"
     . SPARSER::COLLECTION)
    ("-miRNA" . SPARSER::COLLECTION) ("digoxigenin" . SPARSER::MOLECULE)
    ("AR, YB-1 and Ki-67" . SPARSER::COLLECTION)
    ("MTT and colony formation assays" . SPARSER::COLLECTION)
    ("PSA-Luc" . SPARSER::COLLECTION)
    ("specifically targets YB-1" . SPARSER::PROTEIN)
    ("miR-190a specifically targets YB-1" . SPARSER::PROTEIN)
    ("ARE4-luc" . SPARSER::PROTEIN-PAIR) ("PSA-luc" . SPARSER::COLLECTION)
    ("IP Western blot" . SPARSER::PROTEIN)
    ("the endogenous androgenic ligands" . SPARSER::LIGAND)
    ("toYB-1" . SPARSER::COLLECTION) ("LBD" . SPARSER::PROTEIN)
    ("AR-LBD" . SPARSER::COLLECTION) ("Gal4" . SPARSER::PROTEIN)
    ("AR and YB-1" . SPARSER::COLLECTION)
    ("AR, YB-1 and PSA" . SPARSER::COLLECTION)
    ("dihydrotestosterone (DHT)" . SPARSER::DRUG)
    ("LNCaP/DHT" . SPARSER::COLLECTION) ("androgen/AR" . SPARSER::COLLECTION)
    ("oncogene or tumor" . SPARSER::COLLECTION)
    ("Androgen and androgen receptor" . SPARSER::COLLECTION)
    ("YB-1 and AR" . SPARSER::COLLECTION)
    ("β -galactosidase" . SPARSER::PROTEIN) ("C4-2" . SPARSER::PROTEIN)
    ("P3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("miR-125a" . SPARSER::PROTEIN)
    ("miR-200a" . SPARSER::MOLECULE) ("micro-RNA" . SPARSER::MICRO-RNA)
    ("AKT and MEK" . SPARSER::COLLECTION)
    ("complex (KPC)" . SPARSER::BIO-COMPLEX)
    ("The threonine-187-phosphorylated (T187-phosphorylated) P27"
     . SPARSER::PROTEIN)
    ("calpains" . SPARSER::PROTEIN) ("P27 and BCL-2" . SPARSER::COLLECTION)
    ("BAK and BAX" . SPARSER::COLLECTION) ("BAK" . SPARSER::PROTEIN)
    ("The NAC's" . SPARSER::PROTEIN) ("CDK1-CyclinB" . SPARSER::COLLECTION)
    ("CDK2-CyclinE" . SPARSER::PROTEIN-PAIR)
    ("CDK4/6-CyclinD" . SPARSER::COLLECTION)
    ("CDK-Cyclin" . SPARSER::COLLECTION) ("CyclinB" . SPARSER::PROTEIN)
    ("CyclinE" . SPARSER::PROTEIN-FAMILY) ("CyclinD" . SPARSER::PROTEIN)
    ("p18-BAX" . SPARSER::COLLECTION) ("BID and BAD" . SPARSER::COLLECTION)
    ("BCL-2, BCL-XL and MCL-1" . SPARSER::COLLECTION)
    ("BIM, BID and BAD" . SPARSER::COLLECTION) ("BAD" . SPARSER::PROTEIN)
    ("the pro-apoptotic BCL-2 family" . SPARSER::PROTEIN-FAMILY)
    ("NAC or MitoTEMPO" . SPARSER::COLLECTION)
    ("SMAC/Diablo" . SPARSER::COLLECTION) ("Diablo" . SPARSER::PROTEIN)
    ("three representative substances" . SPARSER::SUBSTANCE)
    ("Mitochondria" . SPARSER::PROTEIN)
    ("NAC and MitoTEMPO" . SPARSER::COLLECTION)
    ("cysteine (NAC)" . SPARSER::MOLECULE) ("MitoTEMPO" . SPARSER::DRUG)
    ("NAC" . SPARSER::PROTEIN) ("FCM" . SPARSER::MOLECULE)
    ("caspase-3 and PARP" . SPARSER::COLLECTION)
    ("simultaneous P27" . SPARSER::PROTEIN)
    ("NC or siP27" . SPARSER::COLLECTION)
    ("siP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDK2-Cyclin E" . SPARSER::PROTEIN-PAIR)
    ("CDK4/6-Cyclin D" . SPARSER::COLLECTION) ("Propidium" . SPARSER::MOLECULE)
    ("the INK4A family and its downstream effector RB" . SPARSER::COLLECTION)
    ("the over-activated SCF" . SPARSER::PROTEIN)
    ("a well-defined substrate" . SPARSER::SUBSTRATE)
    ("IAP-binding mitochondrial protein (SMAC/DIABLO) and cytochrome c"
     . SPARSER::COLLECTION)
    ("the robust ROS" . SPARSER::PROTEIN) ("SMAC/DIABLO" . SPARSER::COLLECTION)
    ("DIABLO" . SPARSER::PROTEIN) ("SMAC" . SPARSER::PROTEIN)
    ("IAP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("AIF" . SPARSER::PROTEIN)
    ("SKP" . SPARSER::PROTEIN) ("JC-1" . SPARSER::MOLECULE)
    ("caspase9" . SPARSER::PROTEIN) ("Kip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("regulator of cell cycle" . SPARSER::PROTEIN) ("MCL-1" . SPARSER::PROTEIN)
    ("DCFH-DA" . SPARSER::DRUG) ("INK4A" . SPARSER::PROTEIN)
    ("P16" . SPARSER::PROTEIN) ("CCK8" . SPARSER::PROTEIN)
    ("Cyclin D" . SPARSER::PROTEIN) ("CDK4/6" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinase inhibitor 1B" . SPARSER::PROTEIN)
    ("CUL1" . SPARSER::PROTEIN) ("apoptosis-inducing" . SPARSER::PROTEIN)
    ("MLN4924" . SPARSER::DRUG) ("Cullin1" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor 1B" . SPARSER::PROTEIN)
    ("the retrospective part" . SPARSER::COMPONENT)
    ("the largest cohort" . SPARSER::MOLECULE)
    ("MLH1, PMS2, and MSH6" . SPARSER::COLLECTION)
    ("MLH1 and PMS2" . SPARSER::COLLECTION)
    ("MLH1, MSH2, MSH6, and PMS2" . SPARSER::COLLECTION)
    ("HER2, E-cadherin, and MSI" . SPARSER::COLLECTION)
    ("a retrospective cohort" . SPARSER::MOLECULE)
    ("the monoclonal anti-HER2 antibody trastuzumab" . SPARSER::DRUG)
    ("at least one DNA MMR proteins" . SPARSER::PROTEIN)
    ("E-cadherin and DNA" . SPARSER::COLLECTION) ("MMR" . SPARSER::PROTEIN)
    ("MSH6" . SPARSER::PROTEIN) ("PMS2" . SPARSER::PROTEIN)
    ("MSH-6" . SPARSER::PROTEIN) ("MSH2" . SPARSER::PROTEIN)
    ("p11" . SPARSER::PROTEIN)
    ("p38α, p38β, p38γ, and p38δ" . SPARSER::COLLECTION)
    ("p38, IL-6 and TNF-α" . SPARSER::COLLECTION)
    ("saposin" . SPARSER::PROTEIN)
    ("the p38 pro-inflammatory kinase" . SPARSER::KINASE)
    ("PMA and TNF-α" . SPARSER::COLLECTION)
    ("PMA or TNF-α" . SPARSER::COLLECTION)
    ("a potent inflammatory cytokine" . SPARSER::PROTEIN)
    ("proinflammatory cytokines or inflammation inducers"
     . SPARSER::COLLECTION)
    ("a predominant kinase" . SPARSER::KINASE)
    ("inflammatory mediators, and p38" . SPARSER::COLLECTION)
    ("mediators, and p38" . SPARSER::COLLECTION)
    ("prosaposin" . SPARSER::PROTEIN) ("The former two types" . TYPE)
    ("hematopoietic growth factors and proinflammatory cytokines"
     . SPARSER::COLLECTION)
    ("p38-inducible proinflammatory cytokines" . SPARSER::PROTEIN)
    ("the pro-inflammatory kinase p38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("glucosidase" . SPARSER::PROTEIN)
    ("colony-stimulating factor" . SPARSER::PROTEIN)
    ("GBA1" . SPARSER::PROTEIN) ("p53-wildtype" . SPARSER::COLLECTION)
    ("DDX3X and CTNNB1" . SPARSER::COLLECTION)
    ("SW480 and DLD-1" . SPARSER::COLLECTION)
    ("APC or CTNNB1" . SPARSER::COLLECTION)
    ("DDX3 and DDX5" . SPARSER::COLLECTION)
    ("DDX5 and DDX17" . SPARSER::COLLECTION)
    ("CCND1 , c -MYC and BIRC5A" . SPARSER::COLLECTION)
    ("AXIN2 , CCND1 and BIRC5A" . SPARSER::COLLECTION)
    ("c -MYC , AXIN2 , CCND1 and BIRC5A" . SPARSER::COLLECTION)
    ("CTNNB1 and DDX3X" . SPARSER::COLLECTION)
    ("APC and TP53" . SPARSER::COLLECTION)
    ("DLD-1 and SW480" . SPARSER::COLLECTION) ("APC-" . SPARSER::PROTEIN)
    ("RK" . SPARSER::PROTEIN) ("c- MYC" . SPARSER::PROTEIN)
    ("RNAse A" . SPARSER::PROTEIN) ("DDX17" . SPARSER::PROTEIN)
    ("DDX5" . SPARSER::PROTEIN) ("c -MYC" . SPARSER::PROTEIN)
    ("TCF-4" . SPARSER::PROTEIN) ("protein dishevelled" . SPARSER::PROTEIN)
    ("DDX3" . SPARSER::PROTEIN) ("RNA helicase family" . SPARSER::PROTEIN)
    ("PTEN/Akt" . SPARSER::COLLECTION) ("ani-miR-21" . SPARSER::COLLECTION)
    ("“onco-miR" . SPARSER::COLLECTION)
    ("oncogenes and suppressor oncogenes" . SPARSER::COLLECTION)
    ("autophagic proteins LC3 and Beclin-1" . SPARSER::COLLECTION)
    ("LC3 and Beclin-1" . SPARSER::COLLECTION)
    ("anti-miR-21 or sorafenib" . SPARSER::COLLECTION)
    ("Akt and caspase-3" . SPARSER::COLLECTION)
    ("protein, and sorafenib" . SPARSER::COLLECTION)
    ("pepstatin" . SPARSER::DRUG) ("rapamycin (RAP)" . SPARSER::DRUG)
    ("mTOR and an inducer" . SPARSER::COLLECTION)
    ("two key autophagic proteins" . SPARSER::PROTEIN)
    ("LC3-II and Beclin-1" . SPARSER::COLLECTION) ("MDC" . SPARSER::PROTEIN)
    ("monodansylcadaverine" . SPARSER::DRUG) ("ATGs" . SPARSER::DRUG)
    ("protein (ATG)" . SPARSER::PROTEIN) ("PCD" . SPARSER::PROTEIN)
    ("phosphatase and tensin homolog (PTEN)" . SPARSER::PROTEIN)
    ("programmed cell death 4, maspin and metallopeptidase"
     . SPARSER::COLLECTION)
    ("metallopeptidase" . SPARSER::PROTEIN) ("tropomyosin" . SPARSER::PROTEIN)
    ("ribosomal protein S6 kinase (S6K) and eukaryotic translation initiation factor 4E-binding protein 1 (4EBP1)"
     . SPARSER::COLLECTION)
    ("Raf/MAPK/ERK" . SPARSER::COLLECTION)
    ("Raf/mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("a first-line systemic drug" . SPARSER::DRUG)
    ("sorafenib, and miR-21" . SPARSER::COLLECTION) ("H-2b" . SPARSER::PROTEIN)
    ("p62" . SPARSER::PROTEIN) ("ATG8" . SPARSER::PROTEIN)
    ("interferon-α" . SPARSER::DRUG)
    ("programmed cell death 4" . SPARSER::PROTEIN)
    ("regulated kinase" . SPARSER::PROTEIN)
    ("inhibitor and PI3K" . SPARSER::COLLECTION)
    ("caspase-3, caspase-9, and PARP" . SPARSER::COLLECTION)
    ("pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("Bcl-2 and Beclin1" . SPARSER::COLLECTION) ("Licorice" . SPARSER::DRUG)
    ("Atg12-Atg5" . SPARSER::COLLECTION) ("silibinin" . SPARSER::DRUG)
    ("ICE" . SPARSER::PROTEIN) ("Tetrapeptide" . SPARSER::MOLECULE)
    ("HL60" . SPARSER::PROTEIN) ("Atg12 and Beclin1" . SPARSER::COLLECTION)
    ("Beclin1 or Atg7" . SPARSER::COLLECTION) ("AAI" . SPARSER::PROTEIN)
    ("Atg7, Beclin1, and LC3-II" . SPARSER::COLLECTION)
    ("U0126, 3-MA, and wortmannin" . SPARSER::COLLECTION)
    ("DP" . SPARSER::PROTEIN)
    ("Atg5, Atg7, Atg12, Beclin1, and LC3-II" . SPARSER::COLLECTION)
    ("Atg5, Atg7, and Atg12" . SPARSER::COLLECTION)
    ("The autophagic genes Beclin-1, Atg5, Atg7, Atg12, and LC3"
     . SPARSER::COLLECTION)
    ("Beclin-1, Atg5, Atg7, Atg12, and LC3" . SPARSER::COLLECTION)
    ("fucoxanthin" . SPARSER::DRUG) ("chloroquine" . SPARSER::PROTEIN)
    ("Atg12 and autophagosome-associated form (LC3-II)" . SPARSER::COLLECTION)
    ("the selective autophagy protein Beclin 1, Atg5, Atg7, Atg12 and autophagosome-associated form (LC3-II)"
     . SPARSER::COLLECTION)
    ("autophagosome-associated form" . SPARSER::FORM)
    ("Bax and Bak" . SPARSER::COLLECTION)
    ("Bcl-2 and Bid" . SPARSER::COLLECTION)
    ("caspase-9, caspase-3, and PARP" . SPARSER::COLLECTION)
    ("Bid" . SPARSER::PROTEIN) ("isoliquiritigenin" . SPARSER::DRUG)
    ("cleaved-PARP, cleaved-caspase-3 and LC3-II" . SPARSER::COLLECTION)
    ("rapamycin and LicA" . SPARSER::COLLECTION)
    ("LicA and LY294002" . SPARSER::COLLECTION)
    ("cleaved-caspase-9, cleaved-caspase-3, and cleaved-PARP"
     . SPARSER::COLLECTION)
    ("Bcl-2 and LC3-II" . SPARSER::COLLECTION)
    ("PI3/Akt" . SPARSER::COLLECTION) ("si" . SPARSER::PROTEIN)
    ("phosphorylated-ERK1/2, phosphorylated-p38, or phosphorylated-JNK1/2"
     . SPARSER::COLLECTION)
    ("Atg12/Beclin1" . SPARSER::COLLECTION)
    ("cytoplasmic LC3-II and acidic autophagic vacuoles (Figure xref , down)"
     . SPARSER::COLLECTION)
    ("LicA and 10 mM 3-MA (an inhibitor of autophagy)" . SPARSER::COLLECTION)
    ("other autophagy-associated proteins" . SPARSER::PROTEIN)
    ("Beclin1, Atg5, and Atg7" . SPARSER::COLLECTION)
    ("Beclin-1 and the Atg family" . SPARSER::COLLECTION)
    ("cleaved-caspase-3, cleaved-caspase-9, and cleaved-PARP"
     . SPARSER::COLLECTION)
    ("siRNA-Akt" . SPARSER::COLLECTION)
    ("Atg5, Atg7, Atg12 and Beclin1" . SPARSER::COLLECTION)
    ("curcumin, resveratrol, oridonin, and quercetin" . SPARSER::COLLECTION)
    ("quercetin" . SPARSER::MOLECULE) ("oridonin" . SPARSER::DRUG)
    ("resveratrol" . SPARSER::PROTEIN) ("MKK4/JNK" . SPARSER::COLLECTION)
    ("proliferating cell nuclear antigen, beta-catenin, COX-2, and iNOS"
     . SPARSER::COLLECTION)
    ("a characteristic chalcone" . SPARSER::MOLECULE)
    ("Glycyrrhiza" . SPARSER::DRUG) ("licorice" . SPARSER::DRUG)
    ("chalcone" . SPARSER::MOLECULE) ("kinase (MAPK)" . SPARSER::KINASE)
    ("PI3K-AKT-mTOR" . SPARSER::COLLECTION)
    ("phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin"
     . SPARSER::COLLECTION)
    ("caspases and Bcl-2" . SPARSER::COLLECTION)
    ("si-Akt" . SPARSER::COLLECTION)
    ("Atg5, Atg7, Atg12 and microtubule-associated protein"
     . SPARSER::COLLECTION)
    ("Atg7" . SPARSER::PROTEIN) ("LicA" . SPARSER::PROTEIN)
    ("mM 3" . SPARSER::PROTEIN) ("Stat 2" . SPARSER::PROTEIN)
    ("LC3-II" . SPARSER::PROTEIN) ("JNK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("acridine orange" . SPARSER::MOLECULE)
    ("Acridine orange" . SPARSER::MOLECULE) ("HK-2" . SPARSER::PROTEIN)
    ("GFP-LC3" . SPARSER::PROTEIN) ("Bafilomycin A1" . SPARSER::DRUG)
    ("Z-VAD-FMK" . SPARSER::DRUG) ("MKK4" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-9" . SPARSER::PROTEIN)
    ("bcl-2" . SPARSER::PROTEIN) ("anti-microbial" . SPARSER::DRUG)
    ("Beclin-1" . SPARSER::PROTEIN) ("bafilomycin A1" . SPARSER::DRUG)
    ("LC3" . SPARSER::PROTEIN) ("light chain 3" . SPARSER::PROTEIN)
    ("Atg12" . SPARSER::PROTEIN)
    ("LIX1L and the modifying kinase" . SPARSER::COLLECTION)
    ("peptides and inhibitors" . SPARSER::COLLECTION)
    ("known ligand" . SPARSER::LIGAND)
    ("WT ROS1 and a ligand" . SPARSER::COLLECTION)
    ("miRNA-mRNA" . SPARSER::COLLECTION)
    ("GPCPD1 and TDRP" . SPARSER::COLLECTION)
    ("EGFR/Akt" . SPARSER::COLLECTION)
    ("GPCPD1, LRIG1, COL4A1, CSDE1, HAS2 and TDRP" . SPARSER::COLLECTION)
    ("noninvasive biomarker" . SPARSER::MOLECULE)
    ("methionine- and choline-deficient (MCD)-fed mice xref"
     . SPARSER::COLLECTION)
    ("methionine-" . SPARSER::AMINO-ACID) ("MCD" . SPARSER::PROTEIN)
    ("LIX1L-associated putative miRNAs" . SPARSER::PROTEIN)
    ("ROS1, ABL1 and ABL2" . SPARSER::COLLECTION)
    ("mutated peptide" . SPARSER::PEPTIDE)
    ("Cofilin, and PY136" . SPARSER::COLLECTION)
    ("Cofilin and LIX1L" . SPARSER::COLLECTION)
    ("phosphoprotein" . SPARSER::PROTEIN) ("TDRP" . SPARSER::PROTEIN)
    ("Collagen" . SPARSER::PROTEIN) ("Leucine" . SPARSER::AMINO-ACID)
    ("PITA, TargetScan, and microRNA" . SPARSER::COLLECTION)
    ("PITA, TargetScan and microRNA" . SPARSER::COLLECTION)
    ("PITA" . SPARSER::PROTEIN) ("LIX1L and miRNAs" . SPARSER::COLLECTION)
    ("tRNA, exons, introns and small RNA pseudogenes" . SPARSER::COLLECTION)
    ("tRNA" . SPARSER::PROTEIN) ("snoRNA" . SPARSER::RNA)
    ("snRNA" . SPARSER::RNA)
    ("DHX9, nucleolin and hnRNPL" . SPARSER::COLLECTION)
    ("nucleolin (N-p100) and hnRNPL (N-p68)" . SPARSER::COLLECTION)
    ("DHX9 (N-p150), nucleolin (N-p100) and hnRNPL (N-p68)"
     . SPARSER::COLLECTION)
    ("hnRNPL" . SPARSER::PROTEIN)
    ("nucleolin (C-p80) and PABPC4 (C-p80)" . SPARSER::COLLECTION)
    ("RIOK1 (C-p89), nucleolin (C-p80) and PABPC4 (C-p80)"
     . SPARSER::COLLECTION)
    ("proteins, C-p89 and C-p80 " . SPARSER::COLLECTION)
    ("pSer" . SPARSER::PROTEIN) ("pThr" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("FLAG-LIX1L" . SPARSER::COLLECTION) ("FLG" . SPARSER::PROTEIN)
    ("HEK" . SPARSER::PROTEIN)
    ("only one homeodomain peptide" . SPARSER::PEPTIDE)
    ("Ser, Thr and Tyr" . SPARSER::COLLECTION)
    ("PKB and p38" . SPARSER::COLLECTION) ("PKB and MK2" . SPARSER::COLLECTION)
    ("phosphoinositide-3-kinase (PI3K) and mitogen-activated protein kinase (MAPK)"
     . SPARSER::COLLECTION)
    ("TIS11b and KSRP" . SPARSER::COLLECTION) ("TIS11b" . SPARSER::PROTEIN)
    ("KSRP" . SPARSER::PROTEIN) ("#1 or #2" . SPARSER::COLLECTION)
    ("#1" . SPARSER::PROTEIN) ("shRNA-#1 or -#2" . SPARSER::COLLECTION)
    ("shRNA-#1" . SPARSER::COLLECTION)
    ("Normal cardiac muscle" . SPARSER::PROTEIN)
    ("IHC and western blot" . SPARSER::COLLECTION) ("Lft" . SPARSER::PROTEIN)
    ("Approximately 180 genes" . SPARSER::GENE) ("TYR" . SPARSER::AMINO-ACID)
    ("HCK" . SPARSER::PROTEIN) ("PY" . SPARSER::MOLECULE)
    ("pTyr" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("proteins and the microRNAs (miRNAs)" . SPARSER::COLLECTION)
    ("proteins (RIOK1, nucleolin and PABPC4) and miRNAs (has-miRNA-520a-5p, −300, −216b, −326, −190a, −548b-3p, −7–5p and −1296)"
     . SPARSER::COLLECTION)
    ("RIOK1, nucleolin and PABPC4" . SPARSER::COLLECTION)
    ("nucleolin" . SPARSER::PROTEIN) ("TOF" . SPARSER::PROTEIN)
    ("RNA-binding protein (RBP)" . SPARSER::PROTEIN)
    ("top 1" . SPARSER::PROTEIN) ("RNA-binding Protein" . SPARSER::PROTEIN)
    ("3-(4,5-dimethylthiazol-2-yl)- 2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("NH 2" . SPARSER::MOLECULE) ("Full-length" . SPARSER::PROTEIN)
    ("α Tubulin" . SPARSER::PROTEIN) ("MCM2" . SPARSER::PROTEIN)
    ("IRS-2" . SPARSER::PROTEIN) ("IGF2BP2" . SPARSER::PROTEIN)
    ("Testis development related protein" . SPARSER::PROTEIN)
    ("HAS2" . SPARSER::PROTEIN) ("Hyaluronan synthase 2" . SPARSER::PROTEIN)
    ("Cold shock domain containing E1" . SPARSER::PROTEIN)
    ("COL4A1" . SPARSER::PROTEIN) ("LRIG1" . SPARSER::PROTEIN)
    ("GPCPD1" . SPARSER::PROTEIN)
    ("Glycerophosphocholine phosphodiesterase 1" . SPARSER::PROTEIN)
    ("N-p" . SPARSER::PROTEIN) ("p80" . SPARSER::PROTEIN)
    ("p80 " . SPARSER::PROTEIN) ("p89" . SPARSER::PROTEIN)
    ("TIS11" . SPARSER::PROTEIN) ("cardiac muscle" . SPARSER::PROTEIN)
    ("LIX1" . SPARSER::PROTEIN) ("ABL2" . SPARSER::PROTEIN)
    ("ROS1" . SPARSER::PROTEIN) ("PABPC4" . SPARSER::PROTEIN)
    ("RIOK1" . SPARSER::PROTEIN) ("LIX1L" . SPARSER::PROTEIN)
    ("medicine, PHA665752 and AG490" . SPARSER::COLLECTION)
    ("AKT and sonic hedgehog" . SPARSER::COLLECTION)
    ("cMET and phospho-cMET" . SPARSER::COLLECTION)
    ("a traditional medicine" . SPARSER::DRUG)
    ("antibodies [ xref ] and antagonist [ xref ]" . SPARSER::COLLECTION)
    ("indeed its receptor cMET" . SPARSER::PROTEIN)
    ("EGFR-TK" . SPARSER::COLLECTION)
    ("PHA665752 and their combination (Fig.  xref , top)"
     . SPARSER::COLLECTION)
    ("HGF-" . SPARSER::PROTEIN) ("HGF/cMET" . SPARSER::COLLECTION)
    ("p " . SPARSER::PROTEIN) ("inhibitor (TKI)" . SPARSER::INHIBITOR)
    ("TGF" . SPARSER::DRUG) ("HGF and its receptor" . SPARSER::COLLECTION)
    ("cMET" . SPARSER::PROTEIN) ("HGF/EGF" . SPARSER::COLLECTION)
    ("HGF and EGF" . SPARSER::COLLECTION)
    ("HGF receptor and EGF" . SPARSER::COLLECTION)
    ("PHA665752 and SU11274" . SPARSER::COLLECTION)
    ("scatter factor" . SPARSER::PROTEIN)
    ("a 2 " . SPARSER::HUMAN-PROTEIN-FAMILY) ("AG490" . SPARSER::DRUG)
    ("hepatocyte growth factor" . SPARSER::PROTEIN)
    ("PI3 K" . SPARSER::PROTEIN-FAMILY) ("PHA665752" . SPARSER::MOLECULE)
    ("HGF receptor" . SPARSER::PROTEIN)
    ("Hepatocyte growth factor" . SPARSER::PROTEIN)
    ("SRSF1 (encoding SRSF1) or U2AF2 (encoding U2AF65)" . SPARSER::COLLECTION)
    ("larger protein" . SPARSER::PROTEIN)
    ("Sam68-associated RBP" . SPARSER::PROTEIN)
    ("U2AF2 and SRSF1" . SPARSER::COLLECTION)
    ("Sam68 (n = 371; R = −0.01; FDR = 0.86) and AR-V7 ( xref , left panel)"
     . SPARSER::COLLECTION)
    ("SRSF1 (n = 371; R = 0.14; FDR = 0.01) and U2AF65 (n = 371; R = 0.23; FDR = 0.00003)"
     . SPARSER::COLLECTION)
    ("AR-V7 (ENST00000504326) and the major Ensembl transcripts encoding Sam68 (ENST00000327300)"
     . SPARSER::COLLECTION)
    ("PCa (n = 59) and CRPCa (n = 35)" . SPARSER::COLLECTION)
    ("KHDRBS1 or SRSF1" . SPARSER::COLLECTION)
    ("KHDRBS1 as well as SRSF1 and U2AF2" . SPARSER::COLLECTION)
    ("SRSF1 and U2AF2" . SPARSER::COLLECTION)
    ("SRSF1 and U2AF65" . SPARSER::COLLECTION)
    ("neither wild-type Sam68 nor the Sam68 V229F mutant"
     . SPARSER::COLLECTION)
    ("canonical AR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p " . SPARSER::PROTEIN)
    ("Sam68 and AR" . SPARSER::COLLECTION)
    ("ectopically-expressed Sam68 and AR-V7 proteins" . SPARSER::PROTEIN)
    ("Sam68-AR-V7" . SPARSER::COLLECTION) ("antiserum" . SPARSER::PROTEIN)
    ("Sam68 and full-length" . SPARSER::COLLECTION)
    ("AR-V7 nor full-length AR mRNAs" . SPARSER::COLLECTION)
    ("AR-V7 and full-length" . SPARSER::COLLECTION)
    ("mRNA or Sam68" . SPARSER::COLLECTION)
    ("AR-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the constitutively-active cytomegalovirus (CMV) promoter"
     . SPARSER::PROMOTER)
    ("RNA-binding proteins (RBPs) SRSF1 (encoded by SRSF1 ) and U2AF65 (encoded by U2AF2 )"
     . SPARSER::COLLECTION)
    ("U2AF2" . SPARSER::PROTEIN) ("U2AF65" . SPARSER::PROTEIN)
    ("AR and AR-V7" . SPARSER::COLLECTION)
    ("an important predictive biomarker" . SPARSER::MOLECULE)
    ("amine" . SPARSER::MOLECULE)
    ("variants as well as their downstream functions" . SPARSER::COLLECTION)
    ("Sam68 and other RBPs" . SPARSER::COLLECTION)
    ("Sam68 and AR-V7" . SPARSER::COLLECTION) ("RBP" . SPARSER::PROTEIN)
    ("cryptic" . SPARSER::PROTEIN) ("PCa" . SPARSER::PROTEIN)
    ("β–Galactosidase" . SPARSER::PROTEIN) ("G418S" . SPARSER::MOLECULE)
    ("SC35" . SPARSER::PROTEIN) ("GAL4" . SPARSER::PROTEIN)
    ("HNRNPA2B1" . SPARSER::PROTEIN) ("hnRNPA2" . SPARSER::PROTEIN)
    ("U2AF" . SPARSER::BIO-COMPLEX) ("SRSF1" . SPARSER::PROTEIN)
    ("UBE2C" . SPARSER::PROTEIN) ("KHDRBS1" . SPARSER::PROTEIN)
    ("Sam68" . SPARSER::PROTEIN) ("RNA-binding protein" . SPARSER::PROTEIN)
    ("Akt and XIAP" . SPARSER::COLLECTION)
    ("ubiquitin-proteasomal" . SPARSER::COLLECTION)
    ("Cyclin–Cdk" . SPARSER::COLLECTION)
    ("Cdk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("inhibitor and tumor" . SPARSER::COLLECTION)
    ("p16/RB" . SPARSER::COLLECTION) ("Bad and Bax" . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-XL" . SPARSER::COLLECTION)
    ("Bad, Bax, Bcl-2, and Bcl-XL" . SPARSER::COLLECTION)
    ("/PI" . SPARSER::COLLECTION)
    ("flow cytometric DNA-histogram" . SPARSER::DNA)
    ("DNA-histogram" . SPARSER::DNA)
    ("the S-related protein Cyclin A and the G 2 /M-related protein Cyclin B1"
     . SPARSER::COLLECTION)
    ("p53 and p21 Cip1" . SPARSER::COLLECTION)
    ("p16 and pRB" . SPARSER::COLLECTION)
    ("NF-κB and AP-1" . SPARSER::COLLECTION)
    ("Ginsenoside" . SPARSER::MOLECULE) ("Fluorouracil" . SPARSER::DRUG)
    ("a steroidal saponin" . SPARSER::DRUG)
    ("-ginsenoside" . SPARSER::MOLECULE) ("saponin" . SPARSER::DRUG)
    ("ginsenoside" . SPARSER::MOLECULE) ("Waf1" . SPARSER::PROTEIN)
    ("p16" . SPARSER::PROTEIN) ("GLB1" . SPARSER::PROTEIN)
    ("CS4" . SPARSER::PROTEIN) ("GB-1" . SPARSER::PROTEIN)
    ("p16 INK4A" . SPARSER::PROTEIN) ("Bcl-XL" . SPARSER::PROTEIN)
    ("Dendriplexes" . SPARSER::PROTEIN)
    ("dendriplexes and h-R3-dendriplexes in tumor-bearing BALB/c nude mice"
     . SPARSER::COLLECTION)
    ("the first-line chemotherapeutic drug" . SPARSER::DRUG)
    ("Paclitaxel" . SPARSER::DRUG)
    ("p53, h-R3-PAMAM and h-R3-DNA-PAMAM" . SPARSER::COLLECTION)
    ("nucleic acid nanoparticles" . SPARSER::MOLECULE)
    ("H-R3" . SPARSER::PROTEIN)
    ("dendriplexes and h-R3-dendriplexes" . SPARSER::COLLECTION)
    ("LysoTracker" . SPARSER::DRUG)
    ("enhanced green fluorescent protein (EGFP)" . SPARSER::PROTEIN)
    ("pEGFP-N1" . SPARSER::COLLECTION) ("EPR" . SPARSER::PROTEIN)
    ("dendriplex" . SPARSER::PROTEIN)
    ("h-R3-dendriplex and the free h-R3" . SPARSER::COLLECTION)
    ("h-R3-dendriplex" . SPARSER::COLLECTION)
    ("Dynamic light" . SPARSER::PROTEIN) ("anionic DNA" . SPARSER::DNA)
    ("H-R3-dendriplexes" . SPARSER::COLLECTION)
    ("Self-assembled h-R3-dendriplexes" . SPARSER::COLLECTION)
    ("dendrimer" . SPARSER::MOLECULE)
    ("Amino-terminated PAMAM dendrimers" . SPARSER::MOLECULE)
    ("dendrimers" . SPARSER::MOLECULE) ("dynamic light" . SPARSER::PROTEIN)
    ("zeta" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("self-assembled h-R3-dendriplexes" . SPARSER::COLLECTION)
    ("h-R3 and EGF" . SPARSER::COLLECTION) ("Nimotuzumab" . SPARSER::DRUG)
    ("biomacromolecule" . SPARSER::MOLECULE)
    ("EGF [ xref ] and antibody [ xref ]" . SPARSER::COLLECTION)
    ("folate" . SPARSER::MOLECULE) ("polymer" . SPARSER::MOLECULE)
    ("cationic polymers" . SPARSER::MOLECULE)
    ("dendriplexes" . SPARSER::PROTEIN)
    ("h-R3-dendriplexes" . SPARSER::COLLECTION) ("PAMAM" . SPARSER::MOLECULE)
    ("Anti-EGFR" . SPARSER::PROTEIN) ("P 20" . SPARSER::PROTEIN)
    ("3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("enhanced green fluorescent protein" . SPARSER::PROTEIN)
    ("H-R" . SPARSER::PROTEIN) ("h-R3" . SPARSER::PROTEIN)
    ("at least one validated TPA response element"
     . SPARSER::DNA-RESPONSE-ELEMENT)
    ("a dimeric protein" . SPARSER::PROTEIN)
    ("Fra-1 and c-Jun" . SPARSER::COLLECTION)
    ("IKK-IkB-NFκB" . SPARSER::COLLECTION)
    ("pro-inflammatory chemokines" . SPARSER::PROTEIN)
    ("enhancers and/or loss-of-function" . SPARSER::COLLECTION)
    ("the mammary fat" . SPARSER::PROTEIN)
    ("RKIP, or RKIP" . SPARSER::COLLECTION)
    ("RKIP and AP1" . SPARSER::COLLECTION)
    ("a hetero-dimeric protein" . SPARSER::PROTEIN)
    ("Fos and Jun" . SPARSER::COLLECTION)
    ("Fos" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RKIP, Erk2, and MMP13" . SPARSER::COLLECTION)
    ("RKIP and Erk2Q103A" . SPARSER::COLLECTION)
    ("Erk2 and Erk1" . SPARSER::COLLECTION)
    ("Erk1 and Erk2" . SPARSER::COLLECTION)
    ("Erk1 or Erk2" . SPARSER::COLLECTION)
    ("Stat3, Akt and IKK2" . SPARSER::COLLECTION)
    ("Erk2, IKK2, Akt1, or Stat3" . SPARSER::COLLECTION)
    ("Erk, IKK, Akt, and Stat3" . SPARSER::COLLECTION)
    ("GSK-catenin" . SPARSER::COLLECTION) ("IkB-NFκB" . SPARSER::COLLECTION)
    ("IKK-" . SPARSER::PROTEIN) ("IkB" . SPARSER::PROTEIN)
    ("a heterologous promoter" . SPARSER::PROMOTER)
    ("a possible repressor" . SPARSER::REPRESSOR)
    ("MMP/RKIP" . SPARSER::COLLECTION) ("MMP13/RKIP" . SPARSER::COLLECTION)
    ("RKIP and MMP13" . SPARSER::COLLECTION) ("Inhibitor" . SPARSER::INHIBITOR)
    ("RKIP-" . SPARSER::PROTEIN) ("RKIP/MMP13" . SPARSER::COLLECTION)
    ("MMP1 and MMP2" . SPARSER::COLLECTION)
    ("possible effector" . SPARSER::EFFECTOR)
    ("strong mediators" . SPARSER::PROTEIN)
    ("protein or RKIP" . SPARSER::COLLECTION)
    ("STAT3, and GSK" . SPARSER::COLLECTION)
    ("keap1/nrf2" . SPARSER::COLLECTION)
    ("RKIP and MMPs" . SPARSER::COLLECTION)
    ("MMP1, MMP3, MMP10 and MMP13" . SPARSER::COLLECTION)
    ("metalloproteases" . SPARSER::PROTEIN)
    ("Raf-MEK-Erk" . SPARSER::COLLECTION)
    ("Protein or RKIP" . SPARSER::COLLECTION) ("Fra1" . SPARSER::PROTEIN)
    ("Fra-1" . SPARSER::PROTEIN) ("Erk1" . SPARSER::PROTEIN)
    ("IKK2" . SPARSER::PROTEIN) ("nrf2" . SPARSER::PROTEIN)
    ("keap1" . SPARSER::PROTEIN) ("Erk2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("symptomatic stroke group" . SPARSER::MOLECULE)
    ("corona" . SPARSER::MOLECULE) ("Migraine" . SPARSER::PROTEIN)
    ("MIM" . SPARSER::PROTEIN) ("A-M" . SPARSER::PROTEIN)
    ("single-pass" . SPARSER::PROTEIN-FAMILY) ("AAs" . SPARSER::MOLECULE)
    ("a strong independent prognostic biomarker" . SPARSER::MOLECULE)
    ("RR" . SPARSER::MOLECULE) ("Cohort" . SPARSER::MOLECULE)
    ("mTORC2 or ERK" . SPARSER::COLLECTION)
    ("a previously validated Rab1A shRNA or a scrambled control shRNA"
     . SPARSER::COLLECTION)
    ("a previously validated Rab1A shRNA" . SPARSER::PROTEIN)
    ("lentiviral shRNA" . SPARSER::PROTEIN)
    ("SK-HEP-1-Rab1A or BEL-7402-Rab1A" . SPARSER::COLLECTION)
    ("HCCs" . SPARSER::PROTEIN) ("OH" . SPARSER::PROTEIN)
    ("sirolimus" . SPARSER::DRUG) ("semisynthetic analogs" . SPARSER::ANALOG)
    ("Temsirolimus and everolimus" . SPARSER::COLLECTION)
    ("Temsirolimus" . SPARSER::DRUG)
    ("a master growth regulator and a nutrient sensor" . SPARSER::COLLECTION)
    ("the mTOR kinase subunit and accessory proteins [ xref ]"
     . SPARSER::COLLECTION)
    ("a valuable biomarker" . SPARSER::MOLECULE)
    ("Amino acid" . SPARSER::AMINO-ACID) ("P-ERK" . SPARSER::PROTEIN)
    ("2-4" . SPARSER::PROTEIN) ("18 h" . SPARSER::PROTEIN)
    ("P-S6K" . SPARSER::PROTEIN) ("FK506" . SPARSER::DRUG)
    ("Rab1A" . SPARSER::PROTEIN) ("JMP" . SPARSER::PROTEIN)
    ("Flagellar fragments" . SPARSER::FRAGMENT)
    ("flagellar fragments" . SPARSER::FRAGMENT) ("Percoll" . SPARSER::DRUG)
    ("2% sodium dodecyl sulphate (SDS) and 1% β-mercaptoethanol (final concentrations)"
     . SPARSER::COLLECTION)
    ("sulphate (SDS)" . SPARSER::MOLECULE) ("SDS" . SPARSER::PROTEIN)
    ("sulphate" . SPARSER::MOLECULE) ("dodecyl" . SPARSER::MOLECULE)
    ("ATP (3 × 10 6 cpm/nmol) and 0.1 mM vanadate and 200 μM cdc2 peptide"
     . SPARSER::COLLECTION)
    ("0.1 mM vanadate and 200 μM cdc2 peptide" . SPARSER::COLLECTION)
    ("cpm" . SPARSER::PROTEIN) ("vanadate and protease" . SPARSER::COLLECTION)
    ("Sepharose" . SPARSER::MOLECULE) ("hydrate (CHAPS)" . SPARSER::MOLECULE)
    ("orthovanadate and protease" . SPARSER::COLLECTION)
    ("hydrate" . SPARSER::MOLECULE) ("orthovanadate" . SPARSER::MOLECULE)
    ("-lysine" . SPARSER::COLLECTION) ("glass" . SPARSER::MOLECULE)
    ("-FITC" . SPARSER::MOLECULE) ("iodide (PI)" . SPARSER::PROTEIN)
    ("PNA" . SPARSER::PROTEIN) ("agglutinin" . SPARSER::PROTEIN)
    ("vanadate" . SPARSER::MOLECULE) ("VSL/VCL" . SPARSER::COLLECTION)
    ("VSL" . SPARSER::PROTEIN) ("VAP" . SPARSER::PROTEIN)
    ("VCL" . SPARSER::PROTEIN) ("formylmethionyl" . SPARSER::MOLECULE)
    ("peroxidase" . SPARSER::PROTEIN) ("sulphoxide (DMSO)" . SPARSER::DRUG)
    ("sulphoxide" . SPARSER::DRUG) ("ester (PMA)" . SPARSER::MOLECULE)
    ("reagents and anti-tubulin" . SPARSER::COLLECTION)
    ("PMA" . SPARSER::PROTEIN) ("phorbol" . SPARSER::DRUG)
    ("fluorescein isothiocyanate (FITC)" . SPARSER::MOLECULE)
    ("fluorochrome" . SPARSER::MOLECULE) ("Medicine" . SPARSER::DRUG)
    ("the successive AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("normal CG" . SPARSER::PROTEIN) ("strong anti-oxidants" . SPARSER::DRUG)
    ("Lyn and Lyn-Ip" . SPARSER::COLLECTION)
    ("PTK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PG and CG" . SPARSER::COLLECTION)
    ("CG and PG" . SPARSER::COLLECTION)
    ("either CG (panel A) or PG (panel B)" . SPARSER::COLLECTION)
    ("food" . SPARSER::MOLECULE) ("pyrimidine" . SPARSER::DRUG)
    ("PTKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("lipid and protein" . SPARSER::COLLECTION)
    ("proteins and enzymes" . SPARSER::COLLECTION)
    ("B subunit (CTB)" . SPARSER::PROTEIN)
    ("serine and tyrosine" . SPARSER::COLLECTION)
    ("Both patient group (PG) and control group (CG)" . SPARSER::COLLECTION)
    ("group (CG)" . SPARSER::MOLECULE) ("group (PG)" . SPARSER::MOLECULE)
    ("ARC" . SPARSER::PROTEIN) ("PG" . SPARSER::PROTEIN)
    ("carotenoid" . SPARSER::MOLECULE) ("Astaxanthin" . SPARSER::MOLECULE)
    ("cdc2" . SPARSER::PROTEIN) ("subunit B" . SPARSER::PROTEIN)
    ("per 2" . SPARSER::PROTEIN) ("anti-oxidants" . SPARSER::DRUG)
    ("p60src" . SPARSER::PROTEIN) ("t -butyl" . SPARSER::MOLECULE)
    ("CAV 1" . SPARSER::PROTEIN) ("Caveolin 1" . SPARSER::PROTEIN)
    ("CASP3 and PARP1" . SPARSER::COLLECTION)
    ("CASP8 and CASP6" . SPARSER::COLLECTION) ("kras" . SPARSER::PROTEIN)
    ("RELA/p65" . SPARSER::COLLECTION) ("ADC" . SPARSER::PROTEIN)
    ("p53 or p65-pS536" . SPARSER::COLLECTION)
    ("p53/p65" . SPARSER::COLLECTION) ("GABRE" . SPARSER::PROTEIN)
    ("CASP7 (Figure xref ) and/or CASP3 (Figure xref )" . SPARSER::COLLECTION)
    ("CASP7 (Figure xref ) or CASP3 ( xref )" . SPARSER::COLLECTION)
    ("CASP3 (3.70E-04) and CASP7 (2.33E-06) mRNA" . SPARSER::COLLECTION)
    ("State" . SPARSER::BIO-STATE)
    ("miR-224 directly targets CASP3 and CASP7" . SPARSER::COLLECTION)
    ("CASP3 or CASP7" . SPARSER::COLLECTION)
    ("SMAD4 and TNFAIP1" . SPARSER::COLLECTION)
    ("Lenti-miR" . SPARSER::COLLECTION) ("receptor-" . SPARSER::RECEPTOR)
    ("CASP3 and CASP7" . SPARSER::COLLECTION)
    ("TPD52 and/or TRIB1 [ xref , xref ]" . SPARSER::COLLECTION)
    ("API5, SMAD4, PHLPP1, PHLPP2, RKIP and TNFAIP1" . SPARSER::COLLECTION)
    ("RKIP" . SPARSER::PROTEIN) ("CASP7 and CASP3" . SPARSER::COLLECTION)
    ("caspase3 (CASP3) and caspase7 (CASP7)" . SPARSER::COLLECTION)
    ("TNFAIP1 and SMAD4" . SPARSER::COLLECTION) ("CASP 3" . SPARSER::PROTEIN)
    ("B-5" . SPARSER::PROTEIN) ("C-20" . SPARSER::PROTEIN)
    ("CASP6" . SPARSER::PROTEIN) ("CASP8" . SPARSER::PROTEIN)
    ("NF-kb" . SPARSER::PROTEIN) ("caspase8" . SPARSER::PROTEIN)
    ("TRIB1" . SPARSER::PROTEIN) ("TPD52" . SPARSER::PROTEIN)
    ("PHLPP2" . SPARSER::PROTEIN) ("PHLPP1" . SPARSER::PROTEIN)
    ("API5" . SPARSER::PROTEIN) ("CASP7" . SPARSER::PROTEIN)
    ("caspase7" . SPARSER::PROTEIN) ("CASP3" . SPARSER::PROTEIN)
    ("caspase3" . SPARSER::PROTEIN) ("TNFAIP1" . SPARSER::PROTEIN)
    ("circular miRNA" . SPARSER::PROTEIN)
    ("increasingly more complex" . SPARSER::BIO-COMPLEX)
    ("CDR" . SPARSER::PROTEIN) ("circular RNAs" . SPARSER::RNA)
    ("RB1 and CD34" . SPARSER::COLLECTION) ("VCAN" . SPARSER::PROTEIN)
    ("VAPA" . SPARSER::PROTEIN)
    ("PTEN and vice versa ( xref )" . SPARSER::COLLECTION)
    ("onco-miRNA" . SPARSER::COLLECTION) ("-AKT" . SPARSER::COLLECTION)
    ("mRNA and trigger" . SPARSER::COLLECTION)
    ("GAS5-siRNA" . SPARSER::COLLECTION)
    ("the normal human gastric epithelial cell line GES-1" . SPARSER::PROTEIN)
    ("the human normal gastric epithelial cell line GES-1" . SPARSER::PROTEIN)
    ("tumor suppressor gene-phosphatase and tensin homolog"
     . SPARSER::COLLECTION)
    ("linc-MD1" . SPARSER::COLLECTION) ("BGL" . SPARSER::PROTEIN)
    ("ATB" . SPARSER::PROTEIN) ("RoR" . SPARSER::PROTEIN-FAMILY)
    ("lincRNA" . SPARSER::RNA) ("lncRNAs and other RNAs" . SPARSER::COLLECTION)
    ("mRNAs, lncRNAs and other RNAs" . SPARSER::COLLECTION)
    ("natural miRNA" . SPARSER::PROTEIN) ("lncRNA-" . SPARSER::RNA)
    ("ZEB2" . SPARSER::PROTEIN) ("CNOT6L" . SPARSER::PROTEIN)
    ("GAS5" . SPARSER::PROTEIN) ("GES-1" . SPARSER::PROTEIN)
    ("MD1" . SPARSER::PROTEIN) ("miR-106a" . SPARSER::MOLECULE)
    ("family member 4" . SPARSER::PROTEIN) ("FER1" . SPARSER::PROTEIN)
    ("new biomarkers" . SPARSER::MOLECULE)
    ("alternative AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the mature AR protein" . SPARSER::PROTEIN)
    ("the hyperandrogenic state" . SPARSER::BIO-STATE)
    ("steroidogenic" . SPARSER::PROTEIN)
    ("two alternative AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Androgen" . SPARSER::PROTEIN) ("CYP17A1" . SPARSER::PROTEIN)
    ("AR-V7" . SPARSER::PROTEIN) ("X chromosome" . SPARSER::PROTEIN)
    ("dexamethasone, melphalan or bortezomib" . SPARSER::COLLECTION)
    ("–extracellular signal-regulated kinase" . SPARSER::COLLECTION)
    ("Ras–Raf–MAPK kinase" . SPARSER::COLLECTION)
    ("glucocorticoids" . SPARSER::PROTEIN) ("cAMP/PKA" . SPARSER::COLLECTION)
    ("the pro-apoptotic BCL-2 member BIM" . SPARSER::PROTEIN)
    ("melphalan- and dexamethasone-induced cell death in patient-derived primary MM cells"
     . SPARSER::COLLECTION)
    ("melphalan-" . SPARSER::DRUG)
    ("dexamethasone and PDE" . SPARSER::COLLECTION) ("PDE" . SPARSER::PROTEIN)
    ("melphalan, cyclophosphamide, doxorubicin, bortezomib, and dexamethasone"
     . SPARSER::COLLECTION)
    ("the three patient-derived cells MMP5, MMP6 and MMP10"
     . SPARSER::COLLECTION)
    ("MMP5, MMP6 and MMP10" . SPARSER::COLLECTION)
    ("MMP7 and MMP8" . SPARSER::COLLECTION)
    ("bortezomib and melphalan" . SPARSER::COLLECTION)
    ("bortezomib ( xref ) and dexamethasone ( xref )" . SPARSER::COLLECTION)
    ("melphalan, cyclophosphamide, bortezomib or dexamethasone"
     . SPARSER::COLLECTION)
    ("PARP and caspase 3" . SPARSER::COLLECTION)
    ("BCL-2, BCL-XL, and BAX" . SPARSER::COLLECTION)
    ("dexamethasone or forskolin" . SPARSER::COLLECTION)
    ("variants of BIM protein (BIM EL , BIM L and BIM S ) and all"
     . SPARSER::COLLECTION)
    ("EL" . SPARSER::PROTEIN) ("caspase 3 and PARP" . SPARSER::COLLECTION)
    ("cleaved caspase 3 and the caspase substrate poly (ADP-Ribose) polymerase (PARP)"
     . SPARSER::COLLECTION)
    ("Dexamethasone" . SPARSER::PROTEIN) ("RPMI8226" . SPARSER::PROTEIN)
    ("forskolin and dexamethasone" . SPARSER::COLLECTION)
    ("only 2 μM melphalan" . SPARSER::DRUG)
    ("melphalan, cyclophosphamide and doxorubicin" . SPARSER::COLLECTION)
    ("RPMI 8226" . SPARSER::PROTEIN)
    ("the pro-apoptotic protein BIM" . SPARSER::PROTEIN)
    ("cyclophosphamide and melphalan" . SPARSER::COLLECTION)
    ("antibiotic" . SPARSER::DRUG) ("anthracycline" . SPARSER::MOLECULE)
    ("Forskolin or its derivative" . SPARSER::COLLECTION)
    ("Forskolin" . SPARSER::PROTEIN) ("a central cytokine" . SPARSER::PROTEIN)
    ("dexamethasone and forskolin" . SPARSER::COLLECTION)
    ("melphalan, cyclophosphamide, doxorubicin, bortezomib and dexamethasone"
     . SPARSER::COLLECTION)
    ("cyclophosphamide" . SPARSER::DRUG) ("melphalan" . SPARSER::DRUG)
    ("BCL-XL" . SPARSER::PROTEIN) ("ADP-Ribose" . SPARSER::MOLECULE)
    ("CD138" . SPARSER::PROTEIN) ("alpha tubulin" . SPARSER::PROTEIN)
    ("alkylating agent" . SPARSER::MOLECULE)
    ("adenosine monophosphate" . SPARSER::MOLECULE)
    ("actively signalling protein" . SPARSER::PROTEIN)
    ("HER‐2 lacking the antibody's" . SPARSER::PROTEIN)
    ("gefitinib or iressa" . SPARSER::COLLECTION) ("iressa" . SPARSER::DRUG)
    ("HER‐2 and EGFR" . SPARSER::COLLECTION)
    ("lapatinib and trastuzumab" . SPARSER::COLLECTION)
    ("FGF2 and neuregulin 2" . SPARSER::COLLECTION)
    ("EGFR, HER‐2 and FGFR2" . SPARSER::COLLECTION)
    ("PDGFB" . SPARSER::PROTEIN)
    ("the most active signalling complex" . SPARSER::BIO-COMPLEX)
    ("two consecutive valines" . SPARSER::AMINO-ACID)
    ("valines" . SPARSER::AMINO-ACID) ("Ile" . SPARSER::AMINO-ACID)
    ("isoleucine" . SPARSER::AMINO-ACID)
    ("the protective Herstatin" . SPARSER::PROTEIN)
    ("HER‐2/EGFR" . SPARSER::COLLECTION) ("Herstatin" . SPARSER::PROTEIN)
    ("at least two antibodies" . SPARSER::ANTIBODY)
    ("receptor and 648‐CTF" . SPARSER::COLLECTION) ("CTF" . SPARSER::PROTEIN)
    ("incomplete HER‐2 or fragments" . SPARSER::COLLECTION)
    ("HER‐2 or fragments" . SPARSER::COLLECTION) ("Parts" . SPARSER::COMPONENT)
    ("EGFR or HER‐3" . SPARSER::COLLECTION)
    ("phospholipase γ C1" . SPARSER::PROTEIN)
    ("phospholipase" . SPARSER::PROTEIN) ("transducers" . SPARSER::PROTEIN)
    ("HER‐2" . SPARSER::PROTEIN) ("ins" . SPARSER::PROTEIN)
    ("anti" . SPARSER::PROTEIN) ("NRG2" . SPARSER::PROTEIN)
    ("neuregulin 2" . SPARSER::PROTEIN) ("FGF2" . SPARSER::PROTEIN)
    ("FGF1" . SPARSER::PROTEIN)
    ("fibroblast growth factor 1" . SPARSER::PROTEIN)
    ("of 45 " . SPARSER::PROTEIN) ("phospholipase C" . SPARSER::PROTEIN)
    ("γ C" . SPARSER::PROTEIN) ("Adenosine triphosphate" . SPARSER::MOLECULE)
    ("PKA and PP1 and PP2" . SPARSER::COLLECTION)
    ("ion channels and transporters" . SPARSER::COLLECTION)
    ("ATP1a1" . SPARSER::PROTEIN) ("transporters" . SPARSER::PROTEIN)
    ("renin/angiotensin/aldosterone" . SPARSER::COLLECTION)
    ("angiotensin" . SPARSER::PROTEIN) ("renin" . SPARSER::PROTEIN)
    ("PKA and/or PP2A" . SPARSER::COLLECTION)
    ("MR target genes and recruitment" . SPARSER::COLLECTION)
    ("HDAC4 and MR" . SPARSER::COLLECTION)
    ("PP1 and PP2" . SPARSER::COLLECTION)
    ("HDAC4 and PP2A" . SPARSER::COLLECTION)
    ("SIK2 and SIK3" . SPARSER::COLLECTION)
    ("PKA and PP2A" . SPARSER::COLLECTION)
    ("kinase, and protein" . SPARSER::COLLECTION)
    ("active HDAC3 and its co-regulators" . SPARSER::COLLECTION)
    ("nuclear receptor co-repressor1/silencing mediator of retinoic acid and thyroid hormone receptor"
     . SPARSER::COLLECTION)
    ("HDAC1 and HDAC3" . SPARSER::COLLECTION)
    ("HDAC4 and HDAC6" . SPARSER::COLLECTION)
    ("deoxycorticosterone" . SPARSER::MOLECULE)
    ("the histone deacetylase 3 and 4 complex" . SPARSER::COLLECTION)
    ("MR and wild-type HDAC4" . SPARSER::COLLECTION)
    ("A representative blot" . SPARSER::PROTEIN)
    ("Aldo and FSK" . SPARSER::COLLECTION)
    ("Aldo or forskolin" . SPARSER::COLLECTION)
    ("forskolin" . SPARSER::PROTEIN)
    ("Constitutively expressed cyan fluorescent protein (CFP)"
     . SPARSER::PROTEIN)
    ("CFP" . SPARSER::PROTEIN) ("LLC-PK1" . SPARSER::PROTEIN)
    ("the GILZ ( xref ) and SGK-1 ( xref ) promoters" . SPARSER::COLLECTION)
    ("GILZ ( xref ) and SGK-1 ( xref )" . SPARSER::COLLECTION)
    ("MR and PolII" . SPARSER::COLLECTION)
    ("MS-275 or MC1568" . SPARSER::COLLECTION) ("Gilz" . SPARSER::PROTEIN)
    ("MR and Pol" . SPARSER::COLLECTION)
    ("GILZ and SGK-1" . SPARSER::COLLECTION) ("Pol" . SPARSER::PROTEIN)
    ("MS-275 and MC1568" . SPARSER::COLLECTION) ("GILZ" . SPARSER::PROTEIN)
    ("HDAC4 and HDAC5" . SPARSER::COLLECTION) ("Aldo" . SPARSER::PROTEIN)
    ("HA-tagged MR and Flag-tagged HDAC4" . SPARSER::COLLECTION)
    ("MR and class II HDACs" . SPARSER::COLLECTION)
    ("HDAC3 and HDAC4" . SPARSER::COLLECTION)
    ("Aldosterone" . SPARSER::PROTEIN) ("HDAC3/HDAC4" . SPARSER::COLLECTION)
    ("MR or HDAC3" . SPARSER::COLLECTION)
    ("proteins, and cAMP response element-binding protein"
     . SPARSER::COLLECTION)
    ("GATA" . SPARSER::PROTEIN) ("a repressive complex" . SPARSER::BIO-COMPLEX)
    ("PKA, PP1, and PP2" . SPARSER::COLLECTION)
    ("serine-proline" . SPARSER::COLLECTION)
    ("PP1, PP2, and myosin phosphatase" . SPARSER::COLLECTION)
    ("CaMK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IIb" . SPARSER::DRUG)
    ("PKA and PP1/2" . SPARSER::COLLECTION)
    ("calyculin A, and HDAC4" . SPARSER::COLLECTION)
    ("calyculin A, and MS-275" . SPARSER::COLLECTION)
    ("phosphatases (PP)" . SPARSER::PHOSPHATASE) ("PP" . SPARSER::PROTEIN)
    ("MR and HDAC3" . SPARSER::COLLECTION) ("aldosterone" . SPARSER::PROTEIN)
    ("MR and RNA polymerase II" . SPARSER::COLLECTION)
    ("mineralocorticoid receptor (MR)" . SPARSER::PROTEIN)
    ("corepressors" . SPARSER::PROTEIN) ("ATP1" . SPARSER::PROTEIN)
    ("protein-1" . SPARSER::PROTEIN) ("SIK3" . SPARSER::PROTEIN)
    ("SIK2" . SPARSER::PROTEIN)
    ("silencing mediator of retinoic acid and thyroid hormone receptor"
     . SPARSER::PROTEIN)
    ("nuclear receptor co-repressor1" . SPARSER::PROTEIN)
    ("glucose-6-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("histone deacetylase 3" . SPARSER::PROTEIN) ("SGK-1" . SPARSER::PROTEIN)
    ("protein kinase-1" . SPARSER::PROTEIN)
    ("Glucocorticoid-induced leucine zipper" . SPARSER::PROTEIN)
    ("HDAC7" . SPARSER::PROTEIN) ("HDAC5" . SPARSER::PROTEIN)
    ("Calyculin A" . SPARSER::MOLECULE)
    ("cAMP response element-binding protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MEF2" . SPARSER::PROTEIN) ("SIK1" . SPARSER::PROTEIN)
    ("salt-inducible kinase" . SPARSER::PROTEIN)
    ("calcium/calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("HDAC1" . SPARSER::PROTEIN) ("MC1568" . SPARSER::DRUG)
    ("calyculin A" . SPARSER::MOLECULE)
    ("mineralocorticoid receptor" . SPARSER::PROTEIN)
    ("HDAC3" . SPARSER::PROTEIN)
    ("zinc-dependent endopeptidases" . SPARSER::PROTEIN)
    ("endopeptidases" . SPARSER::PROTEIN)
    ("a multifunctional cytokine" . SPARSER::PROTEIN)
    ("more metastatic foci" . SPARSER::PROTEIN)
    ("the metastatic foci" . SPARSER::PROTEIN)
    ("IL-8/AR/MMP1/MMP13" . SPARSER::COLLECTION)
    ("AR, MMP1 and MMP13" . SPARSER::COLLECTION)
    ("10 ug/ml anti-IL-8" . SPARSER::ANTIBODY)
    ("chemokines and cytokines" . SPARSER::COLLECTION)
    ("MMP1 or MMP13" . SPARSER::COLLECTION)
    ("MMP1 and MMP 13" . SPARSER::COLLECTION) ("AR/MMPs" . SPARSER::COLLECTION)
    ("hrs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("media (CM)" . SPARSER::PROTEIN)
    ("/AR/Matrix" . SPARSER::COLLECTION)
    ("Metalloproteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("antibody, AR-siRNA," . SPARSER::PROTEIN)
    ("antibody, AR-siRNA, or MMPs inhibitors" . SPARSER::COLLECTION)
    ("AR-siRNA" . SPARSER::COLLECTION) ("IL-8/AR/MMPs" . SPARSER::COLLECTION)
    ("MMP1 and MMP13" . SPARSER::COLLECTION)
    ("IL-8/androgen receptor" . SPARSER::COLLECTION) ("BCa" . SPARSER::PROTEIN)
    ("Thymidine kinase" . SPARSER::PROTEIN) ("p28" . SPARSER::PROTEIN)
    ("MMP 13" . SPARSER::PROTEIN) ("CD20" . SPARSER::PROTEIN)
    ("IGFBP1 or IGFBP4" . SPARSER::COLLECTION)
    ("RAC1 and BMPR2" . SPARSER::COLLECTION) ("Bmpr2" . SPARSER::PROTEIN)
    ("the bioavailable IGFs" . SPARSER::PROTEIN)
    ("IGF1 and IGF2" . SPARSER::COLLECTION)
    ("IGFBP1, IGFBP2, IGFBP3, and IGFBP4" . SPARSER::COLLECTION)
    ("decidual Rac1" . SPARSER::PROTEIN) ("Rac1-Rab27b" . SPARSER::COLLECTION)
    ("VEGF-GFP" . SPARSER::COLLECTION) ("sphingolipid" . SPARSER::MOLECULE)
    ("the endothelial-specific receptor tyrosine kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("VEGFA and semaphorin family" . SPARSER::COLLECTION)
    ("VEGFA and IGFBP4" . SPARSER::COLLECTION)
    ("receptors, integrins, and growth factor" . SPARSER::COLLECTION)
    ("RAC1 , RAC2 , RHOA , CDC42 , or VEGFA" . SPARSER::COLLECTION)
    ("bromo" . SPARSER::MOLECULE)
    ("the decidual phase of pregnancy" . SPARSER::PROTEIN)
    ("IGFBP1 and IGFBP4" . SPARSER::COLLECTION)
    ("maternal insulin-like growth factor binding proteins" . SPARSER::PROTEIN)
    ("growth factors, IGF1 and IGF2" . SPARSER::COLLECTION)
    ("estrogen and progesterone" . SPARSER::COLLECTION)
    ("PL" . SPARSER::PROTEIN) ("TGCs" . SPARSER::PROTEIN)
    ("uterine vasculature" . SPARSER::PROTEIN) ("Egln1" . SPARSER::PROTEIN)
    ("Angpt1" . SPARSER::PROTEIN) ("Vegfa" . SPARSER::PROTEIN)
    ("Angpt2 , Nrp1 , Sphk1 , and Epas1/Hif2α" . SPARSER::COLLECTION)
    ("Nrp1" . SPARSER::PROTEIN) ("uterine Rac1" . SPARSER::PROTEIN)
    ("Pgr , Bmp2 , and Gja1" . SPARSER::COLLECTION)
    ("Pgr, Bmp2 and Gja1" . SPARSER::COLLECTION) ("Gja1" . SPARSER::PROTEIN)
    ("Bmp2" . SPARSER::PROTEIN) ("Bmp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("prolactin-related protein (PRL8A2/dPRP) and alkaline phosphatase (ALPL)"
     . SPARSER::COLLECTION)
    ("ALPL" . SPARSER::PROTEIN) ("dPRP" . SPARSER::PROTEIN-FAMILY)
    ("dams" . SPARSER::PROTEIN)
    ("Rac2 , Rhoa , and Cdc42" . SPARSER::COLLECTION)
    ("Rhoa" . SPARSER::PROTEIN) ("Pgr" . SPARSER::PROTEIN)
    ("family and WNTs" . SPARSER::COLLECTION) ("WNTs" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor A (VEGFA) and insulin-like growth factor binding protein 4 (IGFBP4)"
     . SPARSER::COLLECTION)
    ("endometrial Rac1" . SPARSER::PROTEIN) ("RPLP0" . SPARSER::PROTEIN)
    ("A 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CS6" . SPARSER::PROTEIN)
    ("Alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("placental lactogen" . SPARSER::PROTEIN)
    ("insulin-like growth factor-binding protein 4" . SPARSER::PROTEIN)
    ("KRT8" . SPARSER::PROTEIN) ("E 2" . SPARSER::MOLECULE)
    ("17β-estradiol" . SPARSER::PROTEIN)
    ("P 4" . SPARSER::HUMAN-PROTEIN-FAMILY) ("tm2" . SPARSER::PROTEIN-FAMILY)
    ("BMPR2" . SPARSER::PROTEIN)
    ("bone morphogenetic protein receptor type 2" . SPARSER::PROTEIN)
    ("IGFBP-4" . SPARSER::PROTEIN) ("IGFBP-1" . SPARSER::PROTEIN)
    ("IGFBP2" . SPARSER::PROTEIN) ("angiopoietin-1" . SPARSER::PROTEIN)
    ("TIE2" . SPARSER::PROTEIN) ("semaphorin family" . SPARSER::PROTEIN-FAMILY)
    ("sphingosine kinase 1" . SPARSER::PROTEIN)
    ("angiopoietin 2" . SPARSER::PROTEIN) ("neuropilin 1" . SPARSER::PROTEIN)
    ("seven-transmembrane" . SPARSER::PROTEIN) ("RAB27B" . SPARSER::PROTEIN)
    ("IGFBP1" . SPARSER::PROTEIN) ("IGF2" . SPARSER::PROTEIN)
    ("vascular-endothelial growth factor" . SPARSER::PROTEIN)
    ("Rab27B" . SPARSER::PROTEIN) ("Rab27a" . SPARSER::PROTEIN)
    ("Rab27" . SPARSER::PROTEIN) ("PECAM1" . SPARSER::PROTEIN)
    ("endothelial cell adhesion molecule" . SPARSER::PROTEIN)
    ("Hif1α" . SPARSER::PROTEIN) ("Hif2α" . SPARSER::PROTEIN)
    ("Sphk1" . SPARSER::PROTEIN) ("Angpt2" . SPARSER::PROTEIN)
    ("Rac 1" . SPARSER::PROTEIN) ("Cx43" . SPARSER::PROTEIN)
    ("Rac2" . SPARSER::PROTEIN) ("IGFBP4" . SPARSER::PROTEIN)
    ("Ras-related C3 botulinum toxin substrate 1" . SPARSER::PROTEIN)
    ("of pregnancy" . SPARSER::PROTEIN)
    ("insulin-like growth factor binding protein 4" . SPARSER::PROTEIN)
    ("Rab27b" . SPARSER::PROTEIN) ("repressive histone" . SPARSER::PROTEIN)
    ("supports PARP1’s" . SPARSER::PROTEIN)
    ("CTCF and PARP1" . SPARSER::COLLECTION)
    ("PARP1 and H3K4" . SPARSER::COLLECTION)
    ("active promoters and gene bodies" . SPARSER::COLLECTION)
    ("a global regulator" . SPARSER::REGULATOR)
    ("the internal cytosine" . SPARSER::NUCLEOBASE) ("CpGs" . SPARSER::PROTEIN)
    ("39 PARylation-methylation-mediated genes" . SPARSER::GENE)
    ("PARylation-mediated hypomethylated genes" . SPARSER::GENE)
    ("spliceosome" . SPARSER::BIO-COMPLEX)
    ("sea" . SPARSER::HUMAN-PROTEIN-FAMILY) ("decitabine" . SPARSER::DRUG)
    ("cytidine" . SPARSER::MOLECULE) ("hemi-CpG1" . SPARSER::COLLECTION)
    ("CG" . SPARSER::PROTEIN) ("CG1" . SPARSER::PROTEIN)
    ("cytosine" . SPARSER::NUCLEOBASE) ("dinucleotide" . SPARSER::MOLECULE)
    ("cytosines" . SPARSER::NUCLEOBASE)
    ("MCF7 and GSM699947" . SPARSER::COLLECTION)
    ("PARP1, CTCF and DNA" . SPARSER::COLLECTION)
    ("nucleosomes and DNase" . SPARSER::COLLECTION)
    ("CCCTC-binding factor (CTCF)" . SPARSER::PROTEIN)
    ("a sequence-specific transcription factor" . SPARSER::PROTEIN)
    ("PARP1 and histone" . SPARSER::COLLECTION)
    ("the repressive heterochromatin" . SPARSER::PROTEIN)
    ("heterochromatin" . SPARSER::PROTEIN)
    ("particular histone" . SPARSER::PROTEIN)
    ("distinct histone" . SPARSER::PROTEIN)
    ("active gene promoters" . SPARSER::PROMOTER)
    ("IGFBP7 and IGFBP6" . SPARSER::COLLECTION)
    ("two PARP1-binding representative genes" . SPARSER::GENE)
    ("PARP1-nucleosome" . SPARSER::COLLECTION)
    ("active promoters" . SPARSER::PROMOTER)
    ("The mononucleosomal DNA fragment" . SPARSER::FRAGMENT)
    ("the eluted fraction contained PARP1 bound nucleosomal fragments"
     . SPARSER::FRAGMENT)
    ("nucleosome-chromatin" . SPARSER::COLLECTION) ("nuc" . SPARSER::PROTEIN)
    ("active genes" . SPARSER::GENE)
    ("nucleosome and linker" . SPARSER::COLLECTION)
    ("an NAD-dependent chromatin-associated protein" . SPARSER::PROTEIN)
    ("chromatin architectural proteins" . SPARSER::PROTEIN)
    ("PARP1 and DNA" . SPARSER::COLLECTION)
    ("CTCF and DNase" . SPARSER::COLLECTION) ("DNase" . SPARSER::PROTEIN)
    ("CTCF" . SPARSER::PROTEIN)
    ("chromatin architectural multi-protein" . SPARSER::COLLECTION)
    ("TROVE2" . SPARSER::PROTEIN) ("ZNF140" . SPARSER::PROTEIN)
    ("PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DNMT1" . SPARSER::PROTEIN)
    ("CCCTC-binding factor" . SPARSER::PROTEIN) ("IGFBP7" . SPARSER::PROTEIN)
    ("IGFBP6" . SPARSER::PROTEIN) ("PJ34" . SPARSER::DRUG)
    ("HMGN1" . SPARSER::PROTEIN) ("ARTD1" . SPARSER::PROTEIN)
    ("ADP-ribosyl" . SPARSER::MOLECULE)
    ("the profound AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HIF2α-VEGF" . SPARSER::COLLECTION) ("AR-siRNAs" . SPARSER::COLLECTION)
    ("ASC" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Bak1" . SPARSER::PROTEIN)
    ("Bak" . SPARSER::PROTEIN) ("Shi" . SPARSER::PROTEIN)
    ("those metastatic foci" . SPARSER::PROTEIN)
    ("AR, HIF2α, VEGF, MMP9 and CCND1" . SPARSER::COLLECTION)
    ("such metastatic foci" . SPARSER::PROTEIN)
    ("metastatic foci" . SPARSER::PROTEIN) ("Vec-AR" . SPARSER::COLLECTION)
    ("Vec" . SPARSER::PROTEIN) ("Vec-AR+NC" . SPARSER::PROTEIN-PAIR)
    ("MMP9 and CCND1" . SPARSER::COLLECTION) ("AR+NC" . SPARSER::PROTEIN)
    ("AR+miR-145" . SPARSER::PROTEIN) ("HIF2α/VEGF" . SPARSER::COLLECTION)
    ("functional AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HIF2α, VEGF, MMP9 and CCND1" . SPARSER::COLLECTION)
    ("HIF2α and its downstream targets" . SPARSER::COLLECTION)
    ("VEGF, MMP9 and CCND1" . SPARSER::COLLECTION)
    ("p53-shRNA" . SPARSER::COLLECTION) ("sh-AR+NC" . SPARSER::COLLECTION)
    ("sh-AR+miR-145" . SPARSER::COLLECTION)
    ("VHL/HIF2α/VEGF" . SPARSER::COLLECTION)
    ("suppressors or oncogenes" . SPARSER::COLLECTION)
    ("AR-shRNA" . SPARSER::COLLECTION)
    ("HIF2α/VEGF/MMP9/CCND1" . SPARSER::COLLECTION) ("HK2" . SPARSER::PROTEIN)
    ("CAND1" . SPARSER::PROTEIN) ("miR-125b" . SPARSER::MOLECULE)
    ("HIF2α" . SPARSER::PROTEIN) ("Bipartite" . SPARSER::PROTEIN)
    ("the major pocket-blocked Impα variant" . SPARSER::VARIANT)
    ("an incorrect conformation" . SPARSER::BIO-CONFORMATION)
    ("amides" . SPARSER::MOLECULE)
    ("helical conformations" . SPARSER::BIO-CONFORMATION)
    ("IBB or Nup50" . SPARSER::COLLECTION)
    ("complex molecules and rapid loading/unloading behavior—characteristics that are fundamentally in opposition"
     . SPARSER::COLLECTION)
    ("PS" . SPARSER::PROTEIN) ("M2 , and ρ" . SPARSER::COLLECTION)
    ("Impα" . SPARSER::PROTEIN)
    ("typical cationic binding peptides" . SPARSER::PEPTIDE)
    ("peptide-" . SPARSER::PEPTIDE) ("pdb" . SPARSER::MOLECULE)
    ("around arm" . SPARSER::PROTEIN) ("arm" . SPARSER::PROTEIN)
    ("IBB" . SPARSER::PROTEIN-FAMILY) ("JWA" . SPARSER::PROTEIN)
    ("nuclear forms of Lig3α and germ cell-specific nuclear Lig3β xref  xref"
     . SPARSER::COLLECTION)
    ("Lig3" . SPARSER::PROTEIN) ("Lig" . SPARSER::PROTEIN-FAMILY)
    ("DNA-repair" . SPARSER::DNA) ("linkers" . SPARSER::LINKER)
    ("aprataxin" . SPARSER::PROTEIN) ("Imp" . SPARSER::MOLECULE)
    ("Importin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Xrcc1" . SPARSER::PROTEIN)
    ("cm −1" . SPARSER::PROTEIN) ("M −1" . SPARSER::PROTEIN)
    ("bis-tris" . SPARSER::MOLECULE) ("D-1" . SPARSER::PROTEIN)
    ("Nucleoporin 50" . SPARSER::PROTEIN) ("CK2" . SPARSER::PROTEIN)
    ("casein kinase 2" . SPARSER::PROTEIN) ("CBP80" . SPARSER::PROTEIN)
    ("microtubule-associated protein" . SPARSER::PROTEIN)
    ("DNA ligase 3" . SPARSER::PROTEIN) ("nuclear pore" . SPARSER::BIO-COMPLEX)
    ("Nup50" . SPARSER::PROTEIN) ("ERK/AP1" . SPARSER::COLLECTION)
    ("CTGF and HGF" . SPARSER::COLLECTION) ("CSL or p53" . SPARSER::COLLECTION)
    ("CSL and CDKN1A" . SPARSER::COLLECTION)
    ("a cancer-associated stromal matrix protein" . SPARSER::PROTEIN)
    ("periostin" . SPARSER::PROTEIN) ("POSTN" . SPARSER::PROTEIN)
    ("PTSG" . SPARSER::PROTEIN) ("CDKN1A and miR-34a" . SPARSER::COLLECTION)
    ("ponatinib" . SPARSER::DRUG) ("PF4 and IL6" . SPARSER::COLLECTION)
    ("skin-derived CAFs" . SPARSER::PROTEIN)
    ("p53 and CDKN1A" . SPARSER::COLLECTION)
    ("CD45 and CD31" . SPARSER::COLLECTION)
    ("CSL, p53 and CDKN1A" . SPARSER::COLLECTION)
    ("surgical excisions around SCCs" . SPARSER::PROTEIN)
    ("CDKN1A and IL6" . SPARSER::COLLECTION) ("LCM" . SPARSER::PROTEIN-FAMILY)
    ("invasive SCCs" . SPARSER::PROTEIN) ("AK" . SPARSER::PROTEIN)
    ("p53 and p300" . SPARSER::COLLECTION)
    ("the CDKN1A gene and a control" . SPARSER::COLLECTION)
    ("MST" . SPARSER::PROTEIN) ("p53 and CSL" . SPARSER::COLLECTION)
    ("CSL-p53" . SPARSER::COLLECTION) ("MMP13 and FOSL2" . SPARSER::COLLECTION)
    ("PTGS2/COX-2" . SPARSER::COLLECTION) ("JunB" . SPARSER::PROTEIN)
    ("Tenascin" . SPARSER::PROTEIN)
    ("at least 40 CAF-related genes" . SPARSER::GENE)
    ("enhancers and promoter" . SPARSER::COLLECTION)
    ("CDKN1A, CDKN2A, miR-34a, and IL6" . SPARSER::COLLECTION)
    ("MX1, HMOX1, IFIH1, CCL2, SERPINB2 and IL12A" . SPARSER::COLLECTION)
    ("Fzd, Wnt2 and DKK1" . SPARSER::COLLECTION)
    ("CSL and Jagged1" . SPARSER::COLLECTION) ("SCCs" . SPARSER::PROTEIN)
    ("CDKN1A (p21 WAF1/Cip1 ) and miR-34a" . SPARSER::COLLECTION)
    ("SMS and CAF marker genes ( xref ; xref )" . SPARSER::COLLECTION)
    ("shRNA or siRNA" . SPARSER::COLLECTION) ("p53/p21" . SPARSER::COLLECTION)
    ("CAFs" . SPARSER::PROTEIN) ("CSL/p53" . SPARSER::COLLECTION)
    ("CSL and p53" . SPARSER::COLLECTION) ("CSL/RBP-Jκ" . SPARSER::COLLECTION)
    ("CSL" . SPARSER::PROTEIN) ("epidermolysis bullosa" . SPARSER::PROTEIN)
    ("green fluorescent" . SPARSER::PROTEIN)
    ("interleukin-2 receptor gamma" . SPARSER::PROTEIN)
    ("TGF- β3" . SPARSER::PROTEIN) ("IL-1 β" . SPARSER::PROTEIN)
    ("CXCL12" . SPARSER::PROTEIN) ("MCP1" . SPARSER::PROTEIN)
    ("CXCL4" . SPARSER::PROTEIN) ("ACTIVIN-A" . SPARSER::MOLECULE)
    ("Jagged-1" . SPARSER::PROTEIN) ("guide RNA" . SPARSER::RNA)
    ("FGFR 1" . SPARSER::PROTEIN) ("Cox-2" . SPARSER::PROTEIN)
    ("PF4" . SPARSER::PROTEIN) ("FGF-2" . SPARSER::PROTEIN)
    ("FOSL2" . SPARSER::PROTEIN) ("IL12A" . SPARSER::PROTEIN)
    ("SERPINB2" . SPARSER::PROTEIN) ("HMOX1" . SPARSER::PROTEIN)
    ("MX1" . SPARSER::PROTEIN) ("Wnt2" . SPARSER::PROTEIN)
    ("Jagged1" . SPARSER::PROTEIN) ("Jagged 1" . SPARSER::PROTEIN)
    ("Notch1" . SPARSER::PROTEIN) ("miR-34a" . SPARSER::MOLECULE)
    ("p15 INK4b" . SPARSER::PROTEIN) ("CBF-1" . SPARSER::PROTEIN)
    ("INK4" . SPARSER::PROTEIN) ("RBP-Jκ" . SPARSER::PROTEIN)
    ("everolimus or EGFR" . SPARSER::COLLECTION)
    ("EGFR, c-Met and mTOR" . SPARSER::COLLECTION)
    ("MAPK/ERK-mTOR" . SPARSER::COLLECTION)
    ("GATA-6 and Wnt/β-catenin" . SPARSER::COLLECTION)
    ("c-Met and EGFR" . SPARSER::COLLECTION)
    ("linking EGFR" . SPARSER::PROTEIN) ("RAS/RAF/MEK" . SPARSER::COLLECTION)
    ("p-EGFR" . SPARSER::COLLECTION)
    ("EGFR, Wnt and mTOR" . SPARSER::COLLECTION)
    ("EGFR or EGFR" . SPARSER::COLLECTION)
    ("2.5 μM erlotinib (53% inhibition, p<0.01) and 5 μM everolimus"
     . SPARSER::COLLECTION)
    ("everolimus and erlotinib" . SPARSER::COLLECTION)
    ("XAV939 and mTOR" . SPARSER::COLLECTION)
    ("SU11274 and GATA-6" . SPARSER::COLLECTION)
    ("p-LRP5/6" . SPARSER::COLLECTION) ("p-p70S6K" . SPARSER::COLLECTION)
    ("p-mTOR" . SPARSER::COLLECTION)
    ("erlotinib and both erlotinib and EGF" . SPARSER::COLLECTION)
    ("erlotinib and EGF" . SPARSER::COLLECTION)
    ("H2170-ER and H2170-SR" . SPARSER::COLLECTION)
    ("HGF and SU11274" . SPARSER::COLLECTION)
    ("p-GSK-3b" . SPARSER::COLLECTION)
    ("EGF and erlotinib" . SPARSER::COLLECTION)
    ("Wnt and mtor" . SPARSER::COLLECTION)
    ("10 μM erlotinib or 10 μM SU11274" . SPARSER::COLLECTION)
    ("erlotinib (0.5 to 14 μM) and SU11274 (2.5 to 17 μM)"
     . SPARSER::COLLECTION)
    ("erlotinib and SU11274" . SPARSER::COLLECTION)
    ("EGFR/c-Met TKI’s" . SPARSER::PROTEIN)
    ("Rapamycin and its derivative" . SPARSER::COLLECTION)
    ("EGFR and Wnt" . SPARSER::COLLECTION)
    ("EGF and HGF" . SPARSER::COLLECTION) ("Wnt or mTOR" . SPARSER::COLLECTION)
    ("everolimus (mTOR inhibitor) and erlotinib" . SPARSER::COLLECTION)
    ("Wnt and mTOR" . SPARSER::COLLECTION)
    ("the EGFR TKI erlotinib and the c-Met TKI SU11274" . SPARSER::COLLECTION)
    ("EGFR/c-Met" . SPARSER::COLLECTION)
    ("EGFR and c-Met" . SPARSER::COLLECTION)
    ("MAP Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Caveolin-1" . SPARSER::PROTEIN) ("Akt-mTOR" . SPARSER::PROTEIN)
    ("GATA6" . SPARSER::PROTEIN)
    ("transcription factor GATA-6" . SPARSER::PROTEIN)
    ("LRP5/6" . SPARSER::PROTEIN) ("GSK-3b" . SPARSER::PROTEIN)
    ("Mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("GATA-6" . SPARSER::PROTEIN) ("SU11274" . SPARSER::DRUG)
    ("Tyrosine kinase" . SPARSER::PROTEIN)
    ("NF-κB and cyclin D1" . SPARSER::COLLECTION)
    ("cisplatin and paclitaxel" . SPARSER::COLLECTION)
    ("Pdx-1-Cre" . SPARSER::COLLECTION) ("KPC" . SPARSER::PROTEIN)
    ("sulforaphane" . SPARSER::PROTEIN) ("thiols" . SPARSER::MOLECULE)
    ("Keap1-KD" . SPARSER::COLLECTION) ("NRF2 and BCL2" . SPARSER::COLLECTION)
    ("tBHQ" . SPARSER::DRUG) ("NRF2 and IKKβ" . SPARSER::COLLECTION)
    ("KEAP1-IKKβ" . SPARSER::COLLECTION)
    ("doxorubicin or cisplatin" . SPARSER::COLLECTION)
    ("glutathione, or ROS" . SPARSER::COLLECTION)
    ("Nqo1 , Gclc , Gclm , or Hmox1" . SPARSER::COLLECTION)
    ("Hmox1" . SPARSER::PROTEIN) ("Gclc" . SPARSER::PROTEIN)
    ("LSL-" . SPARSER::PROTEIN) ("cre" . SPARSER::PROTEIN)
    ("adenoviral Cre recombinase" . SPARSER::PROTEIN)
    ("STOP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LSL-Kras" . SPARSER::COLLECTION)
    ("LSL" . SPARSER::PROTEIN)
    ("NFE2L2 and some NRF2 target genes [ xref ]" . SPARSER::COLLECTION)
    ("NRF2, NQO1, and GCLM" . SPARSER::COLLECTION)
    ("CCND1, XIAP, and BIRC2" . SPARSER::COLLECTION)
    ("Ccnd1 and Mmp9" . SPARSER::COLLECTION)
    ("nuclear NRF2 and several NRF2" . SPARSER::COLLECTION)
    ("Nqo1 and Gclm" . SPARSER::COLLECTION) ("Gclm" . SPARSER::PROTEIN)
    ("NRF2, BCL2 and IKKβ" . SPARSER::COLLECTION)
    ("SRB" . SPARSER::PROTEIN-FAMILY)
    ("significantly more Keap1  -/- MEFs" . SPARSER::PROTEIN)
    ("Ccl2 , Birc3 or Il1b" . SPARSER::COLLECTION) ("Ccl5" . SPARSER::PROTEIN)
    ("Il1b" . SPARSER::PROTEIN) ("Birc3" . SPARSER::PROTEIN)
    ("Ptgs2" . SPARSER::PROTEIN) ("Mmp9" . SPARSER::PROTEIN)
    ("Ccnd1" . SPARSER::PROTEIN)
    ("NRF2 and its downstream target genes" . SPARSER::COLLECTION)
    ("NQO1 and GCLM" . SPARSER::COLLECTION)
    ("KEAP1, IKKβ, and BCL2" . SPARSER::COLLECTION)
    ("NFKBIA or IκBα" . SPARSER::COLLECTION)
    ("KEAP1/CUL3" . SPARSER::COLLECTION) ("CUL3/RBX1" . SPARSER::COLLECTION)
    ("NQO1 and glutathione" . SPARSER::COLLECTION)
    ("mRNA, ROS, and glutathione" . SPARSER::COLLECTION)
    ("NRF2 and NQO1" . SPARSER::COLLECTION)
    ("KEAP1 or NFE2L2" . SPARSER::COLLECTION)
    ("NRF2, and NQO1" . SPARSER::COLLECTION)
    ("KEAP1 and NFE2L2" . SPARSER::COLLECTION)
    ("KEAP1 and exon" . SPARSER::COLLECTION)
    ("IKKβ and BCL2—two" . SPARSER::COLLECTION) ("Amide" . SPARSER::MOLECULE)
    ("CDDO" . SPARSER::DRUG) ("KEAP1-NRF2" . SPARSER::COLLECTION)
    ("KEAP1 or NRF2" . SPARSER::COLLECTION)
    ("JAK1 and STAT3" . SPARSER::COLLECTION)
    ("antioxidant and anti-inflammatory" . SPARSER::COLLECTION)
    ("antioxidant and cytoprotective proteins" . SPARSER::COLLECTION)
    ("cellular redox" . SPARSER::PROTEIN)
    ("cytoprotective proteins" . SPARSER::PROTEIN)
    ("CUL3-RBX1" . SPARSER::COLLECTION)
    ("bardoxolone methyl and RTA" . SPARSER::COLLECTION)
    ("oleanane" . SPARSER::DRUG) ("doxorubicin-" . SPARSER::PROTEIN)
    ("IKKβ or BCL2" . SPARSER::COLLECTION)
    ("NRF2, IKKβ, and BCL2" . SPARSER::COLLECTION)
    ("KEAP1 and NRF2" . SPARSER::COLLECTION) ("RTA" . SPARSER::PROTEIN)
    ("functional KEAP1" . SPARSER::PROTEIN)
    ("IKKβ and BCL2" . SPARSER::COLLECTION) ("AIMs" . SPARSER::PROTEIN)
    ("triterpenoids" . SPARSER::MOLECULE) ("Pdx-1" . SPARSER::PROTEIN)
    ("AZD6244" . SPARSER::DRUG) ("tert -Butylhydroquinone" . SPARSER::DRUG)
    ("Nfe2l2" . SPARSER::PROTEIN) ("BIRC2" . SPARSER::PROTEIN)
    ("Nqo1" . SPARSER::PROTEIN) ("DU 145" . SPARSER::PROTEIN)
    ("CM-H" . SPARSER::MOLECULE) ("ribosomal protein L19" . SPARSER::PROTEIN)
    ("RPS9" . SPARSER::PROTEIN) ("Ribosomal protein S9" . SPARSER::PROTEIN)
    ("C-T" . SPARSER::PROTEIN) ("PANC-1" . SPARSER::PROTEIN)
    ("CUL3" . SPARSER::PROTEIN) ("bardoxolone methyl" . SPARSER::DRUG)
    ("AMP and WT+AMP" . SPARSER::COLLECTION)
    ("pre- and post-neoadjuvant" . SPARSER::COLLECTION)
    ("PIK3CA and HER2" . SPARSER::COLLECTION)
    ("HER2 and chromosome 17" . SPARSER::COLLECTION)
    ("PIK3CA E542K and TP53 R175H" . SPARSER::COLLECTION)
    ("mixtures" . SPARSER::MOLECULE) ("HER2/ERBB2" . SPARSER::COLLECTION)
    ("nucleotide and copy" . SPARSER::COLLECTION)
    ("STAR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("To-Pro-3" . SPARSER::MOLECULE)
    ("L15" . SPARSER::PROTEIN) ("RP11" . SPARSER::PROTEIN)
    ("IgG2a" . SPARSER::PROTEIN) ("mutated forms" . SPARSER::FORM)
    ("BRAF and/or MEK inhibitors" . SPARSER::COLLECTION)
    ("KRAS- and BRAF-" . SPARSER::COLLECTION) ("MHC" . SPARSER::PROTEIN)
    ("BRAF and MEK" . SPARSER::COLLECTION)
    ("RAF and HGF/MET inhibitors" . SPARSER::COLLECTION)
    ("HGF/MET" . SPARSER::COLLECTION) ("RAF and MEK" . SPARSER::COLLECTION)
    ("LGX818 and the Wnt ligand maturation inhibitor WNT974 [ xref ]"
     . SPARSER::COLLECTION)
    ("Cetuximab, LGX818 and the Wnt ligand maturation inhibitor WNT974 [ xref ]"
     . SPARSER::COLLECTION)
    ("PIK3CA/mTOR" . SPARSER::COLLECTION) ("RAS-RAF-MEK" . SPARSER::COLLECTION)
    ("LGX818 and the PI3K inhibitor BYL719" . SPARSER::COLLECTION)
    ("Cetuximab, LGX818 and the PI3K inhibitor BYL719" . SPARSER::COLLECTION)
    ("4EBP1 and eIF4F" . SPARSER::COLLECTION)
    ("PIK3CA-AKT" . SPARSER::COLLECTION)
    ("EGFR-RAS-RAF-MEK-ERK" . SPARSER::COLLECTION)
    ("MEK and wildtype" . SPARSER::COLLECTION)
    ("BRAF and RAF-1" . SPARSER::COLLECTION)
    ("KRAS- and BRAF-mutant" . SPARSER::COLLECTION)
    ("RAS and wildtype" . SPARSER::COLLECTION) ("wildtype" . SPARSER::PROTEIN)
    ("EGFR-MEK-BRAF" . SPARSER::COLLECTION)
    ("EGFR and BRAF or MEK" . SPARSER::COLLECTION)
    ("BRAF or MEK" . SPARSER::COLLECTION)
    ("EGFR and RAF" . SPARSER::COLLECTION) ("RAF or MEK" . SPARSER::COLLECTION)
    ("DUSP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("recent siRNA" . SPARSER::PROTEIN) ("SPRY" . SPARSER::PROTEIN)
    ("EGFR and EGFR" . SPARSER::COLLECTION)
    ("primary and resistant CRC" . SPARSER::PROTEIN)
    ("KRAS- or BRAF-mutant" . SPARSER::COLLECTION)
    ("RAS-wildtype" . SPARSER::PROTEIN-PAIR)
    ("KRAS/NRAS" . SPARSER::COLLECTION) ("BRAF/MSS" . SPARSER::COLLECTION)
    ("Cetuximab and Panitumumab" . SPARSER::COLLECTION)
    ("KRAS and NRAS" . SPARSER::COLLECTION)
    ("Cetuximab or Panitumumab" . SPARSER::COLLECTION)
    ("Panitumumab" . SPARSER::DRUG)
    ("EGFR, KRAS and BRAF" . SPARSER::COLLECTION)
    ("EGFR-KRAS-BRAF" . SPARSER::COLLECTION)
    ("BRAF/KRAS" . SPARSER::COLLECTION) ("MSI/MSS" . SPARSER::COLLECTION)
    ("MSS" . SPARSER::PROTEIN) ("mucinous (i.e. Goblet-cell rich) type" . TYPE)
    ("BACH1 and the epigenetic modifiers CHD8 and DNMT3B"
     . SPARSER::COLLECTION)
    ("CHD8 and DNMT3B" . SPARSER::COLLECTION)
    ("BRAF-MEK-ERK" . SPARSER::COLLECTION) ("MAFG" . SPARSER::PROTEIN)
    ("pG" . SPARSER::MOLECULE) ("KRAS-" . SPARSER::PROTEIN)
    ("the KRAS and the BRAF oncogenes" . SPARSER::COLLECTION)
    ("p16INK4a or p53" . SPARSER::COLLECTION)
    ("BRAF and FBXW7" . SPARSER::COLLECTION)
    ("Wnt pathway-associated genes" . SPARSER::GENE)
    ("AXIN1, CDX2, SOX9, FBXW7, TCF7L1/2 and RSPO1/2" . SPARSER::COLLECTION)
    ("Wnt and MAPK" . SPARSER::COLLECTION)
    ("Advanced dysplastic foci" . SPARSER::PROTEIN)
    ("Apc or Lrp1b" . SPARSER::COLLECTION) ("Lrp1b" . SPARSER::PROTEIN)
    ("Ctnnb1" . SPARSER::PROTEIN) ("Apc" . SPARSER::PROTEIN)
    ("serrated" . SPARSER::PROTEIN) ("APC/Wnt" . SPARSER::COLLECTION)
    ("KRAS-RAF1" . SPARSER::COLLECTION)
    ("Wnt-APC-β-Catenin" . SPARSER::COLLECTION)
    ("EGFR-RAS-RAF" . SPARSER::COLLECTION)
    ("BRAF and KRAS" . SPARSER::COLLECTION)
    ("KRAS, NRAS , BRAF, NF1, DAB2IP and MAP2K4" . SPARSER::COLLECTION)
    ("JNKK" . SPARSER::PROTEIN) ("MEK and ERK" . SPARSER::COLLECTION)
    ("RAS and NFκB" . SPARSER::COLLECTION) ("RAS-GAP" . SPARSER::COLLECTION)
    ("RAS and RAF" . SPARSER::COLLECTION)
    ("ARAF or RAF1" . SPARSER::COLLECTION) ("MEK-ERK" . SPARSER::COLLECTION)
    ("ARAF and RAF1" . SPARSER::COLLECTION) ("ARAF" . SPARSER::PROTEIN)
    ("KRAS, NRAS and HRAS" . SPARSER::COLLECTION)
    ("further mutations involving other genes" . SPARSER::GENE)
    ("KRAS/BRAF" . SPARSER::COLLECTION) ("APC and KRAS" . SPARSER::COLLECTION)
    ("APC and BRAF" . SPARSER::COLLECTION)
    ("KRAS or BRAF" . SPARSER::COLLECTION)
    ("KRAS-mutant CRC and vice versa" . SPARSER::COLLECTION)
    ("BRAF or RAF1" . SPARSER::COLLECTION) ("KRAS-BRAF" . SPARSER::COLLECTION)
    ("KRAS and loss of heterozygosity" . SPARSER::COLLECTION)
    ("BRAF and CRAF" . SPARSER::COLLECTION) ("CRAF" . SPARSER::PROTEIN)
    ("BRAF and other MAPK network genes" . SPARSER::COLLECTION)
    ("KRAS , BRAF and other MAPK network genes" . SPARSER::COLLECTION)
    ("PIK3CA-AKT-mTOR" . SPARSER::COLLECTION)
    ("cytoskeletal components" . SPARSER::COMPONENT)
    ("RAF-MEK-ERK" . SPARSER::COLLECTION)
    ("proto-oncogenes and functional loss of tumor suppressor genes [ xref ]"
     . SPARSER::COLLECTION)
    ("metastatic CRC" . SPARSER::PROTEIN) ("RAS-RAF" . SPARSER::COLLECTION)
    ("BRAF or KRAS" . SPARSER::COLLECTION)
    ("KRAS and BRAF" . SPARSER::COLLECTION) ("CXCL8" . SPARSER::PROTEIN)
    ("CXCL1" . SPARSER::PROTEIN) ("TGF-alpha" . SPARSER::PROTEIN)
    ("HB-EGF" . SPARSER::PROTEIN) ("WNT974" . SPARSER::DRUG)
    ("BYL719" . SPARSER::DRUG) ("LGX818" . SPARSER::DRUG)
    ("TRAP1" . SPARSER::PROTEIN) ("RAF-1" . SPARSER::PROTEIN)
    ("DNMT3B" . SPARSER::PROTEIN) ("CHD8" . SPARSER::PROTEIN)
    ("BACH1" . SPARSER::PROTEIN) ("p16INK4a" . SPARSER::PROTEIN)
    ("RSPO1" . SPARSER::PROTEIN) ("TCF7L1" . SPARSER::PROTEIN)
    ("SOX9" . SPARSER::PROTEIN) ("CDX2" . SPARSER::PROTEIN)
    ("β-Catenin" . SPARSER::PROTEIN) ("MAP2K4" . SPARSER::PROTEIN)
    ("DAB2IP" . SPARSER::PROTEIN) ("Neurofibromin 1" . SPARSER::PROTEIN)
    ("RAS family" . SPARSER::PROTEIN)
    ("loss of heterozygosity" . SPARSER::PROTEIN) ("RAF1" . SPARSER::PROTEIN)
    ("gonadal" . SPARSER::PROTEIN-FAMILY)
    ("IGF-1 and SHGB" . SPARSER::COLLECTION) ("Afro" . SPARSER::PROTEIN)
    ("prolactin" . SPARSER::PROTEIN) ("FSH and inhibin" . SPARSER::COLLECTION)
    ("IGF-1 and estradiol" . SPARSER::COLLECTION)
    ("IGFBP-3 and inhibin" . SPARSER::COLLECTION)
    ("PRL, FSH, LH, IGF-1, estradiol, testosterone, DHEA and DHEAS"
     . SPARSER::COLLECTION)
    ("SHGB" . SPARSER::PROTEIN) ("DHEAS" . SPARSER::MOLECULE)
    ("DHEA" . SPARSER::DRUG) ("estradiol" . SPARSER::PROTEIN)
    ("PRL" . SPARSER::PROTEIN) ("the predominant allele" . SPARSER::ALLELE)
    ("polyglycine" . SPARSER::MOLECULE) ("polyglutamine" . SPARSER::MOLECULE)
    ("Testosterone and DHT" . SPARSER::COLLECTION)
    ("dihydrotestosterone" . SPARSER::DRUG)
    ("Testosterone" . SPARSER::MOLECULE) ("Androgens" . SPARSER::DRUG)
    ("Inhibin" . SPARSER::PROTEIN) ("FSH" . SPARSER::DRUG)
    ("inhibin" . SPARSER::PROTEIN) ("IGF-1" . SPARSER::PROTEIN)
    ("IGFBP-3" . SPARSER::PROTEIN) ("Androgen receptor" . SPARSER::PROTEIN)
    ("sex-hormone-binding globulin" . SPARSER::PROTEIN)
    ("a considerable cohort" . SPARSER::MOLECULE)
    ("isotretinoin" . SPARSER::DRUG) ("ALK-siRNA" . SPARSER::COLLECTION)
    ("targeted liposomes entrapped siRNA" . SPARSER::PROTEIN)
    ("ALK-" . SPARSER::PROTEIN) ("nanoparticles" . SPARSER::MOLECULE)
    ("BLI" . SPARSER::PROTEIN) ("SH-SY5Y-Luc" . SPARSER::COLLECTION)
    ("MTD" . SPARSER::PROTEIN) ("BID" . SPARSER::PROTEIN)
    ("-inhibitor" . SPARSER::INHIBITOR) ("AlamarBlue" . SPARSER::DRUG)
    ("liposomal siRNAs" . SPARSER::PROTEIN)
    ("ALK  F1174L or ALK  R1275Q [ xref ]" . SPARSER::COLLECTION)
    ("Palm" . SPARSER::PROTEIN) ("-mutants" . SPARSER::MUTANT)
    ("The mutated variants" . SPARSER::VARIANT)
    ("ALK-driven NB" . SPARSER::PROTEIN) ("Crizotinib" . SPARSER::DRUG)
    ("NB and tractable ‘oncogene’" . SPARSER::COLLECTION)
    ("‘oncogene’" . SPARSER::ONCOGENE) ("ALK and MYCN" . SPARSER::COLLECTION)
    ("subcutaneous NB" . SPARSER::PROTEIN) ("-siRNA" . SPARSER::COLLECTION)
    ("-siRNAs" . SPARSER::COLLECTION) ("Liposomes" . SPARSER::PROTEIN)
    ("Anaplastic Lymphoma Kinase ( ALK )" . SPARSER::PROTEIN)
    ("Nano-S" . SPARSER::PROTEIN) ("Methyl-Cellulose" . SPARSER::DRUG)
    ("Anaplastic Lymphoma Kinase" . SPARSER::PROTEIN)
    ("AREG and/or VEGF" . SPARSER::COLLECTION)
    ("1B and 1C" . SPARSER::COLLECTION) ("immunogen" . SPARSER::MOLECULE)
    ("the Sigma and Cell Signaling FOXM1 antibodies" . SPARSER::COLLECTION)
    ("the 1B or the 1C form" . SPARSER::COLLECTION)
    ("the predominant form" . SPARSER::FORM)
    ("a typical proliferation-associated transcription factor"
     . SPARSER::PROTEIN)
    ("PLK1 and ROCK1" . SPARSER::COLLECTION)
    ("AREG, uPA, uPAR, and VEGF" . SPARSER::COLLECTION)
    ("ROCK1, uPA, uPAR, and vascular endothelial growth factor A"
     . SPARSER::COLLECTION)
    ("both mitogen-activated protein (MAP) kinase (MEK) and p38 MAP kinase"
     . SPARSER::COLLECTION)
    ("kinase (MEK)" . SPARSER::KINASE) ("MAP" . SPARSER::PROTEIN)
    ("pharmacological inhibitors and genetic approaches" . SPARSER::COLLECTION)
    ("-PI3K" . SPARSER::COLLECTION) ("gene or protein" . SPARSER::COLLECTION)
    ("AREG and VEGF" . SPARSER::COLLECTION)
    ("PLK1, AURKB, AREG, ROCK1, uPA and uPAR" . SPARSER::COLLECTION)
    ("AREG" . SPARSER::PROTEIN) ("aurora kinase B (AURKB)" . SPARSER::PROTEIN)
    ("amphiregulin (ARGE)" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor A (VEGFA)" . SPARSER::PROTEIN)
    ("several representative genes" . SPARSER::GENE)
    ("PLAUR" . SPARSER::PROTEIN) ("uPAR" . SPARSER::PROTEIN)
    ("PLAU" . SPARSER::PROTEIN) ("uPA" . SPARSER::PROTEIN)
    ("AURKB" . SPARSER::PROTEIN) ("amphiregulin" . SPARSER::PROTEIN)
    ("FOXM1-KD" . SPARSER::COLLECTION)
    ("shRNA and FOXM1" . SPARSER::COLLECTION) ("NOD" . SPARSER::PROTEIN)
    ("an apparent MW ∼80 KDa and the Cell Signaling antibody"
     . SPARSER::COLLECTION)
    ("the anti-FOXM1" . SPARSER::ANTIBODY) ("AV" . SPARSER::MOLECULE)
    ("FOXM1-KD1" . SPARSER::PROTEIN-PAIR) ("KD-2" . SPARSER::COLLECTION)
    ("shRNA-FOXM1" . SPARSER::COLLECTION)
    ("both actinomycin D (ActD, 1 μg/mL) and cyclohexamine (CHX, 20 μg/mL) in OVCA433 cells (Figure xref )"
     . SPARSER::COLLECTION)
    ("ActD" . SPARSER::MOLECULE) ("FOXM1B and FOXM1C" . SPARSER::COLLECTION)
    ("proteins, RhoA and RhoB" . SPARSER::COLLECTION)
    ("RhoB" . SPARSER::PROTEIN) ("-PI3K-ERK-AKT" . SPARSER::COLLECTION)
    ("MK" . SPARSER::PROTEIN)
    ("LPA 1 , LPA 2 , and LPA 3" . SPARSER::COLLECTION)
    ("/LPA 3" . SPARSER::COLLECTION) ("PI3K and Rho" . SPARSER::COLLECTION)
    ("LPA’s" . SPARSER::LPA) ("GPCRs and their ligands" . SPARSER::COLLECTION)
    ("Monty-1" . SPARSER::COLLECTION)
    ("lysophosphatidic acid (LPA)" . SPARSER::LPA)
    ("receptors (GPCRs) and their ligands" . SPARSER::COLLECTION)
    ("CCND1 and FOXM1" . SPARSER::COLLECTION)
    ("proto-oncoproteins (such as AKT and Ras) and growth factors and/or their receptors [such as epidermal growth factor receptors (EGFRs) and hepatocyte growth factor receptor (HGFR)]"
     . SPARSER::COLLECTION)
    ("growth factors and/or their receptors [such as epidermal growth factor receptors (EGFRs) and hepatocyte growth factor receptor (HGFR)]"
     . SPARSER::COLLECTION)
    ("AKT and Ras" . SPARSER::COLLECTION)
    ("proto-oncoproteins" . SPARSER::PROTEIN-PAIR) ("HGFR" . SPARSER::PROTEIN)
    ("thiostrepton" . SPARSER::PROTEIN)
    ("phospho-ERK and FOXM1" . SPARSER::COLLECTION)
    ("-PI3K-AKT" . SPARSER::COLLECTION)
    ("receptors, and Forkhead box protein M1" . SPARSER::COLLECTION)
    ("LPA" . SPARSER::LPA) ("FoxM1" . SPARSER::PROTEIN)
    ("Amino Acids" . SPARSER::AMINO-ACID) ("MK2206" . SPARSER::DRUG)
    ("1B" . SPARSER::PROTEIN) ("proliferation-associated" . SPARSER::PROTEIN)
    ("aurora-B" . SPARSER::PROTEIN) ("S1P" . SPARSER::PROTEIN)
    ("plasminogen activator, urokinase" . SPARSER::PROTEIN)
    ("ROCK1" . SPARSER::PROTEIN) ("polo-like kinase 1" . SPARSER::PROTEIN)
    ("FOXM1B" . SPARSER::PROTEIN) ("PP1A" . SPARSER::PROTEIN)
    ("LPA 2" . SPARSER::PROTEIN) ("LPA 3" . SPARSER::PROTEIN)
    ("Ki16425" . SPARSER::MOLECULE)
    ("G protein coupled receptor" . SPARSER::PROTEIN)
    ("hepatocyte growth factor receptor" . SPARSER::PROTEIN)
    ("epidermal growth factor receptors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("forkhead box M1" . SPARSER::PROTEIN) ("LPA 1" . SPARSER::PROTEIN)
    ("Forkhead box protein M1" . SPARSER::PROTEIN)
    ("G protein" . SPARSER::PROTEIN) ("Lysophosphatidic acid" . SPARSER::LPA)
    ("CDH13 and ADIPOQ" . SPARSER::COLLECTION)
    ("adiponectin and T2DM, inflammation, and cancer" . SPARSER::COLLECTION)
    ("PPARG" . SPARSER::PROTEIN) ("ERK1/2 and Sp1" . SPARSER::COLLECTION)
    ("prolyl" . SPARSER::PROTEIN) ("AMPK/mTOR" . SPARSER::COLLECTION)
    ("TNF-α and IL-1β" . SPARSER::COLLECTION)
    ("kinase and Akt" . SPARSER::COLLECTION)
    ("TNF-α (tumor necrosis factor-α) and IL-6 (interleukin-6)"
     . SPARSER::COLLECTION)
    ("TNF-α and IL-6" . SPARSER::COLLECTION) ("MAPK/ER" . SPARSER::COLLECTION)
    ("Rac1-Nox-ROS" . SPARSER::COLLECTION) ("hyperglycemia" . SPARSER::PROTEIN)
    ("adiponectin and BMI-adjusted adiponectin" . SPARSER::COLLECTION)
    ("PI3K-Rac1" . SPARSER::COLLECTION)
    ("Cdc42 and Rac1" . SPARSER::COLLECTION)
    ("the RAC-IRSP53-WAVE2 trimolecular complex" . SPARSER::BIO-COMPLEX)
    ("RAC-IRSP53-WAVE2" . SPARSER::COLLECTION) ("RAC" . SPARSER::PROTEIN)
    ("ARP" . SPARSER::PROTEIN) ("quantitative adiponectin" . SPARSER::PROTEIN)
    ("GO0045296, GO0030100, and GO0007156" . SPARSER::COLLECTION)
    ("ADIPOQ and C/EBP" . SPARSER::COLLECTION)
    ("ADIPOQ and other genes" . SPARSER::COLLECTION)
    ("both quantitative adiponectin and BMI-adjusted adiponectin"
     . SPARSER::COLLECTION)
    ("both quantitative adiponectin" . SPARSER::PROTEIN)
    ("binary adiponectin" . SPARSER::PROTEIN) ("MAL" . SPARSER::PROTEIN)
    ("Par1, and GH" . SPARSER::COLLECTION) ("GH" . SPARSER::PROTEIN)
    ("log-adiponectin" . SPARSER::PROTEIN) ("Cdc42/Rac" . SPARSER::COLLECTION)
    ("CREG" . SPARSER::PROTEIN) ("Weaker" . SPARSER::PROTEIN)
    ("genes and signaling pathways" . SPARSER::COLLECTION)
    ("ADIPOQ , ARL15 , and CDH13" . SPARSER::COLLECTION)
    ("ADIPOQ" . SPARSER::PROTEIN)
    ("an adipocyte-specific secretory protein" . SPARSER::PROTEIN)
    ("Adiponectin" . SPARSER::PROTEIN) ("GSA-SNP" . SPARSER::COLLECTION)
    ("GSA" . SPARSER::PROTEIN) ("genes or loci" . SPARSER::COLLECTION)
    ("KCNJ11" . SPARSER::PROTEIN) ("interleukin-6" . SPARSER::PROTEIN)
    ("WAVE2" . SPARSER::PROTEIN) ("IRSP53" . SPARSER::PROTEIN)
    ("N-WASP" . SPARSER::PROTEIN) ("KNG1" . SPARSER::PROTEIN)
    ("ETV5" . SPARSER::PROTEIN) ("Rac-1" . SPARSER::PROTEIN)
    ("Par1" . SPARSER::PROTEIN) ("CDH13" . SPARSER::PROTEIN)
    ("ARL15" . SPARSER::PROTEIN) ("RAC1" . SPARSER::PROTEIN)
    ("cdc42" . SPARSER::PROTEIN)
    ("a strategic therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("HSF1-" . SPARSER::PROTEIN)
    ("hypoxia and novel PKC isoforms" . SPARSER::COLLECTION)
    ("HSF1 and glucose" . SPARSER::COLLECTION)
    ("a new light" . SPARSER::PROTEIN)
    ("significantly more cytotoxic" . SPARSER::PROTEIN)
    ("HSF1 and PKCθ" . SPARSER::COLLECTION)
    ("the protein kinase C (PKC) activator bryostatin 1 and analogues"
     . SPARSER::COLLECTION)
    ("ester" . SPARSER::MOLECULE) ("diterpene" . SPARSER::MOLECULE)
    ("Tonantzitlolone" . SPARSER::DRUG)
    ("PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a dual PKCα and PKCθ activator" . SPARSER::ACTIVATOR)
    ("PKCα and PKCθ" . SPARSER::COLLECTION)
    ("tonantzitlolone (TZL)" . SPARSER::DRUG)
    ("tonantzitlolone" . SPARSER::DRUG) ("HSP70" . SPARSER::PROTEIN)
    ("bryostatin 1" . SPARSER::DRUG) ("O 6" . SPARSER::PROTEIN)
    ("PKCζ" . SPARSER::PROTEIN) ("PKCδ" . SPARSER::PROTEIN)
    ("insulin receptor substrate 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HSF1" . SPARSER::PROTEIN) ("PKCα" . SPARSER::PROTEIN)
    ("NPM1 and CEBPA" . SPARSER::COLLECTION)
    ("FLT3 and NFkB" . SPARSER::COLLECTION)
    ("several pro-inflammatory mediators" . SPARSER::PROTEIN)
    ("nonsteroidal anti-inflammatory drugs" . SPARSER::DRUG)
    ("NSAIDs" . SPARSER::DRUG) ("NFkB" . SPARSER::PROTEIN)
    ("TERT and POT1" . SPARSER::COLLECTION) ("LSCs" . SPARSER::PROTEIN)
    ("imetelstat" . SPARSER::DRUG)
    ("additional prognostic biomarkers" . SPARSER::MOLECULE)
    ("NPM1 or CEBPA" . SPARSER::COLLECTION)
    ("clinical prognostic and predictive biomarkers" . SPARSER::MOLECULE)
    ("other pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("entire cohort" . SPARSER::MOLECULE)
    ("the TC or TT genotypes" . SPARSER::COLLECTION)
    ("FLT3 or NPM1" . SPARSER::COLLECTION) ("-ITD" . SPARSER::COLLECTION)
    ("ATG" . SPARSER::DRUG) ("forms and hallmarks" . SPARSER::COLLECTION)
    ("ABCB1, WT1 and IDH" . SPARSER::COLLECTION) ("IDH" . SPARSER::PROTEIN)
    ("fms-related tyrosine kinase 3 ( FLT3 ) and CCAAT/enhancer binding protein alpha ( CEBPA ) genes"
     . SPARSER::COLLECTION)
    ("CEBPA" . SPARSER::PROTEIN) ("TERT or POT1" . SPARSER::COLLECTION)
    ("NFκB and co-activate" . SPARSER::COLLECTION)
    ("IL-6 and TNFα" . SPARSER::COLLECTION) ("OB" . SPARSER::PROTEIN)
    ("oligosaccharide" . SPARSER::MOLECULE)
    ("the transcriptional catalytic subunit" . SPARSER::PROTEIN)
    ("TERT and protection of telomeres 1" . SPARSER::COLLECTION)
    ("TERT" . SPARSER::PROTEIN) ("HPRT1" . SPARSER::PROTEIN)
    ("β-glucuronidase" . SPARSER::PROTEIN) ("SDS 1" . SPARSER::PROTEIN)
    ("POT 1" . SPARSER::PROTEIN) ("Ets2" . SPARSER::PROTEIN)
    ("WT1" . SPARSER::PROTEIN)
    ("CCAAT/enhancer binding protein alpha" . SPARSER::PROTEIN)
    ("NPM1" . SPARSER::PROTEIN) ("POT1" . SPARSER::PROTEIN)
    ("protection of telomeres 1" . SPARSER::PROTEIN)
    ("Telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("many centrosomal proteins" . SPARSER::PROTEIN)
    ("salt and detergent" . SPARSER::COLLECTION)
    ("detergent" . SPARSER::MOLECULE)
    ("cognate centriolar satellite proteins" . SPARSER::PROTEIN)
    ("still other centriolar satellite proteins" . SPARSER::PROTEIN)
    ("other centrosomal proteins" . SPARSER::PROTEIN)
    ("the other centrosomal protein" . SPARSER::PROTEIN)
    ("CEP63 and the other three MCPH-associated proteins"
     . SPARSER::COLLECTION)
    ("the other three MCPH-associated proteins" . SPARSER::PROTEIN)
    ("the four MCPH-associated proteins" . SPARSER::PROTEIN)
    ("a weak promoter" . SPARSER::PROMOTER)
    ("CEP63 and CEP152" . SPARSER::COLLECTION)
    ("CEP215/CDK5RAP2" . SPARSER::COLLECTION)
    ("MCPH-associated proteins or their cognate centriolar satellite protein"
     . SPARSER::COLLECTION)
    ("their cognate centriolar satellite protein" . SPARSER::PROTEIN)
    ("CEP131, MNR or CEP90" . SPARSER::COLLECTION)
    ("these centriolar satellite protein" . SPARSER::PROTEIN)
    ("CEP131, MNR, CEP90 or CCDC14" . SPARSER::COLLECTION)
    ("tagged centriolar satellite proteins" . SPARSER::PROTEIN)
    ("these centriolar satellite proteins" . SPARSER::PROTEIN)
    ("CEP250 and CEP170" . SPARSER::COLLECTION)
    ("CEP135, STIL and SAS4" . SPARSER::COLLECTION)
    ("centrin" . SPARSER::PROTEIN) ("CEP90" . SPARSER::PROTEIN)
    ("strongly one component" . SPARSER::COMPONENT)
    ("SPAG5, CEP72, CEP131, MNR, or CEP90" . SPARSER::COLLECTION)
    ("their respective centriolar satellite proteins" . SPARSER::PROTEIN)
    ("CEP152, WDR62, and Cep63" . SPARSER::COLLECTION)
    ("Cep72 or SPAG5" . SPARSER::COLLECTION) ("IPs" . SPARSER::PROTEIN)
    ("these five centriolar satellite proteins" . SPARSER::PROTEIN)
    ("centriolar satellite proteins SPAG5, CEP72, CEP131, MNR, and CEP90"
     . SPARSER::COLLECTION)
    ("functionally link satellite proteins" . SPARSER::PROTEIN)
    ("microcephaly-associated proteins and centriolar satellite proteins"
     . SPARSER::COLLECTION)
    ("microcephaly-associated proteins" . SPARSER::PROTEIN)
    ("different microcephaly-associated proteins" . SPARSER::PROTEIN)
    ("cognate MCPH-associated proteins" . SPARSER::PROTEIN)
    ("MCPH1, STIL, CDK5RAP2, and ASPM" . SPARSER::COLLECTION)
    ("other centriolar satellite components" . SPARSER::COMPONENT)
    ("the centriolar satellite protein PCM1" . SPARSER::PROTEIN)
    ("dynein-dynactin" . SPARSER::COLLECTION)
    ("dynactin" . SPARSER::PROTEIN-FAMILY)
    ("their cognate MCPH-associated protein" . SPARSER::PROTEIN)
    ("different MCPH-associated proteins" . SPARSER::PROTEIN)
    ("the centriolar satellite proteins form" . SPARSER::FORM)
    ("WDR62, and CEP90" . SPARSER::COLLECTION)
    ("the centriolar satellite components SPAG5, CEP72, CEP131, MNR, and CEP90"
     . SPARSER::COLLECTION)
    ("SPAG5, CEP72, CEP131, MNR, and CEP90" . SPARSER::COLLECTION)
    ("the other MCPH-associated proteins CDK5RAP2, CEP152 and WDR62"
     . SPARSER::COLLECTION)
    ("The MCPH-associated protein CEP63" . SPARSER::PROTEIN)
    ("CEP152 and WDR62" . SPARSER::COLLECTION)
    ("some previously reported interactors" . SPARSER::PROTEIN)
    ("CDK5RAP2, WDR62 and CEP131" . SPARSER::COLLECTION)
    ("CEP192, SAS4, CENTROBIN and PLK4" . SPARSER::COLLECTION)
    ("CENTROBIN" . SPARSER::PROTEIN)
    ("CDK5RAP2 and CEP152, Centrosomin and Asterless" . SPARSER::COLLECTION)
    ("CEP152, Centrosomin and Asterless" . SPARSER::COLLECTION)
    ("Centrosomin" . SPARSER::PROTEIN)
    ("MCPH-associated proteins and CDK2" . SPARSER::COLLECTION)
    ("proteins and CDK2" . SPARSER::COLLECTION)
    ("CEP63 and its interactor CDK2" . SPARSER::COLLECTION)
    ("the other centriolar satellites components" . SPARSER::COMPONENT)
    ("centrosomes and centriole" . SPARSER::COLLECTION)
    ("a previously recognized regulator" . SPARSER::REGULATOR)
    ("the centriolar satellite gene" . SPARSER::GENE)
    ("the centriolar satellite proteins" . SPARSER::PROTEIN)
    ("distinct centriolar satellite components" . SPARSER::COMPONENT)
    ("These MCPH-associated proteins" . SPARSER::PROTEIN)
    ("these MCPH-associated genes and centriolar satellite genes"
     . SPARSER::COLLECTION)
    ("centriolar satellite genes" . SPARSER::GENE)
    ("these MCPH-associated genes" . SPARSER::GENE)
    ("CDK5RAP2, CEP152, WDR62, CEP63, SPAG5, CEP72, CEP131, MNR, or CEP90"
     . SPARSER::COLLECTION)
    ("the MCPH-associated protein" . SPARSER::PROTEIN)
    ("CDK5RAP2 , CEP152 , WDR62 , or CEP63" . SPARSER::COLLECTION)
    ("CEP63, CDK5RAP2, CEP152 and WDR62" . SPARSER::COLLECTION)
    ("the supernumerary Centrin foci" . SPARSER::PROTEIN)
    ("pericentriolar matrices" . SPARSER::PROTEIN-FAMILY)
    ("supernumary Centrin foci" . SPARSER::PROTEIN)
    ("the pericentrosomal matrix" . SPARSER::PROTEIN-FAMILY)
    ("γ-tubulin and CP110" . SPARSER::COLLECTION)
    ("supernumerary Centrin foci" . SPARSER::PROTEIN)
    ("CEP63 and CCDC14" . SPARSER::COLLECTION)
    ("another centriolar satellite component" . SPARSER::COMPONENT)
    ("CEP63 and CDK2" . SPARSER::COLLECTION)
    ("PCM1 and CEP63" . SPARSER::COLLECTION)
    ("an intronic SNP" . SPARSER::PROTEIN)
    ("a homozygous intronic variant" . SPARSER::VARIANT)
    ("AP4S1" . SPARSER::PROTEIN) ("The nonconservative p" . SPARSER::PROTEIN)
    ("ESP" . SPARSER::PROTEIN) ("hg" . SPARSER::MOLECULE)
    ("a consanguineous Pakistani family" . SPARSER::PROTEIN-FAMILY)
    ("a homozygous missense variant" . SPARSER::VARIANT)
    ("established MCPH-associated proteins" . SPARSER::PROTEIN)
    ("centriolar satellite proteins" . SPARSER::PROTEIN)
    ("the other centriolar satellite proteins CEP72, SPAG5, CEP131 and MNR"
     . SPARSER::COLLECTION)
    ("CEP72, SPAG5, CEP131 and MNR" . SPARSER::COLLECTION)
    ("CDK5RAP2, CEP152, and WDR62" . SPARSER::COLLECTION)
    ("the MCPH-associated proteins form" . SPARSER::FORM)
    ("an interacting MCPH-associated protein" . SPARSER::PROTEIN)
    ("a larger complex" . SPARSER::BIO-COMPLEX)
    ("their cognate MCPH-associated proteins" . SPARSER::PROTEIN)
    ("an associated centriolar satellite component" . SPARSER::COMPONENT)
    ("the interacting MCPH-associated proteins" . SPARSER::PROTEIN)
    ("CEP63 and CEP90" . SPARSER::COLLECTION)
    ("CEP63 and its co-immunoprecipitated proteins" . SPARSER::COLLECTION)
    ("MCPH-associated protein CEP63" . SPARSER::PROTEIN)
    ("this centriolar satellite component" . SPARSER::COMPONENT)
    ("CEP63 and centriole" . SPARSER::COLLECTION)
    ("CDK5RAP2 and CEP152" . SPARSER::COLLECTION)
    ("its associated MCPH protein" . SPARSER::PROTEIN)
    ("CEP131 and CEP152" . SPARSER::COLLECTION)
    ("WDR62 no longer co-precipitated CEP152 or CEP63" . SPARSER::COLLECTION)
    ("the MCPH-associated proteins CEP152 and CEP63" . SPARSER::COLLECTION)
    ("its cognate centriolar satellite protein" . SPARSER::PROTEIN)
    ("CEP63 and MNR" . SPARSER::COLLECTION)
    ("MNR and CEP63" . SPARSER::COLLECTION)
    ("WDR62 or CEP63" . SPARSER::COLLECTION)
    ("MNR and WDR62" . SPARSER::COLLECTION)
    ("MCPH-associated protein WDR62" . SPARSER::PROTEIN)
    ("the centriolar satellite protein CEP131" . SPARSER::PROTEIN)
    ("the CEP152-dependent MCPH-associated proteins, WDR62 and CEP63"
     . SPARSER::COLLECTION)
    ("proteins, WDR62 and CEP63" . SPARSER::COLLECTION)
    ("CEP152 and CEP152" . SPARSER::COLLECTION)
    ("Centrin and CEP131" . SPARSER::COLLECTION) ("Centrin" . SPARSER::PROTEIN)
    ("the MCPH-associated proteins" . SPARSER::PROTEIN)
    ("its MCPH-associated partner proteins" . SPARSER::PROTEIN)
    ("CDK5RAP2, CEP152 or WDR62" . SPARSER::COLLECTION)
    ("its interacting MCPH-associated proteins" . SPARSER::PROTEIN)
    ("Cep131" . SPARSER::PROTEIN)
    ("CDK5RAP2, CEP72 and SPAG5" . SPARSER::COLLECTION)
    ("CDK5RAP2 and its centriolar satellite interactors, CEP72 and SPAG5"
     . SPARSER::COLLECTION)
    ("its centriolar satellite interactors, CEP72 and SPAG5"
     . SPARSER::COLLECTION)
    ("interactors, CEP72 and SPAG5" . SPARSER::COLLECTION)
    ("CEP152 and CEP131" . SPARSER::COLLECTION)
    ("a centriolar satellite protein" . SPARSER::PROTEIN)
    ("MCPH-associated protein CEP152" . SPARSER::PROTEIN)
    ("Centriolar satellite protein CEP131" . SPARSER::PROTEIN)
    ("CDK5RAP2 and its dependent proteins" . SPARSER::COLLECTION)
    ("the centriolar satellite components SPAG5 and CEP72"
     . SPARSER::COLLECTION)
    ("other MCPH-associated proteins CEP152, WDR62 and CEP63"
     . SPARSER::COLLECTION)
    ("CDK5RAP2, and CDK5RAP2" . SPARSER::COLLECTION)
    ("SPAG5 or CEP72" . SPARSER::COLLECTION)
    ("the centriolar satellite proteins CEP72 and SPAG5" . SPARSER::COLLECTION)
    ("CEP72 and SPAG5-" . SPARSER::COLLECTION)
    ("CEP72 or SPAG5" . SPARSER::COLLECTION)
    ("centriolar satellite components help MCPH-associated proteins"
     . SPARSER::PROTEIN)
    ("the other MCPH-associated proteins" . SPARSER::PROTEIN)
    ("CEP152, WDR62 or CEP63" . SPARSER::COLLECTION)
    ("other MCPH-associated proteins" . SPARSER::PROTEIN)
    ("the centriolar satellite proteins, CEP72 and SPAG5"
     . SPARSER::COLLECTION)
    ("proteins, CEP72 and SPAG5" . SPARSER::COLLECTION)
    ("MCPH-associated protein CDK5RAP2" . SPARSER::PROTEIN)
    ("Centriolar satellite proteins CEP72 and SPAG5" . SPARSER::COLLECTION)
    ("CEP72 and SPAG5" . SPARSER::COLLECTION)
    ("four MCPH-associated proteins" . SPARSER::PROTEIN)
    ("all centrosomal proteins" . SPARSER::PROTEIN)
    ("a centriolar satellite component" . SPARSER::COMPONENT)
    ("another unrelated centrosomal protein" . SPARSER::PROTEIN)
    ("CEP72, CEP131, MNR, CEP90 and CCDC14" . SPARSER::COLLECTION)
    ("the core centriolar satellite component PCM1" . SPARSER::PROTEIN)
    ("CEP72, SPAG5, CEP131, MNR, CEP90 and CCDC14" . SPARSER::COLLECTION)
    ("PCM1 and other centriolar satellite proteins" . SPARSER::COLLECTION)
    ("other centriolar satellite proteins" . SPARSER::PROTEIN)
    ("Ian" . SPARSER::PROTEIN-FAMILY) ("MNR" . SPARSER::PROTEIN)
    ("CEP131, CEP90, and CCDC14" . SPARSER::COLLECTION)
    ("ASTRIN" . SPARSER::PROTEIN)
    ("CEP72, CEP131, CEP90, KIAA0753 and CCDC14" . SPARSER::COLLECTION)
    ("MCPH-associated proteins, CDK5RAP2, CEP152, WDR62 and CEP63"
     . SPARSER::COLLECTION)
    ("centriolar satellite components" . SPARSER::COMPONENT)
    ("WDR62 and CEP63" . SPARSER::COLLECTION)
    ("Brown et al. ( CEP63 NB ) efficiently depleted CEP63" . SPARSER::PROTEIN)
    ("NB" . SPARSER::PROTEIN) ("centrosomal CEP152" . SPARSER::PROTEIN)
    ("CDK5RAP2, CEP152 and WDR62" . SPARSER::COLLECTION)
    ("localizing other MCPH-associated protein" . SPARSER::PROTEIN)
    ("CEP152 , WDR62 or CEP63" . SPARSER::COLLECTION)
    ("CEP152, WDR62, and CEP63" . SPARSER::COLLECTION)
    ("CDK5RAP2, CEP152, and CEP63" . SPARSER::COLLECTION)
    ("these four MCPH-associated proteins, CDK5RAP2, CEP152, WDR62 and CEP63"
     . SPARSER::COLLECTION)
    ("proteins, CDK5RAP2, CEP152, WDR62 and CEP63" . SPARSER::COLLECTION)
    ("CDK5RAP2, CEP152, WDR62 or CEP63" . SPARSER::COLLECTION)
    ("two previously published siRNAs" . SPARSER::PROTEIN)
    ("Cdk5rap2 and βGEO" . SPARSER::COLLECTION)
    ("CDK5RAP2 and WDR62" . SPARSER::COLLECTION) ("Wdr62" . SPARSER::PROTEIN)
    ("Cdk5rap2" . SPARSER::PROTEIN) ("CEP152 and CEP63" . SPARSER::COLLECTION)
    ("CDK5RAP2 or WDR62" . SPARSER::COLLECTION)
    ("CEP152 or CEP63" . SPARSER::COLLECTION)
    ("the centrosomal protein CP110" . SPARSER::PROTEIN)
    ("sucrose" . SPARSER::MOLECULE)
    ("CDK5RAP2 and CEP63" . SPARSER::COLLECTION)
    ("likely centrosomal proteins" . SPARSER::PROTEIN)
    ("centrosomal proteins CDK5RAP2, CEP152, WDR62 and CEP63"
     . SPARSER::COLLECTION)
    ("CDK5RAP2, CEP152, WDR62, and CEP63" . SPARSER::COLLECTION)
    ("bringing CDK2" . SPARSER::PROTEIN)
    ("both the MCPH-associated proteins and their centriolar satellite partner proteins"
     . SPARSER::COLLECTION)
    ("their centriolar satellite partner proteins" . SPARSER::PROTEIN)
    ("both the MCPH-associated proteins" . SPARSER::PROTEIN)
    ("the centrosomal MCPH-associated proteins" . SPARSER::PROTEIN)
    ("the previously defined MCPH-associated proteins" . SPARSER::PROTEIN)
    ("these centriolar satellite components" . SPARSER::COMPONENT)
    ("an MCPH-associated protein" . SPARSER::PROTEIN)
    ("MCPH-associated proteins" . SPARSER::PROTEIN)
    ("their MCPH-associated proteins" . SPARSER::PROTEIN)
    ("the interacting MCPH-associated protein" . SPARSER::PROTEIN)
    ("a cognate centriolar satellite proteins" . SPARSER::PROTEIN)
    ("the MCPH-associated proteins CDK5RAP2, CEP152, WDR62 and CEP63"
     . SPARSER::COLLECTION)
    ("each MCPH-associated protein" . SPARSER::PROTEIN)
    ("other MCPH-associated genes" . SPARSER::GENE)
    ("CEP152, CEP135, STIL and SAS4" . SPARSER::COLLECTION)
    ("WDR62, CDK5RAP2 and CEP63" . SPARSER::COLLECTION)
    ("these MCPH-associated proteins" . SPARSER::PROTEIN)
    ("CEP152, CEP135 and STIL" . SPARSER::COLLECTION)
    ("proteins, CEP152, CEP135 and STIL" . SPARSER::COLLECTION)
    ("CPAP or CENPJ" . SPARSER::COLLECTION)
    ("Centriolar satellite proteins" . SPARSER::PROTEIN)
    ("centriolar complexes" . SPARSER::BIO-COMPLEX)
    ("The microcephaly-associated proteins" . SPARSER::PROTEIN)
    ("four microcephaly-associated proteins" . SPARSER::PROTEIN)
    ("distinct centriolar satellite proteins" . SPARSER::PROTEIN)
    ("SPAG5 and CEP72" . SPARSER::COLLECTION)
    ("apex, and CEP152, WDR62 and CEP63" . SPARSER::COLLECTION)
    ("CEP152, WDR62 and CEP63" . SPARSER::COLLECTION)
    ("apex" . SPARSER::PROTEIN) ("microcephaly (MCPH)" . SPARSER::PROTEIN)
    ("CDK5RAP2, CEP152, WDR62 and CEP63" . SPARSER::COLLECTION)
    ("microcephaly" . SPARSER::PROTEIN) ("EF1alpha" . SPARSER::PROTEIN)
    ("CEP170" . SPARSER::PROTEIN) ("CEP250" . SPARSER::PROTEIN)
    ("Cep72" . SPARSER::PROTEIN) ("HCO 3" . SPARSER::MOLECULE)
    ("MCPH1" . SPARSER::PROTEIN) ("SAS-6" . SPARSER::PROTEIN)
    ("SAS-5" . SPARSER::PROTEIN) ("ZYG-1" . SPARSER::PROTEIN)
    ("CEP192" . SPARSER::PROTEIN)
    ("Cyclin dependent kinase 2" . SPARSER::PROTEIN)
    ("AP4S" . SPARSER::HUMAN-PROTEIN-FAMILY) ("chr13" . SPARSER::PROTEIN)
    ("KIAA0753" . SPARSER::PROTEIN) ("SAS6" . SPARSER::PROTEIN)
    ("CEP215" . SPARSER::PROTEIN) ("rap2" . SPARSER::PROTEIN)
    ("Cdk5" . SPARSER::PROTEIN) ("Cyclin A" . SPARSER::PROTEIN)
    ("SAS4" . SPARSER::PROTEIN) ("CEP135" . SPARSER::PROTEIN)
    ("PCM1" . SPARSER::PROTEIN) ("CEP131" . SPARSER::PROTEIN)
    ("CEP72" . SPARSER::PROTEIN) ("SPAG5" . SPARSER::PROTEIN)
    ("CEP63" . SPARSER::PROTEIN) ("WDR62" . SPARSER::PROTEIN)
    ("CEP152" . SPARSER::PROTEIN)
    ("many zinc-associated enzymes" . SPARSER::ENZYME)
    ("some broad spectrum chemotherapeutic drugs" . SPARSER::DRUG)
    ("efficient cytotoxic" . SPARSER::PROTEIN)
    ("a valuable molecule" . SPARSER::MOLECULE)
    ("p53 conformation and transcriptional activity [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("chelator" . SPARSER::MOLECULE) ("MTs" . SPARSER::PROTEIN)
    ("metallothioneins" . SPARSER::PROTEIN)
    ("metalloprotein" . SPARSER::MOLECULE)
    ("a functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Puma and Bax" . SPARSER::COLLECTION)
    ("ADR and ADR/ZnCl" . SPARSER::COLLECTION)
    ("ADR and ZnCl" . SPARSER::COLLECTION) ("CD-1" . SPARSER::PROTEIN)
    ("Noxa and Puma" . SPARSER::COLLECTION)
    ("Puma , p53AIP1 , MDM2 , and p21" . SPARSER::COLLECTION)
    ("Cip" . SPARSER::PROTEIN) ("p53/MDM2" . SPARSER::COLLECTION)
    ("the chemotherapeutic drug ADR" . SPARSER::PROTEIN)
    ("Adriamycin (ADR)" . SPARSER::DRUG) ("ADR" . SPARSER::PROTEIN)
    ("p53 reactivators" . SPARSER::PROTEIN)
    ("a valuable adjuvant" . SPARSER::DRUG)
    ("chemotherapeutic agent Adriamycin" . SPARSER::DRUG)
    ("sequence-specific promoters" . SPARSER::PROMOTER)
    ("p53AIP1" . SPARSER::PROTEIN) ("WAF1" . SPARSER::PROTEIN)
    ("Histone H2AX" . SPARSER::PROTEIN) ("Zn2+" . SPARSER::MOLECULE)
    ("IGFR" . SPARSER::PROTEIN) ("mature astrocytes" . SPARSER::PROTEIN)
    ("a monoclonal IGF1R antibody" . SPARSER::ANTIBODY)
    ("Ras-Raf-MAPK" . SPARSER::COLLECTION)
    ("MAPK (ERK1/2) MAPK" . SPARSER::PROTEIN)
    ("Akt and MAPK" . SPARSER::COLLECTION)
    ("Immunohistochemistry" . SPARSER::PROTEIN)
    ("the temporal lobe" . SPARSER::PROTEIN) ("kinase (GSK)" . SPARSER::KINASE)
    ("the fetal-derived astrocytes" . SPARSER::PROTEIN)
    ("the predominant Ir isoform" . SPARSER::ISOFORM)
    ("neuronal IR" . SPARSER::PROTEIN)
    ("receptors and downstream signalling components" . SPARSER::COLLECTION)
    ("IR and IGF1" . SPARSER::COLLECTION)
    ("the respective receptors" . SPARSER::PROTEIN)
    ("the phosphorylation state of IRS1, calpain overactivation and binding"
     . SPARSER::COLLECTION)
    ("calpain" . SPARSER::PROTEIN) ("IgG and MAB391" . SPARSER::COLLECTION)
    ("MTT and Cyquant assays" . SPARSER::COLLECTION)
    ("pAkt ( p  = 0.0008) and Akt ( p  = 0.0061)" . SPARSER::COLLECTION)
    ("dual labelling immunohistochemistry" . SPARSER::PROTEIN)
    ("gyrus" . SPARSER::PROTEIN) ("dentate" . SPARSER::PROTEIN)
    ("fraction and specificity" . SPARSER::COLLECTION)
    ("complete media" . SPARSER::PROTEIN)
    ("proteins, IRS1 and IRS2" . SPARSER::COLLECTION)
    ("tyrosine and serine" . SPARSER::COLLECTION)
    ("the pre- or mature receptors (Fig.  xref and Additional file xref : Figure S3)"
     . SPARSER::COLLECTION)
    ("mature receptors" . SPARSER::PROTEIN)
    ("the downstream signalling kinases Akt and p44/42 MAPK (ERK1/2) in both the commercially obtained Sciencell astrocytes and astrocytes"
     . SPARSER::PROTEIN)
    ("IRS1 and IRS2" . SPARSER::COLLECTION)
    ("Akt and p44/42" . SPARSER::COLLECTION)
    ("a specific commercial astrocyte media" . SPARSER::PROTEIN)
    ("vimentin and glial fibrillary acidic protein (GFAP)"
     . SPARSER::COLLECTION)
    ("vimentin and glial fibrillary acidic protein" . SPARSER::COLLECTION)
    ("filament" . SPARSER::PROTEIN-FAMILY)
    ("its phosphorylation state and report" . SPARSER::COLLECTION)
    ("insulin-fructose" . SPARSER::PROTEIN)
    ("structurally more complex" . SPARSER::BIO-COMPLEX)
    ("namely insulin receptor substrate (IRS)1 and IRS2" . SPARSER::COLLECTION)
    ("namely insulin receptor substrate (IRS)" . SPARSER::SUBSTRATE)
    ("substrate (IRS)" . SPARSER::SUBSTRATE)
    ("Gab1 and Dos" . SPARSER::COLLECTION) ("Dos" . SPARSER::PROTEIN)
    ("a heterotetrameric receptor tyrosine kinase (RTK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("insulin receptor (IR)" . SPARSER::PROTEIN)
    ("Ras/Mitogen activated protein kinase" . SPARSER::COLLECTION)
    ("/Akt" . SPARSER::COLLECTION) ("IR and IGF1R" . SPARSER::COLLECTION)
    ("fructose and monoclonal antibody" . SPARSER::COLLECTION)
    ("MAB" . SPARSER::DRUG) ("IR and Akt" . SPARSER::COLLECTION)
    ("pAkt" . SPARSER::PROTEIN-FAMILY) ("β -actin" . SPARSER::PROTEIN)
    ("γH2AX" . SPARSER::PROTEIN) ("p42" . SPARSER::PROTEIN)
    ("sodium chloride" . SPARSER::DRUG) ("l-ornithine" . SPARSER::DRUG)
    ("TDP-43" . SPARSER::PROTEIN) ("a 15 " . SPARSER::PROTEIN)
    ("pIRS1" . SPARSER::PROTEIN)
    ("eukaryotic elongation factor" . SPARSER::PROTEIN)
    ("p44" . SPARSER::PROTEIN) ("F10" . SPARSER::PROTEIN)
    ("IRS2" . SPARSER::PROTEIN) ("beta subunit" . SPARSER::PROTEIN)
    ("Mitogen activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphatidylinositol-4,5-bisphosphate 3-kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("insulin-like growth factor" . SPARSER::PROTEIN)
    ("IGF1R" . SPARSER::PROTEIN)
    ("anti-HDGF monoclonal antibodies" . SPARSER::ANTIBODY)
    ("avastin" . SPARSER::DRUG) ("bevacizumab" . SPARSER::DRUG)
    ("Ren" . SPARSER::PROTEIN) ("Antibody" . SPARSER::PROTEIN)
    ("protein and β-catenin" . SPARSER::COLLECTION)
    ("β-catenin and HDGF" . SPARSER::COLLECTION)
    ("Wnt-3a and DKK1" . SPARSER::COLLECTION)
    ("HDGF, β-catenin, c-Myc, cyclin D1, MMP9 and phos-GSK3β"
     . SPARSER::COLLECTION)
    ("β-catenin, c-Myc, cyclin D1, MMP9 and phos-GSK-3β" . SPARSER::COLLECTION)
    ("HDGF, β-catenin, c-Myc, cyclin D1, MMP9 and phos-GSK-3β"
     . SPARSER::COLLECTION)
    ("decreased nuclear and cytoplasmic β-catenin and its down-stream genes"
     . SPARSER::COLLECTION)
    ("β-catenin and its down-stream genes" . SPARSER::COLLECTION)
    ("c-Myc, cyclin D1 and MMP9" . SPARSER::COLLECTION)
    ("exogenous HDGF" . SPARSER::PROTEIN) ("Exogenous HDGF" . SPARSER::PROTEIN)
    ("NC-siRNA group and HDGF-siRNA group" . SPARSER::COLLECTION)
    ("haematoxylin" . SPARSER::MOLECULE)
    ("NC-siRNA transfection group (mean number = 55, p = 0.001) and Mock control group (mean number = 63, p = 0.0003)"
     . SPARSER::COLLECTION)
    ("NC-siRNA transfection group (mean number = 162, p < 0.0001) and Mock control group (mean number = 195, p < 0.0001)"
     . SPARSER::COLLECTION)
    ("NC-siRNA transfection group (mean number = 38, p = 0.0004) and Mock control group (mean number = 42, p = 0.0006)"
     . SPARSER::COLLECTION)
    ("NC-siRNA transfection group (mean number = 76, p = 0.0002) and Mock control group (mean number = 87, p = 0.0004)"
     . SPARSER::COLLECTION)
    ("Annexin-V and PI" . SPARSER::COLLECTION)
    ("NC-siRNA transfection group ( p < 0.0001 and p < 0.0001) and Mock control group ( p < 0.0001 and p = 0.0001)"
     . SPARSER::COLLECTION)
    ("NC-siRNA transfection group (mean number = 210, p < 0.0001) and Mock control group (mean number = 237, p < 0.0001)"
     . SPARSER::COLLECTION)
    ("NC-siRNA transfection group (mean number = 229, p < 0.0001) and Mock control group (mean number = 251, p < 0.0001)"
     . SPARSER::COLLECTION)
    ("HDGF-siRNA" . SPARSER::COLLECTION) ("NC-siRNA" . SPARSER::COLLECTION)
    ("HDGF/β-catenin" . SPARSER::COLLECTION)
    ("Slit2/Robo1" . SPARSER::COLLECTION)
    ("Wnt-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HDGF and β-catenin" . SPARSER::COLLECTION)
    ("Wnt3a and DKK1" . SPARSER::COLLECTION)
    ("HDGF, β-catenin, c-Myc, cyclin D1, MMP9, and phos-GSK-3β"
     . SPARSER::COLLECTION)
    ("hepatoma-derived growth factor (HDGF) and β-catenin"
     . SPARSER::COLLECTION)
    ("HDGF" . SPARSER::PROTEIN)
    ("glyceraldehyde-3-Phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("s 5A" . SPARSER::PROTEIN)
    ("astrocyte elevated gene-1" . SPARSER::PROTEIN)
    ("TGF-beta" . SPARSER::PROTEIN)
    ("nordihydroguaiaretic acid" . SPARSER::DRUG) ("Wnt-3a" . SPARSER::PROTEIN)
    ("Robo1" . SPARSER::PROTEIN) ("Slit2" . SPARSER::PROTEIN)
    ("Astrocyte elevated gene-1" . SPARSER::PROTEIN)
    ("heparin-binding protein" . SPARSER::PROTEIN)
    ("Hepatoma-derived growth factor" . SPARSER::PROTEIN)
    ("hepatoma-derived growth factor" . SPARSER::PROTEIN)
    ("innovative molecular targets" . SPARSER::TARGET-PROTEIN)
    ("maritoclax" . SPARSER::DRUG) ("STAT3 and ERK1/2" . SPARSER::COLLECTION)
    ("JAK/STAT3" . SPARSER::COLLECTION)
    ("gemcitabine or cisplatin" . SPARSER::COLLECTION)
    ("LIF/LIFR" . SPARSER::COLLECTION)
    ("LIFR and the glycoprotein gp130" . SPARSER::COLLECTION)
    ("several pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("TNF-α, IL-6, IL-1β and TGF-β" . SPARSER::COLLECTION)
    ("the chemotherapeutic agents GEM and CDDP" . SPARSER::COLLECTION)
    ("GEM and CDDP" . SPARSER::COLLECTION)
    ("UMI-77 and LIF" . SPARSER::COLLECTION)
    ("Bcl-2 and Mcl-1" . SPARSER::COLLECTION)
    ("Nanog and Oct4" . SPARSER::COLLECTION) ("Nanog" . SPARSER::PROTEIN)
    ("caspases" . SPARSER::PROTEIN)
    ("CDDP, GEM, and GEM+CDDP" . SPARSER::COLLECTION)
    ("rh" . SPARSER::MOLECULE) ("extensive (>30%) LIFR" . SPARSER::PROTEIN)
    ("neutrophils" . SPARSER::PROTEIN)
    ("LIF ( p < 0.001) and LIFR ( p < 0.001)" . SPARSER::COLLECTION)
    ("LIF, LIFR and gp130" . SPARSER::COLLECTION)
    ("LIF, LIFR, and gp130" . SPARSER::COLLECTION)
    ("pro- and anti-apoptotic" . SPARSER::COLLECTION)
    ("LIFR/gp130" . SPARSER::COLLECTION)
    ("/extracellular signal-regulated kinase (ERK)" . SPARSER::COLLECTION)
    ("kinase (JAK)" . SPARSER::KINASE) ("receptor (LIFR)" . SPARSER::RECEPTOR)
    ("/extracellular signal-regulated kinase" . SPARSER::COLLECTION)
    ("pro- and anti-inflammatory" . SPARSER::COLLECTION)
    ("IL-6, IL-1 and tumor necrosis factor" . SPARSER::COLLECTION)
    ("a pleiotropic pro-inflammatory cytokine" . SPARSER::PROTEIN)
    ("tumor-associated macrophages (TAM)" . SPARSER::PROTEIN)
    ("gemcitabine (GEM) and cisplatin (CDDP)" . SPARSER::COLLECTION)
    ("GEM" . SPARSER::PROTEIN) ("STAT3-" . SPARSER::PROTEIN)
    ("Mcl-1 and pAKT" . SPARSER::COLLECTION)
    ("LIF and LIFR" . SPARSER::COLLECTION) ("gemcitabine" . SPARSER::DRUG)
    ("LIF and its receptor (LIFR)" . SPARSER::COLLECTION)
    ("LIF and its receptor" . SPARSER::COLLECTION) ("LIFR" . SPARSER::PROTEIN)
    ("Leukemia inhibitory factor (LIF)" . SPARSER::PROTEIN)
    ("LIF" . SPARSER::PROTEIN) ("Glo 3" . SPARSER::PROTEIN)
    ("ABT-737" . SPARSER::DRUG) ("Oncostatin M" . SPARSER::PROTEIN)
    ("UMI-77" . SPARSER::DRUG) ("caspases 3" . SPARSER::PROTEIN)
    ("Gp130" . SPARSER::PROTEIN) ("α-SMA" . SPARSER::PROTEIN)
    ("gp130" . SPARSER::PROTEIN) ("pERK1/2" . SPARSER::PROTEIN)
    ("Leukemia inhibitory factor" . SPARSER::PROTEIN)
    ("nonpathogenic germ-line variants" . SPARSER::VARIANT)
    ("RET , HRAS , KRAS and STK11" . SPARSER::COLLECTION)
    ("TP53 , KDR , KIT , MET , PIK3CA and ATM" . SPARSER::COLLECTION)
    ("Food and Drug Administration" . SPARSER::COLLECTION)
    ("vandetanib and cabozantinib" . SPARSER::COLLECTION)
    ("a driving oncogene or a therapeutically targetable gene"
     . SPARSER::COLLECTION)
    ("a therapeutically targetable gene" . SPARSER::GENE)
    ("driving oncogene" . SPARSER::ONCOGENE)
    ("a targetable EML4-ALK fusion gene" . SPARSER::GENE)
    ("metastatic MTC" . SPARSER::PROTEIN)
    ("EML4 and intron" . SPARSER::COLLECTION)
    ("GFPT1 and ALK" . SPARSER::COLLECTION)
    ("immunohistochemistry (IHC)" . SPARSER::PROTEIN)
    ("MLH1 , KIT , and KDR" . SPARSER::COLLECTION) ("KDR" . SPARSER::PROTEIN)
    ("MLH1" . SPARSER::PROTEIN) ("16 sporadic MTC group" . SPARSER::MOLECULE)
    ("hereditary MTC" . SPARSER::PROTEIN)
    ("the hereditary MTC" . SPARSER::PROTEIN)
    ("RET , HRAS and KRAS" . SPARSER::COLLECTION)
    ("SMAD family member 4 (N = 1) and von Hippel-Lundau tumor suppressor (N = 1)"
     . SPARSER::COLLECTION)
    ("epidermal growth factor receptor (N = 1), cyclin-dependent kinase inhibitor 2A ( CDKN2A , N = 1), Janus kinase 3 (N = 1), protein tyrosine phosphatase, non-receptor type 1 (N = 1), SMAD family member 4 (N = 1) and von Hippel-Lundau tumor suppressor (N = 1)"
     . SPARSER::COLLECTION)
    ("von" . SPARSER::PROTEIN) ("male and 52" . SPARSER::COLLECTION)
    ("cabozantinib and vandetanib" . SPARSER::COLLECTION)
    ("vandetanib" . SPARSER::DRUG) ("cabozantinib" . SPARSER::DRUG)
    ("iodine" . SPARSER::MOLECULE)
    ("sporadic MTC and other types" . SPARSER::COLLECTION)
    ("sporadic MTC" . SPARSER::PROTEIN)
    ("proto-oncogene ( RET ) and Ras ( RAS )" . SPARSER::COLLECTION)
    ("calcitonin" . SPARSER::PROTEIN) ("GFPT1-ALK" . SPARSER::COLLECTION)
    ("EML4-ALK" . SPARSER::COLLECTION) ("crizotinib" . SPARSER::DRUG)
    ("-ALK" . SPARSER::COLLECTION) ("transaminase" . SPARSER::PROTEIN)
    ("fructose" . SPARSER::PROTEIN) ("Glutamine" . SPARSER::AMINO-ACID)
    ("mutL" . SPARSER::PROTEIN) ("Eighty-four sporadic MTC" . SPARSER::PROTEIN)
    ("Ion" . SPARSER::MOLECULE) ("MTC" . SPARSER::PROTEIN)
    ("RANBP2" . SPARSER::PROTEIN) ("RAN-binding protein 2" . SPARSER::PROTEIN)
    ("HIP1" . SPARSER::PROTEIN) ("N-acetylglucosamine" . SPARSER::MOLECULE)
    ("p23" . SPARSER::PROTEIN) ("SMAD family member 4" . SPARSER::PROTEIN)
    ("protein tyrosine phosphatase, non-receptor type 1" . SPARSER::PROTEIN)
    ("Janus kinase 3" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor 2A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("B-raf" . SPARSER::PROTEIN)
    ("kinase insert domain receptor" . SPARSER::PROTEIN)
    ("ATM serine/threonine kinase" . SPARSER::PROTEIN)
    ("Mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("echinoderm microtubule-associated protein-like 4" . SPARSER::PROTEIN)
    ("GFPT1" . SPARSER::PROTEIN)
    ("anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog"
     . SPARSER::PROTEIN)
    ("serine/threonine kinase 11" . SPARSER::PROTEIN)
    ("the closest proximal gene" . SPARSER::GENE)
    ("CBP/p300" . SPARSER::COLLECTION) ("Ncoa6" . SPARSER::PROTEIN)
    ("methyltransferase" . SPARSER::PROTEIN)
    ("particular H3K27ac" . SPARSER::MOLECULE)
    ("the viral early promoter" . SPARSER::PROMOTER)
    ("Our genome-wide map" . SPARSER::PROTEIN)
    ("2/3 and 1/3" . SPARSER::COLLECTION)
    ("WWC1 , LATS , NF2 , and AMOT" . SPARSER::COLLECTION)
    ("AMOT" . SPARSER::PROTEIN) ("LATS" . SPARSER::PROTEIN)
    ("PI3K-mTOR" . SPARSER::COLLECTION)
    ("previously reported YAP1" . SPARSER::PROTEIN)
    ("YAP1 or TEAD" . SPARSER::COLLECTION)
    ("only distal YAP1/TEAD1" . SPARSER::COLLECTION)
    ("Distal YAP1/TEAD1" . SPARSER::COLLECTION)
    ("YAP1 and FoxO1" . SPARSER::COLLECTION)
    ("acetyltransferase" . SPARSER::PROTEIN)
    ("YAP1 or TEADs" . SPARSER::COLLECTION)
    ("YAP1/TEAD1" . SPARSER::COLLECTION)
    ("proximal promoters" . SPARSER::PROMOTER)
    ("TEAD1 and YAP1" . SPARSER::COLLECTION)
    ("MCAT-luciferase" . SPARSER::COLLECTION) ("MCAT" . SPARSER::PROTEIN)
    ("NNN" . SPARSER::MOLECULE) ("AP-1/TEAD" . SPARSER::COLLECTION)
    ("YAP1/TEAD" . SPARSER::COLLECTION)
    ("a heterodimeric protein complex" . SPARSER::BIO-COMPLEX)
    ("AP-1/JDP2" . SPARSER::COLLECTION)
    ("the predominant co-factors" . SPARSER::MOLECULE)
    ("AXL" . SPARSER::PROTEIN)
    ("ANKRD1 , CYR61 , and NPPB" . SPARSER::COLLECTION)
    ("FAM" . SPARSER::PROTEIN) ("NPPB" . SPARSER::PROTEIN)
    ("associated genes" . SPARSER::GENE)
    ("YAP1-dependent enhancer activation entails characteristic chromatin"
     . SPARSER::PROTEIN)
    ("YAP1 and TEAD" . SPARSER::COLLECTION)
    ("p73, ErbB4, Pax3, AP-1, or TBX5" . SPARSER::COLLECTION)
    ("Runx1/-2" . SPARSER::COLLECTION)
    ("characteristic chromatin" . SPARSER::PROTEIN)
    ("YAP1 and TEAD1" . SPARSER::COLLECTION)
    ("a transcriptional coactivator and well-established oncogene"
     . SPARSER::COLLECTION)
    ("YAP1, a transcriptional coactivator and well-established oncogene"
     . SPARSER::COLLECTION)
    ("the associated genes" . SPARSER::GENE)
    ("distal enhancers" . SPARSER::PROTEIN) ("TEAD3" . SPARSER::PROTEIN)
    ("m 1" . SPARSER::MOLECULE) ("KAT3B" . SPARSER::PROTEIN)
    ("NCOA6" . SPARSER::PROTEIN)
    ("nuclear receptor coactivator 6" . SPARSER::PROTEIN)
    ("H3K4" . SPARSER::PROTEIN) ("Yap1" . SPARSER::PROTEIN)
    ("factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TEF-1" . SPARSER::PROTEIN)
    ("VP16" . SPARSER::DRUG) ("FoxO1" . SPARSER::PROTEIN)
    ("LATS2" . SPARSER::PROTEIN) ("H3K27ac" . SPARSER::MOLECULE)
    ("JDP2" . SPARSER::PROTEIN) ("co-factors" . SPARSER::MOLECULE)
    ("WWC1" . SPARSER::PROTEIN) ("DKK1" . SPARSER::PROTEIN)
    ("HAX1" . SPARSER::PROTEIN) ("TBX5" . SPARSER::PROTEIN)
    ("Pax3" . SPARSER::PROTEIN) ("Runx1" . SPARSER::PROTEIN)
    ("kinase (ILK)" . SPARSER::KINASE) ("ILK" . SPARSER::PROTEIN)
    ("serine-threonine" . SPARSER::COLLECTION)
    ("Src and FAK" . SPARSER::COLLECTION) ("angiogenic EC" . SPARSER::PROTEIN)
    ("tumor-derived pro-angiogenic cues" . SPARSER::PROTEIN-FAMILY)
    ("mTORC2, Akt, and mTORC1" . SPARSER::COLLECTION)
    ("receptor tyrosine kinase and androgen receptor" . SPARSER::COLLECTION)
    ("vascular growth factors" . SPARSER::GROWTH-FACTOR)
    ("investigational mTOR active-site inhibitory drugs" . SPARSER::DRUG)
    ("matrices" . SPARSER::PROTEIN-FAMILY) ("vinculin" . SPARSER::PROTEIN)
    ("a principal regulator" . SPARSER::REGULATOR)
    ("globular actin" . SPARSER::PROTEIN)
    ("polymerized actin" . SPARSER::PROTEIN)
    ("Akt1/mTORC1" . SPARSER::COLLECTION) ("Integrin" . SPARSER::PROTEIN)
    ("Akt and mTORC1" . SPARSER::COLLECTION)
    ("the vascular EC" . SPARSER::PROTEIN)
    ("PP242 or carrier" . SPARSER::COLLECTION) ("CAM" . SPARSER::PROTEIN)
    ("chemotaxis" . SPARSER::PROTEIN)
    ("PP242 or Ku 0063794" . SPARSER::COLLECTION)
    ("exogenous pro-angiogenic growth factors" . SPARSER::GROWTH-FACTOR)
    ("rapamycin, PP242 or Ku-0063794" . SPARSER::COLLECTION)
    ("fibrin" . SPARSER::PROTEIN) ("PP242-" . SPARSER::DRUG)
    ("rapamycin-" . SPARSER::DRUG)
    ("angiogenic cues" . SPARSER::PROTEIN-FAMILY)
    ("PP242 or Ku-0063794" . SPARSER::COLLECTION)
    ("FOXO and S6 kinase" . SPARSER::COLLECTION)
    ("mTORC2 or mTORC1" . SPARSER::COLLECTION) ("mTORC1-" . SPARSER::PROTEIN)
    ("mTORC2-" . SPARSER::PROTEIN)
    ("endothelial Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mTORC2 and Akt" . SPARSER::COLLECTION)
    ("the principal endothelial VEGF receptor" . SPARSER::RECEPTOR)
    ("-kinase" . SPARSER::KINASE)
    ("Pro-angiogenic cues" . SPARSER::PROTEIN-FAMILY)
    ("cues" . SPARSER::PROTEIN-FAMILY)
    ("Akt, a key survival enzyme, and upstream regulator of mTORC1 [ xref ]"
     . SPARSER::COLLECTION)
    ("The principal known target" . SPARSER::TARGET-PROTEIN)
    ("mTOR and mLST8" . SPARSER::COLLECTION)
    ("ribosomal protein S6 kinase (S6K) and eukaryotic translation initiation factor 4E-binding protein 1"
     . SPARSER::COLLECTION)
    ("raptor" . SPARSER::PROTEIN)
    ("pro-angiogenic growth factor–receptor tyrosine kinase inhibitors"
     . SPARSER::INHIBITOR)
    ("growth factor–receptor tyrosine kinase" . SPARSER::COLLECTION)
    ("Endothelial mTORC2" . SPARSER::PROTEIN)
    ("Akt/mTORC1" . SPARSER::COLLECTION) ("Akt1-" . SPARSER::PROTEIN)
    ("pharmacological inhibitors and RNA interference" . SPARSER::COLLECTION)
    ("Akt1 and mTORC1" . SPARSER::COLLECTION)
    ("vascular endothelial growth factor (VEGF) or the receptor"
     . SPARSER::COLLECTION)
    ("angiogenesis inhibitor" . SPARSER::DRUG) ("Ku 0063794" . SPARSER::DRUG)
    ("Filamentous actin" . SPARSER::BIO-COMPLEX) ("ku-0063794" . SPARSER::DRUG)
    ("A 3D" . SPARSER::PROTEIN) ("Anti-S" . SPARSER::ANTIBODY)
    ("Ku-0063794" . SPARSER::DRUG) ("PP242" . SPARSER::DRUG)
    ("stress-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mSin1" . SPARSER::PROTEIN) ("LST8" . SPARSER::PROTEIN)
    ("yeast homolog" . SPARSER::PROTEIN) ("GβL" . SPARSER::PROTEIN)
    ("Growth Factor" . SPARSER::GROWTH-FACTOR)
    ("Vascular Endothelial" . SPARSER::PROTEIN)
    ("phosphoinositide 3 kinase" . SPARSER::PROTEIN)
    ("C-Raf and 14-3-3ζ" . SPARSER::COLLECTION)
    ("the 14-3-3ζ protein and the peptide" . SPARSER::COLLECTION)
    ("a similar conformation and binding interaction with its protein partner"
     . SPARSER::COLLECTION)
    ("protein and methyl group" . SPARSER::COLLECTION)
    ("protein and phosphate group" . SPARSER::COLLECTION)
    ("protein and peptide" . SPARSER::COLLECTION)
    ("a dimeric 14-3-3ζ protein" . SPARSER::PROTEIN)
    ("alanine or aspartic acid" . SPARSER::COLLECTION)
    ("tryptophan" . SPARSER::AMINO-ACID)
    ("explicit solvent" . SPARSER::MOLECULE)
    ("K1 (K615) and β/γ CH 2" . SPARSER::COLLECTION)
    ("peptide and protein" . SPARSER::COLLECTION)
    ("most probable peptide conformation" . SPARSER::BIO-CONFORMATION)
    ("aqueous solution" . SPARSER::MOLECULE)
    ("the N-terminal K1 and the phosphate group" . SPARSER::COLLECTION)
    ("spin" . SPARSER::PROTEIN) ("macromolecule" . SPARSER::MOLECULE)
    ("STD" . SPARSER::PROTEIN) ("tr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Lys/Arg" . SPARSER::COLLECTION) ("Arg or Lys" . SPARSER::COLLECTION)
    ("peptide and vice" . SPARSER::COLLECTION)
    ("the homogeneous human 14-3-3ζ protein" . SPARSER::PROTEIN)
    ("Peptide" . SPARSER::PEPTIDE)
    ("protein and phosphopeptide" . SPARSER::COLLECTION)
    ("KH" . SPARSER::MOLECULE)
    ("proteins, A-Raf, B-Raf and C-Raf" . SPARSER::COLLECTION)
    ("Raf-MEK-ERK" . SPARSER::COLLECTION)
    ("peptide and 14-3-3ζ" . SPARSER::COLLECTION)
    ("C-Raf and scaffold" . SPARSER::COLLECTION) ("C-RAF" . SPARSER::PROTEIN)
    ("CH 2" . SPARSER::PROTEIN) ("CH 3" . SPARSER::MOLECULE)
    ("L11" . SPARSER::PROTEIN) ("A 20" . SPARSER::PROTEIN)
    ("M15" . SPARSER::DRUG) ("MAP2K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("A-Raf" . SPARSER::PROTEIN)
    ("FITC-conjugated anti-mouse secondary antibody" . SPARSER::PROTEIN)
    ("2% bovine serum albumin (BSA)" . SPARSER::PROTEIN)
    ("Aldrich" . SPARSER::PROTEIN) ("paraformaldehyde" . SPARSER::DRUG)
    ("Sigma-Aldrich" . SPARSER::COLLECTION)
    ("sEGFR/EGFR" . SPARSER::COLLECTION) ("nitrocellulose" . SPARSER::MOLECULE)
    ("absolute ethanol" . SPARSER::PROTEIN) ("ethanol" . SPARSER::PROTEIN)
    ("glycerol" . SPARSER::PROTEIN) ("HEPES" . SPARSER::MOLECULE)
    ("Bright" . SPARSER::PROTEIN) ("RPMI" . SPARSER::PROTEIN)
    ("DelE" . SPARSER::PROTEIN) ("Des" . SPARSER::PROTEIN)
    ("hematoxylin" . SPARSER::MOLECULE) ("Formalin" . SPARSER::MOLECULE)
    ("Prism" . SPARSER::PROTEIN)
    ("diagnostic and therapeutic aims" . SPARSER::PROTEIN)
    ("a bio-therapeutic molecule" . SPARSER::MOLECULE)
    ("cyclin D1, iNOS, and Aurora-A" . SPARSER::COLLECTION)
    ("IIIB" . SPARSER::DRUG) ("a prognostic biomarker" . SPARSER::MOLECULE)
    ("more heterogeneous cohort" . SPARSER::MOLECULE)
    ("prognostic biomarker" . SPARSER::MOLECULE) ("Baron" . SPARSER::PROTEIN)
    ("a 110 kDa soluble isoform" . SPARSER::ISOFORM)
    ("EGF and sEGFR" . SPARSER::COLLECTION)
    ("sEGFR and EGF" . SPARSER::COLLECTION)
    ("soluble receptors" . SPARSER::PROTEIN)
    ("Soluble receptors" . SPARSER::PROTEIN)
    ("prognostic aims" . SPARSER::PROTEIN)
    ("Representative FISH" . SPARSER::PROTEIN) ("histological type" . TYPE)
    ("Radical" . SPARSER::MOLECULE)
    ("78 unique COOH-terminal amino acids" . SPARSER::AMINO-ACID)
    ("COOH" . SPARSER::MOLECULE) ("PI-sEGFR" . SPARSER::COLLECTION)
    ("gly" . SPARSER::AMINO-ACID)
    ("two highly-glycosylated EGFR soluble isoforms" . SPARSER::ISOFORM)
    ("soluble EGFR isoforms" . SPARSER::ISOFORM)
    ("the soluble isoform" . SPARSER::ISOFORM)
    ("a heterogeneous cohort" . SPARSER::MOLECULE)
    ("a potential diagnostic biomarker" . SPARSER::MOLECULE)
    ("sEGFR" . SPARSER::PROTEIN) ("K3" . SPARSER::PROTEIN)
    ("BCR-ABL, or BCR-ABL" . SPARSER::COLLECTION) ("Imatinib" . SPARSER::DRUG)
    ("IκBα/p53" . SPARSER::COLLECTION)
    ("TNFα and the tyrosine kinase inhibitor staurosporine"
     . SPARSER::COLLECTION)
    ("IκBα-p53" . SPARSER::COLLECTION)
    ("BCR-ABL and IκBα" . SPARSER::COLLECTION)
    ("exogenous IκBα" . SPARSER::PROTEIN)
    ("BCR-ABL and myc-tag-IκBα" . SPARSER::COLLECTION)
    ("a ternary complex" . SPARSER::BIO-COMPLEX)
    ("IκBα and p53" . SPARSER::COLLECTION)
    ("PP2A and PTEN" . SPARSER::COLLECTION)
    ("BCR-ABL/IκBα/p53" . SPARSER::COLLECTION)
    ("BCR-ABL/IκBα" . SPARSER::COLLECTION) ("as 2" . SPARSER::PROTEIN)
    ("ABL1" . SPARSER::PROTEIN) ("pRK5" . SPARSER::PROTEIN)
    ("NFκ" . SPARSER::PROTEIN) ("p210" . SPARSER::PROTEIN)
    ("BCR-ABL" . SPARSER::PROTEIN) ("snap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphatidylcholine" . SPARSER::MOLECULE) ("TRPC" . SPARSER::PROTEIN)
    ("TRP" . SPARSER::AMINO-ACID) ("DAG" . SPARSER::DAG)
    ("PLC" . SPARSER::PROTEIN) ("Gq" . SPARSER::DRUG)
    ("the intermediary kinase" . SPARSER::KINASE)
    ("FAK, PYK2 or JAK2" . SPARSER::COLLECTION) ("RhoGEF" . SPARSER::PROTEIN)
    ("RhoGEFs" . SPARSER::PROTEIN)
    ("GPCR or growth factors" . SPARSER::COLLECTION) ("TK" . SPARSER::PROTEIN)
    ("BK and CCh‐induced" . SPARSER::COLLECTION)
    ("PP2 or PF‐573228" . SPARSER::COLLECTION) ("Lyn" . SPARSER::PROTEIN)
    ("PP2 and PF‐573228" . SPARSER::COLLECTION)
    ("PP2 and PF" . SPARSER::COLLECTION)
    ("FAK and SrcFK" . SPARSER::COLLECTION)
    ("BK and CCh" . SPARSER::COLLECTION) ("PP2, and FAK" . SPARSER::COLLECTION)
    ("BK or CCh" . SPARSER::COLLECTION)
    ("BK (1 μM) or CCh (100 μM)" . SPARSER::COLLECTION)
    ("PP2 or Y27632" . SPARSER::COLLECTION)
    ("either PP2 or PF‐573228" . SPARSER::COLLECTION)
    ("pCa" . SPARSER::PROTEIN) ("Max or PD 2" . SPARSER::COLLECTION)
    ("Max" . SPARSER::PROTEIN) ("Bradykinin" . SPARSER::BRADYKININ)
    ("PP2 (−5.55 ± 0.09 vs. control −5.8 ± 0.14, P < 0.05, paired t ‐test, n = 8), Y27632 (−5.4 ± 0.07 vs. control −5.82 ± 0.07, P < 0.01, paired t ‐test, n = 6) and PF‐573228 (−5.21 ± 0.08 vs. control −5.69 ± 0.07, P < 0.001, paired t ‐test, n = 8)"
     . SPARSER::COLLECTION)
    ("PP2 ( P < 0.01, paired t ‐test, n = 8), Y27632 ( P < 0.01, paired t ‐test, n = 6) and PF‐573228 ( P < 0.05, paired t ‐test, n = 8)"
     . SPARSER::COLLECTION)
    ("a dual FAK/PYK2 inhibitor" . SPARSER::INHIBITOR)
    ("muscarinic" . SPARSER::PROTEIN)
    ("vascular smooth muscle" . SPARSER::PROTEIN)
    ("Src family kinases (SrcFK) and focal adhesion kinase (FAK)"
     . SPARSER::COLLECTION)
    ("TKs" . SPARSER::PROTEIN) ("MLCP" . SPARSER::PHOSPHATASE)
    ("ROCE" . SPARSER::PROTEIN) ("phosphatase (MLCP)" . SPARSER::PHOSPHATASE)
    ("kinase (MLCK)" . SPARSER::KINASE) ("MLCK" . SPARSER::PROTEIN)
    ("Smooth muscle" . SPARSER::PROTEIN) ("allergens" . SPARSER::MOLECULE)
    ("catecholamine and NANC neurotransmitters" . SPARSER::COLLECTION)
    ("catecholamine" . SPARSER::MOLECULE) ("KDa" . SPARSER::PROTEIN)
    ("PSS" . SPARSER::PROTEIN-FAMILY) ("BK" . SPARSER::PROTEIN)
    ("bradykinin" . SPARSER::BRADYKININ) ("carbachol" . SPARSER::DRUG)
    ("Src‐family kinases (SrcFK) and focal adhesion kinase (FAK)"
     . SPARSER::COLLECTION)
    ("ASM" . SPARSER::PROTEIN) ("α5β1" . SPARSER::PROTEIN)
    ("Orai1" . SPARSER::PROTEIN) ("STIM1" . SPARSER::PROTEIN)
    ("IP 3" . SPARSER::IP3)
    ("guanine nucleotide exchange factors" . SPARSER::GEF)
    ("B–D" . SPARSER::PROTEIN) ("A–D" . SPARSER::PROTEIN)
    ("PD2" . SPARSER::PROTEIN) ("PD 2" . SPARSER::PROTEIN)
    ("YM58483" . SPARSER::DRUG) ("PP3" . SPARSER::PROTEIN)
    ("MYPT1" . SPARSER::PROTEIN) ("S19" . SPARSER::PROTEIN)
    ("Type XI" . SPARSER::PROTEIN) ("K 2" . SPARSER::PROTEIN)
    ("MgSO 4" . SPARSER::DRUG) ("K +" . SPARSER::MOLECULE)
    ("Na +" . SPARSER::MOLECULE) ("myosin phosphatase" . SPARSER::PROTEIN)
    ("PI3k/AKT" . SPARSER::COLLECTION) ("EC and AC" . SPARSER::COLLECTION)
    ("PI3k" . SPARSER::PROTEIN-FAMILY)
    ("EGFR, ERBB2, ERBB3 and ERBB4" . SPARSER::COLLECTION)
    ("KRAS (7.8 %) and ERBB3 (11.8 %)" . SPARSER::COLLECTION)
    ("TP53 (47.1 %), KRAS (7.8 %) and ERBB3 (11.8 %)" . SPARSER::COLLECTION)
    ("SD " . SPARSER::PROTEIN) ("PTEN/PI3k/AKT/mTOR" . SPARSER::COLLECTION)
    ("ERBB4" . SPARSER::PROTEIN) ("ERBB3" . SPARSER::PROTEIN)
    ("Sp1 and p50" . SPARSER::COLLECTION) ("Sp1/NFκB" . SPARSER::COLLECTION)
    ("transcription factor Sp1 and the p50 homodimer" . SPARSER::COLLECTION)
    ("p65–p50" . SPARSER::COLLECTION)
    ("p65, c-Rel, and RelB" . SPARSER::COLLECTION)
    ("c-Rel, and RelB" . SPARSER::COLLECTION) ("MDM2-" . SPARSER::PROTEIN)
    ("DNA and RNA" . SPARSER::COLLECTION)
    ("paternal and maternal alleles" . SPARSER::ALLELE)
    ("/ER/MDM2" . SPARSER::COLLECTION) ("-SNP309" . SPARSER::COLLECTION)
    ("p50–p50" . SPARSER::COLLECTION) ("p50–p65" . SPARSER::COLLECTION)
    ("COS" . SPARSER::MOLECULE) ("NFκB/Rel" . SPARSER::COLLECTION)
    ("Sp1 and NFκB" . SPARSER::COLLECTION)
    ("a new functional SNP" . SPARSER::PROTEIN) ("EMCA" . SPARSER::DRUG)
    ("these artificial RNAs" . SPARSER::RNA) ("CCAAT" . SPARSER::PROTEIN)
    ("AF" . SPARSER::PROTEIN) ("various autosomal genes" . SPARSER::GENE)
    ("FSHB" . SPARSER::PROTEIN)
    ("autosomal genes and a few imprint genes" . SPARSER::COLLECTION)
    ("autosomal genes" . SPARSER::GENE)
    ("a heterozygous state" . SPARSER::BIO-STATE)
    ("transcription factor Sp1 and nuclear factor kappa-B (NFκB)"
     . SPARSER::COLLECTION)
    ("a new functional polymorphism" . SPARSER::PROTEIN)
    ("SNP" . SPARSER::PROTEIN) ("MDM2- 3" . SPARSER::COLLECTION)
    ("polymorphism (SNP)" . SPARSER::PROTEIN)
    ("MDM2 protein" . SPARSER::PROTEIN)
    ("Transcription factor Sp1" . SPARSER::PROTEIN)
    ("C/EBPα" . SPARSER::PROTEIN) ("AGTR1" . SPARSER::PROTEIN)
    ("TGFBR1" . SPARSER::PROTEIN) ("SNP309" . SPARSER::PROTEIN)
    ("its proximal parts" . SPARSER::COMPONENT)
    ("light and electron" . SPARSER::COLLECTION)
    ("CPAP, Cep120, Cep135 and centrobin" . SPARSER::COLLECTION)
    ("centrobin and CPAP" . SPARSER::COLLECTION)
    ("Centrobin" . SPARSER::PROTEIN)
    ("the centrosomal fraction" . SPARSER::COMPONENT)
    ("Cep135, Cep120, hPoc5 and GT335" . SPARSER::COLLECTION)
    ("CPAP-" . SPARSER::PROTEIN) ("CPAP or centrobin" . SPARSER::COLLECTION)
    ("centrosomal protein 4.1-associated protein (CPAP) and centrobin"
     . SPARSER::COLLECTION)
    ("protein (CPAP)" . SPARSER::PROTEIN)
    ("Several centrosomal proteins" . SPARSER::PROTEIN)
    ("CPAP and centrobin" . SPARSER::COLLECTION)
    ("centrobin" . SPARSER::PROTEIN) ("CPAP" . SPARSER::PROTEIN)
    ("CDK5RAP2/Cep215" . SPARSER::COLLECTION)
    ("Pericentrin" . SPARSER::PROTEIN)
    ("centrosomal components" . SPARSER::COMPONENT)
    ("centrosomal proteins and cyclins" . SPARSER::COLLECTION)
    ("proteins and cyclins" . SPARSER::COLLECTION)
    ("centrosomal proteins" . SPARSER::PROTEIN)
    ("several other centrosomal proteins" . SPARSER::PROTEIN)
    ("tubulin and Cep152" . SPARSER::COLLECTION) ("PCMs" . SPARSER::PROTEIN)
    ("inhibitor (RO)" . SPARSER::INHIBITOR) ("RO" . SPARSER::PROTEIN)
    ("CHO" . SPARSER::PROTEIN) ("hydroxyurea" . SPARSER::DRUG)
    ("Gamma tubulin and Cep152-positive daughter centrioles"
     . SPARSER::COLLECTION)
    ("Plk4" . SPARSER::PROTEIN) ("Plk" . SPARSER::PROTEIN)
    ("Cep152/Asterless" . SPARSER::COLLECTION) ("Asterless" . SPARSER::PROTEIN)
    ("their own PCM" . SPARSER::PROTEIN)
    ("whose proximal parts" . SPARSER::COMPONENT) ("Plk1TD" . SPARSER::PROTEIN)
    ("Plk1TD–RFP" . SPARSER::COLLECTION)
    ("Plk1 or Plk1TD" . SPARSER::COLLECTION)
    ("red fluorescent protein (RFP)" . SPARSER::PROTEIN)
    ("a doxycycline (dox)-inducible constitutively active Plk1T210D mutant (Plk1TD) fused"
     . SPARSER::PROTEIN)
    ("distal parts" . SPARSER::COMPONENT) ("Separase" . SPARSER::PROTEIN)
    ("PCM" . SPARSER::PROTEIN) ("Cdc20" . SPARSER::PROTEIN)
    ("Delta)" . SPARSER::PROTEIN) ("Cep192" . SPARSER::PROTEIN)
    ("Cep63" . SPARSER::PROTEIN) ("1–2 " . SPARSER::PROTEIN)
    ("1–8 " . SPARSER::PROTEIN) ("GT335" . SPARSER::PROTEIN)
    ("hPoc5" . SPARSER::PROTEIN) ("hPOC5" . SPARSER::PROTEIN)
    ("Cep135" . SPARSER::PROTEIN) ("centrosomal protein 4" . SPARSER::PROTEIN)
    ("Cep215" . SPARSER::PROTEIN) ("CDK5RAP2" . SPARSER::PROTEIN)
    ("Sas6" . SPARSER::PROTEIN) ("Cep152" . SPARSER::PROTEIN)
    ("RO-3306" . SPARSER::DRUG) ("Centrin1" . SPARSER::PROTEIN)
    ("miR-526b" . SPARSER::PROTEIN) ("hsa-miR-526b" . SPARSER::COLLECTION)
    ("hsa" . SPARSER::PROTEIN) ("orthologs" . SPARSER::PROTEIN)
    ("the largest human miRNA gene" . SPARSER::GENE)
    ("MMP1 and miR-526b" . SPARSER::COLLECTION)
    ("aza and TSA" . SPARSER::COLLECTION)
    ("miRNA and MMP1" . SPARSER::COLLECTION)
    ("MMP8 and MMP13" . SPARSER::COLLECTION)
    ("mature miRNA" . SPARSER::PROTEIN)
    ("membrane-type MMPs and other MMPs" . SPARSER::COLLECTION)
    ("collagenase" . SPARSER::PROTEIN)
    ("collagenases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MMP1 and its mutant form" . SPARSER::COLLECTION)
    ("Ku80" . SPARSER::PROTEIN) ("b-5" . SPARSER::PROTEIN)
    ("c-5" . SPARSER::PROTEIN) ("MMP-1" . SPARSER::PROTEIN)
    ("MMP13" . SPARSER::PROTEIN) ("MMP8" . SPARSER::PROTEIN)
    ("type-3" . SPARSER::PROTEIN) ("stromelysin-1" . SPARSER::PROTEIN)
    ("interstitial collagenase" . SPARSER::PROTEIN)
    ("a specific clinically available downstream kinase (BTK) inhibitor"
     . SPARSER::INHIBITOR)
    ("kinase (BTK)" . SPARSER::KINASE)
    ("patients not currently deemed fit" . SPARSER::PROTEIN-FAMILY)
    ("cytarabine" . SPARSER::MOLECULE)
    ("ibrutinib or BTK" . SPARSER::COLLECTION)
    ("AKT, STAT5 and MAPK" . SPARSER::COLLECTION)
    ("siRNA or shRNA" . SPARSER::COLLECTION)
    ("LYN and SYK" . SPARSER::COLLECTION)
    ("PI3-K, LYN and SYK" . SPARSER::COLLECTION) ("Tec" . SPARSER::PROTEIN)
    ("Midostaurin" . SPARSER::DRUG) ("quizartinib" . SPARSER::DRUG)
    ("a valid therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("BTK-KD" . SPARSER::COLLECTION) ("non-FLT3" . SPARSER::PROTEIN)
    ("AKT, MAPK and STAT5" . SPARSER::COLLECTION)
    ("non-FLT3-ITD" . SPARSER::COLLECTION) ("FLT" . SPARSER::PROTEIN)
    ("Ibrutinib" . SPARSER::DRUG) ("KappaB" . SPARSER::PROTEIN)
    ("lymphoid and myeloid" . SPARSER::COLLECTION)
    ("Protein Kinase B (AKT)" . SPARSER::PROTEIN)
    ("Mitogen-Activated Protein Kinase (MAPK) and Bruton"
     . SPARSER::COLLECTION)
    ("Activator" . SPARSER::ACTIVATOR)
    ("receptor and non-receptor tyrosine kinases" . SPARSER::COLLECTION)
    ("pro-tumoral tyrosine kinases" . SPARSER::PROTEIN)
    ("ITD" . SPARSER::PROTEIN) ("FLT3-ITD" . SPARSER::COLLECTION)
    ("MAPK, AKT and STAT5" . SPARSER::COLLECTION) ("ibrutinib" . SPARSER::DRUG)
    ("our group and others" . SPARSER::COLLECTION) ("FMS" . SPARSER::PROTEIN)
    ("PLCgamma2" . SPARSER::PROTEIN) ("T-cell kinase" . SPARSER::PROTEIN)
    ("interleukin-2" . SPARSER::PROTEIN) ("PI3-K" . SPARSER::PROTEIN)
    ("PKC412" . SPARSER::DRUG) ("PDGF-R" . SPARSER::PROTEIN)
    ("AC220" . SPARSER::DRUG) ("annexin-V" . SPARSER::PROTEIN)
    ("annexin- V" . SPARSER::PROTEIN) ("CD105" . SPARSER::PROTEIN)
    ("CD73" . SPARSER::PROTEIN) ("tyrosine Kinase" . SPARSER::PROTEIN)
    ("Mitogen-Activated Protein Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p110delta" . SPARSER::PROTEIN) ("Protein Kinase B" . SPARSER::PROTEIN)
    ("MTOR and HIF1α" . SPARSER::COLLECTION)
    ("HIF1 α and several other genes (Additional file xref : Figure S9)"
     . SPARSER::COLLECTION)
    ("acute hypoxia" . SPARSER::PROTEIN)
    ("nestin and SOX2" . SPARSER::COLLECTION)
    ("PIK3-AKT" . SPARSER::COLLECTION) ("Met-Leu" . SPARSER::COLLECTION)
    ("NESTIN" . SPARSER::PROTEIN) ("importins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("shorter mRNAs" . SPARSER::PROTEIN)
    ("GLI1 and CCND1" . SPARSER::COLLECTION)
    ("SOX2 and MYC" . SPARSER::COLLECTION)
    ("POU5F1/OCT4" . SPARSER::COLLECTION) ("NANOG" . SPARSER::PROTEIN)
    ("NES and TUBB3" . SPARSER::COLLECTION) ("nestin (NES)" . SPARSER::PROTEIN)
    ("NES" . SPARSER::PROTEIN) ("IGF1/MTOR" . SPARSER::COLLECTION)
    ("chemokine receptor type 4 ( CXCR4 ) and chemokine ligand"
     . SPARSER::COLLECTION)
    ("factor metallothionein 3 (MT3) , CD24 , chemokine receptor type 4 ( CXCR4 ) and chemokine ligand"
     . SPARSER::COLLECTION)
    ("MT3" . SPARSER::PROTEIN)
    ("potassium large conductance calcium-activated channel (KCNMA1) and the integrin receptor ( ITGA2)"
     . SPARSER::COLLECTION)
    ("BP" . SPARSER::PROTEIN) ("Sphingolipid" . SPARSER::MOLECULE)
    ("Ribosome" . SPARSER::BIO-COMPLEX) ("FCCP" . SPARSER::MOLECULE)
    ("Rh" . SPARSER::MOLECULE) ("acute severe hypoxia" . SPARSER::PROTEIN)
    ("Hematoxylin" . SPARSER::MOLECULE) ("-protein" . SPARSER::COLLECTION)
    ("anti-NAT12/NAA30" . SPARSER::COLLECTION) ("nestin" . SPARSER::PROTEIN)
    ("NAT1, NAT2 and NAT10" . SPARSER::COLLECTION)
    ("using another antibody and recombinant protein" . SPARSER::COLLECTION)
    ("around 50 kDa" . SPARSER::PROTEIN)
    ("Oligonucleotide" . SPARSER::MOLECULE)
    ("NAT9, NAT10, NAT14 and NAT15" . SPARSER::COLLECTION)
    ("NAT12, NAT6, NAT8 and NAT8B" . SPARSER::COLLECTION)
    ("NAT2 and NAT5" . SPARSER::COLLECTION)
    ("NAT1, NAT13 and NAT5" . SPARSER::COLLECTION)
    ("NAT5, NAT14, NAT10 and NAT9" . SPARSER::COLLECTION)
    ("GM" . SPARSER::PROTEIN)
    ("p53 and glial fibrillary acidic protein" . SPARSER::COLLECTION)
    ("the NAT-C subunits, led to p53-dependent apoptosis in HeLa and colon carcinoma cell lines with the strongest phenotype"
     . SPARSER::FRAGMENT)
    ("substrates and downstream targets" . SPARSER::COLLECTION)
    ("one catalytic subunit and auxiliary subunit(s)" . SPARSER::COLLECTION)
    ("auxiliary subunit" . SPARSER::FRAGMENT) ("NAT" . SPARSER::PROTEIN)
    ("N-terminal acetyltransferases (NATs) or Nα-acetyltransferases (NAAs)"
     . SPARSER::COLLECTION)
    ("NAAs" . SPARSER::MOLECULE)
    ("all soluble human proteins" . SPARSER::PROTEIN)
    ("p-MTOR" . SPARSER::COLLECTION) ("p53 and GFAP" . SPARSER::COLLECTION)
    ("genes and biochemical pathways" . SPARSER::COLLECTION)
    ("NAT12/NAA30" . SPARSER::COLLECTION) ("NATs" . SPARSER::PROTEIN)
    ("SSEA1" . SPARSER::DRUG) ("NBP1" . SPARSER::PROTEIN)
    ("Na3VO4" . SPARSER::MOLECULE) ("TGF α" . SPARSER::PROTEIN)
    ("TC4" . SPARSER::PROTEIN) ("H-I" . SPARSER::PROTEIN)
    ("CD9" . SPARSER::PROTEIN) ("CD166" . SPARSER::PROTEIN)
    ("L-15" . SPARSER::PROTEIN) ("PIK3" . SPARSER::PROTEIN)
    ("H2A" . SPARSER::PROTEIN) ("GLI1" . SPARSER::PROTEIN)
    ("CD15" . SPARSER::DRUG) ("S10" . SPARSER::PROTEIN)
    ("IGF1" . SPARSER::PROTEIN)
    ("insulin-like growth factor binding protein 3" . SPARSER::PROTEIN)
    ("type 4" . SPARSER::PROTEIN) ("chemokine receptor" . SPARSER::PROTEIN)
    ("CD24" . SPARSER::PROTEIN) ("metallothionein 3" . SPARSER::PROTEIN)
    ("8B" . SPARSER::PROTEIN) ("ITGA2" . SPARSER::PROTEIN)
    ("KCNMA1" . SPARSER::PROTEIN)
    ("potassium large conductance calcium-activated channel"
     . SPARSER::PROTEIN)
    ("hypoxia induced factor 1" . SPARSER::PROTEIN) ("NS 1" . SPARSER::PROTEIN)
    ("D-G" . SPARSER::PROTEIN) ("A-C" . SPARSER::PROTEIN)
    ("NAT8L" . SPARSER::PROTEIN) ("NAT15" . SPARSER::PROTEIN)
    ("NAT2" . SPARSER::PROTEIN) ("NAT6" . SPARSER::PROTEIN)
    ("NAT8B" . SPARSER::PROTEIN) ("NAT8" . SPARSER::PROTEIN)
    ("NAT13" . SPARSER::PROTEIN) ("NAT1" . SPARSER::PROTEIN)
    ("NAT9" . SPARSER::PROTEIN) ("NAT10" . SPARSER::PROTEIN)
    ("NAT14" . SPARSER::PROTEIN) ("NAT5" . SPARSER::PROTEIN)
    ("HIF1 α" . SPARSER::PROTEIN) ("NAA30" . SPARSER::PROTEIN)
    ("NAT12" . SPARSER::PROTEIN) ("Male" . SPARSER::MOLECULE)
    ("traits and male" . SPARSER::COLLECTION)
    ("reasonable fit" . SPARSER::PROTEIN-FAMILY)
    ("ethnic group and CAG" . SPARSER::COLLECTION)
    ("group and CAG" . SPARSER::COLLECTION) ("GGN" . SPARSER::PROTEIN)
    ("testosterone" . SPARSER::MOLECULE)
    ("aberrantly expressed lncRNAs and protein-coding genes in LUAD"
     . SPARSER::COLLECTION)
    ("a robust negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("CDH1, DKKI and INK/ARF" . SPARSER::COLLECTION) ("ARF" . SPARSER::PROTEIN)
    ("hnRNPK" . SPARSER::PROTEIN) ("tip" . SPARSER::PROTEIN)
    ("the crucial nodal" . SPARSER::PROTEIN)
    ("p27 and LUADT1" . SPARSER::COLLECTION)
    ("SUZ12 and H3K27me3" . SPARSER::COLLECTION)
    ("SUZ12 and LUADT1" . SPARSER::COLLECTION)
    ("SUZ12 and EZH2" . SPARSER::COLLECTION)
    ("EZH2 and SUZ12" . SPARSER::COLLECTION)
    ("EZH2, SUZ12 and EED1" . SPARSER::COLLECTION) ("RBPs" . SPARSER::PROTEIN)
    ("GAPDH and RNU1" . SPARSER::COLLECTION)
    ("shRNA or shLUADT1" . SPARSER::COLLECTION)
    ("BrdU and CCK-8" . SPARSER::COLLECTION)
    ("Annexin V and propidium" . SPARSER::COLLECTION)
    ("iodide" . SPARSER::PROTEIN) ("propidium" . SPARSER::MOLECULE)
    ("LUADT1" . SPARSER::PROTEIN) ("siRNA-LUADT1" . SPARSER::COLLECTION)
    ("HBE" . SPARSER::PROTEIN) ("ZNF333 and NF-AT" . SPARSER::COLLECTION)
    ("PIK3CD-AS2" . SPARSER::COLLECTION) ("AC" . SPARSER::PROTEIN)
    ("genes and lncRNAs" . SPARSER::COLLECTION) ("lncRNA" . SPARSER::RNA)
    ("smokes" . SPARSER::MOLECULE) ("lncRNAs" . SPARSER::RNA)
    ("RNA-Binding Protein" . SPARSER::PROTEIN) ("Anti- β" . SPARSER::PROTEIN)
    ("WDR5" . SPARSER::PROTEIN) ("H3K27me3" . SPARSER::PROTEIN)
    ("negative regulator of transcription" . SPARSER::PROTEIN)
    ("EED1" . SPARSER::PROTEIN)
    ("Glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 6" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 4" . SPARSER::PROTEIN)
    ("HIF1-alpha" . SPARSER::PROTEIN) ("NF-AT" . SPARSER::PROTEIN)
    ("ZNF333" . SPARSER::PROTEIN) ("AS2" . SPARSER::PROTEIN)
    ("PRC2" . SPARSER::PROTEIN) ("transcript 2" . SPARSER::PROTEIN)
    ("polycomb repressive complex 2" . SPARSER::PROTEIN)
    ("SUZ12" . SPARSER::PROTEIN)
    ("IncG proteins [ xref ] and a pro-apoptotic effector protein kinase C delta (PKC-δ)"
     . SPARSER::COLLECTION)
    ("a pro-apoptotic effector protein kinase C delta" . SPARSER::PROTEIN)
    ("inhibitor or sensor" . SPARSER::COLLECTION)
    ("Nod1 and Nod2" . SPARSER::COLLECTION)
    ("pro- or anti-apoptotic" . SPARSER::COLLECTION)
    ("pro-" . SPARSER::AMINO-ACID)
    ("chlamydial inclusion membrane protein" . SPARSER::PROTEIN)
    ("IncA" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("infection-induced activated caspase-9" . SPARSER::PROTEIN)
    ("IAP1, IAP2, and XIAP" . SPARSER::COLLECTION) ("XIAP" . SPARSER::PROTEIN)
    ("apoptosomes" . SPARSER::BIO-COMPLEX)
    ("the apaf - 1 gene and the apaf - 1 − / −MEFs (Fig.  xref b)"
     . SPARSER::COLLECTION)
    ("caspase-8 and -3" . SPARSER::COLLECTION) ("Ap-i" . SPARSER::PROTEIN)
    ("hpi" . SPARSER::PROTEIN) ("Apaf-1 and caspase-9" . SPARSER::COLLECTION)
    ("apaf - 1 and caspase - 9" . SPARSER::COLLECTION)
    ("IAPs" . SPARSER::PROTEIN)
    ("a pro-apoptotic effector" . SPARSER::EFFECTOR)
    ("diacylglycerol" . SPARSER::PROTEIN) ("IncG" . SPARSER::PROTEIN)
    ("MAPK/ERK" . SPARSER::COLLECTION)
    ("proteins and CPAF" . SPARSER::COLLECTION)
    ("protease, or proteasome-like" . SPARSER::COLLECTION)
    ("the pro-apoptotic BH3-only proteins" . SPARSER::PROTEIN)
    ("Bik, Puma, Bim, Bad, Bmf, Noxa, and tBid" . SPARSER::COLLECTION)
    ("tBid" . SPARSER::PROTEIN) ("Bmf" . SPARSER::PROTEIN)
    ("Bad" . SPARSER::PROTEIN) ("Bik" . SPARSER::PROTEIN)
    ("STS and TNF-α" . SPARSER::COLLECTION) ("STS" . SPARSER::PROTEIN)
    ("Apaf-1, and pro-caspase-9" . SPARSER::COLLECTION)
    ("apoptosome" . SPARSER::BIO-COMPLEX)
    ("using caspase - 9  −/− and apaf - 1  −/− MEFs" . SPARSER::COLLECTION)
    ("Apaf - 1" . SPARSER::PROTEIN) ("Chk1" . SPARSER::PROTEIN)
    ("Nod2" . SPARSER::PROTEIN) ("Nod1" . SPARSER::PROTEIN)
    ("bcl - 2" . SPARSER::PROTEIN) ("IAP2" . SPARSER::PROTEIN)
    ("CCL23" . SPARSER::PROTEIN) ("Z-LEHD-FMK" . SPARSER::DRUG)
    ("Z-IETD-FMK" . SPARSER::DRUG) ("cIAP2" . SPARSER::PROTEIN)
    ("PKC-δ" . SPARSER::PROTEIN) ("protein kinase C delta" . SPARSER::PROTEIN)
    ("Bag-1" . SPARSER::PROTEIN) ("BH3-only protein" . SPARSER::PROTEIN)
    ("mcl - 1" . SPARSER::PROTEIN) ("CD95" . SPARSER::PROTEIN)
    ("cytochrome c" . SPARSER::PROTEIN) ("NOD1" . SPARSER::PROTEIN)
    ("apaf - 1" . SPARSER::PROTEIN) ("caspase - 9" . SPARSER::PROTEIN)
    ("Apaf-1" . SPARSER::PROTEIN) ("Caspase-9" . SPARSER::PROTEIN)
    ("ARMS" . SPARSER::PROTEIN) ("/chromosome 17" . SPARSER::COLLECTION)
    ("estrogen receptor-" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor ( EGFR )"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("potential etiologic common germline genetic variants" . SPARSER::VARIANT)
    ("histological or molecular subtypes" . SPARSER::PROTEIN)
    ("SHH" . SPARSER::PROTEIN)
    ("known oncogenes and tumor suppressors (e.g., MYC , TP53 , and PTCH1 ) as well as novel medulloblastoma candidate genes (e.g., MML2 )"
     . SPARSER::COLLECTION)
    ("tumor suppressors (e.g., MYC , TP53 , and PTCH1 ) as well as novel medulloblastoma candidate genes (e.g., MML2 )"
     . SPARSER::COLLECTION)
    ("MYC , TP53 , and PTCH1" . SPARSER::COLLECTION) ("MML" . SPARSER::PROTEIN)
    ("PTCH1 or SUFU" . SPARSER::COLLECTION) ("SUFU" . SPARSER::PROTEIN)
    ("CCND2 , PTCH1 , and GLI2" . SPARSER::COLLECTION)
    ("CCND2 , CTNNB1 , DDX3X , GLI2 , SMARCA4, MYC , MYCN , PTCH1 , TP53 , and MLL2"
     . SPARSER::COLLECTION)
    ("MYCN" . SPARSER::PROTEIN) ("cyclin D2" . SPARSER::PROTEIN)
    ("GLI family zinc finger 2" . SPARSER::PROTEIN)
    ("sonic hedgehog" . SPARSER::PROTEIN) ("KMT2D" . SPARSER::PROTEIN)
    ("MLL2" . SPARSER::PROTEIN) ("PTCH1" . SPARSER::PROTEIN)
    ("SMARCA4" . SPARSER::PROTEIN) ("GLI2" . SPARSER::PROTEIN)
    ("DDX3X" . SPARSER::PROTEIN) ("CCND2" . SPARSER::PROTEIN)
    ("RASs" . SPARSER::PROTEIN) ("spike" . SPARSER::PROTEIN)
    ("adrenergic" . SPARSER::PROTEIN)
    ("the growth factors as well as other biologically active molecules"
     . SPARSER::COLLECTION)
    ("SMG ducal component" . SPARSER::COMPONENT)
    ("AKT or ERK" . SPARSER::COLLECTION) ("ERK/AKT" . SPARSER::COLLECTION)
    ("CTX" . SPARSER::PROTEIN) ("WNT, and EMT" . SPARSER::COLLECTION)
    ("EGF/EGFR" . SPARSER::COLLECTION) ("normal SMGs" . SPARSER::PROTEIN)
    ("the residual acini" . SPARSER::PROTEIN)
    ("lost peripheral αSMA" . SPARSER::PROTEIN)
    ("GCTs and other types" . SPARSER::COLLECTION)
    ("the ductal components" . SPARSER::COMPONENT)
    ("some normal GCTs or residual GCTs" . SPARSER::COLLECTION)
    ("residual GCTs" . SPARSER::PROTEIN)
    ("some normal GCTs" . SPARSER::PROTEIN)
    ("Residual acini" . SPARSER::PROTEIN)
    ("the adjacent acini" . SPARSER::PROTEIN)
    ("normal GCTs" . SPARSER::PROTEIN) ("acini" . SPARSER::PROTEIN)
    ("apparently normal SMGs" . SPARSER::PROTEIN)
    ("p63, p40 and AR-status" . SPARSER::COLLECTION) ("LGL" . SPARSER::PROTEIN)
    ("SMGs" . SPARSER::PROTEIN) ("elastase" . SPARSER::PROTEIN)
    ("NRAS , EGFR and BRAF" . SPARSER::COLLECTION) ("AAC" . SPARSER::PROTEIN)
    ("the most aggressive subtypes" . SPARSER::PROTEIN)
    ("KRas or EGFR" . SPARSER::COLLECTION)
    ("other oncogenes or tumor suppressor genes" . SPARSER::COLLECTION)
    ("GCTs" . SPARSER::PROTEIN) ("Cre-recombinase" . SPARSER::COLLECTION)
    ("tamoxifen (TAM)" . SPARSER::DRUG) ("Elastase" . SPARSER::PROTEIN)
    ("KRAS and HRAS" . SPARSER::COLLECTION)
    ("KRAS, HRAS, and BRAF" . SPARSER::COLLECTION)
    ("PLAG1 and HMGA2" . SPARSER::COLLECTION) ("SDCs" . SPARSER::PROTEIN)
    ("LGL-KRas" . SPARSER::COLLECTION) ("cetuximab" . SPARSER::DRUG)
    ("SMG" . SPARSER::PROTEIN) ("recombinase" . SPARSER::PROTEIN)
    ("TAM" . SPARSER::PROTEIN) ("SDC" . SPARSER::PROTEIN)
    ("X-gal" . SPARSER::MOLECULE) ("β-Galactosidase" . SPARSER::PROTEIN)
    ("RAS-binding" . SPARSER::PROTEIN) ("Anti-ERK" . SPARSER::PROTEIN)
    ("Ly-6C" . SPARSER::PROTEIN) ("Ly-6G" . SPARSER::PROTEIN)
    ("EGFR antibody" . SPARSER::PROTEIN) ("αSMA" . SPARSER::PROTEIN)
    ("AQP5" . SPARSER::PROTEIN) ("aquaporin 5" . SPARSER::PROTEIN)
    ("Gr-1" . SPARSER::PROTEIN) ("CD-45" . SPARSER::PROTEIN)
    ("p40" . SPARSER::PROTEIN) ("PLAG1" . SPARSER::PROTEIN)
    ("MDM2 or p21" . SPARSER::COLLECTION) ("EFS" . SPARSER::PROTEIN)
    ("unilateral RB" . SPARSER::PROTEIN) ("bilateral RB" . SPARSER::PROTEIN)
    ("hereditary RB" . SPARSER::PROTEIN) ("HR " . SPARSER::PROTEIN)
    ("RB" . SPARSER::PROTEIN) ("group E" . SPARSER::PROTEIN)
    ("group D" . SPARSER::PROTEIN) ("Ha" . SPARSER::PROTEIN)
    ("IFIH1 and TYK2" . SPARSER::COLLECTION)
    ("possible virus-induced susceptibility gene" . SPARSER::GENE)
    ("IL-6, IL-10, IL-12, and IL-23" . SPARSER::COLLECTION)
    ("MxA" . SPARSER::PROTEIN) ("gene and variant" . SPARSER::COLLECTION)
    ("TID" . SPARSER::PROTEIN) ("autoantibody (GAD)" . SPARSER::PROTEIN)
    ("Variant" . SPARSER::VARIANT) ("Promoter" . SPARSER::PROMOTER)
    ("the exact responsible gene" . SPARSER::GENE)
    ("interferon receptor-associated downstream molecules" . SPARSER::MOLECULE)
    ("JAK1 , TYK2 , STAT1 and STAT2" . SPARSER::COLLECTION)
    ("Interferon" . SPARSER::PROTEIN)
    ("toll-like receptors (TLR) and intracellular helicases"
     . SPARSER::COLLECTION)
    ("receptors (PRR)" . SPARSER::RECEPTOR)
    ("interferon receptor-mediated signaling pathway-associated molecules"
     . SPARSER::MOLECULE)
    ("MDA-5/IFIH1" . SPARSER::COLLECTION) ("helicases" . SPARSER::PROTEIN)
    ("PAMPs" . SPARSER::PROTEIN) ("PRR" . SPARSER::PROTEIN)
    ("toxins" . SPARSER::MOLECULE) ("autoantibody" . SPARSER::PROTEIN)
    ("decarboxylase" . SPARSER::PROTEIN) ("flu" . SPARSER::PROTEIN)
    ("IL-23" . SPARSER::PROTEIN) ("IL-12" . SPARSER::PROTEIN)
    ("interferon-induced" . SPARSER::PROTEIN) ("1A " . SPARSER::PROTEIN)
    ("HbA1" . SPARSER::PROTEIN) ("C-peptide" . SPARSER::MOLECULE)
    ("STAT2" . SPARSER::PROTEIN) ("MDA-5" . SPARSER::PROTEIN)
    ("IFIH1" . SPARSER::PROTEIN) ("interferon induced" . SPARSER::PROTEIN)
    ("β-cell" . SPARSER::PROTEIN) ("TYK2" . SPARSER::PROTEIN)
    ("Tyk2" . SPARSER::PROTEIN) ("Tyrosine kinase 2" . SPARSER::PROTEIN)
    ("two key mitotic checkpoint genes MAD2L1 and BUB1" . SPARSER::COLLECTION)
    ("MAD1L1 , MAD2L1 , MAD2L2 , BUB1 , BUB1B , BUB3 , CDC20 and TTK"
     . SPARSER::COLLECTION)
    ("TTK" . SPARSER::PROTEIN)
    ("the MAD (mitotic arrest-deficient) and BUB (budding uninhibited by benzimidazole) gene families"
     . SPARSER::COLLECTION)
    ("two critical mitotic checkpoint genes" . SPARSER::GENE)
    ("MAD2L1 , PTTG1 and BUB1" . SPARSER::COLLECTION)
    ("only two genes" . SPARSER::GENE) ("ST" . SPARSER::PROTEIN)
    ("MAD2L1 or BUB1" . SPARSER::COLLECTION) ("benzimidazole" . SPARSER::DRUG)
    ("CENPF" . SPARSER::PROTEIN)
    ("MAD2L1 (Mitotic Arrest Deficient 2-like 1) and BUB1 (Budding Uninhibited by Benzimidazoles 1)"
     . SPARSER::COLLECTION)
    ("Benzimidazoles" . SPARSER::DRUG) ("DNA-microarray" . SPARSER::DNA)
    ("MAD2L1 and BUB1" . SPARSER::COLLECTION) ("CDC20" . SPARSER::PROTEIN)
    ("BUB3" . SPARSER::PROTEIN) ("BUB1B" . SPARSER::PROTEIN)
    ("MAD2L2" . SPARSER::PROTEIN) ("MAD1L1" . SPARSER::PROTEIN)
    ("Gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PTTG1" . SPARSER::PROTEIN)
    ("MAD2" . SPARSER::PROTEIN) ("PRC1" . SPARSER::PROTEIN)
    ("MYBL2" . SPARSER::PROTEIN)
    ("growth-factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("L1-2" . SPARSER::PROTEIN) ("Triton x-100" . SPARSER::MOLECULE)
    ("BUB1" . SPARSER::PROTEIN) ("MAD2L1" . SPARSER::PROTEIN)
    ("NCOA1 and NCOA3" . SPARSER::COLLECTION) ("bufalin" . SPARSER::DRUG)
    ("a preferential cancer target" . SPARSER::TARGET-PROTEIN)
    ("PEA3 or AP-1" . SPARSER::COLLECTION)
    ("hypoxia and normoxia" . SPARSER::COLLECTION)
    ("HIF1α, AP-1 and NCOA1" . SPARSER::COLLECTION)
    ("HIF1α or AP-1" . SPARSER::COLLECTION)
    ("HIF1α, AP-1, NF-κB, Sp1 and ERα" . SPARSER::COLLECTION)
    ("c-Fos/c-Jun" . SPARSER::COLLECTION)
    ("growth factors, and VEGFa" . SPARSER::COLLECTION)
    ("both low NCOA1 and low MVD" . SPARSER::COLLECTION)
    ("PyMT or Neu" . SPARSER::COLLECTION)
    ("both high NCOA1 protein and high MVD" . SPARSER::COLLECTION)
    ("both low NCOA1 protein and low MVD (Figure xref )" . SPARSER::COLLECTION)
    ("high NCOA1 protein or high MVD" . SPARSER::COLLECTION)
    ("low NCOA1 protein or low MVD (Figure xref and xref )"
     . SPARSER::COLLECTION)
    ("semi-quantitative immunohistochemistry (IHC)" . SPARSER::PROTEIN)
    ("VEGFa mRNA ( r = 0.23, P < 0.001) and CD31 mRNA ( r = 0.40, P < 0.001)"
     . SPARSER::COLLECTION)
    ("NCOA1 and HIF1α" . SPARSER::COLLECTION) ("MH1-Luc" . SPARSER::COLLECTION)
    ("NCOA1, c-Jun and c-Fos" . SPARSER::COLLECTION)
    ("MA2-Luc and MA1A2-Luc" . SPARSER::COLLECTION)
    ("HIF1α and c-Fos" . SPARSER::COLLECTION)
    ("NCOA1, HIF1α, c-Fos and c-Jun" . SPARSER::COLLECTION)
    ("HIF1α, c-Fos and c-Jun" . SPARSER::COLLECTION)
    ("c-Fos and c-Jun" . SPARSER::COLLECTION)
    ("NCOA1 and HIF1α or NCOA1, c-Fos and c-Jun" . SPARSER::COLLECTION)
    ("HIF1α or NCOA1, c-Fos and c-Jun" . SPARSER::COLLECTION)
    ("NCOA1, c-Fos and c-Jun" . SPARSER::COLLECTION)
    ("HIF1α, c-Fos and NCOA1" . SPARSER::COLLECTION)
    ("VP-Luc" . SPARSER::COLLECTION) ("Luc" . SPARSER::PROTEIN)
    ("c-Jun, c-Fos and HIF1α" . SPARSER::COLLECTION)
    ("c-Jun and c-Fos" . SPARSER::COLLECTION)
    ("HIF1α or c-Fos" . SPARSER::COLLECTION)
    ("c-Fos and/or NF-κB" . SPARSER::COLLECTION)
    ("HIF1α, c-Fos and/or NF-κB" . SPARSER::COLLECTION)
    ("HIF1α, c-Fos or NF-κB" . SPARSER::COLLECTION)
    ("HIF1α, c-Fos and NF-κB" . SPARSER::COLLECTION)
    ("NCOA1 and VEGFa" . SPARSER::COLLECTION)
    ("α v β 3 , FGFR1 and FGFR2" . SPARSER::COLLECTION)
    ("PDGFb" . SPARSER::PROTEIN) ("no functional Ncoa1" . SPARSER::PROTEIN)
    ("the two different shRNAs showed a very low capability" . SPARSER::RNA)
    ("MVDs" . SPARSER::PROTEIN) ("K1 or K2" . SPARSER::COLLECTION)
    ("K1 and K2" . SPARSER::COLLECTION) ("RCAS" . SPARSER::PROTEIN)
    ("MMTV-neu" . SPARSER::COLLECTION) ("RCAS-PyMT" . SPARSER::PROTEIN-PAIR)
    ("MMTV-NCOA1" . SPARSER::COLLECTION) ("TVA" . SPARSER::MOLECULE)
    ("PyMT" . SPARSER::PROTEIN) ("normal Ncoa1" . SPARSER::PROTEIN)
    ("HIF1α and AP-1" . SPARSER::COLLECTION)
    ("c-Jun/c-Fos" . SPARSER::COLLECTION) ("Bevacizumab" . SPARSER::DRUG)
    ("VEGFb" . SPARSER::PROTEIN)
    ("VEGF, TGFβ, Ang1, Ang2, VE-cadherin, CD31 and plasminogen"
     . SPARSER::COLLECTION)
    ("MMTV-PyMT" . SPARSER::COLLECTION) ("Ncoa1" . SPARSER::PROTEIN)
    ("MMTV-Neu" . SPARSER::COLLECTION) ("MMTV" . SPARSER::PROTEIN)
    ("cyclin D1, MMP-2, MMP-9 and macrophage migration inhibitory factor (MIF)"
     . SPARSER::COLLECTION)
    ("cyclin D1, MMP-2, MMP-9 and macrophage migration inhibitory factor"
     . SPARSER::COLLECTION)
    ("MIF" . SPARSER::PROTEIN) ("H-ras-" . SPARSER::PROTEIN)
    ("Ncoa3" . SPARSER::PROTEIN)
    ("CBP and p300 and methyltransferases" . SPARSER::COLLECTION)
    ("p300 and methyltransferases" . SPARSER::COLLECTION)
    ("CARM1 and PRMT1" . SPARSER::COLLECTION)
    ("methyltransferases" . SPARSER::PROTEIN) ("CBP" . SPARSER::PROTEIN)
    ("acetyltransferases" . SPARSER::PROTEIN)
    ("NCOA2 (TIF2, GRIP1, SRC-2) and NCOA3 (SRC-3, AIB1, RAC3, ACTR)"
     . SPARSER::COLLECTION)
    ("NCOA1 or SRC-1" . SPARSER::COLLECTION) ("SRC" . SPARSER::PROTEIN)
    ("both high NCOA1 and high MVD" . SPARSER::COLLECTION)
    ("VEGFa" . SPARSER::PROTEIN) ("MVD" . SPARSER::PROTEIN)
    ("Twist1, ITGA5, CSF-1, SDF1 and CXCR4" . SPARSER::COLLECTION)
    ("CoCl 2" . SPARSER::MOLECULE) ("1-2" . SPARSER::PROTEIN)
    ("Sp1" . SPARSER::PROTEIN) ("HIF1a" . SPARSER::PROTEIN)
    ("MH1" . SPARSER::PROTEIN) ("FGFR1" . SPARSER::PROTEIN)
    ("α v β 3" . SPARSER::PROTEIN) ("K2" . SPARSER::PROTEIN)
    ("CD31" . SPARSER::PROTEIN) ("VE-cadherin" . SPARSER::PROTEIN)
    ("Ang2" . SPARSER::PROTEIN) ("Ang1" . SPARSER::PROTEIN)
    ("delta4" . SPARSER::PROTEIN)
    ("macrophage migration inhibitory factor" . SPARSER::PROTEIN)
    ("PRMT1" . SPARSER::PROTEIN) ("CARM1" . SPARSER::PROTEIN)
    ("RAC3" . SPARSER::PROTEIN) ("SRC-3" . SPARSER::PROTEIN)
    ("NCOA3" . SPARSER::PROTEIN) ("SRC-2" . SPARSER::PROTEIN)
    ("GRIP1" . SPARSER::PROTEIN) ("TIF2" . SPARSER::PROTEIN)
    ("NCOA2" . SPARSER::PROTEIN)
    ("nuclear receptor coactivator 1" . SPARSER::PROTEIN)
    ("c-Fos" . SPARSER::PROTEIN) ("SDF1" . SPARSER::PROTEIN)
    ("CSF-1" . SPARSER::PROTEIN) ("ITGA5" . SPARSER::PROTEIN)
    ("Twist1" . SPARSER::PROTEIN)
    ("Nuclear receptor coactivator 1" . SPARSER::PROTEIN)
    ("Bcr/Abl" . SPARSER::COLLECTION) ("Abl" . SPARSER::PROTEIN)
    ("Bcr" . SPARSER::PROTEIN) ("family, and gene" . SPARSER::COLLECTION)
    ("Group" . SPARSER::MOLECULE) ("Polymorphism" . SPARSER::PROTEIN)
    ("gefitinib or erlotinib or afatinib" . SPARSER::COLLECTION)
    ("erlotinib or afatinib" . SPARSER::COLLECTION) ("DCR" . SPARSER::PROTEIN)
    ("DCRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR-tyrosine kinase inhibitor's" . SPARSER::INHIBITOR)
    ("EGFR-tyrosine kinase" . SPARSER::COLLECTION)
    ("Bcl-2-like protein 11" . SPARSER::PROTEIN)
    ("Bcl-2-like" . SPARSER::PROTEIN) ("OR 1" . SPARSER::PROTEIN)
    ("bcl-2-like" . SPARSER::PROTEIN) ("PC-1–p53" . SPARSER::COLLECTION)
    ("Bax and p21" . SPARSER::COLLECTION) ("Polycystin" . SPARSER::PROTEIN)
    ("PC-1 or PC-2" . SPARSER::COLLECTION)
    ("apolipoprotein" . SPARSER::MOLECULE) ("sterol" . SPARSER::PROTEIN)
    ("impaired arterial myogenic" . SPARSER::PROTEIN)
    ("stretch-activated ion channels" . SPARSER::PROTEIN-FAMILY)
    ("PKD1:PKD2" . SPARSER::BIO-COMPLEX) ("myogenic" . SPARSER::PROTEIN)
    ("the mechanosensitive molecules PC-1 and PC-2" . SPARSER::COLLECTION)
    ("the principal cellular antagonist" . SPARSER::MOLECULE)
    ("p-p53:p53" . SPARSER::BIO-COMPLEX)
    ("both atherosclerotic plaque types" . TYPE)
    ("PKD1 and PKD2" . SPARSER::COLLECTION) ("p-p53" . SPARSER::COLLECTION)
    ("polycystins" . SPARSER::PROTEIN) ("-p53" . SPARSER::COLLECTION)
    ("HSS" . SPARSER::PROTEIN) ("PC-1 and PC-2" . SPARSER::COLLECTION)
    ("SMCs" . SPARSER::PROTEIN) ("PC-1 and p53" . SPARSER::COLLECTION)
    ("PC-1–JNK–p53" . SPARSER::COLLECTION) ("PKD" . SPARSER::PROTEIN)
    ("skeletal muscle" . SPARSER::PROTEIN)
    ("the transmembrane proteins polycystin 1 (PC-1) and polycystin 2 (PC-2)"
     . SPARSER::COLLECTION)
    ("several mechanosensitive molecules" . SPARSER::MOLECULE)
    ("p38 and p53" . SPARSER::COLLECTION) ("PC-1/PC-2" . SPARSER::COLLECTION)
    ("LSS" . SPARSER::PROTEIN) ("PC-1" . SPARSER::PROTEIN)
    ("AAPs" . SPARSER::PROTEIN) ("-1/-2" . SPARSER::COLLECTION)
    ("Polycystins" . SPARSER::PROTEIN) ("type VI" . SPARSER::PROTEIN)
    ("type V" . SPARSER::PROTEIN) ("double minute 2" . SPARSER::PROTEIN)
    ("PKD2" . SPARSER::PROTEIN) ("100 kD" . SPARSER::PROTEIN)
    ("nitric oxide" . SPARSER::MOLECULE) ("PKD1" . SPARSER::PROTEIN)
    ("polycystin 2" . SPARSER::PROTEIN) ("polycystin 1" . SPARSER::PROTEIN)
    ("PC-2" . SPARSER::PROTEIN)
    ("the specific pathological protein" . SPARSER::PROTEIN)
    ("Pre" . SPARSER::PROTEIN) ("an alternative exon" . SPARSER::PROTEIN)
    ("the antigen receptor (B or T cell receptor) and co-stimulatory molecules"
     . SPARSER::COLLECTION)
    ("molecules consisting of a catalytic subunit (p110α, p110β or p110δ) and a regulatory subunit (p85α, p85β, p85γ, p50α or p55α)"
     . SPARSER::COLLECTION)
    ("p110α, p110β or p110δ" . SPARSER::COLLECTION) ("IA" . SPARSER::MOLECULE)
    ("Class" . CLASS) ("IC87114" . SPARSER::MOLECULE)
    ("PI3Kδ" . SPARSER::PROTEIN) ("P110δ" . SPARSER::PROTEIN)
    ("CD8" . SPARSER::PROTEIN) ("Hyper-IgM syndrome" . SPARSER::PROTEIN)
    ("PI3K-δ" . SPARSER::PROTEIN) ("p55" . SPARSER::PROTEIN)
    ("p85β" . SPARSER::PROTEIN) ("p110δ" . SPARSER::PROTEIN)
    ("p110β" . SPARSER::PROTEIN)
    ("trastuzumab and lapatinib" . SPARSER::COLLECTION)
    ("a noninvasive biomarker" . SPARSER::MOLECULE)
    ("a dynamic biomarker" . SPARSER::MOLECULE)
    ("HER2 and p95HER2" . SPARSER::COLLECTION)
    ("the full-length HER2 receptor as well as CTCs" . SPARSER::COLLECTION)
    ("/CK" . SPARSER::COLLECTION) ("/HER2" . SPARSER::COLLECTION)
    ("CK" . SPARSER::PROTEIN) ("full-length and p95HER2" . SPARSER::COLLECTION)
    ("both the full-length and the truncated HER2 receptor [ xref ]"
     . SPARSER::COLLECTION)
    ("taxanes" . SPARSER::DRUG) ("at least part" . SPARSER::COMPONENT)
    ("Trastuzumab" . SPARSER::DRUG) ("p185" . SPARSER::PROTEIN)
    ("p95" . SPARSER::PROTEIN) ("AG" . SPARSER::PROTEIN)
    ("CTNNB1 and APC" . SPARSER::COLLECTION)
    ("Polymorphisms" . SPARSER::PROTEIN) ("fine-mapping" . SPARSER::PROTEIN)
    ("A functional polymorphism" . SPARSER::PROTEIN)
    ("polymorphism" . SPARSER::PROTEIN)
    ("PR-positive group and negative lymph node metastasis group ( xref , xref )"
     . SPARSER::COLLECTION)
    ("aHR" . SPARSER::PROTEIN) ("CAC/CAC" . SPARSER::COLLECTION)
    ("CAC" . SPARSER::PROTEIN) ("polymorphisms" . SPARSER::PROTEIN)
    ("their corresponding heterozygotes and common homozygotes ( xref )"
     . SPARSER::COLLECTION)
    ("heterozygotes" . SPARSER::PROTEIN) ("a 2-SNP" . SPARSER::PROTEIN-PAIR)
    ("a 3-SNP" . SPARSER::PROTEIN-PAIR)
    ("associated SNP alleles" . SPARSER::ALLELE)
    ("a homophilic cell-to-cell adhesion protein" . SPARSER::PROTEIN)
    ("E-cadherin and β-catenin" . SPARSER::COLLECTION)
    ("CDH1 as well as rs4533622" . SPARSER::COLLECTION)
    ("CDH1 as well as rs2293303" . SPARSER::COLLECTION)
    ("TGC" . SPARSER::PROTEIN) ("CDH1 and CTNNB1" . SPARSER::COLLECTION)
    ("dominant and recessive" . SPARSER::PROTEIN)
    ("Platinum" . SPARSER::MOLECULE)
    ("taxol and cisplatin" . SPARSER::COLLECTION)
    ("docetaxel and doxorubicin" . SPARSER::COLLECTION)
    ("docetaxel" . SPARSER::DRUG) ("PIK3CA and RAS" . SPARSER::COLLECTION)
    ("K-RAS and phosphatidylinositol 3-kinase" . SPARSER::COLLECTION)
    ("protein kinase B (AKT)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("clinically relevant predictive biomarkers" . SPARSER::MOLECULE)
    ("ER, PR, HER2 and Ki-67" . SPARSER::COLLECTION)
    ("RASSF2-GFP" . SPARSER::COLLECTION) ("RTCA" . SPARSER::PROTEIN)
    ("BS" . SPARSER::PROTEIN) ("bisulfite" . SPARSER::MOLECULE)
    ("luminal and triple-negative breast cancer cell" . SPARSER::COLLECTION)
    ("RASSF" . SPARSER::PROTEIN-FAMILY) ("RalGDS/AF-6" . SPARSER::COLLECTION)
    ("RalGDS" . SPARSER::PROTEIN) ("AF-6" . SPARSER::PROTEIN)
    ("progesterone receptor (PR) and epidermal growth factor type II receptor (HER2)"
     . SPARSER::COLLECTION)
    ("estrogen receptor (ER), progesterone receptor (PR) and epidermal growth factor type II receptor (HER2)"
     . SPARSER::COLLECTION)
    ("antineoplastic drugs" . SPARSER::DRUG)
    ("RASSF1 and RASSF2" . SPARSER::COLLECTION) ("DNAse I" . SPARSER::PROTEIN)
    ("cytokeratin 17" . SPARSER::PROTEIN) ("cytokeratin 5" . SPARSER::PROTEIN)
    ("family member 1" . SPARSER::PROTEIN) ("RASSF2" . SPARSER::PROTEIN)
    ("BRAFV600E and a downstream integrative molecule" . SPARSER::COLLECTION)
    ("phenformin" . SPARSER::DRUG) ("biguanide" . SPARSER::MOLECULE)
    ("target both the driver mutation BRAFV600E" . SPARSER::PROTEIN)
    ("the respiratory chain complex" . SPARSER::BIO-COMPLEX)
    ("BRAF-" . SPARSER::PROTEIN) ("condensation" . SPARSER::PROTEIN-FAMILY)
    ("rapamycin and vemurafenib" . SPARSER::COLLECTION)
    ("MAPK and mTOR" . SPARSER::COLLECTION) ("Nick" . SPARSER::PROTEIN)
    ("dUTP" . SPARSER::MOLECULE) ("braf" . SPARSER::PROTEIN)
    ("FK" . SPARSER::MOLECULE) ("immunosuppressant" . SPARSER::DRUG)
    ("metformin and vemurafenib" . SPARSER::COLLECTION) ("AMP" . SPARSER::AMP)
    ("vemurafenib and mTOR" . SPARSER::COLLECTION)
    ("HER2/HER3" . SPARSER::COLLECTION)
    ("dabrafenib (BRAFV600E inhibitor) and lapatinib (HER2/neu and EGFR inhibitor)"
     . SPARSER::COLLECTION)
    ("HER2/neu" . SPARSER::COLLECTION) ("lapatinib" . SPARSER::DRUG)
    ("dabrafenib" . SPARSER::DRUG) ("Thyroid" . SPARSER::PROTEIN)
    ("kinases and lenvatinib" . SPARSER::COLLECTION)
    ("RET, and KIT" . SPARSER::COLLECTION) ("KIT" . SPARSER::PROTEIN)
    ("FGFR" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR)"
     . SPARSER::COLLECTION)
    ("receptor (PDGFR)" . SPARSER::RECEPTOR)
    ("receptor (VEGFR)" . SPARSER::RECEPTOR)
    ("Sorafenib and lenvatinib" . SPARSER::COLLECTION)
    ("PDGFR" . SPARSER::PROTEIN) ("lenvatinib" . SPARSER::DRUG)
    ("Metformin or rapamycin" . SPARSER::COLLECTION)
    ("Metformin" . SPARSER::DRUG) ("BRAFV600E and mTOR" . SPARSER::COLLECTION)
    ("vemurafenib and rapamycin" . SPARSER::COLLECTION)
    ("vemurafenib and metformin" . SPARSER::COLLECTION)
    ("trypan" . SPARSER::DRUG)
    ("vemurafenib and mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("metformin and rapamycin" . SPARSER::COLLECTION)
    ("vemurafenib" . SPARSER::DRUG) ("BRAFV" . SPARSER::PROTEIN)
    ("Vemurafenib" . SPARSER::DRUG) ("phenol-red" . SPARSER::DRUG)
    ("OCT1" . SPARSER::PROTEIN) ("3-1" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor" . SPARSER::PROTEIN)
    ("CSF exosomal miRNAs" . SPARSER::PROTEIN)
    ("the total serum miR-21 and serum exosomal miR-21" . SPARSER::COLLECTION)
    ("serum exosomal miR-21" . SPARSER::PROTEIN)
    ("CSF exosomal miR-21" . SPARSER::PROTEIN)
    ("exosomal miRNAs" . SPARSER::PROTEIN)
    ("Annexin V/PI" . SPARSER::COLLECTION)
    ("PDCD4, RECK and PTEN" . SPARSER::COLLECTION)
    ("selected miR-21 targeted genes" . SPARSER::GENE)
    ("cancer-associated genes" . SPARSER::GENE) ("pre-" . SPARSER::PROTEIN)
    ("recent MRIs" . SPARSER::PROTEIN) ("MRIs" . SPARSER::PROTEIN)
    ("MGMT" . SPARSER::PROTEIN)
    ("known neuro-pathological molecules" . SPARSER::MOLECULE)
    ("the exosomal miR-21" . SPARSER::PROTEIN) ("CFS" . SPARSER::PROTEIN)
    ("exosomal miR-21" . SPARSER::PROTEIN)
    ("oncogenesis/tumor suppressors and their mediated signal transduction pathways"
     . SPARSER::COLLECTION)
    ("nucleotide and protein" . SPARSER::COLLECTION)
    ("PTEN, RECK and PDCD4" . SPARSER::COLLECTION) ("RECK" . SPARSER::PROTEIN)
    ("a lentiviral inhibitor" . SPARSER::INHIBITOR) ("CSF-" . SPARSER::PROTEIN)
    ("CSF" . SPARSER::PROTEIN)
    ("O6-methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("CD63" . SPARSER::PROTEIN) ("MiR-21" . SPARSER::PROTEIN)
    ("PDCD4" . SPARSER::PROTEIN)
    ("basic leucine zipper (bZIP) proteins" . SPARSER::PROTEIN)
    ("inhibitors (TSA)" . SPARSER::INHIBITOR) ("TSA" . SPARSER::PROTEIN)
    ("bortezomib and lenalidomide" . SPARSER::COLLECTION)
    ("lenalidomide" . SPARSER::DRUG) ("bortezomib" . SPARSER::DRUG)
    ("iron, and CO" . SPARSER::COLLECTION) ("iron" . SPARSER::MOLECULE)
    ("Survivin and Bcl-2" . SPARSER::COLLECTION)
    ("Survivin" . SPARSER::PROTEIN)
    ("a traditional Chinese medicine" . SPARSER::DRUG)
    ("Methotrexate (MTX), Adriamycin (ADM), cis-dichlorodiamineplatinum (CDDP), and ifosfamide (IFO) xref"
     . SPARSER::COLLECTION)
    ("Methotrexate (MTX)" . SPARSER::DRUG) ("ifosfamide" . SPARSER::DRUG)
    ("CDDP" . SPARSER::DRUG) ("ADM" . SPARSER::PROTEIN)
    ("Adriamycin" . SPARSER::DRUG) ("MTX" . SPARSER::DRUG)
    ("Methotrexate" . SPARSER::DRUG)
    ("RT-QPCT and Western-blot" . SPARSER::COLLECTION)
    ("QPCT" . SPARSER::PROTEIN)
    ("the chemotherapeutic agent arsenic trioxide (ATO)" . SPARSER::MOLECULE)
    ("arsenic trioxide (ATO)" . SPARSER::MOLECULE) ("Heme" . SPARSER::MOLECULE)
    ("Actinomycin D" . SPARSER::MOLECULE) ("erythroid 2" . SPARSER::PROTEIN)
    ("Act-D" . SPARSER::MOLECULE) ("Actinomycin-D" . SPARSER::MOLECULE)
    ("Ccl2 , Cxcl9 , Cxcl10 , and Tnf" . SPARSER::COLLECTION)
    ("Ifng , IL-1b , Il6 , Ccl2 , and Cxcl10" . SPARSER::COLLECTION)
    ("IFNs" . SPARSER::DRUG) ("IL1b and IL6" . SPARSER::COLLECTION)
    ("Ccl2 , Ccl3 , Cxcl9, Cxcl10 , and Tnf" . SPARSER::COLLECTION)
    ("Irf7 , Ifng , Stat4 , and Stat6" . SPARSER::COLLECTION)
    ("other antiviral genes" . SPARSER::GENE)
    ("Ifi44, Nampt , Rtp4 , Trex1 , and Daxx" . SPARSER::COLLECTION)
    ("IL1b , IL6 , Ccl2 , Ccl19 , Cxcl10 , and Tnf" . SPARSER::COLLECTION)
    ("Ccl3 , Ccl7 , Ccl11 , Ccl19 , Cxcl10, Cxcl13 and Cxcl14"
     . SPARSER::COLLECTION)
    ("Cxcl13" . SPARSER::PROTEIN) ("Ccl19" . SPARSER::PROTEIN)
    ("Ccl11" . SPARSER::PROTEIN) ("Ccl7" . SPARSER::PROTEIN)
    ("Ccl3" . SPARSER::PROTEIN)
    ("remarkably higher expression levels 3 dpi and significantly attenuated expression levels 6 dpi"
     . SPARSER::COLLECTION)
    ("remarkably higher expression levels 3 dpi" . SPARSER::PROTEIN)
    ("Cxcl9 , and Tnf" . SPARSER::COLLECTION)
    ("chemokines and their respective receptor genes" . SPARSER::COLLECTION)
    ("their respective receptor genes" . SPARSER::GENE)
    ("the 35 interleukin and respective receptor genes" . SPARSER::COLLECTION)
    ("respective receptor genes" . SPARSER::GENE)
    ("IL1b , IL6 , IL15 , and IL16" . SPARSER::COLLECTION)
    ("IL1b" . SPARSER::PROTEIN)
    ("their respective receptors" . SPARSER::PROTEIN)
    ("Irf5 and Irf7" . SPARSER::COLLECTION)
    ("Irf1 , Irf5 , Irf7 , and Irf9" . SPARSER::COLLECTION)
    ("Irf9" . SPARSER::PROTEIN) ("Irf5" . SPARSER::PROTEIN)
    ("Irf1" . SPARSER::PROTEIN) ("FC " . SPARSER::PROTEIN)
    ("Ifng , Stat4 , and Stat6" . SPARSER::COLLECTION)
    ("Stat4 and Stat6" . SPARSER::COLLECTION) ("Stat6" . SPARSER::PROTEIN)
    ("Stat4" . SPARSER::PROTEIN) ("Jak-Stat" . SPARSER::COLLECTION)
    ("Stat" . SPARSER::PROTEIN) ("Ifng and Ifnab" . SPARSER::COLLECTION)
    ("IFN and IFN" . SPARSER::COLLECTION)
    ("Mx2 , Eif2ak2 , Gbp1 , Ifitm1 , and Ifi44" . SPARSER::COLLECTION)
    ("Other IFN-induced antiviral genes" . SPARSER::GENE)
    ("Ifi44 , Nampt , Rtp4 , Trex1 , and Daxx" . SPARSER::COLLECTION)
    ("Ifi44" . SPARSER::PROTEIN) ("Daxx" . SPARSER::PROTEIN)
    ("Nampt" . SPARSER::PROTEIN) ("protein kinase R (PKR)" . SPARSER::PROTEIN)
    ("IFN-induced antiviral genes" . SPARSER::GENE)
    ("Mx2 , Oas2 , Oas3 , and Eif2ak2" . SPARSER::COLLECTION)
    ("Gbp1 , Ifitm1 , and Bst2" . SPARSER::COLLECTION)
    ("Bst2" . SPARSER::PROTEIN) ("Ifitm1" . SPARSER::PROTEIN)
    ("Gbp1" . SPARSER::PROTEIN) ("Oas3" . SPARSER::PROTEIN)
    ("Oas2" . SPARSER::PROTEIN) ("tetherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FC" . SPARSER::PROTEIN)
    ("Table S2 and Additional file xref" . SPARSER::COLLECTION)
    ("viral hemagglutinin (HA) mRNA" . SPARSER::PROTEIN)
    ("hemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p  " . SPARSER::PROTEIN) ("beginning 3 dpi" . SPARSER::PROTEIN)
    ("dpi" . SPARSER::PROTEIN) ("p53 and IFN" . SPARSER::COLLECTION)
    ("IRF" . SPARSER::PROTEIN) ("interferon (IFN)" . SPARSER::PROTEIN)
    ("proinflammatory cytokines and chemokines" . SPARSER::COLLECTION)
    ("Cxcl10" . SPARSER::PROTEIN) ("Cxcl9" . SPARSER::PROTEIN)
    ("Ccl2" . SPARSER::PROTEIN) ("Ccl" . SPARSER::DRUG)
    ("antiviral genes" . SPARSER::GENE)
    ("Mx2 and Eif2ak2" . SPARSER::COLLECTION) ("Eif2ak2" . SPARSER::PROTEIN)
    ("Irf7" . SPARSER::PROTEIN) ("Irf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ifng" . SPARSER::PROTEIN) ("immune-related genes" . SPARSER::GENE)
    ("CD4" . SPARSER::PROTEIN) ("IL-1b" . SPARSER::PROTEIN)
    ("major histocompatibility complex" . SPARSER::PROTEIN)
    ("MIP-1β" . SPARSER::PROTEIN) ("MIP-1α" . SPARSER::PROTEIN)
    ("IL16" . SPARSER::PROTEIN) ("IL15" . SPARSER::PROTEIN)
    ("Trex1" . SPARSER::PROTEIN) ("Rtp4" . SPARSER::PROTEIN)
    ("bone marrow stromal antigen 2" . SPARSER::PROTEIN)
    ("EIF2AK2" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 2" . SPARSER::PROTEIN)
    ("glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("toll-like receptor 3" . SPARSER::PROTEIN) ("IRF5" . SPARSER::PROTEIN)
    ("IP-10" . SPARSER::PROTEIN) ("ak2" . SPARSER::PROTEIN)
    ("Mx2" . SPARSER::PROTEIN) ("MAPKAPK2/ZFP36L1" . SPARSER::COLLECTION)
    ("the pro-inflammatory SASP" . SPARSER::PROTEIN)
    ("mTOR and ZFP36L1" . SPARSER::COLLECTION)
    ("p21 Cip1 and p16 Ink4a" . SPARSER::COLLECTION)
    ("Nras" . SPARSER::PROTEIN)
    ("depleted mTOR or overexpressing 4EBP1 DN or ZFP36L1 Mut (in the presence or absence of CDKN1A)"
     . SPARSER::COLLECTION)
    ("Mut or shRNAs" . SPARSER::COLLECTION)
    ("both ZFP36L1 Mut and a non-degradable CDKN1A" . SPARSER::COLLECTION)
    ("mTOR, 4EBP1 and MAPKAPK2" . SPARSER::COLLECTION)
    ("CDKIs" . SPARSER::DRUG) ("MMP3 or MMP10" . SPARSER::COLLECTION)
    ("IL8 or IL1β" . SPARSER::COLLECTION) ("GSEA" . SPARSER::PROTEIN)
    ("TTP or ZFP36L2" . SPARSER::COLLECTION)
    ("TTP and ZFP36L2" . SPARSER::COLLECTION) ("TTP" . SPARSER::PROTEIN)
    ("Tis11b or BRF1" . SPARSER::COLLECTION) ("Tis11b" . SPARSER::PROTEIN)
    ("ZFP36L1/BRF1" . SPARSER::COLLECTION)
    ("IL8, IL1β and MMP1" . SPARSER::COLLECTION)
    ("GAPDH and β-ACTIN" . SPARSER::COLLECTION)
    ("AHA-biotin" . SPARSER::MOLECULE) ("streptavidin" . SPARSER::PROTEIN)
    ("MAPKAPK2 or MAPK14" . SPARSER::COLLECTION)
    ("global ribosome" . SPARSER::BIO-COMPLEX)
    ("p38α and MAPKAPK2" . SPARSER::COLLECTION)
    ("MAPKAPK2/MK2" . SPARSER::COLLECTION) ("Substrate" . SPARSER::SUBSTRATE)
    ("Kinase" . SPARSER::KINASE) ("IL8 and IL1α" . SPARSER::COLLECTION)
    ("canonical mTOR" . SPARSER::PROTEIN)
    ("EEF2 or RPS20" . SPARSER::COLLECTION) ("polysome" . SPARSER::BIO-COMPLEX)
    ("Torin1 or vehicle" . SPARSER::COLLECTION)
    ("ribosomes" . SPARSER::BIO-COMPLEX) ("fractioned" . SPARSER::BIO-FRACTION)
    ("mTOR and 4EBP1" . SPARSER::COLLECTION) ("AHA" . SPARSER::MOLECULE)
    ("Torin1 and Cyclohexamide (CHX, which blocks translational elongation)"
     . SPARSER::COLLECTION)
    ("p16 INK4a and p21 CIP1a" . SPARSER::COLLECTION)
    ("rapamycin, Torin1 or NVP-BEZ235" . SPARSER::COLLECTION)
    ("other mTOR inhibitors (Torin1 and NVP-BEZ235) and additional fibroblast strains (BJ and HFFF2)"
     . SPARSER::COLLECTION)
    ("Torin1 and NVP-BEZ235" . SPARSER::COLLECTION)
    ("IL1 or NF-κB" . SPARSER::COLLECTION) ("ER:RAS" . SPARSER::BIO-COMPLEX)
    ("Rapamycin" . SPARSER::DRUG) ("eIF4e" . SPARSER::PROTEIN)
    ("S6K1 and S6K2" . SPARSER::COLLECTION)
    ("protein and lipid" . SPARSER::COLLECTION)
    ("IL6 and IL8" . SPARSER::COLLECTION) ("TOR" . SPARSER::PROTEIN)
    ("DDR" . SPARSER::PROTEIN) ("NF-κB and CEBP/β" . SPARSER::COLLECTION)
    ("CEBP" . SPARSER::PROTEIN) ("MK2/MAPKAPK2" . SPARSER::COLLECTION)
    ("SASP" . SPARSER::PROTEIN) ("2F1" . SPARSER::PROTEIN)
    ("phenol red" . SPARSER::DRUG) ("RPS14" . SPARSER::PROTEIN)
    ("ribosomal protein S14" . SPARSER::PROTEIN) ("EBP1" . SPARSER::PROTEIN)
    ("Sodium bicarbonate" . SPARSER::DRUG) ("p16 Ink4a" . SPARSER::PROTEIN)
    ("p21 Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TIMP1" . SPARSER::PROTEIN)
    ("MMP10" . SPARSER::PROTEIN) ("MMP3" . SPARSER::PROTEIN)
    ("ZFP36L2" . SPARSER::PROTEIN) ("L1 S" . SPARSER::PROTEIN)
    ("BRF1" . SPARSER::PROTEIN) ("β-ACTIN" . SPARSER::PROTEIN)
    ("MMP1" . SPARSER::PROTEIN) ("MKK6" . SPARSER::PROTEIN)
    ("MAPK14" . SPARSER::PROTEIN) ("HSP27" . SPARSER::PROTEIN)
    ("ATF2" . SPARSER::PROTEIN) ("IL1α" . SPARSER::PROTEIN)
    ("RPS20" . SPARSER::PROTEIN) ("EEF2" . SPARSER::PROTEIN)
    ("Cyclin D3" . SPARSER::PROTEIN)
    ("p21 CIP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p16 INK4a" . SPARSER::PROTEIN) ("NVP-BEZ235" . SPARSER::DRUG)
    ("Torin1" . SPARSER::DRUG) ("4OHT" . SPARSER::DRUG)
    ("4-hydroxytamoxifen" . SPARSER::DRUG) ("4E-BP" . SPARSER::PROTEIN)
    ("4EBP" . SPARSER::PROTEIN) ("S6K2" . SPARSER::PROTEIN)
    ("4EBPs" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 4E" . SPARSER::PROTEIN)
    ("IL8" . SPARSER::PROTEIN) ("ZFP36L1" . SPARSER::PROTEIN)
    ("MAPKAPK2" . SPARSER::PROTEIN) ("MK2" . SPARSER::PROTEIN)
    ("available EGFR TKIs" . SPARSER::PROTEIN)
    ("peptidomimetic inhibitors" . SPARSER::INHIBITOR)
    ("The lung cancer-associated EGFR mutants" . SPARSER::MUTANT)
    ("more tumor suppressive genes" . SPARSER::GENE)
    ("pY394" . SPARSER::PROTEIN)
    ("nearly full-length ligand-bound EGFR" . SPARSER::PROTEIN)
    ("semisynthetic Mig6-pY394" . SPARSER::PROTEIN-PAIR)
    ("Mig6-pY394" . SPARSER::PROTEIN-PAIR) ("anchor" . SPARSER::ANCHOR)
    ("selectively target active receptor molecules" . SPARSER::MOLECULE)
    ("EGFR and pY394" . SPARSER::COLLECTION)
    ("a longer fragment" . SPARSER::FRAGMENT)
    ("the doubly-phosphorylated Mig6-pYpY peptide" . SPARSER::PEPTIDE)
    ("amide" . SPARSER::MOLECULE) ("acceptor" . SPARSER::MOLECULE)
    ("YpY" . SPARSER::PROTEIN)
    ("active Myc-tagged EGFR (L858R) and kinase-dead HA-tagged EGFR (L858R/D837N)"
     . SPARSER::COLLECTION)
    ("pYpY" . SPARSER::PROTEIN) ("Mig6-YpY" . SPARSER::COLLECTION)
    ("Mig6-pYpY" . SPARSER::COLLECTION) ("Mig6-pYY" . SPARSER::COLLECTION)
    ("YY, pYY, YpY, and pYpY" . SPARSER::COLLECTION)
    ("the FY and FF mutants" . SPARSER::COLLECTION)
    ("the kinase, the FY and FF mutants" . SPARSER::COLLECTION)
    ("YF and FF" . SPARSER::COLLECTION) ("Mig6-FY" . SPARSER::COLLECTION)
    ("FY" . SPARSER::PROTEIN) ("Dasatinib" . SPARSER::DRUG)
    ("EGFR and Mig6" . SPARSER::COLLECTION) ("dasatinib" . SPARSER::DRUG)
    ("Mig6 and Ack1" . SPARSER::COLLECTION) ("Tyrosines" . SPARSER::AMINO-ACID)
    ("a longer Mig6 fragment" . SPARSER::FRAGMENT)
    ("tyrosines" . SPARSER::AMINO-ACID)
    ("both WT EGFR and the L858R mutant" . SPARSER::COLLECTION)
    ("pYY and YpY" . SPARSER::COLLECTION) ("pYY" . SPARSER::PROTEIN)
    ("YY" . SPARSER::MOLECULE)
    ("an exon20 insertion mutant (insNPG) and an oncogenic C-terminal deletion mutant (CTDel1, which deletes residues 1010-1152) xref"
     . SPARSER::COLLECTION)
    ("an effective substrate-competitive inhibitor" . SPARSER::INHIBITOR)
    ("EGFR or ErbB2-dependent" . SPARSER::COLLECTION)
    ("gefitinib, erlotinib and afatinib" . SPARSER::COLLECTION)
    ("Ins" . SPARSER::PROTEIN) ("CRIB" . SPARSER::DRUG)
    ("Map" . SPARSER::PROTEIN)
    ("a feedback inhibitor of the epidermal growth factor receptor (EGFR) and other ErbB family members xref"
     . SPARSER::COLLECTION)
    ("ERRFI" . SPARSER::PROTEIN) ("EGFR–Mig6" . SPARSER::COLLECTION)
    ("Bis-Tris" . SPARSER::MOLECULE) ("Set 1" . SPARSER::PROTEIN)
    ("phospho-tyrosine" . SPARSER::MOLECULE) ("Erk1/2" . SPARSER::PROTEIN)
    ("DEL1" . SPARSER::PROTEIN) ("pH 3" . SPARSER::MOLECULE)
    ("HCO3" . SPARSER::MOLECULE) ("c-Abl" . SPARSER::PROTEIN)
    ("p31" . SPARSER::PROTEIN) ("CDKN2A" . SPARSER::PROTEIN)
    ("c-Src kinase" . SPARSER::PROTEIN) ("p36" . SPARSER::PROTEIN)
    ("ERRFI1" . SPARSER::PROTEIN) ("Mig6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LXRs" . SPARSER::PROTEIN) ("RXRs" . SPARSER::PROTEIN)
    ("Wnt7A" . SPARSER::PROTEIN) ("p21, p57 or PTEN" . SPARSER::COLLECTION)
    ("p21, p57 and PTEN" . SPARSER::COLLECTION) ("Wnt7a" . SPARSER::PROTEIN)
    ("deacetylases" . SPARSER::PROTEIN) ("TLX and PNR" . SPARSER::COLLECTION)
    ("luminal and basal cells" . SPARSER::COLLECTION)
    ("ERα/PGR/HER2" . SPARSER::COLLECTION)
    ("GR, RARβ, RARγ, RORα, PPARγ and VDR" . SPARSER::COLLECTION)
    ("ERβ, TR2 and TR4" . SPARSER::COLLECTION)
    ("ERα and RORγgene" . SPARSER::COLLECTION)
    ("NR and ERα" . SPARSER::COLLECTION)
    ("B contained ERα and a group" . SPARSER::COLLECTION)
    ("targets and biomarkers" . SPARSER::COLLECTION)
    ("SHP and HNF4α" . SPARSER::COLLECTION)
    ("The NR4 subfamily members Nurr1, Nur77 and NOR1" . SPARSER::COLLECTION)
    ("Nurr1, Nur77 and NOR1" . SPARSER::COLLECTION)
    ("Nurr1" . SPARSER::PROTEIN) ("SHP, HNF4α and NR4A" . SPARSER::COLLECTION)
    ("MMP7, MMP9, vimentin and E-cadherin" . SPARSER::COLLECTION)
    ("vimentin" . SPARSER::PROTEIN) ("– 1" . SPARSER::PROTEIN)
    ("ERα and TLX" . SPARSER::COLLECTION)
    ("ERα and DAX1" . SPARSER::COLLECTION)
    ("receptors, NURR1, NUR77 and NOR1" . SPARSER::COLLECTION)
    ("Rev-erbAβ" . SPARSER::COLLECTION) ("Rev" . SPARSER::PROTEIN-FAMILY)
    ("was run" . SPARSER::PROTEIN-FAMILY) ("run" . SPARSER::PROTEIN-FAMILY)
    ("ERα and RORγ" . SPARSER::COLLECTION)
    ("ERα and PNR" . SPARSER::COLLECTION)
    ("TRβ, ERRγ, RORβ or LRH-1" . SPARSER::COLLECTION)
    ("PGR, AR and RARα" . SPARSER::COLLECTION)
    ("NRs and ERα" . SPARSER::COLLECTION)
    ("ERα, PGR and HER2" . SPARSER::COLLECTION)
    ("receptors and ERα" . SPARSER::COLLECTION)
    ("TRβ, RORβ, and RORγ" . SPARSER::COLLECTION)
    ("ERα and PGR-positivity" . SPARSER::COLLECTION)
    ("AR and PNR" . SPARSER::COLLECTION) ("PNR" . SPARSER::PROTEIN)
    ("PGR, RARα and LRH-1" . SPARSER::COLLECTION)
    ("robust NR" . SPARSER::PROTEIN) ("ERα and PGR" . SPARSER::COLLECTION)
    ("CAR, SHP and FXR" . SPARSER::COLLECTION) ("FXR" . SPARSER::PROTEIN)
    ("SHP" . SPARSER::PROTEIN) ("CAR" . SPARSER::PROTEIN)
    ("COUP-TF2 and EAR2" . SPARSER::COLLECTION)
    ("ERα, RARα, EAR2, COUP-TF2 and RXRβ" . SPARSER::COLLECTION)
    ("RXR" . SPARSER::PROTEIN) ("Bank" . SPARSER::PROTEIN)
    ("the Tailless homolog TLX" . SPARSER::PROTEIN) ("MCF7" . SPARSER::PROTEIN)
    ("estrogen and retinoid" . SPARSER::COLLECTION) ("NCT" . SPARSER::PROTEIN)
    ("progesterone receptor (PGR)" . SPARSER::PROTEIN)
    ("Therapeutic synthetic agonists and antagonists" . SPARSER::COLLECTION)
    ("retinoid, and peroxisome" . SPARSER::COLLECTION)
    ("dexamethasone" . SPARSER::PROTEIN) ("GR" . SPARSER::PROTEIN)
    ("androgen (flutamide, bicalutamide, MDV3100) and progesterone (mifepristone, onapristone, lonaprisan) receptors"
     . SPARSER::COLLECTION)
    ("onapristone" . SPARSER::DRUG) ("mifepristone" . SPARSER::DRUG)
    ("fulvestrant" . SPARSER::DRUG) ("Examples" . SPARSER::EXAMPLE)
    ("receptors (NR)" . SPARSER::RECEPTOR)
    ("retinoids, lipids and xenobiotics" . SPARSER::COLLECTION)
    ("xenobiotics" . SPARSER::MOLECULE) ("retinoids" . SPARSER::DRUG)
    ("anti-estrogen or aromatase" . SPARSER::COLLECTION)
    ("tamoxifen, or drugs" . SPARSER::COLLECTION) ("letrozole" . SPARSER::DRUG)
    ("anastrozole" . SPARSER::DRUG) ("aromatase" . SPARSER::PROTEIN)
    ("TLX" . SPARSER::PROTEIN) ("ROR" . SPARSER::PROTEIN-FAMILY)
    ("ERα and progesterone receptor" . SPARSER::COLLECTION)
    ("NRs" . SPARSER::PROTEIN) ("Receptor (NR)" . SPARSER::RECEPTOR)
    ("NR" . SPARSER::PROTEIN) ("log-2" . SPARSER::PROTEIN)
    ("PPARδ" . SPARSER::PROTEIN) ("Wnt7" . SPARSER::PROTEIN)
    ("LSD1" . SPARSER::PROTEIN) ("SF-1" . SPARSER::PROTEIN)
    ("RORγt" . SPARSER::PROTEIN) ("ERRα" . SPARSER::PROTEIN)
    ("TR4" . SPARSER::PROTEIN) ("TR2" . SPARSER::PROTEIN)
    ("ERβ" . SPARSER::PROTEIN) ("RORα" . SPARSER::PROTEIN)
    ("RARβ" . SPARSER::PROTEIN) ("HNF4α" . SPARSER::PROTEIN)
    ("ALDH1" . SPARSER::PROTEIN) ("aldehyde dehydrogenase" . SPARSER::PROTEIN)
    ("MMP7" . SPARSER::PROTEIN) ("– 2" . SPARSER::PROTEIN)
    ("NOR1" . SPARSER::PROTEIN) ("NURR1" . SPARSER::PROTEIN)
    ("erbAβ" . SPARSER::PROTEIN) ("RARγ" . SPARSER::PROTEIN)
    ("DAX1" . SPARSER::PROTEIN) ("TRβ" . SPARSER::PROTEIN)
    ("ERRγ" . SPARSER::PROTEIN) ("E-12" . SPARSER::PROTEIN)
    ("EAR2" . SPARSER::PROTEIN) ("NR2F2" . SPARSER::PROTEIN)
    ("COUP-TF2" . SPARSER::PROTEIN) ("NR2F1" . SPARSER::PROTEIN)
    ("COUP-TF1" . SPARSER::PROTEIN) ("NR2E1" . SPARSER::PROTEIN)
    ("orphan receptor" . SPARSER::PROTEIN) ("LRH-1" . SPARSER::PROTEIN)
    ("RARα" . SPARSER::PROTEIN) ("retinoic acid" . SPARSER::MOLECULE)
    ("vitamin D3" . SPARSER::MOLECULE) ("MDV3100" . SPARSER::DRUG)
    ("anti-estrogen" . SPARSER::DRUG) ("PLK1 and FOXO" . SPARSER::COLLECTION)
    ("leukemia and other types" . SPARSER::COLLECTION)
    ("FOXO1 and FOXO3" . SPARSER::COLLECTION)
    ("a complex with FOXO3 and other FOXO family members"
     . SPARSER::COLLECTION)
    ("Bim and p27" . SPARSER::COLLECTION)
    ("FOXO3 (F3 WT) and the triple mutant" . SPARSER::COLLECTION)
    ("the triple mutant" . SPARSER::MUTANT)
    ("a shorter variant" . SPARSER::VARIANT) ("Proline" . SPARSER::AMINO-ACID)
    ("FOXO3 and FOXO1" . SPARSER::COLLECTION)
    ("Cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NPM" . SPARSER::PROTEIN)
    ("FOXO3-PLK1" . SPARSER::COLLECTION) ("exogenous PLK1" . SPARSER::PROTEIN)
    ("GST-FOXO3" . SPARSER::COLLECTION)
    ("exogenous FOXO1 and FOXO4 form" . SPARSER::FORM)
    ("FOXO1 and FOXO4" . SPARSER::COLLECTION)
    ("FOXO1, FOXO3 and FOXO4" . SPARSER::COLLECTION)
    ("FOXO-PLK1" . SPARSER::COLLECTION) ("exogenous FOXO3" . SPARSER::PROTEIN)
    ("Exogenous FOXO3" . SPARSER::PROTEIN) ("PLK1-FOXO3" . SPARSER::COLLECTION)
    ("a complex with FOXO3 and other FOXO family members (FOXO1 & FOXO4)"
     . SPARSER::COLLECTION)
    ("TAP" . SPARSER::PROTEIN) ("the pro-apoptotic Bim" . SPARSER::PROTEIN)
    ("Acute Myelocytic Leukemia (AML)" . SPARSER::PROTEIN)
    ("PLK1, PLK2 and PLK3" . SPARSER::COLLECTION)
    ("Leukemia" . SPARSER::PROTEIN)
    ("AKT, IKK, SGK and ERK" . SPARSER::COLLECTION)
    ("FOXOs and PI3K" . SPARSER::COLLECTION)
    ("FasL and TRADD" . SPARSER::COLLECTION)
    ("Apo2L/TRAIL" . SPARSER::COLLECTION) ("TRADD" . SPARSER::PROTEIN)
    ("FasL" . SPARSER::PROTEIN) ("Noxa" . SPARSER::PROTEIN)
    ("Puma" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cyclin D1 and Cyclin D2" . SPARSER::COLLECTION)
    ("Bim" . SPARSER::PROTEIN) ("FOXO3 and PLK1" . SPARSER::COLLECTION)
    ("known kinases" . SPARSER::KINASE)
    ("FOXO1, FOXO3, FOXO4 and FOXO6" . SPARSER::COLLECTION)
    ("FOXOs" . SPARSER::PROTEIN-FAMILY) ("FOXO" . SPARSER::PROTEIN-FAMILY)
    ("BI2536" . SPARSER::DRUG) ("pT-P" . SPARSER::PROTEIN)
    ("USP7" . SPARSER::PROTEIN) ("FKHRL1" . SPARSER::PROTEIN)
    ("K-19" . SPARSER::PROTEIN) ("H12" . SPARSER::PROTEIN)
    ("L-Glutamine" . SPARSER::MOLECULE) ("PLK3" . SPARSER::PROTEIN)
    ("PLK2" . SPARSER::PROTEIN) ("Polo-Like" . SPARSER::PROTEIN)
    ("Bcr-Abl" . SPARSER::PROTEIN) ("Apo2L" . SPARSER::PROTEIN)
    ("Polo Like Kinase 1" . SPARSER::PROTEIN) ("FOXO6" . SPARSER::PROTEIN)
    ("FOXO4" . SPARSER::PROTEIN) ("Inhibitors" . SPARSER::INHIBITOR)
    ("Jmjd1a" . SPARSER::PROTEIN) ("c-Myc and AP-1" . SPARSER::COLLECTION)
    ("AR/c-Myc" . SPARSER::COLLECTION)
    ("JMJD1A or c-Myc" . SPARSER::COLLECTION)
    ("HUWE1/c-Myc" . SPARSER::COLLECTION)
    ("JMJD1A and c-Myc" . SPARSER::COLLECTION)
    ("WWE" . SPARSER::PROTEIN-FAMILY) ("HUWE1 and c-Myc" . SPARSER::COLLECTION)
    ("JMJD1A and HUWE1" . SPARSER::COLLECTION)
    ("JMJD1A/HUWE1" . SPARSER::COLLECTION)
    ("the wild-type (WT) protein or a catalytic site mutant"
     . SPARSER::COLLECTION)
    ("AR and c-Myc" . SPARSER::COLLECTION)
    ("charcoal-stripped FBS" . SPARSER::PROTEIN)
    ("CS-FBS" . SPARSER::COLLECTION) ("CS" . SPARSER::PROTEIN)
    ("the c-Myc ( xref ) or PSA ( xref ) enhancers" . SPARSER::COLLECTION)
    ("JMJD1A or AR" . SPARSER::COLLECTION)
    ("c-Myc and PSA" . SPARSER::COLLECTION)
    ("AR ( xref ) and the c-Myc gene enhancer" . SPARSER::COLLECTION)
    ("JMJD1A and AR" . SPARSER::COLLECTION)
    ("CDKN1A (p21) and CDKN2B (p15) promoters" . SPARSER::COLLECTION)
    ("CDKN1A (p21) and CDKN2B (p15)" . SPARSER::COLLECTION)
    ("GADD45A, and GADD45B" . SPARSER::COLLECTION)
    ("AR, c-Myc or AP-1" . SPARSER::COLLECTION)
    ("AR, p53, c-Myc or AP-1" . SPARSER::COLLECTION)
    ("AR and PR" . SPARSER::COLLECTION)
    ("AR, p53, c-Myc and activating protein" . SPARSER::COLLECTION)
    ("502 genes and upregulation of 211 genes (2-fold cut off; xref )"
     . SPARSER::COLLECTION)
    ("the BrdU immunolabeling and chromogenic readout" . SPARSER::COLLECTION)
    ("normoxia and hypoxia" . SPARSER::COLLECTION)
    ("JMJD1A-KD" . SPARSER::COLLECTION)
    ("both normoxia ( xref ) and hypoxia ( xref )" . SPARSER::COLLECTION)
    ("normoxia" . SPARSER::PROTEIN)
    ("Hes6, Sox9 and JMJD1A" . SPARSER::COLLECTION) ("Hes" . SPARSER::PROTEIN)
    ("enolase (NSE)" . SPARSER::PROTEIN) ("NSE" . SPARSER::PROTEIN)
    ("enolase" . SPARSER::PROTEIN)
    ("JMJD1A mRNA ( xref ) and protein ( xref )" . SPARSER::COLLECTION)
    ("Rv" . SPARSER::MOLECULE) ("MULE" . SPARSER::PROTEIN)
    ("HECT" . SPARSER::PROTEIN)
    ("Fbxw7, Skp2, Pihr2 and HUWE1" . SPARSER::COLLECTION)
    ("mRNA and proteins" . SPARSER::COLLECTION)
    ("enhancers" . SPARSER::PROTEIN)
    ("AREs" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("KDM3A or JHDM2A" . SPARSER::COLLECTION)
    ("a repressive histone" . SPARSER::PROTEIN)
    ("Lysine" . SPARSER::AMINO-ACID) ("demethylases" . SPARSER::PROTEIN)
    ("active or inactive" . SPARSER::COLLECTION) ("Histone" . SPARSER::PROTEIN)
    ("demethylase" . SPARSER::PROTEIN) ("F3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GADD45A" . SPARSER::PROTEIN) ("p18" . SPARSER::PROTEIN)
    ("CDKN2C" . SPARSER::PROTEIN) ("CDKN2B" . SPARSER::PROTEIN)
    ("p57" . SPARSER::PROTEIN) ("CDKN1C" . SPARSER::PROTEIN)
    ("CDKN1B" . SPARSER::PROTEIN) ("GADD45" . SPARSER::PROTEIN)
    ("activating protein" . SPARSER::PROTEIN)
    ("Progesterone receptor" . SPARSER::PROTEIN) ("DU145" . SPARSER::PROTEIN)
    ("Sox9" . SPARSER::PROTEIN) ("TIAM1" . SPARSER::PROTEIN)
    ("UBA and WWE domain containing 1" . SPARSER::PROTEIN)
    ("Fbxw7" . SPARSER::PROTEIN) ("proto-oncogene c-Myc" . SPARSER::PROTEIN)
    ("di-methyl" . SPARSER::DRUG) ("JHDM2A" . SPARSER::PROTEIN)
    ("KDM3A" . SPARSER::PROTEIN) ("demethylase activity" . SPARSER::PROTEIN)
    ("HUWE1" . SPARSER::PROTEIN) ("JMJD1A" . SPARSER::PROTEIN)
    ("a particular histological type" . TYPE)
    ("proliferating cell nuclear antigen (PCNA)" . SPARSER::PROTEIN)
    ("-CDK4" . SPARSER::COLLECTION) ("cyclin-CDK2" . SPARSER::COLLECTION)
    ("tau" . SPARSER::PROTEIN) ("t " . SPARSER::PROTEIN)
    ("pRb" . SPARSER::PROTEIN) ("messenger RNA" . SPARSER::RNA)
    ("RB protein" . SPARSER::PROTEIN)
    ("protein and PTEN" . SPARSER::COLLECTION)
    ("mRNA/protein" . SPARSER::COLLECTION)
    ("mRNA and PTEN" . SPARSER::COLLECTION)
    ("weak NEDD4 protein" . SPARSER::PROTEIN)
    ("PTEN/PI3K" . SPARSER::COLLECTION)
    ("NEDD4 and PTEN" . SPARSER::COLLECTION) ("WWP2" . SPARSER::PROTEIN)
    ("Nedd4" . SPARSER::PROTEIN)
    ("developmentally down-regulated 4" . SPARSER::PROTEIN)
    ("neural precursor cell expressed" . SPARSER::PROTEIN)
    ("catalytic subunit of PI3K" . SPARSER::PROTEIN)
    ("p110-alpha" . SPARSER::PROTEIN) ("NEDD4-1" . SPARSER::PROTEIN)
    ("NEDD4" . SPARSER::PROTEIN)
    ("type and concentration" . SPARSER::COLLECTION)
    ("a molecular prognostic biomarker" . SPARSER::MOLECULE)
    ("HER-2 and TNM" . SPARSER::COLLECTION)
    ("the included studies used IHC" . SPARSER::PROTEIN)
    ("UK" . SPARSER::PROTEIN) ("anti-HER-2/neu" . SPARSER::COLLECTION)
    ("Herceptin" . SPARSER::DRUG)
    ("a 185-kDa transmembrane tyrosine kinase" . SPARSER::PROTEIN)
    ("HER-2/neu" . SPARSER::COLLECTION) ("neu" . SPARSER::PROTEIN)
    ("c-erbB2" . SPARSER::PROTEIN)
    ("etoposide and cisplatin" . SPARSER::COLLECTION)
    ("strong p-ATM" . SPARSER::PROTEIN)
    ("dacarbazine and temozolomide" . SPARSER::COLLECTION)
    ("temozolomide" . SPARSER::DRUG) ("dacarbazine" . SPARSER::DRUG)
    ("p-ATM and AJCC" . SPARSER::COLLECTION) ("IRS" . SPARSER::PROTEIN)
    ("Kappa" . SPARSER::PROTEIN-FAMILY) ("Ataxia" . SPARSER::PROTEIN)
    ("monomers" . SPARSER::MONOMER) ("IRS 6" . SPARSER::PROTEIN)
    ("IRS 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Hypoxia Inducible Factor-1" . SPARSER::PROTEIN)
    ("Akt/PKB" . SPARSER::PROTEIN) ("autosomal recessive" . SPARSER::PROTEIN)
    ("A-T" . SPARSER::PROTEIN) ("MDC1" . SPARSER::PROTEIN)
    ("NBS1" . SPARSER::PROTEIN) ("RAD50" . SPARSER::PROTEIN)
    ("MRE 11" . SPARSER::PROTEIN)
    ("Ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("p-ATM" . SPARSER::PROTEIN)
    ("Ataxia Telangiectasia Mutated" . SPARSER::PROTEIN)
    ("PV and PMF" . SPARSER::COLLECTION)
    ("mTOR/p70S6K/4EBP1" . SPARSER::COLLECTION)
    ("dual PI3K/mTOR inhibitor BEZ235 and JAK1/2 inhibitor ruxolitinib"
     . SPARSER::COLLECTION)
    ("dual PI3K/mTOR inhibitor BEZ235" . SPARSER::DRUG)
    ("ruxolitinib" . SPARSER::DRUG)
    ("p70 S6K and 4E-BP1" . SPARSER::COLLECTION)
    ("thrombopoietin" . SPARSER::PROTEIN)
    ("S6K and 4EBP1" . SPARSER::COLLECTION)
    ("PI3K and Ras" . SPARSER::COLLECTION)
    ("Akt and ERK" . SPARSER::COLLECTION)
    ("Rheb" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Raptor" . SPARSER::PROTEIN)
    ("polypeptide 2 (RPS6KB2) and PTEN" . SPARSER::COLLECTION)
    ("RPS6, 70 kDa, polypeptide 2 (RPS6KB2) and PTEN" . SPARSER::COLLECTION)
    ("4E-BP1 and eIF-4G" . SPARSER::COLLECTION) ("eIF-4G" . SPARSER::PROTEIN)
    ("acute leukemia" . SPARSER::PROTEIN)
    ("PI3K or mTOR" . SPARSER::COLLECTION)
    ("PMF and JAK2V617F" . SPARSER::COLLECTION) ("90kDa" . SPARSER::PROTEIN)
    ("RRAGA" . SPARSER::PROTEIN) ("EIF4EBP1 and EIF4G1" . SPARSER::COLLECTION)
    ("eukaryotic translation initiation factor 4E binding protein 1 ( EIF4EBP1 ) and 4γ1 ( EIF4G1 )"
     . SPARSER::COLLECTION)
    ("Hypoxia" . SPARSER::PROTEIN)
    ("α polypeptide ( PIK3CA ) and regulatory subunit 1 ( PIK3R1 )"
     . SPARSER::COLLECTION)
    ("FNBP1 , GNAI2 and proliferation-associated 2G4" . SPARSER::COLLECTION)
    ("ME" . SPARSER::PROTEIN) ("DLST" . SPARSER::PROTEIN)
    ("glucose-6-phosphate isomerase (GPI)" . SPARSER::PROTEIN)
    ("charged multivesicular body protein" . SPARSER::PROTEIN)
    ("ACTR2, and LTA4H" . SPARSER::COLLECTION)
    ("copine" . SPARSER::PROTEIN-FAMILY) ("MVP" . SPARSER::PROTEIN)
    ("CAI" . SPARSER::DRUG) ("polypeptide" . SPARSER::PROTEIN)
    ("oxidative stress related catalase (CAT)" . SPARSER::PROTEIN)
    ("catalase (CAT)" . SPARSER::PROTEIN)
    ("RAB10, RAP2B, S100A4/6, and superoxide dismutase 1"
     . SPARSER::COLLECTION)
    ("moesin (MSN)" . SPARSER::PROTEIN) ("YWHAB" . SPARSER::PROTEIN)
    ("monooxygenase" . SPARSER::PROTEIN) ("MSN" . SPARSER::PROTEIN)
    ("moesin" . SPARSER::PROTEIN) ("FLNA" . SPARSER::PROTEIN)
    ("filamin" . SPARSER::PROTEIN-FAMILY) ("CA1" . SPARSER::PROTEIN)
    ("phosphoribosyl pyrophosphate synthetase-associated protein"
     . SPARSER::PROTEIN)
    ("S100A9 , and microRNA" . SPARSER::COLLECTION)
    ("myosin" . SPARSER::PROTEIN-FAMILY) ("pyrophosphate" . SPARSER::MOLECULE)
    ("CPNE3 , APEX1 and KDM1A" . SPARSER::COLLECTION)
    ("CIB1 , NBPF10 and GPR160" . SPARSER::COLLECTION)
    ("GLRX , IFI16 and LAMP1" . SPARSER::COLLECTION)
    ("GLRX" . SPARSER::PROTEIN)
    ("up-regulated dual specificity phosphatase 1 ( DUSP1 ) and protein tyrosine phosphatase"
     . SPARSER::COLLECTION)
    ("PTPRJ" . SPARSER::PROTEIN)
    ("up-regulated coiled-coil domain containing 88A ( CCDC88A ) and coronin 1A ( CORO1A ) genes"
     . SPARSER::COLLECTION)
    ("apoptosis-stimulating genes S100 calcium binding protein A8 ( S100A8 ) and TNFRSF19"
     . SPARSER::COLLECTION)
    ("apoptosis-inhibiting genes NLR family apoptosis inhibitory protein ( NAIP , absent in PMF) and tumor necrosis factor"
     . SPARSER::COLLECTION)
    ("NAIP" . SPARSER::PROTEIN)
    ("ras-related C3 botulinum toxin substrate 2 ( RAC2 ) and signal transducer and activator of transcription 1 ( STAT1 )"
     . SPARSER::COLLECTION)
    ("ras" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NFKBIA" . SPARSER::PROTEIN)
    ("LYN" . SPARSER::PROTEIN) ("PYCARD" . SPARSER::PROTEIN)
    ("CNOT2 and FN1" . SPARSER::COLLECTION)
    ("SPSB1 , DLX4 , TSPAN4 , and GNL1" . SPARSER::COLLECTION)
    ("MAPT" . SPARSER::PROTEIN) ("FYB" . SPARSER::PROTEIN)
    ("forkhead" . SPARSER::PROTEIN)
    ("STE20-related kinase adaptor beta ( STRADB )" . SPARSER::PROTEIN)
    ("synuclein" . SPARSER::PROTEIN) ("STRADB" . SPARSER::PROTEIN)
    ("erythropoietin" . SPARSER::PROTEIN) ("JAK2/STAT5" . SPARSER::COLLECTION)
    ("pAKT" . SPARSER::PROTEIN-FAMILY)
    ("acute lymphoblastic leukemia (ALL)" . SPARSER::PROTEIN)
    ("STAT5 and AKT" . SPARSER::COLLECTION)
    ("The classic BCR/ABL-negative MPNs" . SPARSER::PROTEIN)
    ("ABL" . SPARSER::PROTEIN) ("BCR" . SPARSER::PROTEIN)
    ("MAPK and PI3K/AKT signaling regulators" . SPARSER::COLLECTION)
    ("RAC2, MNDA, S100A8/9, CORO1A, and GNAI2" . SPARSER::COLLECTION)
    ("MNDA" . SPARSER::PROTEIN) ("25,100 unique genes" . SPARSER::GENE)
    ("PMF" . SPARSER::PROTEIN) ("PV" . SPARSER::PROTEIN)
    ("gene and protein" . SPARSER::COLLECTION) ("MPNs" . SPARSER::PROTEIN)
    ("p70S6K" . SPARSER::PROTEIN) ("BEZ235" . SPARSER::DRUG)
    ("thrombopoietin receptor" . SPARSER::PROTEIN) ("4EBP1" . SPARSER::PROTEIN)
    ("RPS6KB2" . SPARSER::PROTEIN) ("polypeptide 2" . SPARSER::PROTEIN)
    ("p70 S6K" . SPARSER::PROTEIN) ("RPS6KA1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("polypeptide 1" . SPARSER::PROTEIN) ("RPS6" . SPARSER::PROTEIN)
    ("ribosomal protein S6" . SPARSER::PROTEIN) ("EIF4G1" . SPARSER::PROTEIN)
    ("EIF4EBP1" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 4E binding protein 1"
     . SPARSER::PROTEIN)
    ("STK11" . SPARSER::PROTEIN)
    ("Serine/threonine kinase 11" . SPARSER::PROTEIN)
    ("MAPK1" . SPARSER::PROTEIN) ("PIK3R1" . SPARSER::PROTEIN)
    ("regulatory subunit 1" . SPARSER::PROTEIN)
    ("Phosphoinositide-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("PA2G4" . SPARSER::PROTEIN)
    ("proliferation-associated 2G4" . SPARSER::PROTEIN)
    ("NAD(+)" . SPARSER::MOLECULE) ("malic enzyme 2" . SPARSER::PROTEIN)
    ("dihydrolipoamide S-succinyltransferase" . SPARSER::PROTEIN)
    ("CBX1" . SPARSER::PROTEIN) ("homolog 1" . SPARSER::PROTEIN)
    ("glucose-6-phosphate isomerase" . SPARSER::PROTEIN)
    ("CCT2" . SPARSER::PROTEIN)
    ("chaperonin containing TCP1" . SPARSER::PROTEIN)
    ("CHIT1" . SPARSER::PROTEIN) ("chitinase 1" . SPARSER::PROTEIN)
    ("SF3B2" . SPARSER::PROTEIN) ("subunit 2" . SPARSER::PROTEIN)
    ("splicing factor 3b" . SPARSER::PROTEIN) ("TPM3" . SPARSER::PROTEIN)
    ("tropomyosin 3" . SPARSER::PROTEIN) ("FNBP1" . SPARSER::PROTEIN)
    ("formin binding protein 1" . SPARSER::PROTEIN)
    ("major vault protein" . SPARSER::PROTEIN) ("FCN1" . SPARSER::PROTEIN)
    ("ficolin 1" . SPARSER::PROTEIN) ("CHMP5" . SPARSER::PROTEIN)
    ("ANXA1" . SPARSER::PROTEIN)
    ("myeloid cell nuclear differentiation antigen" . SPARSER::PROTEIN)
    ("SOD1" . SPARSER::PROTEIN) ("S100A4" . SPARSER::PROTEIN)
    ("RAP2B" . SPARSER::PROTEIN) ("RAB10" . SPARSER::PROTEIN)
    ("PTPN6" . SPARSER::PROTEIN)
    ("protein tyrosine phosphatase, non-receptor type 6" . SPARSER::PROTEIN)
    ("LTA4H" . SPARSER::PROTEIN)
    ("leukotriene A4 hydrolase" . SPARSER::PROTEIN)
    ("LGALS1" . SPARSER::PROTEIN)
    ("lectin galactoside-binding soluble 1" . SPARSER::PROTEIN)
    ("KRT10" . SPARSER::PROTEIN) ("keratin 10" . SPARSER::PROTEIN)
    ("HSPA1A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("heat shock 70kDa protein 1A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GDI2" . SPARSER::PROTEIN) ("ANXA5" . SPARSER::PROTEIN)
    ("annexin A5" . SPARSER::PROTEIN)
    ("tryptophan 5-monooxygenase" . SPARSER::PROTEIN)
    ("PSME2" . SPARSER::PROTEIN)
    ("proteasome activator subunit 2" . SPARSER::PROTEIN)
    ("PDIA6" . SPARSER::PROTEIN) ("member 6" . SPARSER::PROTEIN)
    ("protein disulfide isomerase family A" . SPARSER::PROTEIN)
    ("HSP90AB1" . SPARSER::PROTEIN) ("carbonic anhydrase I" . SPARSER::PROTEIN)
    ("beta polypeptide" . SPARSER::PROTEIN)
    ("H+ transporting" . SPARSER::PROTEIN) ("2/3" . SPARSER::PROTEIN)
    ("actin-related protein 2" . SPARSER::PROTEIN) ("ARP2" . SPARSER::PROTEIN)
    ("S100A9" . SPARSER::PROTEIN) ("RBL2" . SPARSER::PROTEIN)
    ("retinoblastoma-like 2" . SPARSER::PROTEIN) ("PRPSAP2" . SPARSER::PROTEIN)
    ("GPR160" . SPARSER::PROTEIN) ("NBPF10" . SPARSER::PROTEIN)
    ("CIB1" . SPARSER::PROTEIN) ("KDM1A" . SPARSER::PROTEIN)
    ("APEX1" . SPARSER::PROTEIN) ("CPNE3" . SPARSER::PROTEIN)
    ("LAMP1" . SPARSER::PROTEIN) ("IFI16" . SPARSER::PROTEIN)
    ("protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("DUSP1" . SPARSER::PROTEIN)
    ("dual specificity phosphatase 1" . SPARSER::PROTEIN)
    ("MAPK10" . SPARSER::PROTEIN) ("GADD45B" . SPARSER::PROTEIN)
    ("growth arrest and DNA-damage-inducible" . SPARSER::PROTEIN)
    ("coronin 1A" . SPARSER::PROTEIN)
    ("coiled-coil domain containing 88A" . SPARSER::PROTEIN)
    ("TNFAIP3" . SPARSER::PROTEIN)
    ("alpha-induced protein 3" . SPARSER::PROTEIN)
    ("NLR family apoptosis inhibitory protein" . SPARSER::PROTEIN)
    ("S100 calcium binding protein A8" . SPARSER::PROTEIN)
    ("TOB1" . SPARSER::PROTEIN) ("RARRES3" . SPARSER::PROTEIN)
    ("retinoic acid receptor responder 3" . SPARSER::PROTEIN)
    ("STAT1" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 1" . SPARSER::PROTEIN)
    ("MAS1" . SPARSER::PROTEIN)
    ("nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor"
     . SPARSER::PROTEIN)
    ("KLF13" . SPARSER::PROTEIN) ("HCLS1" . SPARSER::PROTEIN)
    ("hematopoietic cell-specific Lyn substrate 1" . SPARSER::PROTEIN)
    ("v-yes-1 Yamaguchi sarcoma viral related oncogene homolog"
     . SPARSER::PROTEIN)
    ("INPP5K" . SPARSER::PROTEIN) ("MUC2" . SPARSER::PROTEIN)
    ("FN1" . SPARSER::PROTEIN) ("CNOT2" . SPARSER::PROTEIN)
    ("PTBP2" . SPARSER::PROTEIN) ("GNL1" . SPARSER::PROTEIN)
    ("TSPAN4" . SPARSER::PROTEIN) ("DLX4" . SPARSER::PROTEIN)
    ("SPSB1" . SPARSER::PROTEIN) ("LRRC27" . SPARSER::PROTEIN)
    ("TPSG1" . SPARSER::PROTEIN) ("TBXAS1" . SPARSER::PROTEIN)
    ("ALAS2" . SPARSER::PROTEIN) ("cAMP-specific" . SPARSER::PROTEIN)
    ("phosphodiesterase 4A" . SPARSER::PROTEIN)
    ("STE20-related kinase adaptor beta" . SPARSER::PROTEIN)
    ("tumor necrosis factor receptor superfamily" . SPARSER::PROTEIN)
    ("runt-related transcription factor 1" . SPARSER::PROTEIN)
    ("per 3" . SPARSER::PROTEIN) ("JAK-2" . SPARSER::PROTEIN)
    ("NaHCO 3" . SPARSER::DRUG) ("Mg 2+" . SPARSER::MOLECULE)
    ("phosphoinositide-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Janus kinase 2" . SPARSER::PROTEIN) ("EIF4F" . SPARSER::PROTEIN)
    ("1A" . SPARSER::PROTEIN) ("S100A8" . SPARSER::PROTEIN)
    ("RAC2" . SPARSER::PROTEIN) ("PDE4A" . SPARSER::PROTEIN)
    ("TNFRSF19" . SPARSER::PROTEIN) ("RUNX1" . SPARSER::PROTEIN)
    ("HA-GSK3α" . SPARSER::COLLECTION)
    ("phenylalanine or glutamic acid" . SPARSER::COLLECTION)
    ("the KKKK15/27/32/36 RRRR mutant (S4) and the S4-ubiquitin fusion mutant (Ub-S4, mimicking ubiquitinated form of S4 mutant)"
     . SPARSER::COLLECTION)
    ("Ub-S4" . SPARSER::COLLECTION) ("S4-ubiquitin" . SPARSER::COLLECTION)
    ("monospecific inhibitors" . SPARSER::INHIBITOR)
    ("a dual PYK2/FAK inhibitor" . SPARSER::INHIBITOR)
    ("PYK2/FAK" . SPARSER::COLLECTION)
    ("the dual FAK/PYK2 inhibitor" . SPARSER::INHIBITOR)
    ("a single FAK/PYK dual inhibitor" . SPARSER::INHIBITOR)
    ("FAK/PYK" . SPARSER::COLLECTION) ("PYK" . SPARSER::PROTEIN)
    ("YF" . SPARSER::MOLECULE) ("bTrCP" . SPARSER::PROTEIN)
    ("inhibitor (PF)" . SPARSER::INHIBITOR) ("“FAK/PYK2" . SPARSER::COLLECTION)
    ("FAK/PYK2 dual inhibitor instead of FAK-specific inhibitor"
     . SPARSER::COLLECTION)
    ("FAK/PYK2 dual inhibitor" . SPARSER::INHIBITOR)
    ("intestinal PYK2" . SPARSER::PROTEIN)
    ("cadherin-β-catenin" . SPARSER::COLLECTION)
    ("tumor types and patient subgroups that are most responsive to FAK inhibitors"
     . SPARSER::COLLECTION)
    ("Currently several FAK inhibitors" . SPARSER::INHIBITOR)
    ("coreceptor" . SPARSER::PROTEIN) ("‘activator’" . SPARSER::ACTIVATOR)
    ("FAK/PYK2/p-GSK3α/β" . SPARSER::COLLECTION) ("FAP" . SPARSER::PROTEIN)
    ("PYK2/p-GSK3α/β" . SPARSER::COLLECTION)
    ("FAK/p-GSK3α/β" . SPARSER::COLLECTION) ("GSK3α/β" . SPARSER::PROTEIN)
    ("p-GSK3α/β" . SPARSER::COLLECTION)
    ("the ubiquitinated intestinal GSK3β" . SPARSER::PROTEIN)
    ("intestinal GSK3β" . SPARSER::PROTEIN)
    ("antibody and antibody" . SPARSER::COLLECTION)
    ("c-Myc and FAK" . SPARSER::COLLECTION)
    ("‘effector’ and ‘regulator’" . SPARSER::COLLECTION)
    ("p-FAK" . SPARSER::COLLECTION) ("‘regulator’" . SPARSER::REGULATOR)
    ("‘effector’" . SPARSER::EFFECTOR)
    ("c-Myc (β-catenin target gene) and FAK (c-Myc target)"
     . SPARSER::COLLECTION)
    ("Flag-β-catenin" . SPARSER::COLLECTION) ("/PYK2" . SPARSER::COLLECTION)
    ("leaves FAK's" . SPARSER::PROTEIN) ("FAK/PYk2" . SPARSER::COLLECTION)
    ("GSK3β and FAK" . SPARSER::COLLECTION)
    ("simultaneous KD" . SPARSER::PROTEIN)
    ("either FAK (HT-29 cells) or PYK2 (SW480 cells)" . SPARSER::COLLECTION)
    ("FAK or PYK2" . SPARSER::COLLECTION) ("IB" . SPARSER::DRUG)
    ("a dual inhibitor" . SPARSER::INHIBITOR)
    ("Flag-GSK3α" . SPARSER::COLLECTION) ("p-β-catenin" . SPARSER::COLLECTION)
    ("Y216 phosphorylation mimetic mutant" . SPARSER::MUTANT)
    ("its phosphorylation mimetic mutant" . SPARSER::MUTANT)
    ("HA-GSK3β" . SPARSER::COLLECTION)
    ("GSK3β Y216F and GSK3β Y216E" . SPARSER::COLLECTION)
    ("arginines" . SPARSER::AMINO-ACID) ("GSK3β/Axin" . SPARSER::COLLECTION)
    ("p-GSK3α" . SPARSER::COLLECTION) ("p-GSK3β" . SPARSER::COLLECTION)
    ("β-TrCP1" . SPARSER::PROTEIN) ("/LEF" . SPARSER::COLLECTION)
    ("Axin and β-catenin" . SPARSER::COLLECTION)
    ("about 50% colon carcinoma cells display homogeneous nuclear β-catenin"
     . SPARSER::PROTEIN)
    ("functional APC" . SPARSER::PROTEIN)
    ("GSK3α and GSK3β" . SPARSER::COLLECTION) ("CRCs" . SPARSER::PROTEIN)
    ("PYK2 and FAK" . SPARSER::COLLECTION) ("Gao" . SPARSER::PROTEIN)
    ("which kinases" . SPARSER::KINASE) ("Enzymes" . SPARSER::ENZYME)
    ("FAK/PYK2" . SPARSER::COLLECTION) ("GSK3β/β-TrCP" . SPARSER::COLLECTION)
    ("FAK and PYK2" . SPARSER::COLLECTION) ("/β-catenin" . SPARSER::COLLECTION)
    ("FAK/PYK2/GSK3β" . SPARSER::COLLECTION) ("Wnt3" . SPARSER::PROTEIN)
    ("P75" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("N-ethylmaleimide" . SPARSER::MOLECULE) ("UbcH5b" . SPARSER::PROTEIN)
    ("s 5a" . SPARSER::PROTEIN) ("c-Met" . SPARSER::PROTEIN)
    ("PYk2" . SPARSER::PROTEIN) ("DLD-1" . SPARSER::PROTEIN)
    ("S33" . SPARSER::PROTEIN) ("Wnt3a" . SPARSER::PROTEIN)
    ("glutamic acid" . SPARSER::AMINO-ACID)
    ("low-density lipoprotein receptor" . SPARSER::PROTEIN)
    ("casein kinase 1" . SPARSER::PROTEIN) ("PYK2" . SPARSER::PROTEIN)
    ("b" . SPARSER::PROTEIN) ("Raf/MAPK" . SPARSER::COLLECTION)
    ("acceptors" . SPARSER::MOLECULE) ("fix" . SPARSER::PROTEIN)
    ("GTP/GDP" . SPARSER::PROTEIN-PAIR)
    ("membrane-associated Ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GDP and GMPPNP" . SPARSER::COLLECTION) ("GMPPNP" . SPARSER::MOLECULE)
    ("the more accessible conformation" . SPARSER::BIO-CONFORMATION)
    ("EM" . SPARSER::PROTEIN) ("GTPase-defective RasG12V" . SPARSER::PROTEIN)
    ("heterotrimeric G proteins ( xref ), Rho- and Rab-small GTPases ( xref ), as well as Src-family kinases ( xref )"
     . SPARSER::COLLECTION)
    ("heterotrimeric G proteins" . SPARSER::PROTEIN)
    ("Rho- and Rab-small" . SPARSER::COLLECTION)
    ("Rho-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rab" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GPI" . SPARSER::PROTEIN)
    ("GAPs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GEF" . SPARSER::GEF)
    ("stoichiometric Ras–Raf" . SPARSER::COLLECTION)
    ("Ras and Raf" . SPARSER::COLLECTION) ("anchors" . SPARSER::ANCHOR)
    ("Ras–Raf" . SPARSER::COLLECTION)
    ("The (isoform- or mutation-) specific GTP-Ras conformational states"
     . SPARSER::BIO-STATE)
    ("isoform-" . SPARSER::ISOFORM) ("GTP-" . SPARSER::NUCLEOTIDE)
    ("H-ras and N-ras" . SPARSER::COLLECTION) ("GDP-" . SPARSER::NUCLEOTIDE)
    ("at least two conformational states" . SPARSER::BIO-STATE)
    ("the developmentally most significant Ras isoform" . SPARSER::ISOFORM)
    ("MEK, ERK, and AKT" . SPARSER::COLLECTION)
    ("RASopathy-associated Ras mutants" . SPARSER::MUTANT)
    ("MEK, ERK, or AKT" . SPARSER::COLLECTION) ("compactin" . SPARSER::DRUG)
    ("the computational modeling-derived H-ras switch III mutant D47A"
     . SPARSER::PROTEIN)
    ("the computational modeling-derived mutants" . SPARSER::MUTANT)
    ("HRAS , NRAS , and KRAS" . SPARSER::COLLECTION)
    ("Raf, MEK, and ERK" . SPARSER::COLLECTION)
    ("mGFP-tagged H-ras mutants and the mRFP-tagged Ras binding domain of C-Raf (in the following in short RBD) in BHK cells"
     . SPARSER::COLLECTION)
    ("FLIM" . SPARSER::PROTEIN-FAMILY)
    ("the conformational state" . SPARSER::BIO-STATE)
    ("namely signaling protein" . SPARSER::PROTEIN)
    ("Essentially only three regulators" . SPARSER::REGULATOR)
    ("galectin-3, and nucleophosmin" . SPARSER::COLLECTION)
    ("nucleophosmin" . SPARSER::PROTEIN) ("NRAS or KRAS" . SPARSER::COLLECTION)
    ("facio-cutaneous malformations" . SPARSER::PROTEIN)
    ("malformations" . SPARSER::PROTEIN) ("Ras/MAPK" . SPARSER::COLLECTION)
    ("Mutants" . SPARSER::MUTANT) ("A ‘" . SPARSER::PROTEIN)
    ("Ras family" . SPARSER::PROTEIN) ("H-Ras" . SPARSER::PROTEIN)
    ("glutathione S-transferase" . SPARSER::PROTEIN)
    ("pMEK1" . SPARSER::PROTEIN) ("RAF-RBD" . SPARSER::PROTEIN)
    ("NF1" . SPARSER::PROTEIN) ("RasG12V" . SPARSER::PROTEIN)
    ("Ras-GTP" . SPARSER::PROTEIN) ("phospho-protein" . SPARSER::PROTEIN)
    ("N-ras" . SPARSER::PROTEIN) ("GTPγS" . SPARSER::PROTEIN)
    ("C-Raf" . SPARSER::PROTEIN) ("170A" . SPARSER::PROTEIN)
    ("rasG12V" . SPARSER::PROTEIN) ("β2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("K-ras" . SPARSER::PROTEIN) ("H-ras" . SPARSER::PROTEIN)
    ("galectin-3" . SPARSER::PROTEIN) ("Gal-1" . SPARSER::PROTEIN)
    ("galectin-1" . SPARSER::PROTEIN) ("hydrolase activity" . SPARSER::PROTEIN)
    ("ETS-2 and miR-126" . SPARSER::COLLECTION)
    ("mRNA, protein and miR-126" . SPARSER::COLLECTION)
    ("miRNA and mRNA" . SPARSER::COLLECTION)
    ("miR-126 and ATO" . SPARSER::COLLECTION)
    ("VEGFA and EGFL-7" . SPARSER::COLLECTION)
    ("MAP kinase and PI3 kinase" . SPARSER::COLLECTION)
    ("mitogen" . SPARSER::MITOGEN) ("Electron" . SPARSER::MOLECULE)
    ("mRNA and miR-126" . SPARSER::COLLECTION)
    ("mRNA, miR-126 and VEGFA" . SPARSER::COLLECTION)
    ("Ets-2, miR-126, and VEGFA" . SPARSER::COLLECTION)
    ("miR-126 and VEGFA" . SPARSER::COLLECTION)
    ("siRNA, and Ets-2 and VEGFA" . SPARSER::COLLECTION)
    ("Ets-2 and VEGFA" . SPARSER::COLLECTION)
    ("ATO, and VEGFA" . SPARSER::COLLECTION) ("monolayers" . SPARSER::PROTEIN)
    ("miR-126 and Ets-2" . SPARSER::COLLECTION)
    ("Ets-1 and Ets-2" . SPARSER::COLLECTION)
    ("Ets" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p85-b" . SPARSER::PROTEIN-PAIR)
    ("endothelial-enriched microRNAs" . SPARSER::RNA)
    ("Fish" . SPARSER::PROTEIN)
    ("VEGFA and vascular endothelial" . SPARSER::COLLECTION)
    ("VEGFR" . SPARSER::PROTEIN)
    ("acute promyelocytic leukemia (APL)" . SPARSER::PROTEIN)
    ("APL" . SPARSER::PROTEIN)
    ("growth factor (VEGF)" . SPARSER::GROWTH-FACTOR)
    ("diverse EC" . SPARSER::PROTEIN)
    ("Ets-2 and miR-126" . SPARSER::COLLECTION)
    ("VEGF or VEGFA" . SPARSER::COLLECTION)
    ("acute promyelocytic leukemia" . SPARSER::PROTEIN)
    ("ATO" . SPARSER::PROTEIN) ("Annexin-V" . SPARSER::PROTEIN)
    ("MAP kinase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ETS2" . SPARSER::PROTEIN)
    ("ETS-2" . SPARSER::PROTEIN) ("A-3" . SPARSER::PROTEIN)
    ("SPRED1" . SPARSER::PROTEIN) ("EGFL-7" . SPARSER::PROTEIN)
    ("arsenic trioxide" . SPARSER::MOLECULE)
    ("Vascular endothelial" . SPARSER::PROTEIN)
    ("Arsenic trioxide" . SPARSER::MOLECULE)
    ("Helicase (WRN)" . SPARSER::PROTEIN) ("WRN" . SPARSER::PROTEIN)
    ("Helicase" . SPARSER::PROTEIN) ("glial" . SPARSER::PROTEIN)
    ("RHA and the p53 mRNA" . SPARSER::COLLECTION)
    ("the 40S ribosomal subunit" . SPARSER::FRAGMENT)
    ("40S ribosomal subunit" . SPARSER::FRAGMENT)
    ("some viral and cellular mRNAs" . SPARSER::PROTEIN)
    ("TCP80 and its RBM" . SPARSER::COLLECTION) ("RBM" . SPARSER::PROTEIN)
    ("regulating p53's" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TCP80 and its binding protein RHA" . SPARSER::COLLECTION)
    ("TCP80 and RHA, and p53" . SPARSER::COLLECTION)
    ("RHA, and p53" . SPARSER::COLLECTION)
    ("etoposide and look" . SPARSER::COLLECTION)
    ("RHA and TCP80" . SPARSER::COLLECTION)
    ("RNA helicase A (RHA) or nuclear DNA helicase II (NDH II)"
     . SPARSER::COLLECTION)
    ("TCP80, RNA helicase A (RHA) or nuclear DNA helicase II (NDH II)"
     . SPARSER::COLLECTION)
    ("TCP80 and its associated RNAs (Jiang and Miskimins, unpublished observations)"
     . SPARSER::COLLECTION)
    ("its associated RNAs" . SPARSER::RNA) ("glycine" . SPARSER::AMINO-ACID)
    ("Rluc" . SPARSER::PROTEIN) ("pRF or pR5UTRF" . SPARSER::COLLECTION)
    ("pRF" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TCP80/mRNA" . SPARSER::COLLECTION)
    ("TCP80 and p53" . SPARSER::COLLECTION)
    ("translational control protein 80 (TCP80) and RNA helicase A (RHA)"
     . SPARSER::COLLECTION)
    ("trans" . SPARSER::PROTEIN-FAMILY) ("p53/p47" . SPARSER::COLLECTION)
    ("ribosomal subunits" . SPARSER::PROTEIN)
    ("4E-BP1 and eIF-4E" . SPARSER::COLLECTION) ("eIF-4F" . SPARSER::PROTEIN)
    ("eIF4E-binding protein 1" . SPARSER::PROTEIN)
    ("eIF-4E" . SPARSER::PROTEIN)
    ("almost all eukaryotic mRNAs" . SPARSER::PROTEIN)
    ("IR or etoposide" . SPARSER::COLLECTION)
    ("polysomes" . SPARSER::BIO-COMPLEX)
    ("TCP80 and RHA" . SPARSER::COLLECTION) ("RHA" . SPARSER::PROTEIN)
    ("beta-glucosidase" . SPARSER::PROTEIN) ("NDH II" . SPARSER::PROTEIN)
    ("nuclear DNA helicase II" . SPARSER::PROTEIN)
    ("three domains" . SPARSER::PROTEIN) ("glycine)" . SPARSER::PROTEIN)
    ("RNA binding protein" . SPARSER::PROTEIN)
    ("double-stranded RNA binding protein 76" . SPARSER::PROTEIN)
    ("NF90" . SPARSER::PROTEIN)
    ("Translational control protein 80" . SPARSER::PROTEIN)
    ("DHX9" . SPARSER::PROTEIN) ("DRBP76" . SPARSER::PROTEIN)
    ("IGF-I" . SPARSER::PROTEIN) ("PHAS-I" . SPARSER::PROTEIN)
    ("4E-binding protein 1" . SPARSER::PROTEIN)
    ("7 -methylguanosine" . SPARSER::MOLECULE)
    ("actinomycin D" . SPARSER::MOLECULE) ("RNA helicase A" . SPARSER::PROTEIN)
    ("TCP80" . SPARSER::PROTEIN)
    ("translational control protein 80" . SPARSER::PROTEIN)
    ("yrs" . SPARSER::PROTEIN) ("an acute phase enzyme" . SPARSER::ENZYME)
    ("serpin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-8 and leukotriene" . SPARSER::COLLECTION)
    ("leukotriene" . SPARSER::MOLECULE) ("plasmin" . SPARSER::PROTEIN)
    ("plasminogen" . SPARSER::PROTEIN) ("platelets" . SPARSER::PROTEIN)
    ("A15" . SPARSER::PROTEIN) ("G-A" . SPARSER::PROTEIN)
    ("CD 34" . SPARSER::PROTEIN) ("plasminogen activator" . SPARSER::PROTEIN)
    ("Receptor" . SPARSER::RECEPTOR)
    ("TLR4, MD-2, HMGB1 and LPS" . SPARSER::COLLECTION)
    ("LPS and HMGB1" . SPARSER::COLLECTION) ("MD-2/TLR4" . SPARSER::COLLECTION)
    ("HMGB1-TLR4" . SPARSER::COLLECTION) ("sterile" . SPARSER::PROTEIN-FAMILY)
    ("at least eight distinct receptors" . SPARSER::RECEPTOR)
    ("a ubiquitous dually functioning protein" . SPARSER::PROTEIN)
    ("LPS/MD-2" . SPARSER::COLLECTION) ("MD-2 or LPS" . SPARSER::COLLECTION)
    ("NAMPT/PBEF and MD-2" . SPARSER::COLLECTION) ("Multi" . SPARSER::PROTEIN)
    ("chaperones or cofactors" . SPARSER::COLLECTION)
    ("chaperones" . SPARSER::PROTEIN) ("LBP" . SPARSER::PROTEIN)
    ("glycolipid" . SPARSER::MOLECULE)
    ("effector and transcription factor" . SPARSER::COLLECTION)
    ("TLR4 pharmacologic inhibitors" . SPARSER::INHIBITOR)
    ("NAMPT/PBEF–TLR4" . SPARSER::PROTEIN-PAIR)
    ("antibodies or siRNAs" . SPARSER::COLLECTION)
    ("neutrophil" . SPARSER::PROTEIN) ("visceral fat" . SPARSER::PROTEIN)
    ("fat" . SPARSER::PROTEIN)
    ("an intracellular dimeric type II nicotinamide phosphoribosyltransferase enzyme (NAMPT)"
     . SPARSER::ENZYME)
    ("enzyme (NAMPT)" . SPARSER::ENZYME) ("MD-2-LPS" . SPARSER::COLLECTION)
    ("LPS or MD-2" . SPARSER::COLLECTION)
    ("species-diverse LPS-binding proteins" . SPARSER::PROTEIN)
    ("TLR4-MD-2" . SPARSER::COLLECTION) ("Der" . SPARSER::PROTEIN)
    ("Der-p2" . SPARSER::PROTEIN-PAIR) ("allergen" . SPARSER::MOLECULE)
    ("the LPS- and TLR4-binding protein" . SPARSER::COLLECTION)
    ("an essential LPS cofactor" . SPARSER::MOLECULE)
    ("rPBEF and LPS" . SPARSER::COLLECTION)
    ("murine pulmonary EC" . SPARSER::PROTEIN) ("BAL" . SPARSER::PROTEIN)
    ("rPBEF and rTLR4" . SPARSER::COLLECTION) ("solution" . SPARSER::MOLECULE)
    ("SPR" . SPARSER::PROTEIN)
    ("either TLR4 antibodies (10–20 μg/ml, 1 hr) or TLR4 inhibitors (RS-LPS 10 μg/ml, CLI-095 5 μM, OxPAPC 30 μg/ml; 1 hr)"
     . SPARSER::COLLECTION)
    ("rPBEF or LPS" . SPARSER::COLLECTION)
    ("NFκB and TLR" . SPARSER::COLLECTION)
    ("rPBEF, LPS, and VILI" . SPARSER::COLLECTION) ("rPBEF" . SPARSER::PROTEIN)
    ("HD-rPBEF" . SPARSER::PROTEIN-PAIR) ("endotoxin" . SPARSER::MOLECULE)
    ("LPS and TNF-α" . SPARSER::COLLECTION) ("p-NFκB" . SPARSER::COLLECTION)
    ("Exogenous NAMPT/PBEF" . SPARSER::COLLECTION)
    ("receptors (TLR)" . SPARSER::RECEPTOR)
    ("exogenous NAMPT/PBEF" . SPARSER::COLLECTION) ("NAD" . SPARSER::MOLECULE)
    ("an attractive therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("liposomes" . SPARSER::PROTEIN)
    ("intra-tracheally-instilled NAMPT/PBEF" . SPARSER::COLLECTION)
    ("leukocytes" . SPARSER::PROTEIN) ("visfatin" . SPARSER::PROTEIN)
    ("MD-2-TLR4" . SPARSER::COLLECTION) ("NAMPT/PBEF" . SPARSER::PROTEIN)
    ("PBEF" . SPARSER::PROTEIN) ("nicotinamide" . SPARSER::PROTEIN)
    ("NAMPT" . SPARSER::PROTEIN) ("E. coli)" . SPARSER::PROTEIN)
    ("Gene 2" . SPARSER::PROTEIN) ("-3 " . SPARSER::PROTEIN)
    ("NH 4 Cl" . SPARSER::MOLECULE) ("trypsin inhibitor" . SPARSER::PROTEIN)
    ("CD14" . SPARSER::PROTEIN)
    ("nicotinamide phosphoribosyltransferase" . SPARSER::PROTEIN)
    ("FK-866" . SPARSER::DRUG)
    ("nicotinamide adenine dinucleotide" . SPARSER::MOLECULE)
    ("MD-2" . SPARSER::PROTEIN) ("verteporfin" . SPARSER::DRUG)
    ("β-catenin and Kras" . SPARSER::COLLECTION) ("Kras" . SPARSER::PROTEIN)
    ("NF2 or GNAQ" . SPARSER::COLLECTION) ("GNAQ" . SPARSER::PROTEIN)
    ("Gal" . SPARSER::PROTEIN) ("discs" . SPARSER::BIO-COMPLEX)
    ("VGLL4 and miR-130a" . SPARSER::COLLECTION)
    ("VGLL4 or miR-130a" . SPARSER::COLLECTION)
    ("transposase" . SPARSER::PROTEIN) ("TAZ or TEADs" . SPARSER::COLLECTION)
    ("VGLL4" . SPARSER::PROTEIN) ("VGLL4-TEAD1" . SPARSER::PROTEIN-PAIR)
    ("pre" . SPARSER::PROTEIN) ("CTGF and Cyr61" . SPARSER::COLLECTION)
    ("oligomer" . SPARSER::MOLECULE) ("pre-miR-130a" . SPARSER::COLLECTION)
    ("0 bp proximal promoter" . SPARSER::PROMOTER)
    ("Flag-YAP-5SA" . SPARSER::COLLECTION) ("miR-130a" . SPARSER::PROTEIN)
    ("pri-miR-130a" . SPARSER::PROTEIN-PAIR) ("Yki" . SPARSER::PROTEIN)
    ("a scaffold protein Sav1" . SPARSER::PROTEIN) ("Sav" . SPARSER::PROTEIN)
    ("Yes-associated protein ( YAP ) transgene" . SPARSER::PROTEIN)
    ("transgene" . SPARSER::PROTEIN) ("6B" . SPARSER::PROTEIN)
    ("hypoxanthine phosphoribosyltransferase 1" . SPARSER::PROTEIN)
    ("Cyr61" . SPARSER::PROTEIN) ("TB1" . SPARSER::PROTEIN)
    ("TEAD2" . SPARSER::PROTEIN) ("TEAD1" . SPARSER::PROTEIN)
    ("−2" . SPARSER::PROTEIN) ("NF2" . SPARSER::PROTEIN)
    ("lysophosphatidic acid" . SPARSER::LPA) ("Mob1" . SPARSER::PROTEIN)
    ("Lats1" . SPARSER::PROTEIN) ("relevant genotoxins" . SPARSER::MOLECULE)
    ("genotoxins" . SPARSER::MOLECULE) ("-Arg" . SPARSER::COLLECTION)
    ("-Gln" . SPARSER::COLLECTION)
    ("XRCC1 gene and unhealthy life habits" . SPARSER::COLLECTION)
    ("polymerase, APE1, and OGG1" . SPARSER::COLLECTION)
    ("-phosphatase" . SPARSER::PHOSPHATASE)
    ("the XRCC1 280His allele and colorectal carcinoma risk"
     . SPARSER::COLLECTION)
    ("the XRCC1 280His allele and risk" . SPARSER::COLLECTION)
    ("SSBs" . SPARSER::PROTEIN)
    ("Both the XRCC1 Arg194Trp and Arg280His variants" . SPARSER::COLLECTION)
    ("glycophorin" . SPARSER::PROTEIN-FAMILY) ("Arg/His" . SPARSER::COLLECTION)
    ("oxidative DNA and single-strand" . SPARSER::COLLECTION)
    ("DNA and single-strand" . SPARSER::COLLECTION) ("SSB" . SPARSER::PROTEIN)
    ("polynucleotide kinase (PNK)" . SPARSER::PROTEIN)
    ("PNK" . SPARSER::PROTEIN) ("endonuclease" . SPARSER::PROTEIN)
    ("acetaldehyde" . SPARSER::MOLECULE)
    ("nitrosamines, and arylamines" . SPARSER::COLLECTION)
    ("arylamines" . SPARSER::MOLECULE) ("nitrosamines" . SPARSER::MOLECULE)
    ("alcohol" . SPARSER::DRUG) ("allele or 194Arg" . SPARSER::COLLECTION)
    ("tobacco" . SPARSER::DRUG) ("Gln" . SPARSER::AMINO-ACID)
    ("cigarettes" . SPARSER::DRUG) ("4–1" . SPARSER::PROTEIN)
    ("APE1" . SPARSER::PROTEIN) ("DNA repair enzyme" . SPARSER::PROTEIN)
    ("OGG1" . SPARSER::PROTEIN)
    ("8-oxoguanine DNA glycosylase" . SPARSER::PROTEIN)
    ("XRCC1" . SPARSER::PROTEIN) ("p53 and BAG2" . SPARSER::COLLECTION)
    ("BAG2 and mutant" . SPARSER::COLLECTION) ("letter" . SPARSER::MOLECULE)
    ("the most frequently-mutated gene" . SPARSER::GENE)
    ("interacted BAG2-mutp53 protein complex and no clear accumulation of mutp53 proteins in the normal tissues ( xref and xref )"
     . SPARSER::COLLECTION)
    ("interacted BAG2-mutp53 protein complex" . SPARSER::BIO-COMPLEX)
    ("chaperone and co-chaperone" . SPARSER::COLLECTION)
    ("proteins and wtp53" . SPARSER::COLLECTION) ("Tau" . SPARSER::PROTEIN)
    ("BAG-Hsc70" . SPARSER::COLLECTION) ("HDAC6-HSP90" . SPARSER::COLLECTION)
    ("mutp53 and MDM2" . SPARSER::COLLECTION) ("IF" . SPARSER::PROTEIN)
    ("mutp53 R175H and MDM2 ( xref )" . SPARSER::COLLECTION)
    ("chaperone" . SPARSER::PROTEIN) ("BAG2-Flag" . SPARSER::COLLECTION)
    ("AD1 and AD2" . SPARSER::COLLECTION)
    ("mutp53 and BAG" . SPARSER::COLLECTION)
    ("anti-p53 or anti-HA" . SPARSER::COLLECTION)
    ("BAG2-HA" . SPARSER::COLLECTION) ("BAG2 and mutp53" . SPARSER::COLLECTION)
    ("HSP90, Myosin, Cct8 and Pontin" . SPARSER::COLLECTION)
    ("Pontin" . SPARSER::PROTEIN) ("Myosin" . SPARSER::PROTEIN-FAMILY)
    ("BAG2-mutp53" . SPARSER::COLLECTION)
    ("multifunctional proteins" . SPARSER::PROTEIN)
    ("Mutp53" . SPARSER::PROTEIN) ("p53 and MDM2" . SPARSER::COLLECTION)
    ("Many tumor-associated mutant p53 (mutp53) proteins" . SPARSER::PROTEIN)
    ("mutp53" . SPARSER::PROTEIN) ("MDM2-mutp53" . SPARSER::COLLECTION)
    ("BAG" . SPARSER::PROTEIN-FAMILY) ("GOF" . SPARSER::PROTEIN)
    ("p53 s" . SPARSER::HUMAN-PROTEIN-FAMILY) ("5FU" . SPARSER::DRUG)
    ("caspase 3" . SPARSER::PROTEIN) ("Lamin A/C" . SPARSER::PROTEIN)
    ("α-Tubulin" . SPARSER::PROTEIN) ("Hsc70" . SPARSER::PROTEIN)
    ("Caspase 3" . SPARSER::PROTEIN) ("ataxin3" . SPARSER::PROTEIN)
    ("PINK1" . SPARSER::PROTEIN) ("P5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AD2" . SPARSER::PROTEIN) ("AD1" . SPARSER::PROTEIN)
    ("Cct8" . SPARSER::PROTEIN) ("HSP90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("H/R" . SPARSER::PROTEIN) ("BAG2" . SPARSER::PROTEIN)
    ("Tumor suppressor p53" . SPARSER::PROTEIN)
    ("NF-κB, AP-1 and C/EBP" . SPARSER::COLLECTION)
    ("NF-κB and C/EBP" . SPARSER::COLLECTION)
    ("NF-κB, AP-1 and C/EBP-δ" . SPARSER::COLLECTION)
    ("ceramide" . SPARSER::MOLECULE) ("only β isoform" . SPARSER::ISOFORM)
    ("p38-MAPK isoforms and look" . SPARSER::COLLECTION)
    ("Erk-MAPK" . SPARSER::COLLECTION)
    ("IL-6 and SP600125" . SPARSER::COLLECTION)
    ("PI3K/Akt/NF-κB" . SPARSER::COLLECTION)
    ("Akt-1, Akt-2 and Akt-3" . SPARSER::COLLECTION)
    ("phosphorylated form of Akt and nuclear translocation of p65 subunit of NF-κB"
     . SPARSER::COLLECTION)
    ("only p65 subunit" . SPARSER::FRAGMENT)
    ("the major cytokine" . SPARSER::PROTEIN)
    ("immunoregulatory cytokines IL-6 and IL-8" . SPARSER::COLLECTION)
    ("extracellular Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BBB" . SPARSER::PROTEIN) ("MDM" . SPARSER::PROTEIN)
    ("p-c-jun" . SPARSER::COLLECTION) ("AP-1 and C/EBP" . SPARSER::COLLECTION)
    ("p38α and p38β" . SPARSER::COLLECTION)
    ("p38γ and p38δ" . SPARSER::COLLECTION)
    ("SB203580 and SP600125" . SPARSER::COLLECTION)
    ("IL-6 (71.6 ± 3.3%) and IL-8 (64.4 ± 4.2%)" . SPARSER::COLLECTION)
    ("p38 and Jnk" . SPARSER::COLLECTION)
    ("specific siRNA’s" . SPARSER::PROTEIN)
    ("Akt and p65" . SPARSER::COLLECTION)
    ("IL-6 (42.7 ± 5.3%; 42.5 ± 10.2%) and IL-8 (62.6 ± 4.4%; 52.1 ± 10.8%)"
     . SPARSER::COLLECTION)
    ("p50 and p65" . SPARSER::COLLECTION)
    ("secreted IL-6 (43.3 ± 4.8%; 50.5 ± 8.2%) and IL-8 (50.8 ± 3.6%; 23.7 ± 7.6%) proteins"
     . SPARSER::COLLECTION)
    ("IL-6 (32.4 ± 7.2%; 45.7 ± 6.9%) and IL-8 (43.9 ± 5.2%; 29.8 ± 11.8%)"
     . SPARSER::COLLECTION)
    ("DAPI" . SPARSER::DRUG) ("secondary antibodies" . SPARSER::ANTIBODY)
    ("IL-6, IL-8 and GFAP" . SPARSER::COLLECTION) ("GFAP" . SPARSER::PROTEIN)
    ("IL-6 or IL-8" . SPARSER::COLLECTION) ("pg" . SPARSER::MOLECULE)
    ("IL-6 ( xref ) and IL-8 ( xref )" . SPARSER::COLLECTION)
    ("GFP-Vpr" . SPARSER::COLLECTION)
    ("macrophages and IL-8" . SPARSER::COLLECTION)
    ("exogenous HIV-1 Vpr protein" . SPARSER::PROTEIN)
    ("primary human fetal astrocytes" . SPARSER::PROTEIN)
    ("neuroinflammatory molecules" . SPARSER::MOLECULE)
    ("cytokines and chemokines" . SPARSER::COLLECTION)
    ("Perivascular astrocytes" . SPARSER::PROTEIN)
    ("IL-8 and IL-6" . SPARSER::COLLECTION)
    ("IL-1β and IL-8" . SPARSER::COLLECTION)
    ("accessory gene product Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("viral mediators" . SPARSER::PROTEIN)
    ("the associated viral proteins" . SPARSER::PROTEIN)
    ("viral proteins or pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("proteins or pro-inflammatory" . SPARSER::COLLECTION)
    ("Neurotoxins" . SPARSER::PROTEIN) ("neurotoxins" . SPARSER::PROTEIN)
    ("microglia" . SPARSER::PROTEIN) ("severe forms" . SPARSER::FORM)
    ("Jnk-MAPK" . SPARSER::COLLECTION) ("p38-MAPK" . SPARSER::COLLECTION)
    ("Jnk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("EBP" . SPARSER::PROTEIN)
    ("AP-1" . SPARSER::PROTEIN) ("IL-6 and IL-8" . SPARSER::COLLECTION)
    ("HIV-1 viral proteins" . SPARSER::PROTEIN)
    ("Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Astrocytes" . SPARSER::PROTEIN)
    ("c-jun" . SPARSER::PROTEIN)
    ("AP-1 transcription factor" . SPARSER::PROTEIN)
    ("Mitogen activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CCL5" . SPARSER::PROTEIN) ("BAY 11–7082" . SPARSER::DRUG)
    ("Serum Albumin" . SPARSER::PROTEIN) ("min– 2" . SPARSER::PROTEIN)
    ("glial fibrillary acidic protein" . SPARSER::PROTEIN)
    ("EBP-β" . SPARSER::PROTEIN) ("Akt-3" . SPARSER::PROTEIN)
    ("Akt-2" . SPARSER::PROTEIN) ("p38δ" . SPARSER::PROTEIN)
    ("p38γ" . SPARSER::PROTEIN) ("p38α" . SPARSER::PROTEIN)
    ("UO126" . SPARSER::DRUG) ("Bay 11–7082" . SPARSER::DRUG)
    ("sodium bicarbonate" . SPARSER::DRUG) ("IFN-γ" . SPARSER::PROTEIN)
    ("a cyclin-associated form" . SPARSER::FORM)
    ("The biochemical state" . SPARSER::BIO-STATE)
    ("a binding-incompetent conformation" . SPARSER::BIO-CONFORMATION)
    ("an essential lysine" . SPARSER::AMINO-ACID)
    ("pUL97 and cyclin T1" . SPARSER::COLLECTION)
    ("herpesviral protein kinases and host cell-derived cyclins"
     . SPARSER::COLLECTION)
    ("herpesviral protein kinases" . SPARSER::PROTEIN)
    ("at least one viral substrate protein" . SPARSER::PROTEIN)
    ("cyclin-associated higher order protein" . SPARSER::PROTEIN)
    ("CDKs or other possibly associated protein kinases" . SPARSER::COLLECTION)
    ("other possibly associated protein kinases" . SPARSER::PROTEIN)
    ("CDKs/cyclins" . SPARSER::COLLECTION)
    ("the most abundant viral substrate proteins" . SPARSER::PROTEIN)
    ("pUL97-pUL97" . SPARSER::COLLECTION) ("pUL97-HA" . SPARSER::COLLECTION)
    ("pAb-HA" . SPARSER::COLLECTION)
    ("full-length pUL97(1-707) and pUL97(1-706)" . SPARSER::COLLECTION)
    ("histones" . SPARSER::PROTEIN)
    ("only one amino acid" . SPARSER::AMINO-ACID)
    ("CDK1 or CDK2" . SPARSER::COLLECTION)
    ("CDK1 and CDK2" . SPARSER::COLLECTION)
    ("Both MBV and Ax7396 ( xref A) fit well" . SPARSER::COLLECTION)
    ("fit" . SPARSER::PROTEIN-FAMILY)
    ("active and inactive" . SPARSER::COLLECTION)
    ("quinazolines" . SPARSER::MOLECULE) ("poor inducers" . SPARSER::MOLECULE)
    ("the clinical drug candidate MBV and the experimental compound Ax7396 belonging"
     . SPARSER::COLLECTION)
    ("quinazoline" . SPARSER::MOLECULE)
    ("pUL97 mutation K355M and two chemically distinct pUL97-inhibitory small molecules"
     . SPARSER::COLLECTION)
    ("analog" . SPARSER::ANALOG) ("nucleoside" . SPARSER::MOLECULE)
    ("-Flag" . SPARSER::COLLECTION) ("pUL97-cyclin T1" . SPARSER::COLLECTION)
    ("other viral proteins" . SPARSER::PROTEIN)
    ("pUL97 and cyclin B1" . SPARSER::COLLECTION)
    ("fragment, and pre-immune" . SPARSER::COLLECTION)
    ("pUL97-Flag" . SPARSER::COLLECTION)
    ("pAb-cyclin B1" . SPARSER::COLLECTION) ("pAb" . SPARSER::PROTEIN)
    ("Graf" . SPARSER::PROTEIN) ("kinase-cyclin" . SPARSER::COLLECTION)
    ("pUL97-cyclin" . SPARSER::COLLECTION)
    ("NLS1 and NLS2" . SPARSER::COLLECTION)
    ("importin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("bipartite" . SPARSER::PROTEIN)
    ("herpesviral and cellular protein kinases" . SPARSER::PROTEIN)
    ("maribavir (MBV)" . SPARSER::DRUG) ("MBV" . SPARSER::DRUG)
    ("maribavir" . SPARSER::DRUG) ("CDKs and pUL97" . SPARSER::COLLECTION)
    ("lamins" . SPARSER::PROTEIN) ("Saccharomyces" . SPARSER::PROTEIN)
    ("the viral kinase" . SPARSER::KINASE)
    ("phosphorylating partly-identical substrates" . SPARSER::SUBSTRATE)
    ("the viral protein kinase pUL97" . SPARSER::PROTEIN)
    ("pUL97" . SPARSER::PROTEIN) ("CDK2-cyclin E" . SPARSER::COLLECTION)
    ("CDK1-cyclin" . SPARSER::COLLECTION) ("CDK2-cyclin" . SPARSER::COLLECTION)
    ("CDK6-cyclin D" . SPARSER::COLLECTION)
    ("CDK4-cyclin D" . SPARSER::COLLECTION)
    ("CDK-cyclin" . SPARSER::COLLECTION)
    ("CDKs and cyclins" . SPARSER::COLLECTION)
    ("serine-" . SPARSER::AMINO-ACID) ("CDK9 and CDK7" . SPARSER::COLLECTION)
    ("roscovitine" . SPARSER::DRUG) ("new herpesviral drugs" . SPARSER::DRUG)
    ("drug-resistant viral mutants" . SPARSER::MUTANT)
    ("all currently approved antiviral drugs" . SPARSER::DRUG)
    ("ganciclovir" . SPARSER::DRUG) ("pUL97-cyclin B1" . SPARSER::COLLECTION)
    ("Cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("1-4" . SPARSER::PROTEIN)
    ("mL −1" . SPARSER::PROTEIN) ("pp65" . SPARSER::PROTEIN)
    ("UL44" . SPARSER::PROTEIN) ("NLS1" . SPARSER::PROTEIN)
    ("UL97" . SPARSER::PROTEIN-FAMILY)
    ("retinoblastoma protein" . SPARSER::PROTEIN) ("EF-1" . SPARSER::PROTEIN)
    ("a 3D" . SPARSER::PROTEIN) ("cyclin D" . SPARSER::PROTEIN)
    ("LDC4297" . SPARSER::DRUG) ("CDK7" . SPARSER::PROTEIN)
    ("CDK9" . SPARSER::PROTEIN) ("cyclin B1" . SPARSER::PROTEIN)
    ("cyclin T1" . SPARSER::PROTEIN) ("an extensive MRI" . SPARSER::PROTEIN)
    ("the temporal lobes" . SPARSER::PROTEIN)
    ("only minimal MRI" . SPARSER::PROTEIN) ("disulfide" . SPARSER::MOLECULE)
    ("I-1, II-2, II-5, II-7, II-8, and II-11" . SPARSER::COLLECTION)
    ("MR" . SPARSER::PROTEIN)
    ("the frontal and parietal lobes" . SPARSER::PROTEIN)
    ("lobes" . SPARSER::PROTEIN) ("MOCA" . SPARSER::PROTEIN)
    ("visual aura" . SPARSER::PROTEIN) ("amitriptyline" . SPARSER::DRUG)
    ("aura" . SPARSER::PROTEIN) ("his" . SPARSER::AMINO-ACID)
    ("I-2 and II-3" . SPARSER::COLLECTION) ("Family" . SPARSER::PROTEIN-FAMILY)
    ("families" . SPARSER::PROTEIN-FAMILY) ("ECD" . SPARSER::PROTEIN)
    ("ankyrin" . SPARSER::PROTEIN) ("migraine" . SPARSER::PROTEIN)
    ("MRI" . SPARSER::PROTEIN)
    ("an indigenous Rungus (Kadazan-Dusun) family" . SPARSER::PROTEIN-FAMILY)
    ("I-1" . SPARSER::PROTEIN) ("I-2" . SPARSER::PROTEIN)
    ("Notch3" . SPARSER::PROTEIN) ("Lin12" . SPARSER::PROTEIN)
    ("protein 3" . SPARSER::PROTEIN) ("NOTCH3" . SPARSER::PROTEIN)
    ("autosomal dominant" . SPARSER::PROTEIN)
    ("Ref" . SPARSER::HUMAN-PROTEIN-FAMILY) ("XPA" . SPARSER::PROTEIN)
    ("PARP1 and PARP3" . SPARSER::COLLECTION)
    ("PKM2 and AMPK" . SPARSER::COLLECTION)
    ("Fas and MAP1S" . SPARSER::COLLECTION) ("Kinases" . SPARSER::KINASE)
    ("Moap-1" . SPARSER::PROTEIN)
    ("a pro-apoptotic molecule" . SPARSER::MOLECULE)
    ("cdh1" . SPARSER::PROTEIN) ("cdh" . SPARSER::PROTEIN)
    ("STAT3 and STAT5a" . SPARSER::COLLECTION)
    ("PTEN, and PARP" . SPARSER::COLLECTION)
    ("GNB2L1/RACK1" . SPARSER::COLLECTION) ("STAT5a" . SPARSER::PROTEIN)
    ("transcription factor, and signal transducer and activator of transcription 3"
     . SPARSER::COLLECTION)
    ("anaphase-promoting complex/cyclosome" . SPARSER::COLLECTION)
    ("cyclosome" . SPARSER::PROTEIN)
    ("several pro-apoptotic kinases" . SPARSER::KINASE)
    ("hypoxia or DNA" . SPARSER::COLLECTION)
    ("hypoxia-inducible factor 1α subunit (HIF1α) and the G 2 /M DNA damage checkpoint kinase ataxia telangiectasia mutated (ATM, see xref )"
     . SPARSER::COLLECTION)
    ("TBRG1/NIAM" . SPARSER::COLLECTION) ("NIAM" . SPARSER::PROTEIN)
    ("TNF-R1, RASSF1A, and Bax" . SPARSER::COLLECTION)
    ("nocodazole, or colchicine" . SPARSER::COLLECTION)
    ("colchicine" . SPARSER::DRUG)
    ("α-tubulin or γ-tubulin" . SPARSER::COLLECTION)
    ("nocodazole- and taxol-treated cells (albeit at a much lower stoichiometry, xref  A )"
     . SPARSER::COLLECTION)
    ("nocodazole-" . SPARSER::DRUG)
    ("these two pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("Tubulin" . SPARSER::PROTEIN) ("HA-RASSF1A" . SPARSER::COLLECTION)
    ("RASSF1A and MOAP-1" . SPARSER::COLLECTION)
    ("polymerase (PARP)" . SPARSER::PROTEIN) ("CHX" . SPARSER::PROTEIN)
    ("Myc-MOAP-1" . SPARSER::COLLECTION) ("HEMA" . SPARSER::PROTEIN)
    ("the pro-apoptotic MOAP-1 protein" . SPARSER::PROTEIN)
    ("triple-negative subtypes" . SPARSER::PROTEIN)
    ("ER−, PR−, and Her2−" . SPARSER::COLLECTION)
    ("PR−" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ER−" . SPARSER::PROTEIN)
    ("Neu" . SPARSER::PROTEIN) ("Refs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SK-NAS" . SPARSER::COLLECTION) ("NAS" . SPARSER::PROTEIN)
    ("SK" . SPARSER::PROTEIN) ("MycN" . SPARSER::PROTEIN)
    ("SMS" . SPARSER::PROTEIN) ("MOAP-1 or RASSF1A" . SPARSER::COLLECTION)
    ("MOAP-1 and RASSF1A" . SPARSER::COLLECTION)
    ("a pediatric form" . SPARSER::FORM)
    ("B-cell childhood acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("parathyroid" . SPARSER::PROTEIN-FAMILY) ("synergizes" . SPARSER::PROTEIN)
    ("RASSF6 and MOAP-1" . SPARSER::COLLECTION) ("Cdh1" . SPARSER::PROTEIN)
    ("Cdh" . SPARSER::PROTEIN) ("thapsigargin" . SPARSER::MOLECULE)
    ("inducer" . SPARSER::MOLECULE) ("etoposide" . SPARSER::PROTEIN)
    ("staurosporine" . SPARSER::DRUG) ("Bcl-2 and Bcl-X" . SPARSER::COLLECTION)
    ("RASSF1A/MOAP-1" . SPARSER::COLLECTION)
    ("p53, Fas, and MST1" . SPARSER::COLLECTION)
    ("polymerase and ataxia telangiectasia mutated" . SPARSER::COLLECTION)
    ("ADP" . SPARSER::ADP) ("Fas" . SPARSER::PROTEIN)
    ("a bona fide tumor suppressor protein" . SPARSER::PROTEIN)
    ("the Bcl-2 family pro-apoptotic protein Bax" . SPARSER::PROTEIN)
    ("a pro-apoptotic protein" . SPARSER::PROTEIN)
    ("hypoxia inducible factor 1" . SPARSER::PROTEIN)
    ("activated protein kinase" . SPARSER::PROTEIN)
    ("ATR-interacting protein" . SPARSER::PROTEIN) ("PARP3" . SPARSER::PROTEIN)
    ("Rap1" . SPARSER::PROTEIN) ("cdc20" . SPARSER::PROTEIN)
    ("polo-like kinase" . SPARSER::PROTEIN)
    ("aurora kinase A" . SPARSER::PROTEIN)
    ("insulin receptor" . SPARSER::PROTEIN)
    ("Janus kinase 1" . SPARSER::PROTEIN) ("ELK1" . SPARSER::PROTEIN)
    ("aurora kinase B" . SPARSER::PROTEIN)
    ("ste20-like kinase" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor" . SPARSER::PROTEIN)
    ("proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("TBRG1" . SPARSER::PROTEIN) ("CDC14B" . SPARSER::PROTEIN)
    ("CDK8" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rassf1a" . SPARSER::PROTEIN) ("A–C" . SPARSER::PROTEIN)
    ("MOAP1" . SPARSER::PROTEIN) ("DNase I" . SPARSER::PROTEIN)
    ("MAP1S" . SPARSER::PROTEIN) ("K-3" . SPARSER::PROTEIN)
    ("PKM2" . SPARSER::PROTEIN) ("RACK1" . SPARSER::PROTEIN)
    ("GNB2L1" . SPARSER::PROTEIN) ("RASSF6" . SPARSER::PROTEIN)
    ("RASSF1" . SPARSER::PROTEIN) ("TNF-R1" . SPARSER::PROTEIN)
    ("anaphase-promoting complex" . SPARSER::PROTEIN)
    ("TRIM39" . SPARSER::PROTEIN)
    ("tripartite motif containing 39" . SPARSER::PROTEIN)
    ("TNF-related apoptosis-inducing ligand" . SPARSER::PROTEIN)
    ("Bcl-X" . SPARSER::PROTEIN)
    ("ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("RASSF1A" . SPARSER::PROTEIN) ("family 1" . SPARSER::PROTEIN)
    ("Modulator of apoptosis 1" . SPARSER::PROTEIN)
    ("MOAP-1" . SPARSER::PROTEIN)
    ("cyclin E, cJUN, Notch xref  xref , and the p160 coactivator AIB1/ACTR/SRC3 xref"
     . SPARSER::COLLECTION)
    ("AIB1/ACTR/SRC3" . SPARSER::COLLECTION) ("ACTR" . SPARSER::PROTEIN)
    ("cJUN" . SPARSER::PROTEIN) ("-p65" . SPARSER::COLLECTION)
    ("VDR-FBW7-p105" . SPARSER::COLLECTION)
    ("mTOR, PGC1α and TP63" . SPARSER::COLLECTION)
    ("p50 heterodimeric partner p65" . SPARSER::PROTEIN)
    ("p50 and p105" . SPARSER::COLLECTION)
    ("p105, p65 and p100" . SPARSER::COLLECTION)
    ("NF-κB2/p100" . SPARSER::COLLECTION)
    ("RELA and NF-κB1" . SPARSER::COLLECTION)
    ("NF-κB2/P100" . SPARSER::COLLECTION)
    ("p105, p100 and p65" . SPARSER::COLLECTION)
    ("cycloheximide (CHX)" . SPARSER::PROTEIN)
    ("SIRT1 and protein phosphatase 1" . SPARSER::COLLECTION)
    ("cofactors" . SPARSER::PROTEIN) ("p100/p52" . SPARSER::COLLECTION)
    ("p105/p50" . SPARSER::COLLECTION)
    ("p100, p105 and p65" . SPARSER::COLLECTION)
    ("VDR and FBW7" . SPARSER::COLLECTION) ("SCF" . SPARSER::PROTEIN)
    ("MAD1/MXD1" . SPARSER::COLLECTION) ("Pro" . SPARSER::AMINO-ACID)
    ("p52/p100" . SPARSER::COLLECTION) ("p50:p65" . SPARSER::BIO-COMPLEX)
    ("RELB and REL" . SPARSER::COLLECTION) ("REL" . SPARSER::PROTEIN)
    ("RELB" . SPARSER::PROTEIN) ("calcium and phosphate" . SPARSER::COLLECTION)
    ("p105 and p65" . SPARSER::COLLECTION)
    ("p105 (NF-κB1) and p65 (RELA)" . SPARSER::COLLECTION)
    ("NF-κB subunits p100, p105 (NF-κB1) and p65 (RELA)" . SPARSER::COLLECTION)
    ("RELA" . SPARSER::PROTEIN)
    ("the E3 ligase and tumor suppressor FBW7" . SPARSER::COLLECTION)
    ("cMYC" . SPARSER::PROTEIN) ("receptor (VDR)" . SPARSER::RECEPTOR)
    ("VDR" . SPARSER::PROTEIN) ("hormonal vitamin D" . SPARSER::MOLECULE)
    ("Protein A" . SPARSER::PROTEIN) ("D-6" . SPARSER::PROTEIN)
    ("NF-kB" . SPARSER::PROTEIN) ("SRC3" . SPARSER::PROTEIN)
    ("AIB1" . SPARSER::PROTEIN) ("p160" . SPARSER::PROTEIN)
    ("cyclin E" . SPARSER::PROTEIN) ("GCNT1" . SPARSER::PROTEIN)
    ("TP63" . SPARSER::PROTEIN) ("PGC1α" . SPARSER::PROTEIN)
    ("MCL1" . SPARSER::PROTEIN) ("P100" . SPARSER::PROTEIN)
    ("protein phosphatase 1" . SPARSER::PROTEIN) ("SEL10" . SPARSER::PROTEIN)
    ("CDC4" . SPARSER::PROTEIN) ("FBXW7" . SPARSER::PROTEIN)
    ("MXD1" . SPARSER::PROTEIN) ("MAD1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Vitamin D" . SPARSER::MOLECULE) ("p105" . SPARSER::PROTEIN)
    ("NF-κB2" . SPARSER::PROTEIN) ("FBW7" . SPARSER::PROTEIN)
    ("1,25-dihydroxyvitamin D" . SPARSER::MOLECULE)
    ("vitamin D" . SPARSER::MOLECULE) ("hypoxic HIF1α" . SPARSER::PROTEIN)
    ("genotoxic p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTEN and NIK" . SPARSER::COLLECTION) ("PP2A-NDRG2" . SPARSER::COLLECTION)
    ("NIK-NIK" . SPARSER::COLLECTION)
    ("AKT, PTEN and IKK" . SPARSER::COLLECTION)
    ("IKK and NIK" . SPARSER::COLLECTION)
    ("the key associated molecules" . SPARSER::MOLECULE)
    ("NDRG2-PP2A" . SPARSER::COLLECTION) ("NIK-KK429" . SPARSER::PROTEIN-PAIR)
    ("KOB-NDRG2" . SPARSER::PROTEIN-PAIR)
    ("PP1c or PP5c" . SPARSER::COLLECTION)
    ("PP1c, PP2Ac and PP5c" . SPARSER::COLLECTION)
    ("PP2A, and NDRG2" . SPARSER::COLLECTION)
    ("NIK, PP2Ac and NDRG2" . SPARSER::COLLECTION)
    ("Myc-tagged PP2A and/or Flag-tagged NDRG2" . SPARSER::COLLECTION)
    ("NIK and NDRG2" . SPARSER::COLLECTION)
    ("co-transfecting FLAG-tagged NDRG2 and HA-tagged NIK"
     . SPARSER::COLLECTION)
    ("Flag-NDRG2" . SPARSER::COLLECTION) ("versa" . SPARSER::PROTEIN)
    ("NDRG2 and NIK" . SPARSER::COLLECTION) ("Jurkat" . SPARSER::PROTEIN)
    ("PTEN, AKT, IKKα/β and IκB" . SPARSER::COLLECTION)
    ("PTEN, AKT, IKKα/β and IκBα" . SPARSER::COLLECTION)
    ("IκBα and p52" . SPARSER::COLLECTION)
    ("PP1 and PP2A" . SPARSER::COLLECTION) ("NDRG2/PP2A" . SPARSER::COLLECTION)
    ("LY294002 and Wortmannin" . SPARSER::COLLECTION)
    ("Wortmannin" . SPARSER::PROTEIN) ("Ser32/36" . SPARSER::PROTEIN)
    ("IκBα-Ser32/36" . SPARSER::COLLECTION)
    ("LY294002 and LPS or TNFα" . SPARSER::COLLECTION)
    ("Ndrg2" . SPARSER::PROTEIN) ("Ndrg" . SPARSER::PROTEIN-FAMILY)
    ("LPS-" . SPARSER::PROTEIN)
    ("MCP-1, ICAM-1, iNOS, COX-2, MMP-2, MMP-9 and IL6" . SPARSER::COLLECTION)
    ("LPS or TNFα" . SPARSER::COLLECTION) ("Threonine" . SPARSER::AMINO-ACID)
    ("p52/RelB" . SPARSER::COLLECTION) ("TNF-α-" . SPARSER::PROTEIN)
    ("polyubiquitinated" . SPARSER::PROTEIN) ("kinase (IKK)" . SPARSER::KINASE)
    ("phosphoinositide 3-kinase (PI3K) and its downstream kinase AKT"
     . SPARSER::COLLECTION)
    ("an aggressive form" . SPARSER::FORM) ("kinase (NIK)" . SPARSER::KINASE)
    ("NIK" . SPARSER::PROTEIN) ("ATL" . SPARSER::PROTEIN)
    ("MnCl 2" . SPARSER::DRUG) ("IL2" . SPARSER::PROTEIN)
    ("16A" . SPARSER::PROTEIN) ("C-5" . SPARSER::PROTEIN)
    ("C-21" . SPARSER::PROTEIN) ("Tumor Necrosis Factor" . SPARSER::PROTEIN)
    ("HIF1α" . SPARSER::PROTEIN) ("PP5" . SPARSER::PROTEIN)
    ("PP1c" . SPARSER::PROTEIN) ("PP2Ac" . SPARSER::PROTEIN)
    ("MT2" . SPARSER::PROTEIN) ("KK1" . SPARSER::PROTEIN)
    ("MMP-9" . SPARSER::PROTEIN) ("MMP-2" . SPARSER::PROTEIN)
    ("ICAM-1" . SPARSER::PROTEIN) ("JAK-STAT" . SPARSER::PROTEIN)
    ("protein phosphatase 2" . SPARSER::PROTEIN) ("p100" . SPARSER::PROTEIN)
    ("IL-1" . SPARSER::PROTEIN) ("p47" . SPARSER::PROTEIN)
    ("I-κBs" . SPARSER::PROTEIN) ("I-κB" . SPARSER::PROTEIN)
    ("TNFα" . SPARSER::PROTEIN) ("type 1" . SPARSER::PROTEIN)
    ("N-myc downstream-regulated gene 2" . SPARSER::PROTEIN)
    ("siRNA or an inhibitor" . SPARSER::COLLECTION)
    ("Akt and GSK3α" . SPARSER::COLLECTION)
    ("β-catenin-TCF" . SPARSER::COLLECTION)
    ("β-catenin or control siRNA" . SPARSER::COLLECTION)
    ("Akt-GSK" . SPARSER::COLLECTION) ("a typical target gene" . SPARSER::GENE)
    ("anti-β-catenin" . SPARSER::COLLECTION) ("examples" . SPARSER::EXAMPLE)
    ("GO" . SPARSER::PROTEIN) ("gefitinib and EGF" . SPARSER::COLLECTION)
    ("that gefitinib or EGF-treatment" . SPARSER::COLLECTION)
    ("EGF-TKIs" . SPARSER::COLLECTION) ("ligand and Fzd" . SPARSER::COLLECTION)
    ("Fzd" . SPARSER::PROTEIN-FAMILY)
    ("ubiquitin-protease" . SPARSER::COLLECTION)
    ("α−catenin and E-cadherin" . SPARSER::COLLECTION)
    ("Axin, Adenomatous Polyposis Coli (APC) and β-catenin"
     . SPARSER::COLLECTION)
    ("synthetase" . SPARSER::PROTEIN) ("glycogen" . SPARSER::PROTEIN)
    ("Dsh" . SPARSER::PROTEIN) ("LRP" . SPARSER::PROTEIN)
    ("FZD" . SPARSER::PROTEIN-FAMILY) ("HGF-MET" . SPARSER::COLLECTION)
    ("HGF" . SPARSER::PROTEIN) ("EGFR and gefitinib" . SPARSER::COLLECTION)
    ("two histological subtypes" . SPARSER::PROTEIN)
    ("Akt and GSK3" . SPARSER::COLLECTION) ("Axin" . SPARSER::PROTEIN)
    ("Akt-β-catenin" . SPARSER::COLLECTION) ("EGFR-TKIs" . SPARSER::COLLECTION)
    ("Wnt receptor" . SPARSER::PROTEIN) ("M2  " . SPARSER::MOLECULE)
    ("EGFR-TKI" . SPARSER::PROTEIN) ("ICG-001" . SPARSER::DRUG)
    ("GSK3α" . SPARSER::PROTEIN) ("HER3" . SPARSER::PROTEIN)
    ("α−catenin" . SPARSER::PROTEIN)
    ("low density lipoprotein receptor-related protein" . SPARSER::PROTEIN)
    ("Epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("THC" . SPARSER::DRUG) ("tetrahydrocannabinol" . SPARSER::DRUG)
    ("IL-6, IL-8 and MCP-1" . SPARSER::COLLECTION)
    ("cofilin-PLD" . SPARSER::COLLECTION)
    ("EGFR or other possible receptors" . SPARSER::COLLECTION)
    ("other possible receptors" . SPARSER::PROTEIN)
    ("ROCK and RhoA" . SPARSER::COLLECTION)
    ("Rho-ROCK-LIMK-cofilin" . SPARSER::COLLECTION)
    ("angiotensin II-" . SPARSER::PROTEIN) ("adenosine" . SPARSER::PROTEIN)
    ("LIMK or overexpressing SSH" . SPARSER::COLLECTION)
    ("wild-type cofilin or expressing S3A cofilin (a non-phosphorylated form of cofilin)"
     . SPARSER::COLLECTION)
    ("chitosan" . SPARSER::MOLECULE) ("chitin" . SPARSER::DRUG)
    ("the monoclonal GE2 antibody" . SPARSER::ANTIBODY)
    ("polymers" . SPARSER::MOLECULE) ("RhoA/ROCK" . SPARSER::COLLECTION)
    ("RhoA and ROCK" . SPARSER::COLLECTION)
    ("LIMK and the SSH phosphatase" . SPARSER::COLLECTION)
    ("cofilin/p-cofilin" . SPARSER::COLLECTION)
    ("approximately 15 mpi" . SPARSER::PROTEIN) ("rodA" . SPARSER::PROTEIN)
    ("mpi" . SPARSER::PROTEIN) ("p-cofilin" . SPARSER::COLLECTION)
    ("RhoA-ROCK-LIMK" . SPARSER::COLLECTION)
    ("ROCK-LIMK-cofilin" . SPARSER::COLLECTION)
    ("kinase (PAK)" . SPARSER::KINASE) ("Rac/Cdc42" . SPARSER::COLLECTION)
    ("homologue" . SPARSER::PROTEIN) ("PAK" . SPARSER::PROTEIN-FAMILY)
    ("Rac" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphatases (SSH)" . SPARSER::PHOSPHATASE) ("SSH" . SPARSER::MOLECULE)
    ("kinases (LIMK)" . SPARSER::PROTEIN) ("LIMK" . SPARSER::PROTEIN)
    ("filaments" . SPARSER::PROTEIN-FAMILY) ("Cofilin" . SPARSER::PROTEIN)
    ("‘cofilin’" . SPARSER::PROTEIN)
    ("the most ubiquitous form" . SPARSER::FORM)
    ("cofilin-2 (distributed specifically in muscle cells) and ADF (destrin)"
     . SPARSER::COLLECTION)
    ("cofilin-1, cofilin-2 (distributed specifically in muscle cells) and ADF (destrin)"
     . SPARSER::COLLECTION)
    ("ADF/cofilin" . SPARSER::COLLECTION) ("destrin" . SPARSER::PROTEIN)
    ("an anatomic barrier" . SPARSER::PROTEIN) ("RhoA" . SPARSER::PROTEIN)
    ("slingshot" . SPARSER::PROTEIN) ("/cofilin" . SPARSER::COLLECTION)
    ("cofilin" . SPARSER::PROTEIN) ("ADF" . SPARSER::PROTEIN)
    ("MCP-1" . SPARSER::PROTEIN) ("acetylcholine receptor" . SPARSER::PROTEIN)
    ("endothelin-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("angiotensin II" . SPARSER::PROTEIN) ("IL-8" . SPARSER::PROTEIN)
    ("a 20 " . SPARSER::PROTEIN) ("myc-tagged" . SPARSER::PROTEIN)
    ("phosphatase 1 " . SPARSER::PROTEIN) ("SRα" . SPARSER::PROTEIN)
    ("GE2" . SPARSER::PROTEIN) ("ku80" . SPARSER::PROTEIN)
    ("gp120" . SPARSER::DRUG) ("member A" . SPARSER::PROTEIN)
    ("PAK4" . SPARSER::PROTEIN) ("Cdc42" . SPARSER::PROTEIN)
    ("Rho GTPase" . SPARSER::PROTEIN) ("Cofilin-1" . SPARSER::PROTEIN)
    ("cofilin-2" . SPARSER::PROTEIN) ("cofilin-1" . SPARSER::PROTEIN)
    ("type II" . SPARSER::HUMAN-PROTEIN-FAMILY) ("dectin-1" . SPARSER::PROTEIN)
    ("actin depolymerizing factor" . SPARSER::PROTEIN)
    ("ATP-competitive" . SPARSER::ATP) ("a major barrier" . SPARSER::PROTEIN)
    ("PGR" . SPARSER::PROTEIN) ("Lapatinib" . SPARSER::DRUG)
    ("Cetuximab" . SPARSER::DRUG) ("Erlotinib" . SPARSER::DRUG)
    ("Gefitinib" . SPARSER::DRUG) ("caucasian cohorts" . SPARSER::MOLECULE)
    ("clinically usefull biomarkers" . SPARSER::MOLECULE)
    ("the entire cohort" . SPARSER::MOLECULE) ("HER-1" . SPARSER::PROTEIN)
    ("PIP 3 or direct phosphorylation by AKT" . SPARSER::COLLECTION)
    ("our Western blot" . SPARSER::PROTEIN)
    ("EGFR, EPHA2, MET, EFNB1, and ERBB2" . SPARSER::COLLECTION)
    ("PLC- γ and Shc" . SPARSER::COLLECTION) ("SYK" . SPARSER::PROTEIN)
    ("FER" . SPARSER::PROTEIN) ("INSR" . SPARSER::PROTEIN)
    ("both receptor and nonreceptor tyrosine kinases" . SPARSER::COLLECTION)
    ("TEC" . SPARSER::PROTEIN) ("BTK" . SPARSER::PROTEIN)
    ("BMX" . SPARSER::PROTEIN)
    ("family and ephrin receptor" . SPARSER::COLLECTION)
    ("EGFR and EPHA2" . SPARSER::COLLECTION)
    ("phosphoserine/threonine" . SPARSER::COLLECTION)
    ("a smaller fraction" . SPARSER::COMPONENT)
    ("the tryptic peptides" . SPARSER::PEPTIDE) ("trypsin" . SPARSER::PROTEIN)
    ("mixture" . SPARSER::MOLECULE)
    ("EGFR, EPHA2, and PTK2" . SPARSER::COLLECTION)
    ("phosphoserine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("Tyrosine" . SPARSER::AMINO-ACID)
    ("Phosphotyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("attractive therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("serine and threonine" . SPARSER::COLLECTION)
    ("the phosphatidylinositol (4,5)-bisphosphate (PIP 2 ) phospholipid"
     . SPARSER::PHOSPHOLIPID)
    ("PDK1 and AKT" . SPARSER::COLLECTION) ("PH" . SPARSER::PROTEIN)
    ("receptors and receptor tyrosine kinases" . SPARSER::COLLECTION)
    ("Ras-GAP" . SPARSER::PROTEIN) ("EPHB2" . SPARSER::PROTEIN)
    ("PLC- γ" . SPARSER::PROTEIN-FAMILY) ("TNK2" . SPARSER::PROTEIN)
    ("Receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tyrosine Kinase" . SPARSER::PROTEIN)
    ("ephrin receptor" . SPARSER::PROTEIN) ("ERBB2" . SPARSER::PROTEIN)
    ("PTK2" . SPARSER::PROTEIN) ("TiO 2" . SPARSER::MOLECULE)
    ("anti- β" . SPARSER::PROTEIN) ("EFNB1" . SPARSER::PROTEIN)
    ("EPHA2" . SPARSER::PROTEIN) ("l -arginine" . SPARSER::MOLECULE)
    ("l -glutamine" . SPARSER::MOLECULE) ("p110 α" . SPARSER::PROTEIN)
    ("PIP 3" . SPARSER::PIP3) ("PIP 2" . SPARSER::PIP2)
    ("G-protein" . SPARSER::PROTEIN) ("p110" . SPARSER::PROTEIN)
    ("Class I" . SPARSER::PROTEIN) ("phosphoinositide 3" . SPARSER::PROTEIN)
    ("integrins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FAKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AKT (AKT3) and PKC (PRKCB)" . SPARSER::COLLECTION)
    ("ECM1, GPCR, NUR 77, AKT (AKT3) and PKC (PRKCB)" . SPARSER::COLLECTION)
    ("PKC" . SPARSER::PROTEIN) ("cisplatin and taxol" . SPARSER::COLLECTION)
    ("types and stages" . SPARSER::COLLECTION)
    ("metastasis-associated oncogenes" . SPARSER::ONCOGENE)
    ("a neurotrophic tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("PI3K/PKB" . SPARSER::COLLECTION) ("Anoikis" . SPARSER::PROTEIN)
    ("PIK3CA and PIK3CD" . SPARSER::COLLECTION)
    ("mTOR and PTEN" . SPARSER::COLLECTION) ("PIK" . SPARSER::BIO-COMPLEX)
    ("/AKT/mTOR" . SPARSER::COLLECTION)
    ("kinase/protein kinase B" . SPARSER::COLLECTION)
    ("phosphatidylinositol-3-OH" . SPARSER::PROTEIN-PAIR)
    ("Genes and Genomes" . SPARSER::COLLECTION)
    ("oligo-dT" . SPARSER::COLLECTION) ("dT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("A-L and S-L" . SPARSER::COLLECTION)
    ("cisplatin or taxol" . SPARSER::COLLECTION) ("taxol" . SPARSER::DRUG)
    ("TrkB and Beclin1" . SPARSER::COLLECTION)
    ("had relatively stable biological traits" . SPARSER::PROTEIN)
    ("traits" . SPARSER::PROTEIN)
    ("S15 (S-H) and S4 (S-L)" . SPARSER::COLLECTION)
    ("unique isoforms" . SPARSER::ISOFORM)
    ("PIK3CA, PIK3CD, AKT3, ECM1, GPCR, mTOR and PRKCB" . SPARSER::COLLECTION)
    ("Nur77 and PTEN" . SPARSER::COLLECTION) ("PRKCB" . SPARSER::PROTEIN)
    ("caspase-3 and caspase-7" . SPARSER::COLLECTION)
    ("P-TEN" . SPARSER::PROTEIN) ("PI3Kγ" . SPARSER::PROTEIN)
    ("PI3Kα" . SPARSER::PROTEIN) ("PI3Ks" . SPARSER::PROTEIN)
    ("NUR 77" . SPARSER::PROTEIN) ("Beclin 1" . SPARSER::PROTEIN)
    ("protein kinase B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphatidylinositol-3" . SPARSER::PROTEIN) ("NUR77" . SPARSER::PROTEIN)
    ("NR4A1" . SPARSER::PROTEIN) ("LPAR1" . SPARSER::PROTEIN)
    ("S15" . SPARSER::PROTEIN) ("A1–A" . SPARSER::PROTEIN)
    ("Nur77" . SPARSER::PROTEIN) ("ECM1" . SPARSER::PROTEIN)
    ("PIK3CD" . SPARSER::PROTEIN) ("Beclin1" . SPARSER::PROTEIN)
    ("caspase-7" . SPARSER::PROTEIN) ("A-L" . SPARSER::PROTEIN)
    ("the respective LNCaP-LacZ and LNCaP-wtAR cell derivatives"
     . SPARSER::DERIVATIVE)
    ("LNCaP-wtAR" . SPARSER::PROTEIN-PAIR) ("bicalutamide-" . SPARSER::DRUG)
    ("PSA , KLK2 and TMPRSS2" . SPARSER::COLLECTION)
    ("-chromatin" . SPARSER::COLLECTION)
    ("optimal pre-clinical drug" . SPARSER::DRUG)
    ("active AR W741L dimers" . SPARSER::DIMER)
    ("bicalutamide and impact on their activity" . SPARSER::COLLECTION)
    ("-AR" . SPARSER::COLLECTION)
    ("either endogenous or ectopic AR T877A and AR W741L"
     . SPARSER::COLLECTION)
    ("key siRNAs" . SPARSER::PROTEIN) ("RV" . SPARSER::MOLECULE)
    ("a bona fide biomarker" . SPARSER::MOLECULE)
    ("derivative and KUCaP" . SPARSER::COLLECTION)
    ("a comprehensive PC cohort" . SPARSER::MOLECULE)
    ("GSK" . SPARSER::PROTEIN) ("AR W741L and AR T877A" . SPARSER::COLLECTION)
    ("SGK1 , TIPARP and RASD1" . SPARSER::COLLECTION)
    ("DHT (Figure xref and xref ) only modestly increased SGK1"
     . SPARSER::PROTEIN)
    ("RASD1 (93-fold) and SGK1 (109.5-fold)" . SPARSER::COLLECTION)
    ("RASD1 ( Ras dexamethasone-induced 1 ) and SGK1 ( serum- and glucocorticoid-regulated kinase 1 )"
     . SPARSER::COLLECTION)
    ("glucocorticoid-regulated kinase 1" . SPARSER::COLLECTION)
    ("glucocorticoid" . SPARSER::PROTEIN) ("TCDD" . SPARSER::PROTEIN)
    ("FKBP5 and NDRG1" . SPARSER::COLLECTION)
    ("the respective 21 and 79 androgen-induced genes" . SPARSER::GENE)
    ("PSA ( KLK3 ) and KLK2" . SPARSER::COLLECTION)
    ("the ectopically-expressed receptor" . SPARSER::RECEPTOR)
    ("the global transcriptional targets" . SPARSER::TARGET-PROTEIN)
    ("PSA , TMPRSS2 and KLK2" . SPARSER::COLLECTION)
    ("PSA and KLK2" . SPARSER::COLLECTION) ("Enzalutamide" . SPARSER::DRUG)
    ("LNCaP-LacZ" . SPARSER::COLLECTION) ("LacZ" . SPARSER::PROTEIN)
    ("DHT- and bicalutamide-activated AR W741L" . SPARSER::COLLECTION)
    ("DHT-" . SPARSER::PROTEIN)
    ("1 nM DHT and 10 nM bicalutamide" . SPARSER::COLLECTION)
    ("Bicalutamide" . SPARSER::DRUG)
    ("DHT and bicalutamide" . SPARSER::COLLECTION)
    ("FKBP5 and TMPRSS2" . SPARSER::COLLECTION)
    ("KLK2 and TMPRSS2" . SPARSER::COLLECTION)
    ("the ectopically-expressed protein" . SPARSER::PROTEIN)
    ("ectopically-expressed FLAG-AR" . SPARSER::COLLECTION)
    ("FLAG-AR" . SPARSER::COLLECTION) ("AR and PSA" . SPARSER::COLLECTION)
    ("DHT" . SPARSER::PROTEIN)
    ("ectopically-expressed AR W741L mRNA" . SPARSER::PROTEIN)
    ("LNCaP-AR" . SPARSER::COLLECTION)
    ("specific CRPC-associated receptor mutants" . SPARSER::MUTANT)
    ("ectopically-expressed mutant receptors" . SPARSER::RECEPTOR)
    ("SGK" . SPARSER::PROTEIN) ("SGK1, TIPARP and RASD1" . SPARSER::COLLECTION)
    ("PSA and TMPRSS2" . SPARSER::COLLECTION) ("PSA" . SPARSER::PROTEIN)
    ("key biomarkers" . SPARSER::MOLECULE)
    ("CRPC-associated AR mutants" . SPARSER::MUTANT)
    ("receptors and luciferase" . SPARSER::COLLECTION)
    ("bicalutamide and flutamide" . SPARSER::COLLECTION)
    ("/AR" . SPARSER::COLLECTION) ("flutamide" . SPARSER::DRUG)
    ("aberrantly functioning receptors" . SPARSER::PROTEIN)
    ("androgens or switch anti-androgens" . SPARSER::COLLECTION)
    ("androgens" . SPARSER::DRUG)
    ("variants [ xref ] and de-regulated co-factor expression [ xref , xref ] that facilitate receptor activity"
     . SPARSER::COLLECTION)
    ("CRPC" . SPARSER::PROTEIN) ("abiraterone" . SPARSER::DRUG)
    ("enzalutamide" . SPARSER::DRUG) ("PC (CRPC)" . SPARSER::PROTEIN)
    ("androgen receptor (AR)" . SPARSER::PROTEIN)
    ("androgen" . SPARSER::PROTEIN)
    ("TIPARP , RASD1 and SGK1" . SPARSER::COLLECTION)
    ("TIPARP" . SPARSER::PROTEIN) ("bicalutamide" . SPARSER::DRUG)
    ("Sulforhodamine B" . SPARSER::MOLECULE) ("AF-2" . SPARSER::PROTEIN)
    ("GSK650394" . SPARSER::DRUG) ("regulated kinase 1" . SPARSER::PROTEIN)
    ("dexamethasone-induced 1" . SPARSER::PROTEIN) ("KLK3" . SPARSER::PROTEIN)
    ("SPOCK1" . SPARSER::PROTEIN) ("KCNN2" . SPARSER::PROTEIN)
    ("NKX3.1" . SPARSER::PROTEIN)
    ("phospho-serine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("KLK2" . SPARSER::PROTEIN) ("FKBP5" . SPARSER::PROTEIN)
    ("TMPRSS2" . SPARSER::PROTEIN) ("co-factor" . SPARSER::MOLECULE)
    ("anti-androgen" . SPARSER::DRUG) ("SGK1" . SPARSER::PROTEIN)
    ("RASD1" . SPARSER::PROTEIN) ("anti-androgens" . SPARSER::DRUG)
    ("targets as well as a biomarker" . SPARSER::COLLECTION)
    ("both the major p73" . SPARSER::PROTEIN)
    ("interactors" . SPARSER::PROTEIN)
    ("p21, 14–3–3 and Gadd45" . SPARSER::COLLECTION)
    ("the canonical angiogenic gene" . SPARSER::GENE)
    ("tumor-associated hypoxia" . SPARSER::PROTEIN)
    ("angiogenic genes" . SPARSER::GENE) ("MEFs" . SPARSER::PROTEIN)
    ("hif" . SPARSER::PROTEIN-FAMILY)
    ("the dominant-negative C111S mutant Nedd" . SPARSER::PROTEIN)
    ("Nedd" . SPARSER::PROTEIN) ("Ubc12" . SPARSER::PROTEIN)
    ("Ubc" . SPARSER::PROTEIN) ("VHL" . SPARSER::PROTEIN)
    ("cullin" . SPARSER::PROTEIN-FAMILY)
    ("both these major p73" . SPARSER::PROTEIN)
    ("HIF-1α/Siah1" . SPARSER::COLLECTION)
    ("HIF-1α and SIAH1" . SPARSER::COLLECTION)
    ("deferoxamine (DFX) or dimethyloxaloylglycine (DMOG)"
     . SPARSER::COLLECTION)
    ("DMOG" . SPARSER::DRUG) ("DFX" . SPARSER::PROTEIN)
    ("deferoxamine" . SPARSER::MOLECULE) ("glut-1" . SPARSER::PROTEIN)
    ("vegf" . SPARSER::PROTEIN)
    ("a classical tumor suppressor" . SPARSER::SUPPRESSOR)
    ("p63 and p73" . SPARSER::COLLECTION)
    ("p53 and TAp73" . SPARSER::COLLECTION)
    ("these antagonistic proteins" . SPARSER::PROTEIN)
    ("the prototypic angiogenic gene" . SPARSER::GENE)
    ("several angiogenic genes and blood vessel formation"
     . SPARSER::COLLECTION)
    ("several angiogenic genes" . SPARSER::GENE) ("DNp" . SPARSER::DRUG)
    ("TAp" . SPARSER::HUMAN-PROTEIN-FAMILY) ("−3" . SPARSER::PROTEIN)
    ("B-2" . SPARSER::PROTEIN) ("GLUT1" . SPARSER::PROTEIN)
    ("hif-1 α" . SPARSER::PROTEIN)
    ("caspase-2S" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Gadd45" . SPARSER::HUMAN-PROTEIN-FAMILY) ("14–3–3" . SPARSER::PROTEIN)
    ("CD34" . SPARSER::PROTEIN) ("HIF1" . SPARSER::PROTEIN)
    ("siah1" . SPARSER::PROTEIN) ("hif-1α" . SPARSER::PROTEIN)
    ("Von Hippel-Lindau" . SPARSER::PROTEIN) ("SIAH1" . SPARSER::PROTEIN)
    ("prolyl hydroxylase" . SPARSER::PROTEIN) ("p63" . SPARSER::PROTEIN)
    ("p53 family" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Siah1" . SPARSER::PROTEIN)
    ("HIF-1α" . SPARSER::PROTEIN) ("homolog of" . SPARSER::PROTEIN)
    ("P73" . SPARSER::PROTEIN) ("CDKs" . SPARSER::PROTEIN)
    ("statins" . SPARSER::DRUG) ("Hmga1 and Hmga2" . SPARSER::COLLECTION)
    ("Hmga1" . SPARSER::PROTEIN) ("Hmga2" . SPARSER::PROTEIN)
    ("Hmga" . SPARSER::PROTEIN-FAMILY)
    ("HMGA1 and the highly related HMGA2 protein" . SPARSER::COLLECTION)
    ("Ras/ERK" . SPARSER::COLLECTION) ("ß-catenin" . SPARSER::COLLECTION)
    ("RhoA-ROCK" . SPARSER::COLLECTION) ("ROCK" . SPARSER::PROTEIN-FAMILY)
    ("cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EMT and stemness" . SPARSER::COLLECTION) ("YAP-5SA" . SPARSER::PROTEIN)
    ("Consistently all three inhibitors" . SPARSER::INHIBITOR)
    ("AZD5438, JNJ7706621 and PHA793887" . SPARSER::COLLECTION)
    ("CTGF and CYR61" . SPARSER::COLLECTION)
    ("BIRC5, CYR61 and CTGF" . SPARSER::COLLECTION) ("CTGF" . SPARSER::PROTEIN)
    ("RPPA" . SPARSER::PROTEIN) ("HMGA1-CCNE2" . SPARSER::COLLECTION)
    ("genes or patients" . SPARSER::COLLECTION)
    ("CCNE2 and HMGA1" . SPARSER::COLLECTION)
    ("Matrix" . SPARSER::PROTEIN-FAMILY) ("Scaffold" . SPARSER::SCAFFOLD)
    ("Wiz" . SPARSER::PROTEIN) ("ΔCCNE2" . SPARSER::PROTEIN)
    ("enhanceosomes" . SPARSER::BIO-COMPLEX)
    ("proteins, HMGA1a and HMGA1b" . SPARSER::COLLECTION)
    ("a complex and multistep disease involving the accumulation of both molecular and morphological changes"
     . SPARSER::COLLECTION)
    ("HMGA1 and CCNE2" . SPARSER::COLLECTION) ("TAZ" . SPARSER::PROTEIN)
    ("HMGA1-" . SPARSER::PROTEIN) ("GINS2" . SPARSER::PROTEIN)
    ("CDC25C" . SPARSER::PROTEIN) ("FMN2" . SPARSER::PROTEIN)
    ("KIF14" . SPARSER::PROTEIN) ("ASF1B" . SPARSER::PROTEIN)
    ("PLK4" . SPARSER::PROTEIN) ("DAB2" . SPARSER::PROTEIN)
    ("CDC6" . SPARSER::PROTEIN) ("RRM2" . SPARSER::PROTEIN)
    ("RIMS2" . SPARSER::PROTEIN) ("DDAH1" . SPARSER::PROTEIN)
    ("RAD51AP1" . SPARSER::PROTEIN) ("SHCBP1" . SPARSER::PROTEIN)
    ("SKA1" . SPARSER::PROTEIN) ("NAV3" . SPARSER::PROTEIN)
    ("MCM10" . SPARSER::PROTEIN) ("DIAPH3" . SPARSER::PROTEIN)
    ("RAD51" . SPARSER::PROTEIN) ("SLIT2" . SPARSER::PROTEIN)
    ("TBXA2R" . SPARSER::PROTEIN) ("CCNA2" . SPARSER::PROTEIN)
    ("MATN3" . SPARSER::PROTEIN) ("DEPDC1B" . SPARSER::PROTEIN)
    ("PLCB4" . SPARSER::PROTEIN) ("PTGS2" . SPARSER::PROTEIN)
    ("SERPINE2" . SPARSER::PROTEIN) ("TMEM171" . SPARSER::PROTEIN)
    ("ADAMTS1" . SPARSER::PROTEIN) ("TGM2" . SPARSER::PROTEIN)
    ("IGFBP3" . SPARSER::PROTEIN) ("ITGB2" . SPARSER::PROTEIN)
    ("ORC1" . SPARSER::PROTEIN) ("ANKRD1" . SPARSER::PROTEIN)
    ("THBS1" . SPARSER::PROTEIN) ("OLR1" . SPARSER::PROTEIN)
    ("STXBP6" . SPARSER::PROTEIN) ("KRT34" . SPARSER::PROTEIN)
    ("DNase-I" . SPARSER::PROTEIN) ("pGL4" . SPARSER::PROTEIN)
    ("ACT-1" . SPARSER::PROTEIN) ("Na 3 Vo 4" . SPARSER::MOLECULE)
    ("PHA767491" . SPARSER::DRUG) ("AT7519" . SPARSER::DRUG)
    ("SNS-032" . SPARSER::DRUG) ("b -5" . SPARSER::PROTEIN)
    ("siA1" . SPARSER::PROTEIN) ("HMGA2" . SPARSER::PROTEIN)
    ("PHA793887" . SPARSER::DRUG) ("JNJ7706621" . SPARSER::DRUG)
    ("AZD5438" . SPARSER::DRUG) ("CYR61" . SPARSER::PROTEIN)
    ("BIRC5" . SPARSER::PROTEIN) ("RR2" . SPARSER::PROTEIN)
    ("RR1" . SPARSER::PROTEIN) ("HMGA1b" . SPARSER::PROTEIN)
    ("HMGA1a" . SPARSER::PROTEIN) ("LATS1" . SPARSER::PROTEIN)
    ("CCNE2" . SPARSER::PROTEIN) ("cyclin E2" . SPARSER::PROTEIN)
    ("HMGA1" . SPARSER::PROTEIN) ("Group A" . SPARSER::PROTEIN)
    ("Pten" . SPARSER::PROTEIN)
    ("Akt, P13K, S6K, and 4E-BP1" . SPARSER::COLLECTION)
    ("biologic" . SPARSER::DRUG)
    ("Cyclin D1 proteins (Fig.  xref ) and mRNA (Fig.  xref )"
     . SPARSER::COLLECTION)
    ("P21 and Cyclin D1" . SPARSER::COLLECTION)
    ("AKT, P13K, S6K, and 4E-BP1" . SPARSER::COLLECTION)
    ("miR-" . SPARSER::PROTEIN)
    ("3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)"
     . SPARSER::MOLECULE)
    ("GSCs" . SPARSER::PROTEIN) ("astrocytes" . SPARSER::PROTEIN)
    ("AKT/mTOR" . SPARSER::COLLECTION) ("AKT/FOXO3a" . SPARSER::COLLECTION)
    ("S6K1 and 4E-BP1" . SPARSER::COLLECTION)
    ("cyclin D1 and VEGF-A" . SPARSER::COLLECTION)
    ("/AKT" . SPARSER::COLLECTION) ("adipocytes" . SPARSER::PROTEIN)
    ("proto-oncogenes or tumor suppressors [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("MiRNA" . SPARSER::PROTEIN) ("p-S6K" . SPARSER::PROTEIN)
    ("cyclinD1" . SPARSER::PROTEIN) ("BP1" . SPARSER::PROTEIN)
    ("K1" . SPARSER::PROTEIN) ("anti-S" . SPARSER::ANTIBODY)
    ("P13" . SPARSER::PROTEIN) ("UBE2T" . SPARSER::PROTEIN)
    ("U87" . SPARSER::PROTEIN) ("FOXO3a" . SPARSER::PROTEIN)
    ("miR-7" . SPARSER::PROTEIN) ("EGF and EGFR" . SPARSER::COLLECTION)
    ("a Cbl-dominant-negative mutant Cbl70Z" . SPARSER::PROTEIN)
    ("‘ubiquitinatable' EGFRs" . SPARSER::PROTEIN)
    ("Ub and pY" . SPARSER::COLLECTION) ("Ub" . SPARSER::PROTEIN)
    ("Cbl/Grb2" . SPARSER::COLLECTION) ("ov" . SPARSER::MOLECULE)
    ("phy" . SPARSER::PROTEIN-FAMILY) ("EGFRs" . SPARSER::PROTEIN)
    ("MPM and MPM-B" . SPARSER::COLLECTION)
    ("EGFR and receptor" . SPARSER::COLLECTION)
    ("only one pY" . SPARSER::PROTEIN)
    ("the MPM and the MPM-B" . SPARSER::COLLECTION)
    ("the dominant-negative Cbl70Z mutant" . SPARSER::MUTANT)
    ("EGFR and Grb2" . SPARSER::COLLECTION) ("Cbl-pY" . SPARSER::COLLECTION)
    ("Cbl:Grb2" . SPARSER::BIO-COMPLEX)
    ("Cbl, Grb2 and EGFR" . SPARSER::COLLECTION)
    ("Grb2 and Cbl" . SPARSER::COLLECTION)
    ("the multimeric complex" . SPARSER::BIO-COMPLEX)
    ("EGFR, Cbl and Grb2" . SPARSER::COLLECTION)
    ("EGFR and Cbl" . SPARSER::COLLECTION) ("Cbl:EGFR" . SPARSER::BIO-COMPLEX)
    ("EAM" . SPARSER::PROTEIN) ("PTP" . SPARSER::PROTEIN)
    ("KIN" . SPARSER::PROTEIN) ("net" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Phosphatases" . SPARSER::PHOSPHATASE) ("MPM" . SPARSER::MOLECULE)
    ("Grb2:Cbl" . SPARSER::BIO-COMPLEX) ("PM" . SPARSER::PROTEIN)
    ("Molecules" . SPARSER::MOLECULE)
    ("conformations" . SPARSER::BIO-CONFORMATION) ("dimers" . SPARSER::DIMER)
    ("receptor and/or ligand" . SPARSER::COLLECTION)
    ("Cbl and Grb2" . SPARSER::COLLECTION)
    ("pY1045, pY1068 and pY1086" . SPARSER::COLLECTION)
    ("sharp" . SPARSER::PROTEIN)
    ("phosphotyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("Cbl" . SPARSER::PROTEIN) ("YL1" . SPARSER::PROTEIN)
    ("alpha-tubulin" . SPARSER::PROTEIN) ("P4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("I-EGF" . SPARSER::PROTEIN)
    ("newly developed CSC-targeting drugs" . SPARSER::DRUG)
    ("CYT" . SPARSER::MOLECULE) ("JAK2-STAT3" . SPARSER::COLLECTION)
    ("daunorubicin" . SPARSER::DRUG) ("IBS" . SPARSER::DRUG)
    ("STAT3 and gene" . SPARSER::COLLECTION)
    ("ALDH1A1, COMT, ENG, ESRRB, LIN28 and PROM1" . SPARSER::COLLECTION)
    ("complementing" . SPARSER::PROTEIN)
    ("STAT3 and NOTCH1" . SPARSER::COLLECTION)
    ("the only two candidate genes" . SPARSER::GENE)
    ("ESRRB and LIN28" . SPARSER::COLLECTION)
    ("ALDH1A1 , COMT , ENG , ESRRB, LIN28, NOTCH1, PROM1 and STAT3"
     . SPARSER::COLLECTION)
    ("ESRRB" . SPARSER::PROTEIN) ("ENG" . SPARSER::PROTEIN)
    ("COMT" . SPARSER::PROTEIN)
    ("paclitaxel and carboplatin" . SPARSER::COLLECTION)
    ("IRs and CRs" . SPARSER::COLLECTION) ("IR and CR" . SPARSER::COLLECTION)
    ("ovarian CSC-related genes" . SPARSER::GENE)
    ("Variants" . SPARSER::VARIANT)
    ("CD44 , CD133 and STAT3" . SPARSER::COLLECTION)
    ("cisplatin or carboplatin" . SPARSER::COLLECTION)
    ("CR" . SPARSER::PROTEIN) ("carboplatin" . SPARSER::DRUG)
    ("24 ovarian CSC-related genes" . SPARSER::GENE) ("IRs" . SPARSER::PROTEIN)
    ("PIAS-3" . SPARSER::PROTEIN) ("JAK2 inhibitor AZD1480" . SPARSER::DRUG)
    ("JAK2" . SPARSER::PROTEIN) ("LIN28" . SPARSER::PROTEIN)
    ("THY1" . SPARSER::PROTEIN) ("SOX2" . SPARSER::PROTEIN)
    ("THAP11" . SPARSER::PROTEIN) ("PROM1" . SPARSER::PROTEIN)
    ("POU5F1" . SPARSER::PROTEIN) ("OCT4" . SPARSER::PROTEIN)
    ("NOTCH1" . SPARSER::PROTEIN) ("LIN28B" . SPARSER::PROTEIN)
    ("LIN28A" . SPARSER::PROTEIN) ("KLF4" . SPARSER::PROTEIN)
    ("CD117" . SPARSER::PROTEIN) ("HES1" . SPARSER::PROTEIN)
    ("CXCR4" . SPARSER::PROTEIN) ("BMI1" . SPARSER::PROTEIN)
    ("ALDH1A1" . SPARSER::PROTEIN) ("1-1" . SPARSER::PROTEIN)
    ("CD44" . SPARSER::PROTEIN) ("CA-125" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("The respective proteins" . SPARSER::PROTEIN)
    ("rabbit anti-goat secondary antibody" . SPARSER::PROTEIN)
    ("goat" . SPARSER::PROTEIN) ("HRP" . SPARSER::PROTEIN)
    ("1% bovine serum albumin (BSA)" . SPARSER::PROTEIN)
    ("TX" . SPARSER::PROTEIN) ("deoxycholate" . SPARSER::MOLECULE)
    ("EGTA" . SPARSER::MOLECULE) ("ethidium" . SPARSER::MOLECULE)
    ("agarose" . SPARSER::MOLECULE) ("Polymerase" . SPARSER::PROTEIN)
    ("TRIzol" . SPARSER::DRUG) ("PBS" . SPARSER::PROTEIN)
    ("UT" . SPARSER::PROTEIN-FAMILY) ("VA" . SPARSER::MOLECULE) ("Type" . TYPE)
    ("CCD" . SPARSER::PROTEIN) ("DAD" . SPARSER::PROTEIN)
    ("crude MAAs" . SPARSER::MOLECULE) ("chloroform" . SPARSER::MOLECULE)
    ("methanol" . SPARSER::MOLECULE)
    ("Proinflammatory cytokines" . SPARSER::PROTEIN)
    ("Inflammatory cytokines" . SPARSER::PROTEIN) ("iNOS" . SPARSER::PROTEIN)
    ("proinflammatory cytokines and LPS" . SPARSER::COLLECTION)
    ("cytokines and LPS" . SPARSER::COLLECTION)
    ("highly toxic ROS" . SPARSER::PROTEIN)
    ("antioxidant and detoxification enzymes" . SPARSER::COLLECTION)
    ("NQO1 and HO-1" . SPARSER::COLLECTION)
    ("cytoprotective genes" . SPARSER::GENE) ("-Nrf2" . SPARSER::COLLECTION)
    ("Nrf2 and NF-κB" . SPARSER::COLLECTION)
    ("Bcl2 and Bax" . SPARSER::COLLECTION)
    ("especially 50–250 kDa" . SPARSER::PROTEIN)
    ("nitrotyrosine" . SPARSER::MOLECULE)
    ("antioxidative enzymes" . SPARSER::ENZYME)
    ("HO-1 and GST" . SPARSER::COLLECTION)
    ("antioxidative response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("TNF- and IL-6" . SPARSER::COLLECTION)
    ("IL-1β, mRNA and protein" . SPARSER::COLLECTION)
    ("TNF-" . SPARSER::PROTEIN) ("inflammatory cytokines" . SPARSER::PROTEIN)
    ("TNF-α, IL-1β, and IL-6" . SPARSER::COLLECTION)
    ("Nrf2/NF-κB" . SPARSER::COLLECTION) ("MAA" . SPARSER::MOLECULE)
    ("MAAs" . SPARSER::MOLECULE) ("Mycosporine" . SPARSER::MOLECULE)
    ("keratinocytes" . SPARSER::PROTEIN)
    ("enzymes and antioxidant" . SPARSER::COLLECTION)
    ("harmful ROS" . SPARSER::PROTEIN)
    ("harmful chemicals" . SPARSER::MOLECULE)
    ("an efficient protective barrier" . SPARSER::PROTEIN)
    ("barrier" . SPARSER::PROTEIN) ("IL-6 and TNF-κ" . SPARSER::COLLECTION)
    ("NQO-1" . SPARSER::PROTEIN) ("NF-E2-related factor 2" . SPARSER::PROTEIN)
    ("HD" . SPARSER::PROTEIN) ("secondary antibody" . SPARSER::PROTEIN)
    ("anti-β-actin" . SPARSER::COLLECTION) ("Tris" . SPARSER::MOLECULE)
    ("PVDF" . SPARSER::DRUG) ("Reagent" . SPARSER::MOLECULE)
    ("t" . SPARSER::PROTEIN) ("caspases-3 and microRNAs" . SPARSER::COLLECTION)
    ("Trizol" . SPARSER::DRUG) ("-Hcy" . SPARSER::MOLECULE)
    ("Sigma" . SPARSER::PROTEIN-FAMILY)
    ("5% FBS and 100 U/mL penicillin/streptomycin" . SPARSER::COLLECTION)
    ("streptomycin" . SPARSER::DRUG) ("FBS" . SPARSER::PROTEIN)
    ("San" . SPARSER::PROTEIN) ("Dr" . SPARSER::MOLECULE)
    ("metabolites" . SPARSER::MOLECULE) ("ischemia" . SPARSER::PROTEIN)
    ("the most important nucleic acid-cleaving enzyme" . SPARSER::ENZYME)
    ("cysteine-aspartic acid" . SPARSER::COLLECTION)
    ("caspase" . SPARSER::PROTEIN) ("LDL" . SPARSER::PROTEIN)
    ("The Western Blot" . SPARSER::PROTEIN) ("Western Blot" . SPARSER::PROTEIN)
    ("AnnexinV/PI" . SPARSER::COLLECTION) ("AnnexinV" . SPARSER::PROTEIN)
    ("Blot" . SPARSER::PROTEIN) ("Ets-1/p21" . SPARSER::COLLECTION)
    ("Qin" . SPARSER::PROTEIN)
    ("biologically active substances" . SPARSER::SUBSTANCE)
    ("chemokines" . SPARSER::PROTEIN)
    ("cysteine and methionine" . SPARSER::COLLECTION)
    ("methionine" . SPARSER::AMINO-ACID)
    ("microRNAs and cell" . SPARSER::COLLECTION)
    ("homocysteine" . SPARSER::MOLECULE) ("Hcy" . SPARSER::MOLECULE)
    ("Homocysteine" . SPARSER::MOLECULE) ("caspases-3" . SPARSER::PROTEIN)
    ("I/R" . SPARSER::PROTEIN) ("L–1" . SPARSER::PROTEIN)
    ("Caspase-3" . SPARSER::PROTEIN)
    ("insulin-like growth factor 1 receptor" . SPARSER::PROTEIN)
    ("miR-23a" . SPARSER::MOLECULE) ("miR-126" . SPARSER::PROTEIN)
    ("Ets-1" . SPARSER::PROTEIN) ("ox-LDL" . SPARSER::PROTEIN)
    ("etc ." . SPARSER::PROTEIN)
    ("ErbB4, TEAD and RUNX2" . SPARSER::COLLECTION)
    ("ErbB4" . SPARSER::PROTEIN) ("TEAD" . SPARSER::PROTEIN)
    ("p73 and promyelocytic leukemia" . SPARSER::COLLECTION)
    ("bad" . SPARSER::PROTEIN) ("Serine" . SPARSER::AMINO-ACID)
    ("PI3K/mTOR" . SPARSER::COLLECTION) ("TGF-β/SMAD" . SPARSER::COLLECTION)
    ("a significant prognostic biomarker" . SPARSER::MOLECULE)
    ("a pooled HR and its 95% CI" . SPARSER::COLLECTION)
    ("NOS" . SPARSER::PROTEIN)
    ("21 observational studies met" . SPARSER::AMINO-ACID)
    ("met" . SPARSER::AMINO-ACID)
    ("human hepatocellular carcinoma (HCC) etc. YAP1" . SPARSER::PROTEIN)
    ("disc" . SPARSER::BIO-COMPLEX)
    ("YAP1 and various types" . SPARSER::COLLECTION)
    ("RUNX2" . SPARSER::PROTEIN) ("promyelocytic leukemia" . SPARSER::PROTEIN)
    ("p73" . SPARSER::PROTEIN) ("large tumor suppressor" . SPARSER::PROTEIN)
    ("YAP-1" . SPARSER::PROTEIN) ("yap1" . SPARSER::PROTEIN)
    ("TEAD4" . SPARSER::PROTEIN) ("etc." . SPARSER::PROTEIN)
    ("YAP1" . SPARSER::PROTEIN) ("Yes-associated protein 1" . SPARSER::PROTEIN)
    ("Antioxidant and detoxification genes" . SPARSER::COLLECTION)
    ("Antioxidant" . SPARSER::PROTEIN)
    ("intractable epilepsy" . SPARSER::PROTEIN) ("hPAP" . SPARSER::PROTEIN)
    ("JNK or p38" . SPARSER::COLLECTION) ("JNK and p38" . SPARSER::COLLECTION)
    ("kinase (JNK)" . SPARSER::KINASE) ("ERK1/2 and p38" . SPARSER::COLLECTION)
    ("intrinsic antioxidant" . SPARSER::PROTEIN)
    ("phytochemicals" . SPARSER::DRUG) ("SRS" . SPARSER::PROTEIN)
    ("Nrf2 and its target genes ( i.e. , HO-1, and NQO1)"
     . SPARSER::COLLECTION)
    ("HO-1, and NQO1" . SPARSER::COLLECTION)
    ("spontaneous recurrent seizures (SRS)" . SPARSER::PROTEIN)
    ("TLE" . SPARSER::PROTEIN) ("Seizures" . SPARSER::PROTEIN)
    ("MDA and GSH" . SPARSER::COLLECTION)
    ("Nrf2, HO-1, and NQO1" . SPARSER::COLLECTION)
    ("protein and gene" . SPARSER::COLLECTION) ("GSH" . SPARSER::DRUG)
    ("the epileptic seizures" . SPARSER::PROTEIN)
    ("HO-1 and NQO1" . SPARSER::COLLECTION)
    ("Nrf2, HO-1 and NQO1" . SPARSER::COLLECTION) ("MDA" . SPARSER::DRUG)
    ("malondialdehyde" . SPARSER::MOLECULE) ("SF" . SPARSER::PROTEIN)
    ("Sulforaphane" . SPARSER::PROTEIN)
    ("Wang and coworkers" . SPARSER::COLLECTION)
    ("epileptic seizures" . SPARSER::PROTEIN)
    ("intra-mitochondrial Ca 2+" . SPARSER::CALCIUM-ION)
    ("deoxyguanosine" . SPARSER::MOLECULE)
    ("malonaldehyde and 4-hydroxy-2" . SPARSER::COLLECTION)
    ("sham" . SPARSER::DRUG) ("malonaldehyde" . SPARSER::MOLECULE)
    ("TBARS" . SPARSER::SUBSTANCE) ("substances (TBARS)" . SPARSER::SUBSTANCE)
    ("substances" . SPARSER::SUBSTANCE)
    ("kainic acid-induced seizures" . SPARSER::PROTEIN)
    ("metallothionein-I and HO-1" . SPARSER::COLLECTION)
    ("c-fos, heat shock protein-70, and interleukin-1β" . SPARSER::COLLECTION)
    ("metallothionein" . SPARSER::PROTEIN) ("pilocarpine" . SPARSER::MOLECULE)
    ("cyclooxygenase" . SPARSER::PROTEIN) ("indomethacin" . SPARSER::DRUG)
    ("bicuculline" . SPARSER::MOLECULE) ("DNA, and RNA" . SPARSER::COLLECTION)
    ("excessive ROS" . SPARSER::PROTEIN)
    ("N -methyl- d -aspartate (NMDA)" . SPARSER::MOLECULE)
    ("EPSPs" . SPARSER::PROTEIN)
    ("neurotransmitters and receptors" . SPARSER::COLLECTION)
    ("neurotransmitters" . SPARSER::MOLECULE) ("SE" . SPARSER::PROTEIN)
    ("antiepileptic drugs" . SPARSER::DRUG) ("Epilepsy" . SPARSER::PROTEIN)
    ("Nrf2-Keap1" . SPARSER::COLLECTION) ("DLG and ETGF" . SPARSER::COLLECTION)
    ("Keap1-Cul3" . SPARSER::COLLECTION) ("helicase" . SPARSER::PROTEIN)
    ("coactivators" . SPARSER::PROTEIN) ("Maf and Jun" . SPARSER::COLLECTION)
    ("Jun" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NRF1 and Nrf2" . SPARSER::COLLECTION)
    ("glutathione S -transferase (GST)" . SPARSER::PROTEIN)
    ("ligase (GCL)" . SPARSER::LIGASE) ("flavoprotein" . SPARSER::MOLECULE)
    ("Fgr" . SPARSER::PROTEIN) ("Keap1/Cul3/RBX1" . SPARSER::COLLECTION)
    ("GSK-3β and β-TrCP" . SPARSER::COLLECTION)
    ("Nrf2/Keap1/Cul3/RBX1" . SPARSER::COLLECTION)
    ("the S-phase kinase-associated protein 1 (Skp1)-Cul1-Rbx1 core E3 complex"
     . SPARSER::BIO-COMPLEX)
    ("-Cul1-Rbx1" . SPARSER::COLLECTION) ("transducin" . SPARSER::PROTEIN)
    ("DLG" . SPARSER::PROTEIN) ("Nrf2:Keap1" . SPARSER::BIO-COMPLEX)
    ("dimer" . SPARSER::DIMER) ("proteasomes" . SPARSER::PROTEIN)
    ("The resultant Keap1-Nrf2 complex" . SPARSER::BIO-COMPLEX)
    ("Keap1-Nrf2" . SPARSER::COLLECTION) ("CNC-bZIP" . SPARSER::COLLECTION)
    ("strong activators" . SPARSER::ACTIVATOR) ("Antioxidants" . SPARSER::DRUG)
    ("glutamate-cysteine ligase catalytic subunit (GCLC) and glutamate-cysteine ligase modulatory subunit (GCLM) [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("glutamate-cysteine ligase modulatory subunit (GCLM)" . SPARSER::FRAGMENT)
    ("GCLM" . SPARSER::PROTEIN) ("GCLC" . SPARSER::PROTEIN)
    ("glutathione" . SPARSER::DRUG) ("Maf and Nrf2" . SPARSER::COLLECTION)
    ("proteins, MafF, MafG and MafK" . SPARSER::COLLECTION)
    ("MafK" . SPARSER::PROTEIN) ("MafG" . SPARSER::PROTEIN)
    ("MafF" . SPARSER::PROTEIN) ("NF-E2/AP1" . SPARSER::COLLECTION)
    ("AP1" . SPARSER::PROTEIN) ("oxygenase" . SPARSER::PROTEIN)
    ("peroxiredoxins" . SPARSER::PROTEIN) ("superoxide" . SPARSER::MOLECULE)
    ("these cytoprotective proteins" . SPARSER::PROTEIN)
    ("biological molecules" . SPARSER::MOLECULE)
    ("reactive oxygen (ROS)" . SPARSER::MOLECULE)
    ("response elements (ARE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("seizures" . SPARSER::PROTEIN) ("epilepsy" . SPARSER::PROTEIN)
    ("a biochemical state" . SPARSER::BIO-STATE)
    ("oxygen and nitrogen" . SPARSER::COLLECTION) ("SB203580" . SPARSER::DRUG)
    ("SP600125" . SPARSER::PROTEIN) ("U0126" . SPARSER::DRUG)
    ("NH2" . SPARSER::MOLECULE)
    ("extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("α-tocopherol" . SPARSER::MOLECULE) ("Ca 2+" . SPARSER::CALCIUM-ION)
    ("thiobarbituric acid" . SPARSER::MOLECULE)
    ("glutathione- S -transferase" . SPARSER::PROTEIN)
    ("Mn-SOD" . SPARSER::PROTEIN) ("interleukin-1β" . SPARSER::PROTEIN)
    ("heat shock protein-70" . SPARSER::PROTEIN) ("c-fos" . SPARSER::PROTEIN)
    ("metallothionein-I" . SPARSER::PROTEIN)
    ("superoxide anion" . SPARSER::MOLECULE)
    ("N -methyl- d -aspartate" . SPARSER::MOLECULE)
    ("GSK-3" . SPARSER::PROTEIN) ("CREB binding protein" . SPARSER::PROTEIN)
    ("CH3" . SPARSER::MOLECULE)
    ("transcriptional coactivator" . SPARSER::PROTEIN)
    ("CHD6" . SPARSER::PROTEIN) ("Cullin 3" . SPARSER::PROTEIN)
    ("NRF1" . SPARSER::PROTEIN) ("RBX1" . SPARSER::PROTEIN)
    ("GSK-3β" . SPARSER::PROTEIN) ("Rbx1" . SPARSER::PROTEIN)
    ("Cul1" . SPARSER::PROTEIN) ("Skp1" . SPARSER::PROTEIN)
    ("β-TrCP" . SPARSER::PROTEIN) ("Bric-a-brac" . SPARSER::PROTEIN)
    ("Cul3" . SPARSER::PROTEIN) ("Neh2" . SPARSER::PROTEIN)
    ("Neh1" . SPARSER::PROTEIN)
    ("glutamate-cysteine ligase" . SPARSER::PROTEIN)
    ("glutamate-cysteine ligase catalytic subunit" . SPARSER::PROTEIN)
    ("musculoaponeurotic fibrosarcoma" . SPARSER::PROTEIN)
    ("β-globin" . SPARSER::PROTEIN) ("NF-E2" . SPARSER::PROTEIN)
    ("NQO1" . SPARSER::PROTEIN) ("quinone oxidoreductase" . SPARSER::PROTEIN)
    ("NAD(P)H" . SPARSER::MOLECULE)
    ("glutathione peroxidases" . SPARSER::PROTEIN-FAMILY)
    ("nuclear factor (erythroid-derived 2)" . SPARSER::PROTEIN)
    ("response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("Nrf2" . SPARSER::PROTEIN) ("factor 2" . SPARSER::PROTEIN)
    ("the temporal Src-translocation CC map" . SPARSER::PROTEIN)
    ("The temporal CC map" . SPARSER::PROTEIN)
    ("the 2D temporal CC map" . SPARSER::PROTEIN)
    ("the two-dimensional Src-translocation temporal CC map"
     . SPARSER::PROTEIN)
    ("the spatiotemporal maps" . SPARSER::PROTEIN) ("maps" . SPARSER::PROTEIN)
    ("receptors and ECM" . SPARSER::COLLECTION) ("hot" . SPARSER::PROTEIN)
    ("KRas-Src" . SPARSER::COLLECTION) ("KRas" . SPARSER::PROTEIN)
    ("Homology" . SPARSER::PROTEIN) ("PDMS" . SPARSER::MOLECULE)
    ("Rac1 and RhoA, Src and Rac1" . SPARSER::COLLECTION)
    ("mDia" . SPARSER::PROTEIN) ("Src, Rac1 and PI3K" . SPARSER::COLLECTION)
    ("Rac1 and Arp2/3" . SPARSER::COLLECTION)
    ("regenerative medicine" . SPARSER::DRUG) ("Arp2/3" . SPARSER::PROTEIN)
    ("p53 and Bax" . SPARSER::COLLECTION) ("metformin" . SPARSER::DRUG)
    ("VIII and AICAR" . SPARSER::COLLECTION)
    ("AICAR and Akt" . SPARSER::COLLECTION)
    ("p53 and estrogen receptor" . SPARSER::COLLECTION)
    ("LKB/AMPK" . SPARSER::COLLECTION) ("LKB" . SPARSER::PROTEIN)
    ("AICAR (0.415 mM) and Akt inhibitor VIII" . SPARSER::COLLECTION)
    ("VIII" . SPARSER::PROTEIN) ("AICAR" . SPARSER::PROTEIN)
    ("PI3K/Akt" . SPARSER::COLLECTION)
    ("a pleiotropic hormone" . SPARSER::MOLECULE) ("Leptin" . SPARSER::PROTEIN)
    ("Akt and AMPK" . SPARSER::COLLECTION) ("phosphatidyl" . SPARSER::MOLECULE)
    ("PKBα or Akt1, PKBβ/Akt2 and PKBγ or Akt3" . SPARSER::COLLECTION)
    ("Akt1, PKBβ/Akt2 and PKBγ or Akt3" . SPARSER::COLLECTION)
    ("PKBγ or Akt3" . SPARSER::COLLECTION)
    ("Protein kinase B (PKB)" . SPARSER::PROTEIN)
    ("enzymes, fatty acid synthase and acetyl" . SPARSER::COLLECTION)
    ("p53 and p21" . SPARSER::COLLECTION) ("coA" . SPARSER::MOLECULE)
    ("acetyl" . SPARSER::MOLECULE) ("a pleiotropic enzyme" . SPARSER::ENZYME)
    ("leptin" . SPARSER::PROTEIN) ("AMPK and Akt" . SPARSER::COLLECTION)
    ("PI3K/Akt/mTOR" . SPARSER::COLLECTION) ("kinase (AMPK)" . SPARSER::KINASE)
    ("AMPK" . SPARSER::PROTEIN) ("leptin receptor" . SPARSER::PROTEIN)
    ("PKC-α" . SPARSER::PROTEIN) ("p-Thr" . SPARSER::PROTEIN)
    ("Akt-1" . SPARSER::PROTEIN) ("OB-R" . SPARSER::PROTEIN)
    ("AKT3" . SPARSER::PROTEIN) ("AKT2" . SPARSER::PROTEIN)
    ("inositol 3-kinase" . SPARSER::PROTEIN)
    ("gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Akt3" . SPARSER::PROTEIN)
    ("PKBγ" . SPARSER::PROTEIN) ("Akt2" . SPARSER::PROTEIN)
    ("PKBα" . SPARSER::PROTEIN) ("Protein kinase B" . SPARSER::PROTEIN)
    ("fatty acid synthase" . SPARSER::PROTEIN)
    ("HOX transcript antisense RNA (HOTAIR) and histone modification ( xref , xref )"
     . SPARSER::COLLECTION)
    ("RNA (HOTAIR)" . SPARSER::RNA) ("HOTAIR" . SPARSER::PROTEIN)
    ("AKT/MAPK" . SPARSER::COLLECTION)
    ("Ras-Raf-Mek-Erk" . SPARSER::COLLECTION)
    ("Erk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mek" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3K/AKT/mTOR" . SPARSER::COLLECTION)
    ("PI3K/AKT/MAPK" . SPARSER::COLLECTION)
    ("AKT and MAPK" . SPARSER::COLLECTION)
    ("AKT and ERK1/2" . SPARSER::COLLECTION)
    ("HOXD10/RHOC" . SPARSER::COLLECTION)
    ("invasive factors MMP2 and MMP9" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinase (MAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AKT and ERK" . SPARSER::COLLECTION)
    ("tumor metastatic-associated gene" . SPARSER::GENE)
    ("RHOC/AKT" . SPARSER::COLLECTION) ("Matrigel" . SPARSER::PROTEIN)
    ("Ne-CTRL" . SPARSER::COLLECTION) ("CTRL" . SPARSER::PROTEIN)
    ("Lv" . SPARSER::MOLECULE) ("nitrogen" . SPARSER::MOLECULE)
    ("GFP and HOXD10" . SPARSER::COLLECTION) ("puromycin" . SPARSER::DRUG)
    ("HOXD10 and RHOC" . SPARSER::COLLECTION) ("HOX" . SPARSER::PROTEIN)
    ("RHOC/AKT/MAPK" . SPARSER::COLLECTION)
    ("MMP2 and MMP9" . SPARSER::COLLECTION)
    ("HOXD10 and its downstream effector RHOC" . SPARSER::COLLECTION)
    ("RHOC" . SPARSER::PROTEIN) ("miR-10b" . SPARSER::MOLECULE)
    ("RHO family" . SPARSER::PROTEIN) ("Rho family" . SPARSER::PROTEIN)
    ("p-ERK1" . SPARSER::PROTEIN) ("MMP14" . SPARSER::PROTEIN)
    ("MMP2" . SPARSER::PROTEIN) ("HOXD10" . SPARSER::PROTEIN)
    ("TNF and IL1-β" . SPARSER::COLLECTION)
    ("CD163 and STAT3" . SPARSER::COLLECTION)
    ("pathological states" . SPARSER::BIO-STATE)
    ("the senescent macrophages" . SPARSER::PROTEIN)
    ("IL6 and anti-inflammatory" . SPARSER::COLLECTION)
    ("SOCS3 and STAT3" . SPARSER::COLLECTION)
    ("matrix metallopeptidase 9 (MMP9) and IL6" . SPARSER::COLLECTION)
    ("TNF" . SPARSER::PROTEIN) ("macrophages and CD163+" . SPARSER::COLLECTION)
    ("the neovascular complex" . SPARSER::BIO-COMPLEX)
    ("P65-NF-κB" . SPARSER::COLLECTION)
    ("CD68 and CD163" . SPARSER::COLLECTION)
    ("macrophage and neovascular AMD" . SPARSER::COLLECTION)
    ("neovascular AMD" . SPARSER::PROTEIN)
    ("monocytes/macrophages" . SPARSER::COLLECTION)
    ("oncogene (FOS)" . SPARSER::ONCOGENE) ("FOS" . SPARSER::PROTEIN)
    ("LPS and IL10" . SPARSER::COLLECTION) ("Socs3" . SPARSER::PROTEIN)
    ("LysM  Cre and control macrophages" . SPARSER::COLLECTION)
    ("Suppressor" . SPARSER::SUPPRESSOR)
    ("phenotypic state" . SPARSER::BIO-STATE)
    ("the active IL10/STAT3 signalling pathway state and an M2-like phenotype"
     . SPARSER::COLLECTION)
    ("both young and old macrophages" . SPARSER::PROTEIN)
    ("diphenyl" . SPARSER::DRUG) ("DPP" . SPARSER::MOLECULE)
    ("NF-κB and STAT3" . SPARSER::COLLECTION)
    ("choroidal neovascular complexes" . SPARSER::BIO-COMPLEX)
    ("IL10 and STAT3" . SPARSER::COLLECTION)
    ("IL1β , Il6 and Tnf" . SPARSER::COLLECTION)
    ("LPS or IL10" . SPARSER::COLLECTION)
    ("functional STAT3" . SPARSER::PROTEIN)
    ("Cd163 and Arg1 genes" . SPARSER::COLLECTION)
    ("Il6 ( xref ) and Tnf ( xref )" . SPARSER::COLLECTION)
    ("Il6" . SPARSER::PROTEIN) ("Cd163" . SPARSER::PROTEIN)
    ("Tnf" . SPARSER::PROTEIN) ("young and old macrophages" . SPARSER::PROTEIN)
    ("IL10 or lipopolysaccharides" . SPARSER::COLLECTION)
    ("injury-induced neovascular complexes" . SPARSER::BIO-COMPLEX)
    ("the naive state" . SPARSER::BIO-STATE)
    ("Il4, Il10 and Il13" . SPARSER::COLLECTION) ("Il13" . SPARSER::PROTEIN)
    ("Il10" . SPARSER::PROTEIN) ("Il4" . SPARSER::PROTEIN)
    ("senescent macrophages" . SPARSER::PROTEIN)
    ("IL10/IL10R" . SPARSER::COLLECTION) ("Vegf" . SPARSER::PROTEIN)
    ("Food and Drug Administration (FDA)" . SPARSER::COLLECTION)
    ("Drug" . SPARSER::DRUG) ("Food" . SPARSER::MOLECULE)
    ("vascular endothelial growth factor A (VEGF-A), basic fibroblast growth factor-2 and placental growth factor"
     . SPARSER::COLLECTION)
    ("placental growth factor" . SPARSER::GROWTH-FACTOR)
    ("homodimer" . SPARSER::HOMODIMER) ("Jak1" . SPARSER::PROTEIN)
    ("a classic anti-inflammatory cytokine" . SPARSER::PROTEIN)
    ("M1-like young syngeneic macrophages" . SPARSER::PROTEIN)
    ("a regulatory macrophage" . SPARSER::PROTEIN)
    ("Macrophages" . SPARSER::PROTEIN) ("fragments" . SPARSER::FRAGMENT)
    ("IL10/STAT3" . SPARSER::COLLECTION) ("IL4 or IL13" . SPARSER::COLLECTION)
    ("Macrophage" . SPARSER::PROTEIN)
    ("fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("IgG1" . SPARSER::BIO-COMPLEX) ("1B1" . SPARSER::PROTEIN)
    ("CD210" . SPARSER::PROTEIN) ("ml -1" . SPARSER::PROTEIN)
    ("housekeeping gene" . SPARSER::PROTEIN) ("Il1β" . SPARSER::PROTEIN)
    ("Tnfα" . SPARSER::DRUG) ("18 h" . SPARSER::PROTEIN)
    ("rd1" . SPARSER::PROTEIN) ("Ikkβ" . SPARSER::PROTEIN)
    ("IL1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transmembrane protein" . SPARSER::PROTEIN) ("GP130" . SPARSER::PROTEIN)
    ("IL6" . SPARSER::PROTEIN) ("MMP9" . SPARSER::PROTEIN)
    ("matrix metallopeptidase 9" . SPARSER::PROTEIN)
    ("CCL2" . SPARSER::PROTEIN) ("C-C motif" . SPARSER::PROTEIN)
    ("P65" . SPARSER::PROTEIN) ("CD68" . SPARSER::PROTEIN)
    ("inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta"
     . SPARSER::PROTEIN)
    ("IL1β" . SPARSER::PROTEIN) ("Stat3" . SPARSER::PROTEIN)
    ("anti-angiogenic" . SPARSER::DRUG) ("IL10R" . SPARSER::PROTEIN)
    ("anti-VEGF" . SPARSER::DRUG)
    ("basic fibroblast growth factor" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor A" . SPARSER::PROTEIN)
    ("IL10R2" . SPARSER::PROTEIN) ("IL10R1" . SPARSER::PROTEIN)
    ("receptor 1" . SPARSER::PROTEIN) ("CD163" . SPARSER::PROTEIN)
    ("IL13" . SPARSER::PROTEIN) ("IL4" . SPARSER::PROTEIN)
    ("IL10" . SPARSER::PROTEIN) ("Nat" . SPARSER::PROTEIN)
    ("mitotic kinases and proteins" . SPARSER::COLLECTION)
    ("kinases and proteins" . SPARSER::COLLECTION)
    ("RSF1 S1375A and RSF1 S1359A" . SPARSER::COLLECTION)
    ("the phosphorylation-defective RSF1 S1375A mutants" . SPARSER::MUTANT)
    ("−1" . SPARSER::PROTEIN) ("pS" . SPARSER::PROTEIN)
    ("stably position PLK1" . SPARSER::PROTEIN)
    ("RSF1 and INCENP" . SPARSER::COLLECTION)
    ("RSF1 or INCENP" . SPARSER::COLLECTION)
    ("residual PLK1" . SPARSER::PROTEIN)
    ("other kinetochore/centromere-associated proteins" . SPARSER::PROTEIN)
    ("these proteins and other mitotic kinases" . SPARSER::COLLECTION)
    ("other mitotic kinases" . SPARSER::KINASE)
    ("complex (CPC)" . SPARSER::BIO-COMPLEX) ("CPC" . SPARSER::PROTEIN)
    ("PBIP1–PLK1" . SPARSER::COLLECTION)
    ("the inner centromeric protein INCENP" . SPARSER::PROTEIN)
    ("INCENP" . SPARSER::PROTEIN) ("Active" . SPARSER::ACTIVE)
    ("GFP-H2B" . SPARSER::COLLECTION) ("-fused" . SPARSER::COLLECTION)
    ("Our group and others xref" . SPARSER::COLLECTION)
    ("enzyme and substrates" . SPARSER::COLLECTION)
    ("PLK1–RSF1" . SPARSER::COLLECTION) ("CDK1 and PLK1" . SPARSER::COLLECTION)
    ("the phosphomimetic RSF1-C1 S1359D" . SPARSER::COLLECTION)
    ("RSF1-C1 S1359D" . SPARSER::COLLECTION)
    ("the phosphomimetic RSF1-C1 S1375D" . SPARSER::COLLECTION)
    ("PLK1 and RSF1" . SPARSER::COLLECTION)
    ("a phosphomimetic mutant" . SPARSER::MUTANT)
    ("RSF1-C1 S1375D" . SPARSER::COLLECTION)
    ("cyclinB1/CDK1" . SPARSER::COLLECTION)
    ("RSF1-C1 S1359A" . SPARSER::COLLECTION)
    ("RSF1-C1 S1375A" . SPARSER::COLLECTION)
    ("a triple mutant" . SPARSER::MUTANT) ("Ser and Thr" . SPARSER::COLLECTION)
    ("Ser or Thr" . SPARSER::COLLECTION) ("Ala" . SPARSER::AMINO-ACID)
    ("transfectants" . SPARSER::PROTEIN)
    ("both full-length RSF1 (RSF1-FL) and RSF1-C2" . SPARSER::COLLECTION)
    ("Commercially available cyclin B and CDK1 proteins" . SPARSER::PROTEIN)
    ("cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RSF1-N3" . SPARSER::COLLECTION) ("RSF1-N2" . SPARSER::COLLECTION)
    ("RSF1 and PLK1" . SPARSER::COLLECTION) ("Rsf1" . SPARSER::PROTEIN)
    ("labile" . SPARSER::PROTEIN)
    ("immobilized GST-tagged RSF1 or FLAG-tagged PLK1" . SPARSER::COLLECTION)
    ("immobilized glutathione S -transferase (GST)-tagged RSF1 or FLAG-tagged PLK1"
     . SPARSER::COLLECTION)
    ("PLK1 and SNF2H" . SPARSER::COLLECTION)
    ("RSF1–PLK1" . SPARSER::COLLECTION) ("HA" . SPARSER::PROTEIN)
    ("V5-tagged full-length RSF1 protein" . SPARSER::PROTEIN)
    ("ref" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a centromeric nucleosome component" . SPARSER::COMPONENT)
    ("RSF1 and SNF2H" . SPARSER::COLLECTION)
    ("the soluble fraction" . SPARSER::COMPONENT)
    ("the outer kinetochore-associated Mad2" . SPARSER::PROTEIN)
    ("Mad2" . SPARSER::PROTEIN) ("Topo" . SPARSER::PROTEIN)
    ("Mad" . SPARSER::PROTEIN) ("soluble chromatin" . SPARSER::PROTEIN)
    ("NaCl" . SPARSER::PROTEIN) ("antibodies (ACA)" . SPARSER::ANTIBODY)
    ("ACA" . SPARSER::PROTEIN) ("a centromeric component" . SPARSER::COMPONENT)
    ("the phosphomimetic RSF1 mutants" . SPARSER::MUTANT)
    ("this protein's" . SPARSER::PROTEIN)
    ("CENP-S and CENP-X" . SPARSER::COLLECTION)
    ("centromeric core nucleosomes" . SPARSER::BIO-COMPLEX)
    ("nucleosomes" . SPARSER::BIO-COMPLEX)
    ("nucleosome" . SPARSER::BIO-COMPLEX) ("ATPase" . SPARSER::PROTEIN)
    ("PLK1 and other interacting kinases and phosphatases"
     . SPARSER::COLLECTION)
    ("kinases and phosphatases" . SPARSER::COLLECTION)
    ("survivin and haspin" . SPARSER::COLLECTION)
    ("haspin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the microtubule-associated proteins CLASP2 and CLIP170"
     . SPARSER::COLLECTION)
    ("CLASP2 and CLIP170" . SPARSER::COLLECTION) ("refs" . SPARSER::PROTEIN)
    ("centromeres" . SPARSER::PROTEIN)
    ("an essential mitotic kinase" . SPARSER::KINASE)
    ("the mitotic kinase CDK1" . SPARSER::PROTEIN)
    ("an essential centromeric component" . SPARSER::COMPONENT)
    ("RSF1 S1375D or RSF1 S1359D" . SPARSER::COLLECTION)
    ("RO3306" . SPARSER::DRUG) ("Cdk1" . SPARSER::PROTEIN)
    ("Cyclin B1" . SPARSER::PROTEIN) ("Na 3 VO 4" . SPARSER::MOLECULE)
    ("pRG2" . SPARSER::PROTEIN) ("ml −1" . SPARSER::PROTEIN)
    ("CCL-2" . SPARSER::PROTEIN) ("Mis18" . SPARSER::PROTEIN-FAMILY)
    ("X-R" . SPARSER::PROTEIN) ("Bub1" . SPARSER::PROTEIN)
    ("CENP-U" . SPARSER::PROTEIN) ("PBIP1" . SPARSER::PROTEIN)
    ("H2B" . SPARSER::PROTEIN) ("histone H2B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclinB1" . SPARSER::PROTEIN) ("C1 S" . SPARSER::PROTEIN)
    ("Ro3306" . SPARSER::DRUG) ("N3" . SPARSER::PROTEIN)
    ("N2" . SPARSER::PROTEIN) ("glutathione S -transferase" . SPARSER::PROTEIN)
    ("Myc-tagged" . SPARSER::PROTEIN) ("CENP-X" . SPARSER::PROTEIN)
    ("CENP-S" . SPARSER::PROTEIN) ("CENP-A" . SPARSER::PROTEIN)
    ("SNF2H" . SPARSER::PROTEIN) ("BubR1" . SPARSER::PROTEIN)
    ("CLIP170" . SPARSER::PROTEIN) ("CLASP2" . SPARSER::PROTEIN)
    ("CDK1" . SPARSER::PROTEIN) ("RSF1" . SPARSER::PROTEIN)
    ("MDS" . SPARSER::PROTEIN) ("hemoglobin" . SPARSER::MOLECULE)
    ("Sotatercept" . SPARSER::DRUG)
    ("activin and other TGFβ" . SPARSER::COLLECTION)
    ("trap" . SPARSER::PROTEIN) ("sotatercept" . SPARSER::DRUG)
    ("TRIM33-SMAD2/3 and SMAD4-SMAD2/3" . SPARSER::COLLECTION)
    ("TGFβ/SMAD" . SPARSER::COLLECTION)
    ("SMAD4-SMAD2/3" . SPARSER::PROTEIN-PAIR)
    ("TRIM33-SMAD2/3" . SPARSER::PROTEIN-PAIR)
    ("TRIM33 and SMAD4" . SPARSER::COLLECTION)
    ("endothelial SMAD4" . SPARSER::PROTEIN)
    ("TGFβ-SMAD4" . SPARSER::COLLECTION)
    ("RPL11 and RPL5" . SPARSER::COLLECTION)
    ("TGFβ2 , TGFβ1R , CDKN1A and SERPINE1" . SPARSER::COLLECTION)
    ("molecules and pathways" . SPARSER::COLLECTION)
    ("TP53 , TGFB1R , TGFβ2 , and GATA1" . SPARSER::COLLECTION)
    ("USP9x and TRIM33" . SPARSER::COLLECTION) ("USP9x" . SPARSER::PROTEIN)
    ("monoubiquitin" . SPARSER::PROTEIN)
    ("PAI-1 and collagens" . SPARSER::COLLECTION)
    ("SMAD3 and p-SMAD3 ( xref )" . SPARSER::COLLECTION)
    ("JNK and TGFβ" . SPARSER::COLLECTION)
    ("p-ERK, p-p38 and p-JNK in the DBA cells" . SPARSER::COLLECTION)
    ("p38, ERK and JNK" . SPARSER::COLLECTION)
    ("of-SMAD2, and TGFβ" . SPARSER::COLLECTION)
    ("SMAD5 mRNA or nuclear p-SMAD5" . SPARSER::COLLECTION)
    ("p-SMAD5" . SPARSER::COLLECTION)
    ("SMAD1, SMAD5, and SMAD8" . SPARSER::COLLECTION)
    ("SMAD3 and SMAD4" . SPARSER::COLLECTION) ("p-SMAD3" . SPARSER::COLLECTION)
    ("p-SMAD2" . SPARSER::COLLECTION) ("p-SMAD" . SPARSER::COLLECTION)
    ("SMAD2 and SMAD3" . SPARSER::COLLECTION)
    ("SMAD3 and their active forms" . SPARSER::COLLECTION)
    ("R-SMADs, SMAD2 and SMAD3" . SPARSER::COLLECTION)
    ("pR-SMAD/SMAD4" . SPARSER::COLLECTION)
    ("pR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("collagen" . SPARSER::PROTEIN)
    ("a transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("BMP and activin" . SPARSER::COLLECTION)
    ("glycoprotein" . SPARSER::PROTEIN) ("activin" . SPARSER::PROTEIN)
    ("BMP" . SPARSER::PROTEIN)
    ("SERPINE1 (18.30±1.7 fold for DBA line with RPS19 mutation; 2.40±0.08 fold for RPL5 line) and TGFBI (8.58±0.34 fold for RPS19 line; 4.78±0.14 fold for RPL5 line)"
     . SPARSER::COLLECTION)
    ("plasminogen activator inhibitor-1 ( PAI-1 or SERPINE1 ) and transforming growth factor"
     . SPARSER::COLLECTION)
    ("PAI-1 or SERPINE1" . SPARSER::COLLECTION) ("Genes" . SPARSER::GENE)
    ("ECM" . SPARSER::PROTEIN) ("IPA" . SPARSER::MOLECULE)
    ("genes and pathways" . SPARSER::COLLECTION) ("Exon" . SPARSER::PROTEIN)
    ("RPL5 and RPS19" . SPARSER::COLLECTION)
    ("small GTPases and the MAP kinases ERK" . SPARSER::COLLECTION)
    ("JNK/p38" . SPARSER::COLLECTION)
    ("Phosphorylated receptor activated SMADs" . SPARSER::PROTEIN)
    ("SMADs" . SPARSER::PROTEIN) ("MAD" . SPARSER::PROTEIN)
    ("Drosophila" . SPARSER::PROTEIN) ("elegans" . SPARSER::PROTEIN)
    ("SMAD" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Type I or Type II" . SPARSER::COLLECTION) ("heme" . SPARSER::PROTEIN)
    ("ribosomal proteins" . SPARSER::PROTEIN) ("globin" . SPARSER::PROTEIN)
    ("ribosome" . SPARSER::BIO-COMPLEX) ("erythroid" . SPARSER::PROTEIN)
    ("both large and small ribosomal subunits" . SPARSER::PROTEIN)
    ("ribosomal proteins (RP)" . SPARSER::PROTEIN) ("RPs" . SPARSER::PROTEIN)
    ("RP" . SPARSER::PROTEIN) ("p-JNK" . SPARSER::COLLECTION)
    ("TGFBI , BAMBI , COL3A1 and SERPINE1" . SPARSER::COLLECTION)
    ("BAMBI" . SPARSER::PROTEIN) ("TGFBI" . SPARSER::PROTEIN)
    ("RPS19 or RPL5" . SPARSER::COLLECTION)
    ("receptor type" . SPARSER::PROTEIN)
    ("TGF β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("elongation factor" . SPARSER::PROTEIN)
    ("E3 ubiquitin-protein ligase TRIM33" . SPARSER::PROTEIN)
    ("bone morphogenetic protein 4" . SPARSER::PROTEIN)
    ("RPL11" . SPARSER::PROTEIN) ("GATA-1" . SPARSER::PROTEIN)
    ("X-linked" . SPARSER::PROTEIN) ("TGFB1" . SPARSER::PROTEIN)
    ("CD41" . SPARSER::PROTEIN) ("PS341" . SPARSER::DRUG)
    ("JNK protein" . SPARSER::PROTEIN) ("JNK1" . SPARSER::PROTEIN)
    ("p-p38" . SPARSER::PROTEIN) ("p-ERK" . SPARSER::PROTEIN)
    ("activin receptor-like kinase" . SPARSER::PROTEIN)
    ("SB431542" . SPARSER::DRUG) ("SMAD8" . SPARSER::PROTEIN)
    ("SMAD1" . SPARSER::PROTEIN) ("type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("membrane-bound" . SPARSER::PROTEIN) ("PAI-1" . SPARSER::PROTEIN)
    ("plasminogen activator inhibitor-1" . SPARSER::PROTEIN)
    ("TRIM33" . SPARSER::PROTEIN) ("TIF1γ" . SPARSER::PROTEIN)
    ("USP9" . SPARSER::PROTEIN) ("SMAD5" . SPARSER::PROTEIN)
    ("SMAD3" . SPARSER::PROTEIN) ("SMAD2" . SPARSER::PROTEIN)
    ("Reverse Transcriptase" . SPARSER::PROTEIN)
    ("Reverse-Transcriptase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("N 2" . SPARSER::PROTEIN) ("MAP kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("R-SMADs" . SPARSER::PROTEIN-FAMILY)
    ("Type II" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Type I" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GATA1" . SPARSER::PROTEIN)
    ("TGFβ2" . SPARSER::PROTEIN) ("TGFβ1" . SPARSER::PROTEIN)
    ("SMAD4" . SPARSER::PROTEIN) ("SERPINE1" . SPARSER::PROTEIN)
    ("COL3A1" . SPARSER::PROTEIN) ("RPL5" . SPARSER::PROTEIN)
    ("RPS19" . SPARSER::PROTEIN) ("ribosomal protein" . SPARSER::PROTEIN)
    ("MiRs" . SPARSER::PROTEIN)
    ("many other accessory proteins" . SPARSER::PROTEIN) ("hTR" . SPARSER::RNA)
    ("hTERT and TRF2" . SPARSER::COLLECTION)
    ("mut-hTERT-3" . SPARSER::COLLECTION) ("hTERT-3" . SPARSER::COLLECTION)
    ("a clinically useful diagnostic or prognostic molecule biomarker"
     . SPARSER::MOLECULE)
    ("miRs" . SPARSER::PROTEIN) ("ribonucleoprotein" . SPARSER::PROTEIN)
    ("Mcl-1" . SPARSER::PROTEIN) ("factor-κB" . SPARSER::PROTEIN)
    ("TRF2" . SPARSER::PROTEIN) ("Telomerase activity" . SPARSER::PROTEIN)
    ("3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("miR-181a" . SPARSER::MOLECULE) ("messenger RNAs" . SPARSER::RNA)
    ("dual-luciferase" . SPARSER::PROTEIN)
    ("telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("telomerase activity" . SPARSER::PROTEIN)
    ("the largest genes" . SPARSER::GENE) ("Biomarkers" . SPARSER::MOLECULE)
    ("temsirolimus and everolimus" . SPARSER::COLLECTION)
    ("TSC-RHEB-mTOR" . SPARSER::COLLECTION) ("TSC" . SPARSER::PROTEIN)
    ("TSC1 or TSC2" . SPARSER::COLLECTION)
    ("PRAS40 and DEPTOR" . SPARSER::COLLECTION)
    ("genes encoding upstream RTK's" . SPARSER::GENE)
    ("RTK" . SPARSER::PROTEIN) ("multiple sporadic cancer types" . TYPE)
    ("alanine or phenylalanine" . SPARSER::COLLECTION)
    ("phenylalanine" . SPARSER::AMINO-ACID) ("TSC1/TSC2" . SPARSER::COLLECTION)
    ("RAPTOR or RICTOR" . SPARSER::COLLECTION)
    ("mTORC1 or mTORC2" . SPARSER::COLLECTION)
    ("S6K and 4E-BP1" . SPARSER::COLLECTION) ("Rag" . SPARSER::PROTEIN)
    ("myc" . SPARSER::PROTEIN) ("BPs" . SPARSER::PROTEIN)
    ("lipids and nucleic acids [ xref ]" . SPARSER::COLLECTION)
    ("carboxy" . SPARSER::MOLECULE) ("ser" . SPARSER::AMINO-ACID)
    ("another previously characterized mutant" . SPARSER::MUTANT)
    ("accessory proteins" . SPARSER::PROTEIN)
    ("both the N lobe and the C lobe" . SPARSER::COLLECTION)
    ("lobe" . SPARSER::PROTEIN) ("FATC" . SPARSER::PROTEIN-FAMILY)
    ("clamps" . SPARSER::PROTEIN-FAMILY)
    ("family and form" . SPARSER::COLLECTION) ("TPR" . SPARSER::PROTEIN)
    ("ID" . SPARSER::PROTEIN) ("Mapping" . SPARSER::PROTEIN)
    ("TSC1 (tuberous sclerosis 1; also known as hamartin) and TSC2 (tuberous sclerosis 2; also known as tuberin)"
     . SPARSER::COLLECTION)
    ("GTPase-activating protein (GAP)" . SPARSER::PROTEIN)
    ("tuberin" . SPARSER::PROTEIN) ("hamartin" . SPARSER::PROTEIN)
    ("S6K1 (S6 Kinase 1) and 4E-BP1 (eIF-4E binding protein 1)"
     . SPARSER::COLLECTION)
    ("mTORC1 and mTORC2 share mLST8(mammalian lethal with sec-13) and the negative regulator DEPTOR [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("PROTOR (protein observed with rictor 1 and 2) and mSIN1(mammalian stress-activated map kinase-interacting protein 1)"
     . SPARSER::COLLECTION)
    ("Unique components" . SPARSER::COMPONENT)
    ("PROTOR" . SPARSER::PROTEIN-FAMILY)
    ("RAPTOR (regulatory associated protein of mTOR) and RICTOR (rapamycin-insensitive companion of mTOR)"
     . SPARSER::COLLECTION)
    ("RICTOR" . SPARSER::PROTEIN) ("RAPTOR" . SPARSER::PROTEIN)
    ("everolimus and temsirolimus" . SPARSER::COLLECTION)
    ("temsirolimus" . SPARSER::DRUG) ("everolimus" . SPARSER::DRUG)
    ("GAP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DEPTOR" . SPARSER::PROTEIN)
    ("mTORC1 and mTORC2" . SPARSER::COLLECTION)
    ("FRAP-ATM-TTRAP" . SPARSER::COLLECTION) ("TTRAP" . SPARSER::PROTEIN)
    ("FRAP" . SPARSER::PROTEIN) ("FAT" . SPARSER::PROTEIN)
    ("MTOR and its upstream regulator RHEB" . SPARSER::COLLECTION)
    ("RHEB" . SPARSER::PROTEIN) ("MTOR" . SPARSER::PROTEIN)
    ("N 1" . SPARSER::PROTEIN) ("ammonium chloride" . SPARSER::MOLECULE)
    ("Akt1" . SPARSER::PROTEIN) ("S16" . SPARSER::PROTEIN)
    ("PP2A" . SPARSER::PROTEIN) ("protein phosphatase" . SPARSER::PROTEIN)
    ("LKB1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p110α" . SPARSER::PROTEIN)
    ("catalytic subunit" . SPARSER::PROTEIN)
    ("phospholipase D1" . SPARSER::PROTEIN) ("PLD1" . SPARSER::PROTEIN)
    ("Amino acids" . SPARSER::AMINO-ACID)
    ("scaffolding protein" . SPARSER::PROTEIN) ("S6Ks" . SPARSER::PROTEIN)
    ("S6 kinases" . SPARSER::PROTEIN-FAMILY)
    ("eukaryotic initiation factor 4E" . SPARSER::PROTEIN-FAMILY)
    ("S6K" . SPARSER::PROTEIN) ("tuberous sclerosis 2" . SPARSER::PROTEIN)
    ("tuberous sclerosis 1" . SPARSER::PROTEIN) ("TSC1" . SPARSER::PROTEIN)
    ("4E-BP1" . SPARSER::PROTEIN) ("S6 Kinase" . SPARSER::PROTEIN-FAMILY)
    ("S6K1" . SPARSER::PROTEIN) ("mLST8" . SPARSER::PROTEIN)
    ("stress-activated map kinase-interacting protein 1" . SPARSER::PROTEIN)
    ("mSIN1" . SPARSER::PROTEIN)
    ("rapamycin-insensitive companion of mTOR" . SPARSER::PROTEIN)
    ("regulatory associated protein of mTOR" . SPARSER::PROTEIN)
    ("GTPase activating protein" . SPARSER::PROTEIN)
    ("Tuberous Sclerosis 2" . SPARSER::PROTEIN) ("PRAS40" . SPARSER::PROTEIN)
    ("mTORC1" . SPARSER::PROTEIN) ("brain)" . SPARSER::PROTEIN)
    ("mechanistic target of rapamycin" . SPARSER::PROTEIN)
    ("PUMA and NOXA" . SPARSER::COLLECTION) ("NOXA" . SPARSER::PROTEIN)
    ("PERK and ATF6" . SPARSER::COLLECTION) ("zebularine" . SPARSER::DRUG)
    ("ATF6 and PERK/eIF2α" . SPARSER::COLLECTION)
    ("p53 and SYVN1" . SPARSER::COLLECTION)
    ("DMSO or STF-083010" . SPARSER::COLLECTION)
    ("ATF6, PERK, or IRE1α" . SPARSER::COLLECTION) ("DsRed" . SPARSER::PROTEIN)
    ("BiP and P-eIF2α" . SPARSER::COLLECTION)
    ("SEAP" . SPARSER::PROTEIN-FAMILY)
    ("a triple complex" . SPARSER::BIO-COMPLEX)
    ("p53, SYVN1 and IRE1α" . SPARSER::COLLECTION)
    ("p53-SYVN1-IRE1α" . SPARSER::COLLECTION)
    ("Wild-type p53 and two p53 mutants (R249S and R273H)"
     . SPARSER::COLLECTION)
    ("SYVN1–IRE1α" . SPARSER::COLLECTION)
    ("SYVN1 and IRE1α" . SPARSER::COLLECTION) ("Synoviolin" . SPARSER::PROTEIN)
    ("IRE" . SPARSER::PROTEIN) ("IRE1α and BiP" . SPARSER::COLLECTION)
    ("BFA" . SPARSER::MOLECULE) ("BiP" . SPARSER::PROTEIN)
    ("eIF2α" . SPARSER::PROTEIN) ("ATF6, and PERK/eIF2α" . SPARSER::COLLECTION)
    ("tunicamycin" . SPARSER::MOLECULE) ("shp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MEF" . SPARSER::PROTEIN) ("p53–SYVN1–IRE1α" . SPARSER::COLLECTION)
    ("kinase (PERK)" . SPARSER::KINASE) ("eIF2" . SPARSER::PROTEIN)
    ("protein-kinase/endoribonuclease" . SPARSER::COLLECTION)
    ("PERK" . SPARSER::PROTEIN) ("eIF" . SPARSER::PROTEIN)
    ("inositol" . SPARSER::PROTEIN) ("endoribonuclease" . SPARSER::PROTEIN)
    ("/HRD1/DER3" . SPARSER::COLLECTION) ("synoviolin" . SPARSER::PROTEIN)
    ("IRE1α/XBP1" . SPARSER::COLLECTION) ("GADD34" . SPARSER::PROTEIN)
    ("Synoviolin1" . SPARSER::PROTEIN) ("membrane protein" . SPARSER::PROTEIN)
    ("IRE1" . SPARSER::PROTEIN)
    ("alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("IRE1 α" . SPARSER::PROTEIN) ("p90" . SPARSER::PROTEIN)
    ("brefeldin A" . SPARSER::MOLECULE) ("STF-083010" . SPARSER::DRUG)
    ("ATF6" . SPARSER::PROTEIN)
    ("activating transcription factor 6" . SPARSER::PROTEIN)
    ("protein kinase R" . SPARSER::PROTEIN) ("DER3" . SPARSER::PROTEIN)
    ("HRD1" . SPARSER::PROTEIN) ("SYVN1" . SPARSER::PROTEIN)
    ("XBP1" . SPARSER::PROTEIN) ("IRE1α" . SPARSER::PROTEIN)
    ("tumor suppressor p53" . SPARSER::PROTEIN)
    ("gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PirH2, Jab1, KPC1 or Skp2" . SPARSER::COLLECTION)
    ("p53 as well as p27" . SPARSER::COLLECTION)
    ("c-Jun and ETV1" . SPARSER::COLLECTION)
    ("KPC1, Jab1, PirH2, or SKP2" . SPARSER::COLLECTION)
    ("wt p27 and all these different mutants" . SPARSER::COLLECTION)
    ("Skp2" . SPARSER::PROTEIN) ("COP1-shRNA" . SPARSER::COLLECTION)
    ("exogenous p27" . SPARSER::PROTEIN) ("p27-COP1" . SPARSER::COLLECTION)
    ("TNT" . SPARSER::PROTEIN) ("p27 and COP1" . SPARSER::COLLECTION)
    ("nocodazole" . SPARSER::DRUG) ("COP1 and p27" . SPARSER::COLLECTION)
    ("KPC1, Jab1, PirH2 or Skp2" . SPARSER::COLLECTION)
    ("Skp" . SPARSER::PROTEIN) ("p53 and 14-3-3" . SPARSER::COLLECTION)
    ("MDM2-p53" . SPARSER::COLLECTION) ("Cullin" . SPARSER::PROTEIN-FAMILY)
    ("HYH" . SPARSER::PROTEIN) ("COP1-p27" . SPARSER::COLLECTION)
    ("ligase" . SPARSER::LIGASE) ("VP" . SPARSER::PROTEIN)
    ("ring finger and WD repeat domain 2" . SPARSER::PROTEIN)
    ("UbcH5a" . SPARSER::PROTEIN) ("Nonidet P-40" . SPARSER::DRUG)
    ("aa1" . SPARSER::PROTEIN) ("COP1 S" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cyclin E" . SPARSER::PROTEIN) ("Pirh2" . SPARSER::PROTEIN)
    ("CA5" . SPARSER::PROTEIN) ("Lamin B1" . SPARSER::PROTEIN)
    ("penicillin G" . SPARSER::MOLECULE)
    ("F-box protein Skp2" . SPARSER::PROTEIN) ("Cdk2" . SPARSER::PROTEIN)
    ("aa 1" . SPARSER::PROTEIN) ("PirH2" . SPARSER::PROTEIN)
    ("Jab1" . SPARSER::PROTEIN) ("KPC1" . SPARSER::PROTEIN)
    ("RING finger protein" . SPARSER::PROTEIN) ("14-3-3" . SPARSER::PROTEIN)
    ("MTA1" . SPARSER::PROTEIN) ("TORC2" . SPARSER::PROTEIN)
    ("acetyl-CoA" . SPARSER::MOLECULE) ("C/EBPalpha" . SPARSER::PROTEIN)
    ("ETV1" . SPARSER::PROTEIN) ("c-Jun" . SPARSER::PROTEIN)
    ("MDM2" . SPARSER::PROTEIN) ("CSN6" . SPARSER::PROTEIN)
    ("COP9 signalosome subunit 6" . SPARSER::PROTEIN)
    ("HY5" . SPARSER::PROTEIN) ("p27 Kip1" . SPARSER::PROTEIN)
    ("COP1" . SPARSER::PROTEIN) ("p27" . SPARSER::PROTEIN)
    ("NRAS, HRAS, and KRAS" . SPARSER::COLLECTION) ("HRAS" . SPARSER::PROTEIN)
    ("NRAS" . SPARSER::PROTEIN) ("PI3/AKT" . SPARSER::COLLECTION)
    ("classical variant PTCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the RAS -positive" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RET-PTC" . SPARSER::COLLECTION) ("PAX8-PPARγ" . SPARSER::COLLECTION)
    ("a large consecutive cohort" . SPARSER::MOLECULE)
    ("BRAF or RAS" . SPARSER::COLLECTION) ("PAX8/PPARγ" . SPARSER::COLLECTION)
    ("RET/PTC" . SPARSER::COLLECTION) ("PTC" . SPARSER::PROTEIN)
    ("all follicular variants" . SPARSER::VARIANT) ("BRAF" . SPARSER::PROTEIN)
    ("-oncogene" . SPARSER::ONCOGENE) ("thyroid" . SPARSER::PROTEIN)
    ("PI3" . SPARSER::PROTEIN) ("H- RAS" . SPARSER::PROTEIN)
    ("K-RAS" . SPARSER::PROTEIN) ("H-RAS" . SPARSER::PROTEIN)
    ("PPARγ" . SPARSER::PROTEIN) ("PAX8" . SPARSER::PROTEIN)
    ("TCF/LEF" . SPARSER::COLLECTION)
    ("IQGAP1 and its interacting protein β-catenin" . SPARSER::COLLECTION)
    ("IQGAP1 ( xref ), IQGAP1 and its interacting protein β-catenin"
     . SPARSER::COLLECTION)
    ("APC and Axin1" . SPARSER::COLLECTION)
    ("IQGAP1 and its binding protein β-catenin" . SPARSER::COLLECTION)
    ("part" . SPARSER::COMPONENT)
    ("β-catenin, APC, GSK3B, AXIN1, LEF1, and TCF7L2" . SPARSER::COLLECTION)
    ("parts" . SPARSER::COMPONENT) ("CDC42/Rac1" . SPARSER::COLLECTION)
    ("cadherin-catenin" . SPARSER::COLLECTION)
    ("E-cadherin–β-catenin–α-catenin" . SPARSER::COLLECTION)
    ("E-cadherin–β-catenin–IQGAP1" . SPARSER::COLLECTION)
    ("CDC42, E-cadherin and APC" . SPARSER::COLLECTION)
    ("map" . SPARSER::PROTEIN)
    ("E-cadherin (CDH1) and adenomatous polyposis coli (APC)"
     . SPARSER::COLLECTION)
    ("non-target control oligonucleotides (si NC) and those"
     . SPARSER::COLLECTION)
    ("FITC" . SPARSER::MOLECULE)
    ("IQGAP1 and beta-catenin" . SPARSER::COLLECTION)
    ("β-catenin and IQGAP1" . SPARSER::COLLECTION)
    ("c-myc, cyclin D1 and Axin2" . SPARSER::COLLECTION)
    ("the upregulated β-catenin induced some target gene" . SPARSER::GENE)
    ("pGL3-catenin" . SPARSER::COLLECTION)
    ("catenin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proteins, IQGAP1 and β-catenin" . SPARSER::COLLECTION)
    ("si-IQGAP1" . SPARSER::COLLECTION) ("pFlag-IQGAP1" . SPARSER::COLLECTION)
    ("IQGAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDC42 and Rac1" . SPARSER::COLLECTION)
    ("metastatic HCC" . SPARSER::PROTEIN)
    ("IQGAP1 and β-catenin" . SPARSER::COLLECTION)
    ("a multifunctional scaffold protein" . SPARSER::PROTEIN)
    ("Axin1" . SPARSER::PROTEIN) ("TCF7L2" . SPARSER::PROTEIN)
    ("LEF1" . SPARSER::PROTEIN) ("GSK3B" . SPARSER::PROTEIN)
    ("α-catenin" . SPARSER::PROTEIN) ("CDH1" . SPARSER::PROTEIN)
    ("cell division cycle 42" . SPARSER::PROTEIN)
    ("cyclin D1" . SPARSER::PROTEIN) ("beta-catenin" . SPARSER::PROTEIN)
    ("cell membrane" . SPARSER::PROTEIN) ("LMNB1" . SPARSER::PROTEIN)
    ("MK3" . SPARSER::PROTEIN) ("Dimethyl Sulfoxide" . SPARSER::MOLECULE)
    ("A -3" . SPARSER::PROTEIN) ("G -3" . SPARSER::PROTEIN)
    ("AG-3" . SPARSER::PROTEIN) ("T-3" . SPARSER::PROTEIN)
    ("Rac1" . SPARSER::PROTEIN) ("CDC42" . SPARSER::PROTEIN)
    ("GTPase-activating" . SPARSER::PROTEIN) ("IQGAP1" . SPARSER::PROTEIN)
    ("GTPase-activating protein" . SPARSER::PROTEIN)
    ("p53, p21, Mdm2, BAX and PUMA" . SPARSER::COLLECTION)
    ("p21 and Mdm2" . SPARSER::COLLECTION) ("the 5th exon" . SPARSER::PROTEIN)
    ("valine" . SPARSER::AMINO-ACID)
    ("arginine (CGC) or proline (CCC)" . SPARSER::COLLECTION)
    ("the 4th exon" . SPARSER::PROTEIN)
    ("pro-apoptotic targets PUMA and BAX" . SPARSER::COLLECTION)
    ("PUMA and BAX" . SPARSER::COLLECTION)
    ("p53, BAX and PUMA" . SPARSER::COLLECTION) ("PUMA" . SPARSER::PROTEIN)
    ("BAX and PUMA protein" . SPARSER::COLLECTION)
    ("lenti-sh" . SPARSER::COLLECTION) ("sh" . SPARSER::PROTEIN-FAMILY)
    ("-E2" . SPARSER::MOLECULE) ("p53, p21 and Mdm2" . SPARSER::COLLECTION)
    ("p53, p21Waf1/Cip1 and Mdm2" . SPARSER::COLLECTION)
    ("Cisplatin (33.33 µ M) and Nutlin-3 (10 µ M)" . SPARSER::COLLECTION)
    ("cisplatin ( xref ) or Nutlin-3 ( xref )" . SPARSER::COLLECTION)
    ("NPC and NPE cells" . SPARSER::COLLECTION)
    ("cisplatin and Nutlin-3" . SPARSER::COLLECTION) ("HK1" . SPARSER::PROTEIN)
    ("recurrent radioresistant NPC" . SPARSER::MOLECULE)
    ("acute myeloid" . SPARSER::PROTEIN) ("myeloid" . SPARSER::PROTEIN)
    ("-imidazoline" . SPARSER::MOLECULE) ("analogs" . SPARSER::ANALOG)
    ("imidazoline" . SPARSER::MOLECULE) ("Nutlins" . SPARSER::DRUG)
    ("ubiquitin-proteosome" . SPARSER::PROTEIN-PAIR)
    ("which controls genes" . SPARSER::GENE)
    ("cisplatin and 5-fluorouracil" . SPARSER::COLLECTION)
    ("cisplatin and Nutlin-3 as" . SPARSER::COLLECTION)
    ("NPC" . SPARSER::MOLECULE) ("p53-Mdm2" . SPARSER::COLLECTION)
    ("PUMA protein" . SPARSER::PROTEIN) ("p21 protein" . SPARSER::PROTEIN)
    ("NH 3" . SPARSER::MOLECULE) ("Bcl2" . SPARSER::PROTEIN)
    ("Waf1/Cip1" . SPARSER::PROTEIN) ("AC-3" . SPARSER::PROTEIN)
    ("G-3" . SPARSER::PROTEIN) ("C-3" . SPARSER::PROTEIN)
    ("ATG-3" . SPARSER::PROTEIN) ("CA-3" . SPARSER::PROTEIN)
    ("LMP1" . SPARSER::PROTEIN) ("ubiquitin ligase" . SPARSER::PROTEIN)
    ("Nutlin-3 as" . SPARSER::DRUG) ("Nutlin-3" . SPARSER::DRUG)
    ("Mdm2" . SPARSER::PROTEIN) ("ER/PR" . SPARSER::COLLECTION)
    ("ER and PR-B" . SPARSER::COLLECTION)
    ("hormonal receptors" . SPARSER::PROTEIN)
    ("ER-beta/ER-alpha" . SPARSER::COLLECTION)
    ("southern blot" . SPARSER::PROTEIN) ("EC" . SPARSER::PROTEIN)
    ("cytotoxic" . SPARSER::PROTEIN) ("progesterone" . SPARSER::PROTEIN)
    ("ER-alpha and p53" . SPARSER::COLLECTION)
    ("ER-alpha, PRA and p53" . SPARSER::COLLECTION) ("HPF" . SPARSER::PROTEIN)
    ("ECC" . SPARSER::MOLECULE) ("para" . SPARSER::PROTEIN-FAMILY)
    ("ER/PR/p53" . SPARSER::COLLECTION)
    ("beta) and the different PR isoforms (A and B)" . SPARSER::COLLECTION)
    ("Estrogens" . SPARSER::MOLECULE)
    ("estrogens and progestins" . SPARSER::COLLECTION)
    ("progestins" . SPARSER::DRUG) ("estrogens" . SPARSER::MOLECULE)
    ("ER-alpha and PRA" . SPARSER::COLLECTION)
    ("ER-alpha (p = 0.002) and PRA (p<0.001) median H-scores"
     . SPARSER::COLLECTION)
    ("p" . SPARSER::PROTEIN) ("ER-alpha/PRA" . SPARSER::COLLECTION)
    ("ER-alpha/PRA/p53" . SPARSER::COLLECTION) ("PRA" . SPARSER::PROTEIN)
    ("PR-B" . SPARSER::PROTEIN) ("ER-beta" . SPARSER::PROTEIN)
    ("ERS1" . SPARSER::PROTEIN) ("ESR1" . SPARSER::PROTEIN)
    ("F11" . SPARSER::PROTEIN) ("beta)" . SPARSER::PROTEIN)
    ("ER-alpha" . SPARSER::PROTEIN)
    ("especially tumor-associated gangliosides" . SPARSER::MOLECULE)
    ("Ifenprodil" . SPARSER::DRUG) ("GABA or GABA" . SPARSER::COLLECTION)
    ("GABA" . SPARSER::MOLECULE)
    ("analgesic and anticonvulsant" . SPARSER::COLLECTION)
    ("neurotransmitter" . SPARSER::MOLECULE) ("anticonvulsant" . SPARSER::DRUG)
    ("analgesic" . SPARSER::DRUG) ("Gabapentin" . SPARSER::DRUG)
    ("systemic gabapentin" . SPARSER::DRUG) ("gabapentin" . SPARSER::DRUG)
    ("NMDA-R and Ca ++" . SPARSER::COLLECTION)
    ("PP2 or ketamine" . SPARSER::COLLECTION) ("cation" . SPARSER::MOLECULE)
    ("GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("client receptors" . SPARSER::PROTEIN) ("BDNF-TrkB" . SPARSER::COLLECTION)
    ("SY5Y-TrkB, and NMB-7" . SPARSER::COLLECTION)
    ("artificial ligands" . SPARSER::LIGAND) ("ganglioside" . SPARSER::PROTEIN)
    ("Src or Fyn" . SPARSER::COLLECTION) ("LCK" . SPARSER::PROTEIN)
    ("Src and Fyn" . SPARSER::COLLECTION)
    ("irrelevant IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("toxin" . SPARSER::MOLECULE) ("media" . SPARSER::PROTEIN)
    ("SY5Y-trkB and NMB-7" . SPARSER::COLLECTION) ("trkB" . SPARSER::PROTEIN)
    ("their corresponding negative controls mIgG and a non-binding peptide SS57"
     . SPARSER::COLLECTION)
    ("mIgG" . SPARSER::PROTEIN) ("GPCR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Src and NR2B" . SPARSER::COLLECTION) ("Csk" . SPARSER::PROTEIN)
    ("PKA" . SPARSER::PROTEIN) ("EDTA" . SPARSER::MOLECULE)
    ("ionomycin" . SPARSER::DRUG) ("ionophore" . SPARSER::MOLECULE)
    ("calcium" . SPARSER::CALCIUM) ("ligand (BDNF)" . SPARSER::MOLECULE)
    ("ketamine" . SPARSER::DRUG) ("Fyn" . SPARSER::PROTEIN)
    ("neurotrophin" . SPARSER::PROTEIN) ("SH-SY5Y-TrkB" . SPARSER::COLLECTION)
    ("SH-SY5Y" . SPARSER::PROTEIN) ("carbohydrate" . SPARSER::MOLECULE)
    ("SS" . SPARSER::PROTEIN) ("gangliosides" . SPARSER::MOLECULE)
    ("kinases (SFK)" . SPARSER::PROTEIN)
    ("using anti-GD2 monoclonal antibodies" . SPARSER::ANTIBODY)
    ("TrkB" . SPARSER::PROTEIN) ("agonist" . SPARSER::AGONIST)
    ("BDNF" . SPARSER::PROTEIN) ("NMDA-receptor" . SPARSER::MOLECULE)
    ("cAMP" . SPARSER::PROTEIN) ("NMDA" . SPARSER::MOLECULE)
    ("mAb" . SPARSER::DRUG) ("morphine" . SPARSER::MOLECULE)
    ("anti-GD2 monoclonal antibodies" . SPARSER::ANTIBODY)
    ("mAbs" . SPARSER::DRUG) ("Ganglioside" . SPARSER::PROTEIN)
    ("calcium channel" . SPARSER::PROTEIN) ("voltage-gated" . SPARSER::PROTEIN)
    ("GABA)" . SPARSER::PROTEIN)
    ("gamma-aminobutyric acid" . SPARSER::MOLECULE)
    ("ion channels" . SPARSER::PROTEIN-FAMILY)
    ("non-selective" . SPARSER::PROTEIN) ("IP3" . SPARSER::IP3)
    ("PLC-γ" . SPARSER::PROTEIN-FAMILY) ("GD3" . SPARSER::MOLECULE)
    ("PLCγ" . SPARSER::PROTEIN-FAMILY) ("p56 LCK" . SPARSER::PROTEIN)
    ("CD45" . SPARSER::HUMAN-PROTEIN-FAMILY) ("G10" . SPARSER::PROTEIN)
    ("NR2A" . SPARSER::PROTEIN) ("B subunit" . SPARSER::PROTEIN)
    ("NONIDET P-40" . SPARSER::DRUG) ("Src kinase" . SPARSER::PROTEIN)
    ("p56 Lck" . SPARSER::PROTEIN) ("NMDA-R" . SPARSER::PROTEIN)
    ("aspartic acid" . SPARSER::AMINO-ACID) ("IgG3" . SPARSER::BIO-COMPLEX)
    ("NR2B" . SPARSER::PROTEIN) ("GD2" . SPARSER::MOLECULE)
    ("KRAS and RREB1" . SPARSER::COLLECTION) ("rs4705343T" . SPARSER::PROTEIN)
    ("rs4705343C" . SPARSER::PROTEIN)
    ("pGL3-rs4705343T" . SPARSER::PROTEIN-PAIR)
    ("pGL3-rs4705343C" . SPARSER::PROTEIN-PAIR)
    ("gene or promoter" . SPARSER::COLLECTION) ("GT" . SPARSER::PROTEIN)
    ("TC" . SPARSER::PROTEIN) ("fragment" . SPARSER::FRAGMENT)
    ("KRAS and Ras-responsive element-binding protein ( RREB1 )"
     . SPARSER::COLLECTION)
    ("Ras-responsive element-binding protein" . SPARSER::PROTEIN)
    ("6.3" . SPARSER::PROTEIN) ("RREB1" . SPARSER::PROTEIN)
    ("5-FU and leucovorin" . SPARSER::COLLECTION)
    ("leucovorin" . SPARSER::DRUG)
    ("5-FU-based preoperative CRT" . SPARSER::PROTEIN)
    ("capecitabine" . SPARSER::DRUG) ("CEA" . SPARSER::PROTEIN)
    ("preoperative CRT" . SPARSER::PROTEIN) ("CRT" . SPARSER::PROTEIN)
    ("fluorouracil" . SPARSER::DRUG) ("N1-2" . SPARSER::PROTEIN)
    ("m 2" . SPARSER::MOLECULE) ("of 45 " . SPARSER::PROTEIN)
    ("phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("5-FU" . SPARSER::PROTEIN) ("proteins and mRNA" . SPARSER::COLLECTION)
    ("PA/PLD" . SPARSER::COLLECTION)
    ("phospholipase D (PLD)" . SPARSER::PROTEIN) ("PLD" . SPARSER::PROTEIN)
    ("PA" . SPARSER::PROTEIN) ("IGFs" . SPARSER::PROTEIN)
    ("wortmannin (inhibiting Akt phosphorylation) and rapamycin (inhibiting mTOR phosphorylation)"
     . SPARSER::COLLECTION)
    ("essential functional molecules" . SPARSER::MOLECULE)
    ("ATP5B and ATP5F1" . SPARSER::COLLECTION)
    ("phosphoenolpyruvate" . SPARSER::MOLECULE) ("pyruvate" . SPARSER::PROTEIN)
    ("electron" . SPARSER::MOLECULE)
    ("ATP5B and ATP5J proteins and energy metabolism-related enzymes genes (apart from enolase 1)"
     . SPARSER::COLLECTION)
    ("wortmannin and rapamycin" . SPARSER::COLLECTION)
    ("mTOR and p70s6k" . SPARSER::COLLECTION)
    ("Akt and mTOR" . SPARSER::COLLECTION)
    ("Akt, mTOR or p70s6k" . SPARSER::COLLECTION)
    ("p-Akt" . SPARSER::COLLECTION)
    ("Akt, mTOR and p70s6k" . SPARSER::COLLECTION)
    ("ATP5B and ATP5J" . SPARSER::COLLECTION)
    ("mTOR/p70s6k" . SPARSER::COLLECTION) ("hepatocytes" . SPARSER::PROTEIN)
    ("Ser/Thr" . SPARSER::COLLECTION)
    ("serine/threonine" . SPARSER::COLLECTION) ("ion" . SPARSER::MOLECULE)
    ("osteoclasts" . SPARSER::PROTEIN)
    ("mitochondrial ATP synthase and LDHA" . SPARSER::COLLECTION)
    ("Akt or mTOR" . SPARSER::COLLECTION)
    ("wortmannin or rapamycin" . SPARSER::COLLECTION)
    ("ATP synthase and LDHA" . SPARSER::COLLECTION)
    ("Akt/mTOR/p70s6k" . SPARSER::COLLECTION) ("wortmannin" . SPARSER::PROTEIN)
    ("antagonist" . SPARSER::MOLECULE)
    ("mammalian target of rapamycin (mTOR) and p70s6k (measured by western blot analysis)"
     . SPARSER::COLLECTION)
    ("p70s6k" . SPARSER::PROTEIN) ("LDHA" . SPARSER::PROTEIN)
    ("Luciferin" . SPARSER::MOLECULE) ("ATP" . SPARSER::ATP)
    ("lactate" . SPARSER::LACTATE) ("elongation" . SPARSER::PROTEIN)
    ("substance" . SPARSER::SUBSTANCE)
    ("Growth factors" . SPARSER::GROWTH-FACTOR)
    ("phospholipase D" . SPARSER::PROTEIN) ("TGF-β1" . SPARSER::PROTEIN)
    ("ATP5F1" . SPARSER::PROTEIN) ("CCK-8" . SPARSER::PROTEIN)
    ("phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("ATP5J" . SPARSER::PROTEIN) ("ATP5B" . SPARSER::PROTEIN)
    ("ribosomal protein S6 kinase" . SPARSER::PROTEIN)
    ("s6k" . SPARSER::PROTEIN) ("p70" . SPARSER::PROTEIN)
    ("enolase 1" . SPARSER::PROTEIN)
    ("lactate dehydrogenase A" . SPARSER::PROTEIN)
    ("ATP synthase" . SPARSER::PROTEIN)
    ("adenosine triphosphate" . SPARSER::MOLECULE)
    ("RHOA and KRAS" . SPARSER::COLLECTION) ("-mutant" . SPARSER::MUTANT)
    ("KRAS , PIK3CA and RHOA" . SPARSER::COLLECTION)
    ("P53 , KRAS and APC" . SPARSER::COLLECTION)
    ("Lysozyme" . SPARSER::PROTEIN)
    ("larger patient cohorts" . SPARSER::MOLECULE)
    ("Val" . SPARSER::AMINO-ACID) ("Leu" . SPARSER::AMINO-ACID)
    ("Glu" . SPARSER::AMINO-ACID)
    ("the only single-centre GC cohort" . SPARSER::MOLECULE)
    ("cisplatin and oxaliplatin" . SPARSER::COLLECTION)
    ("oxaliplatin" . SPARSER::DRUG) ("β-catenin-" . SPARSER::PROTEIN)
    ("lysozyme" . SPARSER::PROTEIN) ("mucin" . SPARSER::PROTEIN)
    ("an unclassifiable type" . TYPE)
    ("proteins and guanine" . SPARSER::COLLECTION)
    ("GDP" . SPARSER::NUCLEOTIDE) ("GTP" . SPARSER::NUCLEOTIDE)
    ("GTPases" . SPARSER::GTPASE) ("Rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MSI" . SPARSER::PROTEIN) ("mutant and wildtype" . SPARSER::COLLECTION)
    ("KRAS and RHOA" . SPARSER::COLLECTION) ("distal GCs" . SPARSER::PROTEIN)
    ("Efs" . SPARSER::PROTEIN) ("GC" . SPARSER::PROTEIN)
    ("RHOA" . SPARSER::PROTEIN) ("GCs" . SPARSER::PROTEIN)
    ("GTPase activating" . SPARSER::PROTEIN)
    ("exchange factors" . SPARSER::EXCHANGE-FACTOR)
    ("PIK3CA" . SPARSER::PROTEIN) ("G17" . SPARSER::PROTEIN)
    ("E2F, p300, and TBP" . SPARSER::COLLECTION) ("TBP" . SPARSER::PROTEIN)
    ("E7-" . SPARSER::PROTEIN-FAMILY) ("E7 and Dnmt1" . SPARSER::COLLECTION)
    ("E7-Dnmt1" . SPARSER::COLLECTION) ("-E7" . SPARSER::COLLECTION)
    ("E7 , and PC" . SPARSER::COLLECTION)
    ("Dnmt1, Dnmt3a, and Dnmt3b" . SPARSER::COLLECTION)
    ("PC" . SPARSER::PROTEIN) ("Dnmt3a and Dnmt3b" . SPARSER::COLLECTION)
    ("Dnmt" . SPARSER::PROTEIN)
    ("IRS1 , GNA11 , GNAI2 , EREG , CCNA1 , RGS4 , and PKIG"
     . SPARSER::COLLECTION)
    ("Dnmt3a and Dnmt1" . SPARSER::COLLECTION) ("EREG" . SPARSER::PROTEIN)
    ("p53 and pRB" . SPARSER::COLLECTION) ("E6 and E7" . SPARSER::COLLECTION)
    ("pRB" . SPARSER::PROTEIN) ("CR3-" . SPARSER::PROTEIN)
    ("E7–Dnmt1" . SPARSER::COLLECTION) ("oncoproteins" . SPARSER::PROTEIN)
    ("p300" . SPARSER::PROTEIN) ("Dnmt3b" . SPARSER::PROTEIN)
    ("methyltransferase activity" . SPARSER::PROTEIN)
    ("Zinc finger" . SPARSER::PROTEIN) ("cyclin A1" . SPARSER::PROTEIN)
    ("Dnmt3a" . SPARSER::PROTEIN) ("RGS4" . SPARSER::PROTEIN)
    ("GNAI2" . SPARSER::PROTEIN) ("GNA11" . SPARSER::PROTEIN)
    ("IRS1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E6" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CR3" . SPARSER::PROTEIN)
    ("Dnmt1" . SPARSER::PROTEIN) ("DNA methyltransferase 1" . SPARSER::PROTEIN)
    ("E7" . SPARSER::PROTEIN-FAMILY) ("CCNA1" . SPARSER::PROTEIN)
    ("Cyclin A1" . SPARSER::PROTEIN)
    ("MASPIN, NDRG1, NDRG2, and NDRG3" . SPARSER::COLLECTION)
    ("a p53- and demethylation-upregulated gene" . SPARSER::COLLECTION)
    ("EMT and F-actin" . SPARSER::COLLECTION)
    ("cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NDRG1, NDRG2, NDRG3, and NDRG4" . SPARSER::COLLECTION)
    ("NDRG" . SPARSER::PROTEIN-FAMILY)
    ("a mammary serine protease inhibitor" . SPARSER::PROTEIN)
    ("doxorubicin or camptothecin" . SPARSER::COLLECTION)
    ("E-cadherin and higher N-cadherin, SNAIL, and SLUG" . SPARSER::COLLECTION)
    ("N-cadherin, SNAIL, and SLUG" . SPARSER::COLLECTION)
    ("SLUG" . SPARSER::PROTEIN) ("SNAIL" . SPARSER::PROTEIN)
    ("NDRG1, NDRG2, NDRG3, and MASPIN" . SPARSER::COLLECTION)
    ("NDRG1, NDRG3, and MASPIN" . SPARSER::COLLECTION)
    ("MASPIN, NDRG1, and NDRG3" . SPARSER::COLLECTION)
    ("matrigel" . SPARSER::PROTEIN) ("thymidine" . SPARSER::PROTEIN)
    ("-deoxycytidine" . SPARSER::COLLECTION)
    ("deoxycytidine" . SPARSER::PROTEIN) ("aza" . SPARSER::DRUG)
    ("doxorubicin and camptothecin" . SPARSER::COLLECTION)
    ("camptothecin" . SPARSER::DRUG) ("p53 and GDF15" . SPARSER::COLLECTION)
    ("PDF" . SPARSER::PROTEIN) ("PLAB" . SPARSER::PROTEIN)
    ("a secretory dimeric protein" . SPARSER::PROTEIN)
    ("a new biomarker" . SPARSER::MOLECULE)
    ("MASPIN and N-myc" . SPARSER::COLLECTION)
    ("mammary serine protease inhibitor (MASPIN) and N-myc downstream-regulated family genes (NDRG1, NDRG2, and NDRG3)"
     . SPARSER::COLLECTION)
    ("mammary serine protease inhibitor (MASPIN)" . SPARSER::PROTEIN)
    ("NDRG1, NDRG2, and NDRG3" . SPARSER::COLLECTION)
    ("MASPIN" . SPARSER::PROTEIN) ("Foxn1" . SPARSER::PROTEIN)
    ("PR3" . SPARSER::PROTEIN) ("pGL3" . SPARSER::PROTEIN)
    ("I-19" . SPARSER::PROTEIN) ("interleukin 6" . SPARSER::PROTEIN)
    ("NDRG4" . SPARSER::PROTEIN)
    ("N-myc downstream-regulated gene" . SPARSER::PROTEIN)
    ("N-cadherin" . SPARSER::PROTEIN)
    ("prostate differentiation factor" . SPARSER::PROTEIN)
    ("NAG-1" . SPARSER::PROTEIN)
    ("transforming growth factor" . SPARSER::PROTEIN)
    ("placental bone morphogenetic protein" . SPARSER::PROTEIN)
    ("NDRG3" . SPARSER::PROTEIN) ("NDRG2" . SPARSER::PROTEIN)
    ("NDRG1" . SPARSER::PROTEIN) ("N-myc" . SPARSER::PROTEIN)
    ("serine protease inhibitor" . SPARSER::PROTEIN)
    ("TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GDF15" . SPARSER::PROTEIN)
    ("DBC1 and DBC1" . SPARSER::COLLECTION)
    ("AR and DBC1" . SPARSER::COLLECTION) ("prostatic" . SPARSER::PROTEIN)
    ("anoikis" . SPARSER::PROTEIN)
    ("NFκB, TGFβ and RhoA" . SPARSER::COLLECTION)
    ("P21 and P27" . SPARSER::COLLECTION)
    ("P53 and mutant" . SPARSER::COLLECTION) ("ell" . SPARSER::PROTEIN)
    ("DBC1 and BRCA1" . SPARSER::COLLECTION)
    ("DBC1 and SIRT1" . SPARSER::COLLECTION)
    ("complex, and RNA" . SPARSER::COLLECTION) ("LXR" . SPARSER::PROTEIN)
    ("both SIRT1 and tumor suppressor SUV39H1" . SPARSER::COLLECTION)
    ("SUV39H1-SIRT1" . SPARSER::COLLECTION)
    ("siRNA or DBC1" . SPARSER::COLLECTION)
    ("cycloheximide" . SPARSER::PROTEIN)
    ("protein and DBC1" . SPARSER::COLLECTION)
    ("P27 and BAX" . SPARSER::COLLECTION)
    ("TGFβ and RhoA" . SPARSER::COLLECTION)
    ("P53, P21, P27, and BAX" . SPARSER::COLLECTION)
    ("TGFβ and NFκB" . SPARSER::COLLECTION)
    ("P21, P27, and BAX" . SPARSER::COLLECTION)
    ("BCL2, TGFβ, RhoA, NFκB, and PCNA" . SPARSER::COLLECTION)
    ("BAX" . SPARSER::PROTEIN)
    ("the conventional chemotherapeutic drugs" . SPARSER::DRUG)
    ("RFS" . SPARSER::PROTEIN) ("rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DBC1 or AR" . SPARSER::COLLECTION)
    ("DBC1 and/or AR" . SPARSER::COLLECTION) ("DBC1-AR" . SPARSER::COLLECTION)
    ("DBC1 and AR" . SPARSER::COLLECTION) ("DBC1/CCAR2" . SPARSER::COLLECTION)
    ("AR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DBC1" . SPARSER::PROTEIN)
    ("anti-Androgen" . SPARSER::DRUG) ("MG132" . SPARSER::PROTEIN)
    ("N-20" . SPARSER::PROTEIN) ("H-2" . SPARSER::PROTEIN)
    ("3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("PEA3" . SPARSER::PROTEIN) ("SUV39H1" . SPARSER::PROTEIN)
    ("tumor suppressor P53" . SPARSER::PROTEIN) ("MG-132" . SPARSER::DRUG)
    ("TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY) ("P27" . SPARSER::PROTEIN)
    ("PARP1" . SPARSER::PROTEIN) ("SIRT1" . SPARSER::PROTEIN)
    ("androgen receptor" . SPARSER::PROTEIN) ("CCAR2" . SPARSER::PROTEIN)
    ("cancer 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("gefitinib and erlotinib" . SPARSER::COLLECTION)
    ("gefitinib [ xref ] or afatinib [ xref ]" . SPARSER::COLLECTION)
    ("afatinib" . SPARSER::DRUG) ("prone" . SPARSER::PROTEIN-FAMILY)
    ("the triple negative cohort" . SPARSER::MOLECULE)
    ("nodal" . SPARSER::PROTEIN) ("HR " . SPARSER::PROTEIN)
    ("LM" . SPARSER::MOLECULE) ("EGFR and KRAS" . SPARSER::COLLECTION)
    ("TKI" . SPARSER::PROTEIN) ("IV" . SPARSER::PROTEIN)
    ("EGFR , KRAS and EML4" . SPARSER::COLLECTION) ("ALK" . SPARSER::PROTEIN)
    ("KRAS" . SPARSER::PROTEIN) ("6–16" . SPARSER::PROTEIN)
    ("1–2" . SPARSER::PROTEIN) ("Chi2" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor Receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EML4" . SPARSER::PROTEIN) ("cellular antioxidant" . SPARSER::PROTEIN)
    ("chemotherapeutic drugs" . SPARSER::DRUG)
    ("Bcl-2 and Bcl-xL" . SPARSER::COLLECTION)
    ("K-Ras, B-Raf, and Myc" . SPARSER::COLLECTION)
    ("Oncogenes" . SPARSER::ONCOGENE)
    ("glucose and glutamine" . SPARSER::COLLECTION)
    ("glucose" . SPARSER::PROTEIN) ("shRNA-NRF2" . SPARSER::COLLECTION)
    ("antioxidants" . SPARSER::DRUG)
    ("downstream cytoprotective genes" . SPARSER::GENE)
    ("NRF2/Keap1" . SPARSER::COLLECTION) ("Keap1/NRF2" . SPARSER::COLLECTION)
    ("Keap1 and NRF2" . SPARSER::COLLECTION)
    ("NRF2-shRNA" . SPARSER::COLLECTION)
    ("CpG1, CpG3, CpG6, and CpG10" . SPARSER::COLLECTION)
    ("IIB" . SPARSER::PROTEIN) ("Representative IHC" . SPARSER::PROTEIN)
    ("formalin" . SPARSER::MOLECULE) ("Antibodies" . SPARSER::ANTIBODY)
    ("NRF2 and Keap1" . SPARSER::COLLECTION)
    ("many cytoprotective genes" . SPARSER::GENE)
    ("Maf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("heterodimer" . SPARSER::HETERODIMER) ("Cysteine" . SPARSER::AMINO-ACID)
    ("oxidant or xenobiotic" . SPARSER::COLLECTION)
    ("oxidant" . SPARSER::PROTEIN) ("CNC" . SPARSER::PROTEIN)
    ("bZIP" . SPARSER::PROTEIN-FAMILY)
    ("response element (ARE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("promoters" . SPARSER::PROMOTER)
    ("ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("redox" . SPARSER::PROTEIN) ("Pap" . SPARSER::MOLECULE)
    ("Keap1-NRF2" . SPARSER::COLLECTION) ("Bcl-xL" . SPARSER::PROTEIN)
    ("B-Raf" . SPARSER::PROTEIN) ("CpG6" . SPARSER::PROTEIN)
    ("CpG3" . SPARSER::PROTEIN) ("CpG1" . SPARSER::PROTEIN)
    ("annexin V" . SPARSER::PROTEIN) ("FL-2" . SPARSER::PROTEIN)
    ("DNA polymerase" . SPARSER::PROTEIN) ("KEAP1" . SPARSER::PROTEIN)
    ("Kelch-like ECH-associated protein 1" . SPARSER::PROTEIN)
    ("response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("nuclear factor erythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("Keap1" . SPARSER::PROTEIN) ("NFE2L2" . SPARSER::PROTEIN)
    ("Nuclear factor erythroid-2-related factor 2" . SPARSER::PROTEIN)
    ("clathrin and regulators" . SPARSER::COLLECTION)
    ("EGFR and ErbB2" . SPARSER::COLLECTION)
    ("Akt and p42/44" . SPARSER::COLLECTION)
    ("kinases and scaffolds" . SPARSER::COLLECTION)
    ("kinase (SFK)" . SPARSER::KINASE) ("Src" . SPARSER::PROTEIN)
    ("EGFR or Grb2" . SPARSER::COLLECTION)
    ("Gab1 and clathrin" . SPARSER::COLLECTION)
    ("clathrin ( xref ) and pGab1" . SPARSER::COLLECTION)
    ("phosphatase" . SPARSER::PHOSPHATASE)
    ("SHP2, Crk, and PLCγ1" . SPARSER::COLLECTION) ("Crk" . SPARSER::PROTEIN)
    ("EGFR and MET" . SPARSER::COLLECTION) ("MET" . SPARSER::PROTEIN)
    ("a productive CCP" . SPARSER::PROTEIN)
    ("abortive clathrin" . SPARSER::PROTEIN)
    ("endocytically abortive clathrin" . SPARSER::PROTEIN)
    ("proteins and lipids" . SPARSER::COLLECTION)
    ("dynasore or dyngo4a" . SPARSER::COLLECTION)
    ("two distinct siRNA" . SPARSER::PROTEIN)
    ("complemented" . SPARSER::PROTEIN)
    ("c-Src ( xref ; xref ) and c-Cbl ( xref )" . SPARSER::COLLECTION)
    ("ErbB2 (Supplemental Figure S7A) or ErbB3 ( xref )" . SPARSER::COLLECTION)
    ("the plasma membrane clathrin adaptor AP-2 as well as pGab1"
     . SPARSER::COLLECTION)
    ("clathrin and pGab1" . SPARSER::COLLECTION)
    ("dense punctate" . SPARSER::PROTEIN)
    ("both small and large clathrin" . SPARSER::PROTEIN)
    ("RFP-CLC" . SPARSER::COLLECTION)
    ("red fluorescent protein (RFP)–CLC" . SPARSER::COLLECTION)
    ("–CLC" . SPARSER::COLLECTION) ("GFP-Gab1" . SPARSER::COLLECTION)
    ("RFP" . SPARSER::PROTEIN) ("EGFR-Gab1-PI3K-Akt" . SPARSER::COLLECTION)
    ("PI3K and Akt" . SPARSER::COLLECTION) ("punctate" . SPARSER::PROTEIN)
    ("GFP-p85" . SPARSER::COLLECTION) ("puncta" . SPARSER::PROTEIN)
    ("dynasore or dyngo4A" . SPARSER::COLLECTION)
    ("Grb2 and Shc" . SPARSER::COLLECTION) ("Shc" . SPARSER::PROTEIN)
    ("CHC or dynamin2" . SPARSER::COLLECTION)
    ("clathrin or dynamin2" . SPARSER::COLLECTION)
    ("CHC and CLC" . SPARSER::COLLECTION) ("mCherry" . SPARSER::PROTEIN)
    ("mitochondria" . SPARSER::PROTEIN) ("fused" . SPARSER::PROTEIN)
    ("CLC and CHC" . SPARSER::COLLECTION)
    ("light chain (CLC)" . SPARSER::PROTEIN) ("CLC" . SPARSER::PROTEIN)
    ("FKBP" . SPARSER::PROTEIN) ("rapamycin" . SPARSER::DRUG)
    ("dynasore and dyngo4A" . SPARSER::COLLECTION)
    ("S2, C and D" . SPARSER::COLLECTION)
    ("fluorescent EGF" . SPARSER::PROTEIN)
    ("endocytic accessory proteins" . SPARSER::PROTEIN)
    ("neither CHC nor dynamin2" . SPARSER::COLLECTION)
    ("CHC and dynamin2" . SPARSER::COLLECTION)
    ("transferrin" . SPARSER::PROTEIN) ("CHC" . SPARSER::PROTEIN)
    ("clathrin heavy chain (CHC)" . SPARSER::PROTEIN)
    ("c-Src and ErbB2" . SPARSER::COLLECTION)
    ("homodimers or heterodimers" . SPARSER::COLLECTION)
    ("ErbBs" . SPARSER::PROTEIN) ("homodimers" . SPARSER::HOMODIMER)
    ("RTKs" . SPARSER::PROTEIN) ("delta" . SPARSER::PROTEIN)
    ("Gab1-PI3K-Akt" . SPARSER::COLLECTION) ("dynasore" . SPARSER::MOLECULE)
    ("GTPase" . SPARSER::GTPASE)
    ("Clathrin and other proteins" . SPARSER::COLLECTION)
    ("CCPs" . SPARSER::PROTEIN) ("TSC2 or FOXO1" . SPARSER::COLLECTION)
    ("PDK1 and Akt" . SPARSER::COLLECTION)
    ("PDK1 and mTORC2" . SPARSER::COLLECTION)
    ("phosphatidylinositol-" . SPARSER::PROTEIN)
    ("phosphatidylinositol" . SPARSER::PROTEIN) ("PRD" . SPARSER::PROTEIN)
    ("the receptor’s" . SPARSER::RECEPTOR) ("PTB" . SPARSER::PROTEIN)
    ("Ligand" . SPARSER::LIGAND) ("receptor (EGFR)" . SPARSER::RECEPTOR)
    ("scaffolds" . SPARSER::SCAFFOLD) ("ErbB2" . SPARSER::PROTEIN)
    ("Gab1 and phospho-Gab1" . SPARSER::COLLECTION)
    ("Gab1 or Akt" . SPARSER::COLLECTION)
    ("Gab1 and Akt" . SPARSER::COLLECTION)
    ("clathrin-coated pits—membrane structures containing clathrin and other proteins—eventually"
     . SPARSER::COLLECTION)
    ("EGF" . SPARSER::PROTEIN) ("Clathrin" . SPARSER::PROTEIN)
    ("dynamin" . SPARSER::PROTEIN) ("clathrin" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("α-adaptin" . SPARSER::PROTEIN) ("S3B" . SPARSER::PROTEIN)
    ("β-mercaptoethanol" . SPARSER::MOLECULE) ("PBS 2" . SPARSER::PROTEIN)
    ("receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("dynamin 1" . SPARSER::PROTEIN) ("CVAK104" . SPARSER::PROTEIN)
    ("AAK1" . SPARSER::PROTEIN) ("Ack1" . SPARSER::PROTEIN)
    ("PP2" . SPARSER::DRUG) ("TOM1L1" . SPARSER::PROTEIN)
    ("PP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("delta-" . SPARSER::PROTEIN)
    ("PLCγ1" . SPARSER::PROTEIN) ("dyngo4a" . SPARSER::DRUG)
    ("c-Cbl" . SPARSER::PROTEIN) ("ErbB3" . SPARSER::PROTEIN)
    ("S6B" . SPARSER::PROTEIN) ("p42/44" . SPARSER::PROTEIN)
    ("anti–" . SPARSER::ANTIBODY)
    ("green fluorescent protein" . SPARSER::PROTEIN)
    ("FKBP12" . SPARSER::PROTEIN) ("Dyngo4a" . SPARSER::DRUG)
    ("dyngo4A" . SPARSER::DRUG) ("anti-EGFR" . SPARSER::PROTEIN)
    ("clathrin heavy chain" . SPARSER::PROTEIN) ("c-Src" . SPARSER::PROTEIN)
    ("2–4" . SPARSER::PROTEIN) ("opioid receptor" . SPARSER::PROTEIN)
    ("PI3K-Akt" . SPARSER::COLLECTION) ("AP-2" . SPARSER::PROTEIN)
    ("FOXO1" . SPARSER::PROTEIN) ("TSC2" . SPARSER::PROTEIN)
    ("GSK3β" . SPARSER::PROTEIN)
    ("glycogen synthase" . SPARSER::PROTEIN-FAMILY)
    ("APPL1" . SPARSER::PROTEIN) ("PDK1" . SPARSER::PROTEIN)
    ("SHP2" . SPARSER::PROTEIN) ("p85" . SPARSER::PROTEIN)
    ("PIP2" . SPARSER::PIP2) ("PIP3" . SPARSER::PIP3)
    ("Phosphatidylinositol-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("adaptor protein" . SPARSER::PROTEIN) ("Grb2" . SPARSER::PROTEIN)
    ("Gab1" . SPARSER::PROTEIN) ("dynamin2" . SPARSER::PROTEIN)
    ("its receptor" . SPARSER::PROTEIN)
    ("Epidermal growth factor" . SPARSER::PROTEIN)
    ("example" . SPARSER::EXAMPLE)
    ("nine clinically relevant BRCA1 alleles" . SPARSER::ALLELE)
    ("modifiers" . SPARSER::MOLECULE) ("BRCA-" . SPARSER::PROTEIN-FAMILY)
    ("multi" . SPARSER::PROTEIN) ("stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a major centrosomal core protein" . SPARSER::PROTEIN)
    ("ɣ-tubulin" . SPARSER::PROTEIN-PAIR) ("centrosomes" . SPARSER::PROTEIN)
    ("BRCA1 mutants and VUS" . SPARSER::COLLECTION)
    ("this neutral variant" . SPARSER::VARIANT)
    ("BRCA1  D67Y and BRCA1  S316G" . SPARSER::COLLECTION)
    ("fractions" . SPARSER::COMPONENT)
    ("a larger fraction" . SPARSER::COMPONENT)
    ("the BRCA1  I379M benign variant" . SPARSER::VARIANT)
    ("the only VUS derivatives" . SPARSER::DERIVATIVE)
    ("BRCA1  C61G and BRCA1  R71G" . SPARSER::COLLECTION)
    ("MYC and RET" . SPARSER::COLLECTION) ("MYC" . SPARSER::PROTEIN)
    ("a benign variant" . SPARSER::VARIANT)
    ("BRCA1  C64R and BRCA1  Q356R" . SPARSER::COLLECTION)
    ("the BRCA1  C61G , BRCA1  R71G , BRCA1  C64R and BRCA1  Q356R"
     . SPARSER::COLLECTION)
    ("both parental MCF-10A" . SPARSER::PROTEIN)
    ("parental MCF-10A" . SPARSER::PROTEIN)
    ("one benign variant" . SPARSER::VARIANT)
    ("Ex2-3Stop" . SPARSER::COLLECTION)
    ("Stop" . SPARSER::HUMAN-PROTEIN-FAMILY) ("states" . SPARSER::BIO-STATE)
    ("adeno-associated viral (AAV) mediated gene" . SPARSER::GENE)
    ("MCF-10A" . SPARSER::PROTEIN)
    ("the heterozygous carrier state" . SPARSER::BIO-STATE)
    ("intronic and regulatory region variants" . SPARSER::VARIANT)
    ("nearly 2,000 distinct BRCA alleles" . SPARSER::ALLELE)
    ("BRCA1 or BRCA2" . SPARSER::COLLECTION) ("BRCA" . SPARSER::PROTEIN-FAMILY)
    ("eight clinically relevant BRCA1 alleles" . SPARSER::ALLELE)
    ("BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("sulforhodamine B" . SPARSER::MOLECULE) ("53BP1" . SPARSER::PROTEIN)
    ("core protein" . SPARSER::PROTEIN) ("Ex2" . SPARSER::PROTEIN)
    ("BRCA2" . SPARSER::PROTEIN) ("NVP-TNKS656" . SPARSER::COLLECTION)
    ("therapeutics" . SPARSER::THERAPEUTICS) ("chemicals" . SPARSER::MOLECULE)
    ("β-catenin/TCF" . SPARSER::COLLECTION) ("TCF" . SPARSER::PROTEIN)
    ("β-catenin/TCF4" . SPARSER::COLLECTION)
    ("a classic downstream transcriptional target" . SPARSER::TARGET-PROTEIN)
    ("AXIN1, AXIN2, and β-catenin" . SPARSER::COLLECTION)
    ("survivin" . SPARSER::PROTEIN) ("XAV939 or WXL-8" . SPARSER::COLLECTION)
    ("classes" . CLASS) ("DMSO" . SPARSER::MOLECULE)
    ("Tankyrase inhibitors XAV939 and WXL-8" . SPARSER::COLLECTION)
    ("using Western blot" . SPARSER::PROTEIN)
    ("Western blot" . SPARSER::PROTEIN)
    ("TNKS1 or TNKS2" . SPARSER::COLLECTION)
    ("XAV939 and a novel nitro-substituted derivative (WXL-8)"
     . SPARSER::COLLECTION)
    ("derivatives" . SPARSER::DERIVATIVE) ("tankyrases" . SPARSER::PROTEIN)
    ("Tankyrases" . SPARSER::PROTEIN) ("Tankyrase" . SPARSER::PROTEIN)
    ("tankyrase 1 (TNKS1/PARP5A) and tankyrase 2 (TNKS2/PARP5B)"
     . SPARSER::COLLECTION)
    ("TNKS2/PARP5B" . SPARSER::COLLECTION)
    ("TNKS1/PARP5A" . SPARSER::COLLECTION) ("PARP" . SPARSER::PROTEIN)
    ("chemical" . SPARSER::MOLECULE) ("Wnt/β-catenin" . SPARSER::COLLECTION)
    ("Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-myc [ xref ] and Cyclin D1 [ xref ]" . SPARSER::COLLECTION)
    ("TCF4/LEF" . SPARSER::COLLECTION) ("LEF" . SPARSER::PROTEIN)
    ("Glycogen synthase kinase-3 (GSK3) and casein kinase (CK1)α/β"
     . SPARSER::COLLECTION)
    ("multi-protein" . SPARSER::COLLECTION) ("casein" . SPARSER::PROTEIN)
    ("APC" . SPARSER::PROTEIN) ("effector" . SPARSER::EFFECTOR)
    ("sorafenib" . SPARSER::DRUG) ("Sorafenib" . SPARSER::DRUG)
    ("XAV939 and WXL-8" . SPARSER::COLLECTION)
    ("AXIN1 and AXIN2" . SPARSER::COLLECTION) ("WXL" . SPARSER::PROTEIN-FAMILY)
    ("derivative" . SPARSER::DERIVATIVE) ("TNKS" . SPARSER::PROTEIN)
    ("TNKS1 and TNKS2" . SPARSER::COLLECTION) ("AXIN" . SPARSER::PROTEIN)
    ("tankyrase" . SPARSER::PROTEIN) ("WNT/β-catenin" . SPARSER::COLLECTION)
    ("HCC" . SPARSER::PROTEIN) ("WNT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Dual-Luciferase" . SPARSER::PROTEIN) ("histone 3" . SPARSER::PROTEIN)
    ("H11" . SPARSER::PROTEIN) ("TNKS 1" . SPARSER::PROTEIN)
    ("dimethyl sulfoxide" . SPARSER::MOLECULE) ("Axin2" . SPARSER::PROTEIN)
    ("CTNNB1" . SPARSER::PROTEIN) ("WNT3A" . SPARSER::PROTEIN)
    ("ADP-ribose" . SPARSER::MOLECULE) ("PARP5B" . SPARSER::PROTEIN)
    ("tankyrase 2" . SPARSER::PROTEIN) ("tankyrase 1" . SPARSER::PROTEIN)
    ("LRP6" . SPARSER::PROTEIN) ("co-receptor" . SPARSER::PROTEIN)
    ("c-myc" . SPARSER::PROTEIN) ("TCF4" . SPARSER::PROTEIN)
    ("CK1" . SPARSER::PROTEIN) ("GSK3" . SPARSER::PROTEIN)
    ("Glycogen synthase kinase-3" . SPARSER::PROTEIN)
    ("AXIN2" . SPARSER::PROTEIN) ("AXIN1" . SPARSER::PROTEIN)
    ("XAV939" . SPARSER::DRUG) ("TNKS2" . SPARSER::PROTEIN)
    ("TNKS1" . SPARSER::PROTEIN) ("ciliary proteins" . SPARSER::PROTEIN)
    ("other ciliary regulatory proteins" . SPARSER::PROTEIN)
    ("diverse ciliary regulatory proteins" . SPARSER::PROTEIN)
    ("peroxiredoxin" . SPARSER::PROTEIN) ("se" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cytochalasin D or vehicle control" . SPARSER::COLLECTION)
    ("phalloidin" . SPARSER::MOLECULE)
    ("F-actin, and 9KR" . SPARSER::COLLECTION)
    ("Flag-cortactin" . SPARSER::COLLECTION) ("KR" . SPARSER::PROTEIN-FAMILY)
    ("glutamines" . SPARSER::AMINO-ACID) ("lysines" . SPARSER::AMINO-ACID)
    ("Cortactin" . SPARSER::PROTEIN) ("just α-tubulin" . SPARSER::PROTEIN)
    ("GFP-α-tubulin" . SPARSER::COLLECTION) ("glutamine" . SPARSER::AMINO-ACID)
    ("these known ciliary regulators" . SPARSER::REGULATOR)
    ("these ciliary regulators" . SPARSER::REGULATOR)
    ("intraflagellar transport protein" . SPARSER::PROTEIN)
    ("centrosomal protein" . SPARSER::PROTEIN)
    ("several key ciliary regulators" . SPARSER::REGULATOR)
    ("ninein" . SPARSER::PROTEIN) ("alanines" . SPARSER::AMINO-ACID)
    ("tubacin" . SPARSER::DRUG) ("GFP-HDAC6" . SPARSER::COLLECTION)
    ("GFP" . SPARSER::PROTEIN) ("HA-HDAC6" . SPARSER::PROTEIN-PAIR)
    ("HDAC6 and γ-tubulin" . SPARSER::COLLECTION)
    ("the microtubule component α-tubulin and the actin-binding protein cortactin"
     . SPARSER::COLLECTION)
    ("Dio3" . SPARSER::PROTEIN) ("Dio" . SPARSER::MOLECULE)
    ("smoke" . SPARSER::MOLECULE) ("cigarette" . SPARSER::DRUG)
    ("HEF1, MST1/2, calmodulin, inversin, β-catenin, and aPKC"
     . SPARSER::COLLECTION)
    ("aPKC" . SPARSER::PROTEIN) ("inversin" . SPARSER::PROTEIN)
    ("calmodulin" . SPARSER::PROTEIN) ("dynein" . SPARSER::PROTEIN)
    ("microtubules" . SPARSER::PROTEIN)
    ("α-tubulin or cortactin" . SPARSER::COLLECTION)
    ("known ciliary regulators" . SPARSER::REGULATOR)
    ("α-tubulin and cortactin" . SPARSER::COLLECTION)
    ("cortactin" . SPARSER::PROTEIN) ("Tween 20" . SPARSER::MOLECULE)
    ("SP5" . SPARSER::PROTEIN) ("TMEM67" . SPARSER::PROTEIN)
    ("MYH9" . SPARSER::PROTEIN) ("myosin heavy chain 9" . SPARSER::PROTEIN)
    ("Hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cytochalasin D" . SPARSER::DRUG) ("F-actin" . SPARSER::BIO-COMPLEX)
    ("filamentous actin" . SPARSER::BIO-COMPLEX)
    ("β-tubulin" . SPARSER::PROTEIN) ("Cep164" . SPARSER::PROTEIN)
    ("MKS1" . SPARSER::PROTEIN) ("Meckel syndrome" . SPARSER::PROTEIN)
    ("IFT140" . SPARSER::PROTEIN) ("IFT88" . SPARSER::PROTEIN)
    ("CP110" . SPARSER::PROTEIN) ("deacetylase activity" . SPARSER::PROTEIN)
    ("β-catenin" . SPARSER::PROTEIN) ("MST1" . SPARSER::PROTEIN)
    ("HEF1" . SPARSER::PROTEIN) ("α-tubulin" . SPARSER::PROTEIN)
    ("Histone deacetylase 6" . SPARSER::PROTEIN)
    ("Jak3-STAT3/STAT5" . SPARSER::COLLECTION)
    ("MAX, MYCBP, HDAC4, HDAC6, CDK6, and NCoA1" . SPARSER::COLLECTION)
    ("microRNA" . SPARSER::RNA) ("STAT3/STAT5" . SPARSER::COLLECTION)
    ("antagonists" . SPARSER::MOLECULE)
    ("oligonucleotides" . SPARSER::MOLECULE) ("LNA" . SPARSER::PROTEIN)
    ("NCoA1 and PTEN" . SPARSER::COLLECTION) ("bexarotene" . SPARSER::DRUG)
    ("retinoid" . SPARSER::PROTEIN) ("tamoxifen" . SPARSER::MOLECULE)
    ("MAX and MYCBP" . SPARSER::COLLECTION)
    ("NCoA1, MAX, MYCBP, and PTEN" . SPARSER::COLLECTION)
    ("NCoA1, MAX, MYCBP, HDAC4, HDAC6, CDK6, and PTEN" . SPARSER::COLLECTION)
    ("STAT proteins and other molecules" . SPARSER::COLLECTION)
    ("kappa" . SPARSER::PROTEIN-FAMILY) ("Ig" . SPARSER::MOLECULE)
    ("STAT3 and STAT5-" . SPARSER::COLLECTION) ("STAT5-" . SPARSER::PROTEIN)
    ("Cyclin D2 and BCL6" . SPARSER::COLLECTION)
    ("Glucose-6-Phosphatase and p53" . SPARSER::COLLECTION)
    ("STAT5 and STAT3" . SPARSER::COLLECTION)
    ("MAX, MYCBP, NCoA1, and CDK6" . SPARSER::COLLECTION)
    ("Jak3, STAT5A, and STAT5B and STAT3" . SPARSER::COLLECTION)
    ("STAT5B and STAT3" . SPARSER::COLLECTION) ("NCoA1" . SPARSER::PROTEIN)
    ("CDK6, HDAC4 and HDAC6" . SPARSER::COLLECTION)
    ("MAX, MYCBP, NCoA1, and PTEN" . SPARSER::COLLECTION)
    ("seven" . SPARSER::PROTEIN)
    ("HDACs and transcriptional co-activators/regulators"
     . SPARSER::COLLECTION)
    ("SAHA" . SPARSER::DRUG) ("EZH2 and HDACs" . SPARSER::COLLECTION)
    ("HDACs" . SPARSER::PROTEIN) ("IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RelA and RelB" . SPARSER::COLLECTION) ("RelB" . SPARSER::PROTEIN)
    ("RelA" . SPARSER::PROTEIN) ("Chromatin" . SPARSER::PROTEIN)
    ("pY-STAT3" . SPARSER::COLLECTION) ("pY-STAT5" . SPARSER::COLLECTION)
    ("pY" . SPARSER::PROTEIN) ("Orf" . SPARSER::PROTEIN)
    ("HG" . SPARSER::MOLECULE)
    ("a transcriptional activator or a transcriptional repressor [ xref - xref ]"
     . SPARSER::COLLECTION)
    ("repressor" . SPARSER::REPRESSOR)
    ("STAT3, STAT5A, and STAT5B" . SPARSER::COLLECTION)
    ("STAT3, STAT5A, and STAT5b" . SPARSER::COLLECTION)
    ("STATs" . SPARSER::PROTEIN) ("Jak3-" . SPARSER::PROTEIN)
    ("II" . SPARSER::PROTEIN) ("curcumin" . SPARSER::DRUG)
    ("Jak/STAT" . SPARSER::COLLECTION) ("Jak" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MYCBP and MAX" . SPARSER::COLLECTION)
    ("onco-miRNAs" . SPARSER::COLLECTION)
    ("a leukemic variant" . SPARSER::VARIANT)
    ("only three miRNAs" . SPARSER::PROTEIN)
    ("disease-associated genes" . SPARSER::GENE)
    ("repressors" . SPARSER::REPRESSOR) ("HDAC" . SPARSER::PROTEIN)
    ("Cytokine Signaling-3 (SOCS3) and the protein tyrosine phosphatases (e.g. SHP1)"
     . SPARSER::COLLECTION)
    ("phosphatases" . SPARSER::PHOSPHATASE) ("tyrosine" . SPARSER::AMINO-ACID)
    ("Suppressors" . SPARSER::SUPPRESSOR)
    ("IL-2, IL-4, IL-7, IL-15, and IL-21" . SPARSER::COLLECTION)
    ("Jak3/STAT3" . SPARSER::COLLECTION)
    ("STAT3 and STAT5" . SPARSER::COLLECTION)
    ("Transducers and Activators" . SPARSER::COLLECTION)
    ("src" . SPARSER::PROTEIN) ("Activators" . SPARSER::ACTIVATOR)
    ("Transducers" . SPARSER::PROTEIN)
    ("Jak3/STAT3/STAT5" . SPARSER::COLLECTION)
    ("HDAC6, MAX, MYCBP, PTEN, and CDK2" . SPARSER::COLLECTION)
    ("MYCBP" . SPARSER::PROTEIN) ("MAX" . SPARSER::PROTEIN)
    ("activator" . SPARSER::ACTIVATOR) ("NCoA" . SPARSER::PROTEIN)
    ("HDACi" . SPARSER::MOLECULE) ("Curcumin" . SPARSER::DRUG)
    ("Jak3, STAT3, and STAT5" . SPARSER::COLLECTION)
    ("microRNAs" . SPARSER::RNA) ("Jak3/STAT" . SPARSER::COLLECTION)
    ("Signal Transducer and Activator of Transcription-3 (STAT3) and STAT5"
     . SPARSER::COLLECTION)
    ("effectors" . SPARSER::EFFECTOR) ("Janus" . SPARSER::PROTEIN-FAMILY)
    ("m1" . SPARSER::MOLECULE) ("AT3" . SPARSER::PROTEIN)
    ("CA3" . SPARSER::PROTEIN) ("β- Actin" . SPARSER::PROTEIN)
    ("NCOA1" . SPARSER::PROTEIN) ("MS-275" . SPARSER::DRUG)
    ("JAK3" . SPARSER::PROTEIN) ("SRC-1" . SPARSER::PROTEIN)
    ("C-Myc" . SPARSER::PROTEIN) ("light chain" . SPARSER::PROTEIN)
    ("Glucose-6-Phosphatase" . SPARSER::PROTEIN) ("BCL6" . SPARSER::PROTEIN)
    ("Cyclin D2" . SPARSER::PROTEIN) ("HDAC4" . SPARSER::PROTEIN)
    ("EZH2" . SPARSER::PROTEIN) ("oligo-nucleotide" . SPARSER::MOLECULE)
    ("siRNA- mediated" . SPARSER::PROTEIN) ("BLIMP-1" . SPARSER::PROTEIN)
    ("transcriptional activators" . SPARSER::PROTEIN-FAMILY)
    ("STAT5B" . SPARSER::PROTEIN) ("siRNA-mediated" . SPARSER::PROTEIN)
    ("STAT5b" . SPARSER::PROTEIN) ("STAT5A" . SPARSER::PROTEIN)
    ("IL-2R" . SPARSER::PROTEIN) ("T- cell" . SPARSER::PROTEIN)
    ("PB2" . SPARSER::PROTEIN) ("miR-21" . SPARSER::PROTEIN)
    ("transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("IL-17F" . SPARSER::PROTEIN) ("IL-17A" . SPARSER::PROTEIN)
    ("IL-10" . SPARSER::PROTEIN) ("SHP1" . SPARSER::PROTEIN)
    ("SOCS3" . SPARSER::PROTEIN) ("Cytokine Signaling-3" . SPARSER::PROTEIN)
    ("IL-21" . SPARSER::PROTEIN) ("IL-15" . SPARSER::PROTEIN)
    ("IL-7" . SPARSER::PROTEIN) ("IL-4" . SPARSER::PROTEIN)
    ("Interleukin-2 receptor" . SPARSER::PROTEIN) ("GATA3" . SPARSER::PROTEIN)
    ("NFκB" . SPARSER::PROTEIN) ("COX-2" . SPARSER::PROTEIN)
    ("CDK2" . SPARSER::PROTEIN) ("HDAC6" . SPARSER::PROTEIN)
    ("histone deacetylase" . SPARSER::PROTEIN) ("STAT5" . SPARSER::PROTEIN)
    ("Signal Transducer and Activator of Transcription-3" . SPARSER::PROTEIN)
    ("Jak3" . SPARSER::PROTEIN)
    ("the respective patient cohorts" . SPARSER::MOLECULE)
    ("antiestrogens" . SPARSER::DRUG)
    ("a more homogenous cohort" . SPARSER::MOLECULE)
    ("PAR-2 and ER" . SPARSER::COLLECTION) ("MAPKs" . SPARSER::PROTEIN)
    ("receptor tyrosine kinases and G-protein coupled receptors and their downstream signaling molecules"
     . SPARSER::COLLECTION)
    ("receptor tyrosine kinases and G-protein coupled" . SPARSER::COLLECTION)
    ("ER, PAR-1 and PAR-2" . SPARSER::COLLECTION)
    ("ER, PAR-1, and PAR-2" . SPARSER::COLLECTION)
    ("ER and PAR-1" . SPARSER::COLLECTION)
    ("The corresponding cumulative BCM" . SPARSER::DRUG)
    ("BCM" . SPARSER::DRUG) ("ER- and PR-negativity" . SPARSER::COLLECTION)
    ("ER-" . SPARSER::PROTEIN)
    ("matrix metalloproteinases and coagulation proteases"
     . SPARSER::COLLECTION)
    ("a unique class" . CLASS) ("proteases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Proteases" . SPARSER::PROTEIN) ("PAR-1 and PAR-2" . SPARSER::COLLECTION)
    ("protease activated receptors" . SPARSER::PROTEIN)
    ("β-arrestins" . SPARSER::PROTEIN) ("G-protein coupled" . SPARSER::PROTEIN)
    ("receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("steroid hormone" . SPARSER::MOLECULE) ("ERα" . SPARSER::PROTEIN)
    ("–3" . SPARSER::PROTEIN) ("or 2" . SPARSER::MOLECULE)
    ("VEGF-A" . SPARSER::PROTEIN) ("HER-2" . SPARSER::PROTEIN)
    ("G protein-coupled" . SPARSER::PROTEIN) ("PAR-2" . SPARSER::PROTEIN)
    ("PAR-1" . SPARSER::PROTEIN)
    ("a potential drug target" . SPARSER::TARGET-PROTEIN)
    ("p53 and DNA" . SPARSER::COLLECTION) ("Asp" . SPARSER::AMINO-ACID)
    ("Cys" . SPARSER::AMINO-ACID) ("Asn" . SPARSER::AMINO-ACID)
    ("DNA-contact mutants (R273C and R273H) and rescue mutants (R273C_T284R, R273H_T284R and R273C-S240R)"
     . SPARSER::COLLECTION)
    ("the p53 protein and the DNA molecule" . SPARSER::COLLECTION)
    ("guanine" . SPARSER::PROTEIN) ("BSA" . SPARSER::PROTEIN)
    ("monomer" . SPARSER::MONOMER) ("protein-protein" . SPARSER::COLLECTION)
    ("Protein" . SPARSER::PROTEIN)
    ("its flexible conformation" . SPARSER::BIO-CONFORMATION)
    ("a more rigid conformation" . SPARSER::BIO-CONFORMATION)
    ("the DNA-contact mutant (R273C and R273H) and rescue mutant (R273C_T284R, R273H_T284R and R273H_S240R)"
     . SPARSER::COLLECTION)
    ("PC2 and PC1" . SPARSER::COLLECTION)
    ("the first two principal components" . SPARSER::COMPONENT)
    ("components" . SPARSER::COMPONENT) ("PC1" . SPARSER::PROTEIN)
    ("solvent" . SPARSER::MOLECULE)
    ("DNA-contact (R273C and R273H) and rescue mutants (R273C_T284R, R273H_T284R and R273H_S240R) of the p53 protein"
     . SPARSER::COLLECTION)
    ("DNA-contact (R273C)" . SPARSER::DNA)
    ("the flexible conformation" . SPARSER::BIO-CONFORMATION)
    ("conformation" . SPARSER::BIO-CONFORMATION)
    ("DNA-contact and rescue" . SPARSER::COLLECTION)
    ("DNA-contact (R273C and R273H)" . SPARSER::DNA)
    ("DNA contact mutants(R273H and R273C) and rescue mutants(T284R/S240R)"
     . SPARSER::COLLECTION)
    ("DNA-contact mutants and rescue mutants" . SPARSER::COLLECTION)
    ("serine" . SPARSER::AMINO-ACID) ("threonine" . SPARSER::AMINO-ACID)
    ("Mutant" . SPARSER::MUTANT)
    ("histidine or cysteine" . SPARSER::COLLECTION)
    ("salt" . SPARSER::MOLECULE) ("guanidinium" . SPARSER::MOLECULE)
    ("PDB" . SPARSER::MOLECULE) ("Gly" . SPARSER::AMINO-ACID)
    ("Arg" . SPARSER::AMINO-ACID)
    ("several electropositive arginine amino acids and one zinc atom"
     . SPARSER::COLLECTION)
    ("several electropositive arginine amino acids" . SPARSER::AMINO-ACID)
    ("TP" . SPARSER::PROTEIN) ("subdomains" . SPARSER::PROTEIN)
    ("tetramer" . SPARSER::TETRAMER)
    ("the p53 protein and a DNA molecule" . SPARSER::COLLECTION)
    ("protein and DNA" . SPARSER::COLLECTION)
    ("suppressor or rescue" . SPARSER::COLLECTION)
    ("DNA-contact" . SPARSER::DNA) ("protein can" . SPARSER::PROTEIN)
    ("PC2" . SPARSER::PROTEIN) ("D–A" . SPARSER::PROTEIN)
    ("D–H" . SPARSER::PROTEIN) ("nm 3" . SPARSER::DRUG)
    ("TIP3" . SPARSER::PROTEIN) ("zinc atom" . SPARSER::MOLECULE)
    ("P53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tumor suppressor protein" . SPARSER::PROTEIN)
    ("our mostly Chinese cohort" . SPARSER::MOLECULE)
    ("AA" . SPARSER::MOLECULE) ("van" . SPARSER::PROTEIN)
    ("TA" . SPARSER::PROTEIN) ("BCL2-homology" . SPARSER::COLLECTION)
    ("chronic myelogenous leukemia" . SPARSER::PROTEIN)
    ("gefitinib or erlotinib" . SPARSER::COLLECTION)
    ("erlotinib" . SPARSER::DRUG) ("gefitinib" . SPARSER::DRUG)
    ("EGFR" . SPARSER::PROTEIN) ("leukemia" . SPARSER::PROTEIN)
    ("imatinib" . SPARSER::DRUG) ("TKIs" . SPARSER::PROTEIN)
    ("ABCB1 and another efflux transporter" . SPARSER::COLLECTION)
    ("ABCB1/ABCG2" . SPARSER::COLLECTION) ("substrate" . SPARSER::SUBSTRATE)
    ("transporter" . SPARSER::PROTEIN)
    ("ABCG2 [ xref , xref ] and ABCB1 [ xref , xref , xref ]"
     . SPARSER::COLLECTION)
    ("multidrug" . SPARSER::PROTEIN) ("xenobiotic" . SPARSER::MOLECULE)
    ("eNOS" . SPARSER::PROTEIN) ("VEGFA" . SPARSER::PROTEIN)
    ("FDA" . SPARSER::PROTEIN)
    ("Fms-like tyrosine kinase 3 (FLT3) and the RET protein [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("vascular endothelial growth factor receptors (VEGFR1, VEGFR2 and VEGFR3), platelet-derived growth factors (PDGFRα and PDGFβ), Fms-like tyrosine kinase 3 (FLT3) and the RET protein [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("VEGFR1, VEGFR2 and VEGFR3" . SPARSER::COLLECTION)
    ("PDGFRα and PDGFβ" . SPARSER::COLLECTION) ("RET" . SPARSER::PROTEIN)
    ("FLT3 738T and sunitinib-induced leucopenia" . SPARSER::COLLECTION)
    ("ABCB1 and FLT3" . SPARSER::COLLECTION)
    ("ABCG2 421A (OR=0.3) alleles and ABCB1" . SPARSER::COLLECTION)
    ("alleles" . SPARSER::ALLELE)
    ("FLT3 , ABCB1 , VEGFR2 , ABCG2 and BIM" . SPARSER::COLLECTION)
    ("BIM" . SPARSER::PROTEIN) ("aims" . SPARSER::PROTEIN)
    ("biomarkers" . SPARSER::MOLECULE) ("sunitinib" . SPARSER::DRUG)
    ("Sunitinib" . SPARSER::DRUG) ("BCL2" . SPARSER::PROTEIN)
    ("a 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NR1" . SPARSER::PROTEIN)
    ("CYP1A1" . SPARSER::PROTEIN) ("CYP3A5" . SPARSER::PROTEIN)
    ("FGFR2" . SPARSER::PROTEIN) ("FLT4" . SPARSER::PROTEIN)
    ("Fms-like tyrosine kinase 3" . SPARSER::PROTEIN)
    ("PDGFRα" . SPARSER::PROTEIN)
    ("derived growth factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("VEGFR3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("VEGFR1" . SPARSER::PROTEIN)
    ("ABCG2" . SPARSER::PROTEIN) ("VEGFR2" . SPARSER::PROTEIN)
    ("ABCB1" . SPARSER::PROTEIN) ("FLT3" . SPARSER::PROTEIN)
    ("integrin/FAK" . SPARSER::COLLECTION)
    ("MFG-E8/αvβ5" . SPARSER::COLLECTION)
    ("pyrroloquinoline quinone [ xref ], AMP-activated protein kinase activators such as 5-aminoimidazole-4-carboxamide ribonucleotide [ xref ], and adiponectin receptor agonists [ xref ]"
     . SPARSER::COLLECTION)
    ("agonists" . SPARSER::AGONIST) ("adiponectin" . SPARSER::PROTEIN)
    ("ribonucleotide" . SPARSER::MOLECULE) ("activators" . SPARSER::ACTIVATOR)
    ("quinone" . SPARSER::MOLECULE) ("inducers" . SPARSER::MOLECULE)
    ("metabolite" . SPARSER::MOLECULE) ("estrogen" . SPARSER::MOLECULE)
    ("PPARs" . SPARSER::PROTEIN) ("TFAM" . SPARSER::PROTEIN)
    ("lectin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("retina" . SPARSER::DRUG)
    ("whose PGC-1α" . SPARSER::PROTEIN)
    ("PGC-1α siRNA and control siRNA" . SPARSER::COLLECTION)
    ("a major cathepsin" . SPARSER::PROTEIN)
    ("rhodopsin and POS" . SPARSER::COLLECTION)
    ("rhodopsin" . SPARSER::PROTEIN) ("cathepsin" . SPARSER::PROTEIN)
    ("tripeptidyl peptidase I, and cathepsin F" . SPARSER::COLLECTION)
    ("hexosaminidase" . SPARSER::PROTEIN) ("weaker" . SPARSER::PROTEIN)
    ("TFEB and PGC-1α" . SPARSER::COLLECTION) ("catabolism" . SPARSER::PROTEIN)
    ("TFEB" . SPARSER::PROTEIN) ("lipids and lipofuscin" . SPARSER::COLLECTION)
    ("lipids" . SPARSER::LIPID) ("prohibitin" . SPARSER::PROTEIN)
    ("GPx4, superoxide dismutase 1, and catalase" . SPARSER::COLLECTION)
    ("catalase" . SPARSER::PROTEIN) ("GPx" . SPARSER::PROTEIN)
    ("siRNA and RGD" . SPARSER::COLLECTION)
    ("siRNAs and antibodies" . SPARSER::COLLECTION)
    ("reagents" . SPARSER::MOLECULE)
    ("CD36 ( xref ) or MerTK ( xref )" . SPARSER::COLLECTION)
    ("CD36 (2 μg/mL) and MerTK (3.44 μg/mL)" . SPARSER::COLLECTION)
    ("CD36 or MerTK" . SPARSER::COLLECTION)
    ("integrin, CD36, MerTK, and Atg5" . SPARSER::COLLECTION)
    ("peptides" . SPARSER::PEPTIDE) ("integrin and FAK" . SPARSER::COLLECTION)
    ("phospholipid" . SPARSER::PHOSPHOLIPID) ("light" . SPARSER::PROTEIN)
    ("AMD" . SPARSER::PROTEIN) ("integrin/FAK/PGC-1α" . SPARSER::COLLECTION)
    ("vasculature" . SPARSER::PROTEIN) ("lipid" . SPARSER::LIPID)
    ("antioxidant" . SPARSER::PROTEIN)
    ("β5 integrin and a FAK inhibitor" . SPARSER::COLLECTION)
    ("BODIPY" . SPARSER::DRUG) ("Lipid" . SPARSER::LIPID)
    ("transcriptional factor EB and its target genes" . SPARSER::COLLECTION)
    ("EB" . SPARSER::PROTEIN-FAMILY) ("Lysosomal" . SPARSER::PROTEIN)
    ("senescence-associated β-galactosidase" . SPARSER::PROTEIN)
    ("lysosomal" . SPARSER::PROTEIN) ("ROS" . SPARSER::PROTEIN)
    ("oxygen" . SPARSER::MOLECULE) ("kinase (FAK)" . SPARSER::KINASE)
    ("CD36 and MerTK" . SPARSER::COLLECTION) ("Atg5" . SPARSER::PROTEIN)
    ("FAK" . SPARSER::PROTEIN) ("Atg" . SPARSER::DRUG)
    ("MerTK" . SPARSER::PROTEIN) ("Mer" . SPARSER::PROTEIN)
    ("integrin" . SPARSER::PROTEIN) ("RPE" . SPARSER::PROTEIN)
    ("peroxisome" . SPARSER::PROTEIN) ("MFG-E8" . SPARSER::PROTEIN)
    ("5-aminoimidazole-4-carboxamide" . SPARSER::MOLECULE)
    ("AMP-activated" . SPARSER::PROTEIN) ("NRF2" . SPARSER::PROTEIN)
    ("transcription factor 2" . SPARSER::PROTEIN)
    ("fatty acid" . SPARSER::MOLECULE)
    ("transcription factor A" . SPARSER::PROTEIN) ("Type 2" . SPARSER::PROTEIN)
    ("cathepsin F" . SPARSER::PROTEIN)
    ("tripeptidyl peptidase I" . SPARSER::PROTEIN)
    ("Transcription factor EB" . SPARSER::PROTEIN)
    ("superoxide dismutase 1" . SPARSER::PROTEIN)
    ("glutathione peroxidase 1" . SPARSER::PROTEIN)
    ("agglutinin-I" . SPARSER::PROTEIN) ("β-Gal" . SPARSER::PROTEIN)
    ("beta-galactosidase" . SPARSER::PROTEIN) ("Complex I" . SPARSER::PROTEIN)
    ("complex I" . SPARSER::PROTEIN) ("NAD+" . SPARSER::MOLECULE)
    ("H 2 DCFDA" . SPARSER::DRUG) ("cytochrome b" . SPARSER::PROTEIN)
    ("glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("Cathepsin D" . SPARSER::PROTEIN) ("ZO-1" . SPARSER::PROTEIN)
    ("F-12" . SPARSER::PROTEIN)
    ("peroxisome proliferator-activated receptor gamma coactivator 1-alpha"
     . SPARSER::PROTEIN)
    ("αvβ5" . SPARSER::PROTEIN) ("type 2" . SPARSER::PROTEIN)
    ("C11" . SPARSER::PROTEIN) ("cathepsin D" . SPARSER::PROTEIN)
    ("H 2 O 2" . SPARSER::DRUG) ("CD36" . SPARSER::PROTEIN)
    ("β5" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PGC-1α" . SPARSER::PROTEIN)
    ("available FOXM1 inhibitors" . SPARSER::INHIBITOR)
    ("Thiostrepton" . SPARSER::PROTEIN) ("genesis" . SPARSER::PROTEIN)
    ("platinum and taxane" . SPARSER::COLLECTION)
    ("RAF/MEK/MAPK" . SPARSER::COLLECTION)
    ("RAF" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the predominant FOXM1 isoform" . SPARSER::ISOFORM)
    ("p53, Rb, and E2F1" . SPARSER::COLLECTION)
    ("Myc and FOXO3" . SPARSER::COLLECTION) ("Rb" . SPARSER::PROTEIN)
    ("cyclin-dependent kinases (CDK) and a direct transcriptional target"
     . SPARSER::COLLECTION)
    ("Rb-E2F" . SPARSER::COLLECTION) ("CDK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("regulators" . SPARSER::REGULATOR) ("E2F and Myc" . SPARSER::COLLECTION)
    ("FOXM1b or FOXM1c" . SPARSER::COLLECTION)
    ("PLK1 and CCNB1" . SPARSER::COLLECTION)
    ("relevant FOXM1 target genes" . SPARSER::GENE)
    ("SKP2 , PLK1 , and CCNB1" . SPARSER::COLLECTION)
    ("FOXM1 and E2F1" . SPARSER::COLLECTION)
    ("E2F1 and FOXM1" . SPARSER::COLLECTION) ("actin" . SPARSER::PROTEIN)
    ("cytokeratin" . SPARSER::PROTEIN-FAMILY) ("complement" . SPARSER::PROTEIN)
    ("p53/Rb1" . SPARSER::COLLECTION)
    ("which leaves both proteins" . SPARSER::PROTEIN)
    ("p53 and Rb, or hTERT" . SPARSER::COLLECTION)
    ("tumor suppressor gene (TSG)" . SPARSER::PROTEIN)
    ("TSG" . SPARSER::PROTEIN) ("Cre" . SPARSER::PROTEIN)
    ("TP53 and RB1" . SPARSER::COLLECTION) ("mOSE" . SPARSER::DRUG)
    ("Isoform" . SPARSER::ISOFORM)
    ("the predominant isoform" . SPARSER::ISOFORM)
    ("FOXM1b and FOXM1a" . SPARSER::COLLECTION)
    ("different EOC histological subtypes" . SPARSER::PROTEIN)
    ("type and progression" . SPARSER::COLLECTION)
    ("CNA and FOXM1" . SPARSER::COLLECTION) ("oncogene" . SPARSER::ONCOGENE)
    ("exons Va and VIIa" . SPARSER::COLLECTION) ("isoform" . SPARSER::ISOFORM)
    ("FOXM1b" . SPARSER::PROTEIN) ("Va" . SPARSER::MOLECULE)
    ("p53, Rb, and FOXO3" . SPARSER::COLLECTION)
    ("Myc, HIF-1, Gli1, SP1, STAT3 and E2F" . SPARSER::COLLECTION)
    ("SP1" . SPARSER::PROTEIN) ("MMB" . SPARSER::PROTEIN)
    ("Myb" . SPARSER::PROTEIN) ("Forkhead" . SPARSER::PROTEIN)
    ("suppressors and oncogenes" . SPARSER::COLLECTION)
    ("oncogenes" . SPARSER::ONCOGENE) ("mRNA and miRNA" . SPARSER::COLLECTION)
    ("CNA" . SPARSER::PROTEIN) ("taxane" . SPARSER::DRUG)
    ("p53 and Rb" . SPARSER::COLLECTION)
    ("OSE and HGSOC" . SPARSER::COLLECTION)
    ("E2F1, and FOXM1" . SPARSER::COLLECTION) ("hTERT" . SPARSER::PROTEIN)
    ("SV" . SPARSER::MOLECULE) ("Rb1" . SPARSER::PROTEIN)
    ("Trp" . SPARSER::AMINO-ACID) ("isoforms" . SPARSER::ISOFORM)
    ("OSE" . SPARSER::PROTEIN) ("pMD2" . SPARSER::MOLECULE)
    ("H2O2" . SPARSER::DRUG) ("g protein" . SPARSER::PROTEIN)
    ("epidermal growth factor" . SPARSER::PROTEIN)
    ("β-Actin" . SPARSER::PROTEIN) ("NP40" . SPARSER::MOLECULE)
    ("of 45" . SPARSER::PROTEIN) ("Reverse transcriptase" . SPARSER::PROTEIN)
    ("cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Nutlin 3" . SPARSER::DRUG)
    ("transcriptional regulator" . SPARSER::PROTEIN-FAMILY)
    ("CCNB1" . SPARSER::PROTEIN) ("PLK1" . SPARSER::PROTEIN)
    ("SKP2" . SPARSER::PROTEIN) ("Foxm1" . SPARSER::PROTEIN)
    ("RB1" . SPARSER::PROTEIN) ("p13" . SPARSER::PROTEIN)
    ("E2F" . SPARSER::PROTEIN-FAMILY) ("STAT3" . SPARSER::PROTEIN)
    ("Gli1" . SPARSER::PROTEIN) ("HIF-1" . SPARSER::PROTEIN)
    ("FOXO3" . SPARSER::PROTEIN)
    ("transcriptional activator" . SPARSER::PROTEIN-FAMILY)
    ("CCNE1" . SPARSER::PROTEIN) ("BRCA1" . SPARSER::PROTEIN)
    ("TP53" . SPARSER::PROTEIN) ("E2F1" . SPARSER::PROTEIN)
    ("T antigen" . SPARSER::MOLECULE) ("FOXM1" . SPARSER::PROTEIN)
    ("Aurora-A/Bora" . SPARSER::COLLECTION)
    ("the kinase Aurora-A and its cofactor Bora" . SPARSER::COLLECTION)
    ("Bora" . SPARSER::PROTEIN) ("cofactor" . SPARSER::MOLECULE)
    ("SLK" . SPARSER::PROTEIN) ("Plk1/MAPK" . SPARSER::COLLECTION)
    ("ribosomal S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("kinase, and cPLA2" . SPARSER::COLLECTION)
    ("mTORC2 (mammalian target of rapamycin complex 2) and DNA-PK [ xref ]"
     . SPARSER::COLLECTION)
    ("MEK1/2 and AKT" . SPARSER::COLLECTION)
    ("differentially" . SPARSER::PROTEIN) ("fibronectin" . SPARSER::PROTEIN)
    ("Ser" . SPARSER::AMINO-ACID) ("Tyr" . SPARSER::AMINO-ACID)
    ("MEK/ERK" . SPARSER::COLLECTION) ("ERK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ras-Raf" . SPARSER::COLLECTION) ("Raf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("smooth muscle" . SPARSER::PROTEIN)
    ("Ras" . SPARSER::HUMAN-PROTEIN-FAMILY) ("AKT/PKB" . SPARSER::COLLECTION)
    ("PKB" . SPARSER::PROTEIN) ("BrdU" . SPARSER::DRUG)
    ("purified unactive MEK1" . SPARSER::PROTEIN)
    ("MEK1/2, and Plk1" . SPARSER::COLLECTION)
    ("shRNA and Plk1" . SPARSER::COLLECTION)
    ("phospho-Raf-1 and total Raf-1" . SPARSER::COLLECTION)
    ("antibodies" . SPARSER::ANTIBODY) ("Plk1/GAPDH" . SPARSER::COLLECTION)
    ("GAPDH" . SPARSER::PROTEIN) ("MEK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Plk1, MEK1/2 and ERK1/2" . SPARSER::COLLECTION)
    ("several protein kinases, transcription factors, and other proteins"
     . SPARSER::COLLECTION)
    ("substrates" . SPARSER::SUBSTRATE) ("Raf-1 and AKT" . SPARSER::COLLECTION)
    ("MEK1/2 and ERK1/2" . SPARSER::COLLECTION) ("Thr" . SPARSER::AMINO-ACID)
    ("phosphorylatable" . SPARSER::PROTEIN)
    ("Plk1 and MAPK" . SPARSER::COLLECTION)
    ("phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Aurora-A" . SPARSER::PROTEIN) ("G2/M" . SPARSER::PROTEIN)
    ("Ste20-like kinase" . SPARSER::PROTEIN) ("cPLA2" . SPARSER::PROTEIN)
    ("S6 kinase" . SPARSER::PROTEIN-FAMILY) ("Ets-2" . SPARSER::PROTEIN)
    ("Elk-1" . SPARSER::PROTEIN) ("DNA-PK" . SPARSER::PROTEIN)
    ("mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("mTORC2" . SPARSER::PROTEIN) ("PI3 kinase" . SPARSER::PROTEIN)
    ("kinase activity" . SPARSER::PROTEIN) ("as 2 " . SPARSER::PROTEIN)
    ("-3 " . SPARSER::PROTEIN) ("MEK1" . SPARSER::PROTEIN)
    ("PDGF-BB" . SPARSER::PROTEIN) ("18 h" . SPARSER::PROTEIN)
    ("D-glucose" . SPARSER::MOLECULE) ("Raf-1" . SPARSER::PROTEIN)
    ("MEK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("derived growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("serine/threonine protein kinase" . SPARSER::PROTEIN)
    ("Plk1" . SPARSER::PROTEIN) ("Polo-like kinase" . SPARSER::PROTEIN)
    ("only Han Chinese cohorts" . SPARSER::MOLECULE)
    ("cohorts" . SPARSER::MOLECULE) ("autoantibodies" . SPARSER::PROTEIN)
    ("cytokine and chemokine" . SPARSER::COLLECTION)
    ("chemokine" . SPARSER::PROTEIN)
    ("a crucial transcription factor" . SPARSER::PROTEIN)
    ("probably different target genes and pathway of regulation in these two similar diseases"
     . SPARSER::COLLECTION)
    ("a more severe disease state" . SPARSER::BIO-STATE)
    ("male" . SPARSER::MOLECULE)
    ("Systemic lupus erythematosus" . SPARSER::PROTEIN)
    ("v-ets" . SPARSER::COLLECTION) ("GGAA" . SPARSER::PROTEIN)
    ("ets" . SPARSER::HUMAN-PROTEIN-FAMILY) ("cis" . SPARSER::PROTEIN)
    ("TCC" . SPARSER::PROTEIN) ("allele" . SPARSER::ALLELE)
    ("c-reactive protein (CRP) and anti-keratin antibody (AKA)"
     . SPARSER::COLLECTION)
    ("antibody (AKA)" . SPARSER::ANTIBODY) ("AKA" . SPARSER::PROTEIN)
    ("CCP" . SPARSER::PROTEIN) ("peptide" . SPARSER::PEPTIDE)
    ("SD" . SPARSER::PROTEIN) ("Igh" . SPARSER::PROTEIN)
    ("Lck" . SPARSER::PROTEIN)
    ("Many viral and cellular genes" . SPARSER::GENE)
    ("genes and proto-oncogenes" . SPARSER::COLLECTION)
    ("lymphoid" . SPARSER::PROTEIN) ("MMPs" . SPARSER::PROTEIN)
    ("metalloproteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("matrix" . SPARSER::PROTEIN-FAMILY) ("SH" . SPARSER::PROTEIN-FAMILY)
    ("PTPN22, NFAIP3, STAT4, TRAF1/C5, IL2RB, AFF3, CD40, CTLA4, MMEL1 and PADI4"
     . SPARSER::COLLECTION)
    ("HLA" . SPARSER::PROTEIN) ("variants" . SPARSER::VARIANT)
    ("Allele" . SPARSER::ALLELE) ("ETS-1 and RA" . SPARSER::COLLECTION)
    ("CRP" . SPARSER::PROTEIN) ("DAS" . SPARSER::DRUG)
    ("HRM" . SPARSER::PROTEIN-FAMILY) ("polymerase" . SPARSER::PROTEIN)
    ("Han" . SPARSER::PROTEIN) ("RA" . SPARSER::PROTEIN)
    ("various immune-related genes" . SPARSER::GENE)
    ("T-cell" . SPARSER::PROTEIN) ("vascular endothelial" . SPARSER::PROTEIN)
    ("proto-oncogene" . SPARSER::PROTEIN)
    ("c-reactive protein" . SPARSER::PROTEIN) ("Anti-" . SPARSER::ANTIBODY)
    ("MgCl2" . SPARSER::MOLECULE) ("DNA Polymerase" . SPARSER::PROTEIN)
    ("C-reactive protein" . SPARSER::PROTEIN) ("ETS1" . SPARSER::PROTEIN)
    ("IL-2" . SPARSER::PROTEIN) ("TCRβ" . SPARSER::PROTEIN)
    ("csf2" . SPARSER::PROTEIN) ("c-fms" . SPARSER::PROTEIN)
    ("IL-5" . SPARSER::PROTEIN) ("Cd3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proto-oncogenes" . SPARSER::PROTO-ONCOGENE)
    ("growth factor" . SPARSER::GROWTH-FACTOR) ("PADI4" . SPARSER::PROTEIN)
    ("MMEL1" . SPARSER::PROTEIN) ("CTLA4" . SPARSER::PROTEIN)
    ("CD40" . SPARSER::PROTEIN) ("AFF3" . SPARSER::PROTEIN)
    ("IL2RB" . SPARSER::PROTEIN) ("TRAF1" . SPARSER::PROTEIN)
    ("STAT4" . SPARSER::PROTEIN) ("PTPN22" . SPARSER::PROTEIN)
    ("HLA-DRB1" . SPARSER::PROTEIN) ("ETS family" . SPARSER::PROTEIN)
    ("ETS-1" . SPARSER::PROTEIN) ("adjuvant" . SPARSER::DRUG)
    ("node-positive luminal" . SPARSER::DRUG)
    ("ER, PR and HER2" . SPARSER::COLLECTION)
    ("ER, PR, HER2 and Ki67" . SPARSER::COLLECTION) ("PAM" . SPARSER::PROTEIN)
    ("Gene" . SPARSER::GENE) ("HRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hormone" . SPARSER::MOLECULE) ("paclitaxel" . SPARSER::DRUG)
    ("doxorubicin" . SPARSER::PROTEIN) ("Lara" . SPARSER::MOLECULE)
    ("TM" . SPARSER::PROTEIN) ("Endocrine" . SPARSER::PROTEIN)
    ("endocrine" . SPARSER::PROTEIN) ("p53 or Ki-67" . SPARSER::COLLECTION)
    ("ER and PR" . SPARSER::COLLECTION) ("log-rank" . SPARSER::PROTEIN)
    ("HR" . SPARSER::PROTEIN) ("Hormone" . SPARSER::MOLECULE)
    ("p53 and Ki-67" . SPARSER::COLLECTION)
    ("p53-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HER2-" . SPARSER::PROTEIN)
    ("PR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ER" . SPARSER::PROTEIN)
    ("Luminal" . SPARSER::DRUG) ("Dec" . SPARSER::PROTEIN)
    ("luminal" . SPARSER::DRUG) ("Ki67" . SPARSER::PROTEIN)
    ("MIB-1" . SPARSER::PROTEIN) ("HER 2" . SPARSER::PROTEIN)
    ("progesterone receptor" . SPARSER::PROTEIN)
    ("estrogen receptor" . SPARSER::PROTEIN) ("de-" . SPARSER::MOLECULE)
    ("TP 53" . SPARSER::PROTEIN) ("medicine" . SPARSER::DRUG)
    ("TMA" . SPARSER::MOLECULE) ("HER" . SPARSER::PROTEIN)
    ("cohort" . SPARSER::MOLECULE) ("Lae" . SPARSER::PROTEIN)
    ("the micropapillary variant" . SPARSER::VARIANT)
    ("variant" . SPARSER::VARIANT) ("-FISH" . SPARSER::COLLECTION)
    ("bright" . SPARSER::PROTEIN) ("FISH" . SPARSER::PROTEIN)
    ("trastuzumab" . SPARSER::DRUG) ("invasive component" . SPARSER::COMPONENT)
    ("HER2-IHC and HER2" . SPARSER::COLLECTION)
    ("immunohistochemistry and gene" . SPARSER::COLLECTION)
    ("immunohistochemistry" . SPARSER::PROTEIN) ("LMP" . SPARSER::PROTEIN)
    ("20% pT1 and 10% CIS ( xref  xref )" . SPARSER::COLLECTION)
    ("70% pTa, 20% pT1 and 10% CIS ( xref  xref )" . SPARSER::COLLECTION)
    ("a 185-kDa transmembrane tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("RAS" . SPARSER::HUMAN-PROTEIN-FAMILY) ("kDa" . SPARSER::PROTEIN)
    ("BCG" . SPARSER::DRUG)
    ("p53, Cyclin D1, FGFR-3, Ki-67, Cathepsin E, and maspin"
     . SPARSER::COLLECTION)
    ("maspin" . SPARSER::PROTEIN) ("CIS" . SPARSER::PROTEIN)
    ("HER2-IHC, and HER2" . SPARSER::COLLECTION) ("IHC" . SPARSER::PROTEIN)
    ("pTa" . SPARSER::PROTEIN) ("HER2-IHC" . SPARSER::PROTEIN-PAIR)
    ("Chromosome 17" . SPARSER::PROTEIN) ("tyrosine kinase" . SPARSER::PROTEIN)
    ("chromosome 17" . SPARSER::PROTEIN)
    ("tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cathepsin E" . SPARSER::PROTEIN) ("FGFR-3" . SPARSER::PROTEIN)
    ("p53" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pT1" . SPARSER::PROTEIN)
    ("HER2" . SPARSER::PROTEIN) ("YB-1 and Lin28" . SPARSER::COLLECTION)
    ("linker" . SPARSER::LINKER) ("aa" . SPARSER::MOLECULE)
    ("oligomeric complexes" . SPARSER::BIO-COMPLEX)
    ("pri- or pre-miRNAs" . SPARSER::COLLECTION) ("melting" . SPARSER::DRUG)
    ("RNA-chaperon" . SPARSER::RNA)
    ("a new potential biomarker" . SPARSER::MOLECULE)
    ("biomarker" . SPARSER::MOLECULE) ("oncoprotein" . SPARSER::PROTEIN)
    ("type" . TYPE) ("YB-1 and miR-29b" . SPARSER::COLLECTION)
    ("Drosha/DGCR8" . SPARSER::COLLECTION) ("pre-miR-29b-2" . SPARSER::PROTEIN)
    ("DGCR8 and the pri-miR-24-1" . SPARSER::COLLECTION)
    ("DGCR8 and Dicer" . SPARSER::COLLECTION) ("–1" . SPARSER::PROTEIN)
    ("His" . SPARSER::AMINO-ACID) ("ribozyme" . SPARSER::RNA)
    ("recombinant GST or GST-YB-1 fusion protein" . SPARSER::COLLECTION)
    ("GST-YB-1" . SPARSER::COLLECTION) ("GST" . SPARSER::PROTEIN)
    ("pri- and pre-miR-29b-2" . SPARSER::COLLECTION)
    ("pri-" . SPARSER::PROTEIN) ("Drosha and Dicer" . SPARSER::COLLECTION)
    ("YB-1 and wildtype or mutant" . SPARSER::COLLECTION)
    ("FLAG" . SPARSER::PROTEIN-FAMILY) ("RIP" . SPARSER::PROTEIN)
    ("mature miR-29b-2" . SPARSER::PROTEIN)
    ("miR-29b-2/miR-29c" . SPARSER::COLLECTION)
    ("miR-29b-2" . SPARSER::PROTEIN) ("pri-miR-29b-2" . SPARSER::COLLECTION)
    ("pri" . SPARSER::PROTEIN) ("individual mature miRNA" . SPARSER::PROTEIN)
    ("pri-miR-221" . SPARSER::PROTEIN-PAIR) ("YB-1-" . SPARSER::PROTEIN)
    ("exon–exon" . SPARSER::COLLECTION) ("exon" . SPARSER::PROTEIN)
    ("tdf" . SPARSER::DRUG) ("mismatch" . SPARSER::PROTEIN)
    ("partial" . SPARSER::PROTEIN) ("RNase" . SPARSER::PROTEIN)
    ("Genome-wide mapping" . SPARSER::PROTEIN) ("mapping" . SPARSER::PROTEIN)
    ("mRNP" . SPARSER::BIO-COMPLEX) ("RNP-1 and RNP-2" . SPARSER::COLLECTION)
    ("a central CSD" . SPARSER::PROTEIN) ("proline" . SPARSER::AMINO-ACID)
    ("EMT" . SPARSER::PROTEIN) ("CSD" . SPARSER::PROTEIN)
    ("The mature miRNA" . SPARSER::PROTEIN)
    ("the active RNA-induced silencing complex (RISC)" . SPARSER::BIO-COMPLEX)
    ("complex (RISC)" . SPARSER::BIO-COMPLEX) ("RISC" . SPARSER::PROTEIN)
    ("Argonaute" . SPARSER::PROTEIN-FAMILY) ("Drosha" . SPARSER::PROTEIN)
    ("enzyme" . SPARSER::ENZYME) ("RNaseIII" . SPARSER::PROTEIN)
    ("class" . CLASS) ("Dicer" . SPARSER::PROTEIN)
    ("mature mRNAs" . SPARSER::PROTEIN) ("a major mRNA" . SPARSER::PROTEIN)
    ("1–4" . SPARSER::PROTEIN) ("miR-29c" . SPARSER::PROTEIN)
    ("miR-29" . SPARSER::PROTEIN) ("miR-221" . SPARSER::PROTEIN)
    ("MiR-221" . SPARSER::PROTEIN) ("pre-mRNA" . SPARSER::RNA)
    ("a 20" . SPARSER::PROTEIN) ("Pre-miRNAs" . SPARSER::RNA)
    ("N1" . SPARSER::PROTEIN) ("a 15" . SPARSER::PROTEIN)
    ("YB1" . SPARSER::PROTEIN) ("32 P" . SPARSER::|32P|)
    ("γ-tubulin" . SPARSER::PROTEIN) ("NP-40" . SPARSER::DRUG)
    ("amino acids" . SPARSER::AMINO-ACID) ("pri-miRNA" . SPARSER::RNA)
    ("k11" . SPARSER::PROTEIN) ("polynucleotide kinase" . SPARSER::PROTEIN)
    ("protein A" . SPARSER::PROTEIN) ("RNP-2" . SPARSER::PROTEIN)
    ("RNP-1" . SPARSER::PROTEIN) ("RNA binding" . SPARSER::PROTEIN)
    ("protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pre-miRNAs" . SPARSER::RNA)
    ("DGCR8" . SPARSER::PROTEIN) ("RNA polymerase II" . SPARSER::PROTEIN)
    ("pri-miRNAs" . SPARSER::RNA) ("miR-29b" . SPARSER::MOLECULE)
    ("pre-mRNAs" . SPARSER::RNA) ("YB-1" . SPARSER::PROTEIN)
    ("UBA" . SPARSER::PROTEIN) ("NEMO and masks" . SPARSER::COLLECTION)
    ("masks" . SPARSER::PROTEIN) ("oligomers" . SPARSER::PROTEIN)
    ("Met" . SPARSER::AMINO-ACID) ("NF-κB and type I" . SPARSER::COLLECTION)
    ("TLR2, TLR4, and TLR7/8" . SPARSER::COLLECTION)
    ("A20, CYLD, and IκB" . SPARSER::COLLECTION) ("IKB" . SPARSER::PROTEIN)
    ("DUB" . SPARSER::PROTEIN) ("NEMO and LUBAC" . SPARSER::COLLECTION)
    ("forms" . SPARSER::FORM) ("TRAF" . SPARSER::PROTEIN-FAMILY)
    ("Deubiquitinases" . SPARSER::DEUBIQUITINASE)
    ("IL-6, TNF-α and IL-1β" . SPARSER::COLLECTION) ("VSV" . SPARSER::PROTEIN)
    ("CSK" . SPARSER::PROTEIN) ("Pam" . SPARSER::PROTEIN)
    ("TLR2" . SPARSER::PROTEIN) ("macrophage" . SPARSER::PROTEIN)
    ("ligand" . SPARSER::MOLECULE)
    ("interferon, viral infection, and genotoxic stress xref"
     . SPARSER::COLLECTION)
    ("lysine" . SPARSER::AMINO-ACID) ("NEMO or NEMO" . SPARSER::COLLECTION)
    ("WT NEMO or these NEMO double mutants" . SPARSER::COLLECTION)
    ("NEMO double mutants NEMO (K325/326R) and NEMO (K285/309R)"
     . SPARSER::COLLECTION)
    ("the NEMO (WT) and NEMO (K285/309R)" . SPARSER::COLLECTION)
    ("NEMO (WT)" . SPARSER::PROTEIN)
    ("almost abrogated using NEMO K325R and K326R mutants" . SPARSER::MUTANT)
    ("weak polyubiquitination" . SPARSER::PROTEIN)
    ("arginine" . SPARSER::AMINO-ACID)
    ("MyD88, TAK1-TAB1, and IKKβ" . SPARSER::COLLECTION)
    ("luc" . SPARSER::PROTEIN)
    ("both USP18 (C64S) and USP18 (C64S H318A) mutants" . SPARSER::COLLECTION)
    ("USP18 (C64S) and USP18 (C64S H318A) mutants" . SPARSER::COLLECTION)
    ("NEMO and IKKβ" . SPARSER::COLLECTION) ("IsoT" . SPARSER::PROTEIN)
    ("Flag" . SPARSER::PROTEIN-FAMILY) ("state" . SPARSER::BIO-STATE)
    ("neither USP18 (C64S) mutant nor USP18 (C64S H318A) mutant"
     . SPARSER::COLLECTION)
    ("wild type USP18 ( xref ), neither USP18 (C64S) mutant nor USP18 (C64S H318A) mutant"
     . SPARSER::COLLECTION)
    ("alanine" . SPARSER::AMINO-ACID) ("histidine" . SPARSER::AMINO-ACID)
    ("cysteine" . SPARSER::AMINO-ACID) ("K63-" . SPARSER::PROTEIN)
    ("THP-1 derived macrophages" . SPARSER::PROTEIN)
    ("USP18 and NEMO" . SPARSER::COLLECTION)
    ("TAK1 complex and IKK complex" . SPARSER::COLLECTION)
    ("USP18 and TAK1" . SPARSER::COLLECTION)
    ("USP18 and IKKα/β" . SPARSER::COLLECTION)
    ("TAK1, IKKα, or IKKβ" . SPARSER::COLLECTION)
    ("USP18 and IKKβ" . SPARSER::COLLECTION) ("LZ" . SPARSER::PROTEIN)
    ("leucine" . SPARSER::AMINO-ACID) ("KD" . SPARSER::PROTEIN)
    ("mutants" . SPARSER::MUTANT) ("IKKα, IKKβ, or NEMO" . SPARSER::COLLECTION)
    ("IKKα, IKKβ, and NEMO" . SPARSER::COLLECTION)
    ("TAK1-TAB1 complex and the IKK complex" . SPARSER::COLLECTION)
    ("NF-κB-luc" . SPARSER::COLLECTION) ("MAVS, or TBK1" . SPARSER::COLLECTION)
    ("MAVS" . SPARSER::PROTEIN)
    ("MyD88, TRAF2, TRAF6, TAK1-TAB1, IKKα and IKKβ" . SPARSER::COLLECTION)
    ("MyD88, TRAF2, TRAF6, TAK1-TAB1, IKKα, IKKβ, or p65"
     . SPARSER::COLLECTION)
    ("IL-6 and TNF-α" . SPARSER::COLLECTION)
    ("USP18 in THP-1 cells or THP-1-derived macrophages" . SPARSER::COLLECTION)
    ("TNF-α, IL-6, and IL-1β" . SPARSER::COLLECTION) ("JNK" . SPARSER::PROTEIN)
    ("IKK and IκBα" . SPARSER::COLLECTION) ("Myc-USP18" . SPARSER::COLLECTION)
    ("Myc" . SPARSER::PROTEIN)
    ("transfected USP18 and endogenous USP18" . SPARSER::COLLECTION)
    ("EGFP" . SPARSER::PROTEIN) ("LPS" . SPARSER::PROTEIN)
    ("Luciferase" . SPARSER::PROTEIN) ("potential DUBs" . SPARSER::PROTEIN)
    ("ABIN and NEMO" . SPARSER::COLLECTION)
    ("masking" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ABIN" . SPARSER::PROTEIN)
    ("proinflammatory cytokines" . SPARSER::PROTEIN)
    ("THP-1" . SPARSER::PROTEIN)
    ("JAK and the IFN receptor" . SPARSER::COLLECTION)
    ("subunit" . SPARSER::FRAGMENT) ("IFN" . SPARSER::DRUG)
    ("JAK/STAT" . SPARSER::COLLECTION) ("kinase" . SPARSER::KINASE)
    ("STAT" . SPARSER::PROTEIN) ("JAK" . SPARSER::PROTEIN)
    ("CYLD, A20, and USP4" . SPARSER::COLLECTION)
    ("proteasomal" . SPARSER::PROTEIN)
    ("TRAF2, TRAF6, and RIP1" . SPARSER::COLLECTION)
    ("deubiquitinase" . SPARSER::DEUBIQUITINASE) ("CYLD" . SPARSER::PROTEIN)
    ("nearly 100 DUBs" . SPARSER::PROTEIN) ("USP" . SPARSER::PROTEIN)
    ("DUBs" . SPARSER::PROTEIN) ("enzymes" . SPARSER::ENZYME)
    ("TAK1 and IKK" . SPARSER::COLLECTION)
    ("TRAF6 and TRIM8" . SPARSER::COLLECTION)
    ("apoptosis protein (c-IAP1) and the UbcH5 family" . SPARSER::COLLECTION)
    ("c-IAP1" . SPARSER::COLLECTION) ("Lys-" . SPARSER::AMINO-ACID)
    ("TRAFs" . SPARSER::PROTEIN) ("ligases" . SPARSER::LIGASE)
    ("Lys" . SPARSER::AMINO-ACID) ("polyubiquitination" . SPARSER::PROTEIN)
    ("serines" . SPARSER::AMINO-ACID)
    ("the essential regulatory subunit NEMO" . SPARSER::PROTEIN)
    ("kinases (IKK)" . SPARSER::PROTEIN)
    ("IKKα and IKKβ" . SPARSER::COLLECTION)
    ("active TAK1 complex" . SPARSER::BIO-COMPLEX)
    ("MAPK and NF-κB" . SPARSER::COLLECTION) ("MAPK" . SPARSER::PROTEIN)
    ("active" . SPARSER::ACTIVE)
    ("TAK1 and other kinases" . SPARSER::COLLECTION)
    ("TRAF2, TRAF3, TRAF5, or TRAF6" . SPARSER::COLLECTION)
    ("kinases" . SPARSER::KINASE) ("scaffold" . SPARSER::SCAFFOLD)
    ("molecules" . SPARSER::MOLECULE)
    ("RIP1, MyD88, and TRIF" . SPARSER::COLLECTION) ("TRIF" . SPARSER::PROTEIN)
    ("IL" . SPARSER::PROTEIN) ("interleukin" . SPARSER::PROTEIN)
    ("-1" . SPARSER::PROTEIN) ("TAK1 and NEMO" . SPARSER::COLLECTION)
    ("polyubiquitin" . SPARSER::PROTEIN)
    ("TAK1-TAB1 complex and IKKα/β-NEMO complex" . SPARSER::COLLECTION)
    ("NEMO" . SPARSER::PROTEIN)
    ("pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("cytokines" . SPARSER::PROTEIN) ("pro" . SPARSER::AMINO-ACID)
    ("IKK" . SPARSER::PROTEIN)
    ("monocytes and macrophages" . SPARSER::COLLECTION)
    ("monocytes" . SPARSER::PROTEIN) ("ligands" . SPARSER::LIGAND)
    ("interferon" . SPARSER::PROTEIN) ("macrophages" . SPARSER::PROTEIN)
    ("TLR" . SPARSER::PROTEIN-FAMILY)
    ("protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ubiquitin" . SPARSER::PROTEIN)
    ("deubiquitinases" . SPARSER::DEUBIQUITINASE)
    ("a key transcription factor" . SPARSER::PROTEIN)
    ("hIL-6" . SPARSER::PROTEIN) ("reverse transcriptase" . SPARSER::PROTEIN)
    ("serum albumin" . SPARSER::PROTEIN) ("MgCl 2" . SPARSER::MOLECULE)
    ("monoclonal antibody" . SPARSER::DRUG) ("IkBα" . SPARSER::PROTEIN)
    ("anti-ERK" . SPARSER::PROTEIN) ("phospho-ERK" . SPARSER::PROTEIN)
    ("phospho-JNK" . SPARSER::PROTEIN) ("c-Myc" . SPARSER::PROTEIN)
    ("anti-β" . SPARSER::PROTEIN) ("M2" . SPARSER::MOLECULE)
    ("L-glutamine" . SPARSER::MOLECULE) ("Rhbdd3" . SPARSER::PROTEIN)
    ("HO-1" . SPARSER::PROTEIN) ("zinc finger" . SPARSER::PROTEIN)
    ("poly-ubiquitin" . SPARSER::PROTEIN) ("TLR7" . SPARSER::PROTEIN)
    ("TLR4" . SPARSER::PROTEIN) ("USP18 " . SPARSER::PROTEIN)
    ("USP5" . SPARSER::PROTEIN) ("K33" . SPARSER::PROTEIN)
    ("K29" . SPARSER::PROTEIN) ("serine residue" . SPARSER::MOLECULE)
    ("full-length" . SPARSER::PROTEIN) ("TBK1" . SPARSER::PROTEIN)
    ("RIG-I" . SPARSER::PROTEIN) ("IL-6" . SPARSER::PROTEIN)
    ("IFN-α" . SPARSER::PROTEIN) ("IFIT2" . SPARSER::PROTEIN)
    ("ISG-54" . SPARSER::PROTEIN) ("IFIT1" . SPARSER::PROTEIN)
    ("p38" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MAPK kinase" . SPARSER::PROTEIN)
    ("amino acid" . SPARSER::AMINO-ACID) ("JAK1" . SPARSER::PROTEIN)
    ("IFNAR2" . SPARSER::PROTEIN) ("isopeptidase activity" . SPARSER::PROTEIN)
    ("ISG15" . SPARSER::PROTEIN) ("IFN-β" . SPARSER::PROTEIN)
    ("type I" . SPARSER::HUMAN-PROTEIN-FAMILY) ("UBP43" . SPARSER::PROTEIN)
    ("USP4" . SPARSER::PROTEIN) ("ligase activity" . SPARSER::PROTEIN)
    ("A20" . SPARSER::PROTEIN)
    ("negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("TRIM8" . SPARSER::PROTEIN) ("UbcH5" . SPARSER::PROTEIN)
    ("IAP1" . SPARSER::PROTEIN) ("βTrCP" . SPARSER::PROTEIN)
    ("E3" . SPARSER::MOLECULE) ("K11" . SPARSER::PROTEIN)
    ("M1" . SPARSER::MOLECULE) ("IKKγ" . SPARSER::PROTEIN)
    ("IKKβ" . SPARSER::PROTEIN) ("TRAF6" . SPARSER::PROTEIN)
    ("TRAF5" . SPARSER::PROTEIN) ("TRAF3" . SPARSER::PROTEIN)
    ("TRAF2" . SPARSER::PROTEIN) ("MyD88" . SPARSER::PROTEIN)
    ("RIP1" . SPARSER::PROTEIN) ("TNF-α" . SPARSER::PROTEIN)
    ("tumor necrosis factor" . SPARSER::PROTEIN) ("K63" . SPARSER::PROTEIN)
    ("IKKα" . SPARSER::PROTEIN) ("TAK1" . SPARSER::PROTEIN)
    ("IκB" . SPARSER::PROTEIN) ("USP18" . SPARSER::PROTEIN)
    ("Rep" . SPARSER::PROTEIN) ("VEGF" . SPARSER::PROTEIN)
    ("subunits" . SPARSER::FRAGMENT)
    ("a sequence-specific DNA-binding transcription factor" . SPARSER::PROTEIN)
    ("inactive" . SPARSER::INACTIVE)
    ("p65, p50, p52, c-Rel and Rel" . SPARSER::COLLECTION)
    ("Rel" . SPARSER::PROTEIN) ("heterodimers" . SPARSER::HETERODIMER)
    ("RAGE and TLR-4" . SPARSER::COLLECTION) ("MMP" . SPARSER::PROTEIN)
    ("IL-1β and IL-18" . SPARSER::COLLECTION) ("mediators" . SPARSER::PROTEIN)
    ("Yan" . SPARSER::PROTEIN) ("TRAIL" . SPARSER::PROTEIN)
    ("caspase-3 and caspase-9" . SPARSER::COLLECTION)
    ("LNCaP" . SPARSER::PROTEIN) ("PCNA and Cyclin D1" . SPARSER::COLLECTION)
    ("PCNA" . SPARSER::PROTEIN) ("antibody" . SPARSER::ANTIBODY)
    ("Chen" . SPARSER::PROTEIN)
    ("essential growth factors" . SPARSER::GROWTH-FACTOR)
    ("nutrient" . SPARSER::MOLECULE) ("hypoxia" . SPARSER::PROTEIN)
    ("cytokine" . SPARSER::PROTEIN) ("complexes" . SPARSER::BIO-COMPLEX)
    ("nucleoprotein" . SPARSER::PROTEIN) ("component" . SPARSER::COMPONENT)
    ("protein and mRNA" . SPARSER::COLLECTION)
    ("IκBα and VEGF-C" . SPARSER::COLLECTION)
    ("NF-κB/p65" . SPARSER::COLLECTION) ("PI" . SPARSER::PROTEIN)
    ("A2 and A3" . SPARSER::COLLECTION) ("E1 and E2" . SPARSER::COLLECTION)
    ("mRNA and protein" . SPARSER::COLLECTION) ("siRNAs" . SPARSER::PROTEIN)
    ("shRNA" . SPARSER::PROTEIN)
    ("a new potential therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("TLRs" . SPARSER::PROTEIN-FAMILY) ("RAGE" . SPARSER::PROTEIN)
    ("receptor" . SPARSER::RECEPTOR) ("receptors" . SPARSER::RECEPTOR)
    ("chromatin" . SPARSER::BIO-COMPLEX) ("States" . SPARSER::BIO-STATE)
    ("a potential therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("shRNAs" . SPARSER::RNA)
    ("evolutionarily non-histone nuclear protein" . SPARSER::PROTEIN)
    ("variety" . SPARSER::VARIETY) ("a 2 " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RNase A" . SPARSER::PROTEIN) ("Annexin V" . SPARSER::PROTEIN)
    ("ddH 2" . SPARSER::PROTEIN) ("polyvinylidene fluoride" . SPARSER::DRUG)
    ("TG-3" . SPARSER::PROTEIN) ("transcription factor" . SPARSER::PROTEIN)
    ("IκBs" . SPARSER::PROTEIN) ("c-Rel" . SPARSER::PROTEIN)
    ("p52" . SPARSER::PROTEIN) ("p50" . SPARSER::PROTEIN)
    ("matrix metalloproteinase" . SPARSER::PROTEIN)
    ("TLR-4" . SPARSER::PROTEIN) ("ERK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-18" . SPARSER::PROTEIN) ("IL-1β" . SPARSER::PROTEIN)
    ("caspase-1" . SPARSER::PROTEIN) ("CD 95" . SPARSER::PROTEIN)
    ("caspase-8" . SPARSER::PROTEIN) ("caspase-9" . SPARSER::PROTEIN)
    ("c-IAP2" . SPARSER::PROTEIN) ("Cyclin D1" . SPARSER::PROTEIN)
    ("growth factors" . SPARSER::GROWTH-FACTOR)
    ("DNA-binding protein" . SPARSER::PROTEIN) ("VEGF-C" . SPARSER::PROTEIN)
    ("IκBα" . SPARSER::PROTEIN) ("p65" . SPARSER::PROTEIN)
    ("A3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("E2" . SPARSER::MOLECULE)
    ("E1" . SPARSER::MOLECULE) ("A2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("–2" . SPARSER::PROTEIN) ("High mobility group box 1" . SPARSER::PROTEIN)
    ("non-muscle" . SPARSER::PROTEIN) ("NF-κB" . SPARSER::PROTEIN)
    ("HMGB1" . SPARSER::PROTEIN)
    ("high mobility group box 1" . SPARSER::PROTEIN)
    ("a potential clinical therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("PTEN and miR-106b" . SPARSER::COLLECTION)
    ("PTEN/PI3K-AKT" . SPARSER::COLLECTION)
    ("p21 and PTEN" . SPARSER::COLLECTION)
    ("CD133 or sox2" . SPARSER::COLLECTION)
    ("PTEN/PI3K/Akt" . SPARSER::COLLECTION)
    ("CRC and PTEN" . SPARSER::COLLECTION) ("TNM" . SPARSER::MOLECULE)
    ("promoter or inhibitor" . SPARSER::COLLECTION) ("Wang" . SPARSER::PROTEIN)
    ("suppressors" . SPARSER::SUPPRESSOR)
    ("Akt" . SPARSER::HUMAN-PROTEIN-FAMILY) ("siRNA/p21" . SPARSER::COLLECTION)
    ("siRNA" . SPARSER::PROTEIN) ("PI3K/AKT" . SPARSER::COLLECTION)
    ("PTEN/PI3K/AKT" . SPARSER::COLLECTION) ("p21-3" . SPARSER::COLLECTION)
    ("p21- 3" . SPARSER::COLLECTION) ("pLuc-PTEN-mut" . SPARSER::COLLECTION)
    ("mut" . SPARSER::PROTEIN) ("mutant" . SPARSER::MUTANT)
    ("miR-NC" . SPARSER::COLLECTION) ("pLuc-PTEN-3" . SPARSER::COLLECTION)
    ("PTEN-3" . SPARSER::COLLECTION) ("NC" . SPARSER::PROTEIN)
    ("RNA and protein" . SPARSER::COLLECTION)
    ("oligonucleotide" . SPARSER::MOLECULE)
    ("Oct4 and Bmi1" . SPARSER::COLLECTION)
    ("CD133 and Sox2" . SPARSER::COLLECTION)
    ("CD133, Sox2, Oct4 and Bmi1" . SPARSER::COLLECTION)
    ("western blot" . SPARSER::PROTEIN)
    ("genes and proteins" . SPARSER::COLLECTION) ("form" . SPARSER::FORM)
    ("Bcl-2 and Bax" . SPARSER::COLLECTION) ("Bax" . SPARSER::PROTEIN)
    ("cytometry" . SPARSER::PROTEIN) ("ray" . SPARSER::PROTEIN)
    ("a western blot" . SPARSER::PROTEIN) ("blot" . SPARSER::PROTEIN)
    ("foci" . SPARSER::PROTEIN) ("histone" . SPARSER::PROTEIN)
    ("trigger" . SPARSER::PROTEIN) ("fraction" . SPARSER::COMPONENT)
    ("rays" . SPARSER::PROTEIN) ("IGF-FoxO" . SPARSER::PROTEIN-PAIR)
    ("FoxO" . SPARSER::PROTEIN-FAMILY) ("IGF" . SPARSER::PROTEIN)
    ("DNA-PKcs and ATM" . SPARSER::COLLECTION) ("ATM" . SPARSER::PROTEIN)
    ("MicroRNA" . SPARSER::RNA) ("NFkappaB" . SPARSER::PROTEIN)
    ("mRNAs" . SPARSER::PROTEIN) ("family" . SPARSER::PROTEIN-FAMILY)
    ("approximately 50% CRC" . SPARSER::PROTEIN)
    ("radical" . SPARSER::MOLECULE) ("PTEN or p21" . SPARSER::COLLECTION)
    ("p-AKT" . SPARSER::COLLECTION) ("AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTEN and p21" . SPARSER::COLLECTION) ("genes" . SPARSER::GENE)
    ("MiR-106b" . SPARSER::PROTEIN) ("IR" . SPARSER::PROTEIN)
    ("MicroRNAs" . SPARSER::RNA) ("CRC" . SPARSER::PROTEIN)
    ("sox2" . SPARSER::PROTEIN) ("S5" . SPARSER::MOLECULE)
    ("colon cancer" . SPARSER::PROTEIN) ("S4" . SPARSER::PROTEIN-FAMILY)
    ("LY294002" . SPARSER::MOLECULE) ("3D" . SPARSER::PROTEIN-FAMILY)
    ("AKT1" . SPARSER::PROTEIN) ("PI3K" . SPARSER::PROTEIN-FAMILY)
    ("- 3" . SPARSER::PROTEIN) ("P21" . SPARSER::PROTEIN)
    ("S3A" . SPARSER::PROTEIN) ("CDKN1A" . SPARSER::PROTEIN)
    ("G 2 /M" . SPARSER::PROTEIN) ("PI3K-AKT" . SPARSER::COLLECTION)
    ("negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("S2" . SPARSER::MOLECULE) ("Bmi1" . SPARSER::PROTEIN)
    ("Oct4" . SPARSER::PROTEIN) ("1D" . SPARSER::PROTEIN)
    ("caspase-3" . SPARSER::PROTEIN) ("1C" . SPARSER::PROTEIN)
    ("H2AX" . SPARSER::PROTEIN) ("S1B" . SPARSER::PROTEIN)
    (NIL . SPARSER::DRUG) ("hydrogen peroxide" . SPARSER::MOLECULE)
    ("γ-H2AX" . SPARSER::PROTEIN) ("E-cadherin" . SPARSER::PROTEIN)
    ("Tween20" . SPARSER::MOLECULE) ("Texas Red" . SPARSER::DRUG)
    ("Triton X-100" . SPARSER::MOLECULE) ("F12" . SPARSER::PROTEIN)
    ("a 37" . SPARSER::PROTEIN) ("a 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Dual-luciferase" . SPARSER::PROTEIN) ("small nuclear RNA" . SPARSER::RNA)
    ("U6" . SPARSER::PROTEIN) ("CO2" . SPARSER::PROTEIN)
    ("DNA-PKcs" . SPARSER::PROTEIN) ("Bcl-2" . SPARSER::PROTEIN)
    ("U87MG" . SPARSER::PROTEIN) ("K-Ras" . SPARSER::PROTEIN)
    ("let7" . SPARSER::RNA) ("Lin28" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p21" . SPARSER::PROTEIN) ("Sox2" . SPARSER::PROTEIN)
    ("CD133" . SPARSER::PROTEIN) ("SW480" . SPARSER::PROTEIN)
    ("regulator" . SPARSER::REGULATOR) ("AZA" . SPARSER::DRUG)
    ("drug" . SPARSER::DRUG) ("a new miRNA" . SPARSER::PROTEIN)
    ("PTEN" . SPARSER::PROTEIN) ("molecule" . SPARSER::MOLECULE)
    ("tubulin" . SPARSER::PROTEIN) ("drugs" . SPARSER::DRUG)
    ("histological subtypes" . SPARSER::PROTEIN)
    ("subtypes" . SPARSER::PROTEIN) ("mTOR, and p70S6K1" . SPARSER::COLLECTION)
    ("rank" . SPARSER::PROTEIN) ("mTOR/p70S6K1" . SPARSER::COLLECTION)
    ("miR-497 directly target mTOR and p70S6K1" . SPARSER::COLLECTION)
    ("group" . SPARSER::MOLECULE) ("water" . SPARSER::MOLECULE)
    ("mTOR or p70S6K1" . SPARSER::COLLECTION)
    ("miR-497 directly targets mTOR and p70S6K1" . SPARSER::COLLECTION)
    ("inhibitors" . SPARSER::INHIBITOR) ("antisense" . SPARSER::PROTEIN)
    ("target" . SPARSER::TARGET-PROTEIN) ("luciferase" . SPARSER::PROTEIN)
    ("Mut" . SPARSER::PROTEIN) ("nucleotide" . SPARSER::NUCLEOTIDE)
    ("possible mRNA" . SPARSER::PROTEIN) ("doxycycline" . SPARSER::DRUG)
    ("Doxycycline" . SPARSER::DRUG) ("ON" . SPARSER::PROTEIN)
    ("MTT" . SPARSER::MOLECULE)
    ("anti-miR-497 inhibitor or a control inhibitor (anti-miR-NS)"
     . SPARSER::COLLECTION)
    ("inhibitor" . SPARSER::INHIBITOR) ("reagent" . SPARSER::MOLECULE)
    ("dC" . SPARSER::MOLECULE) ("Aza" . SPARSER::DRUG)
    ("MSP" . SPARSER::PROTEIN) ("CpG" . SPARSER::PROTEIN)
    ("DNA" . SPARSER::DNA) ("platinum" . SPARSER::MOLECULE)
    ("Differentially" . SPARSER::PROTEIN) ("mature miRNAs" . SPARSER::PROTEIN)
    ("the crucial miRNAs" . SPARSER::PROTEIN)
    ("suppressor" . SPARSER::SUPPRESSOR) ("MiR" . SPARSER::PROTEIN)
    ("targets or chemoresistant" . SPARSER::COLLECTION)
    ("modulators" . SPARSER::PROTEIN) ("miRNAs" . SPARSER::PROTEIN)
    ("miRNA" . SPARSER::PROTEIN) ("targets" . SPARSER::TARGET-PROTEIN)
    ("protein" . SPARSER::PROTEIN) ("complex" . SPARSER::BIO-COMPLEX)
    ("RNA" . SPARSER::RNA) ("mRNA" . SPARSER::PROTEIN)
    ("homology" . SPARSER::PROTEIN) ("nucleotides" . SPARSER::NUCLEOTIDE)
    ("RNAs" . SPARSER::RNA) ("MiRNAs" . SPARSER::PROTEIN)
    ("Cisplatin" . SPARSER::DRUG) ("Tet" . SPARSER::PROTEIN)
    ("mTOR and p70S6K1" . SPARSER::COLLECTION) ("types" . TYPE)
    ("proteins" . SPARSER::PROTEIN) ("gene" . SPARSER::GENE)
    ("mTOR" . SPARSER::PROTEIN) ("promoter" . SPARSER::PROMOTER)
    ("miR" . SPARSER::PROTEIN) ("cisplatin" . SPARSER::DRUG)
    ("β-gal" . SPARSER::PROTEIN) ("β-galactosidase" . SPARSER::PROTEIN)
    ("-3" . SPARSER::PROTEIN) ("hsa-Let-7" . SPARSER::RNA)
    ("pre-miRNA" . SPARSER::RNA) ("G418" . SPARSER::MOLECULE)
    ("-2" . SPARSER::PROTEIN) ("β-actin" . SPARSER::PROTEIN)
    ("CO 2" . SPARSER::PROTEIN) ("TUBB3" . SPARSER::PROTEIN)
    ("MiR-200c" . SPARSER::MOLECULE) ("anti-" . SPARSER::ANTIBODY)
    ("let-7" . SPARSER::RNA) ("tumor suppressor gene" . SPARSER::PROTEIN)
    ("BCL-2" . SPARSER::PROTEIN) ("CDK4" . SPARSER::PROTEIN)
    ("CDK6" . SPARSER::PROTEIN) ("CDC25A" . SPARSER::PROTEIN)
    ("CCND1" . SPARSER::PROTEIN) ("IGF-1R" . SPARSER::PROTEIN)
    ("p70S6K1" . SPARSER::PROTEIN)))